Citrus Sinensis ID: 006244
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 654 | 2.2.26 [Sep-21-2011] | |||||||
| Q9CAV6 | 700 | Serine/threonine-protein | yes | no | 0.784 | 0.732 | 0.557 | 1e-169 | |
| Q0D598 | 704 | Probable serine/threonine | yes | no | 0.917 | 0.852 | 0.487 | 1e-160 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.917 | 0.852 | 0.485 | 1e-160 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.660 | 0.760 | 0.584 | 1e-150 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.587 | 0.780 | 0.632 | 1e-143 | |
| Q65X23 | 621 | Probable serine/threonine | no | no | 0.532 | 0.560 | 0.560 | 1e-113 | |
| Q9STK6 | 516 | Probable serine/threonine | no | no | 0.467 | 0.593 | 0.558 | 1e-107 | |
| Q0D847 | 601 | Probable serine/threonine | no | no | 0.634 | 0.690 | 0.480 | 1e-104 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.547 | 0.631 | 0.493 | 1e-99 | |
| Q9SCU5 | 549 | Probable serine/threonine | no | no | 0.504 | 0.601 | 0.512 | 2e-98 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 594 bits (1532), Expect = e-169, Method: Compositional matrix adjust.
Identities = 332/596 (55%), Positives = 401/596 (67%), Gaps = 83/596 (13%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTE+FTSGTLRQYRL+H+RVNIRA+KHWCRQIL GL YLHS D
Sbjct: 86 MKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHD 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNEL
Sbjct: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV+SGKKP+AL+KV+DPEV+ FIEKCLAT
Sbjct: 206 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLAT 265
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLY-------------- 226
VS R+SARELL DPFL+IDD + DLR + + D + PL RQ +
Sbjct: 266 VSLRVSARELLDDPFLRIDDGEFDLRSVDME---DSVGPLYRQPHHLPDYYNYPSNSSSL 322
Query: 227 ------GIYHSNSSSNN---GCGHYIGYDTENGLDYHPHEFQESE-IDLFTC------QE 270
G Y SNSSS N G+ ++ +NG Y+P E +E+ I+LF +E
Sbjct: 323 NRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETEETHGIELFESRNNDDQEE 382
Query: 271 DEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELD 330
++ N DI+IKGKRR+D G+FLRLRIADKEGR+RNIYFPFDI+TDTALSVATEMV+ELD
Sbjct: 383 EKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFDIETDTALSVATEMVAELD 442
Query: 331 ITDQDVTKIAEIIDSEIASLVPEWKRGMAMEE------SPHRSSFCHNCASN----GCLP 380
+ D VTKIA +ID EI+SLVP W+ G EE + + +S C+NC SN G +
Sbjct: 443 MDDHGVTKIANMIDGEISSLVPSWRPGPEFEECLAAAAAANAASICNNCVSNRTSMGSVM 502
Query: 381 DYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQCAPEGADQAASPQSAVVH 440
D++ ++ GA V+QC ++GC HGRFEEIT + V
Sbjct: 503 DFLRTN-PGA---NVIQCCRNGCGETHGRFEEITI-------------------RETEVR 539
Query: 441 YADIWA---QHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAEEKIINMDSQSKCHERNCFS 497
++W Q E + LSS I H + E NM S +E N S
Sbjct: 540 LRELWKLQQQQESRELSS-----IDSGHNHSEEEEEEEVLYEDPENMFSCEAGNEINHIS 594
Query: 498 MNSAMDYGLLDDY--------ENEIRQELRWLKAKYQIQLRELRDQQLGVKYKSSS 545
+ + + + Y EN+++QELRWLKAK QI+LR+++D+QL ++ S
Sbjct: 595 GSGSFSF-MPSKYCDEPSEKTENQVQQELRWLKAKCQIELRDIQDEQLKTRWPESG 649
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 567 bits (1461), Expect = e-160, Method: Compositional matrix adjust.
Identities = 325/667 (48%), Positives = 414/667 (62%), Gaps = 67/667 (10%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVD + RNINF+TEMFTSGTLRQYR KH RVNI AVKHWCRQILSGLLYLHS D
Sbjct: 89 MKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHD 148
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA CVGTPEFMAPEVYEEEYNEL
Sbjct: 149 PPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNEL 208
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMC+LEMVTF+YPYSECTHP QIYKKVISG KPEAL+KV+DP VRQF+EKCLAT
Sbjct: 209 VDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLAT 268
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
S RLSARELL DPFLQ+D DL DY ++ L + L Y + S +NG
Sbjct: 269 ASRRLSARELLKDPFLQVD----DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLS 324
Query: 241 HYIGYD--TENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIA 298
I D TE+ D + + IDLF EDE L N DI+IKG++ ED IFLRLRIA
Sbjct: 325 ESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITIKGRKSEDGSIFLRLRIA 384
Query: 299 DKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGM 358
D +G +RNIYFPFDI+ DTALSVATEMV+ELDITD +VT+IAE+ID E+++LVP+W+ G
Sbjct: 385 DNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGP 444
Query: 359 AMEESPHRSSFCHNCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEIT 414
+EES +++CHNC SN G L Y+ S G + CA +HGRFEEIT
Sbjct: 445 GIEES-QDTTYCHNCGSNVSSCGSLYAYMSSAARGCQ-----------CAELHGRFEEIT 492
Query: 415 YQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQV--LSSQGSRDIHCDEEHKTLNQ 472
+Q +G + + + H D A H + +G RD C
Sbjct: 493 FQANGEQTDLQDSGGSSDDGGGQTQHVKDQEAVHSNGFVQMGRRGPRDQFC--------F 544
Query: 473 SSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLREL 532
SS+ + C R+ YE + + + K+++++ +
Sbjct: 545 SSF----------QEQSCSPRH---------------YEYDTSLQAKGFDMKHEVKMAKY 579
Query: 533 RDQQLGVKYKSSSLTLITDD-----KTRASDDKVSPSSVLPEPESNRPP--QRTIAHRPT 585
+ +++ ++ +L D+ + ++S +K+ S + + + R P +R+ R
Sbjct: 580 KARKMAHLRRAIHPSLDFDNLNGERRMKSSLNKLQ-SFHIGKNHNFRIPTCERSPGARDA 638
Query: 586 KHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYTPL-LPHSLHRATSL 644
+ + + + QR E ++ SP+ M TA+SYYT LP +L R S+
Sbjct: 639 EEDPDIFNLAYHSRHPDPGAQRARHCE-VDAQSSPDLMFTARSYYTGAQLPTNLPRTKSV 697
Query: 645 PVDSVDV 651
+++VD
Sbjct: 698 TLNAVDA 704
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 564 bits (1454), Expect = e-160, Method: Compositional matrix adjust.
Identities = 324/667 (48%), Positives = 413/667 (61%), Gaps = 67/667 (10%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVD + RNINF+TEMFTSGTLRQYR KH RVNI AVKHWCRQILSGLLYLHS D
Sbjct: 89 MKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCRQILSGLLYLHSHD 148
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA CVGTPEFMAPEVYEEEYNEL
Sbjct: 149 PPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEFMAPEVYEEEYNEL 208
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMC+LEMVTF+YPYSECTHP QIYKKVISG KPEAL+KV+DP VRQF+EKCLAT
Sbjct: 209 VDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKDPMVRQFVEKCLAT 268
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
S RLSARELL DPFLQ+D DL DY ++ L + L Y + S +NG
Sbjct: 269 ASRRLSARELLKDPFLQVD----DLVFCPGDGDYSLMNYLRQPYLEHAYSNVSMMSNGLS 324
Query: 241 HYIGYD--TENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIA 298
I D TE+ D + + IDLF EDE L N DI+IKG++ ED IFLRLRIA
Sbjct: 325 ESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITIKGRKSEDGSIFLRLRIA 384
Query: 299 DKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGM 358
D +G +RNIYFPFDI+ DTALSVATEMV+ELDITD +VT+IAE+ID E+++LVP+W+ G
Sbjct: 385 DNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSALVPDWRPGP 444
Query: 359 AMEESPHRSSFCHNCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEIT 414
+EES +++CHNC SN G L Y+ S G + CA +HGRFEEIT
Sbjct: 445 GIEES-QDTTYCHNCGSNVSSCGSLYAYMSSAARGCQ-----------CAELHGRFEEIT 492
Query: 415 YQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQV--LSSQGSRDIHCDEEHKTLNQ 472
+Q +G + + + H D A H + +G D C
Sbjct: 493 FQANGEQTDLQDSGGSSDDGGGQTQHVKDQEAVHSNGFVQMGRRGPPDQFC--------F 544
Query: 473 SSYGAEEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLREL 532
SS+ + C R+ YE + + + K+++++ +
Sbjct: 545 SSF----------QEQSCSPRH---------------YEYDTSLQAKGFDMKHEVKMAKY 579
Query: 533 RDQQLGVKYKSSSLTLITDD-----KTRASDDKVSPSSVLPEPESNRPP--QRTIAHRPT 585
+ +++ ++ +L D+ + ++S +K+ S + + + R P +R+ R
Sbjct: 580 KARKMAHLRRAIHPSLDFDNLNGERRMKSSLNKLQ-SFHIGKNHNFRIPTCERSPGARDA 638
Query: 586 KHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYTPL-LPHSLHRATSL 644
+ + + + QR E ++ SP+ M TA+SYYT LP +L R S+
Sbjct: 639 EEDPDIFNLAYHSRHPDPGAQRARHCE-VDAQSSPDLMFTARSYYTGAQLPTNLPRTKSV 697
Query: 645 PVDSVDV 651
+++VD
Sbjct: 698 TLNAVDA 704
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 534 bits (1375), Expect = e-150, Method: Compositional matrix adjust.
Identities = 276/472 (58%), Positives = 330/472 (69%), Gaps = 40/472 (8%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDT N +INFVTE+FTSGTLRQYRL+HRRVNIRAVK WC+QIL GLLYLHSR
Sbjct: 86 MKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQILKGLLYLHSRS 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRDLKCDNIF+NGNQGEVKIGDLGLAAILRKSHA RCVGTPEFMAPEVY+EEYNEL
Sbjct: 146 PPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRCVGTPEFMAPEVYDEEYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VD+Y+FGMC+LEMVTFDYPYSECTHPAQIYKKV SGKKPEA + V+DPEVR+F+EKCLA
Sbjct: 206 VDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKDPEVREFVEKCLAN 265
Query: 181 VSSRLSARELLTDPFLQIDDYDS-DLRMIQYQTDYDEISPLLRQSLYG--IYHSNSSSNN 237
V+ RL+A ELL DPFLQ D+ D +R I Y YDE LR L +YH S+
Sbjct: 266 VTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYDETGVFLRHPLIDDPLYHDQFESSQ 325
Query: 238 GCGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRI 297
C EIDLF +++H+ DISIKGKR DDGIFLRLRI
Sbjct: 326 IC----------------------EIDLFANDDEDHV---DISIKGKRNGDDGIFLRLRI 360
Query: 298 ADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRG 357
+D EGRIRNIYFPF+ DTA SVA EMVSELDIT+QDV KIAE+ID+EIA+LVP+WK
Sbjct: 361 SDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWKND 420
Query: 358 MAMEESPHR------SSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKD-GCAAIHGRF 410
++ + + FC CASNG + + + S N S+D C+++HGRF
Sbjct: 421 TESSQNVNNNKNNNTAGFCGECASNGYIQETVSSGEKSHHNHHEFDSSEDKSCSSVHGRF 480
Query: 411 EEI-----TYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQG 457
++ +Y DG +Q + + S + A+H+ Q++ +G
Sbjct: 481 ADMWGLRESYSDDGEKQSSRKVRSGRWSENEMRRELRWLKARHKIQLMKMRG 532
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1307), Expect = e-143, Method: Compositional matrix adjust.
Identities = 272/430 (63%), Positives = 318/430 (73%), Gaps = 46/430 (10%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFY SWVDT NRNINFVTEMFTSGTLRQYRLKH+RVNIRAVK+WCRQIL GL YLH+ D
Sbjct: 87 MKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L+ SHAA CVGTPEFMAPEVY+EEYN+L
Sbjct: 147 PPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQL 206
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMC+LEMVTFDYPYSEC+HPAQIYK+VISGKKP+ L KV+DPEVR FIEKCLAT
Sbjct: 207 VDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLAT 266
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY-DEISPLLRQSLYGIYHSNSSSNNGC 239
VS RLSA ELL D FL ID +SD+R ++ + DE LR S + ++SN
Sbjct: 267 VSLRLSACELLDDHFLCID--ESDMRRVESEKGLIDEAGTPLRHSYHIPHYSN------- 317
Query: 240 GHYIGYDTENGLDYHPHEFQES-EIDLFTCQE-------DEHLTNFDISIKGKRRED-DG 290
G+Y Y+ +N DY+ E ES EIDL Q D+ + DISIKGKRR++ DG
Sbjct: 318 GYYSLYN-QNQWDYNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDG 376
Query: 291 IFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 350
+FLRL+ +KEG +RNIYFPFDI+TDTA+SVA EMV EL++ D+DVTKIA +ID EIASL
Sbjct: 377 LFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASL 436
Query: 351 VPEWKRGMAMEESPHRSSFC---HNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIH 407
VP W S FC N +S G + D+ +QC +DGC H
Sbjct: 437 VPNW------------SIFCSSESNRSSVGSVMDF-----------NEMQCGRDGCEEKH 473
Query: 408 GRFEEITYQV 417
GRFEEIT+++
Sbjct: 474 GRFEEITFEI 483
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1050), Expect = e-113, Method: Compositional matrix adjust.
Identities = 204/364 (56%), Positives = 266/364 (73%), Gaps = 16/364 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+KFY SW+D N NINF+TE+FTSGTLRQYR+KH++V++RA+K W RQILSGL+YLHS D
Sbjct: 90 IKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALKKWSRQILSGLVYLHSHD 149
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNE 119
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA IL + +A +GTPEFMAPE+Y+EEYNE
Sbjct: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARSAHSIIGTPEFMAPELYDEEYNE 209
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
LVDIY+FGMC+LE+VTF+YPY EC++ AQIYKKV G+KP +L K+EDPEVR FIEKC+A
Sbjct: 210 LVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGEKPSSLAKIEDPEVRFFIEKCIA 269
Query: 180 TVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGC 239
S RLSA+ELL DPFL+ DD + +Q T + + S+ Y ++SS
Sbjct: 270 KASQRLSAQELLMDPFLR-DDGEKIFYPLQSNTKASDGAGSSNSSMGYKYDRDASSMAIR 328
Query: 240 GHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIAD 299
H + E+ D + H + + + I+++ + ++ + IFL+LRIAD
Sbjct: 329 EHTGSFAEEHPSDRYIH----------STMDPQAAAGRIITVESQMKDLNTIFLKLRIAD 378
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMA 359
G +NI+FPFDI+ DT++SVATEMV +LD+TDQDVT IAE+ID+EI + +P+W A
Sbjct: 379 STGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAEMIDAEIRAHIPDW----A 434
Query: 360 MEES 363
+EES
Sbjct: 435 LEES 438
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (996), Expect = e-107, Method: Compositional matrix adjust.
Identities = 199/356 (55%), Positives = 254/356 (71%), Gaps = 50/356 (14%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+KFYTSW+D + IN +TE+FTSG LRQYR KH+ V++RA+K W RQIL GL+YLHS D
Sbjct: 84 IKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHD 143
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNE 119
PPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ +A V GTPEFMAPE+YEE+YN
Sbjct: 144 PPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNV 203
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
LVDIY+FGMC+LE+VTF+YPYSECT+ AQIY+KV SG KP AL V DP+VR FIEKC+A
Sbjct: 204 LVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIA 263
Query: 180 TVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGC 239
VS RLSA+ELL DPFL+ Y+ + + +S S NG
Sbjct: 264 KVSQRLSAKELLDDPFLKC-----------YKENTENVS--------------SHKENG- 297
Query: 240 GHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIAD 299
Y G NG+ + +SE+ L T ++G+R++ + IFL+LRI D
Sbjct: 298 --YNG----NGI---VDKLSDSEVGLLT-------------VEGQRKDLNTIFLKLRITD 335
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDIT-DQDVTKIAEIIDSEIASLVPEW 354
+G+IRNI+FPF+I+TDT+ SVA EMV ELD+T DQD++ IA++ID+EI S +P+W
Sbjct: 336 SKGQIRNIHFPFNIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDW 391
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D847|WNK3_ORYSJ Probable serine/threonine-protein kinase WNK3 OS=Oryza sativa subsp. japonica GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 380 bits (977), Expect = e-104, Method: Compositional matrix adjust.
Identities = 225/468 (48%), Positives = 286/468 (61%), Gaps = 53/468 (11%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ + WVD R +NFVTE+F SGTLRQYR +HRRV+ AV+ WC QIL GL YLH+
Sbjct: 96 VRLHAYWVDAPRRALNFVTELFVSGTLRQYRERHRRVSAAAVRRWCAQILDGLAYLHAHS 155
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRDLKCDNIFVNGNQGEVKIGDLGLAA R ARCVGTPEFMAPEVY+E Y+EL
Sbjct: 156 PPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAFRRGGGHARCVGTPEFMAPEVYDESYDEL 215
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
D+YSFGMC+LEMVT DYPYSEC++P QIYK+VISG KP AL++V DP VRQFIE+CLA
Sbjct: 216 ADVYSFGMCVLEMVTLDYPYSECSNPIQIYKRVISGIKPAALYRVSDPVVRQFIERCLAP 275
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTD-------YDEISPLLRQ---------- 223
+ R +ARELL DPFL + D Y+ + L Q
Sbjct: 276 AARRPAARELLDDPFLLPLEDDGFFSGDGGDGHGGFGVGYYNLMYNYLHQPACIDDHHAC 335
Query: 224 SLYGIYHSNSSSNNGCGHYIGYDTENG----LDYHPHEFQESEIDLFTCQEDEHLTNFDI 279
S G+ SNS +N + ++G D H F E + D +E + DI
Sbjct: 336 SNGGLSPSNSVGDNDVDAAVQRGDDDGDNWLRDIH-MLFDEDDDDAAAADANERVGGVDI 394
Query: 280 SIKGKRREDDGIFLRLRIADKE--GRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVT 337
+IKG+R +D G++L LRIADK GR R I F FD + DTA++VA EMV+ELDITD +VT
Sbjct: 395 TIKGRRTDDGGVYLGLRIADKNGTGRGRIICFRFDTEADTAMTVAAEMVAELDITDHEVT 454
Query: 338 KIAEIIDSEIASLVPEWKRGMAMEESPHRSSF----------------CHNCASN----- 376
+IA++ID ++A+LVP W+ G A ++ C NC
Sbjct: 455 RIAQLIDGKVAALVPGWRPGPATDDDDDDDLVGGGDDPDAPGGAAAACCKNCRPAASSSS 514
Query: 377 --GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVDGAEQ 422
G L D++ S + ++ C + CA +HGRFEEIT+Q D E+
Sbjct: 515 SCGSLVDFMSSAAAAERH----GCRR--CAELHGRFEEITFQADDDEE 556
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 181/367 (49%), Positives = 247/367 (67%), Gaps = 9/367 (2%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++FY SW+D N+ +N +TE+FTSG+LR YR KHR+VN++AVK+W RQIL GL YLH ++
Sbjct: 90 IRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQE 149
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL
Sbjct: 150 PPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNEL 209
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
DIYSFGMC+LEMVTFDYPY EC + AQIYKKV SG KP +L +V+DPEV+QFIEKCL
Sbjct: 210 ADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLP 269
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYG--IYHSNSSSNNG 238
S RLSA+ELL DPFLQ++ L M D + P ++ +G S
Sbjct: 270 ASERLSAKELLLDPFLQLN----GLTMNNPLPLPDIVMP--KEGAFGDRCLMSEGPPTTR 323
Query: 239 CGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIA 298
+ D + + F ++ NF + +KG+ ++ + L LRI
Sbjct: 324 PSKTLSIDLDEDSNLPIVTFSDNSGSRCIEVRRAKRGNFFV-LKGEENDEQSVSLILRIV 382
Query: 299 DKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGM 358
D+ GR+RNI+F F + DTA V++EMV +L++TDQ+VT IAE+ID + +++P WK +
Sbjct: 383 DENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFIAELIDILLVNMIPTWKTDV 442
Query: 359 AMEESPH 365
++ H
Sbjct: 443 TVDHLIH 449
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCU5|WNK5_ARATH Probable serine/threonine-protein kinase WNK5 OS=Arabidopsis thaliana GN=WNK5 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 191/373 (51%), Positives = 245/373 (65%), Gaps = 43/373 (11%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+++ TSW+D R NF+TE+FTSGTLR+YR K+++V+IRA+K W RQIL+GL YLH D
Sbjct: 87 IRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNE 119
PPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S A V GTPEFMAPE+YEE+YNE
Sbjct: 147 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNE 206
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
LVDIYSFGMC+LEM+T +YPYSECT+PAQIYKKV SGK P++ ++ E ++F+ KCL
Sbjct: 207 LVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLE 266
Query: 180 TVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGC 239
TVS RL A+ELL DPFL TD +++PL R + N ++N
Sbjct: 267 TVSRRLPAKELLADPFLA-------------ATDERDLAPLFRLP-QQLAIQNLAANGTV 312
Query: 240 GHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGK-RREDDGIFLRLRIA 298
++ T + D+SI GK ED IFL+++I
Sbjct: 313 VEHLPSTT------------------------DPTRTTDMSITGKMNSEDHTIFLQVQIL 348
Query: 299 DKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGM 358
D +G +RNI FPF+I +DT L VA EMV EL+ITD D +IA +I++EI+ LVP W+
Sbjct: 349 DGDGHMRNIQFPFNILSDTPLEVALEMVKELEITDWDPLEIAAMIENEISLLVPNWR--- 405
Query: 359 AMEESPHRSSFCH 371
A + S SF H
Sbjct: 406 ANDSSIRHESFGH 418
|
Regulates flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 654 | ||||||
| 225432654 | 729 | PREDICTED: serine/threonine-protein kina | 0.977 | 0.876 | 0.704 | 0.0 | |
| 255552205 | 732 | conserved hypothetical protein [Ricinus | 0.978 | 0.874 | 0.665 | 0.0 | |
| 449444242 | 740 | PREDICTED: serine/threonine-protein kina | 0.974 | 0.860 | 0.623 | 0.0 | |
| 359487822 | 743 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.858 | 0.614 | 0.0 | |
| 147815157 | 752 | hypothetical protein VITISV_035622 [Viti | 0.975 | 0.848 | 0.615 | 0.0 | |
| 356575845 | 658 | PREDICTED: serine/threonine-protein kina | 0.859 | 0.854 | 0.599 | 0.0 | |
| 351723121 | 652 | with no lysine kinase 2 [Glycine max] gi | 0.857 | 0.860 | 0.598 | 0.0 | |
| 255542364 | 775 | kinase, putative [Ricinus communis] gi|2 | 0.896 | 0.756 | 0.605 | 0.0 | |
| 224125588 | 730 | predicted protein [Populus trichocarpa] | 0.964 | 0.864 | 0.582 | 0.0 | |
| 356535149 | 708 | PREDICTED: serine/threonine-protein kina | 0.925 | 0.854 | 0.571 | 0.0 |
| >gi|225432654|ref|XP_002278361.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 922 bits (2383), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/656 (70%), Positives = 530/656 (80%), Gaps = 17/656 (2%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVD ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL GLLYLH+
Sbjct: 84 MKFYTSWVDPANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILRGLLYLHNHK 143
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEEEYNEL
Sbjct: 144 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNEL 203
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+DPEVRQF+EKCLAT
Sbjct: 204 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVRQFVEKCLAT 263
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
V+ RLSARELL DPFLQ DDY SDLR I+YQ D E+ PL R YGI+HS SS N
Sbjct: 264 VTLRLSARELLKDPFLQSDDYGSDLRPIEYQRDLGEVGPLPRLPHYGIHHSYSSLRNEYS 323
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADK 300
Y ++ ENGLD HP EF+ +EIDLFT QEDEHL N DISI+G++R+D GIFLRLRI+DK
Sbjct: 324 GYPDFEPENGLDCHPVEFERNEIDLFTYQEDEHLENVDISIEGRKRDDHGIFLRLRISDK 383
Query: 301 EGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAM 360
EGR+RNIYFPFD++TDTALSVA EMVSELDITDQDVTKIA++ID EIASLVP WK G+ +
Sbjct: 384 EGRVRNIYFPFDMETDTALSVAMEMVSELDITDQDVTKIADMIDDEIASLVPGWKMGLGI 443
Query: 361 EESP---HRSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV 417
EES H +SFCH+CASNG DY+ + G KNLQVLQCS+ GCAA+HGRFEEITY+V
Sbjct: 444 EESQNYGHDASFCHHCASNGSPLDYVSPNNPGTKNLQVLQCSRQGCAAVHGRFEEITYRV 503
Query: 418 DGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGA 477
+G+EQC EGA S QS + YADIWAQ EG LSS+GSR+I DEEH++L++S YG
Sbjct: 504 EGSEQCVTEGA-PVVSSQSDGMQYADIWAQREGPELSSEGSREIQSDEEHESLDKSIYGK 562
Query: 478 EEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQL 537
+E++IN+D+QS+ + +N F+ LDDYENEIRQELRWLKAKYQ+QLRELRDQQL
Sbjct: 563 DERVINIDNQSESNAKNSFAP--------LDDYENEIRQELRWLKAKYQMQLRELRDQQL 614
Query: 538 GVKYKSSSLTLITDDKTRASDDKVSPSSVLP--EPESNRPPQRTIAHRPTKHLTSCLPIG 595
G K K SLT +D + D+KVSPSS+ E E N PP ++ KH S P+
Sbjct: 615 GAKPKWLSLTPNSDSMEHSRDNKVSPSSLSTPLEGEDNDPPLKSFPC--GKHFNSFFPVD 672
Query: 596 DEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYT-PLLPHSLHRATSLPVDSVD 650
E+ C N+A +R H+ E ++ CSPE MVTAKS++T LLP SLHRATSLPVD+VD
Sbjct: 673 TERGCANLAYRRPHNREPVSESCSPEDMVTAKSFFTGTLLPQSLHRATSLPVDAVD 728
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552205|ref|XP_002517147.1| conserved hypothetical protein [Ricinus communis] gi|223543782|gb|EEF45310.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2246), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/658 (66%), Positives = 506/658 (76%), Gaps = 18/658 (2%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL GLLYLHS +
Sbjct: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILKGLLYLHSHN 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL+KS+AARCVGTPEFMAPEVYEEEYNEL
Sbjct: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILKKSYAARCVGTPEFMAPEVYEEEYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIY+FGMC+LEMVT +YPYSEC HPAQIYKKV+SGKKPEAL+KVEDPEVRQF+EKCLAT
Sbjct: 206 VDIYAFGMCVLEMVTSEYPYSECNHPAQIYKKVVSGKKPEALYKVEDPEVRQFVEKCLAT 265
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFLQIDDY DLR ++YQ D +E+ L+RQ YGI H+N S +
Sbjct: 266 VSRRLSARELLDDPFLQIDDYGYDLRSLEYQGDSNEMGALVRQPFYGINHTNGSLFSSYA 325
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADK 300
HY+GYD EN L YHP F+ SEIDLF+CQEDEHL N DI+I+G+R+ +D IFLRLRIAD+
Sbjct: 326 HYLGYDLENELPYHPVGFEPSEIDLFSCQEDEHLENVDITIQGRRKGNDCIFLRLRIADE 385
Query: 301 EGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAM 360
EG IRNIYFPFDI+TDTALSVA EMVSEL +TDQDV KI ++ID EIASLVPEWKR
Sbjct: 386 EGCIRNIYFPFDIETDTALSVAAEMVSELGMTDQDVLKITDMIDGEIASLVPEWKRRHGK 445
Query: 361 EESPHRS--SFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVD 418
EESPH + +FC NCA L D++ S+ SG KNL VL+CSK GCA IHGRFEEITYQV+
Sbjct: 446 EESPHEANDTFCQNCAPVDYLLDHVSSNNSGVKNLHVLECSKHGCANIHGRFEEITYQVE 505
Query: 419 GAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAE 478
G E+CA +S QS + + DIWAQ E LSSQGS+D+HCDE H +++QS E
Sbjct: 506 GPEKCATMDCVPVSSSQSNGISFTDIWAQREAPDLSSQGSKDVHCDERHNSVDQSVTEKE 565
Query: 479 EKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQLG 538
E+IINM S + RN + + DDYENEIRQELRWLKAKYQ+QLRELRDQQL
Sbjct: 566 ERIINMVSVCESKRRNSVCSSPSTACAHWDDYENEIRQELRWLKAKYQMQLRELRDQQLQ 625
Query: 539 VKYKSSSLTLITDDKTR----ASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPI 594
TLI D + D+ VS S+LP+ + ++ + K + +
Sbjct: 626 --------TLILDPSSNKLGYKKDNGVSLPSILPKVKRDKYKPILESLPSGKQFNTDIST 677
Query: 595 GDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYT-PLLPHSLHRATSLPVDSVDV 651
+K CGN Q +FE +N CSPEQMVTAK++YT LLP+ LHRATSLPVD++DV
Sbjct: 678 DADKNCGNSEYQ---NFEAINKGCSPEQMVTAKNFYTGALLPYPLHRATSLPVDALDV 732
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444242|ref|XP_004139884.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] gi|449492629|ref|XP_004159053.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2005), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/664 (62%), Positives = 495/664 (74%), Gaps = 27/664 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFY+SWVD ANRNINFVTEMFTSGTLRQYRLKH++VNIRAVKHWCRQIL GLLYLHS D
Sbjct: 89 MKFYSSWVDIANRNINFVTEMFTSGTLRQYRLKHKKVNIRAVKHWCRQILKGLLYLHSHD 148
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS+ ARCVGTPEFMAPE+YEEEYNEL
Sbjct: 149 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSYVARCVGTPEFMAPEIYEEEYNEL 208
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+D EVR F+EKCLAT
Sbjct: 209 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDLEVRCFVEKCLAT 268
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEI-SPLLRQS-LYGIYHSNSSSNNG 238
VS+RLSARELL DPFLQID DS LR I Y ++YDE+ + L+R YG H +NG
Sbjct: 269 VSTRLSARELLNDPFLQIDGCDSLLRPIDYYSEYDEVNNSLIRGGPFYGTSH--GPLDNG 326
Query: 239 CGHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIA 298
+Y ++ NGLDY P + + SEIDLF+CQEDEHL + DI+IKG+RR+DD IFLRLRI
Sbjct: 327 YANYFSHEAGNGLDYCPIDNEASEIDLFSCQEDEHLEDVDITIKGRRRDDDDIFLRLRIV 386
Query: 299 DKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGM 358
DKEGRIRNIYFPFD++ D+A SVA EMVSELDITDQDV KIA++ID EIA+LVPEWK+G
Sbjct: 387 DKEGRIRNIYFPFDLENDSASSVANEMVSELDITDQDVKKIADMIDGEIATLVPEWKKGK 446
Query: 359 AMEESPH--RSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKD-GCAAIHGRFEEITY 415
++EE+P+ S+ CHNC+ N L DY+ KNL +LQCS++ GCA+IHGRFEEITY
Sbjct: 447 SLEETPNCSDSNVCHNCSLNSSLLDYVSPHNLAKKNLHILQCSEEHGCASIHGRFEEITY 506
Query: 416 QVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSY 475
QV+G+EQ + + S+ +HYADIWAQ +G + S S + C+E + Q
Sbjct: 507 QVEGSEQFNGDENLHRTTGNSSDIHYADIWAQRDGPDVVSPESLEA-CNEFGAS-EQPKL 564
Query: 476 GAEEKIINMDSQSKCHE-RNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRD 534
EE +NMD E + S +S +DD+ENEIRQELRWLKAKYQ+QLRELRD
Sbjct: 565 EKEESNVNMDDNDHQMEFQTRNSSSSNPSESFVDDHENEIRQELRWLKAKYQMQLRELRD 624
Query: 535 QQLGVKYKSSSL---TLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTSC 591
QQLGVK KS SL + +T+ AS +SP+ E N+ Q +++ K++TS
Sbjct: 625 QQLGVKTKSLSLHPISNLTETDNGASVSYLSPN--FNEAAKNKTVQTSLSF--GKNITSH 680
Query: 592 LPIGDEKKCGNVANQRVHSFEQMNWPC----SPEQMVTAKSYYT-PLLPHSLHRATSLPV 646
P N+ + +F+ N SPE +VTAKS+YT L PHSL RATSLPV
Sbjct: 681 SPY---VAADNILENK--TFQDNNVIVDELSSPELIVTAKSFYTGALFPHSLQRATSLPV 735
Query: 647 DSVD 650
D++D
Sbjct: 736 DAID 739
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487822|ref|XP_003633655.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/670 (61%), Positives = 483/670 (72%), Gaps = 32/670 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTEMFTSGTLRQYR KH+RVNIRAVKHWCRQIL GLLYLHS D
Sbjct: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRQKHKRVNIRAVKHWCRQILRGLLYLHSHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEEEYNEL
Sbjct: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNEL 206
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+DPEVR+F+EKCLA+
Sbjct: 207 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVREFVEKCLAS 266
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFL+IDD +SDLR I+ + + D++ PLLRQ +HSN+S +NG
Sbjct: 267 VSLRLSARELLQDPFLRIDDCESDLRPIECRREPDDMVPLLRQPFLEYHHSNNSFSNGYS 326
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADK 300
+ + +D NG Y P E + + I+LF EDEH N DISIKGKRREDDGIFLRLRIADK
Sbjct: 327 NAVDFDAHNGWGYQPLEMEPTGIELFEYHEDEHPANVDISIKGKRREDDGIFLRLRIADK 386
Query: 301 EGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAM 360
E IRNIYFPFDI+ DTALSVATEMV+ELDITDQDVTKIA++ID EIASLVPEWK G +
Sbjct: 387 EDHIRNIYFPFDIEMDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWKPGPGI 446
Query: 361 EESPHRSS--FCHNCA----SNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEIT 414
EE+P ++ CHNC SNG L D IL++ GAKNLQ+ QCS +GCAA+HGRFEEIT
Sbjct: 447 EETPCFATLNLCHNCVSNHTSNGSLMD-ILANNPGAKNLQIFQCS-NGCAAMHGRFEEIT 504
Query: 415 YQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQS- 473
YQVDGA+ PEG QS +H +IW +HE + LSS S + DEE++ +N S
Sbjct: 505 YQVDGADHHIPEG-------QSEELHCTEIWDKHESRELSSVSSGESPSDEEYEKINHSI 557
Query: 474 -----SYGAEEKIINMDSQSKCHERNCFSMNSAMDY--GLLDDYENEIRQELRWLKAKYQ 526
G + + S H RN S ++ L DDYENEI+Q LRWLKAK+Q
Sbjct: 558 IKDERGSGTGNVVASNVKNSISHLRNPSSSSAIPSMSCALSDDYENEIQQVLRWLKAKHQ 617
Query: 527 IQLRELRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTK 586
+++R LRD QLG K SSL D++ D++ S++ + + + K
Sbjct: 618 MEMRGLRDLQLGFASKPSSL----DNRQLKPDNEGLFSTLSNTSQGHNNGLFLKSSAYDK 673
Query: 587 HLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQM---VTAKSYYTP--LLPHSLHRA 641
H TS K ++ + E S E M VTAKS+YT LLP +HR
Sbjct: 674 HFTSNCATQVNKCSPDLVTHGARNCEANKGSRSAEDMVHVVTAKSFYTAGSLLPCPIHRT 733
Query: 642 TSLPVDSVDV 651
SLPVD+VD+
Sbjct: 734 MSLPVDAVDI 743
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815157|emb|CAN72330.1| hypothetical protein VITISV_035622 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/669 (61%), Positives = 483/669 (72%), Gaps = 31/669 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTEMFTSGTLRQYR KH+RVNIRAVKHWCRQIL GLLYLHS D
Sbjct: 97 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRQKHKRVNIRAVKHWCRQILRGLLYLHSHD 156
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEEEYNEL
Sbjct: 157 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEEYNEL 216
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVISGKKP+AL+KV+DPEVR+F+EKCLA+
Sbjct: 217 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGKKPDALYKVKDPEVREFVEKCLAS 276
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFL+IDD +SDLR I+ + + D++ PLLRQ +HSN+S +NG
Sbjct: 277 VSLRLSARELLQDPFLRIDDCESDLRPIECRREPDDMVPLLRQPFLEYHHSNNSFSNGYS 336
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADK 300
+ + +D NG Y P E + + I+LF EDEH N DISIKGKRREDDGIFLRLRIADK
Sbjct: 337 NAVDFDAHNGWGYQPLEMEPTGIELFEYHEDEHPANVDISIKGKRREDDGIFLRLRIADK 396
Query: 301 EGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAM 360
E IRNIYFPFDI+ DTALSVATEMV+ELDITDQDVTKIA++ID EIASLVPEWK G +
Sbjct: 397 EDHIRNIYFPFDIEMDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWKPGPGI 456
Query: 361 EESPHRSS--FCHNCA----SNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEIT 414
EE+P ++ CHNC SNG L D IL++ GAKNLQ+ QCS +GCAA+HGRFEEIT
Sbjct: 457 EETPCFATLNLCHNCVSNHTSNGSLMD-ILANNPGAKNLQIFQCS-NGCAAMHGRFEEIT 514
Query: 415 YQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSS 474
YQVDGA+ PEG QS +H +IW +HE + LSS S + DEE++ +N S
Sbjct: 515 YQVDGADHHIPEG-------QSEELHCTEIWYKHESRELSSVSSGESPSDEEYEKINHSI 567
Query: 475 YGAEE-----KIINMDSQSKCHERNCFSMNSAMDY--GLLDDYENEIRQELRWLKAKYQI 527
E + + S H RN S ++ L DDYENEI+Q LRWLKAK+Q+
Sbjct: 568 IKDERGSGTGNVASNVKNSISHLRNPSSSSAIPSMSCALSDDYENEIQQVLRWLKAKHQM 627
Query: 528 QLRELRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKH 587
++R LRD QLG K SSL D++ D++ S++ + + + KH
Sbjct: 628 EMRGLRDLQLGFASKPSSL----DNRQLKPDNEGLFSTLSNTSQGHNNGLFLKSSAYDKH 683
Query: 588 LTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQM---VTAKSYYTP--LLPHSLHRAT 642
TS K ++ + E S E M VTAKS+YT LLP +HR
Sbjct: 684 FTSNCATQVNKCSPDLVTHGARNCEANKGSRSAEDMVHVVTAKSFYTAGSLLPCPIHRTM 743
Query: 643 SLPVDSVDV 651
SLPVD+VD+
Sbjct: 744 SLPVDAVDI 752
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575845|ref|XP_003556047.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/662 (59%), Positives = 462/662 (69%), Gaps = 100/662 (15%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MK YTSWVDTANR+INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQIL GLLYLHS D
Sbjct: 86 MKLYTSWVDTANRHINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILEGLLYLHSHD 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAILRKS+AARCVGTPEFMAPEVYEE+YNEL
Sbjct: 146 PPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSNAARCVGTPEFMAPEVYEEDYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSEC HPAQIYKKV+SGKKPEAL+KV++PEVRQF+EKCLAT
Sbjct: 206 VDIYSFGMCILEMVTFEYPYSECNHPAQIYKKVVSGKKPEALYKVDNPEVRQFVEKCLAT 265
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFLQIDDY D +++QYQ D E++PL+RQ + GI N++ +G
Sbjct: 266 VSLRLSARELLEDPFLQIDDYGFDSKVLQYQRDCYEVTPLIRQPVNGICIINNNLMSGDT 325
Query: 241 HYI-GYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIAD 299
I GY + LDYH +F+ +EI LF C+ED++L D +IKG RREDDGIFLRLRIAD
Sbjct: 326 DNIGGYGPVSELDYHQDDFEATEIGLFDCEEDDNLAEVDTTIKG-RREDDGIFLRLRIAD 384
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMA 359
KEGRIRNIYFPFDI+TDTALSVA EMV+ELDI DQDVT +A +ID+EIA LVPEWK G
Sbjct: 385 KEGRIRNIYFPFDIETDTALSVANEMVAELDINDQDVTNLASMIDNEIARLVPEWKTGPR 444
Query: 360 MEESPH--RSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV 417
+EE +S C NCA+NG L DY+ S+ KNLQ L CSK GCAA+HGRFEEITYQV
Sbjct: 445 IEEKSECSSASVCLNCAANGSLFDYVSSNNPCGKNLQFLHCSKTGCAAVHGRFEEITYQV 504
Query: 418 DGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGA 477
+G+E A E H+ N S+
Sbjct: 505 EGSENSAREA---------------------------------------HEASNSSNIKE 525
Query: 478 EEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQL 537
+ K +N+D QS + + S N A + L DYENEIRQELRWLKAKYQ+QLRELRDQQL
Sbjct: 526 DRKTVNVDEQSDLNTKKS-SSNPAPNCVFL-DYENEIRQELRWLKAKYQMQLRELRDQQL 583
Query: 538 GVKYKSSSLTL-------ITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRPTKHLTS 590
G K K +S++ + D R SD +P+ + ++N+P RTI
Sbjct: 584 GRKPKFTSISPDPEKLEHLKDGILRLSD---TPNLKI---QNNKPLLRTI---------- 627
Query: 591 CLPIGDEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYTP-LLPHSLHRATSLPVDSV 649
QM+TA+ ++T LLPHSL RATSLPVD+V
Sbjct: 628 -------------------------------QMITARDFFTGVLLPHSLQRATSLPVDAV 656
Query: 650 DV 651
DV
Sbjct: 657 DV 658
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351723121|ref|NP_001235988.1| with no lysine kinase 2 [Glycine max] gi|225348633|gb|ACN87278.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1882), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/657 (59%), Positives = 457/657 (69%), Gaps = 96/657 (14%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDT NR+INFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQIL GLLYLHS D
Sbjct: 86 MKFYTSWVDTTNRHINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILEGLLYLHSHD 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAILRKS+AARCVGTPEFMAPEVYEE+YNEL
Sbjct: 146 PPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSNAARCVGTPEFMAPEVYEEDYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSEC HPAQIYKKV+SGKKPEAL+KV++ EVRQF+EKCLAT
Sbjct: 206 VDIYSFGMCILEMVTFEYPYSECNHPAQIYKKVVSGKKPEALYKVDNTEVRQFVEKCLAT 265
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFLQI DY D +++QY D E++PL+RQ L GIY N++ +G
Sbjct: 266 VSLRLSARELLDDPFLQIYDYGFDSKVVQYHRDCYEVNPLIRQPLNGIYSINNNLMSGDT 325
Query: 241 HYI-GYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIAD 299
+ GY + LDYH +F+ SEI LF C+ED++L D +IKG RREDDGIFLRLRIAD
Sbjct: 326 DNVGGYGPVSKLDYHRDDFEASEIGLFGCEEDDNLAEVDTTIKG-RREDDGIFLRLRIAD 384
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMA 359
KEGRIRNIYFPFDI+TDTALSVA EMV+ELDI DQDVT +A +ID+EIA+LVPEWK G
Sbjct: 385 KEGRIRNIYFPFDIETDTALSVANEMVAELDINDQDVTNLANMIDNEIATLVPEWKTGPI 444
Query: 360 MEESPH--RSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQV 417
+EE +S C NCA+NG L DY+LS+ KNLQ L CSK GCAA+HGRFEEITYQV
Sbjct: 445 IEEKSECSSASVCLNCAANGYLFDYVLSNNPCGKNLQFLHCSKTGCAAVHGRFEEITYQV 504
Query: 418 DGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGA 477
+G++ A E H+ N S+
Sbjct: 505 EGSKNSAREA---------------------------------------HEASNSSNIKE 525
Query: 478 EEKIINMDSQSKCHERNCFSMNSAMDYGLLDDYENEIRQELRWLKAKYQIQLRELRDQQL 537
+ K IN+D QS + R S N A + L DYENEIRQELRWLKAKYQ+QLRELRDQQL
Sbjct: 526 DGKTINVDEQSDLNTRKP-SSNPAPNCVFL-DYENEIRQELRWLKAKYQMQLRELRDQQL 583
Query: 538 GVKYKSSSLTLITDDKTRASDD--KVSPSSVLPEPESNRPPQRTIAHRPTKHLTSCLPIG 595
G K K +S++ TD D ++S +S L + ++N+P +TI
Sbjct: 584 GGKPKFTSISPDTDKLEHLKDGILRLSDASNL-KIQNNKPLLKTI--------------- 627
Query: 596 DEKKCGNVANQRVHSFEQMNWPCSPEQMVTAKSYYTP-LLPHSLHRATSLPVDSVDV 651
++T LLPHSL RATSLPVD+VDV
Sbjct: 628 --------------------------------DFFTGVLLPHSLQRATSLPVDAVDV 652
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542364|ref|XP_002512245.1| kinase, putative [Ricinus communis] gi|223548206|gb|EEF49697.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1871), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/629 (60%), Positives = 460/629 (73%), Gaps = 43/629 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQIL GLLYLHS D
Sbjct: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILRGLLYLHSHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNEL
Sbjct: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNEL 206
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VD+YSFGMCILEMVTF+YPYSECTHPAQIYKKVISG+KP+AL+KV+DPEVRQF+EKCLAT
Sbjct: 207 VDVYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGRKPDALYKVKDPEVRQFVEKCLAT 266
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFLQ+DD +S+++ I Y ++D + PL+RQ Y + +NG
Sbjct: 267 VSLRLSARELLNDPFLQMDDCESNIKSIDYGEEFDGMGPLIRQPYYEFHDDTYPYSNGYS 326
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADK 300
+ GY+ +N +Y+P EF++S I+LF +DEH N DISIKGKRR+D GIFLRLRIADK
Sbjct: 327 NGYGYEAQNEFEYYPVEFEQSGIELFEHHDDEHSPNLDISIKGKRRDDGGIFLRLRIADK 386
Query: 301 EGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAM 360
+GRIRNIYFPFDI+TDTAL+VATEMV+ELDITDQDVTKIAE+ID EIASLVPEW+RG +
Sbjct: 387 DGRIRNIYFPFDIETDTALTVATEMVAELDITDQDVTKIAEMIDEEIASLVPEWRRGPGI 446
Query: 361 EESPHRS--SFCHNCA----SNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEIT 414
EE+P + + CHNCA SNG L D+I ++ C ++GCA++HGRFEEIT
Sbjct: 447 EETPRFANLTLCHNCASARTSNGSLMDFISNN----------PCCRNGCASMHGRFEEIT 496
Query: 415 YQ-VDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQS 473
+Q D +E E A A S S V Y IWAQHE + ++ GS H DEE++ +QS
Sbjct: 497 FQAADESEHHLTEVAPNALS-HSDCVDYQRIWAQHESREVTPMGSGRSHSDEEYEKFDQS 555
Query: 474 SYGAEEKIINMDSQSKCHERN---------CFSMNSAMDYGLLDDYENEIRQELRWLKAK 524
+E + M++ S+ RN F ++ L D EN+++QELRWLKAK
Sbjct: 556 ISTKDENDVKMENGSQSGSRNSIPYLKGSGSFYRLPSVCSDLQDSNENKMQQELRWLKAK 615
Query: 525 YQIQLRELRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQ--RTIAH 582
YQI+L +LRDQQL +SS+ ++ TD K R + VS S+++ + NR ++ AH
Sbjct: 616 YQIELSKLRDQQLDFASRSST-SINTDCKIR---NGVSSSTIMNSFQENRNEDLLKSFAH 671
Query: 583 ----RPTKHLTSCLPIGDEKKCGNVANQR 607
RP H K C N+ +R
Sbjct: 672 EKLYRPNLHTDV------NKSCPNLDTRR 694
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224125588|ref|XP_002319623.1| predicted protein [Populus trichocarpa] gi|222857999|gb|EEE95546.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1851), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/664 (58%), Positives = 476/664 (71%), Gaps = 33/664 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQIL GLLYLHS D
Sbjct: 87 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILRGLLYLHSHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNEL
Sbjct: 147 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNEL 206
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSECTHP QIYKKVISGKKP+AL+KV+DPEVR F+EKCLAT
Sbjct: 207 VDIYSFGMCILEMVTFEYPYSECTHPVQIYKKVISGKKPDALYKVKDPEVRHFVEKCLAT 266
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFLQID +SDLR++ ++ + D + PL+R + +N+S ++G
Sbjct: 267 VSLRLSARELLNDPFLQIDGCESDLRLLDHRIEVDGLGPLMRPPYLEHHDNNNSYSSGYL 326
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADK 300
+ Y+ +N +YH E + S I+LF DEH N DISIKGKR +D GIFLRLRIADK
Sbjct: 327 NGYDYEAQNEWEYHQVEVELSGIELFEYH-DEHPANVDISIKGKRGDDGGIFLRLRIADK 385
Query: 301 EGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAM 360
EGRIRNIYFPFDI+ DTALSVATEMV+ELDITDQDVTKIA++ID EIASLVPEW+ G +
Sbjct: 386 EGRIRNIYFPFDIENDTALSVATEMVAELDITDQDVTKIADMIDGEIASLVPEWRPGPGI 445
Query: 361 EESP--HRSSFCHNCASNGCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEITYQVD 418
EE+P + CHNCAS S+GS L C GCA++HGRF EI ++VD
Sbjct: 446 EETPCFANQTLCHNCAST------CTSNGSFMDFLSNNPCCSHGCASMHGRFGEIIFEVD 499
Query: 419 GAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQSSYGAE 478
+E EGA + Q +HY +IW Q E + L+ GS DEE++ +QS +
Sbjct: 500 ESEHHLTEGAPNILN-QPDYLHYKEIWGQQESRQLTPIGSGKSQLDEEYENFDQSIPEKD 558
Query: 479 EKIINMDS-----QSKCHERNCFSMN--SAMDYGLLDDYENEIRQELRWLKAKYQIQLRE 531
K M++ +S H S++ +++ L D ENEI+Q+LRWLKAK+Q++LR+
Sbjct: 559 TKDTKMENGIPGGKSFQHFTGSGSLSRLTSLYNDLADSNENEIQQDLRWLKAKHQMELRK 618
Query: 532 LRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSSVLP--EPESNRPPQRTIAHRPTKHLT 589
LRD++LG+ K S+ + + + + VS +S+L + SN +++A + + L
Sbjct: 619 LRDERLGLAVKPST----SRNGEEKTSNVVSSTSMLNSFQEGSNGDLLKSLAKQISHSLH 674
Query: 590 SCLPIGDEKKCGNVAN-QRVHSFEQMNWPCSPEQMVTAKSYYT-PLLPHSLHRATSLPVD 647
+ G +++ QR + + MN P + MV AK+ T P+LPHSLHR TSLPVD
Sbjct: 675 T--------HAGALSDTQRPWNHKVMNQPPRAKDMVNAKNLCTGPMLPHSLHRTTSLPVD 726
Query: 648 SVDV 651
+VDV
Sbjct: 727 AVDV 730
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535149|ref|XP_003536111.1| PREDICTED: serine/threonine-protein kinase WNK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1814), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/669 (57%), Positives = 470/669 (70%), Gaps = 64/669 (9%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH+RVNIRAVKHWCRQILSGLLYLHS D
Sbjct: 86 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKHWCRQILSGLLYLHSHD 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNEL
Sbjct: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTF+YPYSECTHPAQIYKKVISGKKP+AL++V+DPEVRQF+EKCLAT
Sbjct: 206 VDIYSFGMCILEMVTFEYPYSECTHPAQIYKKVISGKKPDALYRVKDPEVRQFVEKCLAT 265
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240
VS RLSARELL DPFLQIDDY+ DLR + + DE PL+RQ + ++ S S+ +N
Sbjct: 266 VSLRLSARELLDDPFLQIDDYEYDLRTVD-NGELDEFGPLMRQPFFDLHRSYSNFSNEYT 324
Query: 241 HYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLT-NFDISIKGKRREDDGIFLRLRIAD 299
+ GY+ + G HP E + S I+LF ++D+ + + DISIKGKR++D GIFLRLRIAD
Sbjct: 325 NGFGYEGDWGP--HPAEIEPSGIELFEYRDDDEPSEDVDISIKGKRKDDGGIFLRLRIAD 382
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMA 359
KEGRIRNIYFPFDI+ DTA+SVATEMV+ELD+TDQDVT+IA++ID EIASLVPEW+ G
Sbjct: 383 KEGRIRNIYFPFDIEMDTAISVATEMVAELDMTDQDVTRIADMIDGEIASLVPEWRPGPG 442
Query: 360 MEESPHRSS--FCHNCASN----GCLPDYILSDGSGAKNLQVLQCSKDGCAAIHGRFEEI 413
++E+P ++ CHNC SN G D+ LS+ KNLQ+L C + GCA++HGRF EI
Sbjct: 443 IDETPRFANQGLCHNCVSNHTSSGSFLDF-LSNNPDNKNLQLLDCCRHGCASMHGRFGEI 501
Query: 414 TYQVDGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGSRDIHCDEEHKTLNQS 473
T+ QS + Y ++W QHE + LS S H DE+++ L++
Sbjct: 502 TF-------------------QSEDLQYQELWNQHESRELSPVESDQSHSDEQYEQLDKP 542
Query: 474 SYGAEE-KIINMDSQSKCHERNCFSMNSAMDYG--------LLDDYENEIRQELRWLKAK 524
++ + + D S + +++ + D+ L DDYE EI++ELRWL+AK
Sbjct: 543 ILAKDKAQDVWEDKFSPNAANSLRNLSGSHDFSTIRSTYCDLEDDYEKEIQKELRWLRAK 602
Query: 525 YQIQLRELRDQQLGVKYKSSSLTLITDDKTRASDDKVSPSSVLPEPESNRPPQRTIAHRP 584
YQ++LR+ +D+Q G S + + R + +SPS E+ + P
Sbjct: 603 YQMELRDHKDRQFGQCSHS------CNSEHRTENGFLSPSLT----ETLKGGNNGTHSHP 652
Query: 585 TKHLTSCLPIGDEKKCGNVANQRVHSFEQMNWPCSP-EQMVTAKSYYT-PLLPHSLHRAT 642
H +S P D ++ N + SP E MVTAKS+YT LLPHSLHR
Sbjct: 653 HVHESS--PNSDTQRAQNCVAIK-----------SPGEGMVTAKSFYTGSLLPHSLHRTV 699
Query: 643 SLPVDSVDV 651
SLPVD+VD+
Sbjct: 700 SLPVDAVDI 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 654 | ||||||
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.336 | 0.314 | 0.847 | 1.1e-160 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.544 | 0.723 | 0.682 | 2.9e-126 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.304 | 0.350 | 0.678 | 4.9e-100 | |
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.301 | 0.381 | 0.722 | 6.7e-100 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.305 | 0.350 | 0.661 | 2.3e-95 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.304 | 0.357 | 0.673 | 4.3e-94 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.311 | 0.371 | 0.669 | 4.3e-94 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.304 | 0.353 | 0.688 | 4.2e-91 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.513 | 0.641 | 0.507 | 1.5e-85 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.307 | 0.640 | 0.617 | 2e-65 |
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 1.1e-160, Sum P(3) = 1.1e-160
Identities = 189/223 (84%), Positives = 204/223 (91%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFYTSWVDTANRNINFVTE+FTSGTLRQYRL+H+RVNIRA+KHWCRQIL GL YLHS D
Sbjct: 86 MKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAMKHWCRQILRGLHYLHSHD 145
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA CVGTPEFMAPEVYEE YNEL
Sbjct: 146 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAHCVGTPEFMAPEVYEEAYNEL 205
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV+SGKKP+AL+KV+DPEV+ FIEKCLAT
Sbjct: 206 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPDALYKVKDPEVKCFIEKCLAT 265
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQ 223
VS R+SARELL DPFL+IDD + DLR + + D + PL RQ
Sbjct: 266 VSLRVSARELLDDPFLRIDDGEFDLRSVDME---DSVGPLYRQ 305
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 258/378 (68%), Positives = 295/378 (78%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MKFY SWVDT NRNINFVTEMFTSGTLRQYRLKH+RVNIRAVK+WCRQIL GL YLH+ D
Sbjct: 87 MKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWCRQILRGLNYLHTHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L+ SHAA CVGTPEFMAPEVY+EEYN+L
Sbjct: 147 PPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCVGTPEFMAPEVYKEEYNQL 206
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMC+LEMVTFDYPYSEC+HPAQIYK+VISGKKP+ L KV+DPEVR FIEKCLAT
Sbjct: 207 VDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVKDPEVRGFIEKCLAT 266
Query: 181 VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY-DEISPLLRQSLYGIYHXXXXXXXGC 239
VS RLSA ELL D FL ID+ SD+R ++ + DE LR S Y I H
Sbjct: 267 VSLRLSACELLDDHFLCIDE--SDMRRVESEKGLIDEAGTPLRHS-YHIPHYSN------ 317
Query: 240 GHYIGYDTENGLDYHPHEFQES-EIDLFTCQ-------EDEHLTNFDISIKGKRRED-DG 290
G+Y Y+ +N DY+ E ES EIDL Q ED+ + DISIKGKRR++ DG
Sbjct: 318 GYYSLYN-QNQWDYNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRDNGDG 376
Query: 291 IFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 350
+FLRL+ +KEG +RNIYFPFDI+TDTA+SVA EMV EL++ D+DVTKIA +ID EIASL
Sbjct: 377 LFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGEIASL 436
Query: 351 VPEWKRGMAMEESPHRSS 368
VP W + E + RSS
Sbjct: 437 VPNWSIFCSSESN--RSS 452
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 772 (276.8 bits), Expect = 4.9e-100, Sum P(3) = 4.9e-100
Identities = 135/199 (67%), Positives = 168/199 (84%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++FY SW+D N+ +N +TE+FTSG+LR YR KHR+VN++AVK+W RQIL GL YLH ++
Sbjct: 90 IRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNMKAVKNWARQILMGLRYLHGQE 149
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL
Sbjct: 150 PPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNEL 209
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
DIYSFGMC+LEMVTFDYPY EC + AQIYKKV SG KP +L +V+DPEV+QFIEKCL
Sbjct: 210 ADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIKPASLSRVKDPEVKQFIEKCLLP 269
Query: 181 VSSRLSARELLTDPFLQID 199
S RLSA+ELL DPFLQ++
Sbjct: 270 ASERLSAKELLLDPFLQLN 288
|
|
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 776 (278.2 bits), Expect = 6.7e-100, Sum P(2) = 6.7e-100
Identities = 143/198 (72%), Positives = 169/198 (85%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+KFYTSW+D + IN +TE+FTSG LRQYR KH+ V++RA+K W RQIL GL+YLHS D
Sbjct: 84 IKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKWSRQILEGLVYLHSHD 143
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNE 119
PPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ +A V GTPEFMAPE+YEE+YN
Sbjct: 144 PPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSAHSVIGTPEFMAPELYEEDYNV 203
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
LVDIY+FGMC+LE+VTF+YPYSECT+ AQIY+KV SG KP AL V DP+VR FIEKC+A
Sbjct: 204 LVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIKPAALLNVTDPQVRAFIEKCIA 263
Query: 180 TVSSRLSARELLTDPFLQ 197
VS RLSA+ELL DPFL+
Sbjct: 264 KVSQRLSAKELLDDPFLK 281
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 2.3e-95, Sum P(2) = 2.3e-95
Identities = 133/201 (66%), Positives = 165/201 (82%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++FYTSW+D N +NF+TE+FTSGTLRQY+ K+ R++IRA+K W RQIL GL+YLH D
Sbjct: 81 IRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQILEGLVYLHEHD 140
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNE 119
PPVIHRDLKCDNIFVNG+ G+VKIGDLGLA +LR H+A + GTPEFMAPE+YEE YNE
Sbjct: 141 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTPEFMAPELYEENYNE 200
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
L+D+YSFGMC LEM+T ++PYSEC HPAQIYKKV+ GK P A ++V D E ++FI KCL
Sbjct: 201 LIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRVGDIEAQRFIGKCLV 260
Query: 180 TVSSRLSARELLTDPFLQIDD 200
+ S R+SA+ELL DPFL D+
Sbjct: 261 SASKRVSAKELLQDPFLASDE 281
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 4.3e-94, Sum P(2) = 4.3e-94
Identities = 134/199 (67%), Positives = 166/199 (83%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++FY SW+D N+ +N +TE+FTSG+LRQYR KHR+VN++AVK W RQIL+GL YLHS+D
Sbjct: 90 IRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCWARQILTGLKYLHSQD 149
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PP+IHRD+KCDNIF+NGN GEVKIGDLGLA ++ +++A +GTPEFMAPE+Y+E YNEL
Sbjct: 150 PPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANAKSVIGTPEFMAPELYDENYNEL 209
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
DIYSFGMC+LEMVTF+YPY EC + AQIYKKV SG KP +L KV+DPEV +FIEKCL
Sbjct: 210 ADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSKVKDPEVMKFIEKCLLP 269
Query: 181 VSSRLSARELLTDPFLQID 199
S RLSA ELL D FL ++
Sbjct: 270 ASERLSAEELLLDSFLNVN 288
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 742 (266.3 bits), Expect = 4.3e-94, Sum P(2) = 4.3e-94
Identities = 138/206 (66%), Positives = 168/206 (81%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+++ TSW+D R NF+TE+FTSGTLR+YR K+++V+IRA+K W RQIL+GL YLH D
Sbjct: 87 IRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAIKSWARQILNGLAYLHGHD 146
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNE 119
PPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAILR S A V GTPEFMAPE+YEE+YNE
Sbjct: 147 PPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSVIGTPEFMAPELYEEDYNE 206
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
LVDIYSFGMC+LEM+T +YPYSECT+PAQIYKKV SGK P++ ++ E ++F+ KCL
Sbjct: 207 LVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDSFHLIQHTEAQRFVGKCLE 266
Query: 180 TVSSRLSARELLTDPFLQIDDYDSDL 205
TVS RL A+ELL DPFL D + DL
Sbjct: 267 TVSRRLPAKELLADPFLAATD-ERDL 291
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 736 (264.1 bits), Expect = 4.2e-91, Sum P(3) = 4.2e-91
Identities = 137/199 (68%), Positives = 164/199 (82%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K + SWVD N+ IN +TE+FTSG+LR YR KHR+V+ +A+K+W RQIL GL YLHS++
Sbjct: 91 IKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQILKGLNYLHSQN 150
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGN GEVKIGDLGLA +L++ A +GTPEFMAPE+YEEEYNEL
Sbjct: 151 PPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTPEFMAPELYEEEYNEL 210
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMC+LEMVT +YPY+EC + AQIYKKV S KP++L KV+DP+VRQFIEKCL
Sbjct: 211 VDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKVDDPQVRQFIEKCLLP 270
Query: 181 VSSRLSARELLTDPFLQID 199
SSR +A EL DPFL D
Sbjct: 271 ASSRPTALELSKDPFLARD 289
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 1.5e-85, Sum P(2) = 1.5e-85
Identities = 178/351 (50%), Positives = 226/351 (64%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K + SWVD N++IN +TE+FTSG+L YR KHR+V+ +A+ +W RQIL GL YLHS+
Sbjct: 78 IKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQILKGLHYLHSQT 137
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNEL 120
PPVIHRDLKCDNIFVNGN G+VKIGDLGLAA++++ A +GTPEFMAPE+YEEEYNEL
Sbjct: 138 PPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTPEFMAPELYEEEYNEL 197
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VDIYSFGMC+LEMVT +YPY EC + AQIYKKV SG KP++L KV+DP+V+QFIEKCL
Sbjct: 198 VDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKVDDPQVKQFIEKCLLP 257
Query: 181 VSSRLSARELLTDPFLQIDDY-DSDLRMIQYQTDYDEISPLLRQSLYGIYHXXXXXXXGC 239
SR +A ELL D L +D DS L T + P + + C
Sbjct: 258 APSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMPPQCEYRPMDVEYKKNTSVSIC 317
Query: 240 GHYIGYDTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIAD 299
E L Q E+ Q T F +S G+RR+D + LRIA
Sbjct: 318 SSAKS-SQECAL------LQTMEV-----QRVAESTEFKLS--GERRDDVAASMALRIAG 363
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 350
G+ R + F F+++TDTA +V EMV ELD++ +VT IAE+ID I L
Sbjct: 364 SSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
Identities = 126/204 (61%), Positives = 153/204 (75%)
Query: 4 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPV 63
Y W D N +NF+TE+ TSG LR+YR KHR V++RA+K W +QIL GL YLH+ DP +
Sbjct: 96 YKVWRDERNNTLNFITEICTSGNLREYRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCI 155
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYEEEYNELVD 122
IHRDL C NIFVNGN G+VKIGDLGLAAI+ K+H A + GTPEFMAPE+YEE Y E+VD
Sbjct: 156 IHRDLNCSNIFVNGNIGQVKIGDLGLAAIVGKNHLAHSILGTPEFMAPELYEENYTEMVD 215
Query: 123 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVS 182
IYS+GMC+LE+V+ + PYSEC A+IYK+V G KPEAL KV DPE + FIEKC+A
Sbjct: 216 IYSYGMCVLELVSLEIPYSECDSVAKIYKRVSKGLKPEALNKVNDPEAKAFIEKCIAQPR 275
Query: 183 SRLSARELLTDPFLQ--IDDYDSD 204
+R SA ELL DPF +DD D D
Sbjct: 276 ARPSAAELLCDPFFDGILDDDDED 299
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0D598 | WNK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.4872 | 0.9174 | 0.8522 | yes | no |
| Q9CAV6 | WNK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5570 | 0.7844 | 0.7328 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 654 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.001 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 0.002 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.002 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 70/201 (34%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ Y + D + V E G L K R++ + + RQILS L YLHS+
Sbjct: 60 VRLYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY-EEEYN 118
++HRDLK +NI ++ + G VK+ D GLA L VGTPE+MAPEV + Y
Sbjct: 118 --IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 119 ELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEK 176
+ VDI+S G IL E++T P+ +++KK+ K P + + PE + I K
Sbjct: 175 KAVDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 177 CLAT-VSSRLSARELLTDPFL 196
L RL+A E L PF
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 70/201 (34%), Positives = 99/201 (49%), Gaps = 9/201 (4%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
++Y S D +N E + G+L K ++ ++ + RQIL GL YLHS
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG- 121
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYE-EE 116
++HRD+K NI V+ + G VK+ D G A L GTP +MAPEV EE
Sbjct: 122 -IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
Y DI+S G ++EM T P+SE +P K+ S +P + + E + F+ K
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239
Query: 177 CLAT-VSSRLSARELLTDPFL 196
CL R +A ELL PFL
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 5e-41
Identities = 67/205 (32%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ ++ D ++ V E G L Y + ++ K QIL GL YLHS
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEV--YEEE 116
+IHRDLK +NI ++ N G VKI D GLA L KS ++ VGTP +MAPEV
Sbjct: 119 --IIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVISGKKPEALFKV--EDPEVRQ 172
Y VD++S G+ + E++T P+S Q+ +++ K E +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 173 FIEKCLAT-VSSRLSARELLTDPFL 196
I+KCL S R +A E+L P+
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 44/200 (22%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
+K Y + D ++ V E G+L+ + +++ + QIL GL YLHS
Sbjct: 54 VKLYGVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-- 115
+IHRDLK +NI ++ + G+VK+ D GL+ +L KS VGTP +MAPEV
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG 169
Query: 116 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 175
Y+E DI+S G+ + E+ PE++ I
Sbjct: 170 YYSEKSDIWSLGVILYEL----------------------------------PELKDLIR 195
Query: 176 KCLA-TVSSRLSARELLTDP 194
K L R SA+E+L
Sbjct: 196 KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 67/162 (41%), Positives = 89/162 (54%), Gaps = 17/162 (10%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
CR++L GL YLHS+ VIHRD+K DNI ++ G VK+ D G AA L K + R VG
Sbjct: 122 CREVLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVG 178
Query: 104 TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISG----K 157
TP +MAPEV + ++Y VDI+S G+ +EM + PY P + ++ G K
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP-PLRALFLITTKGIPPLK 237
Query: 158 KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQI 198
PE PE + F+ KCL R SA ELL PFL+
Sbjct: 238 NPEKW----SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
K+Y S++ + V E + G+L+ + ++ + + + C+++L GL YLHS
Sbjct: 61 KYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE-EEYN 118
+IHRD+K NI + + GEVK+ D GL+A L + A VGTP +MAPEV + Y+
Sbjct: 119 --IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG----KKPEALFKVEDPEVRQFI 174
DI+S G+ +E+ PYSE ++K +G + PE E + F+
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW----SDEFKDFL 231
Query: 175 EKCLA-TVSSRLSARELLTDPF 195
+KCL R +A +LL PF
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 63/162 (38%), Positives = 88/162 (54%), Gaps = 14/162 (8%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAAR 100
++ + RQIL GL YLH R+ +HRD+K NI V+ N G VK+ D G+A ++ S A
Sbjct: 104 IRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKS 160
Query: 101 CVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158
G+P +MAPEV + Y DI+S G +LEM T P+S+ A ++K S +
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220
Query: 159 PEALFKVED---PEVRQFIEKCL-ATVSSRLSARELLTDPFL 196
P + D E + FI KCL S R +A ELL PF+
Sbjct: 221 PP----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI----RAVKHWCRQILSGLLYLH 57
K+Y S+ + + V E G L Q K ++ + W Q+ L YLH
Sbjct: 63 KYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 58 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE 115
SR ++HRD+K NIF+ N G VK+GD G++ +L + A VGTP +++PE+ +
Sbjct: 121 SRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 116 E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 174
+ YN DI+S G + E+ T +P+ E + ++ K++ G+ P + E+R +
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKGQYP-PIPSQYSSELRNLV 235
Query: 175 EKCLATV-SSRLSARELLTDPFL 196
L R S ++L PF+
Sbjct: 236 SSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 63/190 (33%), Positives = 96/190 (50%), Gaps = 10/190 (5%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
I+ V E G+L K ++ + + RQIL GL YLH +IHRD+K N+
Sbjct: 74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLL 132
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYE-EEYNELVDIYSFGMCI 130
+N ++GEVKI D G++ +L + +C VGT +M+PE + E Y+ DI+S G+ +
Sbjct: 133 IN-SKGEVKIADFGISKVLENT-LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 131 LEMVTFDYPYS--ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRLSA 187
LE +P+ ++ + + G P + PE R FI CL R SA
Sbjct: 191 LECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSA 250
Query: 188 RELLTDPFLQ 197
ELL PF++
Sbjct: 251 AELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/186 (36%), Positives = 101/186 (54%), Gaps = 19/186 (10%)
Query: 25 GTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 83
GTL + L+H R+ + ++ + Q+L GL YLHS ++HRD+K NIF++ N G +K
Sbjct: 84 GTLEEL-LEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIK 139
Query: 84 IGDLGLAAILRKSHAARC-------VGTPEFMAPEVY----EEEYNELVDIYSFGMCILE 132
+GD G A L K++ GTP +MAPEV + + DI+S G +LE
Sbjct: 140 LGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLE 198
Query: 133 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLATV-SSRLSAREL 190
M T P+SE + QI V +G KP ++ PE + F+++CL + R +A EL
Sbjct: 199 MATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
Query: 191 LTDPFL 196
L PF+
Sbjct: 259 LQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 57/161 (35%), Positives = 81/161 (50%), Gaps = 16/161 (9%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
CR+ L GL YLH IHRD+K NI + G+VK+ D G++A L + A R +G
Sbjct: 107 CRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIG 163
Query: 104 TPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKK 158
TP +MAPEV E Y+ DI++ G+ +E+ P + HP + ++ S
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD-LHPMRALFLISKSNFP 222
Query: 159 PEALFKVE--DPEVRQFIEKCLATVSSRL--SARELLTDPF 195
P L E P FI+KCL T + +A +LL PF
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCL-TKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 64/158 (40%), Positives = 85/158 (53%), Gaps = 13/158 (8%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
Q L GL YLHS IHRD+K NI +N +G+ K+ D G++ L + A R +G
Sbjct: 105 LYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIG 161
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPA-QIYKKVISGKKPEA 161
TP +MAPEV +E YN DI+S G+ +EM PYS+ HP I+ +I K P
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD-IHPMRAIF--MIPNKPPPT 218
Query: 162 LFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
L E PE F++KCL R SA +LL PF+
Sbjct: 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/156 (34%), Positives = 84/156 (53%), Gaps = 10/156 (6%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
R++L GL YLH IHRD+K NI ++ +G+VK+ D G++ L + + R VG
Sbjct: 104 LREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVG 160
Query: 104 TPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
TP +MAPEV + Y+E DI+S G+ +E+ + P S+ HP ++ +I P +L
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPMRVL-FLIPKNNPPSL 218
Query: 163 FKVE-DPEVRQFIEKCL-ATVSSRLSARELLTDPFL 196
+ + F+ CL R SA+ELL F+
Sbjct: 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 59/189 (31%), Positives = 95/189 (50%), Gaps = 9/189 (4%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ ++ + E +G+LRQ K V + Q+L GL YLH + VIHRD+K
Sbjct: 71 SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAA 128
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGM 128
NI + G VK+ D G+A L VGTP +MAPEV E + DI+S G
Sbjct: 129 NILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC 187
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA 187
++E++T + PY + P +++ P L + PE++ F+ +C + R +A
Sbjct: 188 TVIELLTGNPPYYDLN-PMAALFRIVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPTA 245
Query: 188 RELLTDPFL 196
++LL P++
Sbjct: 246 KQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLH 57
++Y +D +N+ + V E G L ++ + + + + + Q+L L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 58 SRDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEV 112
+R P V+HRDLK NIF++ N VK+GD GLA IL A VGTP +M+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181
Query: 113 Y-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 171
Y+E DI+S G I E+ P++ Q+ K+ GK + E+
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIKEGKFRR-IPYRYSSELN 239
Query: 172 QFIEKCLA-TVSSRLSARELLTDPFL 196
+ I+ L R S ELL P +
Sbjct: 240 EVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 55/172 (31%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ V E G L + K R + + + +I+ L YLHS +I+RDLK +
Sbjct: 65 EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPE 122
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYE-EEYNELVDIYSFG 127
NI ++ G +K+ D GLA L S +R GTPE++APEV + Y + VD +S G
Sbjct: 123 NILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180
Query: 128 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
+ + EM+T P+ +IY+K++ K P + PE R I L
Sbjct: 181 VLLYEMLTGKPPF-YAEDRKEIYEKIL--KDPLRFPEFLSPEARDLISGLLQ 229
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 60/162 (37%), Positives = 82/162 (50%), Gaps = 17/162 (10%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAAR-- 100
+++L GL YLHS IHRD+K NI + G G VKI D G++A L + R
Sbjct: 109 KEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 101 CVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158
VGTP +MAPEV E+ Y+ DI+SFG+ +E+ T PYS+ P ++ +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDP 224
Query: 159 P----EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPF 195
P A +K R+ I CL S R +A ELL F
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 67/185 (36%), Positives = 95/185 (51%), Gaps = 12/185 (6%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V E G L + H R+N + C +L L +LH++ VIHRD+K D+I +
Sbjct: 94 VMEFLEGGALTDI-VTHTRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTS 150
Query: 78 NQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMV 134
+ G VK+ D G A + K R VGTP +MAPEV Y VDI+S G+ ++EMV
Sbjct: 151 D-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
Query: 135 TFDYPYSECTHPAQIYKKVISGKKPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191
+ PY P Q K++ P+ L KV P +R F+++ L + R +A ELL
Sbjct: 210 DGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVS-PRLRSFLDRMLVRDPAQRATAAELL 267
Query: 192 TDPFL 196
PFL
Sbjct: 268 NHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 64/161 (39%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
CR+ L L +LHS VIHRD+K DNI + G G VK+ D G A + + R VG
Sbjct: 121 CRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 104 TPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK----K 158
TP +MAPEV + Y VDI+S G+ +EMV + PY +Y +G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237
Query: 159 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQI 198
PE L R F+ +CL V R SA+ELL PFL+I
Sbjct: 238 PEKL----SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKI 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 58/173 (33%), Positives = 89/173 (51%), Gaps = 25/173 (14%)
Query: 39 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 98
IR V CRQ+L L +LHS VIHRDLK NI + G+VK+ D G++A + +
Sbjct: 105 IRYV---CRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQ 158
Query: 99 AR--CVGTPEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150
R +GTP +MAPEV E Y+ DI+S G+ ++E+ + P+ E +P ++
Sbjct: 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVL 217
Query: 151 KKVISGKKPEALFKVEDP-----EVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
K++ + P ++ P F++ CL R +A ELL PF+
Sbjct: 218 LKILKSEPP----TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 62/157 (39%), Positives = 85/157 (54%), Gaps = 11/157 (7%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGT 104
R++L L Y+H VIHRD+K NI V N G VK+ D G+AA+L ++ + R VGT
Sbjct: 108 REVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGT 164
Query: 105 PEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
P +MAPEV E Y+ DI+S G+ I EM T + PYS+ A +I KP L
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD--VDAFRAMMLIPKSKPPRL 222
Query: 163 FKVE-DPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 197
+R+F+ CL RLSA ELL +++
Sbjct: 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 48/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
V E G L Y K+R + + QI G+ YL S+ IHRDL N V
Sbjct: 79 VMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLV 136
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYSFGMCIL 131
N VKI D GL+ L + G +MAPE +E ++ D++SFG+ +
Sbjct: 137 GENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLW 195
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKC 177
E+ T + PY + A++ + + G + K + PE+ + + +C
Sbjct: 196 EIFTLGEEPYPGMS-NAEVLEYLKKGYRLP---KPPNCPPELYKLMLQC 240
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 6e-23
Identities = 58/165 (35%), Positives = 85/165 (51%), Gaps = 15/165 (9%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------- 93
V+++ RQIL GL YLH+R +IHRD+K NI V+ N+G +KI D G++ L
Sbjct: 108 VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTK 164
Query: 94 RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152
G+ +MAPEV ++ Y DI+S G ++EM+T +P+ +CT I+K
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK- 223
Query: 153 VISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 196
I + E F+EK + R +A ELL PFL
Sbjct: 224 -IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 9e-23
Identities = 65/202 (32%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHW--CRQILSGLLYLHS 58
+++Y S++D NI V E +G L + R + + W QIL GL +LHS
Sbjct: 62 IRYYESFLDKGKLNI--VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE 116
+ ++HRD+K N+F++ VKIGDLG+A +L + A VGTP +++PE+ E++
Sbjct: 120 KK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 117 -YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 175
YNE D+++ G+ + E T +P+ A I K+I G P + ++ ++ Q I+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALI-LKIIRGVFP-PVSQMYSQQLAQLID 234
Query: 176 KCLA-TVSSRLSARELLTDPFL 196
+CL R +LL +P L
Sbjct: 235 QCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 16/183 (8%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E G L Y K+R ++++ + + QI G+ YL S+ IHRDL N V
Sbjct: 79 VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVG 136
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYSFGMCILE 132
N VKI D GL+ L R G +MAPE +E ++ D++SFG+ + E
Sbjct: 137 ENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWE 195
Query: 133 MVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCLAT-VSSRLSAR 188
+ T + PY + ++ + + +G + + + PE+ + +C A R +
Sbjct: 196 IFTLGEQPYPGMS-NEEVLEYLKNGYRLP---QPPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 189 ELL 191
EL+
Sbjct: 252 ELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 99.4 bits (246), Expect = 2e-22
Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 29/253 (11%)
Query: 12 NRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
++ V E G+L + ++ QILS L YLHS+ +IHRD+
Sbjct: 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDI 127
Query: 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--------CVGTPEFMAPEVY----EEE 116
K +NI ++ + VK+ D GLA +L + VGTP +MAPEV
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187
Query: 117 YNELVDIYSFGMCILEMVTFDYPY---SECTHPAQIYKKVISGKKPEALFKV-------E 166
+ DI+S G+ + E++T P+ + +Q K ++ P +
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELI 247
Query: 167 DPEVRQFIEKCLA-TVSSRLSARELLTDPFL-QIDDYDSDLRMIQYQTDYDEISPLLRQS 224
++K LA +RLS+ L+ L + +SDL + D + L S
Sbjct: 248 SKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPS 307
Query: 225 LYGIYHSNSSSNN 237
L + S +S
Sbjct: 308 LEALISSLNSLAI 320
|
Length = 384 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 54/151 (35%), Positives = 82/151 (54%), Gaps = 7/151 (4%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L GL LH + ++HRDLK NI + N VKIGDLG++ +L+K+ A +GTP +
Sbjct: 111 QLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKKNMAKTQIGTPHY 167
Query: 108 MAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE 166
MAPEV++ Y+ DI+S G + EM TF P+ E + KV GK P + +
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP-PIPPIY 225
Query: 167 DPEVRQFIEKCLAT-VSSRLSARELLTDPFL 196
+++ FI L R + ++L P +
Sbjct: 226 SQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 64/171 (37%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 38 NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAIL 93
N + + + +QIL GL YLH ++HRD+K DN+ VN G VKI D G LA I
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI- 162
Query: 94 RKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150
GT ++MAPEV ++ Y DI+S G I+EM T P+ E P
Sbjct: 163 -NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
Query: 151 KKVISGKK----PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
KV K PE+L E + FI +C R SA +LL DPFL
Sbjct: 222 FKVGMFKIHPEIPESL----SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQ-YRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
FY ++ + N +I+ E G+L + + R+ R + +L GL YLH
Sbjct: 63 GFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE-K 119
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEEYNE 119
+IHRD+K NI VN ++G++K+ D G++ L S A VGT +MAPE + +Y+
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV 178
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPA----QIYKKVISGKKPEALFKVEDPEVRQFIE 175
DI+S G+ ++E+ T +PY P ++ + +++ P P+ + F+
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 176 KCL-ATVSSRLSARELLTDPFLQ 197
CL R S +ELL PF++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS------HA 98
+ Q+L GL YLH +IHRD+K N+ ++ ++I D G AA L
Sbjct: 108 YTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 99 ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSE---CTHPAQIYKKVI 154
+ +GT FMAPEV E+Y D++S G I+EM T P++ H A I+ K+
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIA 224
Query: 155 SGKKPEALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDP 194
S ++ + P +R +CL R +RELL P
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHW----CRQILSGLLYLHSRDPPVIHRDLKCDN 72
V E+ G++ R+ R + W R+ L GL YLH VIHRD+K N
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQN 143
Query: 73 IFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEV------YEEEYNELVDIY 124
I + N EVK+ D G++A L + R +GTP +MAPEV + Y+ D++
Sbjct: 144 ILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVW 202
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPE-----VRQFIEKCLA 179
S G+ +E+ P + HP + K+ P ++ PE FI +CL
Sbjct: 203 SLGITAIELADGKPPLCD-MHPMRALFKIPRNPPP----TLKSPENWSKKFNDFISECLI 257
Query: 180 -TVSSRLSARELLTDPFL 196
R ELL PF+
Sbjct: 258 KNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 15/185 (8%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
VTE G L + L+ + QI G+ YL S+ +HRDL N V
Sbjct: 79 VTEYMPGGDLLDF-LRKHGEKLTLKDLLQMALQIAKGMEYLESK--NFVHRDLAARNCLV 135
Query: 76 NGNQGEVKIGDLGLA-AILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDIYSFGMCI 130
VKI D GL+ I + + G +MAPE ++ ++ D++SFG+ +
Sbjct: 136 -TENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSAR 188
E+ T + PY + ++ + + G + E+ + + +C A R +
Sbjct: 195 WEIFTLGEQPYPGMS-NEEVLELLEDGYRLPRPENC-PDELYELMLQCWAYDPEDRPTFS 252
Query: 189 ELLTD 193
EL+ D
Sbjct: 253 ELVED 257
|
Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 57/192 (29%), Positives = 89/192 (46%), Gaps = 13/192 (6%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ ++ E G+++ + + + + RQIL G+ YLHS ++HRD+K
Sbjct: 76 DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGA 133
Query: 72 NIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVYE-EEYNELVDIYS 125
NI + G VK+GD G L I + V GTP +M+PEV E Y D++S
Sbjct: 134 NILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWS 192
Query: 126 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLA-TVSS 183
G ++EM+T P++E A I+K I+ + P+ R F+ +
Sbjct: 193 VGCTVVEMLTEKPPWAEFEAMAAIFK--IATQPTNPQLPSHVSPDARNFLRRTFVENAKK 250
Query: 184 RLSARELLTDPF 195
R SA ELL F
Sbjct: 251 RPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 9e-21
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 43/206 (20%)
Query: 27 LRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
L++Y L R ++ +K Q+L GL Y HS ++HRDLK NI +N + G +K+
Sbjct: 84 LKKY-LDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKL 139
Query: 85 GDLGLAAILRKSHAARCVGTPEFM-----APEVY--EEEYNELVDIYSFGMCILEMVTFD 137
D GLA R T E + APE+ + Y+ VDI+S G EM+T
Sbjct: 140 ADFGLARAF--GIPLRTY-THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
Query: 138 YPYSECTHPAQIYK--------------------------KVISGKKPEALFKVEDPEVR 171
+ + Q++K K E + DPE
Sbjct: 197 PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGI 256
Query: 172 QFIEKCLA-TVSSRLSARELLTDPFL 196
+ K L + R+SA+E L P+
Sbjct: 257 DLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 9e-21
Identities = 62/161 (38%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
CR+ L L +LH+ VIHRD+K DN+ + G G VK+ D G A + + R VG
Sbjct: 121 CRECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG----KK 158
TP +MAPEV + Y VDI+S G+ +EMV + PY +Y +G +
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN 237
Query: 159 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQI 198
PE L P R F+ +CL V R SA+ELL PFL++
Sbjct: 238 PEKL----SPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 9 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
+T ++ E G++ + R + V+ + Q+L GL YLHS+ ++HRDL
Sbjct: 77 ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDL 134
Query: 69 KCDNIFVNGNQGEVKIGDLGL----AAILRKSHAARCVGTPEFMAPEV---YEEEYNELV 121
K DN+ V+ G KI D G+ I G+ +MAPEV Y + Y+ V
Sbjct: 135 KADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKV 193
Query: 122 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFI-E 175
DI+S G +LEM P+S+ A ++K + K+ P + P F+
Sbjct: 194 DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNA 251
Query: 176 KCLATVSSRLSARELLTDPF 195
+R +ARELL PF
Sbjct: 252 CFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+++Y D A + + E G+++ + + + + RQIL G+ YLHS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN- 125
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVYE- 114
++HRD+K NI + + G VK+GD G L I R V GTP +M+PEV
Sbjct: 126 -MIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 115 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 174
E Y D++S G ++EM+T P++E A I+K P+ + + R F+
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE-HARDFL 242
Query: 175 EKCLATVSSRLSARELLTDPFLQI 198
R SA ELL PF Q+
Sbjct: 243 GCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-20
Identities = 63/162 (38%), Positives = 88/162 (54%), Gaps = 17/162 (10%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
CR+ L L +LHS VIHRD+K DNI + G G VK+ D G A + + R VG
Sbjct: 121 CRECLQALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
TP +MAPEV + Y VDI+S G+ +EMV + PY +P + + + PE
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPE-- 234
Query: 163 FKVEDPE-----VRQFIEKCLAT-VSSRLSARELLTDPFLQI 198
+++PE R F+ +CL V R SA+ELL PFL++
Sbjct: 235 --LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 56/169 (33%), Positives = 81/169 (47%), Gaps = 16/169 (9%)
Query: 35 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 94
+ V I A+ C L GL YLHS + IHRD+K NI + G VK+ D G A++
Sbjct: 113 QEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASL-- 164
Query: 95 KSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150
S A VGTP +MAPEV E +Y+ VD++S G+ +E+ P + +Y
Sbjct: 165 VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224
Query: 151 KKVISGKKPEALFKVE-DPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 197
I+ L + R F++ CL + R S+ ELL F+
Sbjct: 225 H--IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 20/175 (11%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK---------HWCRQILSGLLYLHSRDPPVIHRDL 68
V E G L Y K R V K + QI G+ YL S+ +HRDL
Sbjct: 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK--KFVHRDL 131
Query: 69 KCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPE---FMAPEVYEE-EYNELVDI 123
N V + VKI D GL+ + + + G +MAPE ++ + D+
Sbjct: 132 AARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDV 190
Query: 124 YSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
+SFG+ + E+ T PY + ++ + + G + E+ + + C
Sbjct: 191 WSFGVLLWEIFTLGATPYPGLS-NEEVLEYLRKGYRLPKPEYC-PDELYELMLSC 243
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 10/158 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
Y S+ D + N+ V E G L + K R + + Q++ L YLHS D
Sbjct: 65 NLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD- 121
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNEL 120
+++RDLK +N+ + + G +KI D G A ++ C GTPE++APE+ + Y +
Sbjct: 122 -IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRTYTLC-GTPEYLAPEIILSKGYGKA 178
Query: 121 VDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGK 157
VD ++ G+ I EM+ P + + +P QIY+K++ GK
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDD--NPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 9/189 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K Y ++ D + I + E G L + + + ++ YLH+R
Sbjct: 56 VKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG 113
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGTPEFMAPEVYEEE-YN 118
+I+RDLK +N+ ++ + G VK+ D G A L GTPE++APE+ + Y+
Sbjct: 114 --IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 119 ELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKKVISGKKPEALFKVEDPEVRQFIEK- 176
VD +S G+ + E++T P+ E P +IY ++ G D + I++
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230
Query: 177 CLATVSSRL 185
RL
Sbjct: 231 LRRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 6e-20
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N+ FV E +G L QY K+ ++ + + + +IL L YLHS+ +IHRDLK +
Sbjct: 74 EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPE 131
Query: 72 NIFVNGNQGEVKIGDLGLAAIL----------------------RKSHAARCVGTPEFMA 109
NI ++ + +KI D G A +L + A VGT E+++
Sbjct: 132 NILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190
Query: 110 PEVYEEEY-NELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKV 165
PE+ E+ + D+++ G CI+ +M+T P+ ++K++ P
Sbjct: 191 PELLNEKPAGKSSDLWALG-CIIYQMLTGKPPFRGSNEY-LTFQKILKLEYSFPPNFP-- 246
Query: 166 EDPEVRQFIEKCLAT-VSSRL----SARELLTDPF 195
P+ + IEK L RL EL PF
Sbjct: 247 --PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 62/166 (37%), Positives = 87/166 (52%), Gaps = 9/166 (5%)
Query: 36 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 95
R+N + C +L L YLHS+ VIHRD+K D+I + + G VK+ D G A + K
Sbjct: 113 RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISK 169
Query: 96 SHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152
R VGTP +MAPEV Y VDI+S G+ ++EMV + PY + P Q K+
Sbjct: 170 DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKR 228
Query: 153 VISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
+ P+ P +R F+E+ L R +A+ELL PFL
Sbjct: 229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 44/129 (34%), Positives = 66/129 (51%), Gaps = 5/129 (3%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
N+ V ++ G LR + + + + VK W +I+ L YLHS+ +IHRD+K DNI
Sbjct: 74 NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNI 131
Query: 74 FVNGNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVY-EEEYNELVDIYSFGMCIL 131
++ QG V I D +A + GTP +MAPEV + Y+ VD +S G+
Sbjct: 132 LLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAY 190
Query: 132 EMVTFDYPY 140
E + PY
Sbjct: 191 ECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 49/189 (25%), Positives = 79/189 (41%), Gaps = 39/189 (20%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
+K + +Q+L GL YLHS ++HRD+K NI +N N G +K+ D GLA K ++A
Sbjct: 102 IKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADY 158
Query: 102 ---VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT-------------FDYPYSE 142
V T + PE+ Y VD++S G CIL E+ + +
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVG-CILAELFLGKPIFQGSTELEQLEKIFEL 217
Query: 143 CTHPA----------QIYKKVISGKKPEALFK-----VEDPEVRQFIEKCLA-TVSSRLS 186
C P ++ + K + + + DP ++K L R+S
Sbjct: 218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277
Query: 187 ARELLTDPF 195
A + L +
Sbjct: 278 ADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 62/162 (38%), Positives = 87/162 (53%), Gaps = 17/162 (10%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
CR+ L L +LHS VIHRD+K DNI + G G VK+ D G A + + R VG
Sbjct: 122 CRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
TP +MAPEV + Y VDI+S G+ +EM+ + PY +P + + + PE
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPE-- 235
Query: 163 FKVEDPE-----VRQFIEKCL-ATVSSRLSARELLTDPFLQI 198
+++PE R F+ +CL V R SA+ELL FL+I
Sbjct: 236 --LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+++Y D R ++ E G+++ + + + + RQIL G+ YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN- 125
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----SHAARCVGTPEFMAPEVYE- 114
++HRD+K NI + + G VK+GD G + L+ + GTP +M+PEV
Sbjct: 126 -MIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 115 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 174
E Y DI+S G ++EM+T P++E A I+K P V D R F+
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD-HCRDFL 242
Query: 175 EKCLATVSSRLSARELLTDPFLQ 197
++ R SA ELL F+
Sbjct: 243 KRIFVEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 58/187 (31%), Positives = 96/187 (51%), Gaps = 15/187 (8%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLY 55
+K+ S+++ N +N V E+ +G L + +KH R + R + + Q+ S L +
Sbjct: 65 IKYLASFIE--NNELNIVLELADAGDLSRM-IKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 56 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARC-VGTPEFMAPE-V 112
+HS+ ++HRD+K N+F+ G VK+GDLGL K+ AA VGTP +M+PE +
Sbjct: 122 MHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 113 YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEVR 171
+E YN DI+S G + EM P Y + + + KK+ P E+R
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238
Query: 172 QFIEKCL 178
+ +C+
Sbjct: 239 DLVSRCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-19
Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 9/153 (5%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTP 105
QI+S + Y+H ++HRD+K NIF+ G +K+GD G++ IL S A VGTP
Sbjct: 109 QIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP 165
Query: 106 EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 164
+M+PE+ + +YN DI++ G + E++T + + T+P + K++ G +
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNY-TPVVS 223
Query: 165 VEDPEVRQFIEKCLAT-VSSRLSARELLTDPFL 196
V E+ + L R +A E+L P L
Sbjct: 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 55/215 (25%), Positives = 107/215 (49%), Gaps = 24/215 (11%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLH 57
K+Y +++D ++ +I E G+L ++ + + R+ + + +L GL YLH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 58 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEE 116
SR +IHRD+K NI + +G+VK+ D G++ L S A GT +MAPE + +
Sbjct: 123 SRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 117 YNELVDIYSFGMCILEMVTFDYPY----SECTHPAQIYKKVISGKKPEALFKVEDPEV-- 170
Y+ D++S G+ +LE+ +P+ P ++ +++ PE ++P
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL---KDEPGNGI 236
Query: 171 ------RQFIEKCLA-TVSSRLSARELLTDPFLQI 198
+ FI++CL + R + ++L P+++
Sbjct: 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 64/187 (34%), Positives = 95/187 (50%), Gaps = 12/187 (6%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V E G L + H R+N + C +L L YLH++ VIHRD+K D+I +
Sbjct: 97 VMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTS 153
Query: 78 NQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMV 134
+ G +K+ D G A + K R VGTP +MAPEV Y VDI+S G+ ++EM+
Sbjct: 154 D-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 135 TFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191
+ PY P Q +++ P + KV +R F++ L S R +A+ELL
Sbjct: 213 DGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVSSV-LRGFLDLMLVREPSQRATAQELL 270
Query: 192 TDPFLQI 198
PFL++
Sbjct: 271 QHPFLKL 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHS 58
+++Y ++++ ++ + V E GTL +Y K ++ + H+ QIL L ++H+
Sbjct: 62 IEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGTPEFMAPEVYE-EE 116
+ ++HRDLK NI ++ ++ VKIGD G++ IL KS A VGTP +++PE+ E +
Sbjct: 120 KL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
YN+ DI++ G + E+ + + PA + K++SG + P++RQ I
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSGTFAPISDRYS-PDLRQLILS 235
Query: 177 CLAT-VSSRLSARELLTDP 194
L S R +++ P
Sbjct: 236 MLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 53/156 (33%), Positives = 79/156 (50%), Gaps = 9/156 (5%)
Query: 49 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEF 107
I+ L YLHS+ VIHRD+K N+ +N G+VK+ D G++ L S A G +
Sbjct: 112 IVKALEYLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169
Query: 108 MAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
MAPE E Y+ D++S G+ ++E+ T +PY P Q K+V+ P+
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229
Query: 163 FKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFLQ 197
+ PE + F+ KCL R + ELL PF +
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 63/185 (34%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V E G L + H R+N + C +L L LH++ VIHRD+K D+I +
Sbjct: 95 VMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT- 150
Query: 78 NQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMV 134
+ G VK+ D G A + K R VGTP +MAPE+ Y VDI+S G+ ++EMV
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
Query: 135 TFDYPYSECTHPAQIYKKVISGKKPEALFKVE--DPEVRQFIEKCLA-TVSSRLSARELL 191
+ PY P K+I P L + P ++ F+++ L + R +A ELL
Sbjct: 211 DGEPPYF--NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 268
Query: 192 TDPFL 196
PFL
Sbjct: 269 KHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 52/164 (31%), Positives = 88/164 (53%), Gaps = 14/164 (8%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
C+Q L L YLH + +IHRDLK NI + G++K+ D G++A ++ R +G
Sbjct: 109 CKQTLEALNYLH--ENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIG 165
Query: 104 TPEFMAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157
TP +MAPEV + Y+ D++S G+ ++EM + P+ E +P ++ K+ +
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSE 224
Query: 158 KPE-ALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDPFLQID 199
P A E + F++KCL V +R + +LL PF+ ++
Sbjct: 225 PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 12/182 (6%)
Query: 22 FTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78
F G ++LK ++ + V W QI L YLH + ++HRDLK N+F+
Sbjct: 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-R 137
Query: 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVT 135
+K+GDLG+A +L A+ +GTP +M+PE++ + YN D+++ G C+ EM T
Sbjct: 138 TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
Query: 136 FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 194
+ ++ + +Y ++I GK P + K PE+ + I L+ R S + +L P
Sbjct: 198 LKHAFNAKDMNSLVY-RIIEGKLPP-MPKDYSPELGELIATMLSKRPEKRPSVKSILRQP 255
Query: 195 FL 196
++
Sbjct: 256 YI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 58/154 (37%), Positives = 86/154 (55%), Gaps = 9/154 (5%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGT 104
R+IL GL YLHS IHRD+K N+ ++ GEVK+ D G+A L + R VGT
Sbjct: 108 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 105 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 163
P +MAPEV ++ Y+ DI+S G+ +E+ + P+SE HP ++ +I P L
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVL-FLIPKNNPPTLE 222
Query: 164 KVEDPEVRQFIEKCLATVSS-RLSARELLTDPFL 196
+++F+E CL S R +A+ELL F+
Sbjct: 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 31/215 (14%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI-----RAVKHWCRQILSGLLYL 56
K Y S+ +N+ V E G L L N+ + + +I+ L YL
Sbjct: 57 KLYYSF--QGKKNLYLVMEYLPGGDL--ASLLE---NVGSLDEDVARIYIAEIVLALEYL 109
Query: 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----------AILRKSHAARCVGTPE 106
HS +IHRDLK DNI ++ N G +K+ D GL+ + R VGTP+
Sbjct: 110 HSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 107 FMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 165
++APEV + +++ VD +S G + E + P+ T P +I++ +++GK
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVE 225
Query: 166 EDPEVRQFIEKCL-ATVSSRL---SARELLTDPFL 196
E I K L RL S E+ PF
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 56/154 (36%), Positives = 84/154 (54%), Gaps = 9/154 (5%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGT 104
R+IL GL YLHS IHRD+K N+ ++ QG+VK+ D G+A L + R VGT
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 105 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 163
P +MAPEV ++ Y+ DI+S G+ +E+ + P S+ HP ++ +I P L
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD-LHPMRVL-FLIPKNSPPTLE 222
Query: 164 KVEDPEVRQFIEKCLATVSS-RLSARELLTDPFL 196
++F+E CL R +A+ELL F+
Sbjct: 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 14/171 (8%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
CRQ+L L YLHS +IHRDLK N+ + G++K+ D G++A K+ R +G
Sbjct: 116 CRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIG 172
Query: 104 TPEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157
TP +MAPEV E Y+ DI+S G+ ++EM + P+ E +P ++ K+ +
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSE 231
Query: 158 KPEALFKVE-DPEVRQFIEKCL-ATVSSRLSARELLTDPFLQIDDYDSDLR 206
P + E R F++ L +R SA +LL PF+ + LR
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 57/186 (30%), Positives = 96/186 (51%), Gaps = 13/186 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYL 56
+K+Y S+++ + +N V E+ +G L + ++ + R + + V + Q+ S L ++
Sbjct: 65 IKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VY 113
HSR V+HRD+K N+F+ G VK+GDLGL + + A VGTP +M+PE ++
Sbjct: 123 HSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 114 EEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 172
E YN DI+S G + EM P Y + + + KK+ P E+RQ
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 173 FIEKCL 178
+ C+
Sbjct: 240 LVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 49/147 (33%), Positives = 80/147 (54%), Gaps = 12/147 (8%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQ----YRLKHRRVNIRAVKHWCRQILSGLLYL 56
+K+ S++ + +N V E+ +G L Q ++ + R + R V + Q+ S + ++
Sbjct: 65 IKYLDSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VY 113
HSR V+HRD+K N+F+ G VK+GDLGL + + A VGTP +M+PE ++
Sbjct: 123 HSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 114 EEEYNELVDIYSFGMCILEMVTFDYPY 140
E YN DI+S G + EM P+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 47/169 (27%), Positives = 86/169 (50%), Gaps = 17/169 (10%)
Query: 45 WCRQ----ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 100
W +Q ++ G+ LH R +IHRD+K +N+ ++ G +K+ D GL+ ++ +
Sbjct: 98 WAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENK--K 152
Query: 101 CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK- 158
VGTP+++APE +++ D +S G I E + F YP P ++ ++S +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAETPDAVFDNILSRRIN 211
Query: 159 -PEALFKVEDPEVRQFIEKCLAT-VSSRLSA---RELLTDPFLQIDDYD 202
PE + + PE I + L + RL A +E+ + PF + ++D
Sbjct: 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 14/181 (7%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ + + D R + + E G L Y R + + +I+ L YLHS++
Sbjct: 64 IRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNE 119
+++RDLK +NI ++ +G +K+ D G A LR C GTPE++APEV + + +N+
Sbjct: 122 --IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTWTLC-GTPEYLAPEVIQSKGHNK 177
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKC 177
VD ++ G+ I EM+ YP +P IY+K+++GK P L D + I+K
Sbjct: 178 AVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAGKLEFPRHL----DLYAKDLIKKL 232
Query: 178 L 178
L
Sbjct: 233 L 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 17/174 (9%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
++ FV E G L + R + + + +I+ GL +LH + +I+RDLK D
Sbjct: 68 KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLD 125
Query: 72 NIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGM 128
N+ ++ G +KI D G+ + + A+ GTP+++APE+ + ++YNE VD +SFG+
Sbjct: 126 NVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGV 184
Query: 129 CILEMVTFDYPYSEC---------THPAQIYKKVISGKKPEALFK--VEDPEVR 171
+ EM+ P+ + + + IS + + L K DP R
Sbjct: 185 LLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+++Y D + ++ E G+++ + + + + RQIL G+ YLHS
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN- 125
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILRKSHAARCV-GTPEFMAPEVYE- 114
++HRD+K NI + + G VK+GD G + I + V GTP +M+PEV
Sbjct: 126 -MIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 115 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 174
E Y D++S ++EM+T P++E A I+K KP V D R F+
Sbjct: 184 EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRDFL 242
Query: 175 EKCLATVSSRLSARELLTDPF 195
++ R +A LL PF
Sbjct: 243 KQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSG-----TLRQYRLKHRRVNIRAVKHWCRQILSGLLY 55
+KF+ S+++ +TE + G L + + + ++ V W Q+L G+ Y
Sbjct: 65 VKFHASFLE--RDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 56 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVY 113
+H R ++HRDLK NIF+ N +KIGD G++ +L S A GTP +M+PE
Sbjct: 122 MHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 114 EEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 172
+ + Y+ DI+S G + EM + + E + + +++ G P +L + ++
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPETYSRQLNS 235
Query: 173 FIEKCLATVSS-RLSARELLTDPFL 196
++ L S R SA E+L +PF+
Sbjct: 236 IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 56/154 (36%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGT 104
++IL GL YLHS IHRD+K N+ ++ QG+VK+ D G+A L + R VGT
Sbjct: 108 KEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 105 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 163
P +MAPEV ++ Y+ DI+S G+ +E+ + P S+ HP ++ +I P L
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVL-FLIPKNNPPTLT 222
Query: 164 KVEDPEVRQFIEKCLATVSS-RLSARELLTDPFL 196
++FI+ CL S R +A+ELL F+
Sbjct: 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 5e-16
Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N I + E G+L + + + RQILSG+ YLH R ++HRD+K
Sbjct: 144 NGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYLHRRH--IVHRDIKPS 197
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEEYNELV------DI 123
N+ +N + VKI D G++ IL ++ VGT +M+PE + N DI
Sbjct: 198 NLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256
Query: 124 YSFGMCILE--MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL-AT 180
+S G+ ILE + F + A + + + PEA E R FI CL
Sbjct: 257 WSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS-REFRHFISCCLQRE 315
Query: 181 VSSRLSARELLTDPFL 196
+ R SA +LL PF+
Sbjct: 316 PAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR-AVKHWCRQILSGLLYLHSR 59
+ FY ++ NR I+ TE G+L YR V R AV ++ GL YL S
Sbjct: 62 IGFYGAFF-VENR-ISICTEFMDGGSLDVYRKIPEHVLGRIAVA-----VVKGLTYLWSL 114
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPE-VYEEEYN 118
++HRD+K N+ VN +G+VK+ D G++ L S A VGT +MAPE + E+Y
Sbjct: 115 K--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTH------PAQIYKKVISGKKPEALFKVEDPEVRQ 172
D++S G+ +E+ +PY + P Q+ + ++ P +
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 173 FIEKCLATV-SSRLSARELLTDPFL-QIDDYDSDL 205
FI +C+ R + L+ PF+ Q +D ++++
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 63/193 (32%), Positives = 80/193 (41%), Gaps = 51/193 (26%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
QIL GL YLHS + VIHRDLK NI VN N ++KI D GLA + F
Sbjct: 111 QILRGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGF 162
Query: 108 M----------APEVY--EEEYNELVDIYSFGMCIL-EMVT----F---DY--------- 138
+ APE+ Y + +DI+S G CI E++T F DY
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLTRKPLFPGRDYIDQLNLIVE 221
Query: 139 ----PYSE----CTHP-AQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRL 185
P E T A+ Y K + K LF PE +EK L R+
Sbjct: 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI 281
Query: 186 SARELLTDPFLQI 198
+A E L P+L
Sbjct: 282 TADEALAHPYLAQ 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 16/161 (9%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPE 106
QI+ GL +LH R +++RDLK +N+ ++ + G V+I DLGLA + GTP
Sbjct: 103 QIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 107 FMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 165
+MAPEV E Y+ VD ++ G + EM+ P+ + ++ K+ + + E +
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ--RKEKVEKEELKRRTLEMAVEY 217
Query: 166 ED---PEVRQFIEKCLAT-VSSRL-----SARELLTDPFLQ 197
D PE + E L RL SA E+ P +
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 18/161 (11%)
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCV 102
W QI GL ++H R ++HRD+K NIF++ N K+GD G+A L S A CV
Sbjct: 106 WFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV 163
Query: 103 GTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 161
GTP +++PE+ + YN DI+S G + E+ T +P+ E + Q+ K+ G
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQGY---- 218
Query: 162 LFKVEDP----EVRQFIEKCLATVS--SRLSARELLTDPFL 196
F P ++R I + L VS R S +L PFL
Sbjct: 219 -FAPISPNFSRDLRSLISQ-LFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 66/214 (30%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
+I FVTE+ GT L R + + ++++ QIL GL Y+HS V+HRDLK NI
Sbjct: 84 DIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNI 139
Query: 74 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL 131
+N N ++KI D GLA I + V T + APE+ ++Y+ VDI+S G
Sbjct: 140 LINEN-CDLKICDFGLARI-QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFA 197
Query: 132 EMVTFDYPYSECTHPAQIY----------KKVISG-----------------KKP-EALF 163
EM+ + H Q VI+ P F
Sbjct: 198 EMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKF 257
Query: 164 KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
K DP +EK L R+SA E L P+L
Sbjct: 258 KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 22/178 (12%)
Query: 49 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 108
++ GL +L + +IHRD+K N+ VNGN G+VK+ D G++ L S A +G +M
Sbjct: 111 VVKGLKFL-KEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYM 168
Query: 109 APEVYEEE-------YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV------IS 155
APE + Y D++S G+ ILEM YPY P + Y + I
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQLSAIV 223
Query: 156 GKKPEALFKVEDPEVRQFIEKCLATVSS-RLSARELLTDPFLQIDDYDSDLRMIQYQT 212
P L + + F+ KCL + + R + +LL P+L + ++D+ M ++ T
Sbjct: 224 DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL-VKYKNADVDMAEWVT 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 49 ILSGLLYL---HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGT 104
I+ L YL H VIHRD+K NI ++ + G VK+ D G++ L S A R G
Sbjct: 123 IVKALHYLKEKHG----VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 105 PEFMAPEVYE-----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159
+MAPE + +Y+ D++S G+ ++E+ T +PY C ++ K++ + P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 160 E-ALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDS 203
+ P+ F++ CL R RELL PF++ Y++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR--RYET 281
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 62/233 (26%), Positives = 95/233 (40%), Gaps = 43/233 (18%)
Query: 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP- 61
FY ++ + I+ E G+L Q K R+ + +L GL YL R+
Sbjct: 64 FYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYL--REKH 119
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNEL 120
++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y
Sbjct: 120 KIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQ 178
Query: 121 VDIYSFGMCILEMVT----------------FDYPYSECTHPAQIYKKVISG---KKPEA 161
DI+S G+ ++EM F P SE +P A
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238
Query: 162 LFKVED----------------PEVRQFIEKCLATV-SSRLSARELLTDPFLQ 197
+F++ D E + F++KCL R +EL PF++
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 54/186 (29%), Positives = 75/186 (40%), Gaps = 34/186 (18%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 99
+K RQ+L G+ +LHS ++HRDLK NI V + G+VKI D GLA I A
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIY-SFEMA 162
Query: 100 R--CVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL-EMVT----FDYPY----------- 140
V T + APEV + Y VD++S G CI E+ F
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAELFRRRPLFRGTSEADQLDKIFDV 221
Query: 141 ----SECTHPAQIYKKVIS-----GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL 190
SE P + S + ++ E ++K L R+SA E
Sbjct: 222 IGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 191 LTDPFL 196
L P+
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + + + +I+ GL +LH R +I+RDLK DN+ ++
Sbjct: 73 FVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEM 133
+G +KI D G+ IL + GTP+++APE+ + Y VD ++ G+ + EM
Sbjct: 131 S-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
Query: 134 VTFDYPY 140
+ P+
Sbjct: 190 LAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 49 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM 108
++ GL YL++ ++HRD+K NI VN +G++K+ D G++ L S A VGT +M
Sbjct: 112 VVEGLTYLYNVHR-IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGTSTYM 169
Query: 109 APE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSE-------CTHPAQIYKKV--ISGKK 158
+PE + +Y D++S G+ I+E+ +P++ P I + I +
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229
Query: 159 PEALFKVEDPEV-RQFIEKCL-ATVSSRLSARELL-TDPFLQID 199
P L + PE R F++ CL + R + ++L PF+Q
Sbjct: 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 42/96 (43%), Positives = 62/96 (64%), Gaps = 6/96 (6%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTP 105
QI+SGL +LH R +I+RDLK +N+ ++ N G V+I DLGLA L+ +S GTP
Sbjct: 105 QIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTP 161
Query: 106 EFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 140
FMAPE+ + EEY+ VD ++ G+ + EM+ P+
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 45/147 (30%), Positives = 81/147 (55%), Gaps = 6/147 (4%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ F+ E G L + K R K + +++ YLHS+D +I+RDLK +
Sbjct: 90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPE 147
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCI 130
N+ ++ N+G VK+ D G A + C GTPE++APEV + + + + VD ++ G+ +
Sbjct: 148 NLLLD-NKGHVKVTDFGFAKKVPDRTFTLC-GTPEYLAPEVIQSKGHGKAVDWWTMGVLL 205
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGK 157
E + P+ + T P +IY+K+++G+
Sbjct: 206 YEFIAGYPPFFDDT-PFRIYEKILAGR 231
|
Length = 329 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 44/111 (39%), Positives = 65/111 (58%), Gaps = 10/111 (9%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR- 100
+ + CR+ L GL YLHS+ +HRD+K NI + N G+VK+ D G+AA + + A R
Sbjct: 108 IAYVCRETLQGLAYLHSKGK--MHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRK 164
Query: 101 -CVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHP 146
+GTP +MAPEV E YN+L DI++ G+ +E+ P + HP
Sbjct: 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD-LHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 53/164 (32%), Positives = 82/164 (50%), Gaps = 13/164 (7%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR- 100
+ + CR+IL GL +LH VIHRD+K N+ + N EVK+ D G++A L ++ R
Sbjct: 113 IAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRN 169
Query: 101 -CVGTPEFMAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153
+GTP +MAPEV + Y+ D++S G+ +EM P + HP + +
Sbjct: 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLI 228
Query: 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
P K + + FIE CL S R + +L+ PF+
Sbjct: 229 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 56/164 (34%), Positives = 83/164 (50%), Gaps = 13/164 (7%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR- 100
+ + CR+IL GL +LH+ VIHRD+K N+ + N EVK+ D G++A L ++ R
Sbjct: 123 IAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRN 179
Query: 101 -CVGTPEFMAPEVY------EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153
+GTP +MAPEV + Y+ DI+S G+ +EM P + HP + +
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLI 238
Query: 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
P+ K + FIE CL SR S +LL PF+
Sbjct: 239 PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 41/118 (34%), Positives = 65/118 (55%), Gaps = 7/118 (5%)
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH--AARCV 102
W QI L ++H R ++HRD+K NIF+ G +K+GD G+A +L + A C+
Sbjct: 106 WFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCI 162
Query: 103 GTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159
GTP +++PE+ E YN DI++ G + EM T + + E + + K+I G P
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 47/136 (34%), Positives = 75/136 (55%), Gaps = 10/136 (7%)
Query: 11 ANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRD 67
A+ ++ V E G L Q ++K +R + + W Q+ G+ ++H + V+HRD
Sbjct: 69 ADGHLYIVMEYCDGGDLMQ-KIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRD 125
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEE-EYNELVDIY 124
+K NIF+ N G+VK+GD G A +L A C VGTP ++ PE++E YN DI+
Sbjct: 126 IKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIW 184
Query: 125 SFGMCILEMVTFDYPY 140
S G + E+ T +P+
Sbjct: 185 SLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 23/182 (12%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
N+ FV E G L + + ++ + +I+ GL +LHS+ +++RDLK DNI
Sbjct: 70 NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNI 127
Query: 74 FVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCI 130
++ G +KI D G+ +L + GTP+++APE+ ++YN VD +SFG+ +
Sbjct: 128 LLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLL 186
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALF---KVEDPEVRQFIEKCLATVSSRLSA 187
EM+ P+ G E LF ++++P +++ + + +L
Sbjct: 187 YEMLIGQSPF--------------HGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 188 RE 189
RE
Sbjct: 233 RE 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR- 100
+ + R+ L GL YLHS+ +HRD+K NI + N G VK+ D G++A + + A R
Sbjct: 108 IAYVSRETLQGLYYLHSKGK--MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRK 164
Query: 101 -CVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVI 154
+GTP +MAPEV E YN+L DI++ G+ +E+ P + HP + ++
Sbjct: 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD-LHPMRALFLMTK 223
Query: 155 SGKKPEALF-KVE-DPEVRQFIEKCLA-TVSSRLSARELLTDPF 195
S +P L K++ F++ L R +A +LL PF
Sbjct: 224 SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 46/135 (34%), Positives = 66/135 (48%), Gaps = 8/135 (5%)
Query: 10 TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
T + + FV E G L + RAV + +L GL YLH +++RDLK
Sbjct: 73 TEDH-VCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL-GLQYLHENK--IVYRDLK 128
Query: 70 CDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSF 126
DN+ ++ +G VKI D GL + + GTPEF+APEV E Y VD +
Sbjct: 129 LDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGL 187
Query: 127 GMCILEMVTFDYPYS 141
G+ I EM+ + P+
Sbjct: 188 GVLIYEMLVGESPFP 202
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 16/188 (8%)
Query: 17 FVTEMFTSGTLRQ--YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
V + G L+ Y + R + + V H+ QI G+L+LHS D +++RD+K +N+
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVL 127
Query: 75 VNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCIL 131
++ +QG ++ DLGLA L+ K+ R GT +MAPE+ +EE Y+ VD ++ G I
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPEILKEEPYSYPVDWFAMGCSIY 185
Query: 132 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE----DPEVRQFIEKCLA-TVSSRLS 186
EMV P+ + H ++ K+ + + E K E E + LA RL
Sbjct: 186 EMVAGRTPFKD--HKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLG 243
Query: 187 ARELLTDP 194
+RE DP
Sbjct: 244 SREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 44/131 (33%), Positives = 63/131 (48%), Gaps = 11/131 (8%)
Query: 12 NRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
N + FV E + G L Q K + + ++ QIL GL ++H HRDLK
Sbjct: 70 NDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLK 126
Query: 70 CDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSF 126
+N+ V+G VKI D GLA I + V T + APE+ Y+ VDI++
Sbjct: 127 PENLLVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWAL 185
Query: 127 GMCIL-EMVTF 136
G CI+ E+ T
Sbjct: 186 G-CIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 54/162 (33%), Positives = 80/162 (49%), Gaps = 22/162 (13%)
Query: 50 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEF 107
L GL +LH+ +IHRD+K +NI + +G VK+ D G++A L + R VGTP +
Sbjct: 138 LLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194
Query: 108 MAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 161
MAPEV Y+ Y+ D++S G+ +E+ D P + HP + K+ P
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTL 253
Query: 162 LFKVEDPE-----VRQFIEKCL-ATVSSRLSARELLTDPFLQ 197
L PE FI +CL +R S LL PF++
Sbjct: 254 L----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 44/114 (38%), Positives = 59/114 (51%), Gaps = 14/114 (12%)
Query: 33 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGL 89
K + VK QIL+G+ YLHS V+HRDLK NI V G +G VKIGDLGL
Sbjct: 101 KRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158
Query: 90 AAILRK-----SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
A + + V T + APE+ Y + +DI++ G CI E++T
Sbjct: 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 40/127 (31%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + R ++ + +I+ GL +LHS+ +I+RDLK DN+ ++
Sbjct: 73 FVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD 130
Query: 77 GNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
+ G +KI D G+ + + A+ GTP+++APE+ + +Y VD +SFG+ + EM
Sbjct: 131 RD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
Query: 134 VTFDYPY 140
+ P+
Sbjct: 190 LIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 50/142 (35%), Positives = 74/142 (52%), Gaps = 12/142 (8%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
RN+ V E G+LR Y KHR R++ R + + QI G+ YL S+ +HRDL
Sbjct: 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATR 137
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE-----FMAPE-VYEEEYNELVDIYS 125
NI V ++ VKIGD GL +L + V P + APE + E +++ D++S
Sbjct: 138 NILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWS 196
Query: 126 FGMCILEMVTFDYPYSECTHPA 147
FG+ + E+ F Y C+ PA
Sbjct: 197 FGVVLYEL--FTYSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 39/179 (21%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA------------------------- 98
IHRD+K DNI + G +K+ D GL + K+
Sbjct: 123 IHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 99 ---ARC---VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151
R VGTP+++APEV Y D +S G+ + EM+ P+ T + Y
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-LQETYN 240
Query: 152 KVISGKKPEALFKVED---PEVRQFIEKCLATVSSRL-SARELLTDPFLQIDDYDSDLR 206
K+I+ K+ F + PE I + L RL S E+ + PF + D+++
Sbjct: 241 KIINWKE-SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWENLRE 298
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 51/152 (33%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 32 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91
+K ++++ ++ QIL GL Y+HS +IHRDLK NI VN + E+KI D GLA
Sbjct: 110 VKCQKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLAR 166
Query: 92 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCIL-EMVTFD--YPYSECTHP 146
V T + APE+ YN+ VDI+S G CI+ E++T +P S+ H
Sbjct: 167 HTDDEMTGY-VATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGKTLFPGSD--HI 222
Query: 147 AQIYK--KVISGKKPEALFKVEDPEVRQFIEK 176
Q+ + ++ E L K+ R +I+
Sbjct: 223 DQLKRIMNLVGTPDEELLQKISSESARNYIQS 254
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 39/127 (30%), Positives = 68/127 (53%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + K RR + + + +I S L++LH + +I+RDLK DN+ ++
Sbjct: 73 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 133
++G K+ D G+ I + GTP+++APE+ +E Y VD ++ G+ + EM
Sbjct: 131 -HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEM 189
Query: 134 VTFDYPY 140
+ P+
Sbjct: 190 LCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 39/102 (38%), Positives = 57/102 (55%), Gaps = 13/102 (12%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
++++ Q+L GL Y+HS + VIHRDLK N+ VN + E++IGD G+A L S
Sbjct: 109 IRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHK 165
Query: 102 ------VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMV 134
V T + APE+ EY +D++S G CI EM+
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 60/185 (32%), Positives = 87/185 (47%), Gaps = 26/185 (14%)
Query: 24 SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 83
S L ++ + V I AV H L GL YLHS + +IHRD+K NI ++ G VK
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGA---LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVK 155
Query: 84 IGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYP 139
+GD G A+I+ + A VGTP +MAPEV E +Y+ VD++S G+ +E+ P
Sbjct: 156 LGDFGSASIM--APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
Query: 140 ------YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLT 192
S H AQ + F R F++ CL + R ++ LL
Sbjct: 214 LFNMNAMSALYHIAQNESPALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLK 266
Query: 193 DPFLQ 197
F+
Sbjct: 267 HRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 9/125 (7%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+T++ G L Y H+ + + + +WC QI G+ YL + ++HRDL N+ V
Sbjct: 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK 143
Query: 77 GNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGMCIL 131
Q VKI D GLA +L K + A P ++MA E + Y D++S+G+ +
Sbjct: 144 TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 132 EMVTF 136
E++TF
Sbjct: 203 ELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 16/136 (11%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEV-YEEEYNELV 121
IHRDLK +N F+ G +K+ D GL+ I+ +++ VG+P++MAPEV + Y+ V
Sbjct: 123 IHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYANSV--VGSPDYMAPEVLRGKGYDFTV 179
Query: 122 DIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKK----P---EALFKVEDPEVRQF 173
D +S G C+L E + P+S T P + ++ + K+ P + F + D E
Sbjct: 180 DYWSLG-CMLYEFLCGFPPFSGST-PNETWENLKYWKETLQRPVYDDPRFNLSD-EAWDL 236
Query: 174 IEKCLATVSSRLSARE 189
I K + S R + E
Sbjct: 237 ITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 57/178 (32%), Positives = 86/178 (48%), Gaps = 14/178 (7%)
Query: 24 SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 83
S L ++ + V I A+ H L GL YLHS + +IHRD+K NI + G+VK
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVK 165
Query: 84 IGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYP 139
+ D G A+I S A VGTP +MAPEV E +Y+ VD++S G+ +E+ P
Sbjct: 166 LADFGSASIA--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
Query: 140 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFL 196
+ +Y + + P R F++ CL + R ++ ELL F+
Sbjct: 224 LFNMNAMSALY-HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + + +I+S L YLHSRD V++RD+K +N+ ++
Sbjct: 72 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD 129
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 133
G +KI D GL I + GTPE++APEV E+ +Y VD + G+ + EM
Sbjct: 130 -KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 134 VTFDYPYSECTH 145
+ P+ H
Sbjct: 189 MCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 51/163 (31%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-------RKSH 97
+ +QIL G+ YLH + V+HRD+K +N+ + N G +K+ D G A L S+
Sbjct: 107 YTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSN 163
Query: 98 AARCV-GTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155
+ + GTP +MAPEV E Y DI+S G + EM T P + A ++ + +
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGA 222
Query: 156 GKKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
+ L F+ CL R SA +LL FL
Sbjct: 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/181 (31%), Positives = 86/181 (47%), Gaps = 14/181 (7%)
Query: 24 SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 83
S L ++ + V I A+ H L GL YLHS + +IHRD+K NI + G+VK
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGA---LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVK 161
Query: 84 IGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYP 139
+ D G A+ S A VGTP +MAPEV E +Y+ VD++S G+ +E+ P
Sbjct: 162 LADFGSASKS--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219
Query: 140 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQI 198
+ +Y + P R F++ CL + R ++ ELL F++
Sbjct: 220 LFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278
Query: 199 D 199
D
Sbjct: 279 D 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 35/114 (30%), Positives = 57/114 (50%), Gaps = 18/114 (15%)
Query: 31 RLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 88
L+ + VK + R +L G+ Y+H+ ++HRDLK N+ + G +KI D G
Sbjct: 88 VLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFG 144
Query: 89 LAAILRK------SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EM 133
LA + + SH V T + APE+ +Y+ VD+++ G CI E+
Sbjct: 145 LARLFSEEEPRLYSHQ---VATRWYRAPELLYGARKYDPGVDLWAVG-CIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 56/196 (28%), Positives = 92/196 (46%), Gaps = 24/196 (12%)
Query: 20 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79
E+FT R++ + V+ + +I+ L +LH +I+RD+K +NI ++
Sbjct: 91 ELFTHLYQREHFTESE------VRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE- 141
Query: 80 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY---EEEYNELVDIYSFGMCILEM 133
G V + D GL+ R GT E+MAPEV +++ VD +S G+ E+
Sbjct: 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
Query: 134 VTFDYPYS---ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL---S 186
+T P++ E ++I ++++ K P K E R FI+K L RL
Sbjct: 202 LTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 187 ARELLTDPFLQIDDYD 202
A E+ PF Q D+D
Sbjct: 260 ADEIKNHPFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 38/102 (37%), Positives = 58/102 (56%), Gaps = 15/102 (14%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-----S 96
VK Q+LSG+ +LH ++HRDLK N+ +N N+G +KI D GLA R+
Sbjct: 108 VKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLN-NRGILKICDFGLA---REYGSPLK 161
Query: 97 HAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
+ V T + APE+ +EY+ +D++S G CI E++T
Sbjct: 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V E+ G L +Y K R + + +K Q+ G+ YL S+ +HRDL N+ +
Sbjct: 73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV- 129
Query: 78 NQGEVKIGDLGLAAILRKS---HAARCVGT-P-EFMAPE-VYEEEYNELVDIYSFGMCIL 131
N+ + KI D G++ L + A G P ++ APE + +++ D++S+G+ +
Sbjct: 130 NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK 158
E ++ PY E ++ + SG++
Sbjct: 190 EAFSYGAKPYGEMKGA-EVIAMLESGER 216
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 41/133 (30%), Positives = 60/133 (45%), Gaps = 30/133 (22%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
NIN V E F L + +K + + + +K + L GL YLHS ++HRDLK +
Sbjct: 76 NINLVFE-FMETDLEKV-IKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPN 131
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPEV----YE--------EEYN 118
N+ + + G +K+ D GL AR G+P M +V Y Y
Sbjct: 132 NLLIASD-GVLKLADFGL---------ARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181
Query: 119 ELVDIYSFGMCIL 131
VD++S G CI
Sbjct: 182 VGVDMWSVG-CIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 45/153 (29%), Positives = 80/153 (52%), Gaps = 13/153 (8%)
Query: 9 DTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
+ I + E SG+L++Y +++ ++N++ + QI G+ YL SR +HRD
Sbjct: 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRD 134
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV----GTPEF-MAPE-VYEEEYNELV 121
L N+ V ++ +VKIGD GL + V +P F APE + + ++
Sbjct: 135 LAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS 193
Query: 122 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154
D++SFG+ + E++T Y SE + P ++ K+I
Sbjct: 194 DVWSFGVTLYELLT--YCDSESS-PMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 36 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 95
R+ + + + L GL +LH IHRD+K +NI + +G VK+ D G++A L
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTS 176
Query: 96 SHAAR--CVGTPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA 147
+ R VGTP +MAPEV + Y+ D++S G+ +E+ D P ++ HP
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD-LHPM 235
Query: 148 QIYKKVISGKKPEALFKVEDPEV-----RQFIEKCLAT-VSSRLSARELLTDPFL 196
+ K+ P + PE+ FI KCL R + +LL F+
Sbjct: 236 RALFKIPRNPPP----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 44/118 (37%), Positives = 62/118 (52%), Gaps = 25/118 (21%)
Query: 35 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 94
R + I +QIL GL YLH++ +IHRD+K +NIF+N + +V IGDLG
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLG------ 202
Query: 95 KSHAARC----------VGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYPYS 141
AA+ GT E APEV ++YN DI+S G+ + EM+ YP +
Sbjct: 203 ---AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPST 255
|
Length = 357 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 36/112 (32%), Positives = 61/112 (54%), Gaps = 11/112 (9%)
Query: 32 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91
L+ ++ + + Q+L GL Y+HS + V+HRDLK N+F+N +KIGD GLA
Sbjct: 106 LEQGPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLAR 163
Query: 92 IL-----RKSHAARCVGTPEFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT 135
I+ K + + + T + +P + Y + +D+++ G CI EM+T
Sbjct: 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
++F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK NI
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANIL 129
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILE 132
++ + G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G + +
Sbjct: 130 LDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 188
Query: 133 MVTFDYPYSE-CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRL----- 185
++ P+ + T ++ E L PE+R +E L V+ RL
Sbjct: 189 LLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFSPELRSLLEGLLQRDVNRRLGCLGR 247
Query: 186 SARELLTDPFLQIDDY 201
A+E+ PF + D+
Sbjct: 248 GAQEVKEHPFFRSLDW 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 30/191 (15%)
Query: 8 VDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65
V T I VTE+ G+L +Y R + + + Q+ SG+ YL +++ IH
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIH 126
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARCVGTP---EFMAPEVYEEEYNELV 121
RDL N+ V G K+ D GLA ++++ + AR G ++ APE YN
Sbjct: 127 RDLAARNVLV-GENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEA--ALYNRFS 182
Query: 122 ---DIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV----- 165
D++SFG+ + E+VT+ PY T+ A++ ++V G + P+ L+ +
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYRMPCPPGCPKELYDIMLDCW 241
Query: 166 -EDPEVRQFIE 175
EDP+ R E
Sbjct: 242 KEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 18 VTEMFTSGTLRQYRLKHR----RVNIRAVKH------WCRQILSGLLYLHSRDPPVIHRD 67
V E+ G L+ Y R +I G+ YL ++ +HRD
Sbjct: 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRD 144
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT---P-EFMAPE-VYEEEYNELVD 122
L N V + VKIGD G+ + ++ R G P +MAPE + + + D
Sbjct: 145 LAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSD 203
Query: 123 IYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 160
++SFG+ + EM T + PY ++ ++ K VI G PE
Sbjct: 204 VWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVIDGGHLDLPE 244
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 41/126 (32%), Positives = 67/126 (53%), Gaps = 3/126 (2%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
I+ E G+L Q + +R+ + +L GL YL + ++HRD+K NI
Sbjct: 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ-IMHRDVKPSNIL 136
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
VN ++GE+K+ D G++ L S A VGT +M+PE + Y+ DI+S G+ ++E+
Sbjct: 137 VN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 134 VTFDYP 139
YP
Sbjct: 196 AIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV + G L + + R + + +I S L YLHS + +I+RDLK +NI ++
Sbjct: 73 FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEM 133
+QG V + D GL I + GTPE++APEV ++ Y+ VD + G + EM
Sbjct: 131 -SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEM 189
Query: 134 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL-ATVSSRLSARELLT 192
+ + P A++Y +++ KP L R +E L + RL A+
Sbjct: 190 L-YGLPPFYSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQKDRTKRLGAK---- 242
Query: 193 DPFLQIDDY 201
D FL+I ++
Sbjct: 243 DDFLEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 38/133 (28%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
V ++ V E + + + + R + +K + Q+L GL + HS ++HRD
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRD 123
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVY--EEEYNELVDI 123
LK +N+ +N G +K+ D GLA V T + APE+ ++ Y+ VDI
Sbjct: 124 LKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182
Query: 124 YSFGMCIL-EMVT 135
+S G CI E+++
Sbjct: 183 WSVG-CIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 39/113 (34%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 28 RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 87
R R + + +K + Q+L G+ + H V+HRDLK N+ V+ +G +KI DL
Sbjct: 98 SNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADL 155
Query: 88 GLA---AILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 135
GL +I KS+ V T + APEV Y+ VDI+S G EM
Sbjct: 156 GLGRAFSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 12/144 (8%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
R++ + E SG+LR Y +HR ++N++ + + QI G+ YL S+ IHRDL
Sbjct: 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAAR 138
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE-----FMAPE-VYEEEYNELVDIYS 125
NI V ++ VKI D GLA +L + V P + APE + +++ D++S
Sbjct: 139 NILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWS 197
Query: 126 FGMCILEMVTFDYPYSECTHPAQI 149
FG+ + E+ F Y + PA+
Sbjct: 198 FGVTLYEL--FTYGDPSQSPPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 10/133 (7%)
Query: 15 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
+ +T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL N+
Sbjct: 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNV 140
Query: 74 FVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGM 128
V Q VKI D GLA +L K + A P ++MA E + Y D++S+G+
Sbjct: 141 LVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 129 CILEMVTFDY-PY 140
+ E++TF PY
Sbjct: 200 TVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 42/128 (32%), Positives = 70/128 (54%), Gaps = 9/128 (7%)
Query: 15 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
I VT++ G L Y +H+ + + + +WC QI G++YL R ++HRDL N+
Sbjct: 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNV 140
Query: 74 FVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFGM 128
V + VKI D GLA +L K + A P ++MA E ++ ++ D++S+G+
Sbjct: 141 LVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGV 199
Query: 129 CILEMVTF 136
I E++TF
Sbjct: 200 TIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 37/100 (37%), Positives = 58/100 (58%), Gaps = 10/100 (10%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--- 98
+K + +Q+L GL Y H ++ +HRD+KC NI +N N+G++K+ D GLA + +
Sbjct: 118 IKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPY 174
Query: 99 ARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
V T + PE+ EE Y +D++S G CIL E+ T
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEEE----Y 117
+IHRD+K NI ++ N G +K+ D G++ L S A R G +MAPE + Y
Sbjct: 129 IIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGY 187
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE---ALFKVEDPEVRQFI 174
+ D++S G+ + E+ T +PY + +V+ G P + + P FI
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFI 247
Query: 175 EKCL-ATVSSRLSARELLTDPFLQIDDYDS 203
CL S R +ELL PF++ DY+
Sbjct: 248 NLCLIKDESKRPKYKELLEHPFIK--DYEE 275
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 63/301 (20%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K + S+ D N + + E G + +K + + + + + + +H
Sbjct: 64 VKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----------------------- 97
IHRD+K DN+ ++ ++G VK+ D GL L+K+H
Sbjct: 122 --FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 98 --------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSE 142
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 143 CTHPAQIYKKVISGKKPEALFKVEDP---EVRQFIEKCLATVSSRLSA---RELLTDPFL 196
T P + YKKV++ K+ +F E P + + I + R+ A E+ T+PF
Sbjct: 239 ET-PQETYKKVMNWKE-TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFF 296
Query: 197 QIDDYDS----------DLRMIQYQTDYDEI--SPLLRQSLYGIYHSNSSSNNGCGHYIG 244
+ D++ +++ I +++DE S +L+ ++ H + N +I
Sbjct: 297 EGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFIN 356
Query: 245 Y 245
Y
Sbjct: 357 Y 357
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 56/189 (29%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 97
IHRD+K DN+ ++ +G +K+ D GL L+KSH
Sbjct: 123 IHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 98 --------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--Y 140
A VGTP+++APEV+ + YN+ D +S G+ + EM+ YP
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV-GYPPFC 240
Query: 141 SECTHPAQIYKKVISGKKPEALFKVED----PEVRQFIEKCLATVSSRL---SARELLTD 193
S+ +P + Y+K+I+ K E L ++ PE + I++ RL E+ +
Sbjct: 241 SD--NPQETYRKIINWK--ETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296
Query: 194 PFLQIDDYD 202
PF + D++
Sbjct: 297 PFFKGVDWE 305
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 20/198 (10%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
VT+ + G L + K R + K + +++ L +LH D +++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 77 GNQGEVKIGDLGLA-AILRKSHAARC-VGTPEFMAPEVYEEE--YNELVDIYSFGMCILE 132
G + + D GL+ A L + GT E++APEV +E Y + VD +S G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 133 MVTFDYP-YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-----TVSSR 184
M P Y+E T Q+Y+ + GK P+ + E RQF++ L + +
Sbjct: 190 MCCGWSPFYAEDTQ--QMYRNIAFGKVRFPKNVLSDEG---RQFVKGLLNRNPQHRLGAH 244
Query: 185 LSARELLTDPFLQIDDYD 202
A EL PF D+D
Sbjct: 245 RDAVELKEHPFFADIDWD 262
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 12/97 (12%)
Query: 41 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 100
VK Q+L GL YLH +IHRDLK N+ + G +KI D GLA A+
Sbjct: 109 QVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLAR--TYGLPAK 163
Query: 101 ----CVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL 131
V T + APE+ Y +D+++ G CIL
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 42/126 (33%), Positives = 67/126 (53%), Gaps = 3/126 (2%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
I+ E G+L Q K R+ + + ++ GL YL + ++HRD+K NI
Sbjct: 78 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNIL 136
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
VN ++GE+K+ D G++ L S A VGT +M+PE + Y+ DI+S G+ ++EM
Sbjct: 137 VN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
Query: 134 VTFDYP 139
YP
Sbjct: 196 AIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 48/134 (35%), Positives = 71/134 (52%), Gaps = 10/134 (7%)
Query: 17 FVTEMFTSGTLRQYRLKHRRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
FV E G L + L RV RA + + +I+S L YLHS D V++RDLK +N+
Sbjct: 72 FVMEYANGGELF-FHLSRERVFSEDRA-RFYGAEIVSALGYLHSCD--VVYRDLKLENLM 127
Query: 75 VNGNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCIL 131
++ + G +KI D GL I + GTPE++APEV E+ +Y VD + G+ +
Sbjct: 128 LDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 132 EMVTFDYPYSECTH 145
EM+ P+ H
Sbjct: 187 EMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + R+ + + + ++ L++LH VI+RDLK DNI ++
Sbjct: 73 FVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 133
+G K+ D G+ IL GTP+++APE+ +E EY VD ++ G+ + EM
Sbjct: 131 A-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEM 189
Query: 134 VTFDYPYS--------------ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
+ P+ + +P + K+ +S K F ++P R L
Sbjct: 190 MAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKA---FMTKNPNKR------LG 240
Query: 180 TVSSRLSARELLTDPFLQIDDYD 202
V+S+ + PF + D+
Sbjct: 241 CVASQGGEDAIKQHPFFKEIDWV 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-11
Identities = 38/114 (33%), Positives = 65/114 (57%), Gaps = 9/114 (7%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVG 103
+Q+L + Y+H + +IHRD+K +NIF+N + G++ +GD G A K A VG
Sbjct: 274 KQLLCAVEYIHDK--KLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVG 330
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-PYSECT-HPAQIYKKVI 154
T +PE+ + Y E+ DI+S G+ +L+M++ D+ P + P + K+I
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384
|
Length = 501 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 38/128 (29%), Positives = 69/128 (53%), Gaps = 5/128 (3%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
F+ ++ G L + +H + + ++ + +I+ GL ++H+R V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD 131
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMV 134
G V+I DLGLA K VGT +MAPEV ++ Y+ D +S G + +++
Sbjct: 132 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 135 TFDYPYSE 142
P+ +
Sbjct: 191 RGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAARCVGTP 105
+I GL +LHS+ +I+RDLK DN+ ++ +G +KI D G+ I GTP
Sbjct: 109 EIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTP 165
Query: 106 EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY 140
+++APE + + Y + VD ++FG+ + EM+ P+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 12/96 (12%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-----ARCV 102
QIL GL Y+HS + V+HRDLK N+ +N N ++KI D GLA I H V
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 103 GTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
T + APE+ + Y + +DI+S G CIL EM++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 43/132 (32%), Positives = 69/132 (52%), Gaps = 5/132 (3%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + + + +I+S L YLHS + V++RDLK +N+ ++
Sbjct: 72 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 133
+ G +KI D GL I + GTPE++APEV E+ +Y VD + G+ + EM
Sbjct: 131 KD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 189
Query: 134 VTFDYPYSECTH 145
+ P+ H
Sbjct: 190 MCGRLPFYNQDH 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 42/132 (31%), Positives = 68/132 (51%), Gaps = 6/132 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + + + +I+S L YLHS +++RDLK +N+ ++
Sbjct: 72 FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD 129
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 133
+ G +KI D GL I + GTPE++APEV E+ +Y VD + G+ + EM
Sbjct: 130 KD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 134 VTFDYPYSECTH 145
+ P+ H
Sbjct: 189 MCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 51/201 (25%), Positives = 76/201 (37%), Gaps = 59/201 (29%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------------------------ 99
IHRD+K DNI ++ G +K+ D GL R +H +
Sbjct: 123 IHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 100 ----------------RC-----VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFD 137
RC VGTP ++APEV Y +L D +S G+ + EM+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 138 YPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFIEKCLATVSSRL---SARE 189
P+ T PA+ KVI+ + +A E I + RL A E
Sbjct: 242 PPFLADT-PAETQLKVINWETTLHIPSQAKLS---REASDLILRLCCGAEDRLGKNGADE 297
Query: 190 LLTDPFLQIDDYDSDLRMIQY 210
+ PF + D+ S +R +
Sbjct: 298 IKAHPFFKGIDFASLIRRQKA 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 45/133 (33%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 99
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETI 158
Query: 100 RC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157
R VGT +MAPEV + E Y D + G I EM+ E P + K+ + +
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI-------EGKSPFRQRKEKVKRE 211
Query: 158 KPEALFKVEDPEV 170
+ E K ED E
Sbjct: 212 EVERRVK-EDQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 59/246 (23%), Positives = 108/246 (43%), Gaps = 51/246 (20%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K + S+ D RN+ + E G + +K ++ A + + + + + +H
Sbjct: 64 VKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----------------------- 97
IHRD+K DN+ ++ +G VK+ D GL L+K+H
Sbjct: 122 --FIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 98 --------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSE 142
A VGTP+++APEV+ + YN+L D +S G+ + EM+ P+
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 143 CTHPAQIYKKVISGKKPEALFKVEDP---EVRQFIEKCLATVSSRL---SARELLTDPFL 196
T P + Y+KV++ K+ +F E P + + I + +R+ E+ + PF
Sbjct: 239 ET-PQETYRKVMNWKE-TLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFF 296
Query: 197 QIDDYD 202
+ D+
Sbjct: 297 EGVDWG 302
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 27/143 (18%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L GL Y+HS + V+HRDLK N+ +N N ++KI D GLA R + +F
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLA---RTTSE-----KGDF 164
Query: 108 M----------APEVY--EEEYNELVDIYSFGMCIL-EMVTFD--YPYSECTHPAQIYKK 152
M APE+ EY +D++S G CI E++ +P + H ++ +
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 153 VISGKKPEALFKVEDPEVRQFIE 175
++ E L + + + R++I
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIR 246
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 40/133 (30%), Positives = 69/133 (51%), Gaps = 10/133 (7%)
Query: 15 INFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
+ VT++ G L Y +++ R+ + + +WC QI G+ YL + ++HRDL N+
Sbjct: 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL--EEVRLVHRDLAARNV 140
Query: 74 FVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGM 128
V + VKI D GLA +L + HA ++MA E + + D++S+G+
Sbjct: 141 LVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199
Query: 129 CILEMVTFDY-PY 140
+ E++TF PY
Sbjct: 200 TVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 23/176 (13%)
Query: 18 VTEMFTSG----TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
VTE+ G LR+ L H I + + QI +G+ YL S+ IHRDL NI
Sbjct: 73 VTELAPLGSLLDRLRKDALGH--FLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNI 128
Query: 74 FVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPE-VYEEEYNELVDIYSF 126
+ + +VKIGD GL L ++ V + APE + ++ D++ F
Sbjct: 129 LLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFA-WCAPESLRTRTFSHASDVWMF 186
Query: 127 GMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCLA 179
G+ + EM T+ + P++ + +QI KK+ K+ E L + E ++ + +C A
Sbjct: 187 GVTLWEMFTYGEEPWAGLS-GSQILKKI--DKEGERLERPEACPQDIYNVMLQCWA 239
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 55/190 (28%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRA-VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
FV + G L Y L+ R + + + +I S L YLHS + +++RDLK +NI +
Sbjct: 73 FVLDYINGGELF-YHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILL 129
Query: 76 NGNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILE 132
+ +QG + + D GL I + GTPE++APEV +++ Y+ VD + G + E
Sbjct: 130 D-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 188
Query: 133 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 191
M+ + P + A++Y +++ KP L R +E L + RL A
Sbjct: 189 ML-YGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLLQKDRTKRLGA---- 241
Query: 192 TDPFLQIDDY 201
D F++I ++
Sbjct: 242 KDDFMEIKNH 251
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 40/170 (23%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--------- 98
+I + + Y+HS+ V+HRDLK DNI + G GEV I D G AAI +K
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWG-AAIFKKLEEEDLLDIDVD 176
Query: 99 ------------ARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTH 145
+ VGTP++MAPE + +E DIY+ G+ + +M+T +PY
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR--- 233
Query: 146 PAQIYKKVISGKKPEALFKVEDP-EVRQFIEKCLATVSSRLSARELLTDP 194
KK G+K + P EV + E + S+++ + L DP
Sbjct: 234 -----KK---GRKISYRDVILSPIEVAPYRE--IPPFLSQIAMKALAVDP 273
|
Length = 932 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 61/189 (32%), Positives = 85/189 (44%), Gaps = 42/189 (22%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA------AILRKSHAARC 101
QIL GL Y+HS + V+HRDLK N+ VN + E+KI D GLA
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEY 169
Query: 102 VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMV----TF---DY------------- 138
V T + APE+ + Y + +D++S G CIL E++ F DY
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVG-CILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 139 PYSEC-----THPAQIYKK---VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARE 189
P E + AQ Y + I K E++F +P +EK LA + R+S E
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEE 288
Query: 190 LLTDPFLQI 198
L P+L I
Sbjct: 289 ALEHPYLAI 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 44/194 (22%)
Query: 41 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR 100
AV+ + Q+L + Y HS + +IHRD+K +NI V+ + G +K+ D G A LR A+
Sbjct: 101 AVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPASP 157
Query: 101 C---VGTPEFMAPE--VYEEEYNELVDIYSFGMCIL-EMVTFD--YPYSECTH------- 145
V T + APE V + Y + VD+++ G CI+ E++ + +P +
Sbjct: 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLDGEPLFP-GDSDIDQLYLIQ 215
Query: 146 -------PAQIY----------KKVISGKKPEAL-----FKVEDPEVRQFIEKCLAT-VS 182
P+ +PE+L KV P + F++ CL
Sbjct: 216 KCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL-DFLKACLRMDPK 274
Query: 183 SRLSARELLTDPFL 196
RL+ ELL P+
Sbjct: 275 ERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAARCVGTPE 106
Q++ L YLH ++ ++HRDL +NI + G +V I D GLA +S VGT
Sbjct: 121 QMVLALRYLH-KEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 107 FMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 165
+ PE+ + E Y E D+++FG + +M T P+ T+ + K++ +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGM 237
Query: 166 EDPEVRQFIEKCLA 179
+V I CL
Sbjct: 238 YSEDVTDVITSCLT 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 45/132 (34%), Positives = 67/132 (50%), Gaps = 8/132 (6%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
QIL GL Y+HS D +IHRDLK N+ VN E+KI D GLA V T +
Sbjct: 128 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGY-VATRWY 183
Query: 108 MAPEVYEE--EYNELVDIYSFGMCILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALF 163
APE+ YN+ VDI+S G + E++T +P ++ ++ +++ E L
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 164 KVEDPEVRQFIE 175
K+ R +I+
Sbjct: 244 KISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 32 LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91
+KH +++ ++ Q+L GL Y+H+ +IHRDLK N+ VN E+KI D GLA
Sbjct: 110 MKHEKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 166
Query: 92 ILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149
S V T + APEV Y + VDI+S G + EM+T + H Q+
Sbjct: 167 -QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225
Query: 150 YK--KVISGKKPEALFKVEDPEVRQFIEK---------------------------CLAT 180
+ KV E + K++ + + +++K +
Sbjct: 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLD 285
Query: 181 VSSRLSARELLTDPFL-QIDDYDSDLRMIQYQTDYDEISPLLRQ 223
SR++A E L P+ + D + + Y +DE+ L +
Sbjct: 286 AESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEE 329
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 19/166 (11%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
+I L +LH + +I+RDLK +NI ++ QG VK+ D GL +I + GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTI 164
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 162
E+MAPE+ + + VD +S G + +M+T P++ I K++ GK P L
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI-DKILKGKLNLPPYL 223
Query: 163 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202
PE R ++K L SSRL A E+ + PF + ++D
Sbjct: 224 ----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWD 265
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 43/133 (32%), Positives = 72/133 (54%), Gaps = 10/133 (7%)
Query: 9 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
+ + + + E G+LR Y KH+ +N+ + + +QI G+ YLHS+ IHRDL
Sbjct: 77 EQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQH--YIHRDL 133
Query: 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG----TPEF-MAPEVYEE-EYNELVD 122
N+ ++ N VKIGD GLA + + H V +P F A E +E +++ D
Sbjct: 134 AARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASD 192
Query: 123 IYSFGMCILEMVT 135
++SFG+ + E++T
Sbjct: 193 VWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 9e-10
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 42/221 (19%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQ-----YRLKHRRVNIRAVKHWCRQILSGLLY 55
+++ +++ AN+ + + E +G L + Y++ ++ A+ RQ+L L Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAY 133
Query: 56 LHS-RDPP----VIHRDLKCDNIFV--------------NGNQGE--VKIGDLGLAA-IL 93
H+ +D P V+HRDLK NIF+ N G KIGD GL+ I
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 94 RKSHAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150
+S A CVGTP + +PE+ E Y++ D+++ G I E+ + P+ H A +
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF----HKANNF 249
Query: 151 KKVISGKK--PEALFKVEDPEVRQFIEKCLATVSSRLSARE 189
++IS K P+ K + E+ I+ L LSA+E
Sbjct: 250 SQLISELKRGPDLPIKGKSKELNILIKNLLN-----LSAKE 285
|
Length = 1021 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + R + +I GL +LHS+ +I+RDLK DN+ ++
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD 135
Query: 77 GNQGEVKIGDLGLAA--ILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
++G +KI D G+ + GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 136 -SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 134 VTFDYPY 140
+ P+
Sbjct: 195 LAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 43/141 (30%), Positives = 72/141 (51%), Gaps = 7/141 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV + G L + + R + + +I S L YLHS + +++RDLK +NI ++
Sbjct: 73 FVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 133
+QG V + D GL I + GTPE++APEV ++ Y+ VD + G + EM
Sbjct: 131 -SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189
Query: 134 VTFDYPYSECTHPAQIYKKVI 154
+ + P C A++Y ++
Sbjct: 190 L-YGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 40/107 (37%), Positives = 53/107 (49%), Gaps = 25/107 (23%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
VK + QIL G+L+ HSR V+HRDLK N+ ++ N+G +K+ D GL AR
Sbjct: 103 VKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGL---------ARA 150
Query: 102 VGTPE-----------FMAPEVY--EEEYNELVDIYSFGMCILEMVT 135
G P + APEV Y+ VDI+S G EM T
Sbjct: 151 FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 23/134 (17%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
IN V ++ + L++ + R+ VK QIL+GL LH +HRDL NIF
Sbjct: 95 INLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIF 151
Query: 75 VNGNQGEVKIGDLGLA-----------AILRKSHAARCVGTPE-----FMAPEVY--EEE 116
+N ++G KI D GLA ++ R T + + APE+ E+
Sbjct: 152 IN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK 210
Query: 117 YNELVDIYSFGMCI 130
Y+ VD++S G CI
Sbjct: 211 YHFAVDMWSVG-CI 223
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 39/125 (31%), Positives = 59/125 (47%), Gaps = 29/125 (23%)
Query: 27 LRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
L++Y ++ +K + Q+L G+ Y HS V+HRDLK N+ ++ +G +K+
Sbjct: 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKL 140
Query: 85 GDLGLAAILRKSHAARCVGTPE-----------FMAPEVY--EEEYNELVDIYSFGMCIL 131
D GL AR G P + APE+ +Y+ VDI+S G CI
Sbjct: 141 ADFGL---------ARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG-CIF 190
Query: 132 -EMVT 135
EMV
Sbjct: 191 AEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R++ + + +I L YLH R +I+RDLK DN+ ++
Sbjct: 73 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
++G +K+ D G+ + + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 -SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 134 VTFDYPY 140
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 18/154 (11%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVYEE----- 115
+HRD+K +N+ ++ G +K+ D G AA L + ++ VGTP+++APEV
Sbjct: 124 VHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 116 --EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV--- 170
Y D +S G+ EM+ P+ E T A+ Y +++ + L EDP+V
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQ--RFLKFPEDPKVSSD 239
Query: 171 -RQFIEKCLATVSSRLSARELLTDPFLQIDDYDS 203
I+ L RL L PF D+++
Sbjct: 240 FLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNN 273
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 66/209 (31%), Positives = 91/209 (43%), Gaps = 44/209 (21%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
V++ Q+L GL Y+HS +IHRDLK N+ VN E+KI D GLA R + A
Sbjct: 119 VQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLA---RHADAEMT 172
Query: 102 --VGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--KVIS 155
V T + APEV YN+ VDI+S G + EM+T + + Q+ + KV
Sbjct: 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 232
Query: 156 GKKPEALFKVEDPEVRQFI--------------------------EKCLA-TVSSRLSAR 188
PE + K+ED + +I EK L V RL+A
Sbjct: 233 VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292
Query: 189 ELLTDPFL-QIDDYDSDLRMIQYQTDYDE 216
E L P+ D D + Q YD+
Sbjct: 293 EALEHPYFDSFRDADEETE----QQPYDD 317
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 33/156 (21%)
Query: 10 TANRNINFVTEMFTSGTLRQYRLKH--RRV-----------------------NIRAVKH 44
TA R I+ + EM +R + H +R+ N R +K
Sbjct: 47 TAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKT 106
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAARC 101
+ QIL G+ Y HS V+HRDLK N+ ++ +K+ D GLA I ++
Sbjct: 107 YLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEV 164
Query: 102 VGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 135
V T + APE+ Y+ VDI+S G EMV
Sbjct: 165 V-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 7/142 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV + G L + + R + + ++ S + YLHS + +I+RDLK +NI ++
Sbjct: 73 FVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 133
+QG V + D GL + + + GTPE++APEV +E Y+ VD + G + EM
Sbjct: 131 -SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEM 189
Query: 134 VTFDYPYSECTHPAQIYKKVIS 155
+ + P +Q+Y ++
Sbjct: 190 L-YGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E + G L + + R++ + + +I L +LH R +I+RDLK DN+ ++
Sbjct: 73 FVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
+G +K+ D G+ I + GTP ++APE+ E+Y VD ++ G+ + EM
Sbjct: 131 A-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
Query: 134 VTFDYPY 140
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 38/142 (26%), Positives = 72/142 (50%), Gaps = 7/142 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V G L + + R ++ + + ++L L LH + VI+RDLK +NI ++
Sbjct: 70 LVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD 127
Query: 77 GNQGEVKIGDLGLAAI-LRKSHAARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
QG + + D GL + ++ GTPE++APE+ Y + VD ++ G+ + EM
Sbjct: 128 -YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
Query: 134 VTFDYPYSECTHPAQIYKKVIS 155
+T P+ + ++Y+K++
Sbjct: 187 LTGLPPFYDENVN-EMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CV 102
RQ+LS + Y+H +IHRD+K +N+ VNG + ++ +GD G A R S +
Sbjct: 267 RQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIA 323
Query: 103 GTPEFMAPEVYE-EEYNELVDIYSFGMCILE 132
GT + APEV + Y VDI+S G+ I E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 12/164 (7%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
++ Y V T R I VTE ++G L Y R +R + C+ + G+ YL S+
Sbjct: 62 VQLYG--VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYE-E 115
IHRDL N V+ +QG VK+ D GL+ + VG+ + PEV
Sbjct: 120 Q--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 116 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK 158
+++ D+++FG+ + E+ + PY + ++ +KV G +
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHA 98
+K + Q+L GL + HS V+HRDLK N+ +N +G +K+ D GLA + +++
Sbjct: 102 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 158
Query: 99 ARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 135
V T + APE+ + Y+ VDI+S G EMVT
Sbjct: 159 HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAA 99
VK + ++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A
Sbjct: 100 VKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAY 156
Query: 100 RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPY 140
GT E+MAPEV + + D +SFG+ + EM+T P+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 41/117 (35%), Positives = 68/117 (58%), Gaps = 13/117 (11%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVG 103
QI+ L +HSR ++HRDLK NIF+ G +K+GD G + S A+ G
Sbjct: 177 QIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 104 TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ--IYKKVISGK 157
TP ++APE++E + Y++ D++S G+ + E++T P+ P+Q I ++V+ GK
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---GPSQREIMQQVLYGK 287
|
Length = 478 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 14/131 (10%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + + + +I GL +LH R +I+RDLK DN+ ++
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD 135
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCV------GTPEFMAPEVYE-EEYNELVDIYSFGMC 129
++G +KI D G+ K H V GTP+++APE+ + Y + VD +++G+
Sbjct: 136 -SEGHIKIADFGMC----KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 130 ILEMVTFDYPY 140
+ EM+ P+
Sbjct: 191 LYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 35 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 94
R V +K Q L + + H + IHRD+K +NI + QG++K+ D G A IL
Sbjct: 95 RGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILT 151
Query: 95 KSHAA--RCVGTPEFMAPE--VYEEEYNELVDIYSFGMCILEMVT 135
V T + APE V + +Y VD+++ G E++T
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 57/205 (27%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRA-VKHWCR----QILSGLLYLHSRDPPVIHRDLK 69
I V + +G LRQ +K R R +H Q+L + ++HS+ +IHRD+K
Sbjct: 114 IALVLDYANAGDLRQ-EIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIK 170
Query: 70 CDNIFVNGNQGEVKIGDLGL----AAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIY 124
NI + N G VK+GD G AA + GTP ++APE++ + Y++ D++
Sbjct: 171 SANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 183
S G+ + E++T P+ + + ++ K ++G+ + L PE+++ + L++
Sbjct: 230 SLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKR 287
Query: 184 RLSARELLTDPFLQIDDYDSDLRMI 208
R S+ +LL P ++ + S L I
Sbjct: 288 RPSSSKLLNMPICKL--FISGLLEI 310
|
Length = 496 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 55/193 (28%), Positives = 80/193 (41%), Gaps = 42/193 (21%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--LRKS-HA 98
VK + QIL GL YLHS ++HRD+K N+ VN N +KI D GLA + +S H
Sbjct: 105 VKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHM 161
Query: 99 ARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCI-------------------LEMVTFD 137
+ V T + APE+ Y VDI+S G CI L+++T D
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CIFAELLGRRILFQAQSPIQQLDLIT-D 219
Query: 138 Y----PYSECTHPAQIYKKVI--SGKKPEA---LFKVEDP---EVRQFIEKCLA-TVSSR 184
+ + I KP + L+ + E + + L R
Sbjct: 220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR 279
Query: 185 LSARELLTDPFLQ 197
+SA + L P+L
Sbjct: 280 ISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
V T R I VTE +G L Y + + ++ + C + + YL S IHR
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHR 124
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYE-EEYNELVD 122
DL N V G VK+ D GLA + GT ++ PEV++ ++ D
Sbjct: 125 DLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 123 IYSFGMCILEMVT 135
++SFG+ + E+ +
Sbjct: 184 VWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 38/94 (40%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-AR 100
+K RQ L GL +LH+ ++HRDLK +NI V + G+VK+ D GLA I A
Sbjct: 110 IKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTP 166
Query: 101 CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEM 133
V T + APEV + Y VD++S G EM
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 45/136 (33%), Positives = 65/136 (47%), Gaps = 16/136 (11%)
Query: 15 INFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
I VTE + G+L + LK +++ + + QI G+ YL SR+ IHRDL
Sbjct: 76 IYIVTEYMSKGSLLDF-LKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAAR 132
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPEVYEEEYNELV---DIYS 125
NI V G KI D GLA ++ G P ++ APE Y D++S
Sbjct: 133 NILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEA--ANYGRFTIKSDVWS 189
Query: 126 FGMCILEMVTF-DYPY 140
FG+ + E+VT+ PY
Sbjct: 190 FGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 39/143 (27%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 14 NINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
++ VT++ G+L + +HR ++ + + +WC QI G+ YL ++HR+L N
Sbjct: 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARN 139
Query: 73 IFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTP-EFMAPE-VYEEEYNELVDIYSFG 127
I + + V+I D G+A +L K + TP ++MA E + Y D++S+G
Sbjct: 140 ILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG 198
Query: 128 MCILEMVTFDY-PYSECTHPAQI 149
+ + EM+++ PY+ P ++
Sbjct: 199 VTVWEMMSYGAEPYAG-MRPHEV 220
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 39/129 (30%), Positives = 67/129 (51%), Gaps = 11/129 (8%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ + V E + L+QY +++ V+ + Q+L GL Y H R V+HRDLK
Sbjct: 76 KTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQ 132
Query: 72 NIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSF 126
N+ ++ +GE+K+ D GLA ++ K+++ V T + P+V EY+ +D++
Sbjct: 133 NLLIS-ERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGV 190
Query: 127 GMCILEMVT 135
G EM T
Sbjct: 191 GCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 36/110 (32%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR------- 94
+K + Q+L G+ YLH ++HRD+K NI ++ NQG +KI D GLA
Sbjct: 117 IKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPK 173
Query: 95 ------KSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
V T + PE+ E Y VDI+ G C+ EM T
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 37 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AIL 93
+N+ VK + Q+L GL Y H R V+HRDLK N+ +N +GE+K+ D GLA +I
Sbjct: 101 INMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIP 157
Query: 94 RKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 135
K+++ V T + P++ +Y+ +D++ G EM T
Sbjct: 158 TKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 37/98 (37%), Positives = 57/98 (58%), Gaps = 11/98 (11%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHA 98
VK + Q+L GL + HS + V+HRDLK N+ +N N GE+K+ D GLA I + ++
Sbjct: 101 VKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYS 157
Query: 99 ARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EM 133
A V T + P+V + Y+ +D++S G CI E+
Sbjct: 158 AEVV-TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 36/127 (28%), Positives = 64/127 (50%), Gaps = 6/127 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E G L + + R++ + + +I L +LH R +I+RDLK DN+ ++
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD 130
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
+ G +K+ D G+ + + GTP ++APE+ EEY VD ++ G+ + EM
Sbjct: 131 AD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 134 VTFDYPY 140
+ P+
Sbjct: 190 MAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 7/98 (7%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
V+ + QIL G+ + HS + +IHRD+K +NI V+ + G VK+ D G A L
Sbjct: 102 VRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYT 158
Query: 102 --VGTPEFMAPE--VYEEEYNELVDIYSFGMCILEMVT 135
V T + APE V + +Y VDI++ G + EM+T
Sbjct: 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 49/195 (25%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAARCV-GT 104
+ +L+ L Y+HS+ IHR +K +I ++G+ G+V + L + ++++ R V
Sbjct: 108 KDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF 164
Query: 105 PEF-------MAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154
P+ ++PEV ++ YNE DIYS G+ E+ P+ + Q+ + +
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD-MPATQMLLEKV 223
Query: 155 SGKKPEALFK-------------------------VEDPEVR-------QFIEKCLA-TV 181
G P L K V+ P R QF+E CL
Sbjct: 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP 283
Query: 182 SSRLSARELLTDPFL 196
SR SA +LL F
Sbjct: 284 ESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L GL Y+HS +IHRDLK N+ VN E++I D GLA V T +
Sbjct: 126 QLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMTGY-VATRWY 181
Query: 108 MAPEVYEE--EYNELVDIYSFGMCILEMVTFD--YPYSECTHPAQIYKKVISGKKPEALF 163
APE+ YN+ VDI+S G + E++ +P ++ + +V+ PE L
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 164 KVEDPEVRQFIE 175
K+ R++I+
Sbjct: 242 KISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 30 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 89
Y R + I + R +L + YLH +IHRD+K +NIF+N + G+V +GD G
Sbjct: 172 YLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGA 228
Query: 90 AAILRKSHAAR---CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVT 135
A +A + GT APE+ + Y VDI+S G+ + EM T
Sbjct: 229 ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 14/98 (14%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------ 101
Q+L L Y+HS + VIHRDLK NI +N + VK+ D GLA L +
Sbjct: 115 QLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPENPVLTD 171
Query: 102 -VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
V T + APE+ Y + VD++S G CIL EM+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 33/124 (26%), Positives = 63/124 (50%), Gaps = 8/124 (6%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E+ G LR Y ++ +++ ++ + Q+ + L YL S+ +HRD+ N+ V+
Sbjct: 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS 141
Query: 77 GNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILE 132
VK+GD GL+ L A++ ++MAPE + + D++ FG+C+ E
Sbjct: 142 SPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 200
Query: 133 MVTF 136
++
Sbjct: 201 ILML 204
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 27/108 (25%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
VK + Q+L G+ + H + V+HRDLK N+ +N +GE+K+ D GL AR
Sbjct: 102 VKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINK-RGELKLADFGL---------ARA 149
Query: 102 VGTPE-----------FMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
G P + AP+V Y+ +DI+S G CI+ EM+T
Sbjct: 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG-CIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA 99
RAV + +I GL LH +++RDLK +NI ++ + G ++I DLGLA + +
Sbjct: 103 RAV-FYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTI 158
Query: 100 RC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157
+ VGT +MAPEV + E Y D ++ G + EM+ P+ Q KK I +
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF-------QQRKKKIKRE 211
Query: 158 KPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDP 194
+ E L K E + ++ L L DP
Sbjct: 212 EVERLVKEVQEEYSEKFSPDARSLCKML----LCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEE----- 115
IHRD+K DN+ ++ + G +K+ D G + + RC VGTP++++PEV +
Sbjct: 164 IHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 116 EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVEDPEV---- 170
Y D +S G+ + EM+ D P Y++ Y K++ K +L +D E+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKN--SLTFPDDIEISKQA 278
Query: 171 RQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSD 204
+ I L RL E+ + PF + D + D
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFD 315
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 43/131 (32%), Positives = 70/131 (53%), Gaps = 13/131 (9%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
R + V E S L+QY L + +++ VK + Q+L GL Y H R ++HRDLK
Sbjct: 75 ERCLTLVFEYLDS-DLKQY-LDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLK 130
Query: 70 CDNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIY 124
N+ +N +GE+K+ D GLA ++ K+++ V T + P+V EY+ +D++
Sbjct: 131 PQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMW 188
Query: 125 SFGMCILEMVT 135
G + EM T
Sbjct: 189 GVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VG 103
+ +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA + + + R VG
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 104 TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPY 140
T +MAPEV + Y D + G I EM+ P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 9/104 (8%)
Query: 37 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AIL 93
+++ VK + QIL GL Y H R V+HRDLK N+ +N +GE+K+ D GLA ++
Sbjct: 101 MSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVP 157
Query: 94 RKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVT 135
K+++ V T + P+V EY+ +D++ G EM +
Sbjct: 158 TKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 27/177 (15%)
Query: 53 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--------LRKSHAAR---- 100
L YLH+ ++HRDLK DN+ + + G +K+ D GL+ I L + H +
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 101 -----CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154
GTPE++APEV + Y + VD ++ G+ + E + P+ T P +++ +VI
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVI 229
Query: 155 SG-----KKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLR 206
S + EAL + + + + A E+ F D++ LR
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 21/177 (11%)
Query: 43 KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC- 101
K + +++ L +HS +IHRD+K DN+ ++ G +K+ D G + ++ RC
Sbjct: 145 KFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCD 201
Query: 102 --VGTPEFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154
VGTP++++PEV + + Y D +S G+ + EM+ D P+ Y K++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIM 260
Query: 155 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAR-------ELLTDPFLQIDDYDSD 204
K +L ED E+ + + + + R E+ PF + D ++ D
Sbjct: 261 DHKN--SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWD 315
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARC---V 102
R++L L YLH R +IHRD+K +NIF++ +GD G A L +C
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 103 GTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133
GT E +PE+ + Y DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 24/153 (15%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLAAILRKSHAARC 101
C + G +YL IHRDL N V+ + VKIGD GLA + KS R
Sbjct: 112 CLDVAKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 102 VGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVIS 155
G +MAPE + + ++ D++SFG+ + E++T PY PA ++V+
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-----PALNNQEVLQ 224
Query: 156 GKKPEALFKVEDPE-----VRQFIEKCLATVSS 183
+++ PE + Q + C A S
Sbjct: 225 HVTAGG--RLQKPENCPDKIYQLMTNCWAQDPS 255
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/199 (26%), Positives = 78/199 (39%), Gaps = 59/199 (29%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------------------------ 99
IHRD+K DNI ++ + G +K+ D GL R +H +
Sbjct: 123 IHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 100 --------------------RC-----VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEM 133
RC VGTP ++APEV + Y +L D +S G+ + EM
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 134 VTFDYPYSECTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLATVSSRL---SA 187
+ P+ T P + KVI+ + K+ PE I K + RL A
Sbjct: 242 LVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERLGRNGA 299
Query: 188 RELLTDPFLQIDDYDSDLR 206
++ PF D+ SD+R
Sbjct: 300 DDIKAHPFFSEVDFSSDIR 318
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 9/85 (10%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEEE---- 116
IHRD+K DN+ ++ G +K+ D G + K RC VGTP++++PEV + +
Sbjct: 164 IHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 117 -YNELVDIYSFGMCILEMVTFDYPY 140
Y D +S G+ + EM+ D P+
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 13/137 (9%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----V 102
Q+L L Y+H+ + V HRDLK NI N + ++KI D GLA + V
Sbjct: 111 QLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYV 167
Query: 103 GTPEFMAPEV---YEEEYNELVDIYSFGMCILEMVTFD--YPYSECTHPAQIYKKVISGK 157
T + APE+ + +Y +DI+S G E++T +P H + ++
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227
Query: 158 KPEALFKVEDPEVRQFI 174
PE + +V + + R+++
Sbjct: 228 SPETISRVRNEKARRYL 244
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 37/94 (39%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAAR 100
+K Q+L GL +LHS V+HRDLK NI V + G++K+ D GLA I +
Sbjct: 112 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTS 168
Query: 101 CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEM 133
V T + APEV + Y VD++S G EM
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/181 (27%), Positives = 81/181 (44%), Gaps = 24/181 (13%)
Query: 15 INFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
I +TE +G+L + LK ++ I + QI G+ ++ ++ IHRDL+
Sbjct: 75 IYIITEYMENGSLVDF-LKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAA 131
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYE-EEYNELVDIYSFG 127
NI V+ KI D GLA ++ + G ++ APE + D++SFG
Sbjct: 132 NILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG 190
Query: 128 MCILEMVTFD-YPYSECTHPAQI------YKKVISGKKPEALFKV------EDPEVRQFI 174
+ + E+VT+ PY T+P I Y+ PE L+++ E PE R
Sbjct: 191 ILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTF 250
Query: 175 E 175
E
Sbjct: 251 E 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/229 (26%), Positives = 85/229 (37%), Gaps = 71/229 (31%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------------------------ 99
IHRD+K DNI ++ G +K+ D GL R +H +
Sbjct: 123 IHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 100 --------------------RC-----VGTPEFMAPEV-YEEEYNELVDIYSFGMCILEM 133
RC VGTP ++APEV Y +L D +S G+ + EM
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 134 VTFDYPYSECTHPAQIYKKVISGKK-----PEALFKVEDPEVRQFIEKCLATVSSRL--- 185
+ P+ T P + KVI+ + P+A PE I K RL
Sbjct: 242 LVGQPPFLAQT-PLETQMKVINWQTSLHIPPQAKLS---PEASDLIIKLCRGPEDRLGKN 297
Query: 186 SARELLTDPFLQIDDYDSDLRM--------IQYQTDYDEISPLLRQSLY 226
A E+ PF + D+ SDLR I + TD P+ L+
Sbjct: 298 GADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLW 346
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 52/145 (35%), Positives = 69/145 (47%), Gaps = 34/145 (23%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L G+ +LHS +IHRDLK NI V + +KI D GL AR GT F
Sbjct: 126 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGT-SF 172
Query: 108 M-----------APEV-YEEEYNELVDIYSFGMCIL-EMV--TFDYPYSECTHPAQIYKK 152
M APEV Y E VDI+S G CI+ EM+ T +P ++ H Q + K
Sbjct: 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIRGTVLFPGTD--HIDQ-WNK 228
Query: 153 VIS--GKKPEALFKVEDPEVRQFIE 175
+I G + P VR ++E
Sbjct: 229 IIEQLGTPSDEFMSRLQPTVRNYVE 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 18/149 (12%)
Query: 20 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79
E+FT + R+ R K + V I + +I+ L +LH +I+RD+K +NI ++ N
Sbjct: 91 ELFTHLSQRE-RFKEQEVQI-----YSGEIVLALEHLHKLG--IIYRDIKLENILLDSN- 141
Query: 80 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVY---EEEYNELVDIYSFGMCILEM 133
G V + D GL+ + R GT E+MAP++ + +++ VD +S G+ + E+
Sbjct: 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201
Query: 134 VTFDYPYS---ECTHPAQIYKKVISGKKP 159
+T P++ E A+I ++++ + P
Sbjct: 202 LTGASPFTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 37/141 (26%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E G + +++R + QI+ YL S + +++RDLK +N+ ++
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD 165
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVT 135
+ G +K+ D G A ++ C GTPE++APE+ + + D ++ G+ I E++
Sbjct: 166 KD-GFIKMTDFGFAKVVDTRTYTLC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV 223
Query: 136 FDYPYSECTHPAQIYKKVISG 156
P+ P IY+K++ G
Sbjct: 224 GCPPFY-ANEPLLIYQKILEG 243
|
Length = 340 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 25/192 (13%)
Query: 20 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79
EMFT R + V+ + +I+ L +LH +++RD+K +NI ++ ++
Sbjct: 91 EMFTHLYQRDN------FSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SE 141
Query: 80 GEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMV 134
G V + D GL+ R GT E+MAPE+ + + + VD +S G+ I E++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201
Query: 135 TFDYPYS---ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT------VSSRL 185
T P++ E +++ ++++ P PE + + K L +
Sbjct: 202 TGASPFTLEGERNTQSEVSRRILKCDPP--FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259
Query: 186 SARELLTDPFLQ 197
A E+ PF +
Sbjct: 260 GASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 20/171 (11%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE T G L Y + R + AV + QI S + YL ++ IHRDL N V
Sbjct: 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 137
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYEEEYNEL---VDIYSFGMC 129
G VK+ D GL+ ++ G ++ APE YN+ D+++FG+
Sbjct: 138 -GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL--AYNKFSIKSDVWAFGVL 194
Query: 130 ILEMVTFD---YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
+ E+ T+ YP + + ++ +K ++PE P+V + + C
Sbjct: 195 LWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGC----PPKVYELMRAC 241
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 13/103 (12%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILRKSHAA 99
+K + +L+GL Y+H ++HRD+K NI + + G +K+ D GLA L K+
Sbjct: 121 IKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 100 RC----VGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
V T + PE+ E +Y +D++ G CI+ EM T
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 39/129 (30%), Positives = 69/129 (53%), Gaps = 17/129 (13%)
Query: 15 INFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ FV E + L QY ++H N+R + Q+L GL Y+H + ++HRDLK
Sbjct: 78 LTFVFE-YMHTDLAQYMIQHPGGLHPYNVRL---FMFQLLRGLAYIHGQH--ILHRDLKP 131
Query: 71 DNIFVNGNQGEVKIGDLGLA---AILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYS 125
N+ ++ GE+K+ D GLA +I +++++ V T + P+V +Y+ +DI+
Sbjct: 132 QNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWG 189
Query: 126 FGMCILEMV 134
G +EM+
Sbjct: 190 AGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE----- 115
+HRD+K DNI ++ N G +++ D G L + ++ VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 116 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKK----PEALFKVEDPE 169
+Y D +S G+C+ EM+ + P Y+E + Y K+++ K+ P + V + +
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHKERFQFPAQVTDVSE-D 239
Query: 170 VRQFIEKCLATVSSRLSA---RELLTDPFLQIDDYDS 203
+ I + + + RL + PF D+D+
Sbjct: 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 30/80 (37%), Positives = 47/80 (58%), Gaps = 3/80 (3%)
Query: 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEYNEL 120
+++RDLK +NI ++ ++G ++I DLGLA + + R VGT +MAPEV E+Y
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 121 VDIYSFGMCILEMVTFDYPY 140
D + G I EM+ P+
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 23/157 (14%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEE----- 115
+HRD+K DN+ ++ N G +++ D G L + VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 116 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEAL-FKVEDPEV-- 170
Y D +S G+C+ EM+ + P Y+E + Y K+++ K E F + +V
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHK--EHFQFPPDVTDVSE 238
Query: 171 --RQFIEKCLATVSSRL---SARELLTDPFLQIDDYD 202
+ I + + + +RL ++ PF + D+D
Sbjct: 239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 38/134 (28%), Positives = 63/134 (47%), Gaps = 14/134 (10%)
Query: 14 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKH-WCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ VTE G+L Y R + R V A + + + G+ YL ++ +HRDL
Sbjct: 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAAR 131
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT-P-EFMAPEVYEE-EYNELVDIYSFGM 128
N+ V+ K+ D GLA + G P ++ APE E +++ D++SFG+
Sbjct: 132 NVLVS-EDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGI 187
Query: 129 CILEMVTFD---YP 139
+ E+ +F YP
Sbjct: 188 LLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-06
Identities = 33/120 (27%), Positives = 54/120 (45%), Gaps = 15/120 (12%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILRKSHAA------ 99
Q+L L H++ ++HRDLK NI V+ K+ D G+ +L A
Sbjct: 87 QVLDALACAHNQG--IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144
Query: 100 ---RCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155
+GTP + APE + E D+Y++G+ LE +T + A+I + +S
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLT-GQRVVQGASVAEILYQQLS 203
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 42/144 (29%), Positives = 64/144 (44%), Gaps = 14/144 (9%)
Query: 8 VDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
V T I V E G L Y R + + + + C + G+ YL S + VIHR
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHR 124
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYE-EEYNELVD 122
DL N V NQ VK+ D G+ + GT ++ +PEV+ +Y+ D
Sbjct: 125 DLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 123 IYSFGMCILEMVTFDYPYSECTHP 146
++SFG+ + E+ +SE P
Sbjct: 184 VWSFGVLMWEV------FSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 51/160 (31%), Positives = 67/160 (41%), Gaps = 31/160 (19%)
Query: 29 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 88
Q L H R++ + Q+L G+ +LHS +IHRDLK NI V + +KI D G
Sbjct: 120 QMELDHERMS-----YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFG 171
Query: 89 LAAILRKSHAARCVGTPEFMAPEVYEEE-----------YNELVDIYSFGMCILEMVTFD 137
L AR GT M P V Y E VDI+S G + EM+
Sbjct: 172 L---------ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
Query: 138 YPYSECTHPAQIYKKVIS--GKKPEALFKVEDPEVRQFIE 175
+ H Q + KVI G K P VR ++E
Sbjct: 223 VLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 15 INFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
I V E+ G+L + R K R+ ++ + +G+ YL S++ IHRDL N
Sbjct: 67 IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNC 124
Query: 74 FVNGNQGEVKIGDLGLA-----AILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFG 127
V G +KI D G++ I S + + ++ APE Y D++S+G
Sbjct: 125 LV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPI-KWTAPEALNYGRYTSESDVWSYG 182
Query: 128 MCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ + E + D PY ++ Q +++ SG + PE ++++ DPE R
Sbjct: 183 ILLWETFSLGDTPYPGMSN-QQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 36/157 (22%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE----- 115
+HRD+K DN+ ++ N G +++ D G + + ++ VGTP++++PE+ +
Sbjct: 124 VHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 116 -EYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKK----PEALFKVEDPE 169
+Y D +S G+C+ EM+ + P Y+E + Y K+++ ++ P + V + E
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESL--VETYGKIMNHEERFQFPSHITDVSE-E 239
Query: 170 VRQFIEKCLATVSSRLSAR---ELLTDPFLQIDDYDS 203
+ I++ + + RL + F + D+++
Sbjct: 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 31/160 (19%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-HAARCVGTP- 105
Q+ G+ YL ++ IHRDL NI V G K+ D GLA ++++ + + P
Sbjct: 112 QVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPY 168
Query: 106 EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA----QIYKKVISG---- 156
++ APE ++ D++SFG+ + EM T Y + +P ++Y ++ +G
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFT----YGQVPYPGMNNHEVYDQITAGYRMP 224
Query: 157 ---KKPEALFKV------EDPEVRQFIEKCLATVSSRLSA 187
K P+ ++K+ +PE R + L
Sbjct: 225 CPAKCPQEIYKIMLECWAAEPEDR----PSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 27/159 (16%)
Query: 27 LRQYRL----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 82
L+Q RL + ++ + + H QI G+ YLH R VIH+D+ N ++ + +V
Sbjct: 100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQV 156
Query: 83 KIGDLGLAAILRKS--HAARCVGTPE-----FMAPEVYE-EEYNELVDIYSFGMCILEMV 134
KI D L+ L H C+G E +MA E +EY+ D++SFG+ + E++
Sbjct: 157 KITDNALSRDLFPMDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
Query: 135 TF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV 165
T PY E P ++ + G + P+ LF V
Sbjct: 214 TLGQTPYVE-IDPFEMAAYLKDGYRLAQPINCPDELFAV 251
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 25/164 (15%)
Query: 18 VTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE G L + R + + + + + Q+ G+ +L S++ IHRDL N+ +
Sbjct: 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL 174
Query: 76 NGNQGEV-KIGDLGLAA-ILRKSH-----AARCVGTP-EFMAPE-VYEEEYNELVDIYSF 126
G++ KI D GLA I+ S+ AR P ++MAPE ++ Y D++S+
Sbjct: 175 T--HGKIVKICDFGLARDIMNDSNYVVKGNAR---LPVKWMAPESIFNCVYTFESDVWSY 229
Query: 127 GMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPE 169
G+ + E+ + PY ++ YK + G +++ PE
Sbjct: 230 GILLWEIFSLGSNPYPGMPVDSKFYKLIKEG------YRMAQPE 267
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAA-ILRKSHAARCVGT- 104
Q+ +G+ +L S++ +HRDL N+ + +G+ VKI D GLA I+R S+ T
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 105 -P-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 160
P ++MAPE ++ Y L D++SFG+ + E+ T PY E Q Y + G +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 161 ALFKVEDPEVRQFIEKC 177
D E+ + ++KC
Sbjct: 363 KPAHASD-EIYEIMQKC 378
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 45/147 (30%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 3 FYTSWVDTANRNI--NFVTEMFTSGTLRQYRLKHRRVNIRA-----VKHWCRQILSGLLY 55
+YT +NI N V E F T+ +Y +KH N A VK + Q+ L Y
Sbjct: 128 YYTECFKKNEKNIFLNVVME-FIPQTVHKY-MKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 56 LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILRKSHAARCVGTPEFMAPEVY- 113
+HS+ + HRDLK N+ ++ N +K+ D G A +L + + + + APE+
Sbjct: 186 IHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243
Query: 114 -EEEYNELVDIYSFGMCILEMVTFDYP 139
Y +D++S G I EM+ YP
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMI-LGYP 269
|
Length = 440 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 18/165 (10%)
Query: 15 INFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
I +TE G+L + LK + + + + QI G+ ++ R+ IHRDL+
Sbjct: 75 IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAA 131
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPE-VYEEEYNELVDIYSFG 127
NI V+ + KI D GLA ++ + G ++ APE + + D++SFG
Sbjct: 132 NILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG 190
Query: 128 MCILEMVTFD-YPYSECTHPAQI------YKKVISGKKPEALFKV 165
+ ++E+VT+ PY ++P I Y+ PE L+ +
Sbjct: 191 ILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK--- 95
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 110 VKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 96 --SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTFDYPYSEC 143
+ V T + APE+ Y + +DI++ G E++T + P C
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 39/112 (34%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILRK--- 95
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A +
Sbjct: 110 VKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 96 --SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMVTFDYPYSEC 143
+ V T + APE+ Y + +DI++ G E++T + P C
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 36/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 8 VDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
V T + + VTE +G L Y R + +++ + C+ + G+ YL IHR
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHR 124
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYE-EEYNELVD 122
DL N V+ + G VK+ D G+ + G ++ PEV+ +Y+ D
Sbjct: 125 DLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 123 IYSFGMCILEMVT 135
++SFG+ + E+ T
Sbjct: 184 VWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 64/203 (31%)
Query: 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-------------------------- 97
IHRD+K DNI ++ G +K+ D GL+ K H
Sbjct: 123 IHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 98 -----------------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 133
A VGTP+++APE++ ++ Y + D +S G + E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 134 VTFDYPY-SECTHPAQIYKKVISGKKPEALFKVED----PEVRQFIEKCLATVSSRL--- 185
+ P+ SE +H + Y+K+I+ + E L+ +D E I + + +RL
Sbjct: 242 LIGWPPFCSENSH--ETYRKIINWR--ETLYFPDDIHLSVEAEDLIRRLITNAENRLGRG 297
Query: 186 SARELLTDPFLQIDDYDSDLRMI 208
A E+ + PF + D+D+ +R I
Sbjct: 298 GAHEIKSHPFFRGVDWDT-IRQI 319
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
H QI SG++YL S+ +HRDL N V G VKIGD G++ + + R G
Sbjct: 127 HIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 104 TP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 136
+M PE + ++ D++SFG+ + E+ T+
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 42/146 (28%), Positives = 74/146 (50%), Gaps = 11/146 (7%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
V T ++ + VTE +G+L + KH + + + R I SG+ YL D +HR
Sbjct: 73 VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL--SDMGYVHR 130
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRK----SHAARCVGTP-EFMAPE-VYEEEYNEL 120
DL NI VN N K+ D GL+ +L ++ R P + APE + ++
Sbjct: 131 DLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA 189
Query: 121 VDIYSFGMCILEMVTF-DYPYSECTH 145
D++S+G+ + E++++ + PY E ++
Sbjct: 190 SDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 8e-06
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 7/97 (7%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHA-A 99
VK + Q+L GL Y+H R ++HRDLK N+ ++ + GE+K+ D GLA A SH +
Sbjct: 105 VKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYS 161
Query: 100 RCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEMV 134
V T + P+V EY+ +D++ G +EM+
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 39/142 (27%), Positives = 70/142 (49%), Gaps = 19/142 (13%)
Query: 18 VTEMFTSGTLRQY---------RLKHRRVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRD 67
+ E G L+Q+ +LK ++ + C QI G+ +L +R +HRD
Sbjct: 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRD 142
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTP-EFMAPE-VYEEEYNELVDI 123
L N V+ +Q EVK+ L L+ + S + R P ++APE V E++++ D+
Sbjct: 143 LAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDV 201
Query: 124 YSFGMCILEMVTF-DYPYSECT 144
+SFG+ + E+ T + P+ +
Sbjct: 202 WSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 46/135 (34%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-- 105
Q+L G+ +LHS +IHRDLK NI V + +KI D GLA ++ + TP
Sbjct: 131 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA----RTACTNFMMTPYV 183
Query: 106 ---EFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 161
+ APEV Y E VDI+S G + E+V + H Q K + P A
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243
Query: 162 LFKVE-DPEVRQFIE 175
F P VR ++E
Sbjct: 244 EFMNRLQPTVRNYVE 258
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 42/149 (28%), Positives = 61/149 (40%), Gaps = 33/149 (22%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCR----------------QILSGLLYLHSRDP 61
V E G LR + R A R Q+ G+ +L S+
Sbjct: 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK- 152
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTP-EFMAPE-VY 113
IHRDL N+ V +KI D GLA + RK+ R P ++MAPE ++
Sbjct: 153 -CIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYYRKTTNGR---LPVKWMAPEALF 207
Query: 114 EEEYNELVDIYSFGMCILEMVTFD---YP 139
+ Y D++SFG+ + E+ T YP
Sbjct: 208 DRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 41/164 (25%), Positives = 62/164 (37%), Gaps = 31/164 (18%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV--- 102
C Q L L LH + K NI + + GL L S A +
Sbjct: 23 CLQCLGALRELHRQA--------KSGNILLTWD---------GLLK-LDGSVAFKTPEQS 64
Query: 103 -GTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 160
P FMAPEV + Y E DIYS G+ + E + ++ PY+E + I + +++G +
Sbjct: 65 RPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124
Query: 161 A------LFKVED-PEVRQFIEKCLATVSS-RLSARELLTDPFL 196
L V F+ C + + R +A L
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 52/151 (34%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 29 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 88
Q L H R++ + Q+L G+ +LHS +IHRDLK NI V + +KI D G
Sbjct: 113 QMELDHERMS-----YLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFG 164
Query: 89 LAAILRKSHAAR-CVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHP 146
LA S V T + APEV Y E VDI+S G + EMV + +
Sbjct: 165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 147 AQIYKKVIS--GKKPEALFKVEDPEVRQFIE 175
Q + KVI G K P VR ++E
Sbjct: 225 DQ-WNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 15/113 (13%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE 106
+Q+ +G+ YL R +HRDL N V N VKI D GL+ R ++A E
Sbjct: 137 KQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS---RNIYSADYYKASE 190
Query: 107 -------FMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIY 150
+M PE ++ Y D++++G+ + E+ ++ PY H IY
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 13/101 (12%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG-LAAILRKSHAAR 100
VK + Q+L L ++H + HRD+K +NI + +K+ D G I K
Sbjct: 102 VKSYMYQLLKSLDHMHRNG--IFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTE 157
Query: 101 CVGTPEFMAPEV-----YEEEYNELVDIYSFGMCILEMVTF 136
+ T + APE Y Y +DI++ G E+++
Sbjct: 158 YISTRWYRAPECLLTDGY---YGPKMDIWAVGCVFFEILSL 195
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 37/133 (27%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+TE +G L +Y R + + R I +G+ YL D +HRDL NI VN
Sbjct: 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL--SDMNYVHRDLAARNILVN 141
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTP-----EFMAPE-VYEEEYNELVDIYSFGMCI 130
+ E K+ D GL+ +L + + APE + ++ D++SFG+ +
Sbjct: 142 -SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200
Query: 131 LEMVTF-DYPYSE 142
E+++F + PY +
Sbjct: 201 WEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 30/168 (17%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH---AARCVGT 104
++ SGLL+LH D IH DL N + + VKIGD GLA C
Sbjct: 108 EVASGLLWLHQAD--FIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 105 P-EFMAPEVYEEEYNELV--------DIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVI 154
P ++APE+ E +L+ +I+S G+ + E+ T D PY + + Q+ K+V+
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQVV 223
Query: 155 SGK-----KPEALFKVEDP--EVRQFIEKCLATVSSRLSARE---LLT 192
+ KP+ K D EV QF C +R +A E LLT
Sbjct: 224 REQDIKLPKPQLDLKYSDRWYEVMQF---CWLDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 31/77 (40%), Positives = 36/77 (46%), Gaps = 19/77 (24%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT-- 104
RQIL L LHS ++HRD+K NI + G KI DLG AA LR VG
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR-------VGINY 312
Query: 105 --------PEFMAPEVY 113
P + APE Y
Sbjct: 313 IPKEFLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 17/103 (16%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK------SHAARC 101
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA + K AR
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR- 236
Query: 102 VGTP-EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD---YP 139
P ++MAPE ++++ Y D++SFG+ + E+ + YP
Sbjct: 237 --LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 37/143 (25%), Positives = 67/143 (46%), Gaps = 13/143 (9%)
Query: 8 VDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
V T +R + +TE +G L + R + + + R I +G+ YL + +HR
Sbjct: 73 VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--SEMNYVHR 130
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTP---EFMAPE-VYEEEYN 118
DL NI VN N K+ D GL+ L + +G + APE + ++
Sbjct: 131 DLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189
Query: 119 ELVDIYSFGMCILEMVTF-DYPY 140
D++S+G+ + E++++ + PY
Sbjct: 190 SASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 18 VTEMFTSGTLRQY-RLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
V E+ + G L + R + R V++ + + + G+ YL S+ ++HRDL NI V
Sbjct: 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILV 133
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFMAPEVYEE-EYNELVDIYSFGMCILEM 133
+ G K+ D GLA + P ++ APE + +++ D++S+G+ + E+
Sbjct: 134 S-EDGVAKVSDFGLARVGSM--GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
Query: 134 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSA 187
+ Y +P K+V + E +++E P E C A V +++
Sbjct: 191 ----FSYGRAPYPKMSLKEV--KECVEKGYRMEPP------EGCPADVYVLMTS 232
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 14/123 (11%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAILRKSHAARCVGTP- 105
Q+ G+ +L S++ +HRDL N+ + QG+ VKI D GLA + G+
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 106 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG---K 157
++MAPE +++ Y L D++S+G+ + E+ + PY + Y K+ SG
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 158 KPE 160
KP+
Sbjct: 361 KPD 363
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 11 ANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
+ I VTE + G+L + LK R + + + Q+ +G+ Y+ + IHRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDF-LKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRD 127
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPE-VYEEEYNELVDI 123
L+ NI V G+ KI D GLA ++ + G ++ APE + D+
Sbjct: 128 LRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 124 YSFGMCILEMVT 135
+SFG+ + E+VT
Sbjct: 187 WSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 10/108 (9%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
+ QI SG+ YL S + +HRDL N V N +KI D G++ L S R G
Sbjct: 134 YMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQG 190
Query: 104 TP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF--DYPYSECT 144
+MA E V ++ D+++FG+ + E++T + PY T
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 40/180 (22%), Positives = 79/180 (43%), Gaps = 28/180 (15%)
Query: 33 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92
K +++ VK RQ++ L LH + +IH D+K +N+ + + + + D GL
Sbjct: 102 KEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGL--- 156
Query: 93 LRKSHAARCVGTP-------EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPY---- 140
+ +GTP ++ +PE + Y+ D ++ G+ E++T +P+
Sbjct: 157 ------CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
Query: 141 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-RELLTDPFLQI 198
E + K+ +K K F++ L ++ RL+ E++ PFL+I
Sbjct: 211 DEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 16/139 (11%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAR 100
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 101 CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQIYKKVISGKK 158
+ ++MAPE ++++ Y D++SFG+ + E+ + PY + +++ G +
Sbjct: 239 PL---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295
Query: 159 PEALFKVEDPEVRQFIEKC 177
A + PE+ + + C
Sbjct: 296 MRAP-ENATPEIYRIMLAC 313
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 34/158 (21%), Positives = 64/158 (40%), Gaps = 41/158 (25%)
Query: 13 RNINFVTEMFTSG----TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
+ V + + G L Q + + ++ + + ++L L YLH +++RDL
Sbjct: 74 TYLCLVMD-YCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDL 129
Query: 69 KCDNIFVNGNQGEVKIGDLGLA-----------AILRKSHAAR----------------- 100
K +NI ++ + G + + D L+ LRK
Sbjct: 130 KPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188
Query: 101 ---CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMV 134
VGT E++APEV + + VD ++ G+ + EM+
Sbjct: 189 SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIH 65
V T +R + +TE +G+L ++ L+ + R I SG+ YL + +H
Sbjct: 73 VVTKSRPVMIITEYMENGSLDKF-LRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVH 129
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA---RCVGTP-EFMAPE-VYEEEYNEL 120
RDL NI VN + K+ D GL+ L S A + P + APE + ++
Sbjct: 130 RDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA 188
Query: 121 VDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG 156
D++SFG+ + E++++ + PY + ++ + K V G
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 12/141 (8%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64
V T I +TE G+L + LK +V + + + QI G+ Y+ ++ I
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YI 125
Query: 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYE-EEYNEL 120
HRDL+ N+ V+ KI D GLA ++ + G ++ APE +
Sbjct: 126 HRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 121 VDIYSFGMCILEMVTF-DYPY 140
D++SFG+ + E+VT+ PY
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 28/142 (19%)
Query: 18 VTEMFTSGTLRQY----------------RLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
+ E + G LR+Y R+ ++ + + Q+ G+ YL S+
Sbjct: 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK- 157
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VYE 114
IHRDL N+ V N +KI D GLA + +K+ R ++MAPE +++
Sbjct: 158 -CIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRL--PVKWMAPEALFD 213
Query: 115 EEYNELVDIYSFGMCILEMVTF 136
Y D++SFG+ + E+ T
Sbjct: 214 RVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
H QI +G+ YL S +H+DL NI + G Q VKI DLGL+ + + R
Sbjct: 128 HIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 104 TP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PY 140
+M PE + +++ DI+SFG+ + E+ +F PY
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 36/143 (25%), Positives = 61/143 (42%), Gaps = 19/143 (13%)
Query: 18 VTEMFTSGTLRQYRLKHRRVN--------IRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
+ E+ G L+ + L+ R ++ + R + G YL IHRD+
Sbjct: 87 LLELMAGGDLKSF-LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIA 143
Query: 70 CDNIFVN--GNQGEVKIGDLGLAA-ILRKSH---AARCVGTPEFMAPEVYEEE-YNELVD 122
N + G KI D G+A I R S+ R + ++M PE + + + D
Sbjct: 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTD 203
Query: 123 IYSFGMCILEMVTFDY-PYSECT 144
++SFG+ + E+ + Y PY T
Sbjct: 204 VWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
QI SG++YL S +HRDL N V G VKIGD G++ + + R G
Sbjct: 126 AIASQIASGMVYLASLH--FVHRDLATRNCLV-GQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 104 TP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 136
+M PE + ++ DI+SFG+ + E+ T+
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 12/96 (12%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA------ILRKSHAARC 101
Q+ G+ YL SR IHRDL N+ V + +KI D GLA +K+ R
Sbjct: 142 QVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRL 198
Query: 102 VGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 136
++MAPE +++ Y D++SFG+ + E+ T
Sbjct: 199 --PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 32/116 (27%), Positives = 59/116 (50%), Gaps = 17/116 (14%)
Query: 35 RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---- 90
R + + + + QI G+ YL + ++HRDL N+ V + ++KI D GL+
Sbjct: 122 RALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDVY 178
Query: 91 ---AILRKSHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD---YP 139
+ +++S V ++MA E +++ Y D++SFG+ + E+VT YP
Sbjct: 179 EEDSYVKRSKGRIPV---KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 8/115 (6%)
Query: 27 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86
L+ + + + QI SG++YL S+ +HRDL N V G VKIGD
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGD 165
Query: 87 LGLAAILRKSHAARCVGTP----EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 136
G++ + + R G +M PE + ++ D++SFG+ + E+ T+
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 30/166 (18%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E+ G L ++ K++ V + + Q+ G+ YL + +HRDL N+ +
Sbjct: 72 LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV 129
Query: 77 GNQGEVKIGDLGLAAILRKS---HAARCVGT-P-EFMAPEVYE-EEYNELVDIYSFGMCI 130
Q KI D GL+ L + A+ G P ++ APE +++ D++SFG+ +
Sbjct: 130 -TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
E F Y G+KP K EV Q IE
Sbjct: 189 WE--AFSY-----------------GQKPYKGMK--GNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-- 105
QI +G+ YL S +HRDL N V G VKI D GL+ + + R
Sbjct: 132 QIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 106 --EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 136
+M PE + ++ DI+SFG+ + E+ ++
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 17/129 (13%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV-KIGDLGLAAILRKSHAARCVGTP- 105
Q+ G+ +L S++ IHRDL NI + G + KI D GLA +R G
Sbjct: 222 QVAKGMSFLASKN--CIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 106 ---EFMAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPE 160
++MAPE ++ Y D++S+G+ + E+ + PY ++ YK + G
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---- 333
Query: 161 ALFKVEDPE 169
+++ PE
Sbjct: 334 --YRMLSPE 340
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 14/97 (14%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-------ILRKSHAAR 100
Q+ G+ +L SR IHRDL NI ++ N VKI D GLA +RK A
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 101 CVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTF 136
+ ++MAPE +++ Y D++SFG+ + E+ +
Sbjct: 244 PL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 30/143 (20%)
Query: 18 VTEMFTSGTLRQYRLKHRR-----------------VNIRAVKHWCRQILSGLLYLHSRD 60
+ E + G LR+Y L+ RR ++ + + Q+ G+ YL S+
Sbjct: 102 IVEYASKGNLREY-LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK 160
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPE-VY 113
IHRDL N+ V + +KI D GLA + +K+ R ++MAPE ++
Sbjct: 161 --CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALF 215
Query: 114 EEEYNELVDIYSFGMCILEMVTF 136
+ Y D++SFG+ + E+ T
Sbjct: 216 DRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 35/127 (27%), Positives = 57/127 (44%), Gaps = 9/127 (7%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIR--AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
I VTE + G+L + +R + QI SG+ Y+ + +HRDL+ N
Sbjct: 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAAN 132
Query: 73 IFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPE-VYEEEYNELVDIYSFGM 128
I V G K+ D GLA ++ + G ++ APE + D++SFG+
Sbjct: 133 ILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 191
Query: 129 CILEMVT 135
+ E+ T
Sbjct: 192 LLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 39/154 (25%), Positives = 64/154 (41%), Gaps = 31/154 (20%)
Query: 18 VTEMFTSGTLRQYRLKHRR--------------------VNIRAVKHWCRQILSGLLYLH 57
+TE +G L Q+ L ++ ++ H QI SG+ YL
Sbjct: 97 ITEYMENGDLNQF-LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 58 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP----EFMAPE-V 112
S + +HRDL N V N +KI D G++ L R G +MA E +
Sbjct: 156 SLN--FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 113 YEEEYNELVDIYSFGMCILEMVTF--DYPYSECT 144
++ D+++FG+ + E++ + PY E T
Sbjct: 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 38/128 (29%), Positives = 59/128 (46%), Gaps = 11/128 (8%)
Query: 15 INFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
I VTE G+L + LK + + + + QI G+ Y+ + IHRDL+
Sbjct: 75 IYIVTEFMGKGSLLDF-LKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAA 131
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPE-VYEEEYNELVDIYSFG 127
NI V N KI D GLA ++ + G ++ APE + D++SFG
Sbjct: 132 NILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG 190
Query: 128 MCILEMVT 135
+ + E+VT
Sbjct: 191 ILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 24/75 (32%), Positives = 41/75 (54%), Gaps = 12/75 (16%)
Query: 25 GTLRQYRLKHRRV---------NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
G L ++ + +++ +I +K RQ+L+GL LH ++HRD+K +N+ V
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLV 342
Query: 76 NGNQGEVKIGDLGLA 90
+ G+VKI D G A
Sbjct: 343 TVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 28/202 (13%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------RKSHAARC 101
Q+ G+ YL S+ IHRDL N+ V +KI D GLA + +K+ R
Sbjct: 142 QVARGMEYLASQK--CIHRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRL 198
Query: 102 VGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFD---YPYSECTHPAQIYKKVISGK 157
++MAPE +++ Y D++SFG+ + E+ T YP ++ K+
Sbjct: 199 --PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 256
Query: 158 KPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDE 216
KP E+ + +C V S R + ++L ++D D L + +Y +
Sbjct: 257 KPANCTH----ELYMIMRECWHAVPSQRPTFKQL-------VEDLDRVLTVTS-TDEYLD 304
Query: 217 ISPLLRQSLYGIYHSNSSSNNG 238
+S Q G S SS ++G
Sbjct: 305 LSVPFEQYSPGCPDSPSSCSSG 326
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 14/133 (10%)
Query: 51 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPE 106
+G+ YL + IHRDL N+ V G KI D GL+ ++K+ V
Sbjct: 130 TGMQYL--SEKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTMGRLPV---R 183
Query: 107 FMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 164
+MA E Y D++SFG+ + E+V+ PY T A++Y+K+ G + E
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRMEKPRN 242
Query: 165 VEDPEVRQFIEKC 177
+D EV + + +C
Sbjct: 243 CDD-EVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 40/133 (30%), Positives = 62/133 (46%), Gaps = 14/133 (10%)
Query: 51 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPE 106
G+ YL + IHRDL NI V N KI D GL+ ++K+ V
Sbjct: 123 RGMDYLSQKQ--FIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPV---R 176
Query: 107 FMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFK 164
+MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G + E
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYRLEKPLN 235
Query: 165 VEDPEVRQFIEKC 177
+D EV + +C
Sbjct: 236 CDD-EVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 14/140 (10%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAA 99
H+ + G+ YL + IHRDL NI V G KI D GL+ ++K+
Sbjct: 128 HFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 100 RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK 157
V +MA E Y D++S+G+ + E+V+ PY T A++Y+K+ G
Sbjct: 185 LPV---RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGY 240
Query: 158 KPEALFKVEDPEVRQFIEKC 177
+ E +D EV + +C
Sbjct: 241 RLEKPLNCDD-EVYDLMRQC 259
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 654 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.93 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.9 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.9 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.9 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.89 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.89 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.87 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.87 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.87 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.84 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.84 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.83 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.83 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.56 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.5 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.49 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.48 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.43 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.39 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.35 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.31 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.31 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.28 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.25 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.05 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 98.99 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.95 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 98.89 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.89 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.89 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.68 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.3 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.23 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.14 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.12 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.07 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.0 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 97.75 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.63 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.51 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.44 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.18 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.03 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 95.76 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.45 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 95.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 95.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 94.44 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 94.26 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 93.75 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 92.33 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 91.63 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 90.17 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.0 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 89.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 89.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 88.04 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 87.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 87.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 84.86 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 84.56 | |
| PLN02236 | 344 | choline kinase | 84.32 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 81.3 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 80.75 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 80.2 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 80.16 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-75 Score=639.81 Aligned_cols=404 Identities=55% Similarity=0.848 Sum_probs=323.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
||||++|++..++++++|||+|++|+|+.|++++++++.++++.|++||++||.|||++.||||||||||+||||+++.|
T Consensus 104 irfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G 183 (632)
T KOG0584|consen 104 IRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLG 183 (632)
T ss_pred eeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcC
Confidence 79999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCc
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE 160 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~ 160 (654)
.|||||+|||+.++.+.+.+.+|||.|||||++.+.|++.+|||||||||+||+|++|||++|.+++|||++|++|.+|.
T Consensus 184 ~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 184 EVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred ceeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCChHHHHHHHHHhhCccCCCCHHHHhcCcccccCCcchhhhhhhhcccccccchhhhhhhcccccCCCCCCCCCC
Q 006244 161 ALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCG 240 (654)
Q Consensus 161 ~l~~~~spelrdLI~kCL~dP~~RpTa~ELL~HPFf~~~~~~~~~r~l~~~~~~~~i~pll~~~l~~~~~s~~s~~~~~~ 240 (654)
.+.++.+|++++||++||...+.|+|+.|||+||||+.++... ..+... ........+...+...... .....
T Consensus 264 sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~--~~~~e~-d~~~~~~~~~~~~~~~~~~----~~~~~ 336 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIV--ELAPED-DMSDPALSLSLRDEDGKKN----KRPKA 336 (632)
T ss_pred HhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccc--cccchh-hcccccccccccccchhhc----CCccc
Confidence 9999999999999999999999999999999999999876531 100000 0000000000000000000 00011
Q ss_pred CcccccCCCCCCCCCccccc--ccccccc-ccc------ccccccccccccccccCCC-cEEEEEEeecccCCccceeee
Q 006244 241 HYIGYDTENGLDYHPHEFQE--SEIDLFT-CQE------DEHLTNFDISIKGKRREDD-GIFLRLRIADKEGRIRNIYFP 310 (654)
Q Consensus 241 ~~~~~d~~~~~~~~~~e~~~--~~~~~~e-~~~------~~~~~~~d~~~~G~~~~~~-~I~L~LRI~d~~g~~r~I~F~ 310 (654)
+.+. .++++-.++.+. ..+..++ ..+ ....+..++.|+|+++++. .++|.|||++++|+.|||+||
T Consensus 337 n~i~----~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fp 412 (632)
T KOG0584|consen 337 NAIQ----FDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFP 412 (632)
T ss_pred cccc----ceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCC
Confidence 1111 112222222211 0011111 111 1235678999999999876 999999999999999999999
Q ss_pred cccCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHHhhCCCccCCCCCCCCCC------CCccccccccCCchhhhhh
Q 006244 311 FDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRGMAMEESPH------RSSFCHNCASNGCLPDYIL 384 (654)
Q Consensus 311 Fd~~~DTa~sVA~EMV~el~i~d~dv~~IA~~ID~~i~~l~p~w~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 384 (654)
|++++|||.+||.|||+++++++++|..||+|||++|.+|+|.|+.....+++++ ..+.|.+|.++.....-.+
T Consensus 413 f~~~~dta~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~~~~~s~~~~~~~~~~s~~~~~~s~~~~~~~~~ 492 (632)
T KOG0584|consen 413 FDLEGDTAPSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKASTPNDESPHEQHTDNSVSIQRSSESATQSQKSFS 492 (632)
T ss_pred CcCCCcchhHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCCCccccchhccCcccccccCCCccccccccccc
Confidence 9999999999999999999999999999999999999999999998877776544 3789999987644443333
Q ss_pred cCCCCCCcccccccccC-cccccccccceeEE
Q 006244 385 SDGSGAKNLQVLQCSKD-GCAAIHGRFEEITY 415 (654)
Q Consensus 385 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 415 (654)
++...+....+.+|+.+ .|+..|+||...+.
T Consensus 493 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~ 524 (632)
T KOG0584|consen 493 SADPQQVAPFVQQSMEDPLSSDVESRFSKNEL 524 (632)
T ss_pred ccccccccccccccccCCCccccccccccccc
Confidence 32333444456666666 89999999987655
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=353.23 Aligned_cols=196 Identities=33% Similarity=0.560 Sum_probs=179.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
|+|||.|+.... .+.|+||||.||+|.+++++.+++++..+.+++.+|++||.|||. ++ ||||||||+|||++.+
T Consensus 140 V~~ygaF~~~~~-~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk- 215 (364)
T KOG0581|consen 140 VGFYGAFYSNGE-EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK- 215 (364)
T ss_pred eeEeEEEEeCCc-eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-
Confidence 789999999433 699999999999999999999999999999999999999999996 76 9999999999999965
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCC----CCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE----CTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~----~~~~~qi~kki~ 154 (654)
|.|||||||.++.+..+...+++||..|||||-+.+ .|+.++||||||+.++|+++|++||.. ..+..+++..|.
T Consensus 216 GeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 216 GEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred CCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 899999999999999888899999999999999886 599999999999999999999999976 346778888999
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+..|.......++++++||..||+ +|++|+++.+||.|||++...
T Consensus 296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 8877765555699999999999999 899999999999999997543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=347.66 Aligned_cols=199 Identities=26% Similarity=0.379 Sum_probs=178.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
|+++++|.. ....||||||+.||+|.+++..++.+.+..-+-+++||+.||.|||++| |+||||||+|||+..+
T Consensus 239 V~~~d~f~~--~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 239 VRIKDFFEV--PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAE 314 (475)
T ss_pred EEEeeeeec--CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCc
Confidence 689999988 6788999999999999999999999999999999999999999999999 9999999999999743
Q ss_pred CCcEEEEecCchhhhccc-CCccccCCCCccChhhhccc----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
...+||+|||+|+..... ...+.+|||.|.|||++... |..++||||+||+||.+++|.+||++......++++|
T Consensus 315 ~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI 394 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI 394 (475)
T ss_pred ceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence 357999999999988643 44567899999999999743 5569999999999999999999999988888899999
Q ss_pred HcCCCCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcch
Q 006244 154 ISGKKPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 203 (654)
Q Consensus 154 ~~G~~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~ 203 (654)
..|..+. ..|...+.++++||.+||. +|++|||+.|+|+||||+......
T Consensus 395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 9998764 4567789999999999999 999999999999999998665443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=346.68 Aligned_cols=190 Identities=33% Similarity=0.529 Sum_probs=174.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+||++|.+ .+++|||+|+|..|+|..++++.+.++|..++.+++||+.||.|||+++ |||||||..|||++.+ .
T Consensus 81 V~f~~~FED--s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~-~ 155 (592)
T KOG0575|consen 81 VQFYHFFED--SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNEN-M 155 (592)
T ss_pred EeeeeEeec--CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCc-C
Confidence 689999999 8999999999999999999999999999999999999999999999999 9999999999999966 5
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+|||||||||+.+... ...+.+|||.|.||||+.+ .++..+||||+||+||.||+|++||.. .+....|.+|....
T Consensus 156 ~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 156 NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNE 234 (592)
T ss_pred cEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcC
Confidence 9999999999998744 4456789999999999975 499999999999999999999999986 67889999998766
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.. ++...+.++++||.++|. +|.+|||+.++|.|+||..
T Consensus 235 Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 235 YS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred cc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 53 345789999999999999 8999999999999999943
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.13 Aligned_cols=196 Identities=30% Similarity=0.493 Sum_probs=175.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+++-+|++ ...+|||+||+.||.|+..+++.+.+++..++.|+.+|+.||.|||+++ ||||||||+|||++ .+|
T Consensus 88 v~l~ysFQt--~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~G 162 (357)
T KOG0598|consen 88 VKLIYSFQT--EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQG 162 (357)
T ss_pred eeeEEeccc--CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCC
Confidence 578888988 7899999999999999999999999999999999999999999999999 99999999999998 559
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+|+|+||||++..-. ....+++||+.|||||++.+ .|+..+|+||||+++|+|++|.+||.. .+...++++|..++
T Consensus 163 Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 163 HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGK 241 (357)
T ss_pred cEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCc
Confidence 999999999985433 24455799999999998875 599999999999999999999999987 67888999999887
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC----CHHHHhcCcccccCCcch
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL----SARELLTDPFLQIDDYDS 203 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp----Ta~ELL~HPFf~~~~~~~ 203 (654)
.+. .+...+++++++|.++|. +|.+|. .+.++-.||||...++..
T Consensus 242 ~~~-~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 242 LPL-PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred CCC-CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 443 345589999999999999 899996 699999999999888763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=317.26 Aligned_cols=193 Identities=31% Similarity=0.567 Sum_probs=176.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+++||||||++||.|++|+++.+++++..++.|+.||+.||+|||+++ |++|||||+|||+|.+ |
T Consensus 107 v~l~~t~~d--~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G 181 (355)
T KOG0616|consen 107 VKLYGTFKD--NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-G 181 (355)
T ss_pred EEEEEeecc--CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-C
Confidence 578999988 7999999999999999999999999999999999999999999999999 9999999999999955 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||+|+.+... ..+.+|||.|+|||++.. .|+.++|.|||||++|||+.|.+||.. .++.++|.+|..|...
T Consensus 182 ~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v~ 259 (355)
T KOG0616|consen 182 HIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKVK 259 (355)
T ss_pred cEEEEeccceEEecCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCccc
Confidence 9999999999988766 455689999999998874 599999999999999999999999987 6679999999999864
Q ss_pred cccccCCChHHHHHHHHHhh-CccCC-----CCHHHHhcCcccccCCcc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSR-----LSARELLTDPFLQIDDYD 202 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~R-----pTa~ELL~HPFf~~~~~~ 202 (654)
++...++++++||.++|+ |-.+| ....++.+||||+..++.
T Consensus 260 --fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 260 --FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred --CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 456789999999999999 88887 468899999999977765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.09 Aligned_cols=196 Identities=35% Similarity=0.610 Sum_probs=175.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+|+++|.. ++.+|+||||+.||+|.+.+... .+++.+|..++++++.||+|||.++ |+|||||.+|||+. .+|
T Consensus 333 Vnfl~Sylv--~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g 406 (550)
T KOG0578|consen 333 VNFLDSYLV--GDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDG 406 (550)
T ss_pred HHHHHHhcc--cceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCC
Confidence 567888887 68999999999999999987664 5999999999999999999999999 99999999999997 458
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.|||+|||++..+... ...+.+|||.|||||++.+ .|++++||||||++++||+-|++||-..+....+|..-..|.
T Consensus 407 ~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~ 486 (550)
T KOG0578|consen 407 SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 486 (550)
T ss_pred cEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC
Confidence 9999999999987643 4567789999999999875 599999999999999999999999987677777888778888
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
.....+...++++++|+.+||+ ++.+|++|.|||.||||+.....
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ 532 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPE 532 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCH
Confidence 8777788899999999999999 99999999999999999765543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=327.06 Aligned_cols=194 Identities=29% Similarity=0.449 Sum_probs=166.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||.+|+. ++.+|+||.||.+|++.+.++.. ..+++..|..+++++++||.|||.+| .||||||+.||||+.+
T Consensus 87 v~~~~sFvv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d 162 (516)
T KOG0582|consen 87 VTYHCSFVV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD 162 (516)
T ss_pred ceEEEEEEe--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC
Confidence 689999999 89999999999999999998864 45999999999999999999999999 9999999999999855
Q ss_pred CCcEEEEecCchhhhcccC-----C-ccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-----A-ARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-----~-~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
|.|||+|||.+..+.... . .+++|||+|||||++.+ .|+.|+|||||||+..||.+|..||........+
T Consensus 163 -G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL 241 (516)
T KOG0582|consen 163 -GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL 241 (516)
T ss_pred -CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 899999999987664321 1 45689999999999653 4999999999999999999999999987666555
Q ss_pred HHHHHcCCCC--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 150 YKKVISGKKP--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 150 ~kki~~G~~p--------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
..++. |..| ....+..+..++.+|..||+ ||.+||||.+||+|+||+...
T Consensus 242 l~tLq-n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 242 LLTLQ-NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHHhc-CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 55553 4443 22234467789999999999 899999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.32 Aligned_cols=192 Identities=30% Similarity=0.583 Sum_probs=171.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. ...+|+|||||.||+|.+++.+.+++.+..++++++||+.||+|||+++ |+||||||+|||++.+.+
T Consensus 83 ~~l~ev~~t--~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~ 158 (370)
T KOG0583|consen 83 IRLLEVFAT--PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEG 158 (370)
T ss_pred eEEEEEEec--CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCC
Confidence 578887776 5669999999999999999999999999999999999999999999999 999999999999997657
Q ss_pred cEEEEecCchhhh--cccCCccccCCCCccChhhhcc-c-CC-cccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 EVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVYEE-E-YN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l--~~~~~~~~vGTp~YmAPEvl~~-~-ys-~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+||+|||++... ......+.+|||.|+|||++.+ . |+ .++||||+|++||.|++|.+||.. .+...++.++..
T Consensus 159 ~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~ 237 (370)
T KOG0583|consen 159 NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK 237 (370)
T ss_pred CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc
Confidence 9999999999988 3455677899999999999985 3 64 689999999999999999999998 677788888888
Q ss_pred CCCCcccccCC-ChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 GKKPEALFKVE-DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 G~~p~~l~~~~-spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
|.... +... +++++.||.+||. +|.+|+|+.+++.||||+..
T Consensus 238 ~~~~~--p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 238 GEFKI--PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CCccC--CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 87653 3334 9999999999999 89999999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=322.19 Aligned_cols=197 Identities=31% Similarity=0.523 Sum_probs=165.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+|||.........++++|||++||+|.+++.+.+ .+++..++.+.+||++||+|||+++ |+||||||+|||++...
T Consensus 77 V~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~ 154 (313)
T KOG0198|consen 77 VQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSN 154 (313)
T ss_pred EeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCC
Confidence 57888643321237999999999999999999987 7999999999999999999999999 99999999999999635
Q ss_pred CcEEEEecCchhhhcc-----cCCccccCCCCccChhhhcccC-C-cccchhhhhhHHHHHhhcCCCCCC-CCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRK-----SHAARCVGTPEFMAPEVYEEEY-N-ELVDIYSFGMCILEMVTFDYPYSE-CTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~-----~~~~~~vGTp~YmAPEvl~~~y-s-~ksDIWSLGiiL~ELlTG~~Pf~~-~~~~~qi~k 151 (654)
+.+||+|||++..... .......|||.|||||++...+ . .++|||||||+++||+||..||.+ ......+++
T Consensus 155 ~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ 234 (313)
T KOG0198|consen 155 GDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL 234 (313)
T ss_pred CeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH
Confidence 7999999999987763 2234567999999999998442 2 499999999999999999999987 344444555
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
....+..| .++...++++++||.+|+. +|.+||||.+||.|||++...
T Consensus 235 ig~~~~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 235 IGREDSLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HhccCCCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 55555445 6777899999999999999 899999999999999997543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.70 Aligned_cols=195 Identities=28% Similarity=0.504 Sum_probs=175.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
||+|-.|.| ...+|+|+||+++|+|.+||++.+.|++.-++.|+.||+.||+|||++| ||||||||+|||++++ |
T Consensus 137 vkLy~TFQD--~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-m 211 (604)
T KOG0592|consen 137 VKLYFTFQD--EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-G 211 (604)
T ss_pred EEEEEEeec--ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-C
Confidence 589999999 7899999999999999999999999999999999999999999999999 9999999999999965 8
Q ss_pred cEEEEecCchhhhcccC---------------CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCC
Q 006244 81 EVKIGDLGLAAILRKSH---------------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECT 144 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---------------~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~ 144 (654)
++||+|||.|+.+.... ..++|||..|.+||++... .+..+|||+||||||.|+.|.+||.+ .
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~ 290 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-A 290 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-c
Confidence 99999999999875321 1457999999999999865 78889999999999999999999987 6
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcch
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 203 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~ 203 (654)
|..-++++|+.-.. .+++..++.+++||+++|+ +|++|+|+.+|..||||...++..
T Consensus 291 NeyliFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 291 NEYLIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred cHHHHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 77888999986443 3456678999999999999 999999999999999999888864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.87 Aligned_cols=196 Identities=26% Similarity=0.477 Sum_probs=172.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
||+|-+|.+ ..++||||||++||++..+|.+.+.|++..++.|+.+++.|++-||+.| +|||||||+|+|||. .|
T Consensus 204 VKLyYsFQD--~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~-~G 278 (550)
T KOG0605|consen 204 VKLYYSFQD--KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDA-KG 278 (550)
T ss_pred EEEEEEecC--CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecC-CC
Confidence 799999999 7999999999999999999999999999999999999999999999999 999999999999995 48
Q ss_pred cEEEEecCchhhhcc-------------------------c------------------------CCccccCCCCccChh
Q 006244 81 EVKIGDLGLAAILRK-------------------------S------------------------HAARCVGTPEFMAPE 111 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~-------------------------~------------------------~~~~~vGTp~YmAPE 111 (654)
++||+||||++-+.. . ...+.+|||.|||||
T Consensus 279 HiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPE 358 (550)
T KOG0605|consen 279 HIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPE 358 (550)
T ss_pred CEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchH
Confidence 999999999953210 0 011357999999999
Q ss_pred hhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhhCccCCCC--
Q 006244 112 VYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLATVSSRLS-- 186 (654)
Q Consensus 112 vl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~--p~~l~~~~spelrdLI~kCL~dP~~RpT-- 186 (654)
|+.+. |+..+|+||||||+||||.|.+||.. .++.+.+++|...+. ..+-....++++++||.+||.+|.+|+.
T Consensus 359 Vll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~ 437 (550)
T KOG0605|consen 359 VLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSK 437 (550)
T ss_pred HHhcCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcc
Confidence 99764 99999999999999999999999987 778999999987652 2222334679999999999999999985
Q ss_pred -HHHHhcCcccccCCcc
Q 006244 187 -ARELLTDPFLQIDDYD 202 (654)
Q Consensus 187 -a~ELL~HPFf~~~~~~ 202 (654)
+.||..||||+..++.
T Consensus 438 G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 438 GAEEIKKHPFFKGVDWD 454 (550)
T ss_pred cHHHHhcCCccccCCcc
Confidence 9999999999988886
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=331.04 Aligned_cols=218 Identities=26% Similarity=0.490 Sum_probs=187.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. +.++|||+||++||.|++|+.+++++++..+.++++||+.|+.|||..+ |+||||||+|+|++.+ +
T Consensus 75 l~LydVwe~--~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~ 149 (786)
T KOG0588|consen 75 LRLYDVWEN--KQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-N 149 (786)
T ss_pred eeeeeeecc--CceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-c
Confidence 579999988 8999999999999999999999999999999999999999999999999 9999999999999966 5
Q ss_pred cEEEEecCchhhhc-ccCCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR-KSHAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~-~~~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.|||+|||+|..-. +....+.||+|.|.|||++.+. | +.++||||.|||||.||||..||.+ .|...++.+|.+|.
T Consensus 150 nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~ 228 (786)
T KOG0588|consen 150 NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGV 228 (786)
T ss_pred CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCc
Confidence 69999999998644 3456678999999999998864 5 5689999999999999999999996 78999999999998
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchhhhhhh--------hcccccccchhhhhhhc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQ--------YQTDYDEISPLLRQSLY 226 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~~r~l~--------~~~~~~~i~pll~~~l~ 226 (654)
.. ++...++++++||.+||. ||.+|+|.+|+++|||+...........+. ......++.|.+.+.+.
T Consensus 229 f~--MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps~~~IDp~Il~~l~ 304 (786)
T KOG0588|consen 229 FE--MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPSIQEIDPLILQHLC 304 (786)
T ss_pred cc--CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCCcccCCHHHHhhhh
Confidence 64 457789999999999999 999999999999999998776543331111 11124466666666554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.93 Aligned_cols=195 Identities=27% Similarity=0.484 Sum_probs=170.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-Q 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-~ 79 (654)
|++++.... .+.+|||||||.||+|..|+++++.+++..++.++.||+.||++||+++ ||||||||.|||++.. .
T Consensus 72 V~l~d~~~~--~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~ 147 (429)
T KOG0595|consen 72 VRLLDCIED--DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTAR 147 (429)
T ss_pred eeEEEEEec--CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCC
Confidence 678887777 7899999999999999999999999999999999999999999999999 9999999999999754 1
Q ss_pred ----CcEEEEecCchhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 80 ----GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 ----g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
-.+||+|||+|+.+... ...+.+|+|-|||||++. ++|+.|+|+||+|+|+|+|++|++||.. .++.+++..+
T Consensus 148 ~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~ 226 (429)
T KOG0595|consen 148 NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYI 226 (429)
T ss_pred CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHH
Confidence 35899999999998754 345668999999999994 7799999999999999999999999987 5677787777
Q ss_pred HcCCC-CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 154 ISGKK-PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 154 ~~G~~-p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
..|.. ...+....++..++++...|. ++..|.+..+.+.|+|+....
T Consensus 227 ~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 227 KKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 77664 334455567788899999998 899999999999999997554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.94 Aligned_cols=193 Identities=26% Similarity=0.467 Sum_probs=165.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ++.++|||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++. .+
T Consensus 58 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~-~~ 132 (323)
T cd05571 58 TALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDK-DG 132 (323)
T ss_pred CCEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECC-CC
Confidence 467787776 7899999999999999999999889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.
T Consensus 133 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~ 211 (323)
T cd05571 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE 211 (323)
T ss_pred CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999875422 22234569999999999875 589999999999999999999999976 45566666666554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
. .++...++++++||.+||. +|.+|| ++.++++||||...++
T Consensus 212 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 212 I--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 3 2445678999999999999 899999 8999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=297.37 Aligned_cols=184 Identities=33% Similarity=0.547 Sum_probs=162.9
Q ss_pred CEEEE-EEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eEecCCCCCcE
Q 006244 1 MKFYT-SWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPP--VIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~-sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~--IIHRDLKpeNI 73 (654)
|+||+ +|.. .+.-++||||||.+|+|.+.++. ++.+++..+++++.|++.||..||+.-|. |+||||||.||
T Consensus 81 VqYy~~~f~~-~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNI 159 (375)
T KOG0591|consen 81 VQYYAHSFIE-DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANI 159 (375)
T ss_pred HHHHHHhhhc-cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchhe
Confidence 46777 4444 34569999999999999998875 45799999999999999999999995444 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
|++++ |.|||+||||++++... .+.+.+|||.||+||.+.+ .|+.++||||+||++|||..-.+||.+ .+..++-
T Consensus 160 Fl~~~-gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~ 237 (375)
T KOG0591|consen 160 FLTAN-GVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLC 237 (375)
T ss_pred EEcCC-CceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHH
Confidence 99965 89999999999998764 3567799999999998875 599999999999999999999999998 5889999
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA 187 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa 187 (654)
++|.+|..|.-+...+|..++.+|..|+. +|..||+.
T Consensus 238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 99999988876667899999999999999 99999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.27 Aligned_cols=192 Identities=26% Similarity=0.493 Sum_probs=168.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ++.+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 81 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~-~~ 155 (329)
T PTZ00263 81 VNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDN-KG 155 (329)
T ss_pred CcEEEEEEc--CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECC-CC
Confidence 578998887 7899999999999999999999889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+ .+...++..+..+..+
T Consensus 156 ~~kl~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~ 233 (329)
T PTZ00263 156 HVKVTDFGFAKKVPDRT-FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRLK 233 (329)
T ss_pred CEEEeeccCceEcCCCc-ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCcC
Confidence 99999999998764432 34569999999999875 488999999999999999999999976 5567778888877643
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 201 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~ 201 (654)
++...++.+++||.+||. +|.+|++ +++++.||||...++
T Consensus 234 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 234 --FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 345578999999999999 8999997 799999999986544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.83 Aligned_cols=196 Identities=28% Similarity=0.504 Sum_probs=163.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.+ ...+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++. .|
T Consensus 64 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~-~~ 138 (363)
T cd05628 64 VKMFYSFQD--KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDS-KG 138 (363)
T ss_pred ceEEEEEec--CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECC-CC
Confidence 578888877 6899999999999999999999889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC-------------------------------------CccccCCCCccChhhhcc-cCCcccc
Q 006244 81 EVKIGDLGLAAILRKSH-------------------------------------AARCVGTPEFMAPEVYEE-EYNELVD 122 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-------------------------------------~~~~vGTp~YmAPEvl~~-~ys~ksD 122 (654)
.+||+|||+++.+.... ....+||+.|+|||++.+ .++.++|
T Consensus 139 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~D 218 (363)
T cd05628 139 HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218 (363)
T ss_pred CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchh
Confidence 99999999987543210 123479999999999864 5899999
Q ss_pred hhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHhhCc---cCCCCHHHHhcCcccc
Q 006244 123 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATV---SSRLSARELLTDPFLQ 197 (654)
Q Consensus 123 IWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~--~~~spelrdLI~kCL~dP---~~RpTa~ELL~HPFf~ 197 (654)
||||||++|||++|..||.. .+....++++..+.....++ ...++++++||.+++.+| ..||++.+|++||||+
T Consensus 219 vwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 219 WWSLGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred hhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 99999999999999999986 45667777777643322222 236889999999977644 3578999999999998
Q ss_pred cCCcc
Q 006244 198 IDDYD 202 (654)
Q Consensus 198 ~~~~~ 202 (654)
..++.
T Consensus 298 ~~~~~ 302 (363)
T cd05628 298 GVDWE 302 (363)
T ss_pred CCCHH
Confidence 76654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.66 Aligned_cols=187 Identities=33% Similarity=0.548 Sum_probs=161.1
Q ss_pred CEEEEEEEecCCC-eEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANR-NINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~-~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|+|||.... .. .+.|||||+++|+|.+++.+ .+.++...+..|+.||+.|+.|||+++| ||||||||+|||++.
T Consensus 102 V~f~G~~~~--~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~ 178 (362)
T KOG0192|consen 102 VQFYGACTS--PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDL 178 (362)
T ss_pred eeEEEEEcC--CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcC
Confidence 679997766 33 79999999999999999988 5789999999999999999999999986 999999999999986
Q ss_pred CCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
+.-++||+|||+++..... ..+...||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... .++...
T Consensus 179 ~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~ 257 (362)
T KOG0192|consen 179 KGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASA 257 (362)
T ss_pred CCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHH
Confidence 5339999999999887653 3334679999999999985 399999999999999999999999998776 555555
Q ss_pred HH-cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VI-SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~-~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+. .+..|. ++...++.+..+|+.||. +|.+||++.+++.
T Consensus 258 v~~~~~Rp~-~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 258 VVVGGLRPP-IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHhcCCCCC-CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 54 555554 555589999999999999 8999999999874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.44 Aligned_cols=192 Identities=29% Similarity=0.507 Sum_probs=166.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.+ ...+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 64 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~-~~ 138 (291)
T cd05612 64 IRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDK-EG 138 (291)
T ss_pred hhhHhhhcc--CCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECC-CC
Confidence 356666665 6799999999999999999999889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+...
T Consensus 139 ~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~ 216 (291)
T cd05612 139 HIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLE 216 (291)
T ss_pred CEEEEecCcchhccCC-cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcC
Confidence 9999999999876543 234569999999998875 488999999999999999999999987 5567778888776543
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 201 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~ 201 (654)
++...++.+++||.+||. +|.+|++ +.+++.||||+..++
T Consensus 217 --~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 217 --FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred --CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 345568999999999999 8999995 999999999976544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=290.55 Aligned_cols=192 Identities=25% Similarity=0.439 Sum_probs=165.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++.|.. .+.+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 56 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~-~~ 130 (312)
T cd05585 56 VPLKFSFQS--PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDY-QG 130 (312)
T ss_pred eceeeEEec--CCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECC-CC
Confidence 467787776 6899999999999999999998889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.
T Consensus 131 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~~ 209 (312)
T cd05585 131 HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQEP 209 (312)
T ss_pred cEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCC
Confidence 9999999999754322 2234569999999999875 489999999999999999999999986 45666777776653
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC---CHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL---SARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp---Ta~ELL~HPFf~~~~ 200 (654)
. .++...++++++||.+||. +|.+|| ++.++|.||||...+
T Consensus 210 ~--~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 210 L--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred C--CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 3 3455678999999999999 899997 589999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=296.06 Aligned_cols=192 Identities=24% Similarity=0.460 Sum_probs=168.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ...+++||||+.||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 94 v~~~~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~-~~ 168 (340)
T PTZ00426 94 VNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDK-DG 168 (340)
T ss_pred cceEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECC-CC
Confidence 578998887 6899999999999999999999889999999999999999999999999 999999999999984 48
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++..+... .....||+.|||||++.+ .++.++|||||||++|+|++|..||.. .+...+++.+..+...
T Consensus 169 ~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~ 246 (340)
T PTZ00426 169 FIKMTDFGFAKVVDTR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGIIY 246 (340)
T ss_pred CEEEecCCCCeecCCC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC
Confidence 9999999999876432 234579999999999875 488999999999999999999999986 5566777888776543
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
++...++.++++|.+||. +|.+|+ ++.++++||||+..++
T Consensus 247 --~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 247 --FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 345678999999999999 899995 8999999999986554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=305.59 Aligned_cols=195 Identities=31% Similarity=0.460 Sum_probs=165.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++++.+.+. ++.+|+|||||. ..|.++++.+ +.+++..|+.|++||++||+|+|.+| +.||||||+|||+.++
T Consensus 72 ikL~Evi~d~-~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~- 146 (538)
T KOG0661|consen 72 IKLKEVIRDN-DRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN- 146 (538)
T ss_pred hhhHHHhhcc-CceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-
Confidence 4556666663 239999999996 5999998765 56999999999999999999999999 9999999999999865
Q ss_pred CcEEEEecCchhhhcc-cCCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 80 GEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~-~~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
..|||+|||||+.+.. +..+.+|.|++|+|||++. +.|+.++||||+|||++|+++-++.|.+.+..+||++...-
T Consensus 147 ~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL 226 (538)
T KOG0661|consen 147 DVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL 226 (538)
T ss_pred ceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence 4899999999998754 5677889999999999885 45999999999999999999999999999999999875421
Q ss_pred CCC-------------------C-------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKK-------------------P-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~-------------------p-------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
|.. | ..+....++++.++|.+||. ||.+||||.++|+||||+...
T Consensus 227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 211 1 11233467899999999999 999999999999999998653
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.24 Aligned_cols=193 Identities=23% Similarity=0.471 Sum_probs=166.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. .+.+|+||||+.||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 59 v~~~~~~~~--~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~ 133 (320)
T cd05590 59 TQLYCCFQT--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-G 133 (320)
T ss_pred hceeeEEEc--CCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-C
Confidence 468888876 6899999999999999999999889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~ 212 (320)
T cd05590 134 HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDE 212 (320)
T ss_pred cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCC
Confidence 999999999875322 22334569999999999874 588999999999999999999999986 55667777777654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH------HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA------RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa------~ELL~HPFf~~~~~ 201 (654)
.. ++...++++++||.+||. +|.+|+++ +++++||||+..++
T Consensus 213 ~~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 213 VV--YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred CC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 33 344578999999999999 89999998 99999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.85 Aligned_cols=195 Identities=28% Similarity=0.537 Sum_probs=164.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.+ +..++||||||.||+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 64 v~~~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~ 138 (364)
T cd05599 64 VKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-G 138 (364)
T ss_pred cceEEEEEc--CCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-C
Confidence 578888887 7899999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC----------------------------------------CccccCCCCccChhhhcc-cCCc
Q 006244 81 EVKIGDLGLAAILRKSH----------------------------------------AARCVGTPEFMAPEVYEE-EYNE 119 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~----------------------------------------~~~~vGTp~YmAPEvl~~-~ys~ 119 (654)
.+||+|||++..+.... ....+||+.|+|||++.. .++.
T Consensus 139 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 218 (364)
T cd05599 139 HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218 (364)
T ss_pred CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCC
Confidence 99999999987543210 112469999999998864 5899
Q ss_pred ccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHhhCccCCCC---HHHHhcCc
Q 006244 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATVSSRLS---ARELLTDP 194 (654)
Q Consensus 120 ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~--~~~spelrdLI~kCL~dP~~RpT---a~ELL~HP 194 (654)
++|||||||++|+|++|..||.. .+....+..+..+......+ ...++++++||.+||.+|.+|++ +.++|.||
T Consensus 219 ~~DiwSlG~il~el~~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 219 ECDWWSLGVIMYEMLVGYPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHP 297 (364)
T ss_pred eeeeecchhHHHHhhcCCCCCCC-CCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCC
Confidence 99999999999999999999987 44566666776654322222 24689999999999999999997 99999999
Q ss_pred ccccCCc
Q 006244 195 FLQIDDY 201 (654)
Q Consensus 195 Ff~~~~~ 201 (654)
||+..++
T Consensus 298 ~~~~~~~ 304 (364)
T cd05599 298 FFKGVDW 304 (364)
T ss_pred CcCCCCH
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=291.92 Aligned_cols=193 Identities=23% Similarity=0.370 Sum_probs=163.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. ...+||||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 64 v~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~-~~ 138 (333)
T cd05600 64 VKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDA-SG 138 (333)
T ss_pred ccEEEEEEc--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECC-CC
Confidence 578888876 7899999999999999999998889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+....+..+......
T Consensus 139 ~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~ 216 (333)
T cd05600 139 HIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKET 216 (333)
T ss_pred CEEEEeCcCCccccc-ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhcccc
Confidence 999999999986644 3345579999999998874 589999999999999999999999987 4556666665543221
Q ss_pred ccc------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 160 EAL------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 160 ~~l------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
... ....++++.+||.+||. +|.+||++.++++||||...+
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 111 12358899999999999 689999999999999998644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=316.89 Aligned_cols=193 Identities=25% Similarity=0.523 Sum_probs=169.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|.+|.. +.++|+||||+.||++.. ++..+.+++..++.|++.|+.||.|||+++ |||||||.+|||+|.+ |
T Consensus 432 ~~L~~~fQT--~~~l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-G 505 (694)
T KOG0694|consen 432 VNLFSCFQT--KEHLFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-G 505 (694)
T ss_pred eeccccccc--CCeEEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-C
Confidence 467888987 789999999999999443 345578999999999999999999999999 9999999999999955 8
Q ss_pred cEEEEecCchhhh--cccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l--~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
++||+|||+++.. ......+++|||.|||||++.+ .|+..+|.|||||+|||||.|++||.+ .+.++++..|..-.
T Consensus 506 h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDE 584 (694)
T ss_pred cEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC
Confidence 9999999999854 3455667899999999999976 599999999999999999999999997 67888999887654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
.. ++...+.++..++.++|. +|.+|+. +.++..||||+..++.
T Consensus 585 ~~--yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 585 VR--YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CC--CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 33 455689999999999999 8999986 5899999999988765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=282.33 Aligned_cols=194 Identities=25% Similarity=0.458 Sum_probs=168.7
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--C
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--Q 79 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~--~ 79 (654)
++.+.... ....|||+|+++||+|..-|.+.-..++..+..+++||+.+|.|||.++ |||||+||+|+|+-++ .
T Consensus 74 rL~~ti~~--~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~ 149 (355)
T KOG0033|consen 74 RLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKG 149 (355)
T ss_pred ehhhhhcc--cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCC
Confidence 34444433 5789999999999999887777677899999999999999999999999 9999999999999643 2
Q ss_pred CcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 80 GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.-|||+|||+|..+... ....++|||.|||||++.. .|+..+|||+.|+|||.|+.|.+||.+ .+...+|..|..|.
T Consensus 150 A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~ 228 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGA 228 (355)
T ss_pred CceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccc
Confidence 36899999999888743 3345679999999999874 699999999999999999999999987 45688999999987
Q ss_pred C--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 K--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
. |...+...++++++||.+||. +|.+|+|+.|+|+|||++...
T Consensus 229 yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 229 YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 4 566788899999999999999 999999999999999998654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=293.26 Aligned_cols=195 Identities=28% Similarity=0.468 Sum_probs=164.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.+ ++++++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~ 138 (350)
T cd05573 64 VKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-G 138 (350)
T ss_pred cchhhheec--CCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-C
Confidence 467777776 6899999999999999999998888999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC-------------------------------CccccCCCCccChhhhcc-cCCcccchhhhhh
Q 006244 81 EVKIGDLGLAAILRKSH-------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGM 128 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-------------------------------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGi 128 (654)
.+||+|||++..+.... ....+||+.|+|||++.+ .++.++|||||||
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 218 (350)
T cd05573 139 HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218 (350)
T ss_pred CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecch
Confidence 99999999998664432 233469999999999875 5899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhhCccCCCC-HHHHhcCcccccCCc
Q 006244 129 CILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLATVSSRLS-ARELLTDPFLQIDDY 201 (654)
Q Consensus 129 iL~ELlTG~~Pf~~~~~~~qi~kki~~G~~--p~~l~~~~spelrdLI~kCL~dP~~RpT-a~ELL~HPFf~~~~~ 201 (654)
++|+|++|..||.... ....+.++..... ........++++++||.+||.+|.+|++ +.++|+||||+..++
T Consensus 219 il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 219 ILYEMLYGFPPFYSDT-LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred hhhhhccCCCCCCCCC-HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCH
Confidence 9999999999998744 5556666665222 1112223689999999999999999999 999999999986554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.96 Aligned_cols=196 Identities=28% Similarity=0.459 Sum_probs=162.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ +..+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 64 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~-~g 138 (382)
T cd05625 64 VRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDR-DG 138 (382)
T ss_pred CeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC-CC
Confidence 678999987 6899999999999999999998888999999999999999999999999 999999999999985 48
Q ss_pred cEEEEecCchhhhccc-------------------------------------------------CCccccCCCCccChh
Q 006244 81 EVKIGDLGLAAILRKS-------------------------------------------------HAARCVGTPEFMAPE 111 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-------------------------------------------------~~~~~vGTp~YmAPE 111 (654)
.+||+|||++..+... .....+||+.|+|||
T Consensus 139 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 218 (382)
T cd05625 139 HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218 (382)
T ss_pred CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHH
Confidence 9999999997532100 012346999999999
Q ss_pred hhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCc--ccccCCChHHHHHHHHHhhCccCCCC--
Q 006244 112 VYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE--ALFKVEDPEVRQFIEKCLATVSSRLS-- 186 (654)
Q Consensus 112 vl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~--~l~~~~spelrdLI~kCL~dP~~RpT-- 186 (654)
++.+ .|+.++|||||||++|||++|.+||... ++.....++....... ......+++++++|.+++.+|.+|++
T Consensus 219 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~ 297 (382)
T cd05625 219 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ-TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKN 297 (382)
T ss_pred HhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC-CHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCC
Confidence 8864 5999999999999999999999999874 4444555555433222 22345689999999998889999987
Q ss_pred -HHHHhcCcccccCCcc
Q 006244 187 -ARELLTDPFLQIDDYD 202 (654)
Q Consensus 187 -a~ELL~HPFf~~~~~~ 202 (654)
+.++++||||+..++.
T Consensus 298 ~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 298 GADEIKAHPFFKTIDFS 314 (382)
T ss_pred CHHHHhcCCCcCCcChH
Confidence 9999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=289.57 Aligned_cols=193 Identities=25% Similarity=0.502 Sum_probs=164.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. ++++||||||+.||+|..++.+...+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 59 ~~~~~~~~~--~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~ 133 (316)
T cd05620 59 THLYCTFQT--KEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-G 133 (316)
T ss_pred cCeeEEEEe--CCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-C
Confidence 468888877 7899999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++.... .......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~ 212 (316)
T cd05620 134 HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT 212 (316)
T ss_pred CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Confidence 99999999986432 223344579999999999875 589999999999999999999999976 45666666666543
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH-HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa-~ELL~HPFf~~~~~ 201 (654)
. .++...++++++||.+||. +|.+|+++ .++++||||+..++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 213 P--HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 2 2344578999999999999 89999997 58999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=289.23 Aligned_cols=193 Identities=22% Similarity=0.430 Sum_probs=166.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. ++.+||||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 59 ~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~ 133 (321)
T cd05591 59 TALHCCFQT--KDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-G 133 (321)
T ss_pred cceeeEEEc--CCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-C
Confidence 468888877 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~ 212 (321)
T cd05591 134 HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDD 212 (321)
T ss_pred CEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999875422 22334569999999998875 589999999999999999999999987 45677777777665
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-------CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-------SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-------Ta~ELL~HPFf~~~~~ 201 (654)
.. ++...+++++++|.+||. +|.+|+ ++.++++||||...++
T Consensus 213 ~~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 213 VL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred CC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 33 334578999999999999 899999 9999999999976554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=295.31 Aligned_cols=196 Identities=28% Similarity=0.537 Sum_probs=163.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.+ ++.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 64 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~-~~ 138 (360)
T cd05627 64 VKMFYSFQD--KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDA-KG 138 (360)
T ss_pred eeEEEEEEc--CCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECC-CC
Confidence 478888877 7899999999999999999998889999999999999999999999999 999999999999985 48
Q ss_pred cEEEEecCchhhhcccC-------------------------------------CccccCCCCccChhhhcc-cCCcccc
Q 006244 81 EVKIGDLGLAAILRKSH-------------------------------------AARCVGTPEFMAPEVYEE-EYNELVD 122 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-------------------------------------~~~~vGTp~YmAPEvl~~-~ys~ksD 122 (654)
.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|
T Consensus 139 ~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~D 218 (360)
T cd05627 139 HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218 (360)
T ss_pred CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcce
Confidence 99999999987542210 123469999999999864 5899999
Q ss_pred hhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHhhCccCCC---CHHHHhcCcccc
Q 006244 123 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQ 197 (654)
Q Consensus 123 IWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~--~~~spelrdLI~kCL~dP~~Rp---Ta~ELL~HPFf~ 197 (654)
||||||++|+|++|.+||.. .++...+.++........++ ...++++++||.+++.+|.+|+ ++.+++.||||+
T Consensus 219 iwSlGvilyel~tG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 219 WWSLGVIMYEMLIGYPPFCS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred eccccceeeecccCCCCCCC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCC
Confidence 99999999999999999986 45666677776543222222 2368899999999888888888 589999999998
Q ss_pred cCCcc
Q 006244 198 IDDYD 202 (654)
Q Consensus 198 ~~~~~ 202 (654)
..++.
T Consensus 298 ~~~~~ 302 (360)
T cd05627 298 GVDWG 302 (360)
T ss_pred CCCHH
Confidence 76554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=295.74 Aligned_cols=195 Identities=25% Similarity=0.461 Sum_probs=161.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ...+||||||+.||+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++. .+
T Consensus 64 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~-~~ 138 (377)
T cd05629 64 VSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDR-GG 138 (377)
T ss_pred ceEEEEEEc--CCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECC-CC
Confidence 578998887 6899999999999999999998889999999999999999999999999 999999999999984 47
Q ss_pred cEEEEecCchhhhcccC-------------------------------------------------CccccCCCCccChh
Q 006244 81 EVKIGDLGLAAILRKSH-------------------------------------------------AARCVGTPEFMAPE 111 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-------------------------------------------------~~~~vGTp~YmAPE 111 (654)
.+||+|||+++.+.... ....+||+.|+|||
T Consensus 139 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 218 (377)
T cd05629 139 HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218 (377)
T ss_pred CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHH
Confidence 99999999986321100 01246999999999
Q ss_pred hhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccc--cCCChHHHHHHHHHhhCccC---CC
Q 006244 112 VYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF--KVEDPEVRQFIEKCLATVSS---RL 185 (654)
Q Consensus 112 vl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~--~~~spelrdLI~kCL~dP~~---Rp 185 (654)
++.+ .|+.++|||||||++|||++|.+||.. .+....+..+........++ ...++++++||.+||.+|.+ |+
T Consensus 219 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~ 297 (377)
T cd05629 219 IFLQQGYGQECDWWSLGAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRG 297 (377)
T ss_pred HHccCCCCCceeeEecchhhhhhhcCCCCCCC-CCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCC
Confidence 9864 589999999999999999999999976 44556666666543222222 24688999999999996655 56
Q ss_pred CHHHHhcCcccccCCc
Q 006244 186 SARELLTDPFLQIDDY 201 (654)
Q Consensus 186 Ta~ELL~HPFf~~~~~ 201 (654)
++.+++.||||+..++
T Consensus 298 ~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 298 GAHEIKSHPFFRGVDW 313 (377)
T ss_pred CHHHHhcCCCcCCCCH
Confidence 9999999999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=288.47 Aligned_cols=194 Identities=27% Similarity=0.514 Sum_probs=160.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. ++.+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+ +|+||||||+|||++.+ +
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~~~-~ 141 (331)
T cd06649 66 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVNSR-G 141 (331)
T ss_pred CeEEEEEEE--CCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEcCC-C
Confidence 578998887 6899999999999999999998888999999999999999999999853 39999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH-------
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK------- 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk------- 152 (654)
.+||+|||++..+.........||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... ...+...
T Consensus 142 ~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~ 220 (331)
T cd06649 142 EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVD 220 (331)
T ss_pred cEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccc
Confidence 99999999998765555555679999999999874 48999999999999999999999996532 2222111
Q ss_pred ---------------------------------------HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 ---------------------------------------VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 ---------------------------------------i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+.....+.......++++++||.+||. +|.+|||+.+||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111112222223467899999999999 8999999999999
Q ss_pred CcccccC
Q 006244 193 DPFLQID 199 (654)
Q Consensus 193 HPFf~~~ 199 (654)
||||+..
T Consensus 301 h~~~~~~ 307 (331)
T cd06649 301 HTFIKRS 307 (331)
T ss_pred ChHHhhc
Confidence 9999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=288.09 Aligned_cols=193 Identities=23% Similarity=0.439 Sum_probs=165.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. .+.+|+||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 64 ~~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~-~~ 138 (324)
T cd05587 64 TQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDA-EG 138 (324)
T ss_pred eeeEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcC-CC
Confidence 357777776 6799999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++.... .......+||+.|+|||++.+ .++.++||||||+++|+|+||..||.. .+...++..+..+.
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~ 217 (324)
T cd05587 139 HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN 217 (324)
T ss_pred CEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999999986432 222334569999999999875 489999999999999999999999986 45667777777654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH-----HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-----RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa-----~ELL~HPFf~~~~~ 201 (654)
. .++...+++++++|.+||. +|.+|+++ .+++.||||+..++
T Consensus 218 ~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 218 V--SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 3 2445678999999999999 89999976 89999999987554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.53 Aligned_cols=194 Identities=22% Similarity=0.412 Sum_probs=162.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. .+.+++||||+.+|+|.+++.+++.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~ 142 (332)
T cd05614 68 VTLHYAFQT--EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-G 142 (332)
T ss_pred ccEEEEEec--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-C
Confidence 467777766 6889999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc---CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCC---CCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSEC---THPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~---~~~~qi~kk 152 (654)
.+||+|||++...... .....+||+.|||||++.+ .++.++||||||+++|+|+||..||... .....+...
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 222 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR 222 (332)
T ss_pred CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence 9999999999765322 1224569999999999875 3788999999999999999999999642 233444455
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
+..... .++...++.++++|.+||. +|.+|| ++.++++||||+..++
T Consensus 223 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 223 ILKCDP--PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred HhcCCC--CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 544332 2445678999999999999 899999 8899999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=289.71 Aligned_cols=193 Identities=24% Similarity=0.452 Sum_probs=163.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. +..++|||||+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++. .+
T Consensus 58 v~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~-~~ 132 (328)
T cd05593 58 TSLKYSFQT--KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDK-DG 132 (328)
T ss_pred cceEEEEEc--CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECC-CC
Confidence 467777776 7899999999999999999988889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+.+.+..+.
T Consensus 133 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~-~~~~~~~~~~~~~~ 211 (328)
T cd05593 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMED 211 (328)
T ss_pred cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC-CCHHHHHHHhccCC
Confidence 999999999875322 22234569999999999864 589999999999999999999999976 34555656655443
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
. .++...++++++||.+||. +|.+|+ ++.++++||||...++
T Consensus 212 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 I--KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred c--cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 3 2455678999999999999 899997 8999999999976544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=289.11 Aligned_cols=193 Identities=26% Similarity=0.465 Sum_probs=163.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.|.. +..++|||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+ .+ |+||||||+|||++. .
T Consensus 58 ~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~-~ 132 (325)
T cd05594 58 TALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDK-D 132 (325)
T ss_pred CceEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECC-C
Confidence 467777776 68999999999999999999888899999999999999999999997 67 999999999999985 4
Q ss_pred CcEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
|.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~ 211 (325)
T cd05594 133 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME 211 (325)
T ss_pred CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcC
Confidence 7999999999875322 22234569999999999864 589999999999999999999999976 4455666666544
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.. .++...++++++||.+||. +|.+|+ ++.++++||||....+
T Consensus 212 ~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 212 EI--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 33 2445678999999999999 899997 9999999999986443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=293.74 Aligned_cols=195 Identities=28% Similarity=0.430 Sum_probs=165.6
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
++|.+|.. .+.++||||||+||+|..+++++ +.+++.+++.|+.+|+.||+|||..| ||+|||||+||||. ++
T Consensus 141 TLYa~fet--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-ed 215 (459)
T KOG0610|consen 141 TLYASFET--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-ED 215 (459)
T ss_pred hhhheeec--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cC
Confidence 57888877 78999999999999999998875 57999999999999999999999999 99999999999998 45
Q ss_pred CcEEEEecCchhhhc----------------------------------ccC------------------------Cccc
Q 006244 80 GEVKIGDLGLAAILR----------------------------------KSH------------------------AARC 101 (654)
Q Consensus 80 g~VKL~DFGLA~~l~----------------------------------~~~------------------------~~~~ 101 (654)
|+|+|.||-|+.... ... ...+
T Consensus 216 GHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSF 295 (459)
T KOG0610|consen 216 GHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSF 295 (459)
T ss_pred CcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccc
Confidence 999999999884320 000 1245
Q ss_pred cCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-
Q 006244 102 VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA- 179 (654)
Q Consensus 102 vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~- 179 (654)
|||.+|.|||++.+. .+.++|+|+|||++|||+.|..||.+.++.+.+...+.+... ..-....+..+++||+++|+
T Consensus 296 VGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-Fp~~~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 296 VGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-FPEEPEVSSAAKDLIRKLLVK 374 (459)
T ss_pred ccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-CCCCCcchhHHHHHHHHHhcc
Confidence 899999999999865 899999999999999999999999997777766655544322 11222567899999999999
Q ss_pred CccCCCC----HHHHhcCcccccCCcc
Q 006244 180 TVSSRLS----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 180 dP~~RpT----a~ELL~HPFf~~~~~~ 202 (654)
+|.+|+. |.||-+||||+..+|.
T Consensus 375 dP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred ChhhhhccccchHHhhcCccccCCChh
Confidence 8999998 9999999999998886
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.22 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=161.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.+ ++.++||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++. .+
T Consensus 64 v~~~~~~~~--~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~-~~ 138 (376)
T cd05598 64 VKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDR-DG 138 (376)
T ss_pred ceEEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECC-CC
Confidence 578888877 7899999999999999999999888999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhccc---------------------------------------------CCccccCCCCccChhhhcc
Q 006244 81 EVKIGDLGLAAILRKS---------------------------------------------HAARCVGTPEFMAPEVYEE 115 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~---------------------------------------------~~~~~vGTp~YmAPEvl~~ 115 (654)
.+||+|||++..+... .....+||+.|||||++.+
T Consensus 139 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 218 (376)
T cd05598 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218 (376)
T ss_pred CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC
Confidence 9999999997532100 0113469999999999875
Q ss_pred -cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC--cccccCCChHHHHHHHHHhhCccCCC---CHHH
Q 006244 116 -EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLATVSSRL---SARE 189 (654)
Q Consensus 116 -~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p--~~l~~~~spelrdLI~kCL~dP~~Rp---Ta~E 189 (654)
.++.++|||||||++|+|++|..||... +.......+...... .......+++++++|.+|+.+|.+|+ ++.+
T Consensus 219 ~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~e 297 (376)
T cd05598 219 TGYTQLCDWWSVGVILYEMLVGQPPFLAD-TPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADE 297 (376)
T ss_pred CCCCcceeeeeccceeeehhhCCCCCCCC-CHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHH
Confidence 4899999999999999999999999874 344444455443221 12223568999999999888999999 9999
Q ss_pred HhcCcccccCCcc
Q 006244 190 LLTDPFLQIDDYD 202 (654)
Q Consensus 190 LL~HPFf~~~~~~ 202 (654)
+++||||+..++.
T Consensus 298 ll~h~~~~~~~~~ 310 (376)
T cd05598 298 IKAHPFFKGIDFA 310 (376)
T ss_pred HhCCCCcCCCCHH
Confidence 9999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.80 Aligned_cols=192 Identities=30% Similarity=0.501 Sum_probs=169.1
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
+||++|+. +..+|++||||.||++.+.++....+++..+..++++++.||.|||.++ .+|||||+.|||+... |.
T Consensus 75 ~yygsyl~--g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~ 149 (467)
T KOG0201|consen 75 EYYGSYLK--GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GD 149 (467)
T ss_pred hhhhheee--cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-Cc
Confidence 78999998 7899999999999999999888777799999999999999999999999 9999999999999865 89
Q ss_pred EEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 82 VKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
|||+|||++..+.... ..+++|||.||||||+.+ .|+.++||||||++++||++|++||.......-+ -++-...
T Consensus 150 vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--flIpk~~ 227 (467)
T KOG0201|consen 150 VKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--FLIPKSA 227 (467)
T ss_pred EEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--EeccCCC
Confidence 9999999998876543 367899999999999986 6999999999999999999999999986542211 2223445
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
|+.+....++.+++||+.||. +|..||+|.+||+|+|++...
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 666666889999999999999 899999999999999998754
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=285.72 Aligned_cols=193 Identities=26% Similarity=0.470 Sum_probs=164.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...+||||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 58 ~~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~-~~ 132 (323)
T cd05595 58 TALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DG 132 (323)
T ss_pred cceeeEEec--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcC-CC
Confidence 467888877 6799999999999999999998888999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.. .+...++..+..+.
T Consensus 133 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~ 211 (323)
T cd05595 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE 211 (323)
T ss_pred CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC
Confidence 9999999998753222 223456999999999886 4589999999999999999999999976 44556666665543
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
. .++...+++++++|.+||. +|.+|+ ++.++++||||....+
T Consensus 212 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 212 I--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 3 2345678999999999999 899998 8999999999986554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=287.11 Aligned_cols=193 Identities=27% Similarity=0.420 Sum_probs=165.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++.|.. +..+++||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 59 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~-~~ 133 (323)
T cd05575 59 VGLHYSFQT--ADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDS-QG 133 (323)
T ss_pred CCeeEEEEe--CCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECC-CC
Confidence 578888877 6899999999999999999998889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~ 212 (323)
T cd05575 134 HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP 212 (323)
T ss_pred cEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999875322 22334569999999998865 589999999999999999999999986 55677777777654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa----~ELL~HPFf~~~~~ 201 (654)
.. +....++.+.++|.+||+ +|.+||++ .+++.||||...++
T Consensus 213 ~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 LR--LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred CC--CCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 32 344568999999999999 89999987 69999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=286.37 Aligned_cols=191 Identities=25% Similarity=0.473 Sum_probs=166.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++.+.|.. +.-+++|+|+|+-|.|++|+...-.++++..+++++|++.|++|||.++ |+||||||+|||++.+ .
T Consensus 86 I~l~D~yes--~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn-~ 160 (411)
T KOG0599|consen 86 IDLQDVYES--DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDN-M 160 (411)
T ss_pred EEeeeeccC--cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccc-c
Confidence 466777765 6789999999999999999998888999999999999999999999999 9999999999999966 5
Q ss_pred cEEEEecCchhhhcccC-CccccCCCCccChhhhcc-------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
++||+|||+|..+.... ....+|||+|+|||.+.. .|+..+|+|++|+|||.|+.|.+||.... .--+.+.
T Consensus 161 ~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-QmlMLR~ 239 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-QMLMLRM 239 (411)
T ss_pred ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-HHHHHHH
Confidence 89999999999887653 456789999999998852 38889999999999999999999997522 2234467
Q ss_pred HHcCCCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 153 VISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 153 i~~G~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
|.+|+.. .+-|...+.++++||.+||+ +|.+|+|++|+|.||||.
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 7888763 33466778899999999999 999999999999999995
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=286.42 Aligned_cols=193 Identities=23% Similarity=0.447 Sum_probs=165.5
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++.+.. .+.++|||||+.+|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 65 ~~~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~ 139 (323)
T cd05616 65 QLHSCFQT--MDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GH 139 (323)
T ss_pred eEEEEEec--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-Cc
Confidence 56777766 6799999999999999999998889999999999999999999999998 9999999999999854 79
Q ss_pred EEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 82 VKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 82 VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
+||+|||++.... ........||+.|+|||++.. .++.++|||||||++|+|+||..||.. .+...++..+..+..
T Consensus 140 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~ 218 (323)
T cd05616 140 IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV 218 (323)
T ss_pred EEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC
Confidence 9999999987543 222334569999999998874 589999999999999999999999987 456677777776543
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
. ++...+++++++|.+||. +|.+|++ ..+++.||||+..++.
T Consensus 219 ~--~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 219 A--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred C--CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 2 345678999999999999 8999997 4899999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=287.39 Aligned_cols=194 Identities=22% Similarity=0.436 Sum_probs=161.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. .+.+|||||||+||+|.+++.+.+++++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 59 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~-~~ 133 (329)
T cd05588 59 VGLHSCFQT--ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDA-EG 133 (329)
T ss_pred CceEEEEEc--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECC-CC
Confidence 578888877 6899999999999999999988889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC--------CCHHHH
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQI 149 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--------~~~~qi 149 (654)
.+||+|||++.... .......+||+.|+|||++.+ .++.++||||||+++|+|++|..||... .....+
T Consensus 134 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 134 HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred CEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 99999999987532 222334579999999999875 5889999999999999999999999632 112234
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC------HHHHhcCcccccCCc
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 201 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT------a~ELL~HPFf~~~~~ 201 (654)
++.+..+.. .++...+++++++|.+||. +|.+|++ +.++++||||...++
T Consensus 214 ~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 214 FQVILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 444544432 2445678999999999999 8999987 799999999975443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=286.09 Aligned_cols=193 Identities=25% Similarity=0.519 Sum_probs=164.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. +..+++||||+.||+|..++...+.+++..+..|+.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 59 ~~~~~~~~~--~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~-~~ 133 (316)
T cd05592 59 THLFCTFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDK-DG 133 (316)
T ss_pred cceeeEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECC-CC
Confidence 467888876 6799999999999999999998889999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+....
T Consensus 134 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~ 212 (316)
T cd05592 134 HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR 212 (316)
T ss_pred CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999975432 22334569999999999875 589999999999999999999999987 45566666665543
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH-HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa-~ELL~HPFf~~~~~ 201 (654)
. .++...++++++||.+||. +|.+||++ .++++||||...++
T Consensus 213 ~--~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 P--HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 2 2445678999999999999 89999986 58999999986554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=286.24 Aligned_cols=193 Identities=25% Similarity=0.508 Sum_probs=164.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. ++.+++||||++||+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 59 v~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~ 133 (316)
T cd05619 59 THLYCTFQT--KENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-G 133 (316)
T ss_pred cceEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-C
Confidence 478888877 6799999999999999999988888999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++.... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~ 212 (316)
T cd05619 134 HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN 212 (316)
T ss_pred CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Confidence 99999999986532 222334569999999999875 589999999999999999999999986 45566666665543
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHH-HHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR-ELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~-ELL~HPFf~~~~~ 201 (654)
. .++...+.++++||.+||. +|.+|+++. +++.||||+..++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 213 P--CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred C--CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 2 2344578899999999999 899999996 9999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=301.60 Aligned_cols=191 Identities=34% Similarity=0.577 Sum_probs=172.2
Q ss_pred CEEEEEEEecCCCe-EEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRN-INFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~-i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|.|+++|+. ++. ++|||+||+||+|.+.+++.+ .++++.+..|+.||+.||.|||++. |+|||||+.|||++.
T Consensus 66 v~y~ds~~~--~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk 141 (426)
T KOG0589|consen 66 VEYKDSFEE--DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTK 141 (426)
T ss_pred eeeccchhc--CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccc
Confidence 579999998 555 999999999999999998765 5999999999999999999999988 999999999999986
Q ss_pred CCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+ +.|||+|||+|+.+... ...+.+|||.||.||++.+ .|+.++||||||||+|||++-+++|.. .+...+..++.
T Consensus 142 ~-~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~ 219 (426)
T KOG0589|consen 142 D-KKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKIN 219 (426)
T ss_pred c-CceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHh
Confidence 5 68899999999998765 5567789999999999986 599999999999999999999999987 67888888888
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+.. .+++..++.+++.+|+.||. +|..||++.+||.+|.++.
T Consensus 220 ~~~~-~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 220 RGLY-SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred hccC-CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 8873 33667889999999999999 8999999999999998763
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.31 Aligned_cols=195 Identities=23% Similarity=0.392 Sum_probs=163.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.+ ...++|||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~-~ 138 (330)
T cd05601 64 PQLQYAFQD--KDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDR-T 138 (330)
T ss_pred cceeeEEec--CCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECC-C
Confidence 467777776 67999999999999999999886 67999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc-------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
|.+||+|||++..+.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||... +....
T Consensus 139 ~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~ 217 (330)
T cd05601 139 GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKT 217 (330)
T ss_pred CCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHH
Confidence 799999999998764332 12346999999999985 24788999999999999999999999874 45556
Q ss_pred HHHHHcCCCCccc--ccCCChHHHHHHHHHhhCccCCCCHHHHhcCcccccCCc
Q 006244 150 YKKVISGKKPEAL--FKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 150 ~kki~~G~~p~~l--~~~~spelrdLI~kCL~dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+.++........+ ....++++++||.+||.+|.+||++.+++.||||...++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred HHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCH
Confidence 6666654432222 224688999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=292.62 Aligned_cols=196 Identities=28% Similarity=0.440 Sum_probs=159.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ..++++|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+|||++. .|
T Consensus 64 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~-~~ 138 (381)
T cd05626 64 VKLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDL-DG 138 (381)
T ss_pred eeeEEEEec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECC-CC
Confidence 578998887 6899999999999999999999889999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhccc-------------------------------------------------CCccccCCCCccChh
Q 006244 81 EVKIGDLGLAAILRKS-------------------------------------------------HAARCVGTPEFMAPE 111 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-------------------------------------------------~~~~~vGTp~YmAPE 111 (654)
.+||+|||++..+... .....+||+.|+|||
T Consensus 139 ~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 218 (381)
T cd05626 139 HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218 (381)
T ss_pred CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHH
Confidence 9999999997533100 012347999999999
Q ss_pred hhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhh---CccCCC
Q 006244 112 VYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA---TVSSRL 185 (654)
Q Consensus 112 vl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~--p~~l~~~~spelrdLI~kCL~---dP~~Rp 185 (654)
++.+ .|+.++|||||||++|||++|..||.... ......++..... ........++++++||.++|. ++..|+
T Consensus 219 ~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~ 297 (381)
T cd05626 219 VLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT-PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297 (381)
T ss_pred HHcCCCCCCccceeehhhHHHHHHhCCCCCcCCC-HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence 8864 58999999999999999999999998744 4444444543222 222223478999999999765 355699
Q ss_pred CHHHHhcCcccccCCcc
Q 006244 186 SARELLTDPFLQIDDYD 202 (654)
Q Consensus 186 Ta~ELL~HPFf~~~~~~ 202 (654)
++.+++.||||+..++.
T Consensus 298 ~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 298 GADDIKAHPFFSEVDFS 314 (381)
T ss_pred CHHHHhcCcccCCCChh
Confidence 99999999999876554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=285.89 Aligned_cols=193 Identities=26% Similarity=0.406 Sum_probs=165.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ++.+|+||||+.||+|.+++.+.+.+.+..+..++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~ 137 (323)
T cd05584 63 VDLIYAFQT--GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-G 137 (323)
T ss_pred hceeeEEec--CCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-C
Confidence 467888876 6799999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..+.
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~ 216 (323)
T cd05584 138 HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGK 216 (323)
T ss_pred CEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999864322 22233569999999998865 488899999999999999999999987 44555666776665
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.+ ++...++.+++||.+||. +|.+|| ++.+++.||||....+
T Consensus 217 ~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 217 LN--LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred CC--CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 43 445678999999999999 899999 8999999999986543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=288.55 Aligned_cols=194 Identities=28% Similarity=0.436 Sum_probs=164.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...+|+||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 59 ~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~ 133 (330)
T cd05586 59 VGLKFSFQT--DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-G 133 (330)
T ss_pred cceEEEEec--CCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-C
Confidence 467777766 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+
T Consensus 134 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~ 212 (330)
T cd05586 134 HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFG 212 (330)
T ss_pred CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcC
Confidence 999999999875322 22334569999999998864 378999999999999999999999976 5567777787766
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCC----CHHHHhcCcccccCCc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRL----SARELLTDPFLQIDDY 201 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~Rp----Ta~ELL~HPFf~~~~~ 201 (654)
..... ....++++++||.+||. +|.+|| ++.++++||||...++
T Consensus 213 ~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 213 KVRFP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred CCCCC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 54321 23468899999999999 899998 7999999999986543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=291.96 Aligned_cols=195 Identities=23% Similarity=0.422 Sum_probs=163.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.+ .+.++||||||+||+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++. .|
T Consensus 106 v~~~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~-~~ 179 (370)
T cd05596 106 VQLHYAFQD--DKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDK-SG 179 (370)
T ss_pred ceEEEEEec--CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcC-CC
Confidence 568888876 68999999999999999998664 6899999999999999999999998 999999999999985 48
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc-----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||++....... ....+||+.|+|||++.. .++.++|||||||++|+|++|..||.. .+....+.+
T Consensus 180 ~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~ 258 (370)
T cd05596 180 HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSK 258 (370)
T ss_pred CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHH
Confidence 99999999997654322 234569999999998853 378899999999999999999999987 455667777
Q ss_pred HHcCCCCccccc--CCChHHHHHHHHHhh-CccC--CCCHHHHhcCcccccCCcc
Q 006244 153 VISGKKPEALFK--VEDPEVRQFIEKCLA-TVSS--RLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 153 i~~G~~p~~l~~--~~spelrdLI~kCL~-dP~~--RpTa~ELL~HPFf~~~~~~ 202 (654)
+..+.....++. ..+.++++||.+||. +|.+ |+++.++++||||+..++.
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 776543332322 468999999999999 6776 9999999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=284.70 Aligned_cols=193 Identities=23% Similarity=0.468 Sum_probs=165.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. .+.+++||||+.||+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 59 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~ 133 (318)
T cd05570 59 TQLHSCFQT--KDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-G 133 (318)
T ss_pred cceeeEEEc--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-C
Confidence 478888877 6799999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~ 212 (318)
T cd05570 134 HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDE 212 (318)
T ss_pred cEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCC
Confidence 99999999986532 222334569999999999875 589999999999999999999999976 45666666666554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH-----HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-----RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa-----~ELL~HPFf~~~~~ 201 (654)
.. ++...++++++||.+||. +|.+||++ .+++.||||+..++
T Consensus 213 ~~--~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 213 VR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CC--CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 32 345678999999999999 89999999 99999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=285.32 Aligned_cols=194 Identities=22% Similarity=0.431 Sum_probs=161.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+++++|.. .+.++|||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 59 v~~~~~~~~--~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~ 133 (329)
T cd05618 59 VGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-G 133 (329)
T ss_pred CceeeEEEe--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-C
Confidence 578898887 6899999999999999999988889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC--------CCHHHH
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQI 149 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--------~~~~qi 149 (654)
.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||... .....+
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 134 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred CEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 999999999875322 22334569999999999875 4889999999999999999999999521 122234
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC------HHHHhcCcccccCCc
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 201 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT------a~ELL~HPFf~~~~~ 201 (654)
++.+..+.. .++...++.++++|.+||. +|.+|++ +.++++||||+..++
T Consensus 214 ~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 214 FQVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHhcCCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 444444332 3455678999999999999 8999998 589999999986544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=284.09 Aligned_cols=194 Identities=21% Similarity=0.419 Sum_probs=162.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. .+.+++||||++||+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 59 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~ 133 (327)
T cd05617 59 VGLHSCFQT--TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-G 133 (327)
T ss_pred eeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-C
Confidence 467888877 6899999999999999999988889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC------CCHHHHHH
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC------THPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~------~~~~qi~k 151 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||... .....++.
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 134 HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred CEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 999999999875322 22334579999999998864 5899999999999999999999999532 22334444
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC------HHHHhcCcccccCCc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS------ARELLTDPFLQIDDY 201 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT------a~ELL~HPFf~~~~~ 201 (654)
.+... +..++...++.++++|.+||. +|.+|++ +.+++.||||...++
T Consensus 214 ~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 214 VILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 54443 333556678999999999999 8999998 579999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=290.62 Aligned_cols=194 Identities=24% Similarity=0.443 Sum_probs=161.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++.|.+ +..+|+|||||.||+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++. .+
T Consensus 106 v~~~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~-~~ 179 (370)
T cd05621 106 VQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDK-HG 179 (370)
T ss_pred eeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECC-CC
Confidence 578888877 78999999999999999998765 6899999999999999999999999 999999999999984 48
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc-----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||++..+.... ....+||+.|||||++.. .++.++|||||||++|+|++|..||.. .+....+.+
T Consensus 180 ~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~ 258 (370)
T cd05621 180 HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSK 258 (370)
T ss_pred CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHH
Confidence 99999999998764322 234569999999999863 278899999999999999999999986 455666777
Q ss_pred HHcCCCCcccc--cCCChHHHHHHHHHhhC-c--cCCCCHHHHhcCcccccCCc
Q 006244 153 VISGKKPEALF--KVEDPEVRQFIEKCLAT-V--SSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 153 i~~G~~p~~l~--~~~spelrdLI~kCL~d-P--~~RpTa~ELL~HPFf~~~~~ 201 (654)
+........++ ...++.++++|.+||.+ + ..|+++.++++||||+...+
T Consensus 259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 76644322222 24588999999999984 3 34899999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=283.75 Aligned_cols=193 Identities=26% Similarity=0.426 Sum_probs=164.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. .+.+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 59 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~-~~ 133 (325)
T cd05602 59 VGLHFSFQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDS-QG 133 (325)
T ss_pred CceeEEEEc--CCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECC-CC
Confidence 467888876 6899999999999999999998888999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+....+..+..+.
T Consensus 134 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~ 212 (325)
T cd05602 134 HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP 212 (325)
T ss_pred CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC
Confidence 999999999875432 22334569999999998875 488999999999999999999999986 45566667766543
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHH----HHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR----ELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~----ELL~HPFf~~~~~ 201 (654)
. .+....++.++++|.+||+ +|.+|+++. ++++|+||...++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred c--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 3 2445678999999999999 899999876 8999999976554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=276.65 Aligned_cols=191 Identities=18% Similarity=0.313 Sum_probs=152.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...+++||||+.+++|..+......+++..++.++.||+.||.|||+.+ |+||||||+|||++. .+
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~-~~ 137 (287)
T cd07848 63 VELKEAFRR--RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISH-ND 137 (287)
T ss_pred cchhhhEec--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcC-CC
Confidence 466777765 6799999999999888776655567999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-c
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI-S 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~-~ 155 (654)
.+||+|||++..+.... .....||+.|+|||++.+ .++.++||||||+++|+|++|++||........+..... .
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (287)
T cd07848 138 VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217 (287)
T ss_pred cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999998764322 223469999999998864 589999999999999999999999987544333322111 0
Q ss_pred CCCCc----------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPE----------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~----------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..|. ......++++++||.+||+ +|.+|||++++|+||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 218 GPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11110 0112357889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=277.45 Aligned_cols=194 Identities=21% Similarity=0.366 Sum_probs=159.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.+ ++.+++||||+.+|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~- 137 (285)
T cd05631 63 VSLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDD- 137 (285)
T ss_pred EEEEEEEcc--CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECC-
Confidence 357777766 67999999999999999887653 36899999999999999999999998 999999999999984
Q ss_pred CCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH---HHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP---AQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~---~qi~kki 153 (654)
.+.+||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... ..+...+
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05631 138 RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV 217 (285)
T ss_pred CCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh
Confidence 479999999999775432 2234579999999999864 5899999999999999999999999764321 2233333
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 201 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~ 201 (654)
..+ +..+....++++.+||.+||. +|.+||+ ++++++||||...++
T Consensus 218 ~~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 218 KED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred hcc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 222 223445678999999999999 8999997 999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=282.08 Aligned_cols=191 Identities=25% Similarity=0.457 Sum_probs=162.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.. ++.+|+||||+.||+|..++.+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 65 ~~~~~~~~~--~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~ 138 (324)
T cd05589 65 VNLFACFQT--EDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-G 138 (324)
T ss_pred hceeeEEEc--CCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-C
Confidence 578898877 7899999999999999988754 57999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~ 217 (324)
T cd05589 139 FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDE 217 (324)
T ss_pred cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Confidence 999999999875322 22334569999999998875 588999999999999999999999986 45566666666654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~ 200 (654)
.. .+...++.+.++|.+||. +|.+|| ++.++++||||+..+
T Consensus 218 ~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 218 VR--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 32 345578999999999999 899999 799999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=283.07 Aligned_cols=193 Identities=26% Similarity=0.413 Sum_probs=164.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++.|.. .+.+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 59 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~-~~ 133 (325)
T cd05604 59 VGLHYSFQT--TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDS-QG 133 (325)
T ss_pred ccEEEEEec--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECC-CC
Confidence 568888876 6899999999999999999998889999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.
T Consensus 134 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~ 212 (325)
T cd05604 134 HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP 212 (325)
T ss_pred CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999875322 22334569999999999875 589999999999999999999999986 55667777776654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa----~ELL~HPFf~~~~~ 201 (654)
.. +....+..+.++|.+||. +|.+||++ .+++.||||....+
T Consensus 213 ~~--~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 LV--LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred cc--CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 32 334578899999999999 89999876 59999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=291.89 Aligned_cols=194 Identities=28% Similarity=0.481 Sum_probs=172.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++++.|.+ ...+++|||+|.||.|.+.+.+. .+++..+..+++||+.|++|||+.+ |+||||||+|+|+....
T Consensus 99 v~l~~~~e~--~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 99 VQLKDAFED--PDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDE 173 (382)
T ss_pred EEEEEEEEc--CCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccC
Confidence 578999988 67999999999999999999887 5999999999999999999999999 99999999999997442
Q ss_pred --CcEEEEecCchhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 --GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 --g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+|++|||++...... .....+|||.|+|||++. ..|+..+||||+|+++|.|++|.+||.. .+....+.++..
T Consensus 174 ~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~-~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG-ETEFEIFLAILR 252 (382)
T ss_pred CCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC-CChhHHHHHHHc
Confidence 47999999999988763 345568999999999998 6799999999999999999999999987 445566678888
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
|.. +...+...+..+++||.++|. +|.+|+||.++|+|||++...
T Consensus 253 ~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 253 GDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 865 556677889999999999999 899999999999999998653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=282.40 Aligned_cols=192 Identities=25% Similarity=0.402 Sum_probs=164.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. ...+|+||||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 61 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~ 135 (318)
T cd05582 61 VKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-G 135 (318)
T ss_pred ccEEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-C
Confidence 578888877 6899999999999999999988888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... ......||+.|+|||++.. .++.++||||||+++|+|++|..||.. .+....+..+..+.
T Consensus 136 ~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~-~~~~~~~~~i~~~~ 214 (318)
T cd05582 136 HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILKAK 214 (318)
T ss_pred cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC-CCHHHHHHHHHcCC
Confidence 9999999998765433 2234569999999999875 588999999999999999999999986 44556666666554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~ 200 (654)
.. ++...++.++++|.+||+ +|.+||+ +.+++.||||...+
T Consensus 215 ~~--~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 215 LG--MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 32 345678999999999999 8999999 78899999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=280.27 Aligned_cols=183 Identities=27% Similarity=0.430 Sum_probs=154.8
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 11 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 11 ~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
.++.++||+|||..--|.++-.....++.+.++++++|++.|+.|||+++ +|||||||+||||+.+ |.+||||||+|
T Consensus 72 rkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFA 148 (396)
T KOG0593|consen 72 RKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFA 148 (396)
T ss_pred hcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhh
Confidence 36899999999987555554344457999999999999999999999999 9999999999999855 89999999999
Q ss_pred hhhcc--cCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCCc-----
Q 006244 91 AILRK--SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKPE----- 160 (654)
Q Consensus 91 ~~l~~--~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G~~p~----- 160 (654)
+.+.. ...+.++.|+||+|||++.+ +|...+||||+||++.||++|++.|++.++.+|+|..... |..++
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 99874 34567789999999998875 5999999999999999999999999999999998864431 22211
Q ss_pred ----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 161 ----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 161 ----------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.-++..+.-+.+|+++||. ||.+|++.++||.||||
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 0122345678999999999 99999999999999999
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=281.04 Aligned_cols=193 Identities=25% Similarity=0.382 Sum_probs=164.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.+ .+.+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .|
T Consensus 59 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~-~~ 133 (321)
T cd05603 59 VGLHYSFQT--AEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDS-QG 133 (321)
T ss_pred cceeeEEEc--CCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECC-CC
Confidence 467887776 6899999999999999999988888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.
T Consensus 134 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~ 212 (321)
T cd05603 134 HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP 212 (321)
T ss_pred CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC
Confidence 999999999875322 22234569999999999874 589999999999999999999999987 45667777776653
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa----~ELL~HPFf~~~~~ 201 (654)
. .++...+.++.++|.+||+ +|.+|+++ .++++||||...++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 L--QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 3 3445678899999999999 89999875 59999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=281.96 Aligned_cols=193 Identities=28% Similarity=0.515 Sum_probs=159.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILId~~~ 79 (654)
|++++.|.. ++.++|||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+. + |+||||||+|||++. .
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~-~ 140 (333)
T cd06650 66 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNS-R 140 (333)
T ss_pred cceeEEEEE--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcC-C
Confidence 578998887 689999999999999999999888899999999999999999999975 5 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH--------
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY-------- 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~-------- 150 (654)
|.+||+|||++..+.........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ...+.
T Consensus 141 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~ 219 (333)
T cd06650 141 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD-AKELELMFGCPVE 219 (333)
T ss_pred CCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-hhHHHHHhcCccc
Confidence 789999999998765544455679999999999875 48899999999999999999999997522 11111
Q ss_pred ------------------------------------HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 151 ------------------------------------KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 151 ------------------------------------kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+.....+.......+.++++||.+||+ +|.+|||+.|+|.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 220 GDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 11111112221222457889999999999 89999999999999
Q ss_pred cccccC
Q 006244 194 PFLQID 199 (654)
Q Consensus 194 PFf~~~ 199 (654)
|||+..
T Consensus 300 ~~~~~~ 305 (333)
T cd06650 300 AFIKRS 305 (333)
T ss_pred HHHhcC
Confidence 999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=280.53 Aligned_cols=192 Identities=23% Similarity=0.439 Sum_probs=164.4
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
+++++|.. .+.+||||||++||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 65 ~~~~~~~~--~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ 139 (323)
T cd05615 65 QLHSCFQT--VDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GH 139 (323)
T ss_pred heeeEEec--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CC
Confidence 56777766 6789999999999999999998889999999999999999999999998 9999999999999854 79
Q ss_pred EEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 82 VKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 82 VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
+||+|||++...... ......||+.|+|||++.. .++.++||||||+++|+|++|..||.. .+...++..+..+..
T Consensus 140 ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~ 218 (323)
T cd05615 140 IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV 218 (323)
T ss_pred EEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC
Confidence 999999998754322 2234569999999999874 489999999999999999999999986 456677777776553
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 201 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~ 201 (654)
. ++...++++++++.+||. +|.+|++ ..++++||||+..++
T Consensus 219 ~--~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 219 S--YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred C--CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 2 445678999999999999 8999997 589999999986554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=279.11 Aligned_cols=195 Identities=27% Similarity=0.390 Sum_probs=153.5
Q ss_pred CEEEEEEEecCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTAN---RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~---~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++++.+..... ..+|+||||| +++|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~ 138 (338)
T cd07859 62 VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANA 138 (338)
T ss_pred eeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC
Confidence 467777765322 4689999999 5799999998888999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
.+.+||+|||++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|++||.......++
T Consensus 139 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~ 217 (338)
T cd07859 139 -DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 217 (338)
T ss_pred -CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 4799999999997643221 123579999999999863 5889999999999999999999999764332211
Q ss_pred H--------------HHHHc-----------CCCCc---ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 150 Y--------------KKVIS-----------GKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 150 ~--------------kki~~-----------G~~p~---~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. ..+.. ...+. ...+..++.++++|.+||. +|.+|||+.++|+||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 1 11100 00111 1123457889999999999 89999999999999999743
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=285.54 Aligned_cols=194 Identities=24% Similarity=0.433 Sum_probs=162.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. ...+++|||||+||+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++. .|
T Consensus 106 v~~~~~~~~--~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~-~~ 179 (371)
T cd05622 106 VQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDK-SG 179 (371)
T ss_pred CeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECC-CC
Confidence 578888877 78999999999999999998764 5899999999999999999999999 999999999999985 48
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc-----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||++..+.... ....+||+.|||||++.. .++.++|||||||++|+|++|..||.. .+....+.+
T Consensus 180 ~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~ 258 (371)
T cd05622 180 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSK 258 (371)
T ss_pred CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHH
Confidence 99999999998764322 234569999999999863 278899999999999999999999986 566677788
Q ss_pred HHcCCCCccc--ccCCChHHHHHHHHHhhCcc---CCCCHHHHhcCcccccCCc
Q 006244 153 VISGKKPEAL--FKVEDPEVRQFIEKCLATVS---SRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 153 i~~G~~p~~l--~~~~spelrdLI~kCL~dP~---~RpTa~ELL~HPFf~~~~~ 201 (654)
+........+ ....++.++++|.+||.+|. .|+++.++++||||+...+
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 8765432222 23578999999999999543 3789999999999987554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=274.99 Aligned_cols=189 Identities=26% Similarity=0.393 Sum_probs=152.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. .+.+++||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~- 139 (288)
T cd07871 66 VTLHDIIHT--ERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK- 139 (288)
T ss_pred eeEEEEEcC--CCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-
Confidence 578888876 678999999997 59999987654 5899999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|+||.+||........+ ..+..
T Consensus 140 ~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~ 218 (288)
T cd07871 140 GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL-HLIFR 218 (288)
T ss_pred CCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH
Confidence 79999999998764332 2233468999999998854 4899999999999999999999999874433332 22221
Q ss_pred --CCCCc--------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 --GKKPE--------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 --G~~p~--------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+. ......++++++||.+||+ +|.+|||++|+|+||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 219 LLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 11110 0112357889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=275.71 Aligned_cols=193 Identities=25% Similarity=0.358 Sum_probs=153.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.+ ...+++||||+. |+|.+++.++ ..+++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~-~ 139 (303)
T cd07869 66 VLLHDIIHT--KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISD-T 139 (303)
T ss_pred CeEEEEEec--CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECC-C
Confidence 578888876 679999999995 6888887764 56999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+..
T Consensus 140 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (303)
T cd07869 140 GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219 (303)
T ss_pred CCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 79999999998754322 2234568999999998854 4888999999999999999999999876554443333321
Q ss_pred --CCC---------------Ccccc-------------cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 --GKK---------------PEALF-------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 --G~~---------------p~~l~-------------~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+.. +..+. ...++.+++||.+||+ +|.+|||+.++|+||||+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 110 00000 0134678999999999 89999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=273.32 Aligned_cols=194 Identities=27% Similarity=0.441 Sum_probs=160.2
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++.+.. .+.+++||||+.+|+|.+++..++.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 61 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~ 135 (279)
T cd05633 61 CMTYAFHT--PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GH 135 (279)
T ss_pred EEEEEEec--CCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CC
Confidence 46666665 6789999999999999999998889999999999999999999999999 9999999999999854 79
Q ss_pred EEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCC
Q 006244 82 VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGK 157 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~--~~qi~kki~~G~ 157 (654)
++|+|||++............||+.|+|||++.. .++.++||||||+++|+|++|..||..... ...+.... ..
T Consensus 136 ~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~ 213 (279)
T cd05633 136 VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LT 213 (279)
T ss_pred EEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--hc
Confidence 9999999987665444444579999999998853 488999999999999999999999965332 22221111 12
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
.+..++...+++++++|.+||. +|.+|+ ++.++++||||+..++.
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 214 VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 2334555678999999999999 899999 69999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=271.47 Aligned_cols=191 Identities=28% Similarity=0.406 Sum_probs=153.5
Q ss_pred CEEEEEEEe---cCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVD---TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd---~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++|+.+.. .....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 67 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~ 143 (290)
T cd07862 67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV 143 (290)
T ss_pred ceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEE
Confidence 567887753 22467999999995 6999998764 35899999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+ +.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|.+||....... .+.++
T Consensus 144 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i 221 (290)
T cd07862 144 TSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKI 221 (290)
T ss_pred cCC-CCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHH
Confidence 854 799999999997654432 23446899999999886 458999999999999999999999998754433 33334
Q ss_pred HcCCC---C----------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 ISGKK---P----------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~G~~---p----------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..... + ..+.+..++.+++||.+||+ +|.+|||+.++|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 32110 0 01123457789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=289.64 Aligned_cols=204 Identities=26% Similarity=0.338 Sum_probs=168.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++-+..++.....+|||+|||.. +|.-++... -+|++.+|+.|++||+.||+|||+++ |+|||||+.||||| +.
T Consensus 179 ikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~ 254 (560)
T KOG0600|consen 179 IKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NN 254 (560)
T ss_pred cceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CC
Confidence 567777777546799999999976 888887664 37999999999999999999999999 99999999999998 56
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
|.+||+|||||+++.... .+..|-|.+|+|||++.+ .|+..+|+||+||||.||++|++.|.+.+..+|+.+.+.
T Consensus 255 G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 255 GVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred CCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 999999999999775433 566678999999998875 499999999999999999999999999888888755443
Q ss_pred c-CCCCcc-------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchhhhh
Q 006244 155 S-GKKPEA-------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRM 207 (654)
Q Consensus 155 ~-G~~p~~-------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~~r~ 207 (654)
- |...+. .++..++...+|+.++|. +|.+|.||.++|+++||.......+...
T Consensus 335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~ 414 (560)
T KOG0600|consen 335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSS 414 (560)
T ss_pred HhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCccc
Confidence 2 322111 133457889999999999 9999999999999999976655544433
Q ss_pred h
Q 006244 208 I 208 (654)
Q Consensus 208 l 208 (654)
+
T Consensus 415 L 415 (560)
T KOG0600|consen 415 L 415 (560)
T ss_pred C
Confidence 3
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=264.92 Aligned_cols=190 Identities=29% Similarity=0.516 Sum_probs=161.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. +..+++|+||++|++|.+++.+.+.+++..++.++.||+.||.|||+.+ |+||||||+||+++. .+
T Consensus 67 ~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~-~~ 141 (263)
T cd06625 67 VQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDS-AG 141 (263)
T ss_pred eeeEEEEcc--CCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC-CC
Confidence 578998887 6799999999999999999998888999999999999999999999999 999999999999984 47
Q ss_pred cEEEEecCchhhhcccCC-----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.++|+|||++........ ....|++.|+|||++.+ .++.++||||||+++|+|++|+.||......... ..+.
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~ 220 (263)
T cd06625 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIA 220 (263)
T ss_pred CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-HHHh
Confidence 999999999876533211 23458899999998875 4889999999999999999999999875444443 3444
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.......+....+..++++|.+||. +|.+|||+.++|.||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 4444444566788999999999999 89999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=272.84 Aligned_cols=187 Identities=22% Similarity=0.314 Sum_probs=160.7
Q ss_pred CEEEEEEEe--cCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd--~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILId~ 77 (654)
|++|+++.+ .....+++|||||+||+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++.
T Consensus 81 v~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~ 158 (283)
T PHA02988 81 LKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTE 158 (283)
T ss_pred EEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECC
Confidence 588999877 44568999999999999999999888899999999999999999999985 6 889999999999985
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+ +.+||+|||++..+.... ...+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+..+++..+.
T Consensus 159 ~-~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~ 235 (283)
T PHA02988 159 N-YKLKIICHGLEKILSSPP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLII 235 (283)
T ss_pred C-CcEEEcccchHhhhcccc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHH
Confidence 4 799999999998765432 34568999999999864 689999999999999999999999987 45667777776
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+.....++...++++++||.+||+ +|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 236 NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 5544444444678999999999999 8999999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=313.30 Aligned_cols=194 Identities=26% Similarity=0.458 Sum_probs=169.8
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 82 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~V 82 (654)
++-.|.| .+++||||||++||+|..++.++.++++..++.|+..|+.||.-||+.| +|||||||+|||+|. .|+|
T Consensus 140 LhyAFQD--~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~-~GHi 214 (1317)
T KOG0612|consen 140 LHYAFQD--ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDK-SGHI 214 (1317)
T ss_pred HHHHhcC--ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecc-cCcE
Confidence 3445667 7999999999999999999999999999999999999999999999999 999999999999984 5999
Q ss_pred EEEecCchhhhcccC---CccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 83 KIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 83 KL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
||+|||.+-.+.... ....||||-|.+||++. +.|+..+|.||+||++|||+.|..||.. .+...-|.+|
T Consensus 215 kLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KI 293 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKI 293 (1317)
T ss_pred eeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHH
Confidence 999999998876432 23457999999999985 3589999999999999999999999986 5677788899
Q ss_pred HcCCCCcccc--cCCChHHHHHHHHHhhCccCCCC---HHHHhcCcccccCCcc
Q 006244 154 ISGKKPEALF--KVEDPEVRQFIEKCLATVSSRLS---ARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p~~l~--~~~spelrdLI~kCL~dP~~RpT---a~ELL~HPFf~~~~~~ 202 (654)
+..+....++ ...|+++++||.+.|.+|..|.. +.++..||||...+|.
T Consensus 294 m~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 294 MNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred hchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChh
Confidence 8764333333 34899999999999999999988 9999999999999983
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=295.76 Aligned_cols=202 Identities=28% Similarity=0.523 Sum_probs=169.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.|+. .+.+||+.|||.||-....+..- +.|.+.+|.-+++|++.||.|||+++ |||||||..|||++.+
T Consensus 92 vkLl~ayy~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld- 166 (1187)
T KOG0579|consen 92 VKLLSAYYF--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD- 166 (1187)
T ss_pred HHHHHHHhc--cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-
Confidence 456777777 68999999999999999887764 56999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhcc--cCCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
|.|+|+|||.+..... ....+++|||+||||||.. ..|+.++||||||++|.||..+++|..+. ++-...-
T Consensus 167 GdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVll 245 (1187)
T KOG0579|consen 167 GDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLL 245 (1187)
T ss_pred CcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHH
Confidence 8999999999976543 3456789999999999864 35999999999999999999999999884 4555555
Q ss_pred HHHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchhhhhh
Q 006244 152 KVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMI 208 (654)
Q Consensus 152 ki~~G~~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~~r~l 208 (654)
+|.....|.-+ +...+..+++|+.+||. +|..||++.+||+||||+..+.....+.+
T Consensus 246 KiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireL 304 (1187)
T KOG0579|consen 246 KIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIREL 304 (1187)
T ss_pred HHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHHHH
Confidence 56555544433 44567899999999999 89999999999999999966654444433
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=293.95 Aligned_cols=193 Identities=24% Similarity=0.316 Sum_probs=151.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
++++++|.. ...+++||||++ |++|.+++.+++.+++..++.++.||+.||.|||+ .+ ||||||||+|||++.+.
T Consensus 194 ~~i~~~~~~-~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~ 269 (467)
T PTZ00284 194 MKIQRYFQN-ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSD 269 (467)
T ss_pred eeeEEEEEc-CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCC
Confidence 356676654 356899999999 88999999988899999999999999999999998 47 99999999999997542
Q ss_pred ---------------CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 80 ---------------GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 80 ---------------g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
+.+||+|||++..... .....+||+.|||||++.+ .|+.++|||||||++|||++|++||...
T Consensus 270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccccccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1599999998864322 2345679999999999875 5999999999999999999999999875
Q ss_pred CCHHHHHHHH-HcCCCCccc--------------------------------------ccCCChHHHHHHHHHhh-CccC
Q 006244 144 THPAQIYKKV-ISGKKPEAL--------------------------------------FKVEDPEVRQFIEKCLA-TVSS 183 (654)
Q Consensus 144 ~~~~qi~kki-~~G~~p~~l--------------------------------------~~~~spelrdLI~kCL~-dP~~ 183 (654)
.+...+.... ..|..|..+ ....++.+.+||.+||+ +|.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 5433322111 012111110 01134668899999999 9999
Q ss_pred CCCHHHHhcCccccc
Q 006244 184 RLSARELLTDPFLQI 198 (654)
Q Consensus 184 RpTa~ELL~HPFf~~ 198 (654)
|||+.|+|+||||+.
T Consensus 429 R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 429 RLNARQMTTHPYVLK 443 (467)
T ss_pred CCCHHHHhcCccccc
Confidence 999999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=295.55 Aligned_cols=191 Identities=26% Similarity=0.419 Sum_probs=167.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.. .+++|+|+|||.| +|+.++...+.++++.++.+++|++.||.|||+++ |+|||+||.|||+.+. |
T Consensus 64 v~m~esfEt--~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~ 137 (808)
T KOG0597|consen 64 VEMLESFET--SAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-G 137 (808)
T ss_pred hhHHHhhcc--cceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-C
Confidence 456777766 7899999999976 99999999999999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+|+||||+|+.+.... .+...|||.|||||++.++ |+..+|+||+|||+|||++|++||.. ....++.+.|....
T Consensus 138 ~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 138 TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDP 216 (808)
T ss_pred ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCC
Confidence 99999999999876532 3445699999999998864 99999999999999999999999976 55677777776533
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
..++...+..++.|+..+|. ||.+|+|..+|+.|||.+..-
T Consensus 217 --v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 217 --VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred --CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 33445788999999999999 899999999999999997553
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=277.47 Aligned_cols=195 Identities=21% Similarity=0.436 Sum_probs=159.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.+ ...++|||||+.+|+|.+++.+ ...+++..++.|+.||+.||.|||+++ |+||||||+|||++. .
T Consensus 64 ~~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~-~ 138 (332)
T cd05623 64 TTLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDM-N 138 (332)
T ss_pred eeEEEEEec--CCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECC-C
Confidence 357777766 6899999999999999999987 467999999999999999999999999 999999999999984 4
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
+.+||+|||++..+.... ....+||+.|+|||++. ..++.++|||||||++|+|++|+.||.. .+....+
T Consensus 139 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~ 217 (332)
T cd05623 139 GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETY 217 (332)
T ss_pred CCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHH
Confidence 799999999987653221 12346999999999885 3488899999999999999999999986 4556666
Q ss_pred HHHHcCCCCccc---ccCCChHHHHHHHHHhhC---ccCCCCHHHHhcCcccccCCc
Q 006244 151 KKVISGKKPEAL---FKVEDPEVRQFIEKCLAT---VSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 151 kki~~G~~p~~l---~~~~spelrdLI~kCL~d---P~~RpTa~ELL~HPFf~~~~~ 201 (654)
.++........+ ....++++++||.+||.. +..|+++.++++||||+..++
T Consensus 218 ~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 218 GKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred HHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 666654322112 234689999999999973 334789999999999986554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=293.06 Aligned_cols=191 Identities=27% Similarity=0.473 Sum_probs=163.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+.|.. ++.+||||||+.||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 128 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~ 203 (478)
T PTZ00267 128 VKHFDDFKS--DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM 203 (478)
T ss_pred eEEEEEEEE--CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC
Confidence 689999987 7899999999999999988754 346899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
. .+.+||+|||++..+.... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++.
T Consensus 204 ~-~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~ 281 (478)
T PTZ00267 204 P-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQ 281 (478)
T ss_pred C-CCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHH
Confidence 5 4799999999998764432 234569999999999864 589999999999999999999999976 45566667
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+..+..+. .+...+++++++|.+||. +|.+||++.++|.|+|++.
T Consensus 282 ~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 282 QVLYGKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHhCCCCC-CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 776665442 344578899999999999 8999999999999999964
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=270.81 Aligned_cols=193 Identities=27% Similarity=0.468 Sum_probs=156.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.|.. +..+++||||++||+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 56 ~~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~ 131 (280)
T cd05608 56 VSLAYAFQT--KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD 131 (280)
T ss_pred eeeeEEEcC--CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC
Confidence 356666665 6789999999999999988743 346999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH---HHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP---AQIY 150 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~---~qi~ 150 (654)
. .+.++|+|||++..+.... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ..+.
T Consensus 132 ~-~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 210 (280)
T cd05608 132 N-DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210 (280)
T ss_pred C-CCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 5 4799999999997654322 223469999999999874 5889999999999999999999999753321 2223
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDD 200 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~ 200 (654)
..+..+ +..++...++.+++++.+||. +|.+|| +++++++||||+...
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 211 QRILND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred Hhhccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 333222 223445678999999999999 899999 889999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-33 Score=284.00 Aligned_cols=199 Identities=30% Similarity=0.487 Sum_probs=168.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~-k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|||||+|+. +..+|+|||||..|++.+.++ +++.+++..+..+++.-++||+|||... -||||||..|||++. .
T Consensus 91 VKYYGSYFK--~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT-~ 165 (502)
T KOG0574|consen 91 VKYYGSYFK--HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNT-D 165 (502)
T ss_pred hhhhhhhcc--CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcc-c
Confidence 689999987 789999999999999999976 4568999999999999999999999988 899999999999984 5
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
|..||+|||.|..+.+.. ..+.+|||.|||||++.+ .|+.++||||||++..||..|++||.+......++..- .
T Consensus 166 G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP--T 243 (502)
T KOG0574|consen 166 GIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP--T 243 (502)
T ss_pred chhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc--C
Confidence 899999999999887653 456789999999999986 59999999999999999999999999865544443221 1
Q ss_pred CCCccc--ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchhhh
Q 006244 157 KKPEAL--FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLR 206 (654)
Q Consensus 157 ~~p~~l--~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~~r 206 (654)
..|+.+ +...+.++-+||++||. +|.+|.||-+|++|||++......-++
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~ 296 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQ 296 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHH
Confidence 122222 23457889999999999 799999999999999998776554333
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=276.63 Aligned_cols=195 Identities=21% Similarity=0.431 Sum_probs=158.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.|.. ++++|+||||+.||+|.+++.+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++. .
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~-~ 138 (331)
T cd05597 64 TNLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDK-N 138 (331)
T ss_pred CceEEEEec--CCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECC-C
Confidence 467887776 6899999999999999999987 457999999999999999999999999 999999999999974 4
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
+.+||+|||++..+..... ...+||+.|||||++. ..++.++|||||||++|+|++|..||.. .+..+.+
T Consensus 139 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~ 217 (331)
T cd05597 139 GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETY 217 (331)
T ss_pred CCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHH
Confidence 7999999999876543221 2246999999999986 3478899999999999999999999976 4455666
Q ss_pred HHHHcCCCCcc---cccCCChHHHHHHHHHhhC---ccCCCCHHHHhcCcccccCCc
Q 006244 151 KKVISGKKPEA---LFKVEDPEVRQFIEKCLAT---VSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 151 kki~~G~~p~~---l~~~~spelrdLI~kCL~d---P~~RpTa~ELL~HPFf~~~~~ 201 (654)
.++........ .....++.+++||.+||.. +..|+++.++|+||||...++
T Consensus 218 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 218 GKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 66655332111 1234688999999999973 334889999999999976543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=268.47 Aligned_cols=193 Identities=27% Similarity=0.480 Sum_probs=160.8
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++.|.. ...+++||||+.||+|..++.+.+.+++..++.|+.|++.||.|||+.+ |+||||||+||+++.+ +.
T Consensus 61 ~~~~~~~~--~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~ 135 (278)
T cd05606 61 CMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GH 135 (278)
T ss_pred eeeeeeec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CC
Confidence 45666665 6799999999999999999988888999999999999999999999998 9999999999999854 79
Q ss_pred EEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHHcCC
Q 006244 82 VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVISGK 157 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--~~~qi~kki~~G~ 157 (654)
++|+|||++..+.........|++.|+|||++.+ .++.++||||+|+++|+|++|..||.... ......+....
T Consensus 136 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 213 (278)
T cd05606 136 VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-- 213 (278)
T ss_pred EEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--
Confidence 9999999997665444445679999999999863 48899999999999999999999997642 22223222222
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.+..++...+++++++|.+||. +|.+|| ++.++++||||+..++
T Consensus 214 ~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 214 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 2233445578999999999999 899999 9999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=280.39 Aligned_cols=184 Identities=30% Similarity=0.439 Sum_probs=157.2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
-+.+|+|+|+| +-+|.+.++..+.++...+..+++||+.||+|+|+-+ |+||||||.|+|++.+ ..+||+|||||+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~-c~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD-CDLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC-CCEEecccccee
Confidence 57899999999 6699999888888999999999999999999999999 9999999999999966 789999999999
Q ss_pred hhc----ccCCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-----------
Q 006244 92 ILR----KSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI----------- 154 (654)
Q Consensus 92 ~l~----~~~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~----------- 154 (654)
... ....+..+-|.+|+|||++. ..|+..+||||+|||+.||++|++.|.+.....|+...+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 885 34456778999999999875 4699999999999999999999999988666666532111
Q ss_pred -----------c--CCCC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 -----------S--GKKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 -----------~--G~~p----~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+ +..| ..+++..+|.+.+|+++||+ +|.+|+|++|+|.||||..-
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 0 1111 23456778999999999999 99999999999999999643
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=290.88 Aligned_cols=195 Identities=26% Similarity=0.379 Sum_probs=153.5
Q ss_pred CEEEEEEEec------CCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDT------ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~------~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
|+++++|... ....+++||||++ |+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||
T Consensus 122 v~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp 198 (440)
T PTZ00036 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKP 198 (440)
T ss_pred cceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCH
Confidence 4566666432 1235789999996 577777653 457999999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHH
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPA 147 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~ 147 (654)
+|||++.+.+.+||+|||+++.+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.....
T Consensus 199 ~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 278 (440)
T PTZ00036 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278 (440)
T ss_pred HHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 99999866568999999999876433 2334579999999998754 58999999999999999999999998866555
Q ss_pred HHHHHHHc-CCC-----------------Cc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 148 QIYKKVIS-GKK-----------------PE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 148 qi~kki~~-G~~-----------------p~--------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
++.+.+.. |.. |. .++...++++++||.+||. +|.+|||+.|+|.||||..
T Consensus 279 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 54443321 111 00 1122356889999999999 8999999999999999963
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.17 Aligned_cols=193 Identities=26% Similarity=0.385 Sum_probs=149.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
|++++.|.......+++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~ 137 (317)
T cd07868 61 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPA 137 (317)
T ss_pred cceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHH
Confidence 57888888766788999999994 6898887643 24899999999999999999999999 999999999
Q ss_pred cEEEe---CCCCcEEEEecCchhhhccc-----CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCC
Q 006244 72 NIFVN---GNQGEVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYS 141 (654)
Q Consensus 72 NILId---~~~g~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~ 141 (654)
|||+. ...+.+||+|||++...... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred HEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 99994 23468999999999876432 1234578999999998864 48899999999999999999999996
Q ss_pred CCCC---------HHHHHHHHHc-CCC-----------C-----------------------cccccCCChHHHHHHHHH
Q 006244 142 ECTH---------PAQIYKKVIS-GKK-----------P-----------------------EALFKVEDPEVRQFIEKC 177 (654)
Q Consensus 142 ~~~~---------~~qi~kki~~-G~~-----------p-----------------------~~l~~~~spelrdLI~kC 177 (654)
.... ..++.+.+.. |.. + .......+..+.+||.+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 297 (317)
T cd07868 218 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 297 (317)
T ss_pred CCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHH
Confidence 4221 1111111100 000 0 000112356789999999
Q ss_pred hh-CccCCCCHHHHhcCccc
Q 006244 178 LA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 178 L~-dP~~RpTa~ELL~HPFf 196 (654)
|+ +|.+|||++|+|+||||
T Consensus 298 L~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 298 LTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hccCcccCCCHHHHhcCCCC
Confidence 99 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.73 Aligned_cols=188 Identities=23% Similarity=0.431 Sum_probs=158.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. .+.+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+.+ ++||||||+||+++.+.+
T Consensus 72 v~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 72 IKLYYSVTT--LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKD 147 (267)
T ss_pred EEEEEEEec--CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCC
Confidence 478888877 6799999999999999999988889999999999999999999999999 999999999999986644
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH----HHHHHHHHc
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP----AQIYKKVIS 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~----~qi~kki~~ 155 (654)
.++|+|||++...... ....|++.|+|||++.+ .++.++||||||+++|+|++|..||...... ..+....
T Consensus 148 ~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 223 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-- 223 (267)
T ss_pred eEEEecCccceecCCC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--
Confidence 8999999998765432 23458999999999874 5889999999999999999999999753321 1122221
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCC-HHHHhcCcccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-ARELLTDPFLQ 197 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-a~ELL~HPFf~ 197 (654)
..+....+..++.+++||.+||+ +|.+|++ ++++|+||||.
T Consensus 224 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 224 -QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred -cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 22334455789999999999999 8999996 59999999996
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=275.85 Aligned_cols=196 Identities=18% Similarity=0.431 Sum_probs=159.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.|.+ .+.+||||||+.||+|.+++.+ ...+++..++.|+.||+.||+|||+++ |+||||||+|||++. .
T Consensus 64 ~~l~~~~~~--~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~-~ 138 (331)
T cd05624 64 TTLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDM-N 138 (331)
T ss_pred eeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcC-C
Confidence 467787776 7899999999999999999987 467999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhcc------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
+.+||+|||++........ ....||+.|+|||++.. .++.++||||||+++|+|++|..||.. .+....+
T Consensus 139 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~ 217 (331)
T cd05624 139 GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETY 217 (331)
T ss_pred CCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHH
Confidence 7999999999976543322 23469999999998863 478899999999999999999999986 4455666
Q ss_pred HHHHcCCCCccc---ccCCChHHHHHHHHHhhCccC---CCCHHHHhcCcccccCCcc
Q 006244 151 KKVISGKKPEAL---FKVEDPEVRQFIEKCLATVSS---RLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 151 kki~~G~~p~~l---~~~~spelrdLI~kCL~dP~~---RpTa~ELL~HPFf~~~~~~ 202 (654)
.++........+ ....+.+++++|.+||..+.+ |++++++++||||+..++.
T Consensus 218 ~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 218 GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 666654321111 233578999999999984333 5799999999999865543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=287.58 Aligned_cols=194 Identities=22% Similarity=0.448 Sum_probs=164.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~-Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++++..-+...+.+|||+|||..|.+..-- ..+. +++.++++|++.++.||+|||.++ ||||||||+|+|++++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~- 246 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD- 246 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-
Confidence 6788887788889999999999999876532 2234 999999999999999999999999 9999999999999865
Q ss_pred CcEEEEecCchhhhccc-------CCccccCCCCccChhhhcc---c--CCcccchhhhhhHHHHHhhcCCCCCCCCCHH
Q 006244 80 GEVKIGDLGLAAILRKS-------HAARCVGTPEFMAPEVYEE---E--YNELVDIYSFGMCILEMVTFDYPYSECTHPA 147 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~-------~~~~~vGTp~YmAPEvl~~---~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~ 147 (654)
|.|||+|||.+...... .....+|||.|||||++.+ . .+.+.||||+||+||.|+.|+.||.+ ....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~ 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFEL 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHH
Confidence 89999999999765221 1223579999999998864 2 35689999999999999999999987 5677
Q ss_pred HHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 148 QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 148 qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.++.+|..........+...+.+++||.++|. ||.+|++..++..|||...+
T Consensus 326 ~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 88999987665544445578999999999999 89999999999999999754
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=260.87 Aligned_cols=192 Identities=25% Similarity=0.462 Sum_probs=162.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.|.. +..+|+|+||+.||+|.+++...+.+++..+..++.||+.||.|||+.+ |+||||+|+|||++. .+
T Consensus 60 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~-~~ 134 (260)
T cd05611 60 AKLYYSFQS--KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQ-TG 134 (260)
T ss_pred eeeeeeEEc--CCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CC
Confidence 478888876 6899999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC-
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK- 158 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~- 158 (654)
.++|+|||++..... .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.. .+...++..+..+..
T Consensus 135 ~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~ 211 (260)
T cd05611 135 HLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSRRIN 211 (260)
T ss_pred cEEEeecccceeccc--cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcccC
Confidence 999999999876433 2334689999999988654 78999999999999999999999976 445666666655443
Q ss_pred -CcccccCCChHHHHHHHHHhh-CccCCCC---HHHHhcCcccccCC
Q 006244 159 -PEALFKVEDPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDD 200 (654)
Q Consensus 159 -p~~l~~~~spelrdLI~kCL~-dP~~RpT---a~ELL~HPFf~~~~ 200 (654)
+.......++.++++|.+||. +|.+||+ +.|+|.||||+..+
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 333444678999999999999 8999995 57999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=261.70 Aligned_cols=190 Identities=27% Similarity=0.484 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. ...+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+|+||||+|||++.+ +
T Consensus 69 i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~ 143 (267)
T cd06645 69 VAYFGSYLR--RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-G 143 (267)
T ss_pred eeEEEEEEe--CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-C
Confidence 578888877 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.++|+|||++....... .....|++.|+|||++. ..++.++|+|||||++|+|++|..||........+.....
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06645 144 HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK 223 (267)
T ss_pred CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc
Confidence 89999999987654322 23346999999999873 3488899999999999999999999976444333333222
Q ss_pred cCCCCcccc--cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 155 SGKKPEALF--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 155 ~G~~p~~l~--~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
....+.... ...+..++++|.+||. +|.+||++.+++.|||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 222222221 1356789999999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=260.62 Aligned_cols=195 Identities=26% Similarity=0.464 Sum_probs=166.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+ ++.+++|+||+.+|+|.+++.+...+++..+..++.||+.||.|||+++ ++|+||||+||+++. .+
T Consensus 56 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~-~~ 130 (262)
T cd05572 56 VKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDS-NG 130 (262)
T ss_pred eeeeeeEEc--CCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcC-CC
Confidence 467887776 6899999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-CHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....|++.|+|||++.. .++.++|+||||+++|+|++|..||.... +...++.++..+.
T Consensus 131 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 210 (262)
T cd05572 131 YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210 (262)
T ss_pred CEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC
Confidence 99999999998765432 223468999999998764 48899999999999999999999997644 3566677776554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~ 200 (654)
.....+...+++++++|.+||. +|.+||+ +.|+++||||+..+
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 4444555558999999999999 8999999 99999999997543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=267.81 Aligned_cols=192 Identities=29% Similarity=0.511 Sum_probs=158.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ++.+++||||++||+|.+++.+.+.+++..+..++.||+.||.|||+ .+ ++||||||+|||++.+
T Consensus 62 v~~~~~~~~--~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~- 136 (308)
T cd06615 62 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR- 136 (308)
T ss_pred CeEEEEEee--CCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-
Confidence 578998887 78999999999999999999988889999999999999999999997 46 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH-----
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV----- 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki----- 153 (654)
+.+||+|||++...........+|++.|+|||++.+ .++.++|+||||+++|+|++|..||.... .......+
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~ 215 (308)
T cd06615 137 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVS 215 (308)
T ss_pred CcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccc
Confidence 789999999997765554555679999999998864 48889999999999999999999996432 22222111
Q ss_pred -------------------------------HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 154 -------------------------------ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 154 -------------------------------~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.....|.......++++++||.+||. +|.+||++.++++||||..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 11111111122367889999999999 8999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=257.15 Aligned_cols=189 Identities=33% Similarity=0.591 Sum_probs=161.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.. ++.+++||||+.|++|.+++... ..++...+..++.||+.||.|||+.+ |+|+||||+|||++.+
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~ 137 (256)
T cd08529 62 IRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY 137 (256)
T ss_pred ehheeeecc--CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC
Confidence 467888877 68999999999999999998774 57999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++..+.... .....|++.|+|||++.. .++.++|+||||+++|+|++|..||... +......++..
T Consensus 138 -~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~ 215 (256)
T cd08529 138 -DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIR 215 (256)
T ss_pred -CCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc
Confidence 799999999987664432 223458999999998874 4889999999999999999999999764 45666667776
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+. +....++.++++|.+||+ +|.+||++.+++.|||+
T Consensus 216 ~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 GVFPP-VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCC-CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 66544 333678899999999999 89999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=261.60 Aligned_cols=193 Identities=31% Similarity=0.557 Sum_probs=162.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. .+.+++|+||+.+++|.+++... ..+++..+..++.||+.||.|||+ .+ ++|+||||+||+++.
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~- 136 (265)
T cd06605 62 VGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNS- 136 (265)
T ss_pred hhhheeeec--CCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECC-
Confidence 356777777 68999999999999999999876 789999999999999999999999 88 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC----CCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC----THPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~----~~~~qi~kki 153 (654)
.+.++|+|||++............+++.|+|||++.+ .++.++||||||+++|+|++|..||... .......+.+
T Consensus 137 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 216 (265)
T cd06605 137 RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216 (265)
T ss_pred CCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH
Confidence 5799999999998765443333678999999998864 4889999999999999999999999764 2334445555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
..+..+.......+++++++|.+||. +|.+|||+.+++.||||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 217 VNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred hcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 55554443333378899999999999 8999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=259.66 Aligned_cols=191 Identities=28% Similarity=0.418 Sum_probs=159.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.+ .+.+++|+||+.||+|.+++.+...+++..+..++.||+.||+|||+.+ |+|+||||+||+++. .+
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~-~~ 139 (265)
T cd06631 65 VQYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMP-NG 139 (265)
T ss_pred eeEeeEeec--CCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECC-CC
Confidence 478888876 6899999999999999999998888999999999999999999999998 999999999999984 47
Q ss_pred cEEEEecCchhhhccc--------CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS--------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--------~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
.++|+|||++...... ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||...........
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 219 (265)
T cd06631 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219 (265)
T ss_pred eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence 9999999999765321 1123458999999999875 488999999999999999999999986554444333
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..........+....+.++++||.+||. +|.+||++.++|.||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred hhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 2222122223455678999999999998 89999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=260.37 Aligned_cols=192 Identities=28% Similarity=0.500 Sum_probs=155.6
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
+++++.|.... ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nil 143 (272)
T cd06637 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVL 143 (272)
T ss_pred eeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEE
Confidence 46788877532 25799999999999999998864 36899999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
++.+ +.++|+|||++...... ......|++.|+|||++. ..|+.++||||||+++|+|++|..||......
T Consensus 144 i~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 144 LTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred ECCC-CCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9854 78999999999765432 223456899999999884 24788999999999999999999999764433
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 147 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 147 ~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
... ..+.....+.......+.++++||.+||. +|.+|||+.+++.||||
T Consensus 223 ~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 223 RAL-FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHH-HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 222 23333222333334567899999999999 89999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=263.38 Aligned_cols=191 Identities=29% Similarity=0.428 Sum_probs=151.9
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++++.+... ....+++|+||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 65 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili 141 (288)
T cd07863 65 VRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV 141 (288)
T ss_pred eeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 4677776642 2357899999996 5899998764 34899999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+. .+.+||+|||++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||........+ .++
T Consensus 142 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~-~~~ 219 (288)
T cd07863 142 TS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL-GKI 219 (288)
T ss_pred CC-CCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH-HHH
Confidence 84 4799999999998765432 234568999999998864 5899999999999999999999999765443332 222
Q ss_pred Hc--CCC-----C------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 IS--GKK-----P------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~--G~~-----p------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.. +.. + ....+..+..++++|.+||+ +|.+|||+.++|.||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 220 FDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 21 100 0 01123456788999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.49 Aligned_cols=196 Identities=24% Similarity=0.305 Sum_probs=163.8
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
+-...+....+.+|||||||.. +|+.++..-+ ++...+++.++.|+++||+|||.+. |+|||||++|+|++ +.|.
T Consensus 140 vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~ 215 (419)
T KOG0663|consen 140 VKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGI 215 (419)
T ss_pred eEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCc
Confidence 3444555556789999999975 9999998765 8999999999999999999999999 99999999999998 5689
Q ss_pred EEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-C
Q 006244 82 VKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-G 156 (654)
Q Consensus 82 VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G 156 (654)
+||+|||||+.+..+ ..+..+-|.+|+|||++.+ .|+..+||||+|||+.||+++++.|.+.....|+.+.+.. |
T Consensus 216 lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 216 LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred EEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 999999999998765 3455678999999998875 4999999999999999999999999998888888765542 3
Q ss_pred CCCccccc--------------------------C--CChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 157 KKPEALFK--------------------------V--EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 157 ~~p~~l~~--------------------------~--~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
.....+|+ . .+....+|+..+|. +|.+|.||.+.|+|.||......
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 22221111 1 34678899999999 99999999999999999875543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=270.32 Aligned_cols=187 Identities=23% Similarity=0.382 Sum_probs=153.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------------------------------------
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------------------------------------------- 34 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------------------------------------------- 34 (654)
|++|+++... +..+++||||+++|+|.+++...
T Consensus 74 v~~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (338)
T cd05102 74 VNLLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPS 152 (338)
T ss_pred eeEEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccc
Confidence 5788877653 45799999999999999998753
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC-
Q 006244 35 ----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH- 97 (654)
Q Consensus 35 ----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~- 97 (654)
..+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPD 229 (338)
T ss_pred cCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcc
Confidence 23778899999999999999999998 9999999999999854 799999999998653321
Q ss_pred ---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHH
Q 006244 98 ---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 172 (654)
Q Consensus 98 ---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrd 172 (654)
.....+++.|+|||++. ..++.++||||||+++|||++ |..||........+...+..+..+. .+...++++++
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~ 308 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR-APENATPEIYR 308 (338)
T ss_pred hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC-CCCCCCHHHHH
Confidence 12234678999999886 458999999999999999997 9999987555555556666555433 34567889999
Q ss_pred HHHHHhh-CccCCCCHHHHhc
Q 006244 173 FIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 173 LI~kCL~-dP~~RpTa~ELL~ 192 (654)
+|.+||. +|.+|||+.+|++
T Consensus 309 li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 9999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=265.89 Aligned_cols=195 Identities=24% Similarity=0.396 Sum_probs=158.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. +..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 63 VSLAYAYET--KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY 138 (285)
T ss_pred eeeeeeecC--CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC
Confidence 467777766 67999999999999999887653 46999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHH---HHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~---qi~kki 153 (654)
+.++|+|||++....... ....+||+.|+|||++.+ .++.++||||+|+++|+|++|..||.+..... .+...+
T Consensus 139 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05605 139 -GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV 217 (285)
T ss_pred -CCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh
Confidence 799999999997654322 233479999999999864 58889999999999999999999998643221 122222
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
..+ +..++...++.+++||.+||. +|.+|| ++.++++||||...++.
T Consensus 218 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 218 KED--QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred hhc--ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 222 223445678899999999999 899999 99999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=263.20 Aligned_cols=194 Identities=24% Similarity=0.429 Sum_probs=157.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. +..+++||||+.||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 56 ~~~~~~~~~--~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~- 130 (277)
T cd05607 56 VNLAYAFES--KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDD- 130 (277)
T ss_pred EEEEEEEec--CCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcC-
Confidence 467777766 689999999999999999886543 5899999999999999999999999 999999999999985
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC---CHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~---~~~qi~kki 153 (654)
.+.++|+|||++....... .....||+.|+|||++.. .++.++|||||||++|+|++|..||.... +...+.+..
T Consensus 131 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~ 210 (277)
T cd05607 131 QGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT 210 (277)
T ss_pred CCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh
Confidence 4799999999987664432 223468999999998864 48999999999999999999999997532 223344444
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCcccccCC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFLQIDD 200 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa----~ELL~HPFf~~~~ 200 (654)
..+..+. .....+++++++|.+||+ +|.+||++ .+++.||||+..+
T Consensus 211 ~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 211 LEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred hcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 4333322 223578899999999999 89999999 6788999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=275.16 Aligned_cols=190 Identities=30% Similarity=0.475 Sum_probs=153.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.. ++.+++||||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 135 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~ 205 (353)
T PLN00034 135 VKCHDMFDH--NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-K 205 (353)
T ss_pred ceeeeEecc--CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-C
Confidence 578888876 7899999999999998753 34678889999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-----c-CCcccchhhhhhHHHHHhhcCCCCCCCC--CHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-----E-YNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIY 150 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-----~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--~~~qi~ 150 (654)
.+||+|||++..+.... ....+||+.|+|||++.. . ++.++|||||||++|+|++|+.||.... ....+.
T Consensus 206 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~ 285 (353)
T PLN00034 206 NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285 (353)
T ss_pred CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence 99999999998765332 234579999999998742 2 3468999999999999999999997422 222333
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
..+..+.. .......++++++||.+||. +|.+||++.|+|+||||....
T Consensus 286 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 286 CAICMSQP-PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHhccCC-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 33333332 23445678999999999999 899999999999999997653
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=269.28 Aligned_cols=192 Identities=21% Similarity=0.417 Sum_probs=153.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|++|.. ++.+++||||+++|+|.+++..+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 62 v~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 62 VPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD 137 (327)
T ss_pred eeEEEEEEE--CCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC
Confidence 578999987 68999999999999999998764 45899999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc---------CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 79 QGEVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~---------~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
+.++++|||.+...... ......++..|+|||++.. .|+.++|||||||++|+|++|..||......
T Consensus 138 -~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 216 (327)
T cd08227 138 -GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 216 (327)
T ss_pred -CcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 79999999865443211 1122357788999999864 4889999999999999999999999764433
Q ss_pred HHHHHHHHcCCCCc--------------------------------------------ccccCCChHHHHHHHHHhh-Cc
Q 006244 147 AQIYKKVISGKKPE--------------------------------------------ALFKVEDPEVRQFIEKCLA-TV 181 (654)
Q Consensus 147 ~qi~kki~~G~~p~--------------------------------------------~l~~~~spelrdLI~kCL~-dP 181 (654)
. .......+..+. ......++++++||.+||+ +|
T Consensus 217 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 295 (327)
T cd08227 217 Q-MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNP 295 (327)
T ss_pred H-HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCc
Confidence 2 222222222211 0112346789999999999 99
Q ss_pred cCCCCHHHHhcCccccc
Q 006244 182 SSRLSARELLTDPFLQI 198 (654)
Q Consensus 182 ~~RpTa~ELL~HPFf~~ 198 (654)
.+|||+.+||+||||+.
T Consensus 296 ~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 296 DARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhcCCHHHHhcChhhhh
Confidence 99999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=268.80 Aligned_cols=194 Identities=27% Similarity=0.534 Sum_probs=166.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+.||+|+. +..+++.||+| +--+..++++ .+++++..+-++..-+++||.||..+. +|||||+||+|||+| ..
T Consensus 154 V~c~GyFi~--n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~ 228 (391)
T KOG0983|consen 154 VQCFGYFIT--NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ER 228 (391)
T ss_pred eeeeeEEee--CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cC
Confidence 689999998 78899999999 4566666665 457999999999999999999998764 599999999999998 55
Q ss_pred CcEEEEecCchhhhcccCCc-cccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~-~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
|.|||||||++..+-++.+. ...|.+.|||||-+. ..|+-.+||||||+.++||+||.+||.+|...-....+|.
T Consensus 229 GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl 308 (391)
T KOG0983|consen 229 GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL 308 (391)
T ss_pred CCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence 89999999999988776554 456999999999886 3499999999999999999999999999988888888888
Q ss_pred cCCCCccccc--CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 155 SGKKPEALFK--VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 155 ~G~~p~~l~~--~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
....| .+.. ..++.+++|+..||+ ++.+||...+||+|||+...+
T Consensus 309 n~ePP-~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 309 NEEPP-LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred hcCCC-CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 74443 3322 279999999999999 899999999999999997554
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=261.40 Aligned_cols=191 Identities=32% Similarity=0.582 Sum_probs=157.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. ...+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+|+||||+|||++ +.+
T Consensus 61 ~~~~~~~~~--~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~ 135 (260)
T PF00069_consen 61 VQILDVFQD--DNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENG 135 (260)
T ss_dssp CHEEEEEEE--SSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTS
T ss_pred ccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccc
Confidence 467888887 7899999999999999999998888999999999999999999999998 99999999999998 558
Q ss_pred cEEEEecCchhhh--cccCCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHH
Q 006244 81 EVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l--~~~~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--~~~qi~kki~ 154 (654)
.++|+|||++... .........+|+.|+|||++. ..++.++||||||+++|+|++|..||.... +......+..
T Consensus 136 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~ 215 (260)
T PF00069_consen 136 EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL 215 (260)
T ss_dssp EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc
Confidence 9999999999753 222334456899999999987 458999999999999999999999998752 2222333332
Q ss_pred cCCCCccccc--CCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 155 SGKKPEALFK--VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~~p~~l~~--~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
....+..... ...++++++|.+||. +|.+||++.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 2222211111 123799999999999 89999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=254.94 Aligned_cols=190 Identities=29% Similarity=0.579 Sum_probs=158.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.. ....+++|+||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 62 ~~~~~~~~~-~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~- 137 (257)
T cd08223 62 VAYRESWEG-EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTR- 137 (257)
T ss_pred eeeeeeecC-CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEec-
Confidence 456676643 245789999999999999998763 45899999999999999999999999 999999999999985
Q ss_pred CCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+.++|+|||++...... ......|++.|+|||++.. .++.++|+||||+++++|++|..||... +.......+..
T Consensus 138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~ 216 (257)
T cd08223 138 TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIE 216 (257)
T ss_pred CCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHh
Confidence 479999999999766432 2233468999999998875 4888999999999999999999999763 44555556666
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+. .....++++.+||.+||. +|.+||++.++++||||
T Consensus 217 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 GKLPP-MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCCCC-CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 65543 445678999999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=259.60 Aligned_cols=195 Identities=29% Similarity=0.571 Sum_probs=160.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.|.. +...++|+||+.+|+|..++.+ .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 65 i~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~- 139 (282)
T cd06643 65 VKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD- 139 (282)
T ss_pred eeEEEEEee--CCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-
Confidence 578888877 6899999999999999998765 457999999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|.+||.... ......
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~ 218 (282)
T cd06643 140 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLL 218 (282)
T ss_pred CCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHH
Confidence 79999999998765332 123346899999999873 237789999999999999999999997644 344444
Q ss_pred HHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 152 KVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 152 ki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
.+..+..+. ..+...+.++++||.+||. +|.+||++.++++||||.....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 219 KIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 444443332 2234567899999999999 8999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=261.43 Aligned_cols=192 Identities=29% Similarity=0.508 Sum_probs=156.8
Q ss_pred CEEEEEEEec----CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~----~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
+++++.|+.. ....+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nil 153 (282)
T cd06636 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVL 153 (282)
T ss_pred EEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence 4678887642 256899999999999999998764 35889999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
++. .+.++|+|||++...... .....+|++.|+|||++. ..++.++|+||||+++|+|++|..||......
T Consensus 154 i~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 154 LTE-NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred ECC-CCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 984 579999999998765432 223456999999999874 34788999999999999999999999765443
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 147 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 147 ~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+. .+.....+.......++++.+||.+||. +|.+||++.+||+||||
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 233 RALF-LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hhhh-hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 3333 3333333333344578899999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=289.27 Aligned_cols=193 Identities=23% Similarity=0.410 Sum_probs=161.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~- 77 (654)
|++|++|+. +++++||+|++ +-+|.+|++.++ .|+...++.++.||+.||.+||+.+ |||+||||+|||+..
T Consensus 251 Vrm~d~F~f--r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~ 325 (586)
T KOG0667|consen 251 VRMLDYFYF--RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDP 325 (586)
T ss_pred EEeeecccc--ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccC
Confidence 689999999 89999999999 679999999864 6999999999999999999999999 999999999999952
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-c
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI-S 155 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~-~ 155 (654)
+...|||+|||.|....+... +++-++.|+|||++.+ .|+.+.||||||||+.||++|.+.|.+.+..+|+...+. .
T Consensus 326 ~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 326 KRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred CcCceeEEecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 334799999999998776655 7788999999999875 699999999999999999999999998776666654331 1
Q ss_pred CCCCc--------------------------c----------------------c-----------ccCCChHHHHHHHH
Q 006244 156 GKKPE--------------------------A----------------------L-----------FKVEDPEVRQFIEK 176 (654)
Q Consensus 156 G~~p~--------------------------~----------------------l-----------~~~~spelrdLI~k 176 (654)
|..|. . . .......+.+||.+
T Consensus 405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 11110 0 0 00123468999999
Q ss_pred Hhh-CccCCCCHHHHhcCcccccC
Q 006244 177 CLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 177 CL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
||. +|.+|+|+.++|+||||...
T Consensus 485 ~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred HhccCchhcCCHHHHhcCcccccc
Confidence 999 99999999999999999844
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=258.61 Aligned_cols=192 Identities=31% Similarity=0.531 Sum_probs=159.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.......+++|+||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.+ +
T Consensus 67 ~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~ 143 (266)
T cd06651 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-G 143 (266)
T ss_pred eeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-C
Confidence 468888876556789999999999999999988888999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc-----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+||+|||++..+... ......++..|+|||++.+ .++.++||||||+++|+|++|+.||........+.+...
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~ 223 (266)
T cd06651 144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (266)
T ss_pred CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 8999999998765421 1123458899999998864 488899999999999999999999987655555544333
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.+. ...++...++.++++| +||. +|.+||+++++++||||+
T Consensus 224 ~~~-~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 224 QPT-NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCC-CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 333 3334556788999999 5655 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=258.23 Aligned_cols=193 Identities=27% Similarity=0.495 Sum_probs=159.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+ ...+++|+||+.|++|.+++.+.+.+++..+..|+.||+.||.|||+++ ++|+||||+||+++.+..
T Consensus 66 v~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 66 IRMLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred ehhhceecc--CCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCC
Confidence 467887776 6799999999999999999998888999999999999999999999999 999999999999986655
Q ss_pred cEEEEecCchhhhcccC------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC--HHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~--~~qi~k 151 (654)
.++|+|||++..+.... .....||..|+|||++.+ .++.++|+||||+++|+|++|..||..... ......
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 221 (268)
T cd06630 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF 221 (268)
T ss_pred EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Confidence 79999999997764321 122458899999998864 588999999999999999999999965332 222222
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.+.....+...+...+++++++|.+||. +|.+||++.++++||||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 3333333444555678999999999998 899999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=261.78 Aligned_cols=192 Identities=30% Similarity=0.541 Sum_probs=165.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+ .+.+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||+|.|||++.+ +
T Consensus 64 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~ 138 (290)
T cd05580 64 VNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-G 138 (290)
T ss_pred cceeeEEEc--CCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-C
Confidence 478888877 6899999999999999999998889999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++...... .....|++.|+|||.+.. .++.++||||||+++|+|++|..||... +....++.+..+..+
T Consensus 139 ~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~ 216 (290)
T cd05580 139 YIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD-NPIQIYEKILEGKVR 216 (290)
T ss_pred CEEEeeCCCccccCCC-CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCcc
Confidence 9999999999876544 334468999999998764 4788999999999999999999999764 456666676655433
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
++...++.++++|.+||. +|.+|+ +++++++||||+..++
T Consensus 217 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 217 --FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred --CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 344568999999999999 899999 9999999999976554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=269.10 Aligned_cols=187 Identities=23% Similarity=0.388 Sum_probs=162.8
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEec
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGDL 87 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~--Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~--~g~VKL~DF 87 (654)
.+.+.+|||.++||.|+.-++.++. +++..+..+++||..|+.|||+.+ |.||||||+|+|...+ +..+||+||
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccc
Confidence 5789999999999999999998765 999999999999999999999999 9999999999999743 346899999
Q ss_pred Cchhhhcc-cCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCC--CCc
Q 006244 88 GLAAILRK-SHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGK--KPE 160 (654)
Q Consensus 88 GLA~~l~~-~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~---~~qi~kki~~G~--~p~ 160 (654)
|+|+.... ....+.+-||.|.|||++. ++|+...|+||+|+++|.|++|.+||..... ...+..+|..|. +|.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 99988663 3455677899999999997 5699999999999999999999999965332 234567777776 467
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 161 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 161 ~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.-|...|..++++|+++|. +|.+|+|+.+++.|||+....
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 7778889999999999999 899999999999999997554
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=254.26 Aligned_cols=191 Identities=32% Similarity=0.507 Sum_probs=164.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLH-----SRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLH-----s~~p~IIHRDLKpe 71 (654)
+++++.+....+..+++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+ |+|+||||+
T Consensus 62 ~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~ 139 (265)
T cd08217 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPA 139 (265)
T ss_pred ceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHH
Confidence 5788888876677899999999999999998763 57999999999999999999999 777 999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
||+++. .+.+||+|||++....... .....|++.|+|||++.. .++.++|+||||+++|+|++|..||... +...
T Consensus 140 nili~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~ 217 (265)
T cd08217 140 NIFLDA-NNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQ 217 (265)
T ss_pred HEEEec-CCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHH
Confidence 999985 4899999999998765433 234568999999998864 4888999999999999999999999874 3566
Q ss_pred HHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 149 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 149 i~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+...+..+..+ .+....+..+.+++.+||. +|.+||++.++|+|||+
T Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 218 LASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 66777666544 3455678999999999999 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=278.60 Aligned_cols=192 Identities=29% Similarity=0.384 Sum_probs=151.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++.|.. +...++|+|++ +++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 146 v~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~ 219 (391)
T PHA03212 146 IQLKGTFTY--NKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-G 219 (391)
T ss_pred CCEeEEEEE--CCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-C
Confidence 578998877 68999999999 5799999988888999999999999999999999998 9999999999999844 7
Q ss_pred cEEEEecCchhhhcc---cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC-------HHHH
Q 006244 81 EVKIGDLGLAAILRK---SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH-------PAQI 149 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~---~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~-------~~qi 149 (654)
.+||+|||++..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... ..++
T Consensus 220 ~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l 299 (391)
T PHA03212 220 DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299 (391)
T ss_pred CEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH
Confidence 999999999975432 22234579999999998864 589999999999999999999988753211 1111
Q ss_pred HHHHH-cCCCCcc--------------------------c-----ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 150 YKKVI-SGKKPEA--------------------------L-----FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 150 ~kki~-~G~~p~~--------------------------l-----~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
...+. .|..|.. . ....+.++++||.+||. +|.+||||.|+|+||||
T Consensus 300 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred HHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 11110 0111100 0 01135679999999999 99999999999999999
Q ss_pred cc
Q 006244 197 QI 198 (654)
Q Consensus 197 ~~ 198 (654)
+.
T Consensus 380 ~~ 381 (391)
T PHA03212 380 QD 381 (391)
T ss_pred cc
Confidence 74
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=257.39 Aligned_cols=193 Identities=30% Similarity=0.510 Sum_probs=160.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.+.....+++||||+++|+|.+++.+...+++..+..++.||+.||.|||+++ |+|+||||+|||++. .+
T Consensus 67 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~-~~ 143 (265)
T cd06652 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDS-VG 143 (265)
T ss_pred eeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecC-CC
Confidence 467888877556789999999999999999988888999999999999999999999999 999999999999984 47
Q ss_pred cEEEEecCchhhhccc-----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.++|+|||++..+... ......|+..|+|||++.+ .++.++||||||+++|+|++|..||........+. ++.
T Consensus 144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~ 222 (265)
T cd06652 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIA 222 (265)
T ss_pred CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHh
Confidence 9999999999765421 1223458999999998864 48889999999999999999999998754444443 333
Q ss_pred cCCCCcccccCCChHHHHHHHHHhhCccCCCCHHHHhcCcccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~dP~~RpTa~ELL~HPFf~ 197 (654)
........+...+..++++|.+||.+|.+||+++++++|||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 223 TQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHhcCcccC
Confidence 3222233445567889999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=260.82 Aligned_cols=191 Identities=28% Similarity=0.537 Sum_probs=158.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. .+..++||||+++|+|..+ ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++. .+
T Consensus 62 v~~~~~~~~--~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~-~~ 132 (279)
T cd06619 62 IGFYGAFFV--ENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNT-RG 132 (279)
T ss_pred eeEEEEEEE--CCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECC-CC
Confidence 578998887 6899999999999999765 35789999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC------HHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH------PAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~------~~qi~kki 153 (654)
.++|+|||++..+........+||+.|+|||++.+ .++.++|+||||+++|+|++|..||..... .......+
T Consensus 133 ~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 212 (279)
T cd06619 133 QVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212 (279)
T ss_pred CEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH
Confidence 99999999998766555555679999999998864 488999999999999999999999964221 22333333
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.....+.......++++++||.+||. +|.+||++.++++||||+..+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 213 VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 33333333334578899999999999 899999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=257.18 Aligned_cols=189 Identities=33% Similarity=0.550 Sum_probs=159.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. ....++|+||+++++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+||+++. .+
T Consensus 69 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~-~~ 143 (267)
T cd06628 69 VQYLGSSLD--ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDN-KG 143 (267)
T ss_pred eeEEEEEEe--CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcC-CC
Confidence 478888877 6799999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC--------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH--------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
.++|+|||++....... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||........+ .
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~ 222 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-F 222 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-H
Confidence 99999999987764211 112358899999998864 4888999999999999999999999876544433 3
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.+..+..+ .+....+..++++|.+||+ +|.+||++.++++||||
T Consensus 223 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 223 KIGENASP-EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHhccCCC-cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 44444333 3445678899999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=286.01 Aligned_cols=188 Identities=30% Similarity=0.433 Sum_probs=158.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+|.| |+++.-.++||||||..|-|...++..+.+....+..|.++|+.|+.|||.+. |||||||.-||||..+ .
T Consensus 175 I~FkG--VCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~-d 249 (904)
T KOG4721|consen 175 ITFKG--VCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYD-D 249 (904)
T ss_pred eeEee--eecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeecc-c
Confidence 46777 44557899999999999999999999999999999999999999999999999 9999999999999866 4
Q ss_pred cEEEEecCchhhhcc-cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 81 EVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~-~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
.|||+|||-++.+.+ .....+.||..||||||++. ..++|+|||||||+|||||||+.||.+....+.| .-|-....
T Consensus 250 ~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-wGVGsNsL 328 (904)
T KOG4721|consen 250 VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-WGVGSNSL 328 (904)
T ss_pred eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-EeccCCcc
Confidence 899999999988765 45567889999999999985 5899999999999999999999999874433222 12222222
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
.-.++...+.-++-||++||. +|..||++.++|.|-
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 233455667789999999999 899999999999983
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=282.70 Aligned_cols=197 Identities=28% Similarity=0.463 Sum_probs=164.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
||+|-+|.+ ++++|+||||++||++..++.+.+-|.+..++.|+.++..|+++.|..| +|||||||+|||||.+ |
T Consensus 692 VrLyySFQD--kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-G 766 (1034)
T KOG0608|consen 692 VRLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-G 766 (1034)
T ss_pred EEEEEEecc--CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-C
Confidence 799999999 8999999999999999999999999999999999999999999999999 9999999999999954 8
Q ss_pred cEEEEecCchhhhccc--------------------------------------------CCccccCCCCccChhhhcc-
Q 006244 81 EVKIGDLGLAAILRKS--------------------------------------------HAARCVGTPEFMAPEVYEE- 115 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--------------------------------------------~~~~~vGTp~YmAPEvl~~- 115 (654)
+|||.||||++-++.. .....+||+.|+||||+..
T Consensus 767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~ 846 (1034)
T KOG0608|consen 767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART 846 (1034)
T ss_pred ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence 9999999999644210 0123479999999999875
Q ss_pred cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--CCcccccCCChHHHHHHHHHhhCccCCCC---HHHH
Q 006244 116 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLATVSSRLS---AREL 190 (654)
Q Consensus 116 ~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~--~p~~l~~~~spelrdLI~kCL~dP~~RpT---a~EL 190 (654)
.|+..+|.||.|+|||||+.|++||-.....+.-+ +|+.-. .-.......++++.++|.++...+..|+. ++++
T Consensus 847 g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~-kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~v 925 (1034)
T KOG0608|consen 847 GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQY-KVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQV 925 (1034)
T ss_pred CccccchhhHhhHHHHHHhhCCCCccCCCCCccee-eeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhh
Confidence 59999999999999999999999997644333222 222111 11223445789999999999998888874 7889
Q ss_pred hcCcccccCCcch
Q 006244 191 LTDPFLQIDDYDS 203 (654)
Q Consensus 191 L~HPFf~~~~~~~ 203 (654)
..||||+..++..
T Consensus 926 KaHpfFkgIDfss 938 (1034)
T KOG0608|consen 926 KAHPFFKGIDFSS 938 (1034)
T ss_pred hcCccccccchHh
Confidence 9999999888764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=291.43 Aligned_cols=197 Identities=32% Similarity=0.518 Sum_probs=172.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~L--se~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|+|.|++-. ++.+-|.||-++||+|.++++.. +++ ++.++..|.+||++||.|||.+. |+|||||-+|+||+.
T Consensus 635 VrYLGs~se--nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNT 710 (1226)
T KOG4279|consen 635 VRYLGSVSE--NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNT 710 (1226)
T ss_pred HHHhhccCC--CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEee
Confidence 567888644 78999999999999999998753 566 89999999999999999999999 999999999999997
Q ss_pred CCCcEEEEecCchhhhcc--cCCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
-.|.+||.|||-++.+.. +...++.||..|||||++.. .|..++|||||||++.||.||++||.+..++...+-+
T Consensus 711 ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 711 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 779999999999998865 33456679999999999973 4999999999999999999999999988888776666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+-.-+.-+.++...+.+++.||.+|+. +|.+||+|.+||.+||++..+.
T Consensus 791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCC
Confidence 655555556777788999999999999 8999999999999999987643
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=263.78 Aligned_cols=194 Identities=32% Similarity=0.532 Sum_probs=160.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...+++||||+.||+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. .+
T Consensus 80 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~-~~ 153 (296)
T cd06654 80 VNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGM-DG 153 (296)
T ss_pred eeEEEEEEe--CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcC-CC
Confidence 478888887 6799999999999999999865 46899999999999999999999998 999999999999974 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........++.....+.
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (296)
T cd06654 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (296)
T ss_pred CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC
Confidence 99999999987654322 223468999999998865 478999999999999999999999977544444444433343
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+.......++.++++|.+||. +|.+||++.+++.||||....
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 3333344567899999999999 899999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=257.46 Aligned_cols=192 Identities=33% Similarity=0.511 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRV--NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~L--se~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++++.+.. ...+++|+||+.+++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 68 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~ 143 (268)
T cd06624 68 VQYLGSDSE--NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNT 143 (268)
T ss_pred eeeeeeecc--CCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcC
Confidence 467887776 68999999999999999998864 445 88899999999999999999998 999999999999986
Q ss_pred CCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
..+.++|+|||++....... .....|++.|+|||++.. .++.++||||||+++|+|++|..||............
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~ 223 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223 (268)
T ss_pred CCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh
Confidence 56799999999987654322 223358999999998853 3788999999999999999999999765443332222
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+........++...++++++|+.+||. +|.+|||+.+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 222222233455678899999999999 89999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=258.60 Aligned_cols=194 Identities=30% Similarity=0.557 Sum_probs=161.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. +..+++||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++ |+|+||||+|||++. .
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~-~ 139 (280)
T cd06611 65 VGLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTL-D 139 (280)
T ss_pred eEEEEEEec--CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECC-C
Confidence 578888876 68999999999999999998774 46999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.++|+|||++....... .....||+.|+|||++. ..++.++|+||||+++|+|++|..||... .......
T Consensus 140 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~ 218 (280)
T cd06611 140 GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLL 218 (280)
T ss_pred CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHH
Confidence 799999999987654322 23346899999999874 23677899999999999999999999764 4445555
Q ss_pred HHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 152 KVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 152 ki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
++..+..+. ......+.++.++|.+||. +|.+||++.++|+||||....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 665554432 2234567899999999999 899999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=256.68 Aligned_cols=192 Identities=29% Similarity=0.487 Sum_probs=155.4
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeN 72 (654)
+++++.|.... ...+++||||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+|
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~n 143 (275)
T cd06608 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQN 143 (275)
T ss_pred heEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHH
Confidence 57889887633 4569999999999999999865 347999999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc------cCCcccchhhhhhHHHHHhhcCCCCCCCC
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECT 144 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~ 144 (654)
|+++.+ +.++|+|||++...... ......|++.|+|||++.. .++.++||||||+++|+|++|..||....
T Consensus 144 i~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 144 ILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred EEEccC-CeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 999854 79999999998765432 2233568999999998742 36788999999999999999999997644
Q ss_pred CHHHHHHHHHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 145 HPAQIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
....+ ..+..+..+... ....+.++++||.+||. +|.+|||+.+++.|||+
T Consensus 223 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 223 PMRAL-FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hHHHH-HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 33333 344444332211 12256789999999999 89999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=272.06 Aligned_cols=192 Identities=28% Similarity=0.379 Sum_probs=148.5
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++|+.|.... ...+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 83 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~ 157 (359)
T cd07876 83 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 157 (359)
T ss_pred eeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC
Confidence 46788776532 2468999999964 6776654 35899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ |.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......+...+.
T Consensus 158 ~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 158 SD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred CC-CCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54 79999999999765432 2234568999999999875 589999999999999999999999986543322211110
Q ss_pred ---------------------cCC--CC----------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 155 ---------------------SGK--KP----------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 155 ---------------------~G~--~p----------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
... .+ .......++++++||.+||. +|.+|||+.|+|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 000 00 00112346789999999999 999999999999999
Q ss_pred cccc
Q 006244 195 FLQI 198 (654)
Q Consensus 195 Ff~~ 198 (654)
||+.
T Consensus 317 ~~~~ 320 (359)
T cd07876 317 YITV 320 (359)
T ss_pred hhhh
Confidence 9963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=263.21 Aligned_cols=193 Identities=26% Similarity=0.391 Sum_probs=148.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
|++++.|....+..+++|+||+. ++|.+++..+ ..+++..++.++.||+.||.|||+++ |+||||||+
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~ 137 (317)
T cd07867 61 IALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPA 137 (317)
T ss_pred eeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHH
Confidence 57888888766789999999995 5888887532 24889999999999999999999998 999999999
Q ss_pred cEEEe---CCCCcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCC
Q 006244 72 NIFVN---GNQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYS 141 (654)
Q Consensus 72 NILId---~~~g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~ 141 (654)
|||+. ...+.+||+|||++....... ....+||+.|+|||++.+ .++.++||||||+++|+|+||.+||.
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred HEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 99994 234689999999998764321 223468999999998864 47899999999999999999999996
Q ss_pred CCCCH---------HHHHHHHHc-CCC--------------C--------------------cccccCCChHHHHHHHHH
Q 006244 142 ECTHP---------AQIYKKVIS-GKK--------------P--------------------EALFKVEDPEVRQFIEKC 177 (654)
Q Consensus 142 ~~~~~---------~qi~kki~~-G~~--------------p--------------------~~l~~~~spelrdLI~kC 177 (654)
..... .++.+.+.. |.. + .......+..+++||.+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 297 (317)
T cd07867 218 CRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL 297 (317)
T ss_pred cccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHH
Confidence 42210 111110000 000 0 000112356788999999
Q ss_pred hh-CccCCCCHHHHhcCccc
Q 006244 178 LA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 178 L~-dP~~RpTa~ELL~HPFf 196 (654)
|+ +|.+|||+.|+|+||||
T Consensus 298 l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 298 LTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hccCcccccCHHHHhcCCCC
Confidence 99 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-30 Score=253.90 Aligned_cols=190 Identities=33% Similarity=0.531 Sum_probs=155.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ...+|+|+||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.+
T Consensus 61 ~~~~~~~~~--~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~- 135 (256)
T cd06612 61 VKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE- 135 (256)
T ss_pred eeeeeeeec--CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-
Confidence 478888887 6899999999999999999876 456899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.++|+|||++....... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||......... ..+...
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~ 214 (256)
T cd06612 136 GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNK 214 (256)
T ss_pred CcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccC
Confidence 799999999998765433 223458999999998864 4888999999999999999999999764332222 222211
Q ss_pred CC-CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 157 KK-PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 157 ~~-p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.. ........+..+.++|.+||. +|.+|||+.++|.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 11 111223456789999999999 89999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=262.90 Aligned_cols=194 Identities=23% Similarity=0.392 Sum_probs=156.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ++.+++||||+.||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 63 ~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~ 138 (285)
T cd05630 63 VSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH 138 (285)
T ss_pred eeeeEEEec--CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC
Confidence 356777766 67999999999999999998654 35999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHH--HHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA--QIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~--qi~kki~ 154 (654)
+.++|+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .....+.
T Consensus 139 -~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05630 139 -GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217 (285)
T ss_pred -CCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh
Confidence 789999999987654322 233469999999999864 58899999999999999999999997643211 1122221
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDD 200 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~ 200 (654)
.. .+.......++++++||.+||+ +|.+||| +.++++||||+..+
T Consensus 218 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 218 KE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred hh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 11 1223445678999999999999 8999999 99999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=312.47 Aligned_cols=192 Identities=31% Similarity=0.511 Sum_probs=172.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+|||.-+. +..++|.||||.||+|.+.+...+-.++...+.|..|++.||.|||+++ ||||||||.|||++.+ |
T Consensus 1297 V~YyGVEvH--Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g 1371 (1509)
T KOG4645|consen 1297 VRYYGVEVH--REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-G 1371 (1509)
T ss_pred cccCceeec--HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-C
Confidence 689996666 7899999999999999999888888999999999999999999999999 9999999999999965 7
Q ss_pred cEEEEecCchhhhcccC------CccccCCCCccChhhhccc----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
.+|++|||.|..+.... .....|||-|||||++.+. ...++|||||||+++||+||+.||.+..+.-+|+
T Consensus 1372 ~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1372 LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM 1451 (1509)
T ss_pred cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH
Confidence 99999999998876543 2245799999999999753 4568999999999999999999999999999999
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
-+|..|.+|... ...+++.++||+.||. ||++|.++.+||.|.|-+.
T Consensus 1452 y~V~~gh~Pq~P-~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1452 YHVAAGHKPQIP-ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hHHhccCCCCCc-hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999998754 4489999999999999 9999999999999999764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=286.28 Aligned_cols=180 Identities=27% Similarity=0.497 Sum_probs=155.6
Q ss_pred eEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCc
Q 006244 14 NINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 89 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGL 89 (654)
.+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~vkL~DFGl 189 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVKLGDFGF 189 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCEEEEeccc
Confidence 478999999999999998753 46899999999999999999999998 9999999999999854 7999999999
Q ss_pred hhhhccc----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 006244 90 AAILRKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 164 (654)
Q Consensus 90 A~~l~~~----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~ 164 (654)
++.+... .....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. .+...++.++..+..+. ++.
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~~-~~~ 267 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDP-LPP 267 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCC-CCC
Confidence 9765432 2234569999999999875 589999999999999999999999986 55666777777765543 456
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 165 VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 165 ~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
..+++++++|.+||. +|.+||++.++|+|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 678999999999999 8999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=261.52 Aligned_cols=190 Identities=23% Similarity=0.441 Sum_probs=171.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRL--KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~--k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+|+|++|.+ ...+||++||.+.|+|...++ +..++++.....|++|++.||.|||..+ ||||||||+|+|+...
T Consensus 85 lrlY~~fhd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~ 160 (281)
T KOG0580|consen 85 LRLYGYFHD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA 160 (281)
T ss_pred Hhhhhheec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC
Confidence 368999999 789999999999999999999 6678999999999999999999999999 9999999999999754
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
|.+||+|||.+..-......+.+||..|.+||+.++. ++..+|+|++|++.||++.|.+||.... ....|++|..-.
T Consensus 161 -~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~ 238 (281)
T KOG0580|consen 161 -GELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD 238 (281)
T ss_pred -CCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc
Confidence 7999999999988776677788999999999999864 9999999999999999999999998744 778888887654
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.. ++...+.+++++|.+||. +|.+|.+..|++.|||+..
T Consensus 239 ~~--~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 239 LK--FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred cc--CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 32 236778999999999999 8999999999999999863
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=258.19 Aligned_cols=190 Identities=27% Similarity=0.405 Sum_probs=153.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++++.+.. +..+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~ 136 (285)
T cd07861 62 VCLQDVLMQ--ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDN 136 (285)
T ss_pred eeeEEEEee--CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcC
Confidence 578998887 689999999996 6899988653 46899999999999999999999998 999999999999984
Q ss_pred CCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
.|.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|+||.+||.+.......+...
T Consensus 137 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~ 215 (285)
T cd07861 137 -KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF 215 (285)
T ss_pred -CCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 5899999999987653321 223457899999998864 37889999999999999999999998755444433322
Q ss_pred HcCCC--------------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 ISGKK--------------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~G~~--------------------------p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..... ........+++++++|.+||. +|.+|||+.+|+.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 216 RILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 11100 001123468899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=275.80 Aligned_cols=194 Identities=24% Similarity=0.352 Sum_probs=154.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++.|.. ...+++|||++. ++|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 149 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~-~~ 222 (392)
T PHA03207 149 INLIHAYRW--KSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDE-PE 222 (392)
T ss_pred cceeeeEee--CCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcC-CC
Confidence 578888876 679999999995 799999987788999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH--HHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP--AQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~--~qi~kki 153 (654)
.++|+|||++..+.... ....+||+.|+|||++.. .|+.++|||||||++|+|++|..||.+.... ...+..+
T Consensus 223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i 302 (392)
T PHA03207 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302 (392)
T ss_pred CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence 99999999997664332 123569999999999874 5899999999999999999999999654321 1111111
Q ss_pred Hc--C------------------------CCC-cccc-----cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 154 IS--G------------------------KKP-EALF-----KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 154 ~~--G------------------------~~p-~~l~-----~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. + ..+ ..+. ...+.++++||.+||. +|.+|||+.++|.||||+...
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 303 IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 11 0 000 0000 1245688999999999 899999999999999997654
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=253.53 Aligned_cols=190 Identities=29% Similarity=0.505 Sum_probs=157.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.+ +..+++||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++. .
T Consensus 63 ~~~~~~~~~--~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~-~ 137 (262)
T cd06613 63 VAYFGSYLR--RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTE-D 137 (262)
T ss_pred hceEEEEEe--CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECC-C
Confidence 578998887 78999999999999999998876 68999999999999999999999998 999999999999984 5
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++...... ......+++.|+|||++.. .++.++|+||||+++|+|++|..||.........+...
T Consensus 138 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 138 GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred CCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 79999999999876542 2234568999999998753 58889999999999999999999998755444443332
Q ss_pred HcCCCCcc--cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 154 ISGKKPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 154 ~~G~~p~~--l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
..+..+.. .....+.++++||.+||. +|..|||+.+++.|+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 218 KSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 22222211 122346789999999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-30 Score=253.86 Aligned_cols=192 Identities=30% Similarity=0.475 Sum_probs=160.3
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++.+.. ++.+|+|+||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+ ++|+||+|+|||++. .+.
T Consensus 57 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~-~~~ 131 (265)
T cd05579 57 KLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDS-NGH 131 (265)
T ss_pred HHHHheec--CcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcC-CCC
Confidence 45555554 6899999999999999999998888999999999999999999999998 999999999999985 479
Q ss_pred EEEEecCchhhhccc----------CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 82 VKIGDLGLAAILRKS----------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 82 VKL~DFGLA~~l~~~----------~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
++|+|||++...... ......+++.|+|||++.. .++.++|+||||+++|+|++|..||.. ......+
T Consensus 132 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~ 210 (265)
T cd05579 132 LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIF 210 (265)
T ss_pred EEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC-CCHHHHH
Confidence 999999998764332 2223458899999998764 488899999999999999999999976 4466667
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH---HHHhcCcccccC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA---RELLTDPFLQID 199 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa---~ELL~HPFf~~~ 199 (654)
..+..+..+.......++.+.+||.+||. +|.+|||+ .++|+||||...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 211 QNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 77766554332222248899999999999 89999999 999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=256.68 Aligned_cols=191 Identities=27% Similarity=0.443 Sum_probs=156.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. .+.+++||||+++++|..++.....+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +
T Consensus 63 ~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~ 137 (286)
T cd07847 63 VNLIEVFRR--KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-G 137 (286)
T ss_pred eeeeeEEee--CCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-C
Confidence 478888877 6899999999999999988877778999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
.++|+|||++..+.... .....++..|+|||++.+ .++.++||||||+++|+|++|++||.+..+.+.++.....
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (286)
T cd07847 138 QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL 217 (286)
T ss_pred cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999999998765432 223458899999998864 4788999999999999999999999876555444332211
Q ss_pred CC-------------------CCc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GK-------------------KPE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~-------------------~p~--------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+. .|. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 000 0122357889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=255.91 Aligned_cols=194 Identities=28% Similarity=0.498 Sum_probs=163.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.+ ...+++|+||+.+|+|.+++... ++++..+..++.||+.||.|||+++ ++|+||+|+||+++. .+
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~-~~ 135 (274)
T cd06609 62 TKYYGSFLK--GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSE-EG 135 (274)
T ss_pred eeeeEEEEE--CCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECC-CC
Confidence 467888887 68999999999999999998765 7999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++..+... ......|++.|+|||++.+ .++.++||||||+++|+|+||..||.... +......+..+.
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~ 214 (274)
T cd06609 136 DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNN 214 (274)
T ss_pred CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcC
Confidence 9999999999876543 2234568999999998864 48999999999999999999999997643 444444555554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
.+.......+++++++|.+||. +|.+|||++++++||||+....
T Consensus 215 ~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 4433322278899999999998 8999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=253.28 Aligned_cols=194 Identities=33% Similarity=0.564 Sum_probs=165.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. .+.+++|+||+.+++|.+++.....+++..+..++.||+.||.|||+ .+ ++||||+|+||+++. .
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~-~ 136 (264)
T cd06623 62 VKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINS-K 136 (264)
T ss_pred eeEEEEEcc--CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECC-C
Confidence 478888877 68999999999999999999988889999999999999999999999 98 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCc--cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC--CHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--HPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~--~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--~~~qi~kki~ 154 (654)
+.++|+|||++......... ...++..|+|||++.. .++.++|+||||+++|+|++|..||.... ...+..+.+.
T Consensus 137 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (264)
T cd06623 137 GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216 (264)
T ss_pred CCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh
Confidence 79999999999876543322 4468899999998864 47889999999999999999999997764 5666666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+..+.......+..++++|.+||. +|.+||++.+++.||||+..
T Consensus 217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 217 DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 5554443222278899999999999 89999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=265.19 Aligned_cols=197 Identities=27% Similarity=0.394 Sum_probs=161.2
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHR----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~----~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeN 72 (654)
|++++.+.... ...++||+||+. -+|.+|+.... .++...++.+++||+.||+|||+++ |+||||||.|
T Consensus 74 v~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQN 150 (323)
T KOG0594|consen 74 VRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQN 150 (323)
T ss_pred EEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcce
Confidence 45677666521 238999999995 59999998865 5888999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
|||+. .|.+||+|||+|+...-+ ..+..++|.+|+|||++-+ .|+..+||||+|||+.||+++++.|.+.....+
T Consensus 151 lLi~~-~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q 229 (323)
T KOG0594|consen 151 LLISS-SGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ 229 (323)
T ss_pred EEECC-CCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH
Confidence 99985 589999999999976533 3456689999999998875 499999999999999999999999999877777
Q ss_pred HHHHHHc-CCCCccc--------------------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 149 IYKKVIS-GKKPEAL--------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 149 i~kki~~-G~~p~~l--------------------------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+.+...- |...+.. .+..++...+++.+||+ +|.+|.||+.+|.||||....
T Consensus 230 l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 230 LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 7654432 2211100 11224689999999999 899999999999999998654
Q ss_pred c
Q 006244 201 Y 201 (654)
Q Consensus 201 ~ 201 (654)
.
T Consensus 310 ~ 310 (323)
T KOG0594|consen 310 E 310 (323)
T ss_pred c
Confidence 3
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=252.47 Aligned_cols=190 Identities=34% Similarity=0.556 Sum_probs=157.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++++.+.. .+.+++|+|++.+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 62 ~~~~~~~~~--~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~ 137 (267)
T cd06610 62 VKYYTSFVV--GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGE 137 (267)
T ss_pred EEEEEEEee--CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcC
Confidence 467888877 68999999999999999999764 45899999999999999999999998 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccCC------ccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~------~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
+ +.++|+|||++..+..... ...+|++.|+|||++.. .++.++|+||||+++|+|++|+.||..... ...
T Consensus 138 ~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~ 215 (267)
T cd06610 138 D-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-MKV 215 (267)
T ss_pred C-CCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh-hhh
Confidence 4 7899999999987654321 23468999999998864 488899999999999999999999987543 334
Q ss_pred HHHHHcCCCCccc----ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 150 YKKVISGKKPEAL----FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 150 ~kki~~G~~p~~l----~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+.++..+..+... ....++.++++|.+||. +|.+||++.+|+.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 4444444322111 12457899999999999 89999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=260.53 Aligned_cols=190 Identities=26% Similarity=0.413 Sum_probs=150.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.+ ...+++|+||+. |+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~- 135 (284)
T cd07839 62 VRLYDVLHS--DKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN- 135 (284)
T ss_pred eeHHHHhcc--CCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-
Confidence 356677766 678999999996 588888765 457999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++..+.... .....+++.|+|||++.+ .++.++||||||+++|+|+||..||....+....++.+..
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 215 (284)
T cd07839 136 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215 (284)
T ss_pred CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH
Confidence 799999999997654322 223457899999998864 3788999999999999999999987554444444333322
Q ss_pred CCC-------------------C--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKK-------------------P--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~-------------------p--------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
... + .......++++++||.+||. +|.+|||+.++|.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 100 0 01123457899999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=262.19 Aligned_cols=194 Identities=23% Similarity=0.388 Sum_probs=158.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ...+++||||+.|++|.+++.+. ..+++..++.++.||+.||.|||+.+ ++|+||||+|||++.+
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~ 139 (316)
T cd05574 64 PTLYASFQT--ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES 139 (316)
T ss_pred hhheeeeec--CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC
Confidence 467787766 67999999999999999998764 46999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC-------------------------------CccccCCCCccChhhhcc-cCCcccchhhh
Q 006244 79 QGEVKIGDLGLAAILRKSH-------------------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSF 126 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-------------------------------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSL 126 (654)
+.++|+|||++....... ....+||+.|+|||++.+ .++.++|||||
T Consensus 140 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 140 -GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred -CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 799999999987542210 113468999999998864 48889999999
Q ss_pred hhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC----HHHHhcCcccccCC
Q 006244 127 GMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS----ARELLTDPFLQIDD 200 (654)
Q Consensus 127 GiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT----a~ELL~HPFf~~~~ 200 (654)
|+++|+|++|..||..... ...+..+.............+++++++|.+||. +|.+||+ +.++|.||||+..+
T Consensus 219 G~ll~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 219 GILLYEMLYGTTPFKGSNR-DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHHHhhCCCCCCCCch-HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 9999999999999987544 344444444333222222368999999999999 8999999 99999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=263.32 Aligned_cols=191 Identities=27% Similarity=0.400 Sum_probs=152.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ++.+++||||+. ++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 67 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~- 140 (309)
T cd07872 67 VTLHDIVHT--DKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER- 140 (309)
T ss_pred ceEEEEEee--CCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-
Confidence 578888877 679999999996 58888887654 5899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++....... .....+|+.|+|||++.+ .++.++||||||+++|+|+||..||...... .....+..
T Consensus 141 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~ 219 (309)
T cd07872 141 GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFR 219 (309)
T ss_pred CCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Confidence 799999999987643322 223468999999998854 4889999999999999999999999874432 22222211
Q ss_pred --CCC-------------------Cc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 --GKK-------------------PE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 --G~~-------------------p~-------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.. +. ......++++++||.+||. +|.+|||+.|+|.||||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 220 LLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred HhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 000 00 0112357899999999999 8999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=257.28 Aligned_cols=194 Identities=30% Similarity=0.526 Sum_probs=158.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILI 75 (654)
|++++++.. +..+++||||+. |+|.+++... ..+++..+..++.||+.||.|||++ + ++||||||+|||+
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~ 137 (283)
T cd06617 63 VTFYGALFR--EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLI 137 (283)
T ss_pred eeeeEEEec--CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE
Confidence 578898876 678999999996 7888887642 3689999999999999999999997 7 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccCC-ccccCCCCccChhhhcc-----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~~-----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
+.+ +.+||+|||++........ ....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.......+.
T Consensus 138 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (283)
T cd06617 138 NRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216 (283)
T ss_pred CCC-CCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH
Confidence 854 7999999999987644322 23468999999998853 3678999999999999999999999764444344
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
...+..+..+.......+.++++||.+||. +|.+||++.+++.||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 444455544433334568899999999999 899999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=257.51 Aligned_cols=196 Identities=30% Similarity=0.513 Sum_probs=160.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. +..+++||||+.||+|..++.+ ...+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 72 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~-~ 146 (292)
T cd06644 72 VKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTL-D 146 (292)
T ss_pred eeeEEEEEe--CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcC-C
Confidence 467888876 6799999999999999988765 456899999999999999999999998 999999999999974 4
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.++|+|||++...... ......+++.|+|||++. ..++.++||||||+++|+|++|..||.... ....+.
T Consensus 147 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~ 225 (292)
T cd06644 147 GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLL 225 (292)
T ss_pred CCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHH
Confidence 79999999998654332 123346899999999874 236789999999999999999999997643 445555
Q ss_pred HHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 152 KVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 152 ki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
++..+..+. ......+.++.++|.+||. +|.+||++.++++||||......
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 226 KIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred HHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 555544432 2234567899999999999 89999999999999999765544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=257.48 Aligned_cols=193 Identities=28% Similarity=0.450 Sum_probs=154.6
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
+++++.|.... ...+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~ni 159 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNI 159 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHE
Confidence 46788776532 3579999999999999998763 357899999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc------cCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
+++. .+.+||+|||++....... .....|++.|+|||++.. .++.++||||||+++|+|++|.+||.....
T Consensus 160 li~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 160 LLTT-EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEcC-CCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 9985 4789999999988654322 223468999999998753 267899999999999999999999987443
Q ss_pred HHHHHHHHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 146 PAQIYKKVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 146 ~~qi~kki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
...+ ..+..+..+. .........++++|.+||. +|.+||++.+++.||||+
T Consensus 239 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 239 VKTL-FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHH-HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 3333 3444333221 1123356789999999999 899999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=272.16 Aligned_cols=194 Identities=27% Similarity=0.384 Sum_probs=153.9
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++++.+.... ...+|+|+||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~ 138 (372)
T cd07853 62 LSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNS 138 (372)
T ss_pred CCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECC
Confidence 35666666521 127899999995 689999888888999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC---CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+.+||+|||++....... ....++|+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....
T Consensus 139 -~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~ 216 (372)
T cd07853 139 -NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDL 216 (372)
T ss_pred -CCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHH
Confidence 4799999999997654321 233468999999999865 3789999999999999999999999874433 22222
Q ss_pred HHc------------------------CCCCc------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 153 VIS------------------------GKKPE------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 153 i~~------------------------G~~p~------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+.. ...+. .+....++++++||.+||. +|.+|||+.++|.||||+..
T Consensus 217 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 217 ITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 211 11111 1223457899999999999 99999999999999999754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=255.84 Aligned_cols=190 Identities=28% Similarity=0.484 Sum_probs=153.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. +..+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+.+ |+||||||+||+++. .+
T Consensus 69 i~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~-~~ 143 (267)
T cd06646 69 VAYFGSYLS--REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTD-NG 143 (267)
T ss_pred eeeeEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECC-CC
Confidence 578888877 6899999999999999999988888999999999999999999999998 999999999999974 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.++|+|||++..+.... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||..............
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06646 144 DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223 (267)
T ss_pred CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec
Confidence 89999999998664322 23346899999999874 3377899999999999999999999975433222221111
Q ss_pred cCCCCccc--ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 155 SGKKPEAL--FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 155 ~G~~p~~l--~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
....+..+ ....+..+++||.+||. +|.+||+++++|+|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 11122111 12357899999999999 8999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-30 Score=270.75 Aligned_cols=189 Identities=24% Similarity=0.460 Sum_probs=168.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|.+|..|.. ++.++|||||..+|.|.+|+.+.+.+++..++.+++||++|+.|||+++ ++|||||.+|||+|.| +
T Consensus 116 I~IyEVFEN--kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~ 190 (668)
T KOG0611|consen 116 IQIYEVFEN--KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-N 190 (668)
T ss_pred eehhhhhcC--CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-C
Confidence 467888876 7899999999999999999999999999999999999999999999999 9999999999999966 7
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+||||+..+.+. ...+++|+|-|.+||++.+. | .+.+|.||||++||.|+.|..||.+ .+...+.++|..|.
T Consensus 191 NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 191 NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGA 269 (668)
T ss_pred CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhccc
Confidence 9999999999887654 45678999999999999875 4 5689999999999999999999998 56777888998887
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.-+. ..+..+..||.-||. +|.+|.|+.++-.|=|+.-
T Consensus 270 YrEP---~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 270 YREP---ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ccCC---CCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 6432 245578999999998 9999999999999999863
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=250.67 Aligned_cols=189 Identities=29% Similarity=0.539 Sum_probs=162.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
++++++|.+ .+.+++||||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 62 ~~~~~~~~~--~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 62 IAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA 137 (256)
T ss_pred eEEEeEEec--CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC
Confidence 578999887 68999999999999999999875 46899999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++....... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..
T Consensus 138 -~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~ 215 (256)
T cd08221 138 -GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQ 215 (256)
T ss_pred -CCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHc
Confidence 799999999987654332 234568999999998864 478899999999999999999999976 456666677777
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+. .....+.++.++|.+||. +|.+||++.++|+|||+
T Consensus 216 ~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 GNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 66544 335678899999999998 89999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=250.37 Aligned_cols=190 Identities=34% Similarity=0.529 Sum_probs=159.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. ...+++|+||+++++|.+++.+...+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. .+
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~-~~ 139 (258)
T cd06632 65 VQYLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDT-NG 139 (258)
T ss_pred hheeeeEec--CCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CC
Confidence 478887766 6899999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC-CccccCCCCccChhhhcc-c-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++....... .....|++.|+|||.+.. . ++.++|+||||+++|+|++|..||..........+ +....
T Consensus 140 ~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~ 218 (258)
T cd06632 140 VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSK 218 (258)
T ss_pred CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcc
Confidence 99999999987654433 234568999999998764 3 78899999999999999999999987554333333 33322
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
....++...++.+++||.+||. +|.+||++.++|.|||+
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 2333455678999999999999 89999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=250.35 Aligned_cols=190 Identities=28% Similarity=0.536 Sum_probs=159.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ++.+++|+||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.+
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~ 137 (256)
T cd08220 62 IEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKH 137 (256)
T ss_pred hheeeeEec--CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence 457777765 68999999999999999999764 35899999999999999999999998 9999999999999866
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++....... .....|++.|+|||++.. .++.++||||||+++|+|++|..||.... .......+..+
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~ 216 (256)
T cd08220 138 KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSG 216 (256)
T ss_pred CCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhc
Confidence 6678999999998765432 223468999999999875 47889999999999999999999997744 44455555554
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+ .+....++.++++|.+||. +|.+|||+.+++.||||
T Consensus 217 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 217 TFA-PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCC-CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 433 2344578899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=258.03 Aligned_cols=192 Identities=29% Similarity=0.518 Sum_probs=158.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId 76 (654)
+++++.+.. .+.+++||||++|++|..++... ..+++..+..++.||+.||.|||. .+ |+||||||+|||++
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~ 137 (286)
T cd06622 62 VDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN 137 (286)
T ss_pred Hhhhhheec--CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC
Confidence 356777766 68999999999999999998764 379999999999999999999996 46 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
. .+.++|+|||++..+.........|++.|+|||++.. .++.++||||||+++|+|++|..||.... ....
T Consensus 138 ~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~ 215 (286)
T cd06622 138 G-NGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANI 215 (286)
T ss_pred C-CCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhH
Confidence 5 5799999999998765554555678999999998753 25789999999999999999999997533 2222
Q ss_pred H---HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 150 Y---KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 150 ~---kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+ ..+..+.. ..++...++++++||.+||. +|.+||++.+++.||||...
T Consensus 216 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 216 FAQLSAIVDGDP-PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHhhcCC-CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 2 23344433 33455588999999999999 89999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=281.79 Aligned_cols=196 Identities=22% Similarity=0.431 Sum_probs=177.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
||+|..|-+ .+++||+||-|-||.|...+++.+.++..+++.++.-+++|++|||+++ ||+|||||+|++++ +.|
T Consensus 483 vrLYrTfrd--~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~G 557 (732)
T KOG0614|consen 483 VRLYRTFRD--SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRG 557 (732)
T ss_pred HHHHHHhcc--chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCC
Confidence 456676766 7899999999999999999999999999999999999999999999999 99999999999998 558
Q ss_pred cEEEEecCchhhhcccCC-ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 81 EVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
-+||.|||+|+.+..... -+++|||+|.|||++. ...+.++|.||||+++|||++|.+||++ .++-..|..|..|..
T Consensus 558 y~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid 636 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGID 636 (732)
T ss_pred ceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhh
Confidence 999999999999876544 4678999999999765 5689999999999999999999999998 678889999999998
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
...+++..+....+||+++.. +|.+|+. +.++-+|.||..-++.
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 888888999999999999887 7999886 8999999999877764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=268.90 Aligned_cols=189 Identities=30% Similarity=0.416 Sum_probs=147.9
Q ss_pred EEEEEEEec----CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 2 KFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 2 kfY~sfvd~----~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
++++.|... ....+|+||||+. ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~ 161 (364)
T cd07875 87 GLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKS 161 (364)
T ss_pred ccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECC
Confidence 456655432 1357899999996 578877754 4889999999999999999999998 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 78 NQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+ +.+||+|||++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+.++..
T Consensus 162 ~-~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~ 239 (364)
T cd07875 162 D-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-IDQWNKVIE 239 (364)
T ss_pred C-CcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHH
Confidence 4 799999999998765432 234579999999998875 589999999999999999999999987443 333333322
Q ss_pred C--CC-------------------Cc-------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 156 G--KK-------------------PE-------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 156 G--~~-------------------p~-------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
. .. |. ......+..+++||.+||. +|.+|||+.++|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 240 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred hcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 1 00 00 0011235678999999999 999999999999999
Q ss_pred ccc
Q 006244 195 FLQ 197 (654)
Q Consensus 195 Ff~ 197 (654)
||.
T Consensus 320 ~~~ 322 (364)
T cd07875 320 YIN 322 (364)
T ss_pred ccc
Confidence 996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.49 Aligned_cols=197 Identities=25% Similarity=0.421 Sum_probs=162.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. +.++++||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++ +.+
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~ 138 (305)
T cd05609 64 VSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMG 138 (305)
T ss_pred eeeEEEEec--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCC
Confidence 478888866 6799999999999999999988888999999999999999999999998 99999999999998 458
Q ss_pred cEEEEecCchhhhccc-----------------CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCC
Q 006244 81 EVKIGDLGLAAILRKS-----------------HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSE 142 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-----------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~ 142 (654)
.++|+|||+++..... ......|++.|+|||.+. ..++.++|+||||+++|+|++|..||.+
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999988642100 011235788999999875 4588999999999999999999999986
Q ss_pred CCCHHHHHHHHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCC---HHHHhcCcccccCCcch
Q 006244 143 CTHPAQIYKKVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDDYDS 203 (654)
Q Consensus 143 ~~~~~qi~kki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpT---a~ELL~HPFf~~~~~~~ 203 (654)
.+..++...+..+..+. ......+++++++|.+||. +|.+||+ +.++|.||||...++..
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 219 -DTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred -CCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 45566666666554322 1222568889999999999 8999998 89999999998766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=275.55 Aligned_cols=193 Identities=25% Similarity=0.448 Sum_probs=167.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+. ....-.+|||+|+=.+|+|.+||.+|. .+++..+++|++||+.|+.|||+.. ++||||||+|+.+....
T Consensus 80 VRLYEV--iDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKl 155 (864)
T KOG4717|consen 80 VRLYEV--IDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKL 155 (864)
T ss_pred eeeeeh--hcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeec
Confidence 577873 334779999999999999999999885 6999999999999999999999998 99999999999888888
Q ss_pred CcEEEEecCchhhhcc-cCCccccCCCCccChhhhccc-CC-cccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVYEEE-YN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~-~~~~~~vGTp~YmAPEvl~~~-ys-~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
|.|||.|||++..+.. ....+.+|+..|-|||++.+. |+ +++||||||+|||.|++|++||.+.++.+.+ -.|+.-
T Consensus 156 GlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-TmImDC 234 (864)
T KOG4717|consen 156 GLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-TMIMDC 234 (864)
T ss_pred CceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-hhhhcc
Confidence 9999999999977654 456778999999999988754 65 5799999999999999999999987665554 444444
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+. .++...+.++++||..||+ +|.+|.+.+++..++|++..+
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 43 3456788999999999999 999999999999999998664
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=260.45 Aligned_cols=194 Identities=32% Similarity=0.557 Sum_probs=159.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. ...+++|+||+.+|+|..++.+. .+++..+..++.||+.||.|||+++ ++||||||+|||++. .+
T Consensus 79 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~-~~ 152 (296)
T cd06655 79 VNFLDSFLV--GDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGM-DG 152 (296)
T ss_pred eeeeeeEec--CceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CC
Confidence 467888876 67999999999999999998654 6899999999999999999999999 999999999999974 57
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++....... .....|++.|+|||.+.. .++.++||||||+++|+|++|..||...............+.
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T cd06655 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (296)
T ss_pred CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999987654332 223468999999998864 488999999999999999999999987544444333322333
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+...+...++.+++||.+||. +|.+||++.+++.||||+...
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 2333445578899999999999 899999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=247.62 Aligned_cols=193 Identities=36% Similarity=0.590 Sum_probs=166.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.....+.+++|+||+.+++|.+++.+...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. .+
T Consensus 62 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~-~~ 138 (260)
T cd06606 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDS-DG 138 (260)
T ss_pred eeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcC-CC
Confidence 467888877333899999999999999999998889999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC----CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.++|+|||.+....... .....++..|+|||.+... ++.++||||||+++|+|++|..||....+.......+..
T Consensus 139 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (260)
T cd06606 139 VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218 (260)
T ss_pred CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc
Confidence 99999999998776543 3345689999999988754 889999999999999999999999876655555555554
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+.....++...+..+++||.+||. +|.+||++.++++||||
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 444445566678999999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=268.08 Aligned_cols=192 Identities=29% Similarity=0.401 Sum_probs=148.4
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.|.... ...+++||||+.+ +|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~ 153 (355)
T cd07874 79 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 153 (355)
T ss_pred hceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC
Confidence 46777776422 2468999999964 67777654 5899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
. .+.+||+|||+++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..........+.
T Consensus 154 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (355)
T cd07874 154 S-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_pred C-CCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5 4799999999998765432 234579999999998875 489999999999999999999999976433222211111
Q ss_pred c-CC-------------------C--------Cc-----------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 155 S-GK-------------------K--------PE-----------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 155 ~-G~-------------------~--------p~-----------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
. +. . +. ......+.++++||.+||. +|.+|||+.|+|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0 00 0 00 0112235678999999999 899999999999999
Q ss_pred cccc
Q 006244 195 FLQI 198 (654)
Q Consensus 195 Ff~~ 198 (654)
||..
T Consensus 313 ~~~~ 316 (355)
T cd07874 313 YINV 316 (355)
T ss_pred chhc
Confidence 9963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=252.07 Aligned_cols=192 Identities=27% Similarity=0.495 Sum_probs=161.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+.....+++|+||+++++|.+++.....+++..++.|+.||+.||.|||+++ ++|+||||+||+++.+ +
T Consensus 67 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~ 143 (264)
T cd06653 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-G 143 (264)
T ss_pred ceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-C
Confidence 478888877556789999999999999999988778999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc-----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.++|+|||++...... ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||........+. ++.
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~ 222 (264)
T cd06653 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIA 222 (264)
T ss_pred CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHH
Confidence 8999999999765421 1223468999999998865 47889999999999999999999998755555444 333
Q ss_pred cCCCCcccccCCChHHHHHHHHHhhCccCCCCHHHHhcCccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLATVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~dP~~RpTa~ELL~HPFf 196 (654)
....+..++...+++++++|.+||++|..||++.+++.|||.
T Consensus 223 ~~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 223 TQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cCCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhcCCCC
Confidence 333334456678899999999999989999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=297.29 Aligned_cols=197 Identities=26% Similarity=0.456 Sum_probs=164.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRD-----PPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~-----p~IIHRDLKpe 71 (654)
|++|+.|+......+|||||||.+|+|.+++... ..+++..++.|+.||+.||.|||+.+ .+||||||||+
T Consensus 75 Vrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPe 154 (1021)
T PTZ00266 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQ 154 (1021)
T ss_pred CeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHH
Confidence 6899999887778999999999999999998753 56999999999999999999999854 24999999999
Q ss_pred cEEEeCC----------------CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc---cCCcccchhhhhhHHH
Q 006244 72 NIFVNGN----------------QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCIL 131 (654)
Q Consensus 72 NILId~~----------------~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ 131 (654)
||||+.. .+.+||+|||++..+.... ....+||+.|+|||++.. .++.++||||||||||
T Consensus 155 NILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 155 NIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred HeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 9999632 2358999999998764332 234579999999998852 4889999999999999
Q ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 132 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 132 ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+|+||..||.......++...+..+.. ......++++.+||..||. +|.+||++.++|.|||++..
T Consensus 235 ELLTGk~PF~~~~~~~qli~~lk~~p~--lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQLISELKRGPD--LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHCCCCCCcCCcHHHHHHHHhcCCC--CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 999999999877777777766655432 2234568899999999999 89999999999999999643
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=255.74 Aligned_cols=194 Identities=25% Similarity=0.489 Sum_probs=159.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ...++||+||+++|+|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+||+++. .
T Consensus 66 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~-~ 140 (284)
T cd06620 66 VSFYGAFLN--ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-R 140 (284)
T ss_pred ceEeeeEec--CCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECC-C
Confidence 578888887 68999999999999999999888889999999999999999999997 46 999999999999984 5
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH----------HH
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP----------AQ 148 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~----------~q 148 (654)
+.++|+|||++...........+|++.|+|||++. ..++.++||||||+++|+|++|..||...... ..
T Consensus 141 ~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd06620 141 GQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD 220 (284)
T ss_pred CcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH
Confidence 79999999998765444444557999999999875 45888999999999999999999999753321 12
Q ss_pred HHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 149 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 149 i~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
....+.....+.......+..+.+||.+||. +|.+|||+.|+++||||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 221 LLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 3333433333322222367789999999999 89999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=271.52 Aligned_cols=182 Identities=30% Similarity=0.473 Sum_probs=155.6
Q ss_pred eEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCc
Q 006244 14 NINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 89 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGL 89 (654)
+.+|||||++ .+|.++++. +.+++.-.++-|++||++||.|||+.+ |+||||||.|||+|.+.|.+||||||.
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCc
Confidence 7789999996 599988874 567999999999999999999999998 999999999999999999999999999
Q ss_pred hhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCC-------
Q 006244 90 AAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKK------- 158 (654)
Q Consensus 90 A~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G~~------- 158 (654)
|+.+... ...+++-|+.|+|||.+.+ .|+.++||||.||++.||+-|++-|.+.+...|+...+.- |..
T Consensus 173 AK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 173 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 9987654 3455678999999998875 5999999999999999999999999997777776543321 111
Q ss_pred ----------C--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 159 ----------P--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 159 ----------p--------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
| ..+.+..++++.+|+.++|+ +|.+|.++.|+|.||||..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 1 11345578999999999999 8999999999999999964
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=254.36 Aligned_cols=191 Identities=26% Similarity=0.431 Sum_probs=154.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. .+.+++|+||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+|+||||+||+++. .
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~-~ 135 (286)
T cd07832 62 VKLLDVFPH--GSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISA-D 135 (286)
T ss_pred cceeeEEec--CCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcC-C
Confidence 467888877 78999999999 9999999875 356999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.++|+|||++....... .....|++.|+|||++.+ .++.++||||||+++|+|++|.+||....+...+...+.
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 215 (286)
T cd07832 136 GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFR 215 (286)
T ss_pred CcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHH
Confidence 799999999998765433 234568999999998753 368899999999999999999888876444333322221
Q ss_pred cCCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 155 SGKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 155 ~G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.-..+ .......+.++.+||.+||. +|.+||+++++|.||||.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 10000 01123456889999999999 899999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=276.12 Aligned_cols=192 Identities=23% Similarity=0.401 Sum_probs=156.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~L-se~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++-+. ++.+||||||= ..+|..++++.... ..-.++.|++||+.++.++|.++ |||.||||.|+|+- .
T Consensus 423 IqL~DYEv~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--k 495 (677)
T KOG0596|consen 423 IQLYDYEVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--K 495 (677)
T ss_pred EEEeeeecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--e
Confidence 578998777 79999999997 46999999887643 33488999999999999999999 99999999999986 3
Q ss_pred CcEEEEecCchhhhcccC----CccccCCCCccChhhhcc------------cCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 80 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~------------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
|.+||+|||+|..+.... ..+.+||+.||+||.+.. +.+.++||||||||||+|+.|++||...
T Consensus 496 G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 496 GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 899999999998876543 345689999999998742 1456899999999999999999999876
Q ss_pred CCHHHHHHHHHcCCCCcccccCCChH-HHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 144 THPAQIYKKVISGKKPEALFKVEDPE-VRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 144 ~~~~qi~kki~~G~~p~~l~~~~spe-lrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+...-+..|+...-...++....+. +.++++.||. +|.+||++.+||+|||++..
T Consensus 576 ~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 576 INQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred HHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 65555555555432222333344444 9999999999 99999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=258.11 Aligned_cols=192 Identities=26% Similarity=0.376 Sum_probs=153.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. .+.+++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 67 ~~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~- 140 (301)
T cd07873 67 VTLHDIIHT--EKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER- 140 (301)
T ss_pred ceEEEEEec--CCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-
Confidence 578998876 689999999996 6999988764 46899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||....... ....+..
T Consensus 141 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~ 219 (301)
T cd07873 141 GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFR 219 (301)
T ss_pred CcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 799999999997654322 223457899999998864 37889999999999999999999998744322 2222211
Q ss_pred C--C-------------------CCc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 G--K-------------------KPE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 G--~-------------------~p~-------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. . .|. ......++.+++||.+||. +|.+|||+.++|+||||+.-
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 220 ILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred HcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 0 000 0112457889999999999 89999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=255.10 Aligned_cols=192 Identities=28% Similarity=0.476 Sum_probs=153.7
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
+++++.+... ....+++||||++||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~ni 155 (286)
T cd06638 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNI 155 (286)
T ss_pred eeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhE
Confidence 4677777542 24689999999999999998753 346899999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
+++.+ +.+||+|||++..+... ......|++.|+|||++. ..++.++||||||+++|+|++|+.||.....
T Consensus 156 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 156 LLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EECCC-CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 99854 78999999998765432 223346999999999874 2378899999999999999999999987544
Q ss_pred HHHHHHHHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 146 PAQIYKKVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 146 ~~qi~kki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
...+. ++..+..+. ......+..++++|.+||. +|.+|||+.++++|+||
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 235 MRALF-KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hHHHh-hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 33332 333332221 2233457789999999999 89999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=261.55 Aligned_cols=194 Identities=32% Similarity=0.543 Sum_probs=159.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.. .+.+++||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++. .+
T Consensus 79 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~-~~ 152 (297)
T cd06656 79 VNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGM-DG 152 (297)
T ss_pred eeEEEEEec--CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CC
Confidence 478888877 6899999999999999999865 46899999999999999999999998 999999999999984 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||........++.....+.
T Consensus 153 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~ 232 (297)
T cd06656 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (297)
T ss_pred CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC
Confidence 99999999987654322 223468999999998865 488999999999999999999999976444333333222333
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+...+...++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 3333445577889999999999 899999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=260.72 Aligned_cols=192 Identities=32% Similarity=0.570 Sum_probs=156.2
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++.+.. ....++||||+++++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++.+ +.
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~ 156 (292)
T cd06658 83 DMYNSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GR 156 (292)
T ss_pred HHHHheec--CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CC
Confidence 45566665 6799999999999999998754 56999999999999999999999998 9999999999999854 79
Q ss_pred EEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 82 VKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
++|+|||++....... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||... .....+..+.....
T Consensus 157 ~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~ 235 (292)
T cd06658 157 IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLP 235 (292)
T ss_pred EEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCC
Confidence 9999999987654322 233468999999998864 5888999999999999999999999763 34444444443322
Q ss_pred Cc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 159 PE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 159 p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+. ......+..++++|.+||. +|.+|||+.+++.||||....
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 236 PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 21 1123467899999999999 899999999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=252.98 Aligned_cols=190 Identities=21% Similarity=0.356 Sum_probs=152.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.+...+.+++|+||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-- 135 (282)
T cd07831 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-- 135 (282)
T ss_pred cceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--
Confidence 46888888754589999999996 5888887763 57899999999999999999999998 999999999999985
Q ss_pred CcEEEEecCchhhhcccCC-ccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 80 GEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
+.+||+|||++..+..... ....+++.|+|||++. +.++.++|||||||++|+|++|..||...+ ....+..+..
T Consensus 136 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~-~~~~~~~~~~~ 214 (282)
T cd07831 136 DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN-ELDQIAKIHDV 214 (282)
T ss_pred CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC-HHHHHHHHHHH
Confidence 8999999999987644322 3446899999999764 347889999999999999999999997643 3332222221
Q ss_pred -CCCCc-------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 -GKKPE-------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 -G~~p~-------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
|..+. ......+.+++++|.+||. +|.+||++.++|.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11000 0112457899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=274.28 Aligned_cols=184 Identities=27% Similarity=0.433 Sum_probs=156.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
||||+.... ...+|||||||..|+|.+|++. .+.++......|+.||++|++||++++ +|||||...||||+.+
T Consensus 264 V~l~gV~~~--~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 264 VKLYGVCTK--QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED 339 (468)
T ss_pred EEEEEEEec--CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC
Confidence 689996655 5689999999999999999997 457999999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccC---CCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vG---Tp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
..+||+|||||+...+.......| ...|.|||.+. +.|+.++|||||||+||||+| |+.||.+. +..+....+
T Consensus 340 -~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~l 417 (468)
T KOG0197|consen 340 -LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLELL 417 (468)
T ss_pred -ceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHHH
Confidence 799999999999655443332222 35899999886 679999999999999999999 99999884 456677888
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
.+|..-+. +..+++++-+++..||. +|++|||++.|.
T Consensus 418 e~GyRlp~-P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 418 ERGYRLPR-PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred hccCcCCC-CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 88876432 35689999999999999 899999999654
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=268.24 Aligned_cols=192 Identities=30% Similarity=0.421 Sum_probs=148.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.|.. ....++|+||+. |+|.+++.+ .+.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 120 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~- 193 (357)
T PHA03209 120 IRMKDTLVS--GAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV- 193 (357)
T ss_pred cChhheEEe--CCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-
Confidence 578888887 678999999994 688888765 457999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-C---------HH
Q 006244 80 GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-H---------PA 147 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-~---------~~ 147 (654)
+.+||+|||++...... ......||+.|+|||++.+ .|+.++|||||||++|||+++..|+.... . ..
T Consensus 194 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~ 273 (357)
T PHA03209 194 DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273 (357)
T ss_pred CCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHH
Confidence 78999999999754322 2234569999999998864 58999999999999999998655543211 1 11
Q ss_pred HHHHHHHc-CCCCcccc------------------------------cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 148 QIYKKVIS-GKKPEALF------------------------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 148 qi~kki~~-G~~p~~l~------------------------------~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
.+.+.+.. +..|..+. ...+.++.+||.+||+ +|.+|||+.|+|+|||
T Consensus 274 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~ 353 (357)
T PHA03209 274 HLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM 353 (357)
T ss_pred HHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence 12221111 11111111 1235677889999999 8999999999999999
Q ss_pred ccc
Q 006244 196 LQI 198 (654)
Q Consensus 196 f~~ 198 (654)
|+.
T Consensus 354 f~~ 356 (357)
T PHA03209 354 FAQ 356 (357)
T ss_pred hcc
Confidence 963
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=256.34 Aligned_cols=191 Identities=24% Similarity=0.384 Sum_probs=159.3
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
+.+.|-. ...+.||+||++ -+|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++.+ |.
T Consensus 66 LiD~F~~--~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~ 139 (318)
T KOG0659|consen 66 LIDVFPH--KSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQ 139 (318)
T ss_pred hhhhccC--CCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-Cc
Confidence 4455544 789999999996 4999887754 46999999999999999999999999 9999999999999855 89
Q ss_pred EEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-C
Q 006244 82 VKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-G 156 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G 156 (654)
+||+|||+|+.+.... .+..+-|.+|+|||++-+ .|+..+||||+|||+.||+-|.+-|.+.++.+|+-+.+.. |
T Consensus 140 lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 140 LKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred EEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 9999999999886543 334478999999998864 5999999999999999999999889998888887654432 2
Q ss_pred CCC-c-----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKP-E-----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p-~-----------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
... . .++...+.++.+|+.++|. +|.+|+|+.|+|+|+||...
T Consensus 220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 211 1 1334456788999999999 99999999999999999753
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=265.59 Aligned_cols=190 Identities=27% Similarity=0.438 Sum_probs=149.7
Q ss_pred EEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 2 KFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 2 kfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
++++.|.... ...+|+++|++ +++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~ 153 (343)
T cd07878 78 GLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNE 153 (343)
T ss_pred hhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECC
Confidence 4555554321 24689999998 889998765 457999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+ +.+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+..
T Consensus 154 ~-~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~ 230 (343)
T cd07878 154 D-CELRILDFGLARQADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIME 230 (343)
T ss_pred C-CCEEEcCCccceecCCC-cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence 4 79999999999876443 344579999999999865 48899999999999999999999997643322 2222221
Q ss_pred --CCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 --GKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 --G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..+ .......++.+.+||.+||. +|.+|||+.++|.||||..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 1100 01122356788999999999 9999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=254.29 Aligned_cols=193 Identities=33% Similarity=0.596 Sum_probs=161.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. .+..++|+||+.|++|.+++.. .++++..+..++.||+.||+|||+++ |+||||+|+||+++. .+
T Consensus 79 v~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~-~~ 152 (285)
T cd06648 79 VEMYSSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTS-DG 152 (285)
T ss_pred heEEEEEEc--CCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcC-CC
Confidence 578888876 6899999999999999999887 67999999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||.. .++......+..+.
T Consensus 153 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~ 231 (285)
T cd06648 153 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNL 231 (285)
T ss_pred cEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcC
Confidence 99999999887654322 223468999999998865 488999999999999999999999976 44555556666553
Q ss_pred CCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+... ....++.+.+||.+||. +|.+||++.+++.||||+...
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 232 PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 32211 22367899999999999 899999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=280.89 Aligned_cols=186 Identities=26% Similarity=0.436 Sum_probs=161.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+ +.++|+|||++.||-|.+-+.+.+.+. ..+..|++||+.|+.|||.++ |+||||||+|||++++.|
T Consensus 379 v~~~~v~~~--~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g 453 (612)
T KOG0603|consen 379 VKSHDVYED--GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAG 453 (612)
T ss_pred eeecceecC--CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCC
Confidence 345665555 789999999999999998887766566 778889999999999999998 999999999999965678
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
+++|+|||.++.+... ..+.+-|..|.|||++.. .|++.+||||||++||+||+|..||....+..+++.++..|...
T Consensus 454 ~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s 532 (612)
T KOG0603|consen 454 HLRLTYFGFWSELERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS 532 (612)
T ss_pred cEEEEEechhhhCchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc
Confidence 9999999999887666 333456889999999975 59999999999999999999999998766666788888766544
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
...|.++++||.+||+ +|.+|+++.+++.||||
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 5679999999999999 99999999999999999
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=253.03 Aligned_cols=186 Identities=20% Similarity=0.322 Sum_probs=156.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++++.. ....++++||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+
T Consensus 71 ~~~~~~~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~ 146 (283)
T cd05048 71 VCLLGVCTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FV 146 (283)
T ss_pred ceEEEEEcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 478888776 57899999999999999999875 45788999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++. .+.++|+|||++....... .....+++.|+|||++. ..++.++|||||||++|||++ |..
T Consensus 147 H~dlkp~Nil~~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~ 225 (283)
T cd05048 147 HRDLAARNCLVGE-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQ 225 (283)
T ss_pred ccccccceEEEcC-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCC
Confidence 9999999999985 4789999999997653321 22345788999999876 568999999999999999998 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.+ .+..++...+..+..+. .....++++.+|+.+||. +|.+||++.+++++
T Consensus 226 p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 226 PYYG-FSNQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCCC-CCHHHHHHHHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9987 44567777777766543 345678999999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=253.99 Aligned_cols=194 Identities=25% Similarity=0.434 Sum_probs=158.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.. .+.+++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+.+ ++||||+|+|||++.
T Consensus 56 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~- 130 (277)
T cd05577 56 VSLAYAFET--KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDD- 130 (277)
T ss_pred eeeeeEEec--CCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECC-
Confidence 467777766 679999999999999999998765 7999999999999999999999999 999999999999985
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC---HHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~---~~qi~kki 153 (654)
.+.++|+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+
T Consensus 131 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 210 (277)
T cd05577 131 HGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT 210 (277)
T ss_pred CCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc
Confidence 4799999999997764322 223458899999998864 488899999999999999999999976432 22222222
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.. .+...+...++.++++|.+||+ +|.+|| ++.+++.||||...++
T Consensus 211 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 211 LE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred cc--ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 21 2333455678999999999999 899999 9999999999976544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=254.39 Aligned_cols=193 Identities=26% Similarity=0.445 Sum_probs=154.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-----KHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~-----k~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNIL 74 (654)
|++|+.+.. ....+++|||+. ++|.++.. ....+++..+..++.|++.||+|||+. + |+||||||+|||
T Consensus 66 v~~~~~~~~--~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil 140 (288)
T cd06616 66 VKFYGALFR--EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNIL 140 (288)
T ss_pred eeeeeEEec--CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEE
Confidence 578898876 678899999995 56655432 235799999999999999999999975 7 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
++. .+.+||+|||++..+.... .....|++.|+|||++.. .++.++||||||+++|+|++|+.||.........
T Consensus 141 ~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 219 (288)
T cd06616 141 LDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ 219 (288)
T ss_pred Ecc-CCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH
Confidence 985 4789999999998765432 233468999999999864 4888999999999999999999999775533333
Q ss_pred HHHHHcCCCCccc---ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 150 YKKVISGKKPEAL---FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 150 ~kki~~G~~p~~l---~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..++..+..|... ....++++.+||.+||. +|.+|||+.+++.||||+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 220 LTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 3444444433222 22368899999999999 89999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=254.02 Aligned_cols=197 Identities=28% Similarity=0.530 Sum_probs=159.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.|.+.....+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++
T Consensus 62 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~ 139 (287)
T cd06621 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT 139 (287)
T ss_pred eeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe
Confidence 578888887666789999999999999998754 345899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC----CCHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC----THPAQIYK 151 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~----~~~~qi~k 151 (654)
.+ +.++|+|||++............++..|+|||.+.+ .++.++||||||+++|+|++|..||... ....++..
T Consensus 140 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (287)
T cd06621 140 RK-GQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218 (287)
T ss_pred cC-CeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence 54 789999999987655444344568899999998864 5889999999999999999999999764 23334444
Q ss_pred HHHcCCCCcc---cc--cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 152 KVISGKKPEA---LF--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 152 ki~~G~~p~~---l~--~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+.....+.. .. ...++.+++||.+||. +|.+|||+.|++.||||+...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 4443222211 11 1235789999999999 899999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=281.50 Aligned_cols=191 Identities=28% Similarity=0.477 Sum_probs=163.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|.|-|+|.- ..+.|||||||- |+-.+++.-+ +++.+..|..++.+.+.||+|||+++ .||||||..|||++ +.
T Consensus 89 ieYkgCyLr--e~TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~ 162 (948)
T KOG0577|consen 89 IEYKGCYLR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EP 162 (948)
T ss_pred ccccceeec--cchHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CC
Confidence 456777776 678999999994 6888887765 47999999999999999999999999 99999999999998 55
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
|.|||+|||.|.+.. +..+++|||.||||||+. ++|+.++|||||||+-.||.-.++|+.+.+-...+|. |.+
T Consensus 163 g~VKLaDFGSAsi~~--PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQ 239 (948)
T KOG0577|consen 163 GLVKLADFGSASIMA--PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQ 239 (948)
T ss_pred CeeeeccccchhhcC--chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHh
Confidence 899999999998864 456889999999999884 6799999999999999999999999988665666654 444
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
...|.-.....+..++.||..||+ -|.+|||+++||+|+|+....
T Consensus 240 NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 240 NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 444544455678899999999999 599999999999999997553
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=253.07 Aligned_cols=183 Identities=21% Similarity=0.292 Sum_probs=151.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. ...+++||||+.||+|.+++.+...+++..+..|+.||+.||.|||+.+ |+||||||+||+++.+ +
T Consensus 48 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~ 122 (237)
T cd05576 48 VCLHKYIVS--EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-G 122 (237)
T ss_pred eehhhheec--CCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-C
Confidence 467777766 6899999999999999999988888999999999999999999999998 9999999999999855 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.++++|||++....... ....+++.|+|||.+. ..++.++|+||+|+++|+|++|..|+...... + .....
T Consensus 123 ~~~l~df~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~-----~~~~~ 194 (237)
T cd05576 123 HIQLTYFSRWSEVEDSC-DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--I-----NTHTT 194 (237)
T ss_pred CEEEecccchhcccccc-ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c-----ccccc
Confidence 89999999887654432 2344678899999886 45888999999999999999999988643211 1 11111
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCH-----HHHhcCccc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSA-----RELLTDPFL 196 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa-----~ELL~HPFf 196 (654)
..++...++.++++|.+||+ +|.+|+++ .++++||||
T Consensus 195 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 195 LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 12344578899999999999 89999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=246.13 Aligned_cols=186 Identities=23% Similarity=0.367 Sum_probs=159.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
+++++.+.. ...+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 59 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~ 134 (262)
T cd00192 59 VRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAAR 134 (262)
T ss_pred heeeeeecC--CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcc
Confidence 477887776 78999999999999999999885 67999999999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCC
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTH 145 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~ 145 (654)
|||++.+ +.++|+|||.+....... .....+++.|+|||.+.. .++.++||||||+++|+|++ |..||... .
T Consensus 135 nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~ 212 (262)
T cd00192 135 NCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-S 212 (262)
T ss_pred eEEECCC-CcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-C
Confidence 9999855 799999999998765432 233457899999998874 58899999999999999999 69999874 5
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 146 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 146 ~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..++...+..+.... .....++++.+++.+||. +|.+||++.+++++
T Consensus 213 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 213 NEEVLEYLRKGYRLP-KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHHHcCCCCC-CCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 667777777654432 345568999999999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=253.17 Aligned_cols=194 Identities=26% Similarity=0.373 Sum_probs=151.6
Q ss_pred CEEEEEEEecCC---CeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTAN---RNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~~---~~i~LVtEy~~gGSL~~~l~k~-----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeN 72 (654)
+++++.+..... ..+|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 64 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~n 140 (295)
T cd07837 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQN 140 (295)
T ss_pred cceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHH
Confidence 467777766321 248999999975 899987653 35899999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
||++.+.+.+||+|||++..+... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||........
T Consensus 141 il~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~ 220 (295)
T cd07837 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ 220 (295)
T ss_pred EEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 999864689999999998765332 1223457899999998753 478999999999999999999999987555444
Q ss_pred HHHHHHc-CCCC------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 149 IYKKVIS-GKKP------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 149 i~kki~~-G~~p------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
..+.+.. +..+ ....+..++++++||.+||. +|.+||++.++|.||||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 221 LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3322211 0000 01113467889999999999 899999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=255.16 Aligned_cols=195 Identities=24% Similarity=0.402 Sum_probs=157.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ++.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 63 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~ 138 (285)
T cd05632 63 VNLAYAYET--KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY 138 (285)
T ss_pred eeEEEEEec--CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC
Confidence 356666665 68999999999999999888653 36999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHH---HHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~---qi~kki 153 (654)
+.++|+|||++...... ......|++.|+|||++. ..++.++|+||||+++|+|++|..||....... .+...+
T Consensus 139 -~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~ 217 (285)
T cd05632 139 -GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV 217 (285)
T ss_pred -CCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence 78999999998765332 223456999999999886 458899999999999999999999998643322 222222
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
..+. ..+....++++.+|+.+||+ +|.+||+ +.+++.|+||+..+..
T Consensus 218 ~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 218 LETE--EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred hccc--cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 2222 22345578899999999999 8999999 8999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=251.87 Aligned_cols=195 Identities=36% Similarity=0.581 Sum_probs=161.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ...+++|+||+.+++|.+++..+. .++...+..++.||+.||.|||+.+ |+|+||+|+||+++. .
T Consensus 78 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~-~ 152 (286)
T cd06614 78 VDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSK-D 152 (286)
T ss_pred eEEEEEEEE--CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcC-C
Confidence 478998888 689999999999999999999876 8999999999999999999999998 999999999999984 4
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.++|+|||++....... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||..... ......+...
T Consensus 153 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-~~~~~~~~~~ 231 (286)
T cd06614 153 GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-LRALFLITTK 231 (286)
T ss_pred CCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc
Confidence 799999999987654322 223458899999998864 488999999999999999999999986443 3333333333
Q ss_pred CCC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 157 KKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 157 ~~p-~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
..+ .......+..++++|.+||. +|.+||++.++|.||||+....
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 222 22223367899999999999 8999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=250.13 Aligned_cols=191 Identities=29% Similarity=0.494 Sum_probs=157.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. ...+++|+||+.+|+|.+++.+...+++..++.++.||+.||.|||+++ ++||||||+||+++. .+
T Consensus 71 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~-~~ 145 (272)
T cd06629 71 VQYLGFETT--EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDA-DG 145 (272)
T ss_pred ceEEEEecc--CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcC-CC
Confidence 478887766 6899999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhccc----CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
.++|+|||++...... ......|++.|+|||++.. .++.++|+||||+++|+|++|..||........+....
T Consensus 146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 225 (272)
T cd06629 146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG 225 (272)
T ss_pred eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh
Confidence 9999999999765432 1223458899999998863 37889999999999999999999997654444443322
Q ss_pred HcCC---CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 ISGK---KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~G~---~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.... .+.......+.+++++|.+||. +|.+||++.++|.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 2221 2233334568899999999999 89999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=247.40 Aligned_cols=189 Identities=28% Similarity=0.543 Sum_probs=160.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. .+.+++|+||+.+++|.+++.... .+++..+..|+.||+.||.|||+++ ++|+||+|+|||++.+
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~ 137 (256)
T cd08218 62 VQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD 137 (256)
T ss_pred eeeEeeecC--CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC
Confidence 467887766 689999999999999999987643 5899999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++....... .....|++.|+|||++.+ .++.++|+||||+++++|++|..||.. .+...++..+..
T Consensus 138 -~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~ 215 (256)
T cd08218 138 -GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIR 215 (256)
T ss_pred -CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhc
Confidence 789999999997654322 223458999999998864 478899999999999999999999976 455666667777
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+. .....+.+++++|.+||. +|.+||++.++|.||||
T Consensus 216 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 GSYPP-VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCCCC-CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 76553 344578899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=247.25 Aligned_cols=190 Identities=35% Similarity=0.601 Sum_probs=157.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. ...+++|+||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. .+
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~-~~ 136 (264)
T cd06626 62 VKYYGVEVH--REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDH-NG 136 (264)
T ss_pred hheeeeEec--CCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECC-CC
Confidence 467777665 6899999999999999999988878999999999999999999999999 999999999999985 57
Q ss_pred cEEEEecCchhhhcccCC------ccccCCCCccChhhhccc----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 81 EVKIGDLGLAAILRKSHA------ARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~------~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
.+||+|||++........ ....+++.|+|||++... ++.++||||||+++|+|++|..||....+.....
T Consensus 137 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~ 216 (264)
T cd06626 137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216 (264)
T ss_pred CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH
Confidence 999999999987654321 123578999999988642 7889999999999999999999997655444444
Q ss_pred HHHHcCCCCccccc--CCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 151 KKVISGKKPEALFK--VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 151 kki~~G~~p~~l~~--~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+..+..+. ++. ..++.+++||.+||+ +|.+||++.+++.|||+
T Consensus 217 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGAGHKPP-IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHhcCCCCC-CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 4444443322 222 348899999999998 89999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=251.96 Aligned_cols=192 Identities=33% Similarity=0.550 Sum_probs=157.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. +..+++||||+.|++|.+++.. +.+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. .+
T Consensus 65 i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~-~~ 138 (277)
T cd06917 65 TKYYGSYLK--GPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTN-TG 138 (277)
T ss_pred eeEeeeeee--CCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcC-CC
Confidence 478888876 6799999999999999999866 47999999999999999999999998 999999999999985 57
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.++|+|||++..+.... .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||..... ......+...
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~ 217 (277)
T cd06917 139 NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLIPKS 217 (277)
T ss_pred CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhccccC
Confidence 99999999997765432 233468999999998864 368899999999999999999999976432 2222222222
Q ss_pred CCCccccc-CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KKPEALFK-VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~p~~l~~-~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+..+.. ..++++.++|.+||. +|.+||++.+++.||||+...
T Consensus 218 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 -KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 2222322 367899999999999 899999999999999997543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=258.23 Aligned_cols=193 Identities=26% Similarity=0.463 Sum_probs=154.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.. ...+++++||+.+|+|.+++.++ ..+++..+..+++||+.||.|||+++ |+||||||+|||++.
T Consensus 62 ~~~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~- 136 (314)
T cd08216 62 LPYVTSFIV--DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSG- 136 (314)
T ss_pred hhhhheeec--CCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEec-
Confidence 467888877 68899999999999999998864 46899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccC---------CccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 79 QGEVKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
.+.+||+|||.+..+.... .....+++.|+|||++.. .|+.++||||||+++|+|++|..||......
T Consensus 137 ~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred CCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4799999999886543211 122347889999999864 3888999999999999999999999875544
Q ss_pred HHHHHHHHcCCCCc--------------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 147 AQIYKKVISGKKPE--------------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 147 ~qi~kki~~G~~p~--------------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.....++. +..+. ......+.++++||.+||. +|.+|||+.++|.|
T Consensus 217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 217 QMLLEKVR-GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHHHHHHh-ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 44433332 11110 0011224678899999999 89999999999999
Q ss_pred cccccC
Q 006244 194 PFLQID 199 (654)
Q Consensus 194 PFf~~~ 199 (654)
|||+..
T Consensus 296 p~~~~~ 301 (314)
T cd08216 296 SFFKQC 301 (314)
T ss_pred chHhhh
Confidence 999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=241.55 Aligned_cols=189 Identities=33% Similarity=0.589 Sum_probs=156.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ....++|+||+.+++|.+++... +.+++..+..++.||+.||.|||..+ ++|+||+|+||+++. .
T Consensus 60 ~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~-~ 134 (253)
T cd05122 60 VKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTS-D 134 (253)
T ss_pred eEEEEEEec--CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEcc-C
Confidence 467888777 68999999999999999998876 67999999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 80 GEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+.++|+|||.+....... .....|+..|+|||.+.. .++.++|+||||+++|+|++|..||........+..... ..
T Consensus 135 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~ 213 (253)
T cd05122 135 GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NG 213 (253)
T ss_pred CeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cC
Confidence 799999999998765543 334568999999998864 478899999999999999999999987544443333222 22
Q ss_pred CCccccc-CCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 158 KPEALFK-VEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 158 ~p~~l~~-~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
.+..... ..+..++++|.+||. +|.+|||+.++|.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 2222222 237889999999999 8999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=263.47 Aligned_cols=186 Identities=27% Similarity=0.499 Sum_probs=164.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
++++++||||..||.|.-.+.+.+.+++...+.|-..|+.||.|||+++ ||+||||.+|+|+|. +|++||+||||++
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDk-DGHIKitDFGLCK 316 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDK-DGHIKITDFGLCK 316 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheecc-CCceEeeecccch
Confidence 7899999999999999999999999999999999999999999999999 999999999999985 5899999999997
Q ss_pred hhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 006244 92 ILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 168 (654)
Q Consensus 92 ~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~sp 168 (654)
.-- .....+++|||.|+|||++.. .|+.++|.|.+|+++|||++|+.||.+ .+...++..|..+... ++...++
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~ed~k--FPr~ls~ 393 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILMEDLK--FPRTLSP 393 (516)
T ss_pred hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhhhcc--CCccCCH
Confidence 532 234557899999999999986 499999999999999999999999987 4456677777655432 4567899
Q ss_pred HHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcch
Q 006244 169 EVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYDS 203 (654)
Q Consensus 169 elrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~~ 203 (654)
+++.|+..+|. +|.+|+. |.|+..|+||...++..
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 99999999999 8999974 89999999999887753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=246.80 Aligned_cols=190 Identities=30% Similarity=0.532 Sum_probs=158.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ...+++|+||+.+++|.+++.+.. .+++..+..|+.||+.||.|||+.+ |+|+||||+||+++.+
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~ 137 (257)
T cd08225 62 VTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKN 137 (257)
T ss_pred hhhhheecc--CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCC
Confidence 457777766 689999999999999999987654 4799999999999999999999998 9999999999999866
Q ss_pred CCcEEEEecCchhhhcccCC--ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~--~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
...+||+|||.+........ ....|++.|+|||++.. .++.++|+||||+++|+|++|..||... +.......+..
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~ 216 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQ 216 (257)
T ss_pred CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhc
Confidence 55679999999987654321 23458999999998864 5889999999999999999999999764 44555555555
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+. .....+.+++++|.+||. +|.+|||+.++++||||
T Consensus 217 ~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 217 GYFAP-ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 44332 334567899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=253.73 Aligned_cols=193 Identities=24% Similarity=0.386 Sum_probs=155.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.+ ...+++||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~- 138 (298)
T cd07841 65 IGLLDVFGH--KSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD- 138 (298)
T ss_pred hhhhheeec--CCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-
Confidence 467788877 68999999999 999999998766 7999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|.+||....... .+.++..
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~ 217 (298)
T cd07841 139 GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFE 217 (298)
T ss_pred CCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHH
Confidence 799999999997765432 223357889999998753 47889999999999999999988887644333 2333321
Q ss_pred CC-CC-------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GK-KP-------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~-~p-------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. .+ .......+..+++||.+||. +|.+|||+.++|.||||+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 10 00 01123346789999999999 899999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=254.65 Aligned_cols=195 Identities=23% Similarity=0.278 Sum_probs=155.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.++....+.+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++. .
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~-~ 144 (309)
T cd07845 69 VELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTD-K 144 (309)
T ss_pred cceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECC-C
Confidence 46888888755578999999996 5898888764 57999999999999999999999999 999999999999984 4
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.... ....+..+..
T Consensus 145 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-~~~~~~~~~~ 223 (309)
T cd07845 145 GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-EIEQLDLIIQ 223 (309)
T ss_pred CCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHH
Confidence 79999999999876543 2223346889999998864 47899999999999999999999998744 4444443332
Q ss_pred CC--CCcc--------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GK--KPEA--------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~--~p~~--------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. .+.. .....++++++||.+||. +|.+|||+.++|.||||+...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 10 0000 012247889999999999 899999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.74 Aligned_cols=193 Identities=34% Similarity=0.583 Sum_probs=157.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.. ++.+++|+||+++++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+
T Consensus 81 ~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~-~~ 154 (297)
T cd06659 81 VEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTL-DG 154 (297)
T ss_pred hhhhhheee--CCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEcc-CC
Confidence 356777776 6899999999999999998755 56899999999999999999999999 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..+.... .....|++.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......+....
T Consensus 155 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~ 233 (297)
T cd06659 155 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSP 233 (297)
T ss_pred cEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccC
Confidence 99999999997654322 233568999999998864 58899999999999999999999997643 344444444332
Q ss_pred CC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p-~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+ .......++.++++|.+||. +|.+||++.++++||||....
T Consensus 234 ~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 234 PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 22 12233467899999999999 899999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=251.98 Aligned_cols=190 Identities=27% Similarity=0.426 Sum_probs=152.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.+ .+.+++||||+. ++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.+
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~ 136 (284)
T cd07860 62 VKLLDVIHT--ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE 136 (284)
T ss_pred cchhhhccc--CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC
Confidence 466777765 679999999995 6899998763 46899999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC--CccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++....... .....+++.|+|||++.+. ++.++||||||+++|+|+||..||........+.+.+.
T Consensus 137 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 137 -GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred -CCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 799999999987654322 2234578999999987642 68889999999999999999999987554444443332
Q ss_pred cCCCCc--------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 155 SGKKPE--------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~~p~--------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
....+. .+.+..+++++++|.+||. +|.+|||+.++|+||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 216 TLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 211110 1123467889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=249.97 Aligned_cols=187 Identities=30% Similarity=0.479 Sum_probs=155.8
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 82 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~V 82 (654)
+++.|.. ...+++|+||+.|++|.+++.+...+++..+..|+.||+.||.|||+++ ++|+||||+|||++. .+.+
T Consensus 65 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~-~~~~ 139 (258)
T cd05578 65 LWYSFQD--EENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDE-QGHV 139 (258)
T ss_pred HHHhhcC--CCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcC-CCCE
Confidence 4455544 6789999999999999999988778999999999999999999999998 999999999999985 4799
Q ss_pred EEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcCCC
Q 006244 83 KIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISGKK 158 (654)
Q Consensus 83 KL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~--~~qi~kki~~G~~ 158 (654)
+|+|||++...... ......|+..|+|||++.. .++.++|+||||+++|+|++|..||..... ...+...... .
T Consensus 140 ~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~ 217 (258)
T cd05578 140 HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--A 217 (258)
T ss_pred EEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--c
Confidence 99999998876543 2233458899999998864 478999999999999999999999987543 3333333322 2
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCH--HHHhcCccc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSA--RELLTDPFL 196 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa--~ELL~HPFf 196 (654)
....+...+..+.++|.+||. +|.+||++ .|+++||||
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 233445567899999999999 89999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=248.28 Aligned_cols=185 Identities=23% Similarity=0.389 Sum_probs=155.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHR 66 (654)
+++|+++.. ....++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ ++||
T Consensus 71 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~ 146 (280)
T cd05049 71 VKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHR 146 (280)
T ss_pred hheeeEEec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecc
Confidence 468888877 589999999999999999997643 3788999999999999999999998 9999
Q ss_pred CCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCC
Q 006244 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPY 140 (654)
Q Consensus 67 DLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf 140 (654)
||||+|||++.+ +.+||+|||++....... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||
T Consensus 147 dlkp~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~ 225 (280)
T cd05049 147 DLATRNCLVGYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred ccccceEEEcCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCC
Confidence 999999999855 899999999987543221 223346789999998864 58999999999999999998 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 141 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 141 ~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
... +.......+..+..+. .....+..++++|.+||. +|.+||++.|+++
T Consensus 226 ~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 226 YGL-SNEEVIECITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCC-CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 774 4556667777666543 334678899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=242.48 Aligned_cols=189 Identities=30% Similarity=0.561 Sum_probs=160.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.+.. ...+++|+||+++++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~ 137 (258)
T cd08215 62 IKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT 137 (258)
T ss_pred hheEEEEec--CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc
Confidence 357777777 58999999999999999998874 67999999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
. .+.++|+|||++....... .....|++.|+|||.+.. .++.++|+||+|+++++|++|..||... +...+....
T Consensus 138 ~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~ 215 (258)
T cd08215 138 S-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKI 215 (258)
T ss_pred C-CCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHH
Confidence 5 4799999999997765432 233468999999998764 4888999999999999999999999764 456666666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+.. ..+....+..++++|.+||. +|.+|||+.++|.||||
T Consensus 216 ~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 216 LKGQY-PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred hcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 65543 33445678899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=273.10 Aligned_cols=192 Identities=29% Similarity=0.402 Sum_probs=152.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. ++..+||+|++ .|+|..++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 223 v~l~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~- 296 (461)
T PHA03211 223 LALLDVRVV--GGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP- 296 (461)
T ss_pred CcEEEEEEE--CCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-
Confidence 578998877 68899999999 57999888764 46999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-------CHH
Q 006244 80 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-------HPA 147 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-------~~~ 147 (654)
+.+||+|||+++.+.... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... ...
T Consensus 297 ~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~ 376 (461)
T PHA03211 297 EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDA 376 (461)
T ss_pred CCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHH
Confidence 789999999998664322 123469999999999875 48999999999999999999876653211 123
Q ss_pred HHHHHHHcCCCCc-c-----------------------------c--ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 148 QIYKKVISGKKPE-A-----------------------------L--FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 148 qi~kki~~G~~p~-~-----------------------------l--~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
++.+.+..+.... . + ....++.+++||.+||+ +|.+|||+.|||+||
T Consensus 377 ~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 377 QILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred HHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 4444443322110 0 0 01245689999999999 999999999999999
Q ss_pred cccc
Q 006244 195 FLQI 198 (654)
Q Consensus 195 Ff~~ 198 (654)
||+.
T Consensus 457 ~f~~ 460 (461)
T PHA03211 457 LFQS 460 (461)
T ss_pred ccCC
Confidence 9963
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=250.36 Aligned_cols=185 Identities=24% Similarity=0.409 Sum_probs=155.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRD 67 (654)
+++++++.. ...+++|+||+.+|+|.+++..++ .+++..+..++.||+.||+|||+++ ++|||
T Consensus 70 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~d 145 (288)
T cd05093 70 VKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRD 145 (288)
T ss_pred ceEEEEEec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence 578888876 689999999999999999997654 3899999999999999999999998 99999
Q ss_pred CCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCC
Q 006244 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYS 141 (654)
Q Consensus 68 LKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~ 141 (654)
|||+|||++. .+.+||+|||++....... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||.
T Consensus 146 lkp~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~ 224 (288)
T cd05093 146 LATRNCLVGE-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 224 (288)
T ss_pred cCcceEEEcc-CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999985 4799999999997653321 122346788999998874 58899999999999999998 899997
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.. +...+...+..+..+. .....++++.+|+.+||. +|.+|||+.+++.
T Consensus 225 ~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 225 QL-SNNEVIECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CC-CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 64 4556667777776543 344578899999999999 8999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=247.70 Aligned_cols=185 Identities=18% Similarity=0.281 Sum_probs=153.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. +..++|||||+.+|+|.+++.++ ..+++..+..++.||+.||+|||+++ ++||||||+|||++.+
T Consensus 69 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~- 143 (266)
T cd05064 69 VRLEGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD- 143 (266)
T ss_pred CeEEEEEec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-
Confidence 578888876 68999999999999999998875 47899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.++++|||++........ ....+++.|+|||++. ..++.++||||||+++|++++ |..||... +...+.+.+.
T Consensus 144 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~ 222 (266)
T cd05064 144 LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVE 222 (266)
T ss_pred CcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHH
Confidence 7999999998765432211 1223567899999876 458999999999999999775 99999874 4455666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+. .+...+..+.+++.+||. +|.+||++.+|++
T Consensus 223 ~~~~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 223 DGFRLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 664433 455678899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=250.33 Aligned_cols=185 Identities=26% Similarity=0.440 Sum_probs=154.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++++.. ....++||||+++|+|.+++..++ .+++..+..++.||+.||+|||+++ |+
T Consensus 70 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~ 145 (291)
T cd05094 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FV 145 (291)
T ss_pred ceEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 578888776 678999999999999999997643 3889999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.++|+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|+| |..
T Consensus 146 H~dlkp~Nil~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 224 (291)
T cd05094 146 HRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224 (291)
T ss_pred ecccCcceEEEccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999854 799999999997653321 22345788999999876 458889999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
||... +.......+..+..+. .....+..+++++.+||. +|.+||++.++++
T Consensus 225 p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 225 PWFQL-SNTEVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCC-CHHHHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 99764 4455566666665543 344568899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=250.15 Aligned_cols=191 Identities=25% Similarity=0.320 Sum_probs=153.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.......+++|+||+. ++|.+++.... .+++..++.++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~- 142 (293)
T cd07843 67 VTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR- 142 (293)
T ss_pred EEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-
Confidence 46888888755589999999996 59999987654 5999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ..++..
T Consensus 143 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~ 221 (293)
T cd07843 143 GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFK 221 (293)
T ss_pred CcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH
Confidence 79999999999876543 2233458899999998864 368899999999999999999999986543332 222221
Q ss_pred CCC-----------------------------CcccccC-CChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKK-----------------------------PEALFKV-EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~-----------------------------p~~l~~~-~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
... ...+... .++.++++|.+||+ +|++|||+.|+|.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 100 0011111 47889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=248.48 Aligned_cols=191 Identities=26% Similarity=0.422 Sum_probs=154.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. ++.+++|+||+.++.|..++.+...+++..+..++.||+.||.|||+++ |+|+||+|+||+++. .+
T Consensus 63 ~~~~~~~~~--~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~-~~ 137 (288)
T cd07833 63 VNLKEAFRR--KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSE-SG 137 (288)
T ss_pred eehhheEEE--CCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CC
Confidence 467787776 6899999999998888877766677999999999999999999999998 999999999999985 57
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+||+|||++....... ....++++.|+|||++.+ .++.++||||||+++|+|++|.+||........+......
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (288)
T cd07833 138 VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC 217 (288)
T ss_pred CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999998765432 234568999999998863 4788999999999999999999999875544433322110
Q ss_pred -CCCC-------------------c---------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 -GKKP-------------------E---------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 -G~~p-------------------~---------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
+..+ . ......++++++||.+||. +|.+||++.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred hCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000 0 1122347889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=244.44 Aligned_cols=184 Identities=21% Similarity=0.357 Sum_probs=154.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+. ....++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||.|||++.+ +
T Consensus 59 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~ 132 (257)
T cd05116 59 VRMIGICE---AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-H 132 (257)
T ss_pred ceEEEEEc---CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-C
Confidence 46777654 3578999999999999999988888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCC-----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+||+|||++..+..... ....+++.|+|||++.. .++.++||||||+++|||++ |..||.. .+...+...+
T Consensus 133 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i 211 (257)
T cd05116 133 YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMI 211 (257)
T ss_pred eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 899999999987643321 12234679999998864 58889999999999999998 9999976 4456677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .+...+++++++|.+||+ +|.+||++.++..
T Consensus 212 ~~~~~~~-~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 212 ESGERME-CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HCCCCCC-CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 7766543 455678999999999999 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=264.67 Aligned_cols=186 Identities=21% Similarity=0.351 Sum_probs=151.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------------------------------------
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------------------------------------------- 34 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------------------------------------------- 34 (654)
|+++++|.. ...++||||||.+|+|.+++.+.
T Consensus 105 v~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 105 VNLLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred eeEeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 578898877 67999999999999999998653
Q ss_pred ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 35 ------------------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 35 ------------------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
.++++..+.+++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~-~~~~kL~DfGla 259 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTD-GRVAKICDFGLA 259 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeC-CCeEEEeeceee
Confidence 14788899999999999999999998 999999999999984 479999999999
Q ss_pred hhhcccCCc----cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 006244 91 AILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFK 164 (654)
Q Consensus 91 ~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~ 164 (654)
+.+...... ...+++.|||||++. ..++.++||||||+++|+|++ |..||........+++.+..+..+ ....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~ 338 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPD 338 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCC
Confidence 765432211 223566899999886 459999999999999999997 999998755444444444444332 3344
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 165 VEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 165 ~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+++++++|.+||. +|.+||++.++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 568999999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=248.85 Aligned_cols=193 Identities=30% Similarity=0.522 Sum_probs=159.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+ ...+++||||+.||+|.+++.. +++++..+..++.|++.||.|||+.+ ++|+||+|+||+++. .+
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~-~~ 138 (277)
T cd06640 65 TKYYGSYLK--GTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSE-QG 138 (277)
T ss_pred eeEEEEEEE--CCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcC-CC
Confidence 478888877 6899999999999999999865 56899999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....++..|+|||++.. .++.++|+||||+++|+|++|..||.... +......+..+.
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~ 217 (277)
T cd06640 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKNN 217 (277)
T ss_pred CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcCC
Confidence 99999999997654322 223458899999998864 48889999999999999999999998744 333333333333
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+..+....+..+.++|.+||. +|.+||++.+++.||||.....
T Consensus 218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 218 -PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred -CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 334455677899999999999 8999999999999999975543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=254.79 Aligned_cols=194 Identities=33% Similarity=0.546 Sum_probs=157.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. .+.+|+|+||+.+|+|.+++.+. .+++..+..++.||+.||.|||+++ ++||||||+||+++. .+
T Consensus 79 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~-~~ 152 (293)
T cd06647 79 VNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGM-DG 152 (293)
T ss_pred eehhheeee--CCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcC-CC
Confidence 467788877 67899999999999999998764 5889999999999999999999999 999999999999984 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....|++.|+|||++.. .++.++|+||||+++|+|++|..||.......++......+.
T Consensus 153 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~ 232 (293)
T cd06647 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (293)
T ss_pred CEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC
Confidence 99999999887654322 223468999999998764 588899999999999999999999987544443332222232
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.........+..++++|.+||. +|.+||++.+++.||||+...
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 2222334457889999999999 899999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=240.05 Aligned_cols=189 Identities=33% Similarity=0.563 Sum_probs=159.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.. .+.+++|+||+.+++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+||+++. .+
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~-~~ 136 (254)
T cd06627 62 VKYIGSIET--SDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTK-DG 136 (254)
T ss_pred cEEEEEEEe--CCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECC-CC
Confidence 467777766 6899999999999999999998888999999999999999999999998 999999999999985 57
Q ss_pred cEEEEecCchhhhcccCC--ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~--~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++........ ....+++.|+|||.+.. .++.++|+||||+++|+|++|..||..........+ ...+.
T Consensus 137 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~ 215 (254)
T cd06627 137 VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDD 215 (254)
T ss_pred CEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccC
Confidence 999999999987654333 33458999999998764 478899999999999999999999976554333333 33333
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.+ .+....+..++++|.+||. +|.+||++.+++.||||
T Consensus 216 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 HP-PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CC-CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 32 3455678899999999999 89999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=248.87 Aligned_cols=194 Identities=23% Similarity=0.422 Sum_probs=159.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. +..+++|+||+.+|+|.+++.....+++..+..++.||+.||.|||+.+ ++||||||+|||++. .+
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~-~~ 142 (290)
T cd05613 68 VTLHYAFQT--DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDS-NG 142 (290)
T ss_pred hceeeEeec--CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECC-CC
Confidence 356777766 6789999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCC---CHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~---~~~qi~k 151 (654)
.+||+|||++....... .....|++.|+|||++.. .++.++||||||+++|+|++|..||.... ....+..
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 222 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR 222 (290)
T ss_pred CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH
Confidence 99999999997654321 223468999999998863 36789999999999999999999996422 2233444
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.+..+..+ +....++.+++++.+||. +|.+|+ ++.+++.||||+..++
T Consensus 223 ~~~~~~~~--~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 223 RILKSEPP--YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred HhhccCCC--CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 44333332 345578999999999999 899997 8999999999987664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=248.62 Aligned_cols=194 Identities=26% Similarity=0.363 Sum_probs=153.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.+ ...+++||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++..
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~ 138 (294)
T PLN00009 64 VRLQDVVHS--EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRR 138 (294)
T ss_pred eeEEEEEec--CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECC
Confidence 578898877 689999999995 68888876644 3688899999999999999999998 9999999999999866
Q ss_pred CCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|+||.+||........+.+.+.
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~ 218 (294)
T PLN00009 139 TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218 (294)
T ss_pred CCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 568999999999765332 1233467899999998864 478899999999999999999999976544444433221
Q ss_pred c-CCCCc-------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 S-GKKPE-------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~-G~~p~-------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. +.... ...+..+++++++|.+||. +|.+||++.++|.||||..-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 219 ILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred HhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 1 11000 0123457889999999999 89999999999999999743
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=245.49 Aligned_cols=187 Identities=24% Similarity=0.330 Sum_probs=148.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-----~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++++.+.. ...+++||||+.+|+|.+++...+ ..++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 58 i~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill 133 (269)
T cd05042 58 LQCLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQL 133 (269)
T ss_pred ceEEEEECC--CCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEe
Confidence 578888876 678999999999999999998753 2467888999999999999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc--------cCCcccchhhhhhHHHHHhh-cCCCCCC
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSE 142 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGiiL~ELlT-G~~Pf~~ 142 (654)
+.+ +.+||+|||++....... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||..
T Consensus 134 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 134 TAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred cCC-CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 854 799999999986532211 122346778999998742 36779999999999999999 7889987
Q ss_pred CCCHHHHHHHHHcCCCC---cccccCCChHHHHHHHHHhhCccCCCCHHHHhc
Q 006244 143 CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLATVSSRLSARELLT 192 (654)
Q Consensus 143 ~~~~~qi~kki~~G~~p---~~l~~~~spelrdLI~kCL~dP~~RpTa~ELL~ 192 (654)
..+...+...+..+..+ ..+....++.++.++..|+.+|.+|||+++|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 213 LSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 55444444444433221 223345678899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-28 Score=242.28 Aligned_cols=187 Identities=30% Similarity=0.494 Sum_probs=157.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.. ++.+++|+||+++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+|+||||+|||++.
T Consensus 61 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~- 135 (255)
T cd08219 61 VAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQ- 135 (255)
T ss_pred ceEEEEEEE--CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECC-
Confidence 468888877 78999999999999999998753 35899999999999999999999999 999999999999985
Q ss_pred CCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+.++|+|||++....... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+..
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~ 214 (255)
T cd08219 136 NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQ 214 (255)
T ss_pred CCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhc
Confidence 4799999999997664322 233568999999999875 488899999999999999999999986 455555666666
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
+..+. ++...+..+++||.+||. +|.+||++.+++.--
T Consensus 215 ~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 215 GSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred CCCCC-CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 65432 345678899999999999 899999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=248.25 Aligned_cols=193 Identities=22% Similarity=0.381 Sum_probs=156.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
+++++++.. ....++||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+||||||
T Consensus 72 ~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp 147 (288)
T cd05061 72 VRLLGVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAA 147 (288)
T ss_pred eeEEEEEcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCCh
Confidence 478888766 678999999999999999997632 3466788999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++.+ +.++|+|||+++...... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||.. .
T Consensus 148 ~nili~~~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~ 225 (288)
T cd05061 148 RNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-L 225 (288)
T ss_pred heEEEcCC-CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-C
Confidence 99999854 799999999987653321 12234567899999886 458999999999999999998 7889976 4
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc------CcccccCC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT------DPFLQIDD 200 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~------HPFf~~~~ 200 (654)
...++.+.+..+..+. .....++.++++|.+||. +|.+|||+.++++ ||||+..+
T Consensus 226 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 226 SNEQVLKFVMDGGYLD-QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 4556666666654443 234457899999999999 8999999999986 89887543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=248.55 Aligned_cols=190 Identities=26% Similarity=0.393 Sum_probs=149.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ++..++||||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 66 ~~~~~~~~~--~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~- 139 (291)
T cd07844 66 VTLHDIIHT--KKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER- 139 (291)
T ss_pred eeEEEEEec--CCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-
Confidence 467888776 689999999997 5999998764 46899999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||..........+.+..
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 219 (291)
T cd07844 140 GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219 (291)
T ss_pred CCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 79999999998754322 1222357889999998854 4788999999999999999999999765533332222211
Q ss_pred C--CC-----------------------Cc---ccccCCC--hHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 G--KK-----------------------PE---ALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G--~~-----------------------p~---~l~~~~s--pelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
. .. +. ......+ +++.++|.+||. +|.+|||+.++|.||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 220 VLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 00 00 0011223 788999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=267.41 Aligned_cols=186 Identities=27% Similarity=0.479 Sum_probs=158.4
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecC
Q 006244 11 ANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 88 (654)
Q Consensus 11 ~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFG 88 (654)
.++.++||+.+|+||+|.=.|-.++ .+++..++.|+.+|+.||++||+.. |++|||||+|||+| +.|+|+|+|+|
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLG 332 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLG 332 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccc
Confidence 3789999999999999998887766 7999999999999999999999999 99999999999998 66999999999
Q ss_pred chhhhcccCCc-cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC---HHHHHHHHHcCCCCcccc
Q 006244 89 LAAILRKSHAA-RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---PAQIYKKVISGKKPEALF 163 (654)
Q Consensus 89 LA~~l~~~~~~-~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~---~~qi~kki~~G~~p~~l~ 163 (654)
||..+...... ..+||.+|||||++.+ .|+..+|.|||||++|||+.|..||..... .+++-+.+. ..+..++
T Consensus 333 LAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~~~~ey~ 410 (591)
T KOG0986|consen 333 LAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--EDPEEYS 410 (591)
T ss_pred eEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--cchhhcc
Confidence 99988765443 3489999999999974 599999999999999999999999965321 122223332 2355566
Q ss_pred cCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 164 KVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 164 ~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
...++++++|.+.+|. +|.+|+ +++++..||||+.-++
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 7889999999999999 899987 4779999999987655
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=241.63 Aligned_cols=188 Identities=31% Similarity=0.518 Sum_probs=159.7
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
++++.+.. ....++|+||+++++|.+++.+ ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.
T Consensus 63 ~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~ 138 (256)
T cd08530 63 SYKEAFLD--GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVA 138 (256)
T ss_pred hhhhhhcc--CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEec
Confidence 45566665 5899999999999999999876 356899999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++............|++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+
T Consensus 139 -~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~ 216 (256)
T cd08530 139 -NDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRG 216 (256)
T ss_pred -CCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC
Confidence 4789999999998776554444568999999998864 4888999999999999999999999874 455555666665
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+. .....+.+++++|.+||. +|.+||++.++++||++
T Consensus 217 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 KYPP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 5543 334678899999999998 89999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=261.63 Aligned_cols=187 Identities=21% Similarity=0.342 Sum_probs=154.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---------------------------------------------
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--------------------------------------------- 35 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--------------------------------------------- 35 (654)
|+++++|.. ....++|||||+||+|.+++...+
T Consensus 102 v~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 102 VNLLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred eeeeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 578888877 678999999999999999986532
Q ss_pred ------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEE
Q 006244 36 ------------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85 (654)
Q Consensus 36 ------------------------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~ 85 (654)
.+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.+||+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~-~~~~kl~ 256 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTH-GRITKIC 256 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEEC-CCcEEEe
Confidence 3688899999999999999999998 999999999999985 4789999
Q ss_pred ecCchhhhcccCCc----cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 86 DLGLAAILRKSHAA----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 86 DFGLA~~l~~~~~~----~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
|||++......... ...+++.|+|||++.+ .++.++||||||+++|+|++ |..||........+++.+..+..+
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 336 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC
Confidence 99999765432211 1234568999998864 58999999999999999998 899998766666666666666543
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
. .+...+.++++||.+||. +|.+||++.+++..
T Consensus 337 ~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 L-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred C-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 3 334567899999999999 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=265.11 Aligned_cols=185 Identities=25% Similarity=0.484 Sum_probs=166.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
-+.+|+||||+.||+|.-.+++-+++.+..+..|+.+|+-||=|||+++ ||+||||.+|||++++ |+|||+|||+++
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcK 498 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCK 498 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeeccccc
Confidence 5789999999999999999999999999999999999999999999999 9999999999999966 899999999997
Q ss_pred h--hcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 006244 92 I--LRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 168 (654)
Q Consensus 92 ~--l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~sp 168 (654)
. +......+++|||.|+|||++. +.|+.++|.||+|++||||+.|++||.+ .+..+++..|..... .+++..|.
T Consensus 499 Eni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehnv--syPKslSk 575 (683)
T KOG0696|consen 499 ENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHNV--SYPKSLSK 575 (683)
T ss_pred ccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHccC--cCcccccH
Confidence 4 3445566789999999999875 7799999999999999999999999988 667889999987654 35678899
Q ss_pred HHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 169 EVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 169 elrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
++..+.+..|. .|.+|+. -.++-.||||+..++.
T Consensus 576 EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWE 615 (683)
T ss_pred HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHH
Confidence 99999999999 7999975 4689999999988775
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=250.11 Aligned_cols=190 Identities=29% Similarity=0.506 Sum_probs=156.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. +..+++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||+++ ++|+||+|+||+++. .+
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~-~~ 138 (277)
T cd06642 65 TRYYGSYLK--GTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSE-QG 138 (277)
T ss_pred Hhhhccccc--CCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeC-CC
Confidence 356777766 6789999999999999998865 56899999999999999999999998 999999999999984 57
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++..+.... .....|+..|+|||++.+ .++.++|+||||+++|+|++|..||.... .......+..+.
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~ 217 (277)
T cd06642 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNS 217 (277)
T ss_pred CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhhcCC
Confidence 99999999997664332 123458899999998875 48889999999999999999999997633 333333333333
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. ..+....+.++.++|.+||. +|.+||++.+++.||||..
T Consensus 218 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 P-PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred C-CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 2 23444567889999999999 8999999999999999964
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=250.48 Aligned_cols=191 Identities=27% Similarity=0.464 Sum_probs=156.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ++..++|+||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||+|+||+++.+
T Consensus 78 v~~~~~~~~--~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~- 151 (307)
T cd06607 78 IEYKGCYLR--EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP- 151 (307)
T ss_pred EEEEEEEEe--CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-
Confidence 478888887 678999999996 677777664 456999999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++...... ....|++.|+|||++. +.++.++||||||+++|+|++|..||........+ ..+..
T Consensus 152 ~~~kL~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-~~~~~ 228 (307)
T cd06607 152 GTVKLADFGSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQ 228 (307)
T ss_pred CCEEEeecCcceecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-HHHhc
Confidence 79999999998765332 3456899999999873 45888999999999999999999999764433333 33443
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+..+.......+..++++|.+||. +|.+||++.+++.||||....
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 433433334467899999999999 899999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=243.27 Aligned_cols=186 Identities=24% Similarity=0.428 Sum_probs=153.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. .+.+++||||++|++|.+++..+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. .
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~-~ 136 (256)
T cd05059 62 VQLYGVCTK--QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGE-D 136 (256)
T ss_pred EEEEEEEcC--CCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECC-C
Confidence 467887765 67899999999999999998764 46899999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCcccc---CCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAARCV---GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~v---GTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++............ ++..|+|||++. ..++.++||||||+++|+|++ |..||... ....+...+.
T Consensus 137 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~ 215 (256)
T cd05059 137 NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVS 215 (256)
T ss_pred CcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHH
Confidence 79999999999765433222222 345799999886 458899999999999999999 89999763 4556666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .+...++++++++.+||. +|.+|||+.++++.
T Consensus 216 ~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 216 AGYRLY-RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 654332 345678999999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=248.12 Aligned_cols=190 Identities=25% Similarity=0.388 Sum_probs=152.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.+ ....++|+||+ +++|.+++.... .+++..+..++.||+.||.|||+++ ++||||+|+|||++.
T Consensus 61 v~~~~~~~~--~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~- 134 (283)
T cd07835 61 VRLLDVVHS--ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDR- 134 (283)
T ss_pred cCHhheecc--CCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcC-
Confidence 466777766 68999999999 579999988766 7999999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+.++|+|||++..+... ......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.......++++.+.
T Consensus 135 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 135 EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred CCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 589999999999765322 1223457899999998754 378899999999999999999999976544333333221
Q ss_pred cCCC--------------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 155 SGKK--------------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~~--------------------------p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.... ........++.+.++|.+||. +|.+|||+.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 215 TLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1000 011123456889999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=241.68 Aligned_cols=185 Identities=21% Similarity=0.355 Sum_probs=153.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++... +..+++|+||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 62 ~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~- 137 (256)
T cd05082 62 VQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSE- 137 (256)
T ss_pred eeEEEEEEcC-CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcC-
Confidence 4677776543 567999999999999999988654 4889999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++....... ....++..|+|||++.. .++.++||||||+++|+|++ |..||.. .+..++...+..+
T Consensus 138 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~ 215 (256)
T cd05082 138 DNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKG 215 (256)
T ss_pred CCcEEecCCccceeccccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcC
Confidence 4799999999987654322 22335678999998864 48889999999999999998 9999976 4566666777665
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+ ......++.++++|.+||. +|.+|||+.++++
T Consensus 216 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 216 YKM-DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 443 3456678999999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=246.77 Aligned_cols=186 Identities=22% Similarity=0.398 Sum_probs=151.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
|++++++.. +..+++||||+++|+|.+++.+.+ .++...+..++.||+.||.|||+.+ ++||||||
T Consensus 72 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp 147 (277)
T cd05062 72 VRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAA 147 (277)
T ss_pred eeEEEEEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcch
Confidence 578887765 678999999999999999987632 2577889999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++.+ +.++|+|||++....... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||.+ .
T Consensus 148 ~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~-~ 225 (277)
T cd05062 148 RNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-M 225 (277)
T ss_pred heEEEcCC-CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 99999854 799999999987653321 112346788999998864 58999999999999999999 7889976 4
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+.....+.+..+..+. .....++.++++|.+||. +|.+|||+.|++.+
T Consensus 226 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 226 SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4555556555554432 345567899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-28 Score=242.20 Aligned_cols=185 Identities=23% Similarity=0.423 Sum_probs=154.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. ...+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 62 ~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~- 136 (256)
T cd05114 62 VQLYGVCTQ--QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST- 136 (256)
T ss_pred eeEEEEEcc--CCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-
Confidence 578888766 67899999999999999998754 46899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++........ ....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .+..+....+.
T Consensus 137 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~-~~~~~~~~~i~ 215 (256)
T cd05114 137 GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-KSNYEVVEMIS 215 (256)
T ss_pred CeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHH
Confidence 7899999999876543221 1223566899999886 458899999999999999999 8999976 44566677777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+. .+...+.++.+++.+||. +|.+||++.++++
T Consensus 216 ~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 216 RGFRLY-RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 765443 234567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=245.28 Aligned_cols=189 Identities=28% Similarity=0.437 Sum_probs=152.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
++++++|.+ .+.++|||||+. |+|.+++..+. .+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 61 ~~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~ 135 (284)
T cd07836 61 VRLHDVIHT--ENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINK 135 (284)
T ss_pred eeeeeeEee--CCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECC
Confidence 478888887 678999999997 58999887643 5899999999999999999999999 999999999999984
Q ss_pred CCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
.+.++|+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||........ +.++
T Consensus 136 -~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~ 213 (284)
T cd07836 136 -RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKI 213 (284)
T ss_pred -CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHH
Confidence 4799999999997654322 223457899999998754 378899999999999999999999987554433 2322
Q ss_pred HcC-CCC--------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 ISG-KKP--------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~G-~~p--------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
... ..| ..+.+..++.++++|.+||+ +|.+||++.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 214 FRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 211 000 01122457889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=245.98 Aligned_cols=187 Identities=20% Similarity=0.347 Sum_probs=152.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
+++++++.. ....++||||+.||+|.+++.+.+ .+++..+..++.||+.||.|||+++ ++||||||+||
T Consensus 72 ~~~~~~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~ni 147 (277)
T cd05036 72 VRLIGVSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNC 147 (277)
T ss_pred eeEEEEEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheE
Confidence 578887776 578899999999999999998754 4899999999999999999999999 99999999999
Q ss_pred EEeCC--CCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCC
Q 006244 74 FVNGN--QGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTH 145 (654)
Q Consensus 74 LId~~--~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~ 145 (654)
|++.+ ...+||+|||++..+..... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||... +
T Consensus 148 l~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~-~ 226 (277)
T cd05036 148 LLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR-T 226 (277)
T ss_pred EEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-C
Confidence 99744 23689999999987633221 1223456899999886 459999999999999999997 99999874 3
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 146 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 146 ~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
...+...+..+..+ ..+...++.+.+++.+||. +|.+||++.++++|
T Consensus 227 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 227 NQEVMEFVTGGGRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 44555555544333 2345568899999999999 89999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=247.84 Aligned_cols=190 Identities=25% Similarity=0.436 Sum_probs=148.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. +...++|+||+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+|+||||+|||++. .
T Consensus 66 ~~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~-~ 139 (291)
T cd07870 66 VLLHDIIHT--KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISY-L 139 (291)
T ss_pred eEEEEEEec--CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcC-C
Confidence 467888776 678999999995 6787776653 46888999999999999999999998 999999999999984 4
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++...... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||...........++..
T Consensus 140 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 219 (291)
T cd07870 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219 (291)
T ss_pred CcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence 79999999998764332 1233457999999998864 4788999999999999999999999765543333222211
Q ss_pred --CCC-----------------------Cccc---c--cCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 --GKK-----------------------PEAL---F--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 --G~~-----------------------p~~l---~--~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
|.. +..+ + -..++.+.+++.+||. +|.+|||+.++|.||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 100 0000 0 0125789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=250.26 Aligned_cols=193 Identities=28% Similarity=0.439 Sum_probs=149.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++++++.+.....+++||||+. ++|.+++..+ ..+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 65 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~ 141 (316)
T cd07842 65 VSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILV 141 (316)
T ss_pred cceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEE
Confidence 57899998855589999999996 5787776543 25899999999999999999999999 9999999999999
Q ss_pred eC---CCCcEEEEecCchhhhcccCC-----ccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 76 NG---NQGEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 76 d~---~~g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
+. ..+.+||+|||++........ ....+|+.|+|||++.+ .++.++||||||+++|+|++|.+||.....
T Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 142 MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 85 147999999999987643221 23458899999998764 478999999999999999999999975332
Q ss_pred HH--------HHHHHHHc----------------------------CCCC-cc------cccCCChHHHHHHHHHhh-Cc
Q 006244 146 PA--------QIYKKVIS----------------------------GKKP-EA------LFKVEDPEVRQFIEKCLA-TV 181 (654)
Q Consensus 146 ~~--------qi~kki~~----------------------------G~~p-~~------l~~~~spelrdLI~kCL~-dP 181 (654)
.. .....+.. ...+ .. .....++.+.++|.+||. +|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 301 (316)
T cd07842 222 KIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301 (316)
T ss_pred cccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCc
Confidence 11 00001000 0000 00 011466789999999999 89
Q ss_pred cCCCCHHHHhcCccc
Q 006244 182 SSRLSARELLTDPFL 196 (654)
Q Consensus 182 ~~RpTa~ELL~HPFf 196 (654)
.+|||+.+++.||||
T Consensus 302 ~~Rps~~eil~~~~f 316 (316)
T cd07842 302 TKRITAEEALEHPYF 316 (316)
T ss_pred ccCcCHHHHhcCCCC
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=243.20 Aligned_cols=186 Identities=25% Similarity=0.458 Sum_probs=154.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+|||++. .
T Consensus 62 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~-~ 136 (256)
T cd05113 62 VQLYGVCTK--QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDD-Q 136 (256)
T ss_pred eeEEEEEcc--CCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcC-C
Confidence 578888765 67899999999999999998774 46899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCcc---ccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~---~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++.......... ..++..|+|||++. ..++.++||||||+++|+|++ |..||... +...+...+.
T Consensus 137 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~ 215 (256)
T cd05113 137 GCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF-NNSETVEKVS 215 (256)
T ss_pred CCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHh
Confidence 799999999987654332222 23556899999986 458899999999999999999 99999764 4455666777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .....+..+++++.+||. +|.+||++.+|+.+
T Consensus 216 ~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 216 QGLRLY-RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 665543 344568899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=241.49 Aligned_cols=184 Identities=22% Similarity=0.373 Sum_probs=152.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++++. ...+++||||+.+|+|.+++.+.+.+++..+..|+.||+.||.|||..+ ++|+||||+|||++.+ +
T Consensus 59 v~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~ 132 (257)
T cd05060 59 VRLIGVCK---GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-H 132 (257)
T ss_pred eeEEEEEc---CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-C
Confidence 56788664 3578999999999999999998888999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCc-----cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSHAA-----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~-----~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+||+|||++..+...... ...++..|+|||++.. .++.++||||||+++|+|++ |..||... +..++.+.+
T Consensus 133 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~ 211 (257)
T cd05060 133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAML 211 (257)
T ss_pred cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHH
Confidence 9999999999866433211 1113467999998864 58899999999999999998 99999774 445666666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+... ......++.++++|.+||. +|.+||++.++++
T Consensus 212 ~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 212 ESGERL-PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 655433 3445678899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=249.88 Aligned_cols=185 Identities=24% Similarity=0.366 Sum_probs=146.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------------------RVNIRAVKHWCRQILSGLLYLHSRDP 61 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------------------~Lse~~i~~i~~QIl~gL~YLHs~~p 61 (654)
|++|+++.+ ...++|||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++
T Consensus 82 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 158 (304)
T cd05096 82 IRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN- 158 (304)
T ss_pred eEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC-
Confidence 578998887 678999999999999999987542 3677889999999999999999999
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT- 135 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT- 135 (654)
|+||||||+|||++.+ +.+||+|||++..+.... .....+++.|||||++. +.++.++||||||+++|+|++
T Consensus 159 -ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 -FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred -ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999999854 799999999997654322 12234678999999876 468999999999999999987
Q ss_pred -cCCCCCCCCCHHHHHHHHHc----CC--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 136 -FDYPYSECTHPAQIYKKVIS----GK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 136 -G~~Pf~~~~~~~qi~kki~~----G~--~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
+..||.... ..+....+.. .. .....+...++.+++||.+||. +|.+|||+.+|.
T Consensus 237 ~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 237 CKEQPYGELT-DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred cCCCCCCcCC-HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 567887644 3333332221 11 1111233467899999999999 899999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=243.32 Aligned_cols=188 Identities=29% Similarity=0.466 Sum_probs=155.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.+.. .+.+++|+||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+|||++
T Consensus 65 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~ 140 (267)
T cd08228 65 IKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeEEE--CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc
Confidence 468888877 6799999999999999998763 335899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-CHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKK 152 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-~~~qi~kk 152 (654)
. .+.++|+|||++....... .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... +...+...
T Consensus 141 ~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08228 141 A-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219 (267)
T ss_pred C-CCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH
Confidence 5 4789999999987654322 223468899999998864 58889999999999999999999996432 44556666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+..+..+.......+..++++|.+||. +|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 665555554445577899999999999 89999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=240.80 Aligned_cols=186 Identities=30% Similarity=0.506 Sum_probs=158.2
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 82 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~V 82 (654)
+++.+.. ++.+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++. .+.+
T Consensus 58 ~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~-~~~~ 132 (250)
T cd05123 58 LHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDA-DGHI 132 (250)
T ss_pred HHHHeec--CCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcC-CCcE
Confidence 4555554 7899999999999999999998888999999999999999999999998 999999999999985 4799
Q ss_pred EEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 83 KIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 83 KL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
+|+|||++...... ......++..|+|||.+.+ .++.++|+||||+++|+|++|..||.. .....++..+..+..
T Consensus 133 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~- 210 (250)
T cd05123 133 KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDPL- 210 (250)
T ss_pred EEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCC-
Confidence 99999999776543 2334468899999998864 478899999999999999999999976 344666666665433
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCH---HHHhcCccc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSA---RELLTDPFL 196 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa---~ELL~HPFf 196 (654)
.++...+..++++|.+||. +|.+||++ .++++||||
T Consensus 211 -~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 -RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 2444568899999999999 89999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=247.51 Aligned_cols=186 Identities=24% Similarity=0.391 Sum_probs=154.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++++.. +..+++||||+.+|+|..++... +.+++..+..++.||+.||.|||+++ |+
T Consensus 79 ~~~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--iv 154 (293)
T cd05053 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CI 154 (293)
T ss_pred eeEEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 478887766 67899999999999999998653 35899999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++. .+.+||+|||++..+..... ....+++.|+|||++. ..++.++||||||+++|+|++ |..
T Consensus 155 H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 233 (293)
T cd05053 155 HRDLAARNVLVTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233 (293)
T ss_pred ccccceeeEEEcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC
Confidence 9999999999985 57999999999987653221 1123567899999876 458999999999999999998 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.. ....+.++.+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 234 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 234 PYPG-IPVEELFKLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCCC-CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9976 45566777777665543 334567899999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=243.77 Aligned_cols=185 Identities=23% Similarity=0.415 Sum_probs=154.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
+++|+++.. ...+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||
T Consensus 72 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p 147 (277)
T cd05032 72 VRLLGVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAA 147 (277)
T ss_pred eEEEEEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCh
Confidence 578998876 688999999999999999987532 3678899999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++.+ +.+||+|||+++.+.... .....++..|+|||++. +.++.++||||||+++|+|++ |..||.. .
T Consensus 148 ~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~ 225 (277)
T cd05032 148 RNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-L 225 (277)
T ss_pred heEEEcCC-CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-C
Confidence 99999855 799999999997654332 22334678999999876 458899999999999999998 9999976 4
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+...+.+.+..+..+. .+...+.++.++|.+||. +|.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 226 SNEEVLKFVIDGGHLD-LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5666666666554332 344568899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=248.60 Aligned_cols=190 Identities=27% Similarity=0.438 Sum_probs=151.9
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
+++++|.. ++.+++|+||+.+++|..+......+++..++.++.||+.||.|||+.+ |+|+||+|+||+++. .+.
T Consensus 64 ~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~-~~~ 138 (286)
T cd07846 64 NLIEVFRR--KKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQ-SGV 138 (286)
T ss_pred hHHHhccc--CCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECC-CCc
Confidence 45666655 6899999999999999988777667999999999999999999999998 999999999999985 479
Q ss_pred EEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-C
Q 006244 82 VKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-G 156 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G 156 (654)
++|+|||++..+.... .....+++.|+|||++.+ .++.++||||||+++|+|++|.+||..........+.... +
T Consensus 139 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07846 139 VKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218 (286)
T ss_pred EEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence 9999999987654332 223468899999998864 3778999999999999999999999764443332221110 0
Q ss_pred C------------------C-Cc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 157 K------------------K-PE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 157 ~------------------~-p~--------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
. . +. ...+..+..+++|+.+||. +|.+||++.++|.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 0 00 0123457789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=256.71 Aligned_cols=193 Identities=27% Similarity=0.444 Sum_probs=163.3
Q ss_pred EEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--Cc
Q 006244 4 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GE 81 (654)
Q Consensus 4 Y~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~--g~ 81 (654)
.++|.+ +..+|||||-|.||.|.+.|.+++.+++..+..+.+.|+.||.|||.++ |.||||||+|||-...+ .-
T Consensus 142 iefFEd--d~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsP 217 (463)
T KOG0607|consen 142 IEFFED--DTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSP 217 (463)
T ss_pred HHHhcc--cceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCc
Confidence 445666 6899999999999999999999999999999999999999999999999 99999999999986332 24
Q ss_pred EEEEecCchhhhcc---------cCCccccCCCCccChhhhc---c---cCCcccchhhhhhHHHHHhhcCCCCCCC---
Q 006244 82 VKIGDLGLAAILRK---------SHAARCVGTPEFMAPEVYE---E---EYNELVDIYSFGMCILEMVTFDYPYSEC--- 143 (654)
Q Consensus 82 VKL~DFGLA~~l~~---------~~~~~~vGTp~YmAPEvl~---~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--- 143 (654)
||||||.|..-+.. +...+.+|+.+|||||+.. + .|+.+.|.||||||+|.||.|.+||.+.
T Consensus 218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence 79999988764432 2234567899999999864 2 3999999999999999999999999641
Q ss_pred --C--------C-HHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 144 --T--------H-PAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 144 --~--------~-~~qi~kki~~G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
. . -..++..|..|.. |..-|...+.+.+++|..+|. ++.+|.++..+++|||++.-.
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 1 0 1347788888875 667788899999999999999 899999999999999997543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=247.17 Aligned_cols=185 Identities=28% Similarity=0.504 Sum_probs=150.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++||.+.. ...+++|+|||++|+|.+++... ..+++..+..|+.||+.||.|||+++ |+|++|++.|||++.+
T Consensus 64 ~~~~g~~~~--~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~ 139 (259)
T PF07714_consen 64 VKLYGFCIE--NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN 139 (259)
T ss_dssp E-EEEEEES--SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT
T ss_pred ccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc
Confidence 578999985 56799999999999999999987 67999999999999999999999998 9999999999999965
Q ss_pred CCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++....... .....+...|+|||++.. .++.++||||||+++|||++ |..||.+. +...+..+
T Consensus 140 -~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~ 217 (259)
T PF07714_consen 140 -GQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEK 217 (259)
T ss_dssp -TEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHH
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 799999999998762211 122346778999999864 48999999999999999999 78999875 66777777
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+. .....+..+.++|.+||. +|.+||++.++++
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 218 LKQGQRLP-IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHTTEETT-SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccce-eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 77666543 445678899999999999 8999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=246.08 Aligned_cols=186 Identities=31% Similarity=0.527 Sum_probs=155.6
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV 82 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~V 82 (654)
+++.+.. +..+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||||+|||++. .+.+
T Consensus 67 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~-~~~~ 141 (280)
T cd05581 67 LYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDK-DMHI 141 (280)
T ss_pred HHHHhcC--CceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECC-CCCE
Confidence 4444544 6789999999999999999999889999999999999999999999998 999999999999974 4799
Q ss_pred EEEecCchhhhcccC----------------------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCC
Q 006244 83 KIGDLGLAAILRKSH----------------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 83 KL~DFGLA~~l~~~~----------------------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
+|+|||++....... .....|++.|+|||++.. .++.++|+||||++++++++|..|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 999999998664322 122357899999998764 478899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCccc
Q 006244 140 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFL 196 (654)
Q Consensus 140 f~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa----~ELL~HPFf 196 (654)
|.... ....+..+..... .++...++.+.+||.+||. +|.+||++ .++|+||||
T Consensus 222 ~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 222 FRGSN-EYLTFQKILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCcc-HHHHHHHHHhcCC--CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 98744 4444555554332 2334568899999999999 89999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=248.51 Aligned_cols=193 Identities=27% Similarity=0.521 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+++.. ...+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||+|+||+++.
T Consensus 77 ~~~~~~~~~--~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~- 150 (296)
T cd06618 77 VKCYGYFIT--DSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDA- 150 (296)
T ss_pred Hhhheeeec--CCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcC-
Confidence 457888877 67999999999 4688887765 4579999999999999999999997 46 999999999999984
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhccc-----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~-----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+.+||+|||++..+.... .....+++.|+|||++... ++.++||||||+++|+|++|+.||.......+...+
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 230 (296)
T cd06618 151 SGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK 230 (296)
T ss_pred CCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH
Confidence 5799999999997664332 2233578899999988632 788999999999999999999999765444455555
Q ss_pred HHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 153 VISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 153 i~~G~~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+..+..+... ....+.++++||.+||. +|.+||++.+++.||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 231 ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 5555433221 22367899999999999 89999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=241.48 Aligned_cols=185 Identities=24% Similarity=0.362 Sum_probs=154.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.. ...+++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|||++.
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~- 139 (263)
T cd05052 65 VQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGE- 139 (263)
T ss_pred hheEEEEcC--CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcC-
Confidence 467887765 67899999999999999998764 35899999999999999999999998 999999999999974
Q ss_pred CCcEEEEecCchhhhcccCCcc---ccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~---~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||++.......... ..+++.|+|||++.. .++.++||||||+++|+|++ |..||.. ......+..+
T Consensus 140 ~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~ 218 (263)
T cd05052 140 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELL 218 (263)
T ss_pred CCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 5799999999998765432211 224668999998864 58889999999999999998 9999976 4566677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ......++++.++|.+||. +|.+||++.++++
T Consensus 219 ~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 219 EKGYRM-ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 665443 3445678999999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=252.67 Aligned_cols=194 Identities=28% Similarity=0.397 Sum_probs=155.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.. ...+++||||+. |+|.+++.....+++..+..++.||+.||.|||+++ |+|+||||+|||++. .+
T Consensus 83 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~-~~ 156 (335)
T PTZ00024 83 MGLVDVYVE--GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINS-KG 156 (335)
T ss_pred eeeeEEEec--CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECC-CC
Confidence 467888876 689999999996 699999988888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcc----------------cCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCC
Q 006244 81 EVKIGDLGLAAILRK----------------SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSE 142 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~----------------~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~ 142 (654)
.++|+|||++..... .......+++.|+|||++.+ .++.++|+||||+++|+|++|.+||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999976541 11122347889999998864 378899999999999999999999987
Q ss_pred CCCHHHHHHHHHc--CCCCc------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 143 CTHPAQIYKKVIS--GKKPE------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 143 ~~~~~qi~kki~~--G~~p~------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
......+ ..+.. +..+. ......+..++++|.+||. +|.+||++.++|.|||
T Consensus 237 ~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 237 ENEIDQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred CCHHHHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 5443333 22221 10000 0112346789999999999 8999999999999999
Q ss_pred cccCCc
Q 006244 196 LQIDDY 201 (654)
Q Consensus 196 f~~~~~ 201 (654)
|+....
T Consensus 316 ~~~~~~ 321 (335)
T PTZ00024 316 FKSDPL 321 (335)
T ss_pred cCCCCC
Confidence 986543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=245.36 Aligned_cols=191 Identities=24% Similarity=0.371 Sum_probs=146.8
Q ss_pred CEEEEEEEecC------CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTA------NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~------~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
+++++.+.... ...+++|+||+. ++|.+++.+.. .+++..++.++.||+.||.|||+++ ++|+||||+||
T Consensus 74 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~ni 150 (310)
T cd07865 74 VNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANI 150 (310)
T ss_pred cceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence 45667665432 246799999995 58888876643 6899999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhcccCC------ccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKSHA------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~~~------~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
+++. .+.+||+|||++..+..... ...++++.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus 151 l~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 151 LITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred EECC-CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9985 47999999999976643221 23457889999998764 378899999999999999999999976432
Q ss_pred HHHHHHHHH--cCCCCccc----------------------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 146 PAQIYKKVI--SGKKPEAL----------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 146 ~~qi~kki~--~G~~p~~l----------------------------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
......+. .|..+..+ ....++.+++||.+||. +|.+|||++++|+||
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~ 308 (310)
T cd07865 230 -QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD 308 (310)
T ss_pred -HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence 22211111 11111110 11246778899999999 899999999999999
Q ss_pred cc
Q 006244 195 FL 196 (654)
Q Consensus 195 Ff 196 (654)
||
T Consensus 309 ~f 310 (310)
T cd07865 309 FF 310 (310)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=247.73 Aligned_cols=186 Identities=23% Similarity=0.348 Sum_probs=152.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++.+.. ...+++|+||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iv 141 (297)
T cd05089 66 INLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FI 141 (297)
T ss_pred hheEEEEcc--CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 467887766 678999999999999999997643 4888999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCCcc-ccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYS 141 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~~-~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~ 141 (654)
||||||+|||++.+ +.+||+|||++.......... ...+..|+|||++.. .++.++||||||+++|+|++ |..||.
T Consensus 142 H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~ 220 (297)
T cd05089 142 HRDLAARNVLVGEN-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC 220 (297)
T ss_pred cCcCCcceEEECCC-CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999854 789999999986433221111 223457999998864 58899999999999999997 999997
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
. .....++.++..+..+. .+...++.+++||.+||. +|.+||++.++++.
T Consensus 221 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 221 G-MTCAELYEKLPQGYRME-KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6 44566667776654432 345678999999999999 89999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=244.25 Aligned_cols=185 Identities=25% Similarity=0.443 Sum_probs=153.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIH 65 (654)
+++++++.. ...+++|+||+.+|+|.+++..++ .+++..+..++.||+.||+|||+++ |+|
T Consensus 70 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H 145 (280)
T cd05092 70 VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVH 145 (280)
T ss_pred ceEEEEEec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence 578888877 678999999999999999998753 4889999999999999999999998 999
Q ss_pred cCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCC
Q 006244 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYP 139 (654)
Q Consensus 66 RDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~P 139 (654)
|||||+|||++. .+.+||+|||++....... .....+++.|+|||++. ..++.++||||||+++|+|++ |.+|
T Consensus 146 ~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 224 (280)
T cd05092 146 RDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224 (280)
T ss_pred ccccHhhEEEcC-CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999984 5799999999987543221 12234578899999876 458999999999999999998 8999
Q ss_pred CCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 140 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 140 f~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
|.... .......+..+..+. .....++.+.++|.+||. +|.+||++.+|+.
T Consensus 225 ~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 225 WYQLS-NTEAIECITQGRELE-RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCC-HHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 97643 445556666665443 344678899999999999 8999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=253.54 Aligned_cols=188 Identities=23% Similarity=0.376 Sum_probs=152.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------------------------------------
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------------------------------------------- 34 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------------------------------------------- 34 (654)
+++++++... ...+++|+||+++|+|.+++...
T Consensus 74 v~~~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (337)
T cd05054 74 VNLLGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKS 152 (337)
T ss_pred hheeeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcc
Confidence 4677777643 56899999999999999998642
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC--
Q 006244 35 ---------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-- 97 (654)
Q Consensus 35 ---------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~-- 97 (654)
..+++..+..++.||+.||.|||+++ |+||||||+|||++. .+.++|+|||++..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeC-CCcEEEeccccchhcccCcch
Confidence 25789999999999999999999998 999999999999985 4799999999998764321
Q ss_pred --CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHH
Q 006244 98 --AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 173 (654)
Q Consensus 98 --~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdL 173 (654)
.....+++.|+|||++. ..++.++|||||||++|+|++ |..||......+.+...+..+..+. .....++++.++
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 308 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR-APEYATPEIYSI 308 (337)
T ss_pred hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC-CCccCCHHHHHH
Confidence 12234677899999876 459999999999999999998 9999977444444445555554432 345578899999
Q ss_pred HHHHhh-CccCCCCHHHHhcC
Q 006244 174 IEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 174 I~kCL~-dP~~RpTa~ELL~H 193 (654)
+.+||+ +|.+||++.++++|
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999 89999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=247.68 Aligned_cols=192 Identities=27% Similarity=0.457 Sum_probs=157.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.+ ....|+||||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+|+||||+||+++. .
T Consensus 84 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~-~ 157 (313)
T cd06633 84 IEYKGCYLK--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTE-P 157 (313)
T ss_pred ccEEEEEEe--CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECC-C
Confidence 468888877 689999999995 577777765 456899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++..... .....|++.|+|||++. +.++.++||||||+++|+|++|..||.........+ .+..
T Consensus 158 ~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~ 234 (313)
T cd06633 158 GQVKLADFGSASKSSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ 234 (313)
T ss_pred CCEEEeecCCCcccCC--CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHh
Confidence 7999999999865322 23456899999999874 458889999999999999999999998754444443 4444
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+..+.......+..+++||.+||+ +|.+||++.+++.||||+....
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 444444444567789999999999 8999999999999999986553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=239.18 Aligned_cols=187 Identities=29% Similarity=0.506 Sum_probs=155.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.+.. .+.+++||||+++|+|..++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||+++
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~ 140 (267)
T cd08224 65 IKYLASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeec--CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC
Confidence 467888877 67999999999999999998652 35899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC-CCHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKK 152 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~-~~~~qi~kk 152 (654)
.+ +.++|+|||++..+.... .....|++.|+|||++.+ .++.++||||||+++|+|++|..||... .+.......
T Consensus 141 ~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08224 141 AT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred CC-CcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh
Confidence 54 789999999987654322 233468999999998764 4889999999999999999999999543 344455666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+.......+..++++|.+||. +|.+||++.+|+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666665544444677899999999999 8999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=241.17 Aligned_cols=187 Identities=30% Similarity=0.509 Sum_probs=155.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
++++++|.. ++.+++|+||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++
T Consensus 65 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~ 140 (267)
T cd08229 65 IKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT 140 (267)
T ss_pred hhhhheeEe--CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc
Confidence 467888877 6799999999999999999874 346899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-CHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYKK 152 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-~~~qi~kk 152 (654)
.+ +.++|+|||++....... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||.... ......+.
T Consensus 141 ~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08229 141 AT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred CC-CCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh
Confidence 54 799999999987764432 223468999999998864 48889999999999999999999996533 23455556
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+.......++.++++|.+||. +|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 655555544445678899999999999 8999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=253.65 Aligned_cols=192 Identities=23% Similarity=0.373 Sum_probs=151.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|++|.. +..+++|+||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 62 v~~~~~~~~--~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~ 137 (328)
T cd08226 62 MTSWTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD 137 (328)
T ss_pred ceEeeeEec--CCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC
Confidence 588999887 67899999999999999998874 35899999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCC---------ccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---------ARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---------~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
+.++++||+.+........ ....++..|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 138 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 216 (328)
T cd08226 138 -GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216 (328)
T ss_pred -CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH
Confidence 7999999986544322110 01124567999999864 3788999999999999999999999875444
Q ss_pred HHHHHHHHcCCCC---------------------------------------------cccccCCChHHHHHHHHHhh-C
Q 006244 147 AQIYKKVISGKKP---------------------------------------------EALFKVEDPEVRQFIEKCLA-T 180 (654)
Q Consensus 147 ~qi~kki~~G~~p---------------------------------------------~~l~~~~spelrdLI~kCL~-d 180 (654)
......+. +... .......++.+++||.+||. +
T Consensus 217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (328)
T cd08226 217 QMLLQKLK-GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295 (328)
T ss_pred HHHHHHhc-CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCC
Confidence 33322221 1100 00112345789999999999 9
Q ss_pred ccCCCCHHHHhcCccccc
Q 006244 181 VSSRLSARELLTDPFLQI 198 (654)
Q Consensus 181 P~~RpTa~ELL~HPFf~~ 198 (654)
|.+|||+.++|+||||..
T Consensus 296 P~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 296 PEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccCCCHHHHhhCHHHHH
Confidence 999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=241.70 Aligned_cols=187 Identities=22% Similarity=0.294 Sum_probs=146.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-----~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
|++++.+.+ ...+++||||+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ ++||||||+||++
T Consensus 58 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~ 133 (269)
T cd05087 58 LQCLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLL 133 (269)
T ss_pred eeEEEEEcC--CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEE
Confidence 477887766 678999999999999999987532 4577788899999999999999998 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc--------cCCcccchhhhhhHHHHHhh-cCCCCCC
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSE 142 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGiiL~ELlT-G~~Pf~~ 142 (654)
+. .+.+||+|||++....... .....|++.|+|||++.. .++.++||||||+++|+|++ |..||..
T Consensus 134 ~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 134 TA-DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred cC-CCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 85 4799999999986543221 122357889999998853 25779999999999999996 9999987
Q ss_pred CCCHHHHHHHHHcCCCC---cccccCCChHHHHHHHHHhhCccCCCCHHHHhc
Q 006244 143 CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLATVSSRLSARELLT 192 (654)
Q Consensus 143 ~~~~~qi~kki~~G~~p---~~l~~~~spelrdLI~kCL~dP~~RpTa~ELL~ 192 (654)
..........+...... ..+....++.+++++.+|+.+|.+|||+.+|+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 213 LSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 55444333333322221 122234678899999999989999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=243.72 Aligned_cols=191 Identities=31% Similarity=0.527 Sum_probs=159.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.. +..+++|+||+.+|+|.+++.. ..+++..+..++.||+.||.|||+.+ ++|+||||+||+++. .+
T Consensus 65 v~~~~~~~~--~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~-~~ 138 (277)
T cd06641 65 TKYYGSYLK--DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSE-HG 138 (277)
T ss_pred eEEEEEEEe--CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECC-CC
Confidence 578898887 6899999999999999999865 46899999999999999999999998 999999999999984 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++..+.... .....|+..|+|||.+.. .++.++|+||||+++|+|++|..||... +.......+..+.
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~ 217 (277)
T cd06641 139 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN 217 (277)
T ss_pred CEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCC
Confidence 99999999987654322 223458899999998864 4788999999999999999999999763 3444444444443
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. ..+....+.++.++|.+||. +|.+||++.+++.||||...
T Consensus 218 ~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 P-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred C-CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 3 33445678899999999999 89999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.13 Aligned_cols=185 Identities=22% Similarity=0.404 Sum_probs=152.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. .+..++|+||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~- 138 (261)
T cd05072 64 VRLYAVVTK--EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSE- 138 (261)
T ss_pred eeEEEEEcC--CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecC-
Confidence 467777765 67899999999999999998763 46899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.++|+|||++........ ....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .........+
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~ 217 (261)
T cd05072 139 SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG-MSNSDVMSAL 217 (261)
T ss_pred CCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC-CCHHHHHHHH
Confidence 47999999999987654221 2233567899999886 458889999999999999998 9999976 3455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+.... .....+.++.++|.+||. +|.+||+++++++
T Consensus 218 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 218 QRGYRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 6554332 334577899999999999 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=247.68 Aligned_cols=186 Identities=22% Similarity=0.357 Sum_probs=154.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.. .+.+++|+||+.+|+|.+++.... .+++.++..++.||+.||.|||+++ |+|+||||+|||++.
T Consensus 102 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~- 176 (302)
T cd05055 102 VNLLGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTH- 176 (302)
T ss_pred ceEEEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcC-
Confidence 578888876 678999999999999999987643 3899999999999999999999998 999999999999984
Q ss_pred CCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
.+.++|+|||++..+..... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||..........+.
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 47899999999986543221 1234678899999876 458899999999999999998 99999875555555555
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+ ......++++++|+.+||. +|.+|||+.+++.
T Consensus 257 ~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 257 IKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5555433 2344568899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=247.53 Aligned_cols=185 Identities=23% Similarity=0.402 Sum_probs=152.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++++.. ++.+++||||+.+|+|.+|+... ..+++..+..++.||+.||.|||+++ |+
T Consensus 81 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~ 156 (314)
T cd05099 81 INLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CI 156 (314)
T ss_pred eeEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 578887766 67899999999999999999764 24888999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++. .+.+||+|||+++...... .....+++.|||||++.+ .++.++||||||+++|+|++ |..
T Consensus 157 H~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~ 235 (314)
T cd05099 157 HRDLAARNVLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235 (314)
T ss_pred eccccceeEEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence 9999999999985 4799999999997654321 111224568999998764 58899999999999999999 889
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
||.. .+...++..+..+..+. .....+.+++++|.+||. +|.+||++.+++.
T Consensus 236 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 236 PYPG-IPVEELFKLLREGHRMD-KPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9976 45666777776665432 334567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.86 Aligned_cols=183 Identities=20% Similarity=0.295 Sum_probs=146.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+.. ....++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 62 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~ 137 (258)
T cd05078 62 VLNYGVCVC--GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREE 137 (258)
T ss_pred hheeeEEEe--CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEeccc
Confidence 578888887 678999999999999999998754 5899999999999999999999998 99999999999997543
Q ss_pred C-------cEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcC-CCCCCCCCHHHH
Q 006244 80 G-------EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFD-YPYSECTHPAQI 149 (654)
Q Consensus 80 g-------~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~-~Pf~~~~~~~qi 149 (654)
. .++++|||++..... .....+++.|+|||++.. .++.++||||||+++|+|++|. .||.... ....
T Consensus 138 ~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~ 214 (258)
T cd05078 138 DRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKK 214 (258)
T ss_pred ccccCCCceEEecccccccccCC--chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHH
Confidence 2 379999999865532 223458899999999874 4788999999999999999985 6665433 3222
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.. +.... ..++...++++.++|.+||+ +|.+|||++++++.
T Consensus 215 ~~-~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 215 LQ-FYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HH-HHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 22 22211 12334456889999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=238.31 Aligned_cols=185 Identities=25% Similarity=0.389 Sum_probs=152.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++++.+.. ..+++|+||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||||+||+++.+
T Consensus 59 v~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~ 133 (257)
T cd05040 59 IRLYGVVLT---HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD 133 (257)
T ss_pred cceeEEEcC---CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC
Confidence 567887765 78999999999999999998764 6899999999999999999999998 9999999999999855
Q ss_pred CCcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYK 151 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++..+.... .....++..|+|||++.. .++.++||||||+++|+|++ |..||... +..++.+
T Consensus 134 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~ 211 (257)
T cd05040 134 -DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILK 211 (257)
T ss_pred -CEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence 799999999998764421 112347789999998864 58999999999999999999 99999764 4455555
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+.............+..+.+++.+||. +|.+||++.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 5553222222334567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=248.26 Aligned_cols=186 Identities=24% Similarity=0.422 Sum_probs=153.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++.+.. ...+++|+||+.+|+|.+++..++ .++...+..++.||+.||+|||+++ ++
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~ 162 (307)
T cd05098 87 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CI 162 (307)
T ss_pred eeEEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cc
Confidence 478887766 678999999999999999998643 4888999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus 163 H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~ 241 (307)
T cd05098 163 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241 (307)
T ss_pred cccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999855 799999999987654321 111224578999998864 48899999999999999998 888
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.. .+..++++.+..+..+ ..+...+.++++||.+||. +|.+||++.+++.+
T Consensus 242 p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 242 PYPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCc-CCHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 8876 5566777777666543 3445678899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=247.35 Aligned_cols=193 Identities=32% Similarity=0.556 Sum_probs=157.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. .++.++||||+++++|.+++.. +++++..+..++.||+.||+|||+++ ++|+||||+||+++.+ +
T Consensus 80 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~ 153 (292)
T cd06657 80 VEMYNSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-G 153 (292)
T ss_pred hheeeEEEe--CCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-C
Confidence 467888877 6899999999999999998654 56899999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.++|+|||++....... .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||... ........+..+.
T Consensus 154 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~ 232 (292)
T cd06657 154 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNL 232 (292)
T ss_pred CEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhC
Confidence 89999999887654322 223458999999998864 5788999999999999999999999763 3333333443332
Q ss_pred CCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+. ......++.+.++|.+||. +|.+||++.++|.||||....
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 221 1223468899999999999 899999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=249.39 Aligned_cols=187 Identities=25% Similarity=0.346 Sum_probs=151.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++++.. .+.+|+|+||+++|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+
T Consensus 71 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~ 146 (303)
T cd05088 71 INLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FI 146 (303)
T ss_pred ceEEEEECC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 578888766 678999999999999999997643 4789999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC-ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYS 141 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~ 141 (654)
||||||+|||++.+ +.+||+|||++........ ....+++.|+|||++.. .++.++||||||+++|+|+| |..||.
T Consensus 147 H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 147 HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred ccccchheEEecCC-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 99999999999854 7999999999864322111 11224668999998864 47889999999999999998 999997
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
. .+..+.+..+..+..+. .+...++++.+||.+||. +|.+||++.++|.+.
T Consensus 226 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 226 G-MTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred c-CChHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6 34455666665543332 233467899999999999 899999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=242.10 Aligned_cols=185 Identities=25% Similarity=0.353 Sum_probs=150.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++|+.+.. ...+++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+++ ++
T Consensus 59 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~ 134 (270)
T cd05047 59 INLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FI 134 (270)
T ss_pred eeEEEEEec--CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--Ee
Confidence 578888766 678999999999999999987643 4789999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC-ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYS 141 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~ 141 (654)
||||||+|||++.+ +.+||+|||++........ .....++.|+|||++.. .++.++||||||+++|+|++ |..||.
T Consensus 135 H~dikp~nili~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 135 HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred ecccccceEEEcCC-CeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999854 7999999999853322111 11224567999998864 58889999999999999997 999997
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
. .+....+..+..+..+. .....+.++.+++.+||. +|.+|||+.+++.
T Consensus 214 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 214 G-MTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred c-cCHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 6 44555666665554332 334567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=238.38 Aligned_cols=185 Identities=21% Similarity=0.354 Sum_probs=149.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ...+++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 56 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~-~ 130 (252)
T cd05084 56 VRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTE-K 130 (252)
T ss_pred ceEEEEEcC--CCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcC-C
Confidence 578888776 678999999999999999987644 6899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCccc----cCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~----vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++........... .++..|+|||.+.. .++.++||||||+++|+|++ |..||... ........+
T Consensus 131 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~ 209 (252)
T cd05084 131 NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAI 209 (252)
T ss_pred CcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHH
Confidence 7899999999876543211111 13457999998864 58889999999999999998 88898753 344444555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ......+..+.+|+.+||. +|.+|||+.++++
T Consensus 210 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 210 EQGVRL-PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCCC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 444332 3445678899999999999 8999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=242.99 Aligned_cols=184 Identities=23% Similarity=0.420 Sum_probs=151.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. ...++|+||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+|||++. .
T Consensus 72 v~~~~~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~-~ 145 (279)
T cd05111 72 VRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKS-D 145 (279)
T ss_pred ceEEEEECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcC-C
Confidence 578887643 5688999999999999999764 56899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+++...... .....+++.|+|||++. +.++.++||||||+++|||++ |..||.+. ....+...+
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~ 224 (279)
T cd05111 146 SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLL 224 (279)
T ss_pred CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH
Confidence 799999999997653321 12234677899999886 458999999999999999998 99999763 444455555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .....+..+..++.+||. +|.+|||+.++++
T Consensus 225 ~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 225 EKGERLA-QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HCCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5555443 334567789999999999 8999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=254.48 Aligned_cols=190 Identities=28% Similarity=0.418 Sum_probs=148.6
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.|.... ...+|+||||+. |+|.+++... +++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 78 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~ 152 (353)
T cd07850 78 IGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 152 (353)
T ss_pred cceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC
Confidence 46777776421 246899999995 6898887654 899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCC-ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||....... .+.++.
T Consensus 153 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~ 230 (353)
T cd07850 153 SD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKII 230 (353)
T ss_pred CC-CCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 55 7999999999987644322 23468999999998864 58999999999999999999999997643322 222221
Q ss_pred c--CCCC-------------------------------ccc--------ccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 S--GKKP-------------------------------EAL--------FKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~--G~~p-------------------------------~~l--------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
. |..+ ... ....+..+++||.+||. +|.+|||+.++|.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 231 EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 0000 000 11245678999999999 9999999999999
Q ss_pred Ccccc
Q 006244 193 DPFLQ 197 (654)
Q Consensus 193 HPFf~ 197 (654)
||||+
T Consensus 311 ~~~~~ 315 (353)
T cd07850 311 HPYIN 315 (353)
T ss_pred ChhHh
Confidence 99986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=241.29 Aligned_cols=186 Identities=20% Similarity=0.343 Sum_probs=146.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++++.+.. ...+++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++
T Consensus 58 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~ 133 (268)
T cd05086 58 LQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT 133 (268)
T ss_pred hheEEEecC--CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc
Confidence 578888876 67899999999999999998764 34677888999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhccc----CCccccCCCCccChhhhcc--------cCCcccchhhhhhHHHHHhh-cCCCCCCC
Q 006244 77 GNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCILEMVT-FDYPYSEC 143 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~ 143 (654)
.+ +.++|+|||++...... ......|++.|+|||++.. .++.++||||||+++|||++ |..||...
T Consensus 134 ~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 212 (268)
T cd05086 134 SD-LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL 212 (268)
T ss_pred CC-ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence 54 79999999998643211 1223458899999998742 25678999999999999997 56788764
Q ss_pred CCHHHHHHHHHcCCC----CcccccCCChHHHHHHHHHhhCccCCCCHHHHhc
Q 006244 144 THPAQIYKKVISGKK----PEALFKVEDPEVRQFIEKCLATVSSRLSARELLT 192 (654)
Q Consensus 144 ~~~~qi~kki~~G~~----p~~l~~~~spelrdLI~kCL~dP~~RpTa~ELL~ 192 (654)
.. ...+..+..+.. ...+....++.+++++..||.+|.+||++.++++
T Consensus 213 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 213 SD-REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CH-HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 43 444444433322 1223345688899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=251.44 Aligned_cols=193 Identities=26% Similarity=0.345 Sum_probs=154.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.......+++||||+. ++|.+++.+. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~ 144 (337)
T cd07852 70 VKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-C 144 (337)
T ss_pred cceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-C
Confidence 57888887655568999999996 6999998775 7899999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc-------CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
.+||+|||++..+... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||..........+
T Consensus 145 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~ 224 (337)
T cd07852 145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK 224 (337)
T ss_pred cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999865432 1223468999999998753 478899999999999999999999976544433222
Q ss_pred HHHcCC----------------------------CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 152 KVISGK----------------------------KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 152 ki~~G~----------------------------~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+.... .+....+..+.+++++|.+||+ +|.+|||+.+++.||||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 111110 0112223367899999999999 8999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=238.79 Aligned_cols=185 Identities=25% Similarity=0.391 Sum_probs=152.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.. .+.+++|+||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++.+
T Consensus 64 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~ 139 (261)
T cd05068 64 IQLYAVCTL--EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN 139 (261)
T ss_pred cceeEEEec--CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC
Confidence 467887766 678999999999999999987654 6999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccC---CCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVG---TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vG---Tp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++............| +..|+|||++.. .++.++||||||+++|+|++ |+.||... +...+...+
T Consensus 140 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~ 217 (261)
T cd05068 140 -NICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQV 217 (261)
T ss_pred -CCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence 799999999998765332222223 357999998764 58899999999999999999 99999763 455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ......+..+++++.+||. +|.+||++.+|+.
T Consensus 218 ~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 218 DQGYRM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HcCCCC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 554332 2344567899999999999 8999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=244.01 Aligned_cols=193 Identities=26% Similarity=0.440 Sum_probs=156.6
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++.|.. +..+++||||+.+|+|.+++.+...+++..++.++.|++.||.|||+.+ ++||||||.||+++.+ +.
T Consensus 69 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~ 143 (288)
T cd05583 69 TLHYAFQT--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GH 143 (288)
T ss_pred hhheeeec--CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CC
Confidence 45666655 6789999999999999999988888999999999999999999999998 9999999999999854 78
Q ss_pred EEEEecCchhhhcccCC---ccccCCCCccChhhhccc---CCcccchhhhhhHHHHHhhcCCCCCCCC---CHHHHHHH
Q 006244 82 VKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKK 152 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~~---ys~ksDIWSLGiiL~ELlTG~~Pf~~~~---~~~qi~kk 152 (654)
++|+|||++..+..... ....|++.|+|||.+.+. ++.++|+||||+++|+|++|..||.... ....+.+.
T Consensus 144 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 223 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223 (288)
T ss_pred EEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH
Confidence 99999999876543221 223589999999987643 6789999999999999999999996422 22334444
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC---HHHHhcCcccccCCc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS---ARELLTDPFLQIDDY 201 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT---a~ELL~HPFf~~~~~ 201 (654)
+.....+ .....++.++++|.+||. +|.+||| +.++|+||||+.-++
T Consensus 224 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 224 ILKSKPP--FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHccCCC--CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 4443332 344578899999999999 8999998 578899999976543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=244.18 Aligned_cols=189 Identities=29% Similarity=0.449 Sum_probs=151.9
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
++++.+.+ +...++||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++ ++|+||+|+||+++. .
T Consensus 62 ~~~~~~~~--~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~-~ 135 (283)
T cd07830 62 KLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSG-P 135 (283)
T ss_pred hHHHHhhc--CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcC-C
Confidence 34555555 68999999999 889999988765 7899999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC-CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.++|+|||++....... .....++..|+|||++.. .++.++|+||||+++++|++|.+||.........++.....
T Consensus 136 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 215 (283)
T cd07830 136 EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215 (283)
T ss_pred CCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhc
Confidence 799999999998665432 234568999999998753 47889999999999999999999998755544443322111
Q ss_pred CCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 157 KKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 157 ~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+ .......++.+++||.+||. +|.+|||+.|++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 216 GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred CCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 100 01112236789999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=247.23 Aligned_cols=191 Identities=27% Similarity=0.466 Sum_probs=157.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ....++|+||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++. .
T Consensus 78 ~~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~-~ 151 (308)
T cd06634 78 IQYRGCYLR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSE-P 151 (308)
T ss_pred ccEEEEEEc--CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECC-C
Confidence 467888877 678999999996 688877654 456899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++...... ....|++.|+|||++. +.++.++||||||+++|+|++|..||.........+ .+..
T Consensus 152 ~~~kl~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~ 228 (308)
T cd06634 152 GLVKLGDFGSASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQ 228 (308)
T ss_pred CcEEECCcccceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhh
Confidence 79999999998765432 3346899999999874 357889999999999999999999997644333333 3444
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+..+.......+..+++||.+||. +|.+||++.+++.|||+....
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 545544445678899999999999 899999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=243.57 Aligned_cols=190 Identities=25% Similarity=0.431 Sum_probs=152.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.+ +..+++|+||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ |+|+||||+||+++.+
T Consensus 61 ~~~~~~~~~--~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~- 134 (283)
T cd05118 61 IKLLDVFRH--KGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE- 134 (283)
T ss_pred chHHHhhcc--CCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-
Confidence 355666665 6899999999964 888887764 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||.+....... .....+++.|+|||++.+ .++.++|+||||+++|+|+||..||.......++.+....
T Consensus 135 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 135 GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred CcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 799999999997765432 223458899999998864 4788999999999999999999999875554444333222
Q ss_pred CCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 156 GKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 156 G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
...+ .......+.++++||.+||. +|.+||++.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1111 01122357889999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=238.19 Aligned_cols=185 Identities=22% Similarity=0.396 Sum_probs=153.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ...+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~- 139 (261)
T cd05148 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGE- 139 (261)
T ss_pred hheeeeEec--CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcC-
Confidence 467777766 67899999999999999999863 46899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCC--ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~--~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
.+.+||+|||++........ ....+++.|+|||++.. .++.++||||||+++|+|++ |..||.. .+....+..+.
T Consensus 140 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~ 218 (261)
T cd05148 140 DLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQIT 218 (261)
T ss_pred CceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHH
Confidence 47999999999987643321 22235678999998864 58889999999999999998 8999976 44556666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+ ......++.+.++|.+||. +|.+|||+.+|++
T Consensus 219 ~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 219 AGYRM-PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred hCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 65433 2345678999999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=241.99 Aligned_cols=184 Identities=25% Similarity=0.433 Sum_probs=150.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ...++++||+++|+|.+++..+ +.+++..+..|+.||+.||.|||+++ |+||||||+|||++. .
T Consensus 72 ~~~~~~~~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~-~ 145 (279)
T cd05109 72 CRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKS-P 145 (279)
T ss_pred ceEEEEEcC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcC-C
Confidence 467777754 4678999999999999998774 46999999999999999999999998 999999999999974 4
Q ss_pred CcEEEEecCchhhhcccCCc----cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+++.+...... ...+++.|+|||.+. ..++.++||||||+++|||++ |..||.. .....+...+
T Consensus 146 ~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~ 224 (279)
T cd05109 146 NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLL 224 (279)
T ss_pred CcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 78999999999876433221 123467899999876 458999999999999999998 8999976 3445555555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .....++.+.++|.+||. +|.+||++.+++.
T Consensus 225 ~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 225 EKGERLP-QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HCCCcCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5554433 345678899999999999 8999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=248.36 Aligned_cols=185 Identities=26% Similarity=0.453 Sum_probs=151.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ...++|+||+.+|+|.+++..+. .++...+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 72 v~~~g~~~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~- 145 (316)
T cd05108 72 CRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP- 145 (316)
T ss_pred CeEEEEEcC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-
Confidence 578888865 46789999999999999998754 6899999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+++.+..... ....+++.|+|||++.+ .++.++||||||+++|||++ |..||.+ ....++...+
T Consensus 146 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~-~~~~~~~~~~ 224 (316)
T cd05108 146 QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSIL 224 (316)
T ss_pred CcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHH
Confidence 7899999999987653221 11224678999998864 58999999999999999998 9999976 3445555555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..+. .....+..+.++|.+||. +|.+||++.+++.+
T Consensus 225 ~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 225 EKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred hCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4444332 345677899999999999 89999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=241.31 Aligned_cols=187 Identities=25% Similarity=0.429 Sum_probs=147.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.......+++||||+.+|+|.+++.+. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~ 144 (283)
T cd05080 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-R 144 (283)
T ss_pred eeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-C
Confidence 4788887766567899999999999999998765 5999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHH-------
Q 006244 81 EVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA------- 147 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~------- 147 (654)
.++|+|||++........ ....++..|+|||++. ..++.++||||||+++|+|+||..||.......
T Consensus 145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 224 (283)
T cd05080 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK 224 (283)
T ss_pred cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccc
Confidence 999999999987643221 1223566799999886 458899999999999999999999986432110
Q ss_pred -------HHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 148 -------QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 148 -------qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+...+..+..+ ......+.++++++.+||. +|++|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 225 QGQMTVVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccccchhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011111111111 1234567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=245.09 Aligned_cols=186 Identities=24% Similarity=0.415 Sum_probs=154.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++.+.. ...+++||||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+
T Consensus 84 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--iv 159 (304)
T cd05101 84 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CI 159 (304)
T ss_pred hheeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 467888776 678999999999999999998642 4778889999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++. .+.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus 160 H~dlkp~Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 238 (304)
T cd05101 160 HRDLAARNVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238 (304)
T ss_pred ecccccceEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 9999999999985 4799999999998664321 112345678999998864 58999999999999999998 788
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.. .+...+++.+..+..+. .....+.++++||.+||. +|.+||++.++++.
T Consensus 239 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 239 PYPG-IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred Cccc-CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8876 45677777776665432 334578899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=239.67 Aligned_cols=188 Identities=21% Similarity=0.334 Sum_probs=152.1
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
|++++.+.... ....++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 63 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp 140 (272)
T cd05075 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAA 140 (272)
T ss_pred ceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccch
Confidence 46777665422 23679999999999999987532 34899999999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++. .+.+||+|||++..+..... ....+++.|+|||++.. .++.++||||||+++|+|++ |..||.. .
T Consensus 141 ~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~ 218 (272)
T cd05075 141 RNCMLNE-NMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-V 218 (272)
T ss_pred hheEEcC-CCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-C
Confidence 9999975 47999999999987643221 12236778999998864 48999999999999999999 8899976 4
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
....++..+..+..+. .....+..++++|.+||. +|.+|||+.+|+++
T Consensus 219 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 219 ENSEIYDYLRQGNRLK-QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4567777777765543 234567889999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=240.21 Aligned_cols=191 Identities=28% Similarity=0.394 Sum_probs=151.0
Q ss_pred CEEEEEEEecCC---CeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTAN---RNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~---~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++++.+..... ..+++|+||+. ++|.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||++
T Consensus 64 ~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili 140 (287)
T cd07838 64 VRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILV 140 (287)
T ss_pred ceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEE
Confidence 468888877321 24999999996 58999887643 5899999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+ +.+||+|||++....... .....+++.|+|||++.+ .++.++|+||||+++|+|++|.+||...... ..+.++
T Consensus 141 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~ 218 (287)
T cd07838 141 TSD-GQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKI 218 (287)
T ss_pred ccC-CCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHH
Confidence 866 899999999997764332 233458899999998864 4888999999999999999999999874433 333333
Q ss_pred HcCC-C------C------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 154 ISGK-K------P------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 154 ~~G~-~------p------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.... . + .......++.+.++|.+||. +|.+||++.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 3210 0 0 01112245788999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=237.00 Aligned_cols=184 Identities=21% Similarity=0.368 Sum_probs=154.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.+ ....++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 63 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~- 137 (256)
T cd05039 63 VQLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSE- 137 (256)
T ss_pred eeeEEEEcC--CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeC-
Confidence 468888776 688999999999999999998765 6999999999999999999999999 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++........ ...++..|+|||++. +.++.++||||||+++|+|++ |..||.. .+...+...+..+
T Consensus 138 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~ 215 (256)
T cd05039 138 DLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKG 215 (256)
T ss_pred CCCEEEcccccccccccccc-cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcC
Confidence 47999999999987643322 233566899999876 458889999999999999997 9999976 4556666666655
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+ ......++.+.++|.+||. +|.+||++.+++.
T Consensus 216 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 YRM-EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCC-CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 433 2345578999999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=237.11 Aligned_cols=187 Identities=20% Similarity=0.330 Sum_probs=149.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++++.+... ++..++|+||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. .
T Consensus 59 v~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~-~ 134 (262)
T cd05058 59 LSLLGICLPS-EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDE-S 134 (262)
T ss_pred ceEEEEeecC-CCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcC-C
Confidence 5778866542 45688999999999999998764 45788888999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC------CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhc-CCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG-~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++..+.... .....+++.|+|||++. ..++.++||||||+++|||++| .+||.. .+...+..
T Consensus 135 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~ 213 (262)
T cd05058 135 FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITV 213 (262)
T ss_pred CcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 789999999997553211 11234677899999876 4588999999999999999995 556654 45556666
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+..+. .....++.+.+++.+||. +|.+||++.++++.
T Consensus 214 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 214 YLLQGRRLL-QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHhcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 666665443 234457889999999999 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=241.26 Aligned_cols=186 Identities=21% Similarity=0.339 Sum_probs=152.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPV 63 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~I 63 (654)
|++++++.. ....++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |
T Consensus 70 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i 145 (283)
T cd05090 70 VCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--F 145 (283)
T ss_pred eeEEEEEec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--e
Confidence 578887766 67899999999999999998643 23788899999999999999999998 9
Q ss_pred EecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cC
Q 006244 64 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FD 137 (654)
Q Consensus 64 IHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~ 137 (654)
+||||||+|||++.+ +.+||+|||+++...... .....++..|+|||++. ..++.++||||||+++|+|++ |.
T Consensus 146 ~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~ 224 (283)
T cd05090 146 VHKDLAARNILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGL 224 (283)
T ss_pred ehhccccceEEEcCC-CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 999999999999854 789999999997654321 22234677899999886 458999999999999999998 99
Q ss_pred CCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 138 YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 138 ~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.||.+. +...+...+..+..+ ..+...++.++++|.+||. +|.+||++.+++++
T Consensus 225 ~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 225 QPYYGF-SNQEVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 999763 445555666554433 3455678999999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=238.40 Aligned_cols=188 Identities=20% Similarity=0.331 Sum_probs=152.5
Q ss_pred CEEEEEEEecCC----CeEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTAN----RNINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~----~~i~LVtEy~~gGSL~~~l~k~------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
+++|+.+..... ...++|+||+.+|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 64 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp 141 (273)
T cd05035 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAA 141 (273)
T ss_pred eeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccch
Confidence 467777665322 3589999999999999998543 25899999999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+||+++.+ +.+||+|||++........ ....+++.|+|||++.. .++.++||||||+++|||++ |..||...
T Consensus 142 ~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~- 219 (273)
T cd05035 142 RNCMLRED-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV- 219 (273)
T ss_pred heEEECCC-CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999854 7999999999976543221 11235678999998864 58899999999999999999 88999764
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
...++++.+..+..+. .+...++++.++|.+||+ +|.+||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 220 ENHEIYDYLRHGNRLK-QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CHHHHHHHHHcCCCCC-CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4556667776665443 445678999999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=238.56 Aligned_cols=184 Identities=20% Similarity=0.368 Sum_probs=151.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++++.+. ...+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+|||++. .
T Consensus 58 i~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~-~ 131 (257)
T cd05115 58 VRMIGVCE---AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVN-Q 131 (257)
T ss_pred EEEEEEEc---CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcC-C
Confidence 46777664 3578999999999999999875 456999999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++..+..... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||... ....+...
T Consensus 132 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~ 210 (257)
T cd05115 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSF 210 (257)
T ss_pred CcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHH
Confidence 7999999999976543211 1112357899999886 458889999999999999996 99999874 44556666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+ ......++++.++|.+||. +|.+||++.++++
T Consensus 211 ~~~~~~~-~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 211 IEQGKRL-DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHCCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7666554 3445678999999999999 8999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=234.35 Aligned_cols=185 Identities=26% Similarity=0.415 Sum_probs=155.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~--Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+.. .+.+++||||+.+++|.+++..... +++..+..++.||+.||.|||+.+ ++|+||||+||+++.+
T Consensus 64 ~~~~~~~~~--~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~ 139 (258)
T smart00219 64 VKLLGVCTE--EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN 139 (258)
T ss_pred heEEEEEcC--CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC
Confidence 578888877 5899999999999999999987554 999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCc---cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~---~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.++|+|||++......... ...+++.|+|||.+.. .++.++||||||+++|+|++ |..||.. .+...++..+
T Consensus 140 -~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~ 217 (258)
T smart00219 140 -LVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYL 217 (258)
T ss_pred -CeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 79999999999766543111 1236789999998854 58899999999999999998 7888876 5566677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .....+.++.+++.+||. +|.+|||+.++++
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 218 KKGYRLP-KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred hcCCCCC-CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 7666543 344578999999999999 8999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=238.29 Aligned_cols=186 Identities=23% Similarity=0.380 Sum_probs=153.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ++.+++||||+.+|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 68 ~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~- 142 (266)
T cd05033 68 IRLEGVVTK--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN- 142 (266)
T ss_pred ceEeEEEec--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-
Confidence 478887766 67899999999999999998775 46899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.++|+|||++........ ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~ 221 (266)
T cd05033 143 LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-SNQDVIKAV 221 (266)
T ss_pred CCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-CHHHHHHHH
Confidence 7899999999987742111 1123567899999886 458899999999999999998 99999764 345566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..+. .....++.+.+++.+||. +|.+||++.+++++
T Consensus 222 ~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 222 EDGYRLP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 6554332 234578899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=241.77 Aligned_cols=186 Identities=23% Similarity=0.320 Sum_probs=150.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-----------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLK 69 (654)
++++++|.. +..+++|+||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++ |+|||||
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk 157 (296)
T cd05051 82 ARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA 157 (296)
T ss_pred eEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence 478888876 689999999999999999998766 6899999999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh--cCCCCCC
Q 006244 70 CDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT--FDYPYSE 142 (654)
Q Consensus 70 peNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT--G~~Pf~~ 142 (654)
|+|||++.+ +.++|+|||++..+.... .....+++.|+|||++.. .++.++||||||+++|+|++ +..||..
T Consensus 158 p~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 158 TRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999855 799999999987654321 223346789999998764 68999999999999999998 7788876
Q ss_pred CCCHHHHHHHHHcC----C--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 143 CTHPAQIYKKVISG----K--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 143 ~~~~~qi~kki~~G----~--~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.. ..++...+... . .........+.++.++|.+||+ +|.+|||+.+|++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cC-hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 43 34444444332 1 1112233456899999999999 8999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=240.44 Aligned_cols=186 Identities=18% Similarity=0.276 Sum_probs=153.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|++++.+.. ...+++++||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+
T Consensus 71 v~~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~ 146 (283)
T cd05091 71 VCLLGVVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VV 146 (283)
T ss_pred CeEEEEEcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--cc
Confidence 578888766 67899999999999999998632 24788899999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++. .+.+||+|||+++.+.... .....+++.|+|||++. +.++.++||||||+++|||++ |..
T Consensus 147 H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 225 (283)
T cd05091 147 HKDLATRNVLVFD-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225 (283)
T ss_pred ccccchhheEecC-CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCC
Confidence 9999999999984 4789999999987654322 12334678999999875 568999999999999999998 888
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.+ ....++...+..+..+. .....+.++.+++.+||+ +|.+||++.+++..
T Consensus 226 p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 226 PYCG-YSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCC-CCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 8876 45566777777665432 345578899999999999 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=240.75 Aligned_cols=191 Identities=25% Similarity=0.368 Sum_probs=152.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.+.....+++|+||+. ++|.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||||+|||++. .
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~-~ 136 (287)
T cd07840 61 VRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINN-D 136 (287)
T ss_pred eeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcC-C
Confidence 46777777633479999999996 5899988765 57999999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++....... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||....... ....+.
T Consensus 137 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~ 215 (287)
T cd07840 137 GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIF 215 (287)
T ss_pred CCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 799999999998765442 233457889999997753 47889999999999999999999998755333 333332
Q ss_pred cCC--CC-c--------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 155 SGK--KP-E--------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~--~p-~--------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
... .+ . .+....++.+.++|.+||. +|.+||++.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 210 00 0 0111137889999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=265.46 Aligned_cols=194 Identities=26% Similarity=0.433 Sum_probs=147.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
|++|+++.. .+..|+|+|++ +++|..++... .......++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 226 v~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl 300 (501)
T PHA03210 226 LKIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFL 300 (501)
T ss_pred CcEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEE
Confidence 578998877 67899999999 56888876542 23456778899999999999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC---CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCC-CCCCC-CH-HH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP-YSECT-HP-AQ 148 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~P-f~~~~-~~-~q 148 (654)
+.+ +.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|||++|.+| |.... ++ .+
T Consensus 301 ~~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 854 799999999998765432 223579999999999875 599999999999999999998865 43221 22 22
Q ss_pred HHHHHHcCC-----CCc-------------------cc-----ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 149 IYKKVISGK-----KPE-------------------AL-----FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 149 i~kki~~G~-----~p~-------------------~l-----~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.+.+.... .|. .+ ....+..+.++|.+||. +|.+|||+.|+|.||||..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 222221100 010 00 01235677888999999 9999999999999999976
Q ss_pred CC
Q 006244 199 DD 200 (654)
Q Consensus 199 ~~ 200 (654)
..
T Consensus 460 ~~ 461 (501)
T PHA03210 460 EE 461 (501)
T ss_pred CC
Confidence 44
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=245.53 Aligned_cols=191 Identities=27% Similarity=0.448 Sum_probs=156.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++++++.. +...++|+||+. |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++. .
T Consensus 88 v~~~~~~~~--~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~-~ 161 (317)
T cd06635 88 IEYKGCYLR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTE-P 161 (317)
T ss_pred EEEEEEEee--CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECC-C
Confidence 478888877 678999999996 577777654 456999999999999999999999998 999999999999975 4
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||++..... .....|++.|+|||++. +.++.++||||||+++|+|++|..||........ ...+..
T Consensus 162 ~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~ 238 (317)
T cd06635 162 GQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 238 (317)
T ss_pred CCEEEecCCCccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHh
Confidence 7999999999875432 23346899999999873 4588899999999999999999999977543333 344444
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+..+.......++.++++|.+||+ +|.+||++.+++.|+|+....
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 239 NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 444444445677899999999999 899999999999999996544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=277.50 Aligned_cols=190 Identities=21% Similarity=0.384 Sum_probs=155.2
Q ss_pred CEEEEE-EEec-C---CCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTS-WVDT-A---NRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~s-fvd~-~---~~~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|.||++ .... . ...+.|+||||.||.|-+|+++ ..+|++..|.+|++|+++|+.+||...|||||||||-+||
T Consensus 98 V~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENv 177 (738)
T KOG1989|consen 98 VSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENV 177 (738)
T ss_pred eeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhhe
Confidence 467773 3221 1 2478999999999999999985 3469999999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecCchhhhcccCCc-----------cccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCC
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKSHAA-----------RCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDY 138 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~~~~-----------~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~ 138 (654)
||..+ |+.||||||.|...-..... ....||.|+|||++. ...++|+|||+|||+||-|+.+..
T Consensus 178 Lls~~-g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 178 LLSAD-GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred EEcCC-CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 99854 89999999999654322211 124799999999986 248999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
||.+... -.|..|.........++..+++||..||+ +|.+||++.+++.+-|.
T Consensus 257 PFe~sg~-----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 257 PFEESGK-----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred CcCcCcc-----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 9987432 24566666555556788999999999999 89999999999876443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=251.81 Aligned_cols=192 Identities=27% Similarity=0.409 Sum_probs=150.6
Q ss_pred EEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 2 KFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 2 kfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
++++.+.... ...++||+||+. ++|.+++...+.+++..+..++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 68 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~ 144 (337)
T cd07858 68 AIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN 144 (337)
T ss_pred chHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC
Confidence 4555554422 146899999995 799999988888999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc--CCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++...... ......++..|+|||++. ..++.++||||||+++|+|++|.+||.+... ...+..+.
T Consensus 145 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~ 222 (337)
T cd07858 145 -CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLIT 222 (337)
T ss_pred -CCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHH
Confidence 79999999999866433 123346899999999875 3588999999999999999999999975321 11111111
Q ss_pred c--CC-----------------------CC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 S--GK-----------------------KP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~--G~-----------------------~p----~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. |. .+ ....+..++++++||.+||. +|.+|||+.++|+||||..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0 00 00 11223567899999999999 8999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=240.13 Aligned_cols=187 Identities=29% Similarity=0.530 Sum_probs=154.7
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
++++++.+ ....++|+||+.+++|.+++.+ ...+++..++.++.||+.||.|||+++ ++|+||||+||+++.
T Consensus 66 ~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~ 141 (260)
T cd08222 66 KFHASFLE--RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN 141 (260)
T ss_pred HHHHHHhc--CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec
Confidence 34555554 5679999999999999998764 346999999999999999999999998 999999999999973
Q ss_pred CCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.++|+|||++....... .....|++.|+|||.+.. .++.++|+||||+++|+|++|..||.. ........++.
T Consensus 142 --~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~ 218 (260)
T cd08222 142 --NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIV 218 (260)
T ss_pred --CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHH
Confidence 579999999987654322 223458899999998764 478899999999999999999999975 34455555666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.+..+. .....+.++.++|.+||. +|.+||++.+++.||||
T Consensus 219 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 219 EGPTPS-LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred cCCCCC-CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 555443 445678899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=235.61 Aligned_cols=182 Identities=23% Similarity=0.331 Sum_probs=145.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ...++|+||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 64 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 64 VKLYGVCVR---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYG 138 (259)
T ss_pred hheeeEEec---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCc
Confidence 467787765 46799999999999999998766 7999999999999999999999998 99999999999998542
Q ss_pred ------CcEEEEecCchhhhcccCCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHH
Q 006244 80 ------GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQI 149 (654)
Q Consensus 80 ------g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi 149 (654)
+.+||+|||++..... .....+++.|+|||++.. .++.++||||||+++|+|++ |..||.... ....
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~ 215 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEK 215 (259)
T ss_pred cccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhH
Confidence 1699999999987543 223457889999999864 48889999999999999999 578886643 2222
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
....... ..........+.++|.+||. +|.+|||+.++++.
T Consensus 216 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 216 ERFYQDQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred HHHHhcC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 2222211 11122234789999999999 89999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=239.00 Aligned_cols=187 Identities=21% Similarity=0.355 Sum_probs=155.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
|++++++.+ ....++||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 71 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~ 146 (275)
T cd05046 71 VRLLGLCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAAR 146 (275)
T ss_pred eeeEEEECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccc
Confidence 578887765 678999999999999999998766 6899999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCH
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHP 146 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~ 146 (654)
|||++. .+.++|+|||++....... .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||... ..
T Consensus 147 Nili~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~ 224 (275)
T cd05046 147 NCLVSS-QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SD 224 (275)
T ss_pred eEEEeC-CCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-ch
Confidence 999985 4799999999987543221 12234678899999876 457889999999999999999 88899763 34
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 147 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 147 ~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+...+..+..+.......+..+.++|.+||. +|.+||++.+++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 556666666665544455678899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=252.13 Aligned_cols=194 Identities=26% Similarity=0.403 Sum_probs=151.3
Q ss_pred EEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 2 KFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 2 kfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
++++.|... ....+++|+||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 68 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~-~ 143 (334)
T cd07855 68 AIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNE-D 143 (334)
T ss_pred CHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcC-C
Confidence 344444422 2468999999995 699999988788999999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC------CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
|.+||+|||++....... ....+|++.|+|||++.. .++.++||||||+++|+|++|..||.......++..
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~ 223 (334)
T cd07855 144 CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223 (334)
T ss_pred CcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHH
Confidence 899999999997654321 123468999999998754 488999999999999999999999976433322211
Q ss_pred HHH-cCCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 152 KVI-SGKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 152 ki~-~G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
... .|..+ ..+.+..+++++++|.+||+ +|.+||++.+++.||||...
T Consensus 224 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred HHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 110 01110 01123467899999999999 89999999999999999743
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=240.96 Aligned_cols=185 Identities=23% Similarity=0.396 Sum_probs=152.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------------------RRVNIRAVKHWCRQILSGLLYL 56 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~------------------------~~Lse~~i~~i~~QIl~gL~YL 56 (654)
|++++.+.. ....++|+||+.+|+|.+++... ..+++..+..++.||+.||+||
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 143 (290)
T cd05045 66 IKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL 143 (290)
T ss_pred eeEEEEEec--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH
Confidence 578888776 67899999999999999998753 2478899999999999999999
Q ss_pred HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHH
Q 006244 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCIL 131 (654)
Q Consensus 57 Hs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ 131 (654)
|+++ |+||||||+|||++. .+.+||+|||++....... .....++..|+|||++.. .++.++||||||+++|
T Consensus 144 H~~~--ivH~dikp~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~ 220 (290)
T cd05045 144 AEMK--LVHRDLAARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 220 (290)
T ss_pred HHCC--eehhhhhhheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHH
Confidence 9998 999999999999985 4799999999997653221 122235678999998754 4889999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 132 EMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 132 ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+|++ |..||.. ..+..++..+..+..+. .....+.++++||.+||. +|.+||++.++++
T Consensus 221 el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 221 EIVTLGGNPYPG-IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhcCCCCCCC-CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999 9999976 45667776666554433 345578899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=243.87 Aligned_cols=190 Identities=25% Similarity=0.377 Sum_probs=145.6
Q ss_pred EEEEEEEecC------CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 2 KFYTSWVDTA------NRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 2 kfY~sfvd~~------~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
++++.+.... ...+++|+||+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil 147 (311)
T cd07866 71 PLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANIL 147 (311)
T ss_pred chhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEE
Confidence 4555554422 346899999996 467776664 457999999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhcccCC-------------ccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCC
Q 006244 75 VNGNQGEVKIGDLGLAAILRKSHA-------------ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~~~-------------~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
++.+ +.++|+|||++........ ...+|++.|+|||++.+ .++.++||||||+++|+|++|.+|
T Consensus 148 ~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 148 IDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred ECCC-CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 9854 7999999999976543211 22357889999998753 478999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHc--CCC-C----------------------c---ccccCCChHHHHHHHHHhh-CccCCCCHHHH
Q 006244 140 YSECTHPAQIYKKVIS--GKK-P----------------------E---ALFKVEDPEVRQFIEKCLA-TVSSRLSAREL 190 (654)
Q Consensus 140 f~~~~~~~qi~kki~~--G~~-p----------------------~---~l~~~~spelrdLI~kCL~-dP~~RpTa~EL 190 (654)
|...... .....+.. +.. + . ......++.+++||.+||. +|.+|||+.++
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 227 LQGKSDI-DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCCCHH-HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 9764433 22233221 100 0 0 0012344788999999999 89999999999
Q ss_pred hcCccc
Q 006244 191 LTDPFL 196 (654)
Q Consensus 191 L~HPFf 196 (654)
+.||||
T Consensus 306 l~~~~f 311 (311)
T cd07866 306 LEHPYF 311 (311)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=250.50 Aligned_cols=181 Identities=32% Similarity=0.469 Sum_probs=149.5
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+.+|+||||+. ++|.+++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.++|+|||++..
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~ 152 (330)
T cd07834 77 NDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARG 152 (330)
T ss_pred cceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEe
Confidence 47899999996 589999988778999999999999999999999999 9999999999999865 8999999999987
Q ss_pred hcccC-----CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCc---
Q 006244 93 LRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPE--- 160 (654)
Q Consensus 93 l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~--G~~p~--- 160 (654)
..... .....+++.|+|||++.+ .++.++|+||||+++|+|++|.+||.... ....++.+.. |..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHh
Confidence 65432 234568999999998864 48889999999999999999999998744 3343444433 11110
Q ss_pred ------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 161 ------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 161 ------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
......++++++||.+||. +|.+||++.++|.||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 0122357889999999999 8999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=231.96 Aligned_cols=186 Identities=21% Similarity=0.343 Sum_probs=151.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++. .
T Consensus 55 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~-~ 129 (250)
T cd05085 55 VKLIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGE-N 129 (250)
T ss_pred CeEEEEEec--CCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcC-C
Confidence 478888766 67899999999999999998764 46899999999999999999999998 999999999999984 4
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++........ ....+++.|+|||++. ..++.++||||||+++|+|++ |..||... +.......+.
T Consensus 130 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~ 208 (250)
T cd05085 130 NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVE 208 (250)
T ss_pred CeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHH
Confidence 7999999999875433221 1123467899999886 458889999999999999998 99999874 4445555555
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+... ..+...+..+.+++.+||. +|.+||++.++++.
T Consensus 209 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 209 KGYRM-SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred cCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 55433 2344568899999999999 89999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=238.51 Aligned_cols=183 Identities=21% Similarity=0.350 Sum_probs=145.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. +...++||||+++|+|..++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+.
T Consensus 67 v~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~ 142 (262)
T cd05077 67 VLLYGVCVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREG 142 (262)
T ss_pred eeEEEEEec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCC
Confidence 578898876 67889999999999999998764 56999999999999999999999998 99999999999997432
Q ss_pred ------CcEEEEecCchhhhcccCCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHh-hcCCCCCCCCCHHHHH
Q 006244 80 ------GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMV-TFDYPYSECTHPAQIY 150 (654)
Q Consensus 80 ------g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELl-TG~~Pf~~~~~~~qi~ 150 (654)
+.++++|||++..... ....+|++.|+|||++. ..++.++||||||+++|+|+ +|..||.... ....
T Consensus 143 ~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~- 218 (262)
T cd05077 143 IDGECGPFIKLSDPGIPITVLS--RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEK- 218 (262)
T ss_pred ccCCCCceeEeCCCCCCccccC--cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHH-
Confidence 1389999999865532 22346889999999885 35889999999999999998 5888887532 2222
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.....+..+ .....++++++||.+||. +|.+||++.+|+.+
T Consensus 219 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 219 ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 222232222 222345789999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=235.54 Aligned_cols=185 Identities=23% Similarity=0.378 Sum_probs=152.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ++.+++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++.+
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~- 142 (267)
T cd05066 68 IHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN- 142 (267)
T ss_pred ceEEEEEec--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-
Confidence 578888865 67899999999999999999875 46899999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.++|+|||++..+..... ....+++.|+|||++. ..++.++|+||||+++|++++ |..||... ...+....
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~-~~~~~~~~ 221 (267)
T cd05066 143 LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM-SNQDVIKA 221 (267)
T ss_pred CeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC-CHHHHHHH
Confidence 7999999999987643221 1112356899999887 468999999999999999886 99999774 34556666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+. .....++.+++++.+||. +|.+||++.+++.
T Consensus 222 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 222 IEEGYRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HhCCCcCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 76664332 234567899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=245.46 Aligned_cols=187 Identities=24% Similarity=0.409 Sum_probs=153.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++++.+.. ...+++|+||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+
T Consensus 81 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--iv 156 (334)
T cd05100 81 INLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CI 156 (334)
T ss_pred eeeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--ee
Confidence 578888766 678999999999999999987632 3788899999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||+++....... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus 157 H~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 235 (334)
T cd05100 157 HRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235 (334)
T ss_pred ccccccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC
Confidence 99999999999854 7999999999976543211 11234568999998864 58899999999999999998 889
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
||.. .+...+++.+..+..+. .....+.++.++|.+||. +|.+||++.+++.+-
T Consensus 236 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 236 PYPG-IPVEELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9976 45666777776655433 334567899999999999 899999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=234.75 Aligned_cols=185 Identities=22% Similarity=0.365 Sum_probs=151.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. .+.+++||||+.+|+|.+++..+ +.+++..+..++.|++.||.|||+.+ ++||||||+|||++. .
T Consensus 69 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~-~ 143 (268)
T cd05063 69 IRLEGVVTK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNS-N 143 (268)
T ss_pred eEEEEEEcc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcC-C
Confidence 467887765 67899999999999999998764 57899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCcc-----ccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~-----~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++.......... ...++.|+|||++. ..++.++||||||+++|+|++ |..||... +...+.+.
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~ 222 (268)
T cd05063 144 LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKA 222 (268)
T ss_pred CcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHH
Confidence 789999999997654322111 12345799999886 458899999999999999998 99999764 44556666
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+.... .....+.++.+++.+||. +|.+||++.++++
T Consensus 223 i~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 223 INDGFRLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HhcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 66553322 233467899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=234.54 Aligned_cols=184 Identities=22% Similarity=0.357 Sum_probs=149.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+. ....++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.
T Consensus 64 ~~~~~~~~---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~- 137 (260)
T cd05069 64 VPLYAVVS---EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGD- 137 (260)
T ss_pred eeEEEEEc---CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcC-
Confidence 46777653 356899999999999999997643 4899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.++|+|||++........ ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+. ........+
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~ 216 (260)
T cd05069 138 NLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQV 216 (260)
T ss_pred CCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 47999999999976543321 1223667899999886 458889999999999999999 89999874 444555555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ..+...+..++++|.+||. +|.+||+++++++
T Consensus 217 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 217 ERGYRM-PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HcCCCC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 554332 2344577899999999999 8999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=231.53 Aligned_cols=185 Identities=24% Similarity=0.386 Sum_probs=149.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ..+.++|+||+.|++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+|||++.+
T Consensus 55 ~~~~~~~~~--~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~- 129 (251)
T cd05041 55 VKLIGVCVQ--KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN- 129 (251)
T ss_pred EEEEEEEec--CCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-
Confidence 357777766 67899999999999999998763 46899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++........ ....++..|+|||++. +.++.++|+||||+++|+|+| |..||... ........+
T Consensus 130 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~ 208 (251)
T cd05041 130 NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERI 208 (251)
T ss_pred CcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHH
Confidence 7999999999976542111 1122356799999876 458899999999999999999 88999763 344455555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+.. ...+...+.++.++|.+||. +|.+|||+.++|+
T Consensus 209 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 209 ESGYR-MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred hcCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 44432 22344567899999999999 8999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=246.09 Aligned_cols=193 Identities=28% Similarity=0.446 Sum_probs=150.8
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+... ....+++++||+. ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 65 v~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~ 141 (332)
T cd07857 65 TCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD 141 (332)
T ss_pred heeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC
Confidence 4566654432 2356899999995 799999988888999999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC------CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
+.+||+|||++..+.... ....+||+.|+|||++.+ .++.++||||||+++|+|++|.+||..... ....
T Consensus 142 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-~~~~ 219 (332)
T cd07857 142 -CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-VDQL 219 (332)
T ss_pred -CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-HHHH
Confidence 799999999997654321 223468999999998754 488999999999999999999999976332 2222
Q ss_pred HHHHc--C-----------------------CCC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 151 KKVIS--G-----------------------KKP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 151 kki~~--G-----------------------~~p----~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
..+.. | ..+ .......++.+++||.+||. +|.+|||+.+++.||||+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 220 NQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred HHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 21111 0 000 11223357899999999999 8999999999999999953
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=254.90 Aligned_cols=153 Identities=25% Similarity=0.389 Sum_probs=125.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChh
Q 006244 36 RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPE 111 (654)
Q Consensus 36 ~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPE 111 (654)
.+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++....... .....+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 3778888999999999999999998 9999999999999854 789999999997653321 12234778999999
Q ss_pred hhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHH
Q 006244 112 VYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR 188 (654)
Q Consensus 112 vl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ 188 (654)
++.+ .++.++||||||+++|+|++ |..||........++..+..+..+. .....+++++++|.+||. +|.+||++.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 8864 58999999999999999997 9999987555555666666664432 344568899999999999 899999999
Q ss_pred HHhc
Q 006244 189 ELLT 192 (654)
Q Consensus 189 ELL~ 192 (654)
+|.+
T Consensus 389 ~l~~ 392 (400)
T cd05105 389 HLSD 392 (400)
T ss_pred HHHH
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=237.65 Aligned_cols=188 Identities=30% Similarity=0.424 Sum_probs=149.9
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++.+.+ ...+++|+||+. ++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||+|+||+++. .+
T Consensus 62 ~~~~~~~~--~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~-~~ 135 (282)
T cd07829 62 KLLDVIHT--ERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINR-DG 135 (282)
T ss_pred HHHhhhhc--CCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcC-CC
Confidence 45566655 579999999997 6999999886 57999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.++|+|||++....... .....+++.|+|||++.. .++.++||||||+++|+|++|.+||........+ .++...
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-~~~~~~ 214 (282)
T cd07829 136 VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL-FKIFQI 214 (282)
T ss_pred CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHHHH
Confidence 99999999997764432 223346788999998753 5888999999999999999999999774433332 222110
Q ss_pred --------------------CCCc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 157 --------------------KKPE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 157 --------------------~~p~-------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
..+. ...+..+..++++|.+||. +|.+||++.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 1112346789999999999 89999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=235.39 Aligned_cols=185 Identities=23% Similarity=0.428 Sum_probs=151.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.+ ...++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ ++||||||+|||++.+
T Consensus 70 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~- 143 (270)
T cd05056 70 VKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP- 143 (270)
T ss_pred hceeEEEcC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-
Confidence 578887764 56789999999999999998744 5899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++........ ....+++.|+|||++.. .++.++||||||+++|+|++ |..||..... ......+.
T Consensus 144 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~ 222 (270)
T cd05056 144 DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIE 222 (270)
T ss_pred CCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHH
Confidence 7999999999876543321 11224568999998864 58899999999999999996 9999987544 44445565
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .+...++.++++|.+||. +|.+|||+.+++..
T Consensus 223 ~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 223 NGERLP-MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred cCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555442 345678899999999999 89999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=247.61 Aligned_cols=180 Identities=29% Similarity=0.500 Sum_probs=141.7
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
..+++|+||+. ++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~-~~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNT-NCDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECC-CCCEEECcccceee
Confidence 46899999995 588887644 57999999999999999999999999 999999999999984 47999999999876
Q ss_pred hcccC-----CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CC------
Q 006244 93 LRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GK------ 157 (654)
Q Consensus 93 l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~--G~------ 157 (654)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||........ ...+.. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHH
Confidence 54321 123468999999998653 488899999999999999999999976432211 111110 00
Q ss_pred --------------CC-------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 --------------KP-------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 --------------~p-------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+ .......++++++||.+||. +|.+|||+.+++.||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 00 00122357889999999999 8999999999999999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=237.90 Aligned_cols=185 Identities=20% Similarity=0.297 Sum_probs=151.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------------RVNIRAVKHWCRQILSGLLYLHS 58 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------------~Lse~~i~~i~~QIl~gL~YLHs 58 (654)
+++++++.+ ...+++|+||+.+|+|.+++.... .+++..+..++.||+.||.|||+
T Consensus 71 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~ 148 (288)
T cd05050 71 VKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE 148 (288)
T ss_pred heEEEEEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 578887766 678999999999999999997532 37788899999999999999999
Q ss_pred CCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHH
Q 006244 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133 (654)
Q Consensus 59 ~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~EL 133 (654)
++ ++||||||+|||++. .+.++|+|||++..+.... .....+++.|+|||++. ..++.++||||||+++|+|
T Consensus 149 ~~--i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 225 (288)
T cd05050 149 RK--FVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225 (288)
T ss_pred CC--eecccccHhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHH
Confidence 98 999999999999985 4799999999987653221 11223567899999876 4589999999999999999
Q ss_pred hh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 134 VT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 134 lT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
++ |..||.+ .+...+...+..+..+. .....++++.+||.+||+ +|.+|||+.|+++
T Consensus 226 ~~~~~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 226 FSYGMQPYYG-MAHEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 98 8889876 44566666666665432 234567899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=237.53 Aligned_cols=183 Identities=24% Similarity=0.309 Sum_probs=145.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~- 78 (654)
+++|+++.. ....+|||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 79 v~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 79 AFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLG 154 (274)
T ss_pred eeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccC
Confidence 578998877 6789999999999999999876 457899999999999999999999998 9999999999999742
Q ss_pred -----CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHh-hcCCCCCCCCCHHHHH
Q 006244 79 -----QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMV-TFDYPYSECTHPAQIY 150 (654)
Q Consensus 79 -----~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELl-TG~~Pf~~~~~~~qi~ 150 (654)
.+.+|++|||++...... ....+++.|+|||.+.+ .++.++||||||+++|||+ +|..||.... .....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~ 231 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT-PSEKE 231 (274)
T ss_pred cccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC-hHHHH
Confidence 124899999988644221 23457889999998864 4889999999999999985 6999997643 23222
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+ .... ..+....+.+.++|.+||. +|.+||++.++|++
T Consensus 232 ~~~-~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFY-EKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHH-Hhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222 2111 1223346789999999999 89999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=226.85 Aligned_cols=190 Identities=36% Similarity=0.583 Sum_probs=161.5
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++++++.. ....++|+||+.+++|.+++.....++...+..++.+++.+|.|||+.+ |+|+||+|.||+++.+ +.
T Consensus 51 ~~~~~~~~--~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~ 125 (244)
T smart00220 51 RLYDVFED--EDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GH 125 (244)
T ss_pred HHHhheee--CCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-Cc
Confidence 34555655 5789999999999999999988767999999999999999999999998 9999999999999855 79
Q ss_pred EEEEecCchhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 82 VKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 82 VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
++|+|||++...... ......+++.|++||.+. ..++.++||||||+++++|++|..||........+...+..+..+
T Consensus 126 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 205 (244)
T smart00220 126 VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 205 (244)
T ss_pred EEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC
Confidence 999999999876554 334456899999999886 458889999999999999999999998756667777766665554
Q ss_pred cccccC-CChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 160 EALFKV-EDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 160 ~~l~~~-~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
...... .+.++.+++.+||. +|.+||++.++++||||
T Consensus 206 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 206 FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 333222 67899999999999 89999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=236.77 Aligned_cols=189 Identities=25% Similarity=0.448 Sum_probs=148.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.......+++||||++||+|.+++.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~-~ 145 (284)
T cd05079 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVES-E 145 (284)
T ss_pred eeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcC-C
Confidence 46788777755578999999999999999987653 5899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC----------
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC---------- 143 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~---------- 143 (654)
+.++|+|||++..+.... .....|+..|+|||++.+ .++.++||||||+++|+|+|+..|+...
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05079 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP 225 (284)
T ss_pred CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence 789999999998764322 123346778999998764 5889999999999999999987665321
Q ss_pred ----CCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 144 ----THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 144 ----~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.......+.+..+... ......+..+.+||.+||. +|.+||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 226 THGQMTVTRLVRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccccccHHHHHHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1112222223333322 2344578899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=233.49 Aligned_cols=183 Identities=23% Similarity=0.372 Sum_probs=148.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+. ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||+++.
T Consensus 64 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~- 137 (260)
T cd05070 64 VQLYAVVS---EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGD- 137 (260)
T ss_pred EEEEeEEC---CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeC-
Confidence 46777653 35689999999999999998763 45899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCCc---cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.++|+|||++..+...... ...++..|+|||++. ..++.++||||||+++|+|++ |..||... +.......+
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~ 216 (260)
T cd05070 138 GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQV 216 (260)
T ss_pred CceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence 479999999999766443221 223556899999876 458889999999999999999 89999764 344555566
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
..+..+ ..+...+..+++|+.+||. +|.+|||+.+++
T Consensus 217 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 217 ERGYRM-PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred HcCCCC-CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 554333 3345678899999999999 899999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=232.04 Aligned_cols=183 Identities=21% Similarity=0.381 Sum_probs=150.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. +..++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+|||++.+
T Consensus 62 ~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~ 136 (254)
T cd05083 62 VRLLGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED 136 (254)
T ss_pred CeEEEEEcC---CCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC
Confidence 577887764 45799999999999999998653 5899999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||++...... ......++.|+|||++. ..++.++|+||||+++|+|++ |..||... +.......+..+
T Consensus 137 -~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~ 213 (254)
T cd05083 137 -GVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKG 213 (254)
T ss_pred -CcEEECCCccceecccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCC
Confidence 79999999998764332 22233567899999886 458889999999999999998 99999764 455566666666
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+. .....++.++++|.+||. +|.+||++.+++.
T Consensus 214 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 214 YRME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5443 344578899999999999 8999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=231.93 Aligned_cols=186 Identities=23% Similarity=0.422 Sum_probs=152.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. ...+++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++. .
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~-~ 136 (256)
T cd05112 62 VQLYGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGE-N 136 (256)
T ss_pred eeEEEEEcc--CCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcC-C
Confidence 467887766 67899999999999999998764 46899999999999999999999998 999999999999984 4
Q ss_pred CcEEEEecCchhhhcccCCc---cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.++|+|||++......... ...++..|+|||++. +.++.++||||||+++|+|++ |..||.. .....+...+.
T Consensus 137 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~ 215 (256)
T cd05112 137 QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETIN 215 (256)
T ss_pred CeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHh
Confidence 79999999998765332221 123457899999887 458889999999999999998 9999976 44556666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .....+..+.+|+.+||. +|.+||++.++++.
T Consensus 216 ~~~~~~-~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 216 AGFRLY-KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCCC-CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 654432 234568899999999999 89999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=246.58 Aligned_cols=188 Identities=24% Similarity=0.386 Sum_probs=151.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------------------------------------
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------------------------------------------- 34 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------------------------------------------- 34 (654)
|++++++... +..+++|||||.+|+|.+++...
T Consensus 74 v~~~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (343)
T cd05103 74 VNLLGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGF 152 (343)
T ss_pred hhhcceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccc
Confidence 4677777653 46789999999999999998653
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhh
Q 006244 35 ---------------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 93 (654)
Q Consensus 35 ---------------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l 93 (654)
..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~ 229 (343)
T cd05103 153 VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDI 229 (343)
T ss_pred cCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEeccccccc
Confidence 23678888999999999999999998 9999999999999854 79999999999765
Q ss_pred cccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 006244 94 RKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVED 167 (654)
Q Consensus 94 ~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~s 167 (654)
..... ....+++.|+|||++. ..++.++||||||+++|+|++ |..||........+...+..+..+. .+...+
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 308 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTT 308 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC-CCCCCC
Confidence 33211 1223567899999875 458999999999999999997 9999987655555656665555432 234567
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 168 PEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 168 pelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+++.+++.+||. +|.+||++.+|++|
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 899999999999 89999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=234.02 Aligned_cols=187 Identities=22% Similarity=0.418 Sum_probs=154.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILI 75 (654)
+++++.+.. ++.+++||||+.|++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+|+||||+|||+
T Consensus 72 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~ 147 (269)
T cd08528 72 VRYYKTFLE--NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIML 147 (269)
T ss_pred eeEEeeEcc--CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEE
Confidence 467887776 7899999999999999998743 3468999999999999999999996 56 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+. .+.++|+|||++....... .....|+..|+|||++.+ .++.++|+||||+++|+|++|..||.. .+.......+
T Consensus 148 ~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~ 225 (269)
T cd08528 148 GE-DDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKI 225 (269)
T ss_pred CC-CCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHH
Confidence 85 4799999999997765432 234468999999998864 488999999999999999999999976 4445555566
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..........++.++++|.+||. +|.+||++.|+..+
T Consensus 226 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 226 VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 55554433334578999999999999 89999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=264.23 Aligned_cols=192 Identities=25% Similarity=0.451 Sum_probs=168.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
||+|...+. ...+|+||||+.+|.+++|+.+++++.+..++.++.|++.|++|||+++ |+|||||.+|||++.+ .
T Consensus 118 vkl~~v~~t--~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~-m 192 (596)
T KOG0586|consen 118 VKLFSVIET--EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDEN-M 192 (596)
T ss_pred eeeeeeeee--cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccc-c
Confidence 588887766 7899999999999999999999999999999999999999999999999 9999999999999966 5
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++..+... ...+++|+|.|.|||++.+. -.+.+|+||+|+++|.|+.|..||.+ .+...+-.++..|+
T Consensus 193 nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 193 NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGK 271 (596)
T ss_pred ceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeee
Confidence 7999999999988643 45677899999999999864 46789999999999999999999987 45555666666666
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.- ++-..+-++.++|.++|. +|.+|++.++++.|.|.....
T Consensus 272 ~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 272 YR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ec--ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 53 333467899999999999 999999999999999997543
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=232.26 Aligned_cols=185 Identities=25% Similarity=0.393 Sum_probs=151.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++++.. ...+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+|+||||+||+++.+
T Consensus 64 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~ 139 (261)
T cd05034 64 VQLYAVCSE--EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN 139 (261)
T ss_pred eeeeeeeec--CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC
Confidence 467887765 578999999999999999997653 6899999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++..+..... ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||... +......++
T Consensus 140 -~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~ 217 (261)
T cd05034 140 -LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQV 217 (261)
T ss_pred -CCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 7999999999876543211 12234678999998874 58889999999999999999 99999764 445566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+.... .....+.++++++.+||. +|.+||++.+++.
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 218 ERGYRMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6553322 233457899999999999 8999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=246.80 Aligned_cols=181 Identities=27% Similarity=0.448 Sum_probs=144.4
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
..+++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++...+.+||+|||++..
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCccccee
Confidence 57899999996 699988764 46999999999999999999999999 999999999999986667899999999976
Q ss_pred hcccC-----CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--------
Q 006244 93 LRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-------- 157 (654)
Q Consensus 93 l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~-------- 157 (654)
+.... .....|++.|+|||++.. .++.++||||||+++|+|++|+.||........ ...+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 243 (342)
T cd07854 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPVVREEDR 243 (342)
T ss_pred cCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHh
Confidence 53321 122358899999997653 488899999999999999999999976443332 22222110
Q ss_pred ----------------CC----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 ----------------KP----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ----------------~p----~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+ .......+.++++||.+||. +|.+|||+.++|.||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 244 NELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 01123467889999999999 8999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=234.19 Aligned_cols=184 Identities=22% Similarity=0.352 Sum_probs=149.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+. ....++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.
T Consensus 64 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~- 137 (262)
T cd05071 64 VQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE- 137 (262)
T ss_pred ceEEEEEC---CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcC-
Confidence 46777653 35689999999999999999864 35899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCCc---cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.++|+|||++..+...... ...++..|+|||++. ..++.++||||||+++|+|+| |..||... ....++..+
T Consensus 138 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~ 216 (262)
T cd05071 138 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQV 216 (262)
T ss_pred CCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHH
Confidence 478999999999766443221 223667899999876 458999999999999999999 88899763 445556666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ......+..+.++|.+||. +|.+||++.+++.
T Consensus 217 ~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 217 ERGYRM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred hcCCCC-CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 554332 2334578899999999999 8999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=232.88 Aligned_cols=186 Identities=25% Similarity=0.403 Sum_probs=150.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
+++++++.. ....++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||||+||
T Consensus 62 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~ni 137 (269)
T cd05044 62 VKLLGVCLL--NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNC 137 (269)
T ss_pred eeEeeeecC--CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheE
Confidence 578888776 67899999999999999998753 24788999999999999999999998 99999999999
Q ss_pred EEeCCC----CcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCC
Q 006244 74 FVNGNQ----GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSEC 143 (654)
Q Consensus 74 LId~~~----g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~ 143 (654)
|++.+. ..++|+|||++....... .....++..|+|||++. +.++.++||||||+++|+|++ |..||...
T Consensus 138 l~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred EEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 998542 179999999997654321 11234578899999886 458999999999999999998 99999764
Q ss_pred CCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 144 THPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 144 ~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+.......+..+..+. .....+..+.++|.+||. +|.+||++.++++
T Consensus 218 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 218 -NNQEVLQHVTAGGRLQ-KPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -CHHHHHHHHhcCCccC-CcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3445555555444332 334567899999999999 8999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=239.20 Aligned_cols=185 Identities=21% Similarity=0.280 Sum_probs=143.5
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+..... ...++++|++ ..++.+++......++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN 162 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence 356665544222 2457889988 4578888777666789999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc---------CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 79 QGEVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~---------~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
+.++|+|||+++.+... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........
T Consensus 163 -~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 163 -NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred -CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 78999999999765321 1123469999999998875 489999999999999999999999987533322
Q ss_pred H--------HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 149 I--------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 149 i--------~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+ .+.+..+.. .....++++.+++..|+. +|.+||++.+|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2 223333322 123457889999999999 9999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=264.87 Aligned_cols=187 Identities=24% Similarity=0.323 Sum_probs=139.4
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 11 ANRNINFVTEMFTSGTLRQYRLKHRR--------------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 11 ~~~~i~LVtEy~~gGSL~~~l~k~~~--------------------Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
....++||+||+.+|+|.+++..... .....+..++.||+.||.|||+++ |+||||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLKP 283 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVKP 283 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCCH
Confidence 35789999999999999999875421 123457789999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhccc---CCccccCCCCccChhhhcc-----------------------cCCcccchh
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE-----------------------EYNELVDIY 124 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~~-----------------------~ys~ksDIW 124 (654)
+|||++.+.+.+||+|||+|+.+... .....+||+.|||||.+.. .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 99999866679999999999865432 2345679999999996531 234567999
Q ss_pred hhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC-------------c------ccccCCChHHHHHHHHHhh-CccCC
Q 006244 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP-------------E------ALFKVEDPEVRQFIEKCLA-TVSSR 184 (654)
Q Consensus 125 SLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p-------------~------~l~~~~spelrdLI~kCL~-dP~~R 184 (654)
||||++|||+++..|+.. ...++.+.+...... . .+....+....+||.+||+ +|.+|
T Consensus 364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999997766542 223333322221110 0 0111123345689999999 99999
Q ss_pred CCHHHHhcCcccccCCc
Q 006244 185 LSARELLTDPFLQIDDY 201 (654)
Q Consensus 185 pTa~ELL~HPFf~~~~~ 201 (654)
||+.++|+||||+....
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 99999999999986543
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=238.24 Aligned_cols=191 Identities=25% Similarity=0.399 Sum_probs=148.4
Q ss_pred CEEEEEEEecC--------CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTA--------NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~--------~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
+++++.+.+.. +..+++|+||+.+ +|..++... ..+++..+..++.||+.||.|||+.+ |+|+||||+
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~ 145 (302)
T cd07864 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCS 145 (302)
T ss_pred eeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 35666665422 3489999999975 777776654 46999999999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccCC---ccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
||+++. .+.+||+|||++..+..... ....+++.|+|||++.+ .++.++||||||+++|+|++|.+||......
T Consensus 146 nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 146 NILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HEEECC-CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999985 47999999999987644321 22346889999998853 3788999999999999999999999764433
Q ss_pred HHHHHHHHc---CCCCcc-------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 147 AQIYKKVIS---GKKPEA-------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 147 ~qi~kki~~---G~~p~~-------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.. ...+.. +..+.. .....++.++++|.+||. +|.+||++.+++.||||
T Consensus 225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 225 AQ-LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HH-HHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 32 222222 111110 122357899999999999 89999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=236.67 Aligned_cols=186 Identities=23% Similarity=0.384 Sum_probs=146.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-----------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLK 69 (654)
+++++++.. .+.+++||||+.+|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+|||||
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlk 157 (296)
T cd05095 82 IRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLA 157 (296)
T ss_pred ceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCC
Confidence 578898877 678999999999999999987643 3677899999999999999999999 9999999
Q ss_pred CCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh--cCCCCCC
Q 006244 70 CDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYPYSE 142 (654)
Q Consensus 70 peNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT--G~~Pf~~ 142 (654)
|+|||++. .+.++|+|||++..+..... ....+++.|+|||+.. +.++.++||||||+++|||++ |..||..
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 158 TRNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred hheEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999985 47999999999976543221 1223467899999765 568999999999999999998 7789976
Q ss_pred CCCHHHHHHHHHc-----CC-CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 143 CTHPAQIYKKVIS-----GK-KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 143 ~~~~~qi~kki~~-----G~-~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.. ..++...... +. .........++.+++||.+||+ +|.+||++.++++
T Consensus 237 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LS-DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cC-hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33 3333322211 11 1111223466899999999999 8999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=264.02 Aligned_cols=177 Identities=28% Similarity=0.448 Sum_probs=150.7
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
+..+.||+-+|.|.+|..++.-. .+|.+.+++.|++||+.|+.|||.++ |||||||..|||+. ++++|||+||||+
T Consensus 459 ~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 459 NPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLA 535 (678)
T ss_pred CCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccce
Confidence 34569999999999999998654 47999999999999999999999999 99999999999998 4489999999999
Q ss_pred hhhcc----cCCccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCc--
Q 006244 91 AILRK----SHAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPE-- 160 (654)
Q Consensus 91 ~~l~~----~~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~-- 160 (654)
..... ......-|...|||||+++. .|++.+||||||+++|||+||..||. ..+.++|.-.+-+|....
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccc
Confidence 76432 23334457889999999973 49999999999999999999999999 688999988888884433
Q ss_pred -ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 161 -ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 161 -~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+......++++|+..||. ++.+||.+.+||.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 2333445699999999999 8999999999985
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=233.75 Aligned_cols=186 Identities=23% Similarity=0.320 Sum_probs=153.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeN 72 (654)
+++|+++... +...++++||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|
T Consensus 71 ~~~~~~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~n 147 (280)
T cd05043 71 LPILHVCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARN 147 (280)
T ss_pred CeEEEEEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhh
Confidence 4678876653 56889999999999999998764 35899999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCH
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHP 146 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~ 146 (654)
||++.+ +.+||+|||+++.+..... ....++..|+|||++.. .++.++||||||+++|++++ |..||... ++
T Consensus 148 il~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~ 225 (280)
T cd05043 148 CVIDEE-LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DP 225 (280)
T ss_pred EEEcCC-CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CH
Confidence 999854 7999999999976533211 12235678999998864 48899999999999999999 99999764 56
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 ~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+...+..+..+. .....++++++++.+||. +|++|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 226 FEMAAYLKDGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 66766666654433 234467899999999999 8999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=245.56 Aligned_cols=180 Identities=31% Similarity=0.459 Sum_probs=147.1
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
..+++|+||+ +++|.+++.. .++++..+..++.||+.||.|||+.+ |+||||||+||+++. .+.++|+|||++..
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~-~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNE-DCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECC-CCCEEEcccccccc
Confidence 4599999999 7899998765 57999999999999999999999998 999999999999985 47999999999987
Q ss_pred hcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--CCc--------
Q 006244 93 LRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPE-------- 160 (654)
Q Consensus 93 l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~--~p~-------- 160 (654)
.... .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+..+.... .+.
T Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHHHhhccc
Confidence 6443 334568999999998864 478899999999999999999999976443 33333333211 110
Q ss_pred -------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 161 -------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 161 -------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
......++.+.+||.+||. +|.+|||+.+|+.||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 1122358899999999999 89999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=257.91 Aligned_cols=195 Identities=29% Similarity=0.461 Sum_probs=168.1
Q ss_pred CCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEEe
Q 006244 11 ANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN--QGEVKIGD 86 (654)
Q Consensus 11 ~~~~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~--~g~VKL~D 86 (654)
....+++|||-+. |++.+.|.. .+++++...+.++.||+.||+|||-++ |+|+||||+|||+.+. ..++||||
T Consensus 634 T~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 634 TPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred CCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecc
Confidence 3689999999994 677777654 468999999999999999999999999 9999999999999743 34899999
Q ss_pred cCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCccc
Q 006244 87 LGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPEAL 162 (654)
Q Consensus 87 FGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~--G~~p~~l 162 (654)
||+|+++... ...+.+|||.|+|||+++. .|+...||||+|+|+|--+.|.+||.+. ++|..+|.. ...|...
T Consensus 711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdIndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDINDQIQNAAFMYPPNP 787 (888)
T ss_pred ccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cchhHHhhccccccCCCc
Confidence 9999998764 4566789999999999985 5999999999999999999999999763 445555554 3457788
Q ss_pred ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchhhhhhhhc
Q 006244 163 FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 211 (654)
Q Consensus 163 ~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~~r~l~~~ 211 (654)
|+..++++.+||..+|+ +-++|.+.+..|.|||++....-.++|.+...
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~ 837 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVR 837 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHh
Confidence 88999999999999999 89999999999999999988877787776543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=236.84 Aligned_cols=186 Identities=24% Similarity=0.379 Sum_probs=146.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDL 68 (654)
+++++++.. ...+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++||||
T Consensus 80 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dl 155 (295)
T cd05097 80 IRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDL 155 (295)
T ss_pred CeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eecccc
Confidence 578888876 678999999999999999986542 3688899999999999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh--cCCCCC
Q 006244 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT--FDYPYS 141 (654)
Q Consensus 69 KpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT--G~~Pf~ 141 (654)
||+|||++. .+.+||+|||++..+..... ....+++.|+|||++. +.++.++||||||+++|+|++ +..||.
T Consensus 156 kp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 156 ATRNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred ChhhEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 999999984 47899999999976543221 2223567899999876 458999999999999999998 678887
Q ss_pred CCCCHHHHHHHHHc-----CC-CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 142 ECTHPAQIYKKVIS-----GK-KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 142 ~~~~~~qi~kki~~-----G~-~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
... ..++...+.. +. .........++.+++||.+||. +|.+||++.++++
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 235 LLS-DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccC-hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 643 3333333221 11 1112234567899999999999 8999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=230.83 Aligned_cols=184 Identities=22% Similarity=0.377 Sum_probs=150.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+. .+.+++|+||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ ++||||||+||+++.
T Consensus 64 ~~~~~~~~---~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~- 137 (260)
T cd05067 64 VRLYAVVT---QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSE- 137 (260)
T ss_pred eeEEEEEc---cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcC-
Confidence 46777653 46799999999999999998764 36899999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.++|+|||++........ ....++..|+|||++. ..++.++||||||+++|+|++ |+.||... +...+...+
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~ 216 (260)
T cd05067 138 TLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNL 216 (260)
T ss_pred CCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHH
Confidence 47999999999976653221 1233567899999886 458889999999999999999 99999874 445555666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ......+.+++++|.+||. +|.+||++++++.
T Consensus 217 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 217 ERGYRM-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 555433 2345567899999999999 8999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=233.66 Aligned_cols=188 Identities=27% Similarity=0.430 Sum_probs=145.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.......+++|+||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 68 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~-~ 144 (284)
T cd05081 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVES-E 144 (284)
T ss_pred eEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECC-C
Confidence 4677877665567899999999999999999765 46899999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCc-----cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH-------
Q 006244 80 GEVKIGDLGLAAILRKSHAA-----RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP------- 146 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~-----~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~------- 146 (654)
+.+||+|||++..+...... ...++..|+|||++.+ .++.++||||||+++|||++|..|+......
T Consensus 145 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd05081 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN 224 (284)
T ss_pred CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc
Confidence 78999999999876433221 1123456999998864 5889999999999999999987775431110
Q ss_pred --------HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 --------AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 --------~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+...+..+..+ ......+.++.+||.+||. +|.+|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 225 DKQGQMIVYHLIELLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ccccccchHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111112222221 2234567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=266.33 Aligned_cols=194 Identities=29% Similarity=0.472 Sum_probs=162.8
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
++||++|.-.+ .+.+|||||||.|||.-+++++. .++.+..|..|++.++.||.+||.+. +||||+|-.|||+
T Consensus 79 ~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLL 156 (953)
T KOG0587|consen 79 ATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLL 156 (953)
T ss_pred ceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEE
Confidence 47888888643 47999999999999999998864 57999999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDYPYSECTHPA 147 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~ 147 (654)
+.+ |.|||.|||++..+... ...+++|||.|||||++.. .|+..+|+||||++..||.-|.+|+.+.....
T Consensus 157 T~e-~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 157 TEN-AEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred ecc-CcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 966 79999999999987654 4556789999999999852 37888999999999999999999998855544
Q ss_pred HHHHHHHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 148 QIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 148 qi~kki~~G~~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+++. .....|... ++..+.++-+||..||. +..+||+..++|+|||++.
T Consensus 236 aLF~I-pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 236 ALFLI-PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhccC-CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 44432 222222222 44567889999999999 8999999999999999983
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=247.98 Aligned_cols=197 Identities=26% Similarity=0.441 Sum_probs=162.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--~ 78 (654)
||+|++|.-. ...++-|+|||+|.+|.=|++.++.++++.++.|+.||+.||.||....|||||-||||.|||+-. .
T Consensus 530 VKlYDyfslD-tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 530 VKLYDYFSLD-TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeeeeec-cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcc
Confidence 6899999763 578999999999999999999999999999999999999999999999999999999999999852 1
Q ss_pred CCcEEEEecCchhhhcccCCc---------cccCCCCccChhhhc-c----cCCcccchhhhhhHHHHHhhcCCCCCCCC
Q 006244 79 QGEVKIGDLGLAAILRKSHAA---------RCVGTPEFMAPEVYE-E----EYNELVDIYSFGMCILEMVTFDYPYSECT 144 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~---------~~vGTp~YmAPEvl~-~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~ 144 (654)
-|.+||.||||++++.+.... ...||-+|++||.+. + +.+.++||||+|+|+|.++.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 368999999999998754322 345999999999774 2 37889999999999999999999997643
Q ss_pred CHHHHHH--HHHc-CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 145 HPAQIYK--KVIS-GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 145 ~~~qi~k--ki~~-G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.-..|.. .|.. .....+..++.++++++||.+||. .-.+|....+|-.||+|..
T Consensus 689 sQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 689 SQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 3333322 2222 111223355789999999999999 6889999999999999964
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=231.62 Aligned_cols=184 Identities=25% Similarity=0.444 Sum_probs=152.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ...++|+||+.+|+|.+++... ..+++..+..|+.||+.||+|||+++ |+||||||+|||++. .
T Consensus 72 ~~~~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~-~ 145 (279)
T cd05057 72 VRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKT-P 145 (279)
T ss_pred ceEEEEEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcC-C
Confidence 478887765 6899999999999999998874 46999999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCCc----cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++..+...... ...+++.|+|||.+. ..++.++|+||||+++|++++ |..||... ....+...+
T Consensus 146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~ 224 (279)
T cd05057 146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLL 224 (279)
T ss_pred CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHH
Confidence 78999999999876532211 112356899999876 458899999999999999998 99999874 566677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+... ..+...+..+.+++.+||. +|..||++.++++
T Consensus 225 ~~~~~~-~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 225 EKGERL-PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred hCCCCC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 765433 2344577899999999999 8999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=242.71 Aligned_cols=192 Identities=27% Similarity=0.399 Sum_probs=151.5
Q ss_pred CEEEEEEEecCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTAN----RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~----~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.+..... ..+++|+||+ |++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 77 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~ 152 (343)
T cd07880 77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN 152 (343)
T ss_pred cceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc
Confidence 456776654321 3579999999 8899988764 57999999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
. .+.++|+|||++...... .....+++.|+|||++.+ .++.++|+||||+++|+|++|..||........ +.++.
T Consensus 153 ~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~ 229 (343)
T cd07880 153 E-DCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIM 229 (343)
T ss_pred C-CCCEEEeecccccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH
Confidence 5 479999999999865432 233468999999998864 478899999999999999999999987543322 22222
Q ss_pred cCC--CC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 SGK--KP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~G~--~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
... .+ ..+....++.++++|.+||. +|.+|||+.+++.||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 110 00 01223467889999999999 89999999999999999743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=230.03 Aligned_cols=185 Identities=19% Similarity=0.364 Sum_probs=149.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ...+++||||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~- 142 (269)
T cd05065 68 IHLEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN- 142 (269)
T ss_pred ceEEEEECC--CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-
Confidence 477887765 67899999999999999998764 56899999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCc----ccc---CCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA----RCV---GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIY 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~----~~v---GTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~ 150 (654)
+.+||+|||++......... ... .+..|+|||++. ..++.++||||||+++|||++ |..||... ....+.
T Consensus 143 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~ 221 (269)
T cd05065 143 LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVI 221 (269)
T ss_pred CcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHH
Confidence 79999999998765432211 111 245799999886 458899999999999999886 99999763 445555
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+.. .......++.+.+++.+||. +|.+||++.+++.
T Consensus 222 ~~i~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 222 NAIEQDYR-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHcCCc-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 66654432 22334567899999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=249.20 Aligned_cols=153 Identities=25% Similarity=0.410 Sum_probs=126.0
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhh
Q 006244 37 VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEV 112 (654)
Q Consensus 37 Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEv 112 (654)
+++..+..++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++....... .....+++.|+|||+
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence 567778899999999999999998 999999999999985 4789999999997653211 123357889999998
Q ss_pred hcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHH
Q 006244 113 YEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARE 189 (654)
Q Consensus 113 l~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~E 189 (654)
+.. .++.++||||||+++|||++ |..||......+.....+..+..+. .+...+.++.+||.+||. +|.+||++.+
T Consensus 313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~e 391 (401)
T cd05107 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA-KPAHASDEIYEIMQKCWEEKFEIRPDFSQ 391 (401)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 864 48889999999999999998 8999987666666666666664432 344578999999999999 8999999999
Q ss_pred HhcC
Q 006244 190 LLTD 193 (654)
Q Consensus 190 LL~H 193 (654)
|++.
T Consensus 392 ll~~ 395 (401)
T cd05107 392 LVHL 395 (401)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=228.89 Aligned_cols=184 Identities=22% Similarity=0.376 Sum_probs=149.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.. ...++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+ ++||||||+||+++.
T Consensus 64 ~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~- 137 (260)
T cd05073 64 VKLHAVVTK---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSA- 137 (260)
T ss_pred ceEEEEEcC---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcC-
Confidence 467777654 6789999999999999999764 35788999999999999999999998 999999999999985
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||++..+..... ....++..|+|||++.. .++.++|+||||+++|+|++ |..||... +...+...+
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~ 216 (260)
T cd05073 138 SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRAL 216 (260)
T ss_pred CCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence 47999999999976543221 12235678999998864 48889999999999999999 99999864 444555555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+... ......+.++.+++.+||. +|.+||++.+++.
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 217 ERGYRM-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred hCCCCC-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 555433 2345677899999999999 8999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=263.93 Aligned_cols=86 Identities=27% Similarity=0.490 Sum_probs=79.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.+.. ..++||||||+.||+|.+++...+.+++..++.|+.||+.||.|||.++ |+||||||+|||++. .+
T Consensus 67 v~~~~~~~~--~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~-~g 141 (669)
T cd05610 67 VHLYYSLQS--ANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISN-EG 141 (669)
T ss_pred CeEEEEEEE--CCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcC-CC
Confidence 578887776 6899999999999999999998888999999999999999999999998 999999999999985 47
Q ss_pred cEEEEecCchh
Q 006244 81 EVKIGDLGLAA 91 (654)
Q Consensus 81 ~VKL~DFGLA~ 91 (654)
.+||+|||+++
T Consensus 142 ~vkL~DFGls~ 152 (669)
T cd05610 142 HIKLTDFGLSK 152 (669)
T ss_pred CEEEEeCCCCc
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=242.86 Aligned_cols=191 Identities=29% Similarity=0.419 Sum_probs=148.2
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++++.... ...+++|+||+. ++|..++ ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 77 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~ 151 (342)
T cd07879 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN 151 (342)
T ss_pred cchhheecccccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC
Confidence 35666665421 246799999995 5887765 346899999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++...... .....+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.... ....+..+.
T Consensus 152 ~~-~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~-~~~~~~~~~ 228 (342)
T cd07879 152 ED-CELKILDFGLARHADAE-MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-YLDQLTQIL 228 (342)
T ss_pred CC-CCEEEeeCCCCcCCCCC-CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Confidence 54 79999999998765332 233468899999998864 48889999999999999999999998643 233333322
Q ss_pred cCC--C--------------------Cc-------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 SGK--K--------------------PE-------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~G~--~--------------------p~-------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
... . +. ...+..++.+++||.+||+ +|.+||++.++|.||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 210 0 00 0122457789999999999 89999999999999999653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=235.73 Aligned_cols=185 Identities=26% Similarity=0.474 Sum_probs=149.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.. ...++|+||+++|+|.+++..+. .+++..+..|+.||+.||.|||+++ |+||||||+|||++. .
T Consensus 72 v~~~~~~~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~-~ 145 (303)
T cd05110 72 VRLLGVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKS-P 145 (303)
T ss_pred ccEEEEEcC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecC-C
Confidence 578887764 35789999999999999988754 6899999999999999999999998 999999999999974 4
Q ss_pred CcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++..+..... ....+++.|+|||++.. .++.++||||||+++|+|++ |..||.+. ....+...+
T Consensus 146 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~ 224 (303)
T cd05110 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLL 224 (303)
T ss_pred CceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 7899999999987643221 12335778999998864 58899999999999999997 89999763 344444444
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..+. .....+..+++++.+||. +|.+||++.+++..
T Consensus 225 ~~~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 225 EKGERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HCCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444332 345577899999999999 89999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=246.75 Aligned_cols=189 Identities=22% Similarity=0.387 Sum_probs=151.6
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
..+.|.. +++++||+|++ |-|+.+|+..+. +++...++.+++||+.+++|||+.+ ++|-||||+|||+-+.
T Consensus 156 m~~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 156 MRDWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEY 230 (415)
T ss_pred eehhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccce
Confidence 3344444 78999999999 779999998764 6999999999999999999999999 9999999999998321
Q ss_pred -----------------CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCC
Q 006244 79 -----------------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPY 140 (654)
Q Consensus 79 -----------------~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf 140 (654)
...|+|+|||.|+...... ...+.|..|+|||++.+ .++..+||||+||||+|++||...|
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 1358999999998866554 55679999999998875 6999999999999999999999999
Q ss_pred CCCCCHHHH--HHHHHcCCCCccc---------------------------------------ccCCC---hHHHHHHHH
Q 006244 141 SECTHPAQI--YKKVISGKKPEAL---------------------------------------FKVED---PEVRQFIEK 176 (654)
Q Consensus 141 ~~~~~~~qi--~kki~~G~~p~~l---------------------------------------~~~~s---pelrdLI~k 176 (654)
....+.+.+ +..|. |..|..+ ....+ .++.+||++
T Consensus 310 qtHen~EHLaMMerIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 310 QTHENLEHLAMMERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred ccCCcHHHHHHHHHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 876666643 22222 2222111 00111 358889999
Q ss_pred Hhh-CccCCCCHHHHhcCccccc
Q 006244 177 CLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 177 CL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
||. ||.+|+|+.|+|.||||+.
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHccCccccccHHHHhcCHHhhc
Confidence 999 9999999999999999974
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=220.88 Aligned_cols=159 Identities=26% Similarity=0.389 Sum_probs=128.9
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCCccccC
Q 006244 25 GTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103 (654)
Q Consensus 25 GSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~~~vG 103 (654)
|+|.+++..+ +.+++..++.|+.||+.||.|||+++ ||+|||++.+ +.+|+ ||++...... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeeccc---cCCC
Confidence 7999999874 46999999999999999999999885 9999999854 78888 9998775442 2368
Q ss_pred CCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCccc-----ccCCCh--HHHHHHH
Q 006244 104 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL-----FKVEDP--EVRQFIE 175 (654)
Q Consensus 104 Tp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l-----~~~~sp--elrdLI~ 175 (654)
|+.|||||++.+ .|+.++|||||||++|||+||+.||.........+..+..+..+... ....+. +++++|.
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 146 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR 146 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence 999999999864 58999999999999999999999997655545555555544332211 111222 6999999
Q ss_pred HHhh-CccCCCCHHHHhcCcccc
Q 006244 176 KCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 176 kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+||. +|.+||++.+++.|+|+.
T Consensus 147 ~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 147 VCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhcccccccCHHHHHHHHHHH
Confidence 9999 899999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=240.93 Aligned_cols=191 Identities=29% Similarity=0.443 Sum_probs=149.2
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.+.... ...+++|++++ |++|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+||+++
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~ 154 (345)
T cd07877 79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 154 (345)
T ss_pred cceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc
Confidence 45677665421 24588999988 8899988765 46999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... .....+.
T Consensus 155 ~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~ 231 (345)
T cd07877 155 ED-CELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLIL 231 (345)
T ss_pred CC-CCEEEeccccccccccc-ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence 54 79999999998765432 234568999999998754 4788999999999999999999999764332 2222222
Q ss_pred c--CCC-----------------------Cc----ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 S--GKK-----------------------PE----ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~--G~~-----------------------p~----~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. +.. +. ......++++++||.+||. +|.+||++.++|.||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 1 100 00 0112357889999999999 8999999999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=238.14 Aligned_cols=186 Identities=31% Similarity=0.505 Sum_probs=149.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEE
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHR-----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN---QGEVK 83 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~-----~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~---~g~VK 83 (654)
++.++|++||.+. +|...|+.|+ .++...++.++.||+.|+.|||++. |+||||||.|||+.++ .|.||
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeE
Confidence 5799999999975 8988887653 5999999999999999999999999 9999999999999854 48999
Q ss_pred EEecCchhhhcccCC-----ccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCC------CCH---H
Q 006244 84 IGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSEC------THP---A 147 (654)
Q Consensus 84 L~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~------~~~---~ 147 (654)
|+|||+++.+..+.. ...+-|.+|+|||++.+ .|+.++||||+|||+.||+|-++.|.+. .++ .
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999999876532 34567999999998875 5999999999999999999999888531 111 1
Q ss_pred HHHHHHHc--CCC-----------Cc----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 148 QIYKKVIS--GKK-----------PE----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 148 qi~kki~~--G~~-----------p~----------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
|+. +|.. |.. |+ ...+..++...+|+.++|. ||.+|+|++++|
T Consensus 257 Ql~-rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 257 QLD-RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHH-HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 221 1211 111 10 0122346778999999999 999999999999
Q ss_pred cCcccccCCc
Q 006244 192 TDPFLQIDDY 201 (654)
Q Consensus 192 ~HPFf~~~~~ 201 (654)
+|+||..+..
T Consensus 336 eh~yF~~d~l 345 (438)
T KOG0666|consen 336 EHPYFTEDPL 345 (438)
T ss_pred cccccccCCC
Confidence 9999998753
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=229.49 Aligned_cols=188 Identities=27% Similarity=0.453 Sum_probs=148.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++....+...++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~- 145 (284)
T cd05038 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE- 145 (284)
T ss_pred heEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-
Confidence 46788777765678999999999999999998765 6999999999999999999999998 9999999999999855
Q ss_pred CcEEEEecCchhhhcccCCc-----cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCC--------
Q 006244 80 GEVKIGDLGLAAILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTH-------- 145 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~-----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~-------- 145 (654)
+.++|+|||++......... ...++..|+|||.+. ..++.++||||||+++|+|++|..|+.....
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 225 (284)
T cd05038 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI 225 (284)
T ss_pred CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc
Confidence 79999999999876532211 123456799999876 4588899999999999999999999864321
Q ss_pred ------HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 146 ------PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 146 ------~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
...+...+..+.. .......+.++.+++.+||. +|.+|||+.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 226 AQGQMIVTRLLELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ccccccHHHHHHHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1112222222222 22234456889999999999 8999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=242.89 Aligned_cols=194 Identities=27% Similarity=0.439 Sum_probs=162.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~-----k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
|||||..+. .+..||.||+| .-||..+.+ +..++++..+-.+..-.+.||.||-..- .|||||+||+|||+
T Consensus 126 VkfyGa~F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILl 201 (361)
T KOG1006|consen 126 VKFYGALFS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILL 201 (361)
T ss_pred HHHhhhhhc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEE
Confidence 589998887 68999999999 468876644 3467999999999999999999998753 49999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccCCc-cccCCCCccChhhhc---ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~~~-~~vGTp~YmAPEvl~---~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.. |.|||||||++..+.++.+. .-.|...|||||-+. ..|+-++|+||||++|||+.||.+||.+-.+.-+-..
T Consensus 202 dr~-G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 202 DRH-GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred ecC-CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 954 89999999999988776543 446999999999886 2499999999999999999999999987555444456
Q ss_pred HHHcCCCCccccc----CCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 152 KVISGKKPEALFK----VEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 152 ki~~G~~p~~l~~----~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+..|..|.-... ..+..++.||..||. +.+.||...+|+++||++..
T Consensus 281 ~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 281 QVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 6677877654433 257899999999999 89999999999999999754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=237.28 Aligned_cols=191 Identities=31% Similarity=0.475 Sum_probs=150.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|... ...+++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||.|||++. .+
T Consensus 72 v~~~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~-~~ 145 (328)
T cd07856 72 ISLSDIFISP-LEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINE-NC 145 (328)
T ss_pred eeEeeeEecC-CCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECC-CC
Confidence 4678887653 45789999999 6799988764 46899999999999999999999999 999999999999984 47
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--C
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--G 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~--G 156 (654)
.++|+|||++...... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... ....+..+.. |
T Consensus 146 ~~~l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~-~~~~~~~~~~~~~ 223 (328)
T cd07856 146 DLKICDFGLARIQDPQ-MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD-HVNQFSIITDLLG 223 (328)
T ss_pred CEEeCccccccccCCC-cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhC
Confidence 9999999998765332 234568899999998754 58899999999999999999999997633 2111111100 0
Q ss_pred C--------------------------CC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 K--------------------------KP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~--------------------------~p-~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. .| ....+..++.++++|.+||. +|.+||++.+++.||||...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 224 TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred CCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 00 11123467899999999999 89999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=267.85 Aligned_cols=181 Identities=34% Similarity=0.541 Sum_probs=152.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~L-se~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
...+||=||||+--+|++++.++... ....++++++||+.||.|+|+.+ ||||||||.|||++.. +.|||+|||+|
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd~~-~~VKIGDFGLA 744 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLDSR-NSVKIGDFGLA 744 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEcCC-CCeeecccccc
Confidence 35889999999988888887776544 57788999999999999999999 9999999999999954 79999999999
Q ss_pred hhhc--------------------ccCCccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 91 AILR--------------------KSHAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 91 ~~l~--------------------~~~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
+... ....+..+||--|+|||++.+ .|+.|+|||||||+++||+. ||......
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER 821 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER 821 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHH
Confidence 8721 013456689999999999963 59999999999999999985 78776667
Q ss_pred HHHHHHHHcCCCCcc--cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 147 AQIYKKVISGKKPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 147 ~qi~kki~~G~~p~~--l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
..+...+..|..|.. ++...-+.-+.+|..+|+ +|.+||||.|||++-||..
T Consensus 822 a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 822 ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 777788888887765 233345678899999999 8999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=253.71 Aligned_cols=186 Identities=23% Similarity=0.392 Sum_probs=157.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~-Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+|||..+. +..++||||+|+||+|.+|+++.+. ++......++.+.+.||+|||+++ +|||||-..|+|++.+
T Consensus 224 Vr~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~- 298 (474)
T KOG0194|consen 224 VRFYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK- 298 (474)
T ss_pred EEEEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-
Confidence 689997766 7899999999999999999999874 999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCcc--ccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~--~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+||||++.-....... ..-...|+|||.+.. .|++++|||||||++||+++ |..||.+ ....++..+|..
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g-~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG-MKNYEVKAKIVK 377 (474)
T ss_pred CeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC-CCHHHHHHHHHh
Confidence 578999999987654221111 123468999999874 59999999999999999999 8899998 456677788855
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
...+...+...+.++..++.+|+. +|.+||++.++.+
T Consensus 378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 444445556778899999999999 8999999998875
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=264.92 Aligned_cols=188 Identities=29% Similarity=0.421 Sum_probs=146.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-----------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLK 69 (654)
|++|+.+.+ ++..++||||++||+|.+++... ..++...+..++.||+.||+|||+++ |+|||||
T Consensus 65 Vkl~~v~~d--~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLK 140 (932)
T PRK13184 65 VPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLK 140 (932)
T ss_pred CeEEEEEee--CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCc
Confidence 578888876 68999999999999999998642 23567788999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEEecCchhhhccc--------------------CCccccCCCCccChhhhcc-cCCcccchhhhhh
Q 006244 70 CDNIFVNGNQGEVKIGDLGLAAILRKS--------------------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGM 128 (654)
Q Consensus 70 peNILId~~~g~VKL~DFGLA~~l~~~--------------------~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGi 128 (654)
|+|||++. .|.+||+|||++...... .....+||+.|||||++.+ .++.++|||||||
T Consensus 141 PeNILLd~-dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGV 219 (932)
T PRK13184 141 PDNILLGL-FGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219 (932)
T ss_pred hheEEEcC-CCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHH
Confidence 99999985 479999999999765210 0112469999999998864 5899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 129 iL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
++|+|+||..||.........+................++.+.+++.+||. +|.+|++..+.|.+
T Consensus 220 ILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 220 ILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred HHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999764332222222211111111223567899999999999 89999887665544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=271.98 Aligned_cols=180 Identities=19% Similarity=0.195 Sum_probs=139.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-------------
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG------------- 77 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~------------- 77 (654)
...+++++|++ +++|.+++... +.+++..++.+++||+.||.|||+++ |+||||||+||||+.
T Consensus 52 ~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~ 128 (793)
T PLN00181 52 DDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCS 128 (793)
T ss_pred cchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccC
Confidence 35789999988 67999999763 46999999999999999999999999 999999999999952
Q ss_pred -----CCCcEEEEecCchhhhccc------------------CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHH
Q 006244 78 -----NQGEVKIGDLGLAAILRKS------------------HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEM 133 (654)
Q Consensus 78 -----~~g~VKL~DFGLA~~l~~~------------------~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~EL 133 (654)
..+.+||+|||+++..... .....+||+.|||||++. ..|+.++|||||||+||||
T Consensus 129 ~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~EL 208 (793)
T PLN00181 129 DSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFEL 208 (793)
T ss_pred cccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHH
Confidence 2345777788877542110 001235899999999876 4599999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 134 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 134 lTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
++|.+|+... ......+.....|... ....+....++.+||. +|.+||++.++|+||||..
T Consensus 209 l~~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 209 FCPVSSREEK---SRTMSSLRHRVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred hhCCCchhhH---HHHHHHHHHhhcChhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 9998887542 2222333333333222 1235677899999999 8999999999999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.3e-26 Score=234.51 Aligned_cols=186 Identities=23% Similarity=0.432 Sum_probs=156.2
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
...+++|.||++||+|.=.+++.++++++.++.|...|..||.|||+++ ||+||||.+|+|++.. |++||.|+|+++
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmck 399 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCK 399 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-Cceeecccchhh
Confidence 5789999999999999999999999999999999999999999999999 9999999999999966 899999999997
Q ss_pred hhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCC-------CCCHHHHHHHHHcCCCCcc
Q 006244 92 ILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE-------CTHPAQIYKKVISGKKPEA 161 (654)
Q Consensus 92 ~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~-------~~~~~qi~kki~~G~~p~~ 161 (654)
.-- .....+++|||.|.|||++++ .|...+|.|+||++++||+.|+.||.- .++..-++..|.... ..
T Consensus 400 e~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--ir 477 (593)
T KOG0695|consen 400 EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IR 477 (593)
T ss_pred cCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--cc
Confidence 532 234556789999999999986 499999999999999999999999942 223333555554432 23
Q ss_pred cccCCChHHHHHHHHHhh-CccCCC------CHHHHhcCcccccCCcc
Q 006244 162 LFKVEDPEVRQFIEKCLA-TVSSRL------SARELLTDPFLQIDDYD 202 (654)
Q Consensus 162 l~~~~spelrdLI~kCL~-dP~~Rp------Ta~ELL~HPFf~~~~~~ 202 (654)
++...+-.+..+++..|. +|.+|+ ...++-.|+||+..++.
T Consensus 478 iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 478 IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 445566677788888998 899886 47899999999976664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=253.66 Aligned_cols=191 Identities=24% Similarity=0.408 Sum_probs=160.0
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+||-+|.. +++++||+|-+ .-.|++.+++.+ .|...+++.|+.|++.||..|-..+ |+|.||||+|||++..
T Consensus 498 rl~r~F~h--knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKH--KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhh--cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccC
Confidence 56667776 89999999999 679999999876 4999999999999999999999999 9999999999999987
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH--Hc
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV--IS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki--~~ 155 (654)
...+||||||.|........+.+.-+..|.|||++.+ .|+...|+||+||+||||+||+..|++.+|...+ +-. ..
T Consensus 573 k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~K 651 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELK 651 (752)
T ss_pred cceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhc
Confidence 7789999999999988887777777889999998876 5999999999999999999999999987665443 211 12
Q ss_pred CCCCcccc-------------------------------------c----------C--C-------ChHHHHHHHHHhh
Q 006244 156 GKKPEALF-------------------------------------K----------V--E-------DPEVRQFIEKCLA 179 (654)
Q Consensus 156 G~~p~~l~-------------------------------------~----------~--~-------spelrdLI~kCL~ 179 (654)
|..|..+. + . . -..+++|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 33332100 0 0 0 1358899999999
Q ss_pred -CccCCCCHHHHhcCccccc
Q 006244 180 -TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 180 -dP~~RpTa~ELL~HPFf~~ 198 (654)
+|.+|.|..++|.||||+.
T Consensus 732 LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cChhhcCCHHHHhcCCcccC
Confidence 9999999999999999974
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=223.25 Aligned_cols=188 Identities=21% Similarity=0.359 Sum_probs=150.0
Q ss_pred CEEEEEEEecCCC----eEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANR----NINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~----~i~LVtEy~~gGSL~~~l~k~------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
+++|+.++..... ..++++||+.+|+|..++... ..++...+..++.||+.||+|||+++ |+||||||
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp 141 (273)
T cd05074 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAA 141 (273)
T ss_pred ceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--Eeecccch
Confidence 5788877764322 347899999999999887532 24789999999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++. .+.+||+|||++....... .....+++.|++||.+.. .++.++||||||+++|+|++ |..||.. .
T Consensus 142 ~nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~ 219 (273)
T cd05074 142 RNCMLNE-NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-V 219 (273)
T ss_pred hhEEEcC-CCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-C
Confidence 9999985 4789999999998654321 122345678999998864 47889999999999999999 8899876 4
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+...++..+..+.... .....+..+.+++.+||. +|.+||++.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 220 ENSEIYNYLIKGNRLK-QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566666666654432 234567899999999999 89999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=241.37 Aligned_cols=189 Identities=24% Similarity=0.379 Sum_probs=145.3
Q ss_pred CEEEEEEEecCCC-eEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANR-NINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRD-PPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~-~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~-p~IIHRDLKpeNILId 76 (654)
|+++|++.+ .+ +.+||+||++.|+|.+++.... .+++....+|+..++.||+|||... |+|||||||+.|||+|
T Consensus 134 v~LlGyC~e--~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 134 VKLLGYCLE--GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred ccEEEEEec--CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 689999988 45 6999999999999999988765 8999999999999999999999954 5899999999999999
Q ss_pred CCCCcEEEEecCchhhhcc-cCC-ccc-cCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCC-----CHH
Q 006244 77 GNQGEVKIGDLGLAAILRK-SHA-ARC-VGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECT-----HPA 147 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~-~~~-~~~-vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-----~~~ 147 (654)
.+ ...||+|||+|+.... ... ... .||.+|+|||.+. +..+.++|||||||+|+||+||+.|..... +..
T Consensus 212 ~~-~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 212 ED-FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CC-CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 55 7999999999976553 222 122 7999999999886 679999999999999999999998886432 112
Q ss_pred HHH-HHHHcCCCCcc----cc-cCCC--hH---HHHHHHHHhh-CccCCCCHHHHhc
Q 006244 148 QIY-KKVISGKKPEA----LF-KVED--PE---VRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 148 qi~-kki~~G~~p~~----l~-~~~s--pe---lrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
... ..+..+....- +. .... .+ +..+..+|++ +|..||+..++++
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 221 22233322111 11 1222 23 4455668998 7999999999743
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=229.67 Aligned_cols=181 Identities=23% Similarity=0.279 Sum_probs=143.5
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEec
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 87 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DF 87 (654)
+..+||++.|+..|+|.+++... ..+++..+..|+.+|.+||++||...||+.||||||.|||+.+ .+.++|+||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEec
Confidence 46899999999999999998753 3699999999999999999999999999999999999999985 589999999
Q ss_pred CchhhhcccCC-----------ccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCC-CHHHHHH
Q 006244 88 GLAAILRKSHA-----------ARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECT-HPAQIYK 151 (654)
Q Consensus 88 GLA~~l~~~~~-----------~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-~~~qi~k 151 (654)
|.++...-... ..-.-|..|+|||++.- ..++++|||||||++|+|+.|..||...- .-..+.-
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99976542211 11236899999999873 37889999999999999999999995310 0001111
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+.....-...++..+.++|+.||+ +|.+||++.+|+.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 2233333222233478899999999999 99999999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=253.50 Aligned_cols=184 Identities=23% Similarity=0.348 Sum_probs=157.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------R----VNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------~----Lse~~i~~i~~QIl~gL~YLHs~~p~IIHR 66 (654)
|||||.+.. ++.++||+|||..|+|.+|++-+. . ++..+...++.||+.|++||-++. ++||
T Consensus 552 VrLlGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHR 627 (774)
T KOG1026|consen 552 VRLLGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHR 627 (774)
T ss_pred EEEEEEEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--cccc
Confidence 789996655 899999999999999999998642 2 788999999999999999999998 9999
Q ss_pred CCCCCcEEEeCCCCcEEEEecCchhhhcccCCcccc----CCCCccChhhh-cccCCcccchhhhhhHHHHHhh-cCCCC
Q 006244 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCV----GTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVT-FDYPY 140 (654)
Q Consensus 67 DLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~~~v----GTp~YmAPEvl-~~~ys~ksDIWSLGiiL~ELlT-G~~Pf 140 (654)
||-..|+||..+ -.|||+||||++..-........ -..+|||||.+ .++|+.++|||||||+|||+++ |..||
T Consensus 628 DLATRNCLVge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy 706 (774)
T KOG1026|consen 628 DLATRNCLVGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPY 706 (774)
T ss_pred chhhhhceeccc-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcc
Confidence 999999999754 68999999999876544333222 24699999965 5889999999999999999998 89999
Q ss_pred CCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 141 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 141 ~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
.+..| ++...-|.+|.. -.-+...+.++..|+..||+ .|++||++.||-
T Consensus 707 ~glSn-~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 707 YGLSN-QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred cccch-HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 88665 556678888887 44567789999999999999 899999999974
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=259.71 Aligned_cols=185 Identities=21% Similarity=0.344 Sum_probs=155.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++.|...+ ....+||+|||.||+|.+||++.+ .++...+..++.||++|+.||++++ +|||||.+.|+
T Consensus 758 v~liGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNC 833 (1025)
T KOG1095|consen 758 VSLIGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNC 833 (1025)
T ss_pred eeEEEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhhe
Confidence 567787777 788999999999999999999863 4999999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhcccCCcccc----CCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKSHAARCV----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPA 147 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~~~~~~v----GTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~ 147 (654)
|++.. ..|||+|||+|+.+.+......- -...|||||.+. +.|+.++|||||||++||++| |..||.+.+|.+
T Consensus 834 LL~~~-r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 834 LLDER-RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred eeccc-CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 99865 78999999999955433222211 225899999887 679999999999999999999 999999876655
Q ss_pred HHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 148 QIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 148 qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
-+......|+.+ .+..++..+.++|.+||+ +|.+||++..|++
T Consensus 913 v~~~~~~ggRL~--~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 913 VLLDVLEGGRLD--PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHhCCccC--CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 554455566544 344567778899999999 8999999999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=220.71 Aligned_cols=187 Identities=26% Similarity=0.383 Sum_probs=149.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
+.++|||+++|.. +|.-++... .+++...|++++.+++.||.|+|.+. |+|||+|+.|+||+++ |.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEEeeccccc
Confidence 4579999999965 888887665 57999999999999999999999999 9999999999999854 89999999999
Q ss_pred hhhccc------CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH-HHcCCC-Cc
Q 006244 91 AILRKS------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK-VISGKK-PE 160 (654)
Q Consensus 91 ~~l~~~------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk-i~~G~~-p~ 160 (654)
+.+... ..+..+-|.+|++||.+.+ .|+.+.|||+.|||+.||+|+.+-+++.++..++.-. ...|.. ++
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 766432 2334456999999998864 5999999999999999999999999875554443210 111211 10
Q ss_pred c-----------------c-------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 161 A-----------------L-------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 161 ~-----------------l-------------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
. + +-..+++..+|++++|. ||.+|+.+.++|+|.||..+...
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0 0 11235689999999999 99999999999999999877653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-25 Score=229.13 Aligned_cols=179 Identities=31% Similarity=0.436 Sum_probs=147.5
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
..+|+||||+ .++|.+.+. -.++-+.++.++.|++.|++|||+.+ |+||||||+||++..+ +.+||.|||+|+.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccchhhcc
Confidence 5789999999 569999877 45788999999999999999999999 9999999999999854 7999999999987
Q ss_pred hccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CC------------
Q 006244 93 LRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GK------------ 157 (654)
Q Consensus 93 l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G~------------ 157 (654)
-... ..+..+.|+.|.|||++-+ .|.+.+||||+||++.||++|..-|.+.....|..+.+.. |.
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~ 247 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT 247 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence 6555 4456789999999998865 4999999999999999999999999876555555443321 11
Q ss_pred -------------------CCcccc-------cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 158 -------------------KPEALF-------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 158 -------------------~p~~l~-------~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.|...+ +.....+++++.+||. +|.+|.+++++|.|||++
T Consensus 248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 111111 1234568999999999 999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=239.96 Aligned_cols=184 Identities=23% Similarity=0.315 Sum_probs=139.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecC
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHR------------------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~------------------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRD 67 (654)
+...+||+||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+ |+|||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrD 334 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRD 334 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCC
Confidence 357899999999999999886421 2456788999999999999999998 99999
Q ss_pred CCCCcEEEeCCCCcEEEEecCchhhhcccCC-c--cccCCCCccChhhhccc---------------------CC--ccc
Q 006244 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHA-A--RCVGTPEFMAPEVYEEE---------------------YN--ELV 121 (654)
Q Consensus 68 LKpeNILId~~~g~VKL~DFGLA~~l~~~~~-~--~~vGTp~YmAPEvl~~~---------------------ys--~ks 121 (654)
|||+|||++.+ +.+||+|||++..+..... . ...+||.|+|||++... |. .+.
T Consensus 335 LKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~ 413 (507)
T PLN03224 335 IKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413 (507)
T ss_pred CchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence 99999999854 7999999999976543221 1 22358999999987421 11 247
Q ss_pred chhhhhhHHHHHhhcCC-CCCCCC----------CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-Cc---cCCCC
Q 006244 122 DIYSFGMCILEMVTFDY-PYSECT----------HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TV---SSRLS 186 (654)
Q Consensus 122 DIWSLGiiL~ELlTG~~-Pf~~~~----------~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP---~~RpT 186 (654)
||||+||++|+|++|.. ||.... +....++.+..+......+...++..++|+.++|. +| .+|+|
T Consensus 414 DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS 493 (507)
T PLN03224 414 DSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS 493 (507)
T ss_pred chhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC
Confidence 99999999999999885 775321 11112222333333333455678999999999998 44 68999
Q ss_pred HHHHhcCccccc
Q 006244 187 ARELLTDPFLQI 198 (654)
Q Consensus 187 a~ELL~HPFf~~ 198 (654)
+.|+|.||||..
T Consensus 494 a~eaL~Hp~f~~ 505 (507)
T PLN03224 494 VGQALSHRFFLP 505 (507)
T ss_pred HHHHhCCCCcCC
Confidence 999999999963
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=210.00 Aligned_cols=191 Identities=25% Similarity=0.382 Sum_probs=153.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+..-. ++.+-||+|||. .+|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||.|+||+.+
T Consensus 64 vrl~dvlhs--dkkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n- 137 (292)
T KOG0662|consen 64 VRLHDVLHS--DKKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN- 137 (292)
T ss_pred eehhhhhcc--CceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-
Confidence 455664443 678999999994 699999876 567999999999999999999999999 9999999999999866
Q ss_pred CcEEEEecCchhhhcccCC--ccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~--~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
|.+|++|||+++.+.-+.. ..-+-|.+|++|.++-+. |+...|+||.|||+.|+.. |.+.|.+.....|+.+.+.
T Consensus 138 gelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 138 GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred CcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 8999999999998765532 223579999999998754 9999999999999999997 7777887655555544332
Q ss_pred c-CCCCccc-------------------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 155 S-GKKPEAL-------------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 155 ~-G~~p~~l-------------------------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
. |...+.. .+..+..-++++.++|. +|.+|++|++.|+||||.
T Consensus 218 ~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~ 287 (292)
T KOG0662|consen 218 LLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFS 287 (292)
T ss_pred HhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccc
Confidence 2 2221111 11223467899999999 899999999999999996
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-25 Score=215.59 Aligned_cols=155 Identities=29% Similarity=0.515 Sum_probs=133.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRL----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~----k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|+|||.+.. ...+|+.||.|. -||..|.+ +.+.+++..+-+++..++.||.|||++- .|||||+||+|||++
T Consensus 108 V~FyGa~~r--egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn 183 (282)
T KOG0984|consen 108 VHFYGALFR--EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN 183 (282)
T ss_pred EEeehhhhc--cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc
Confidence 689998887 679999999994 58877744 4568999999999999999999999874 499999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCcc-ccCCCCccChhhhcc-----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEE-----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~-~vGTp~YmAPEvl~~-----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
. .|+|||||||.+..+.++.+.+ ..|.-.|||||.+.. .|+-++||||||+.++||.++++||..-.++-+..
T Consensus 184 ~-~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL 262 (282)
T KOG0984|consen 184 Y-DGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL 262 (282)
T ss_pred c-CCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence 5 4899999999999988876655 568899999998862 48999999999999999999999998877777777
Q ss_pred HHHHcCCCCc
Q 006244 151 KKVISGKKPE 160 (654)
Q Consensus 151 kki~~G~~p~ 160 (654)
+++.....|.
T Consensus 263 kqvVeep~P~ 272 (282)
T KOG0984|consen 263 KQVVEEPSPQ 272 (282)
T ss_pred HHHhcCCCCC
Confidence 7777655443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=239.06 Aligned_cols=184 Identities=24% Similarity=0.403 Sum_probs=155.3
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHR 66 (654)
+.|.... +..+++|+|||..|+|..|++..+ .++...+..++.||+.|++||++.. +|||
T Consensus 367 llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHR 442 (609)
T KOG0200|consen 367 LLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHR 442 (609)
T ss_pred heeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccch
Confidence 4444433 789999999999999999998876 3899999999999999999999998 9999
Q ss_pred CCCCCcEEEeCCCCcEEEEecCchhhhcccCCcc---ccCC--CCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCC
Q 006244 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGT--PEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYP 139 (654)
Q Consensus 67 DLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~~---~vGT--p~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~P 139 (654)
||-..|||+..+ ..+||+|||+|+......... ..|| ..|||||.+.. .|+.++||||||++||||+| |..|
T Consensus 443 DLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 999999999855 589999999998654433222 2232 35999998875 59999999999999999999 8999
Q ss_pred CCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 140 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 140 f~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
|.+......+++.+..|.+.... ...++++.+++..||. +|.+||++.++..
T Consensus 522 Yp~~~~~~~l~~~l~~G~r~~~P-~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEGNRMEQP-EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCC-CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99866577778888889886543 4569999999999999 8999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7e-24 Score=240.46 Aligned_cols=189 Identities=26% Similarity=0.367 Sum_probs=146.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-R---VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~---Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
||||+.-.+ ....||..|+|. -+|.+|+..+. . ..--..+..+.|+++||++||+.+ ||||||||.||||.
T Consensus 566 iRyyc~E~d--~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~ 640 (903)
T KOG1027|consen 566 IRYYCSEQD--RQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILIS 640 (903)
T ss_pred EEEEeeccC--CceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEE
Confidence 688885555 789999999995 59999998752 1 111345778899999999999999 99999999999998
Q ss_pred CC----CCcEEEEecCchhhhcccC-----CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhc-CCCCCCCCC
Q 006244 77 GN----QGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTF-DYPYSECTH 145 (654)
Q Consensus 77 ~~----~g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG-~~Pf~~~~~ 145 (654)
.. ...++|+|||+++.+.... .....||-+|+|||++.+. -..++||+||||++|+.++| ..||...
T Consensus 641 ~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-- 718 (903)
T KOG1027|consen 641 VPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-- 718 (903)
T ss_pred ccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--
Confidence 52 2468999999999886432 2234599999999999754 56689999999999999996 7999652
Q ss_pred HHHHHHHHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 146 PAQIYKKVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 146 ~~qi~kki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.+--..|..|...- .+....+.++++||.+||. +|..||+|.++|.||||=
T Consensus 719 -~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 719 -LERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -HHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 22223455555432 1222222389999999999 899999999999999993
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.1e-24 Score=233.21 Aligned_cols=184 Identities=26% Similarity=0.481 Sum_probs=155.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
||+.|..++ ..+|||||+++-|.|+.|++.++ .++...+..|++||..||.|||+.. ++||||...|||+.+.
T Consensus 454 ikLIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp- 527 (974)
T KOG4257|consen 454 IKLIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSP- 527 (974)
T ss_pred hheeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCc-
Confidence 578887765 79999999999999999999865 6999999999999999999999999 9999999999999866
Q ss_pred CcEEEEecCchhhhcccCCcc-ccC--CCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAAR-CVG--TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~-~vG--Tp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
.-|||+||||++.+.+..... ..| ...|||||-+. .+++.++|||-||+|+||++. |..||.+..|.+-| -.+.
T Consensus 528 ~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iE 606 (974)
T KOG4257|consen 528 QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIE 606 (974)
T ss_pred ceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEec
Confidence 479999999999987654322 222 45899999886 679999999999999999987 89999886664433 3445
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.|..++ .++.++|.+..++.+||. +|.+||++.+|..
T Consensus 607 nGeRlP-~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 607 NGERLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCCCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 565543 556789999999999999 9999999988753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=208.99 Aligned_cols=193 Identities=21% Similarity=0.368 Sum_probs=156.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++++...+...++..||+||+...+.+++. ..++.-.++.++.||++||.|||+.| |+|||+||.|++|+...-
T Consensus 96 i~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~r 170 (338)
T KOG0668|consen 96 IKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELR 170 (338)
T ss_pred eehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhc
Confidence 4566777777778899999999988877764 35788899999999999999999999 999999999999998777
Q ss_pred cEEEEecCchhhhcccCCc-cccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCC-CCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPY-SECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~-~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf-~~~~~~~qi~kki~~- 155 (654)
+++|+|+|||.+....... -.+.+..|.-||++. ..|+.+.|+|||||++..|+..+-|| .+..|..|+.+...-
T Consensus 171 kLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 171 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 8999999999998765433 345788999999886 45999999999999999999988887 455677776542210
Q ss_pred ------------------------CCCC---------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 ------------------------GKKP---------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 ------------------------G~~p---------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
|.-+ ..-....+|++.+|+.++|. |-.+|+||.|++.||||..
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 0100 01112346999999999999 8999999999999999963
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=226.90 Aligned_cols=219 Identities=24% Similarity=0.352 Sum_probs=171.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++.| +++..-.+|||+|||..|.|.+|+++.. .++.-.+..++.||..|++||..++ +|||||...|+|+..+
T Consensus 326 VqLLG--VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEn 401 (1157)
T KOG4278|consen 326 VQLLG--VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN 401 (1157)
T ss_pred HHHhh--hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccccc
Confidence 34556 3445789999999999999999998753 4787888888999999999999999 9999999999999755
Q ss_pred CCcEEEEecCchhhhcccCCccccC---CCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVG---TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vG---Tp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
..|||+||||++.+.....+...| ...|.|||-+. ..++.++|||+||++|||+.| |-.||.+ .+..+.|..+
T Consensus 402 -hiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LL 479 (1157)
T KOG4278|consen 402 -HIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLL 479 (1157)
T ss_pred -ceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHH
Confidence 589999999999998776655554 35899999775 679999999999999999998 7789988 5678888877
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc---CcccccCCcchhhhhhhhcccccccchhhhhhhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT---DPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLY 226 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~---HPFf~~~~~~~~~r~l~~~~~~~~i~pll~~~l~ 226 (654)
..|-.-. -+..++|.+.+|+..||+ .|++||+++|+-+ .-|-...-.....+.+..+.....+.|+.+.+..
T Consensus 480 EkgyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisdEV~keLgk~~~~~sv~~l~~lp~l 555 (1157)
T KOG4278|consen 480 EKGYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISDEVQKELGKNNDKKSVVPLPRLPIL 555 (1157)
T ss_pred hcccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccHHHHHHHhhcccccccccccccccC
Confidence 7765433 245688999999999999 8999999998743 2222211222333445555566666666665543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=245.77 Aligned_cols=184 Identities=22% Similarity=0.360 Sum_probs=136.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. ....++||||+++|+|.+++. .+++..+..++.||+.||+|||.. .++|+||||||+||+++.+
T Consensus 746 v~~~~~~~~--~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~- 819 (968)
T PLN00113 746 VKLIGLCRS--EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK- 819 (968)
T ss_pred ceEEEEEEc--CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-
Confidence 689999877 578999999999999999985 389999999999999999999954 3349999999999999854
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC----CHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT----HPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~----~~~qi~kki~ 154 (654)
+..++. ||....... .....||+.|||||++.. .|+.++|||||||++|||+||+.||.... ......+...
T Consensus 820 ~~~~~~-~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 820 DEPHLR-LSLPGLLCT--DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred CceEEE-ecccccccc--CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence 566665 665543322 223468999999998874 59999999999999999999999985321 1111111111
Q ss_pred cCC------CCcc-----cccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGK------KPEA-----LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~------~p~~-----l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
... .|.. .......++.+++.+||. +|.+|||+.++++.
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 110 0100 000112357788999999 89999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=230.91 Aligned_cols=193 Identities=28% Similarity=0.499 Sum_probs=164.9
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
-||+++.- +..+|++||||.||+|.+...-.+.+++.++...++..+.||+|||+.+ -+|||||-.|||++ +.|.
T Consensus 76 ay~gsylr--~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gD 150 (829)
T KOG0576|consen 76 AYFGSYLR--RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGD 150 (829)
T ss_pred HHHhhhhh--hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCc
Confidence 46777766 6789999999999999998777789999999999999999999999998 99999999999998 4589
Q ss_pred EEEEecCchhhhccc--CCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 82 VKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 82 VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
||++|||.+..+... ....++|||.||||||.. +.|+.++|||++|+...|+.--++|...-.....++-.-.+
T Consensus 151 vklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS 230 (829)
T KOG0576|consen 151 VKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS 230 (829)
T ss_pred eeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc
Confidence 999999999887654 345678999999999863 56999999999999999999999997765555555555556
Q ss_pred CCCCcccc--cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 GKKPEALF--KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 G~~p~~l~--~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
|-.|..+. ...++.+-.|++.+|. +|++||+++.+|.|||....
T Consensus 231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 66665443 2467889999999999 89999999999999999754
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-23 Score=227.80 Aligned_cols=191 Identities=24% Similarity=0.384 Sum_probs=160.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
||+||...+ ..+.||||++++|+|.+-+.+. ..|-...+..|+.||+.|+.||.+++ +|||||...|+|+-..
T Consensus 174 iRLyGvVl~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp 248 (1039)
T KOG0199|consen 174 IRLYGVVLD---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP 248 (1039)
T ss_pred eEEeeeecc---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc
Confidence 689997775 7899999999999999998872 35888999999999999999999999 9999999999999754
Q ss_pred CCcEEEEecCchhhhcccCCcccc-----CCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCV-----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYK 151 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~v-----GTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~k 151 (654)
..|||+||||.+-+......... -...|.|||.++ ..++.++|+|+|||++|||+| |+.||.++. ..+|.+
T Consensus 249 -rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-g~qIL~ 326 (1039)
T KOG0199|consen 249 -RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-GIQILK 326 (1039)
T ss_pred -ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-HHHHHH
Confidence 58999999999988654332221 234799999886 679999999999999999998 899999864 677888
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+|-.|..-. -++.++..+.+++..||. +|.+|||+..|..+-+++..
T Consensus 327 ~iD~~erLp-RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 327 NIDAGERLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred hccccccCC-CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 887665433 245678899999999999 89999999999876666543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=214.32 Aligned_cols=183 Identities=26% Similarity=0.459 Sum_probs=143.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
++.+.+|+||++..+..++... ++...++.|++.++.||.++|.+| ||||||||.|+|.+...++-.|.|||||.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 6899999999999999998764 679999999999999999999999 99999999999999888889999999997
Q ss_pred hhcc--------c-------C-------------------------------CccccCCCCccChhhhcc--cCCcccch
Q 006244 92 ILRK--------S-------H-------------------------------AARCVGTPEFMAPEVYEE--EYNELVDI 123 (654)
Q Consensus 92 ~l~~--------~-------~-------------------------------~~~~vGTp~YmAPEvl~~--~ys~ksDI 123 (654)
.... . . .....|||+|+|||++.+ ..+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 3210 0 0 002359999999999874 47788999
Q ss_pred hhhhhHHHHHhhcCCCCCCCCCHHHHHHHH--------------HcCC--C-----------------------------
Q 006244 124 YSFGMCILEMVTFDYPYSECTHPAQIYKKV--------------ISGK--K----------------------------- 158 (654)
Q Consensus 124 WSLGiiL~ELlTG~~Pf~~~~~~~qi~kki--------------~~G~--~----------------------------- 158 (654)
||.|+|++-++++.+||..+.+.......+ .-|. .
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999999996543322211111 0122 0
Q ss_pred ----CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 159 ----PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 159 ----p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+.......+..+.+|+.+||. +|.+|+||+++|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 001112234578999999999 99999999999999999743
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.2e-22 Score=215.64 Aligned_cols=73 Identities=29% Similarity=0.532 Sum_probs=66.0
Q ss_pred CEEEEEEEecC--CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~--~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
|+++++|..+. +.+++||+|++ |..|..+|++. +.++...++.|++|||.||.|||..- +|||-||||+|||+
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLL 221 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeee
Confidence 68999998754 56999999999 88999999874 67999999999999999999999875 59999999999997
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-22 Score=223.09 Aligned_cols=132 Identities=30% Similarity=0.476 Sum_probs=114.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCC--cEEEE
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH---RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQG--EVKIG 85 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~---~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId-~~~g--~VKL~ 85 (654)
.+.-.+|||||.||||+.++++. ..+++.++..++..+..||.|||.++ |+||||||+||++. +.+| ..||+
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeee
Confidence 35678999999999999999864 46999999999999999999999999 99999999999885 2324 35999
Q ss_pred ecCchhhhcccC-CccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 86 DLGLAAILRKSH-AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 86 DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
|||.|+-+.+.. ..+.+||+.|.+||+++ +.|+..+|.||||+++|+++||..||--..+
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 999999887654 45678999999999998 4599999999999999999999999954333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=182.60 Aligned_cols=156 Identities=37% Similarity=0.633 Sum_probs=136.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ....++|+|++.|++|.+++... ..++...+..++.+++.+|.|||+.+ ++|+||+|.||+++...
T Consensus 54 ~~~~~~~~~--~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~ 129 (215)
T cd00180 54 VKLYGVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDN 129 (215)
T ss_pred eeEeeeeec--CCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCC
Confidence 356777765 57999999999999999998876 57999999999999999999999998 99999999999998524
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.++|+|||.+....... .....+...|++||.+.. .++.+.|+|++|+++++|
T Consensus 130 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------- 187 (215)
T cd00180 130 GKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187 (215)
T ss_pred CcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------
Confidence 799999999998765543 334558899999999875 678899999999999999
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
..+.+++.+||. +|.+||++.++++++
T Consensus 188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 578999999999 899999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=227.87 Aligned_cols=180 Identities=24% Similarity=0.452 Sum_probs=152.3
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 006244 8 VDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86 (654)
Q Consensus 8 vd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~D 86 (654)
+.++.+.+.||+|||+.|+|..|++++ +.++.-++..+++-|+.|++||-.++ ++||||...|||++.+ -..|++|
T Consensus 698 VVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsn-LvCKVsD 774 (996)
T KOG0196|consen 698 VVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSN-LVCKVSD 774 (996)
T ss_pred EEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccc-eEEEecc
Confidence 556688999999999999999999886 46999999999999999999999999 9999999999999976 4679999
Q ss_pred cCchhhhcccCCc--ccc-C--CCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCC-
Q 006244 87 LGLAAILRKSHAA--RCV-G--TPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKK- 158 (654)
Q Consensus 87 FGLA~~l~~~~~~--~~v-G--Tp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~- 158 (654)
|||++.+.+.... +.. | ...|.|||.+. ++++.++|||||||+|||.++ |+.||.+..| .+..+.|.+|-.
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRL 853 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRL 853 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCC
Confidence 9999988654321 222 2 25899999876 789999999999999999876 9999998655 556677777754
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
|.+ -.++..+-+|+..||+ +...||.+.+|+.+
T Consensus 854 PpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 854 PPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 432 3578899999999999 89999999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.7e-23 Score=210.11 Aligned_cols=182 Identities=27% Similarity=0.432 Sum_probs=146.3
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhh
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 93 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l 93 (654)
.+|+|+|++. .+|...|.....++...++-+++||++||+|||+.+ |.||||||.|+|+++| ..+||||||+++..
T Consensus 131 EiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSN-CvLKICDFGLARve 206 (449)
T KOG0664|consen 131 ELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSN-CILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccC-ceEEeccccccccc
Confidence 5788999995 599999998889999999999999999999999999 9999999999999976 68999999999876
Q ss_pred cccC---CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH---------------
Q 006244 94 RKSH---AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV--------------- 153 (654)
Q Consensus 94 ~~~~---~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki--------------- 153 (654)
.... .+.-+-|-.|+|||++.+ .|+..+||||+|||+.|++..+..|...+..+++--.+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 4332 233457889999998874 59999999999999999999999998766555542111
Q ss_pred --------HcCCCCccc---ccC-----CChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 154 --------ISGKKPEAL---FKV-----EDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 154 --------~~G~~p~~l---~~~-----~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+.++..+ ++. ...+...++.++|. +|.+|.+..+.+.|+++...
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 112222222 222 23467788888888 89999999999999998654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=219.34 Aligned_cols=186 Identities=24% Similarity=0.376 Sum_probs=149.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+++|.++. ++.++|||||++.|+|.+|+.++. .+..+...+++.||+.|++||.+.+ ++||||.+.|+|++++
T Consensus 598 veLvGVC~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e 673 (807)
T KOG1094|consen 598 VELLGVCVQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGE 673 (807)
T ss_pred eEEEeeeec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCc
Confidence 567887766 789999999999999999999984 3455667779999999999999999 9999999999999977
Q ss_pred CCcEEEEecCchhhhcccCCcc----ccCCCCccChhhh-cccCCcccchhhhhhHHHHHhh--cCCCCCCCCCHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYK 151 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~----~vGTp~YmAPEvl-~~~ys~ksDIWSLGiiL~ELlT--G~~Pf~~~~~~~qi~k 151 (654)
+++||+|||+++.+-...... .+-...|||+|.+ .++++.++|+|+||+++||+++ .+.||.... .+++..
T Consensus 674 -~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-~e~vve 751 (807)
T KOG1094|consen 674 -FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-DEQVVE 751 (807)
T ss_pred -ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-HHHHHH
Confidence 699999999998765443332 3445799999955 5889999999999999999876 789998744 444444
Q ss_pred HHH---cCCCCc---ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 152 KVI---SGKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 152 ki~---~G~~p~---~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
... .+..+. ..+...+..+.++|.+||. +-.+||++++|-.
T Consensus 752 n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 752 NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 332 222221 2345678889999999999 8999999999854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-21 Score=204.07 Aligned_cols=176 Identities=32% Similarity=0.503 Sum_probs=134.9
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------CCCCeEecCCCCCcEEEeCCCCcEEEEec
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS------RDPPVIHRDLKCDNIFVNGNQGEVKIGDL 87 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs------~~p~IIHRDLKpeNILId~~~g~VKL~DF 87 (654)
.+|||++|-+.|||.+|+.+ ..++.....+++..++.||++||. ..|.|.|||||..||||..+ |..-|+||
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADL 360 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 360 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEeec
Confidence 68999999999999999998 579999999999999999999995 35889999999999999855 89999999
Q ss_pred Cchhhhccc------CCccccCCCCccChhhhcccCC-------cccchhhhhhHHHHHhhc----------CCCCCC--
Q 006244 88 GLAAILRKS------HAARCVGTPEFMAPEVYEEEYN-------ELVDIYSFGMCILEMVTF----------DYPYSE-- 142 (654)
Q Consensus 88 GLA~~l~~~------~~~~~vGTp~YmAPEvl~~~ys-------~ksDIWSLGiiL~ELlTG----------~~Pf~~-- 142 (654)
|||...... .....+||-+|||||++.+..+ ..+||||||.++||++.. .+||.+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999876543 2345689999999999986533 258999999999999852 578754
Q ss_pred --CCCHHHHHHHHHcC-CCCcccccC-CCh---HHHHHHHHHhh-CccCCCCHHHHh
Q 006244 143 --CTHPAQIYKKVISG-KKPEALFKV-EDP---EVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 143 --~~~~~qi~kki~~G-~~p~~l~~~-~sp---elrdLI~kCL~-dP~~RpTa~ELL 191 (654)
..+.+++.+.+--. ..|...... .++ .+.++++.||. +|.-|.||--+-
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 23444544433222 222211111 233 35567889998 899999986654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.3e-21 Score=205.64 Aligned_cols=176 Identities=30% Similarity=0.471 Sum_probs=136.0
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCeEecCCCCCcEEEeCCCCcEEEE
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-------DPPVIHRDLKCDNIFVNGNQGEVKIG 85 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~-------~p~IIHRDLKpeNILId~~~g~VKL~ 85 (654)
..++|||||-+.|+|-+|++.+ .+++....+++.-|+.||+|||.. .|+|+|||||..||||. +++...|+
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIa 358 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIA 358 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEee
Confidence 4799999999999999999876 599999999999999999999964 47899999999999997 55899999
Q ss_pred ecCchhhhccc----CCccccCCCCccChhhhcccCCc-------ccchhhhhhHHHHHhhcC------------CCCC-
Q 006244 86 DLGLAAILRKS----HAARCVGTPEFMAPEVYEEEYNE-------LVDIYSFGMCILEMVTFD------------YPYS- 141 (654)
Q Consensus 86 DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~~ys~-------ksDIWSLGiiL~ELlTG~------------~Pf~- 141 (654)
|||||..+... .....+||.+|||||++++..+. ..||||+|.+||||++.. .||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 99999887532 23346899999999999876433 489999999999999743 2232
Q ss_pred ---CCCCHHHHHHHHHcCCC----CcccccCC-ChHHHHHHHHHhh-CccCCCCHHHH
Q 006244 142 ---ECTHPAQIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLA-TVSSRLSAREL 190 (654)
Q Consensus 142 ---~~~~~~qi~kki~~G~~----p~~l~~~~-spelrdLI~kCL~-dP~~RpTa~EL 190 (654)
.....+++...+.+.+. |..+.+.. -.-+++.++.||. ||.-|+||.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 11233444444443322 33333332 2458899999999 89999998643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-21 Score=215.79 Aligned_cols=175 Identities=29% Similarity=0.488 Sum_probs=148.9
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
..+-||++|+++|+|.+|++.++ .+..+....|++||++|+.|||.+. ++||||-..|+||.. ...|||.|||+++
T Consensus 770 s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVks-P~hvkitdfgla~ 846 (1177)
T KOG1025|consen 770 STLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKS-PNHVKITDFGLAK 846 (1177)
T ss_pred chHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecC-CCeEEEEecchhh
Confidence 34789999999999999999875 6999999999999999999999998 999999999999974 4699999999999
Q ss_pred hhcccCCccc--c--CCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 006244 92 ILRKSHAARC--V--GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKV 165 (654)
Q Consensus 92 ~l~~~~~~~~--v--GTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~ 165 (654)
.+........ . -.+.|||-|.+. ..|+.++|||||||++||++| |..||.+ ...++|-+.+..|.+ -+-++.
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpi 924 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPI 924 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCC
Confidence 8765432211 1 246789999776 569999999999999999999 8999987 456777777777776 345677
Q ss_pred CChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 166 EDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 166 ~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+.++-.++.+||. |+..||+++++..
T Consensus 925 CtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 925 CTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 89999999999999 9999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=178.36 Aligned_cols=152 Identities=33% Similarity=0.514 Sum_probs=129.8
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~-Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++.. ...+++|+|++.+++|.+++..... +++..+..++.|++.+|.|||+++ ++|+||+|.||+++.+ +
T Consensus 61 ~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~ 135 (225)
T smart00221 61 KLYGVFED--PEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-G 135 (225)
T ss_pred hheeeeec--CCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-C
Confidence 56676665 5789999999999999999988776 899999999999999999999998 9999999999999865 7
Q ss_pred cEEEEecCchhhhccc---CCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCC-CCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSE-CTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~-~~~~~qi~kki~ 154 (654)
.++|+|||++...... ......++..|++||++. ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+.
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 9999999999876544 223446888999999873 3477799999999999999999999977 566667888887
Q ss_pred cCCC
Q 006244 155 SGKK 158 (654)
Q Consensus 155 ~G~~ 158 (654)
.|..
T Consensus 216 ~~~~ 219 (225)
T smart00221 216 FGVP 219 (225)
T ss_pred cCCc
Confidence 7763
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=191.04 Aligned_cols=182 Identities=23% Similarity=0.378 Sum_probs=141.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCCcEEEEecCch
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLA 90 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId-~~~g~VKL~DFGLA 90 (654)
-+.+++++||++-|+|.+-+.. ..+.+...++++.|+++||.|+|+++ ++|||||.+||||- .+..+|||||||+.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred CceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccc
Confidence 4688999999999999987655 45999999999999999999999999 99999999999984 55569999999998
Q ss_pred hhhcccCCccccCCCCccChhhhcc----c--CCcccchhhhhhHHHHHhhcCCCCCCCCCHHH---HHHHHHcCCCCc-
Q 006244 91 AILRKSHAARCVGTPEFMAPEVYEE----E--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQ---IYKKVISGKKPE- 160 (654)
Q Consensus 91 ~~l~~~~~~~~vGTp~YmAPEvl~~----~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q---i~kki~~G~~p~- 160 (654)
+...... ...--+-.|.|||++.. . .++..|||.||+++|.++||.+||........ .+.+...+..+.
T Consensus 171 ~k~g~tV-~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 171 RKVGTTV-KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred cccCcee-hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 7653321 11124567899998752 2 56789999999999999999999975433333 334444555442
Q ss_pred -ccccCCChHHHHHHHHHhh-CccCC---CCHHHHhcCcccc
Q 006244 161 -ALFKVEDPEVRQFIEKCLA-TVSSR---LSARELLTDPFLQ 197 (654)
Q Consensus 161 -~l~~~~spelrdLI~kCL~-dP~~R---pTa~ELL~HPFf~ 197 (654)
..++..++.+..+.++-|. .+.+| -+++...+..|..
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 3455678889999999998 68888 5666667777763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-20 Score=215.16 Aligned_cols=182 Identities=27% Similarity=0.462 Sum_probs=147.4
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhc
Q 006244 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 94 (654)
Q Consensus 15 i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~ 94 (654)
++-+||||++ +|..++.....+....+..+++||+.||.|||..+ |.|||||++|+++..+ |.+||+|||.+..+.
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAASVFR 471 (601)
T ss_pred chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcceeec
Confidence 3444999999 99999988878999999999999999999999999 9999999999999855 799999999998765
Q ss_pred ccC------CccccCCCCccChhhhcc-cCCc-ccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH--cC----CCCc
Q 006244 95 KSH------AARCVGTPEFMAPEVYEE-EYNE-LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI--SG----KKPE 160 (654)
Q Consensus 95 ~~~------~~~~vGTp~YmAPEvl~~-~ys~-ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~--~G----~~p~ 160 (654)
... ....+|+..|+|||++.+ .|++ .+||||.|++++.|++|++||.......+.+.... .+ .-|.
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 332 234579999999999975 4766 58999999999999999999965443333211111 01 1133
Q ss_pred ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 161 ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 161 ~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+....+...+.+|.++|+ +|.+|.|+.+||+++||+...
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 4455567789999999999 999999999999999998543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=205.03 Aligned_cols=137 Identities=29% Similarity=0.465 Sum_probs=125.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFT-SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~-gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+|+.++|.+ ++++||+||--. |.+|++||..+.++++..++.+++||+.|+++||+.+ |||||||-+|+.++++
T Consensus 632 lKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~- 706 (772)
T KOG1152|consen 632 LKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN- 706 (772)
T ss_pred hhhhheeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-
Confidence 577888988 899999999874 4699999999999999999999999999999999999 9999999999999976
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCC
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSE 142 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~ 142 (654)
|-+||+|||.|..........++||..|.|||++.+. | ...-|||++|++||.++..+.||.+
T Consensus 707 g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred CeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 8999999999999888888889999999999999864 4 5568999999999999999999964
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-18 Score=170.27 Aligned_cols=195 Identities=30% Similarity=0.414 Sum_probs=155.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++++.+.. ....+++++++.+++|.+++.... .+....+..++.|++.+|.|+|+.+ ++|||+||+||+++.
T Consensus 61 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~ 136 (384)
T COG0515 61 VKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDR 136 (384)
T ss_pred eeEEEEEec--CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecC
Confidence 357777744 556899999999999998877765 7999999999999999999999999 999999999999986
Q ss_pred CCCcEEEEecCchhhhcccC--------CccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 78 NQGEVKIGDLGLAAILRKSH--------AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~--------~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
....++++|||++..+.... ....+||+.|+|||.+.. .+....|+||+|++++++++|..||.....
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 53379999999998654432 345679999999998875 588899999999999999999999876553
Q ss_pred ---HHHHHHHHHcCCCC-cccccCC------ChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 146 ---PAQIYKKVISGKKP-EALFKVE------DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 146 ---~~qi~kki~~G~~p-~~l~~~~------spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.......+.....+ ....... ...+.+++.+++. +|..|.+..+...++|....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 45555555544433 1111111 2578999999999 89999999999998766543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=175.99 Aligned_cols=175 Identities=22% Similarity=0.312 Sum_probs=146.3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEE
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH--------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVK 83 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~--------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VK 83 (654)
...-+.++.++.-|.|+.|+... +.++..++..++.||..|++|||+++ |||.||...|++|+ +.-+||
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVk 436 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVK 436 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEE
Confidence 34567788899899999999832 34788889999999999999999999 99999999999998 446999
Q ss_pred EEecCchhhhcccCCcccc-----CCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 84 IGDLGLAAILRKSHAARCV-----GTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 84 L~DFGLA~~l~~~~~~~~v-----GTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
|+|=.+++.+-.... .+. ....||+||.+. ..|+..+|+||||++||||+| |+.||.+ -++.+++.-+..|
T Consensus 437 ltDsaLSRDLFP~DY-hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdG 514 (563)
T KOG1024|consen 437 LTDSALSRDLFPGDY-HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDG 514 (563)
T ss_pred eccchhccccCcccc-cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcc
Confidence 999999986643221 122 345899999876 569999999999999999999 9999988 5688888888888
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+-... -.++.++..++..||. .|.+||+++++..
T Consensus 515 yRlaQP-~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQP-FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecCC-CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 876543 3567899999999999 8999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-18 Score=192.11 Aligned_cols=186 Identities=22% Similarity=0.354 Sum_probs=158.7
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
+++..|.. +...++++++..||.|...+.+...+.+...+.+...++.+++++|+.+ |+|||+|++||+++.+ |+
T Consensus 61 ~lhyafqt--~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Gh 135 (612)
T KOG0603|consen 61 KLHYAFQT--DGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GH 135 (612)
T ss_pred eeeeeecc--ccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-Cc
Confidence 45555555 6789999999999999999888889999999999999999999999999 9999999999999965 89
Q ss_pred EEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcc
Q 006244 82 VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA 161 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~ 161 (654)
+++.|||+++..-..... +||..|||||++. .....+|.||||+++++|+||..||.. .+.+.|..-..+
T Consensus 136 i~~tdfglske~v~~~~~--cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~-- 205 (612)
T KOG0603|consen 136 IKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE-- 205 (612)
T ss_pred cccCCchhhhHhHhhhhc--ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC--
Confidence 999999999887554444 8999999999998 667889999999999999999999976 445555543332
Q ss_pred cccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 162 LFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 162 l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
++...++.+++++..++. +|..|.. +.++++|+||+..++.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 455678899999999998 8988875 5799999999876654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-18 Score=189.24 Aligned_cols=174 Identities=28% Similarity=0.482 Sum_probs=141.7
Q ss_pred CeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCc
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 89 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGL 89 (654)
.++||.|++|.-++|.+|+.+.+ ..+....+.|+.|+..|++| ++ .+|||+||.||++. ++..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 47899999999999999998654 47788899999999999999 66 99999999999997 446899999999
Q ss_pred hhhhcccC--------CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 90 AAILRKSH--------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 90 A~~l~~~~--------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
........ .+..+||++||+||.+. ..|+.++||||||+||+|+++ ...++.. ...+..+..|..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCC
Confidence 98765433 34467999999999988 469999999999999999998 4444432 2234456677777
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+.+ ....|.-..|+.++|. .|.+||++.+.-.|.|++
T Consensus 479 ~~~-~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEF-LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHH-hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 533 3455677899999999 899999988888888763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-17 Score=193.55 Aligned_cols=153 Identities=34% Similarity=0.557 Sum_probs=127.5
Q ss_pred HHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhccc-----------------CCccccCCCCccChh
Q 006244 49 ILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----------------HAARCVGTPEFMAPE 111 (654)
Q Consensus 49 Il~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~-----------------~~~~~vGTp~YmAPE 111 (654)
++.+++|||+.+ |+|||+||+|.+|+ ..|++|++|||++++.-.. .....+|||.|+|||
T Consensus 152 mvla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 388999999998 99999999999998 4589999999999764221 122347999999999
Q ss_pred hhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--CCCCcccccCCChHHHHHHHHHhh-CccCCC--
Q 006244 112 VYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS--GKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-- 185 (654)
Q Consensus 112 vl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~--G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-- 185 (654)
|+. ..|...+|+|++|+|+||.+.|.+||.+ .++++++..++. ...|+. .....++++++|.++|+ +|..|.
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 886 4599999999999999999999999998 678888888876 334544 45578999999999999 788875
Q ss_pred -CHHHHhcCcccccCCcchhhh
Q 006244 186 -SARELLTDPFLQIDDYDSDLR 206 (654)
Q Consensus 186 -Ta~ELL~HPFf~~~~~~~~~r 206 (654)
.+-++.+|+||+.-++...+|
T Consensus 307 ~ga~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 307 GGALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred chhhhhhhccceeecccchhhh
Confidence 588999999999888875444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-16 Score=165.49 Aligned_cols=193 Identities=35% Similarity=0.613 Sum_probs=141.8
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|||+.+|-+.+ +..+.+++||+..|+|.+|+++- ..+....+++|+.||+.||.|||+..|||+|+.+.++.|
T Consensus 130 vkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ti 209 (458)
T KOG1266|consen 130 VKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTI 209 (458)
T ss_pred HHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhe
Confidence 46777887743 35789999999999999999864 459999999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecCchhhh-----ccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 74 FVNGNQGEVKIGDLGLAAIL-----RKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l-----~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
|+..+ |.|||+--...... ... ......+-++|.|||.-. .+.+..+|||+|||+.++|..++.--.+....
T Consensus 210 fiq~n-gLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~ 288 (458)
T KOG1266|consen 210 FIQHN-GLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESK 288 (458)
T ss_pred eecCC-ceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcce
Confidence 99854 78888743222111 011 111123678999998654 45677899999999999999988664332211
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 147 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 147 ~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
...-..+. ..+....++--+++|.+||. .|..||++.++|.||.+-..
T Consensus 289 ~~~ee~ia-----~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 289 VEVEENIA-----NVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred eehhhhhh-----hheeeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 11111111 11222344556889999999 89999999999999987544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.7e-15 Score=155.36 Aligned_cols=178 Identities=20% Similarity=0.217 Sum_probs=129.8
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC----CcEEEE
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ----GEVKIG 85 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~----g~VKL~ 85 (654)
...-||||+++ |.+|.+++... +.++..++..++.|++.+|++||+.+ ++||||||+|+++.... ..+.|.
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEE
Confidence 56889999999 89999988654 57999999999999999999999999 99999999999996432 369999
Q ss_pred ecCchhhhc--c-c------C---CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH--HH
Q 006244 86 DLGLAAILR--K-S------H---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ--IY 150 (654)
Q Consensus 86 DFGLA~~l~--~-~------~---~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q--i~ 150 (654)
|||+++... . . . ...+.||..|+++.+..+ ..+.+.|+||++.++.+++.|..||........ .+
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998322 1 1 1 123459999999998765 488999999999999999999999976443222 22
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
++................++..+...+-. +...+|....+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 22221111111222233455555555544 5666776665554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.3e-15 Score=157.87 Aligned_cols=182 Identities=23% Similarity=0.303 Sum_probs=134.5
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEEec
Q 006244 11 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKIGDL 87 (654)
Q Consensus 11 ~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~---g~VKL~DF 87 (654)
..+++|+||.-.. .+|++|+..+ ..+....+-++.|+++|+.|||+++ |.|||||.+|||+.-++ ..+.|+||
T Consensus 314 ~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 314 EPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEccc
Confidence 3679999999995 5999998764 5788888999999999999999999 99999999999995222 25789999
Q ss_pred Cchhhhcc-----cCC---ccccCCCCccChhhhcccC-------CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 88 GLAAILRK-----SHA---ARCVGTPEFMAPEVYEEEY-------NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 88 GLA~~l~~-----~~~---~~~vGTp~YmAPEvl~~~y-------s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
|.+---.. +.. -..-|.-..||||+..... -.++|.|+.|.+.||+++...||.......--.+.
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 97632211 111 1123778899999987321 24899999999999999999999763211111122
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH---HHHhcCcccc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA---RELLTDPFLQ 197 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa---~ELL~HPFf~ 197 (654)
..+...| .++...+|.+++++..+|+ +|++|+++ +.+|+--.+.
T Consensus 470 Yqe~qLP-alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 470 YQESQLP-ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred hhhhhCC-CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 3333344 3566788999999999999 89999984 4555544444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=161.41 Aligned_cols=186 Identities=24% Similarity=0.390 Sum_probs=145.0
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-EecCCCCCcEEEeCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPV-IHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~I-IHRDLKpeNILId~~~ 79 (654)
+|+|..++ ...+++|.+||.-|+|.+.+.. ...++......+++.|+.||.|||... | .|+.|+..|++++..
T Consensus 11 ~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd~~- 85 (484)
T KOG1023|consen 11 KFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVDSR- 85 (484)
T ss_pred hheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccccceeeee-
Confidence 68888888 5899999999999999999887 346888899999999999999999875 5 999999999999965
Q ss_pred CcEEEEecCchhhhccc----CCccccCCCCccChhhhccc--------CCcccchhhhhhHHHHHhhcCCCCCCCC---
Q 006244 80 GEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEEE--------YNELVDIYSFGMCILEMVTFDYPYSECT--- 144 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~~--------ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--- 144 (654)
-.+||.|||+....... ......-..-|.|||++... .+.+.|||||||+++|+++..-||....
T Consensus 86 w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~ 165 (484)
T KOG1023|consen 86 WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVE 165 (484)
T ss_pred EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccC
Confidence 58999999999876431 11111123468999999753 4667999999999999999999997532
Q ss_pred CHHHHHHHHHc-CCCC---ccccc-CCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 145 HPAQIYKKVIS-GKKP---EALFK-VEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 145 ~~~qi~kki~~-G~~p---~~l~~-~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+.++..++.. +..+ .-... ...+++..++..||. +|..||+++.+-.
T Consensus 166 ~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 166 DPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 23456666666 3322 11111 234579999999999 8999999988643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-14 Score=151.55 Aligned_cols=159 Identities=17% Similarity=0.191 Sum_probs=103.6
Q ss_pred eEEEEEecCCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 006244 14 NINFVTEMFTSGTLRQYRLK---HRR----VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k---~~~----Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~D 86 (654)
+.+++++-+ .++|.+++.- ... +...+-..+..|+++.+++||..+ |+|+||||+|+|++.+ |.+.|+|
T Consensus 113 n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~~~-G~v~Lg~ 188 (288)
T PF14531_consen 113 NRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHGDIKPENFLLDQD-GGVFLGD 188 (288)
T ss_dssp SEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEE-TT-S-EEE--
T ss_pred hhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEecccceeeEEEcCC-CCEEEcC
Confidence 457888888 5788887542 221 333344555589999999999999 9999999999999865 8999999
Q ss_pred cCchhhhcccCCccccCCCCccChhhhcc---------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 87 LGLAAILRKSHAARCVGTPEFMAPEVYEE---------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 87 FGLA~~l~~~~~~~~vGTp~YmAPEvl~~---------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
|+........... ...+..|.+||+... .++.+.|.|+||+++|.|+++..||..... ......
T Consensus 189 F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~-~~~~~~----- 261 (288)
T PF14531_consen 189 FSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP-EADPEW----- 261 (288)
T ss_dssp GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG-GSTSGG-----
T ss_pred hHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc-cccccc-----
Confidence 9877655443222 345678999997743 378899999999999999999999975321 110000
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSR 184 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~R 184 (654)
........+..++.||..+|+ +|.+|
T Consensus 262 -~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred -cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 111122456789999999999 88877
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-13 Score=139.43 Aligned_cols=174 Identities=23% Similarity=0.315 Sum_probs=136.8
Q ss_pred cCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEe
Q 006244 10 TANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKIGD 86 (654)
Q Consensus 10 ~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~~g~VKL~D 86 (654)
+.+.+-+||||++ |.+|.+++.- .++++.+++.-++-|++.-++|+|.++ +|||||||+|+|.- ....++.++|
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEe
Confidence 3477889999999 8999999875 567999999999999999999999999 99999999999983 2224789999
Q ss_pred cCchhhhcccCC---------ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC--CCHHHHHHHHH
Q 006244 87 LGLAAILRKSHA---------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKKVI 154 (654)
Q Consensus 87 FGLA~~l~~~~~---------~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--~~~~qi~kki~ 154 (654)
||||+...+... ....||..|.+-....+ ..+...|+-|+|.+|.....|..||.+. .+..|.|.+|.
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 999998754321 23358999988665443 3567789999999999999999999874 45667777777
Q ss_pred cCCC---CcccccCCChHHHHHHHHHhh-CccCCCC
Q 006244 155 SGKK---PEALFKVEDPEVRQFIEKCLA-TVSSRLS 186 (654)
Q Consensus 155 ~G~~---p~~l~~~~spelrdLI~kCL~-dP~~RpT 186 (654)
..+. ++.+.+..+.++.-.+.-|-. --.+-|.
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 6443 445566778888888888865 3333343
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-13 Score=143.45 Aligned_cols=148 Identities=20% Similarity=0.357 Sum_probs=121.8
Q ss_pred EecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe----CCCCcE
Q 006244 8 VDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN----GNQGEV 82 (654)
Q Consensus 8 vd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId----~~~g~V 82 (654)
+..++.+-.||+|++ |-+|.+++.- .++++.+++..++.|++.-++|+|.++ +|+|||||+|+||. .+...|
T Consensus 92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 92 FGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred eccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceE
Confidence 334467888999999 8999999875 467999999999999999999999999 99999999999994 233468
Q ss_pred EEEecCchhhhcccCC---------ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCC--CCCHHHHH
Q 006244 83 KIGDLGLAAILRKSHA---------ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSE--CTHPAQIY 150 (654)
Q Consensus 83 KL~DFGLA~~l~~~~~---------~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~--~~~~~qi~ 150 (654)
.|+|||+|+...++.. .+..||..||+-.... ...+...|+-|||-+++..|.|..||.+ ..+..+.|
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY 248 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY 248 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence 9999999998866432 2335999999987654 4477889999999999999999999976 35667778
Q ss_pred HHHHcCCC
Q 006244 151 KKVISGKK 158 (654)
Q Consensus 151 kki~~G~~ 158 (654)
.+|-..+.
T Consensus 249 eKIGe~Kr 256 (449)
T KOG1165|consen 249 EKIGETKR 256 (449)
T ss_pred HHhccccc
Confidence 88755443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.5e-14 Score=164.92 Aligned_cols=173 Identities=23% Similarity=0.278 Sum_probs=126.3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
++..|||-+|+.. +|.+-+.-+.-+..-..+.|+.||+.||..+|..+ |.|+|||++||||++ -+.+.|+||...+
T Consensus 93 ~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTS-WNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 93 DKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITS-WNWLYLTDFASFK 168 (1431)
T ss_pred hHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEee-echhhhhcccccC
Confidence 4455777777753 77776666556777888888999999999999999 999999999999984 4689999997654
Q ss_pred hh--cccCC---ccc----cCCCCccChhhhccc------------CCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHH
Q 006244 92 IL--RKSHA---ARC----VGTPEFMAPEVYEEE------------YNELVDIYSFGMCILEMVT-FDYPYSECTHPAQI 149 (654)
Q Consensus 92 ~l--~~~~~---~~~----vGTp~YmAPEvl~~~------------ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi 149 (654)
.. ..... ..+ ...-+|.|||-+... ..++.||||+||+++||++ |.+||.- .|+
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL 244 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQL 244 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHH
Confidence 32 11111 111 123489999976421 3567999999999999998 6888842 333
Q ss_pred HHHHHcC-C-CCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 150 YKKVISG-K-KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 150 ~kki~~G-~-~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+.- .+| . .++ -+.+..++.+|.+|..|++ +|++|.+|++.|+.
T Consensus 245 ~aY-r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 245 LAY-RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhH-hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 322 222 1 111 2234567789999999999 99999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.9e-15 Score=167.47 Aligned_cols=184 Identities=27% Similarity=0.378 Sum_probs=151.6
Q ss_pred CCeEEEEEecCCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC-cEEEEec
Q 006244 12 NRNINFVTEMFTSGTLRQYR-LKHR-RVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQG-EVKIGDL 87 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l-~k~~-~Lse~~i~~i~~QIl~gL~YLH-s~~p~IIHRDLKpeNILId~~~g-~VKL~DF 87 (654)
.+..+++++|..||++..-+ .... ..+...+..++.|+..+|.|+| ..+ +.|||+||+|.+++.. + .++++||
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s-~~~l~~~df 169 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDES-GSALKIADF 169 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccC-CCcccCCCc
Confidence 67899999999999999988 5544 6788889999999999999999 887 9999999999999865 5 8999999
Q ss_pred Cchhhhcc-cCC----ccccC-CCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC--
Q 006244 88 GLAAILRK-SHA----ARCVG-TPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK-- 157 (654)
Q Consensus 88 GLA~~l~~-~~~----~~~vG-Tp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~-- 157 (654)
|+|..+.. ... ...+| ++.|+|||...+ ......|+||.|+++.-+++|..||.........+.......
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc
Confidence 99988766 322 23468 999999999876 367789999999999999999999976544443333333322
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.-...+...+....+++.++|. +|..|.+.+++..+||+..
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1244566778899999999997 8999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.5e-13 Score=138.38 Aligned_cols=174 Identities=15% Similarity=0.298 Sum_probs=135.4
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-CcEEEEecC
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLG 88 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~--Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~-g~VKL~DFG 88 (654)
..++.+|+.||+.|+|...+..... ++..++.+++..|+.|++|||+..|-|.---|....++||.+- .++-++|--
T Consensus 259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence 4688999999999999999887653 7788999999999999999999986455557888899998542 133344432
Q ss_pred chhhhcccCCccccCCCCccChhhhccc----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCccccc
Q 006244 89 LAAILRKSHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFK 164 (654)
Q Consensus 89 LA~~l~~~~~~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~ 164 (654)
++.. .....-.|.||+||.+..+ --..+|+|||++++||+.|.+.||.+-.+.+--.+.-..|..+. +++
T Consensus 339 fsfq-----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~-ipp 412 (448)
T KOG0195|consen 339 FSFQ-----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH-IPP 412 (448)
T ss_pred eeee-----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc-CCC
Confidence 2211 0112346899999998754 23478999999999999999999998777776666667777664 667
Q ss_pred CCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 165 VEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 165 ~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
..++.+..|+.-|+. ||.+||.++.++
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 789999999999999 899999877653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.9e-13 Score=145.19 Aligned_cols=92 Identities=22% Similarity=0.279 Sum_probs=73.9
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEEecCchh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDL-KpeNILId~~~g~VKL~DFGLA~ 91 (654)
...|||||||.|++|... .. .. ...|+.|++.||.|||+++ |+|||| ||+|||++.+ +.+||+|||+|+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~~ikLiDFGlA~ 160 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-GEAAVIDFQLAS 160 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-CCEEEEECccce
Confidence 458999999999999732 11 11 2578899999999999998 999999 9999999744 789999999998
Q ss_pred hhcccC----------CccccCCCCccChhhhc
Q 006244 92 ILRKSH----------AARCVGTPEFMAPEVYE 114 (654)
Q Consensus 92 ~l~~~~----------~~~~vGTp~YmAPEvl~ 114 (654)
.+.... .....+++.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 664322 13446889999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.4e-12 Score=129.06 Aligned_cols=75 Identities=19% Similarity=0.236 Sum_probs=66.7
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhc
Q 006244 16 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 94 (654)
Q Consensus 16 ~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YL-Hs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~ 94 (654)
+|||||+.|++|...+.+...+++..+..++.||+.+|.|| |+.+ |+||||||+|||++ + +.++|+|||+|....
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D-GKLYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C-CcEEEEEccccccCC
Confidence 89999999988876655567899999999999999999999 7888 99999999999998 3 689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-12 Score=125.17 Aligned_cols=77 Identities=22% Similarity=0.229 Sum_probs=66.3
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhh
Q 006244 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 93 (654)
Q Consensus 15 i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l 93 (654)
.+|||||+.|+++.........++...+..++.|++.+|.+||. .+ |+||||||+|||++ .+.++|+|||++..+
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~--~~~~~liDFG~a~~~ 167 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH--DGKPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--CCCEEEEEcccceec
Confidence 38999999988665443444578899999999999999999999 88 99999999999998 478999999999876
Q ss_pred cc
Q 006244 94 RK 95 (654)
Q Consensus 94 ~~ 95 (654)
..
T Consensus 168 ~~ 169 (190)
T cd05145 168 DH 169 (190)
T ss_pred CC
Confidence 43
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-12 Score=128.55 Aligned_cols=120 Identities=18% Similarity=0.118 Sum_probs=92.0
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEEecCchh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDL-KpeNILId~~~g~VKL~DFGLA~ 91 (654)
...+++|||+.|.+|.+.+.. . ...++.|++.+|.+||.++ |+|||| ||+|||++. .|.++|+|||+|.
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~-~g~i~LIDFG~A~ 140 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQE-DGSPAVIDFQLAV 140 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcC-CCCEEEEECCCce
Confidence 356999999999999754321 1 2457889999999999999 999999 799999984 4799999999998
Q ss_pred hhcccCC---------------ccccCCCCccChhhhc--ccCC-cccchhhhhhHHHHHhhcCCCCCC
Q 006244 92 ILRKSHA---------------ARCVGTPEFMAPEVYE--EEYN-ELVDIYSFGMCILEMVTFDYPYSE 142 (654)
Q Consensus 92 ~l~~~~~---------------~~~vGTp~YmAPEvl~--~~ys-~ksDIWSLGiiL~ELlTG~~Pf~~ 142 (654)
....... .....+|.|+.|+-.. ...+ ...+.++.|.-+|.++|+..|+.+
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 5543221 0112688888887543 2333 456788889999999999998765
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.7e-12 Score=129.50 Aligned_cols=101 Identities=19% Similarity=0.190 Sum_probs=77.3
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
...+|||||++|.+|.++.. +++ ....+|+.+|..||..+ ++|||+||+||+++.+ | ++|+|||....
T Consensus 116 ~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i~liDfg~~~~ 183 (232)
T PRK10359 116 HTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-LRIIDLSGKRC 183 (232)
T ss_pred CCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-EEEEECCCccc
Confidence 46899999999999988732 333 24569999999999999 9999999999999854 6 99999998765
Q ss_pred hcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHh
Q 006244 93 LRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMV 134 (654)
Q Consensus 93 l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELl 134 (654)
......... =++...|+.++|+|+||+++..+.
T Consensus 184 ~~e~~a~d~---------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 184 TAQRKAKDR---------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccchhhHHH---------HHHHhHhcccccccceeEeehHHH
Confidence 532211110 123455888999999999876554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.6e-12 Score=150.01 Aligned_cols=132 Identities=20% Similarity=0.211 Sum_probs=111.8
Q ss_pred EEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------
Q 006244 4 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG------ 77 (654)
Q Consensus 4 Y~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~------ 77 (654)
+..++. .+.-+||+||.+.|||.++++..+.+++..+..++.||+.-++.||..+ |||+||||+|+||..
T Consensus 760 ~~a~~~--~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~ 835 (974)
T KOG1166|consen 760 SSAHVF--QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADS 835 (974)
T ss_pred HHHHcc--CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCC
Confidence 334444 5778999999999999999998889999999999999999999999999 999999999999942
Q ss_pred CCCcEEEEecCchhhhcc---c-CCccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCC
Q 006244 78 NQGEVKIGDLGLAAILRK---S-HAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~---~-~~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
+..-++|+|||-+..+.- . .....++|-.|-.+|+..++ ++..+|-|.|+.+++.||.|++.
T Consensus 836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 223589999999975542 2 22334688899999999875 99999999999999999998854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.4e-12 Score=148.47 Aligned_cols=189 Identities=24% Similarity=0.392 Sum_probs=158.9
Q ss_pred CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 11 ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 11 ~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
.....+||++|+.||+|...+...+..+.+.++.++..+..+++|||+.. +.|||++|.|+|+. ..|+.++.|||+.
T Consensus 875 ~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 875 CRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTL 951 (1205)
T ss_pred CCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccc
Confidence 36789999999999999999998888999999999999999999999997 99999999999997 4589999999844
Q ss_pred hhhcc----------------------------c-----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhc
Q 006244 91 AILRK----------------------------S-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTF 136 (654)
Q Consensus 91 ~~l~~----------------------------~-----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG 136 (654)
....- . .....+||+.|.+||...+ .....+|+|++|++++|.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 32100 0 0123469999999998765 477889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHH---HHhcCcccccCCcch
Q 006244 137 DYPYSECTHPAQIYKKVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSAR---ELLTDPFLQIDDYDS 203 (654)
Q Consensus 137 ~~Pf~~~~~~~qi~kki~~G~~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~---ELL~HPFf~~~~~~~ 203 (654)
.+||.. ..+++++..+..+..|... ....++++++++.+.|. ++.+|..+. ++-.|+||+..++..
T Consensus 1032 ~pp~na-~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1032 IPPFNA-ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CCCCCC-cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 999986 6788899888887765433 34568899999999999 899999887 999999999887754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.9e-11 Score=119.79 Aligned_cols=85 Identities=19% Similarity=0.185 Sum_probs=66.9
Q ss_pred CEEEEEEEecCC-CeEE-EEEec--CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTAN-RNIN-FVTEM--FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGL-LYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~-~~i~-LVtEy--~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL-~YLHs~~p~IIHRDLKpeNILI 75 (654)
++||+.+....+ ..++ +|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||+
T Consensus 64 vr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl 138 (210)
T PRK10345 64 PRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILC 138 (210)
T ss_pred ceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEE
Confidence 589998887432 3434 78999 5589999999764 46666 46788999888 9999999 9999999999999
Q ss_pred eCC---CCcEEEEecCch
Q 006244 76 NGN---QGEVKIGDLGLA 90 (654)
Q Consensus 76 d~~---~g~VKL~DFGLA 90 (654)
+.. .+.++|+||+.+
T Consensus 139 ~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 139 QRISESEVIPVVCDNIGE 156 (210)
T ss_pred eccCCCCCcEEEEECCCC
Confidence 742 247999995433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.3e-11 Score=133.92 Aligned_cols=191 Identities=23% Similarity=0.267 Sum_probs=155.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILS----GLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~-Lse~~i~~i~~QIl~----gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++|..|.. .+..++-+|+| +.+|.+|...-.. ++...+...+.+... ||.++|+.+ ++|-|+||+||+.
T Consensus 181 v~~~~~~e~--~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 181 VRDSPAWEG--SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFT 255 (524)
T ss_pred cccCccccc--CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheec
Confidence 345667766 78999999999 5899998776444 888899999999999 999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccCCc-------cccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~~~-------~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
..+....+++|||+...+...... ..-|...|++||+..+-+....|||++|.++.+..++..++....+.
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-- 333 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS-- 333 (524)
T ss_pred ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--
Confidence 866568899999999887654321 11477899999999999999999999999999999987776543111
Q ss_pred HHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 149 IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 149 i~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+..+..+..|..+....+.+++..+..++. ++..|++++.+++++++..
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1223344456767777778888888999998 7999999999999999973
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-10 Score=116.85 Aligned_cols=78 Identities=26% Similarity=0.254 Sum_probs=66.9
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhh
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 93 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l 93 (654)
..+|||||+.|++|..+......+....+..++.||+.+|.+||.++ .|+||||||+||+++ .+.++|+|||.+...
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~--~~~i~LiDFg~a~~~ 198 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH--DGKVVIIDVSQSVEL 198 (237)
T ss_pred CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE--CCCEEEEEChhhhcc
Confidence 35899999999998877655556777788899999999999999986 599999999999998 478999999998764
Q ss_pred c
Q 006244 94 R 94 (654)
Q Consensus 94 ~ 94 (654)
.
T Consensus 199 ~ 199 (237)
T smart00090 199 D 199 (237)
T ss_pred C
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.4e-09 Score=107.16 Aligned_cols=73 Identities=26% Similarity=0.330 Sum_probs=65.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
....++||||+.|++|.+++..... ....++.+|+.+|.+||+.+ ++|+|++|.|||++ .+.++|+|||++.
T Consensus 71 ~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~ 142 (211)
T PRK14879 71 PENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAE 142 (211)
T ss_pred CCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCccc
Confidence 4678899999999999999876432 78899999999999999998 99999999999998 4689999999886
Q ss_pred h
Q 006244 92 I 92 (654)
Q Consensus 92 ~ 92 (654)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 5
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.1e-09 Score=105.17 Aligned_cols=70 Identities=24% Similarity=0.304 Sum_probs=61.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
....++||||++|++|.+++..... .++.||+.+|.+||+.+ ++|+|++|.||+++ .+.++++|||++.
T Consensus 69 ~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~ 137 (199)
T TIGR03724 69 PDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGK 137 (199)
T ss_pred CCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCc
Confidence 4567899999999999998765421 88999999999999998 99999999999998 4789999999886
Q ss_pred h
Q 006244 92 I 92 (654)
Q Consensus 92 ~ 92 (654)
.
T Consensus 138 ~ 138 (199)
T TIGR03724 138 Y 138 (199)
T ss_pred C
Confidence 5
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.4e-09 Score=120.55 Aligned_cols=70 Identities=20% Similarity=0.270 Sum_probs=62.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
....++||||+.|++|.+++. ....++.||+.+|.|||+.+ |+||||||+|||++ .+.++|+|||+++
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~ 475 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGK 475 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccc
Confidence 456789999999999999875 35778999999999999999 99999999999994 4689999999986
Q ss_pred hh
Q 006244 92 IL 93 (654)
Q Consensus 92 ~l 93 (654)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 63
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-09 Score=105.78 Aligned_cols=74 Identities=20% Similarity=0.191 Sum_probs=62.3
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
...++||||+.|++|..+... .....++.+|+.++.++|..+ |+||||||+||+++. .+.++|+|||++..
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~-~~~~~liDfg~~~~ 174 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD-DEKIYIIDWPQMVS 174 (198)
T ss_pred CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC-CCcEEEEECCcccc
Confidence 456899999999999875321 346788899999999999998 999999999999985 57999999999865
Q ss_pred hcc
Q 006244 93 LRK 95 (654)
Q Consensus 93 l~~ 95 (654)
...
T Consensus 175 ~~~ 177 (198)
T cd05144 175 TDH 177 (198)
T ss_pred CCC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.5e-09 Score=106.67 Aligned_cols=69 Identities=17% Similarity=0.250 Sum_probs=58.9
Q ss_pred EEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 16 NFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 16 ~LVtEy~~g-GSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+||||+++| .+|.+++.. ..+++.. +.||+.+|.+||..+ |+||||||.|||++.+ +.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEECCCccc
Confidence 599999997 699998765 3456543 578999999999999 9999999999999854 6899999998865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.79 E-value=9.1e-09 Score=99.53 Aligned_cols=77 Identities=27% Similarity=0.288 Sum_probs=59.4
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
..+|||||++||++........... ..+..++.+++.++.++|. .+ |+||||||+||+++ .+.++|+|||.+..
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~--~~~~~liDfg~a~~ 163 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD--DGKVYIIDVPQAVE 163 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--CCcEEEEECccccc
Confidence 4589999999954322111110111 6788999999999999999 87 99999999999998 47899999999976
Q ss_pred hcc
Q 006244 93 LRK 95 (654)
Q Consensus 93 l~~ 95 (654)
...
T Consensus 164 ~~~ 166 (187)
T cd05119 164 IDH 166 (187)
T ss_pred ccC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=5.8e-09 Score=117.06 Aligned_cols=184 Identities=21% Similarity=0.195 Sum_probs=134.5
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE 81 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~ 81 (654)
++|..|.. .+..|+=.|||.++++...+.-...+++.-.++...|++.++.++|+.. ++|+|+||+||++..+++.
T Consensus 330 g~~~~W~~--~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 330 GKNSSWSQ--LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFF 405 (524)
T ss_pred CCCCCccc--cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhh
Confidence 46777877 6788899999999999887765667899999999999999999999998 9999999999999754467
Q ss_pred EEEEecCchhhhcccCCccccCCCCcc-Chhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 82 VKIGDLGLAAILRKSHAARCVGTPEFM-APEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 82 VKL~DFGLA~~l~~~~~~~~vGTp~Ym-APEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
-+++|||.++.+.-... ...++-+++ .+|++.+ .+..++|++|||.-+.+.+++.+--.... ....+..|..
T Consensus 406 ~~~~~~~~~t~~~~~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~ 480 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDT 480 (524)
T ss_pred hhccccccccccceecc-cccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccc
Confidence 89999998875322211 112333444 3555543 37789999999999999998763322211 1234445554
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
|... ....++..+.+.++. ++..|+.+.++..|+-|
T Consensus 481 p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 PNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 4321 222667777777777 78899999999888755
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.2e-08 Score=88.21 Aligned_cols=81 Identities=22% Similarity=0.159 Sum_probs=65.4
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCcEEEeCCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD-PPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~-p~IIHRDLKpeNILId~~~g 80 (654)
+++..... .+..++++||+.|+.+..+ +......++.+++.+|.+||... .+++|+|++|.||+++. .+
T Consensus 57 ~~~~~~~~--~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~ 126 (155)
T cd05120 57 KVLASGES--DGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GK 126 (155)
T ss_pred eEEEEcCC--CCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-Cc
Confidence 34554433 4689999999999888765 55677888999999999999852 24999999999999985 47
Q ss_pred cEEEEecCchhh
Q 006244 81 EVKIGDLGLAAI 92 (654)
Q Consensus 81 ~VKL~DFGLA~~ 92 (654)
.++++|||.+..
T Consensus 127 ~~~l~Df~~~~~ 138 (155)
T cd05120 127 ILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecccccC
Confidence 899999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-07 Score=92.24 Aligned_cols=78 Identities=21% Similarity=0.247 Sum_probs=61.1
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYL-HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YL-Hs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
..-+|||||+.++.+..-..+...++...+..++.|++.+|..| |..+ |+|+||++.|||++ .+.+.|+|||.+.
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~--~~~v~iIDF~qav 172 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWH--DGKVWFIDVSQSV 172 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEE--CCcEEEEECCCce
Confidence 45688999997654432222333466677788899999999999 8888 99999999999997 3689999999886
Q ss_pred hhc
Q 006244 92 ILR 94 (654)
Q Consensus 92 ~l~ 94 (654)
...
T Consensus 173 ~~~ 175 (197)
T cd05146 173 EPT 175 (197)
T ss_pred eCC
Confidence 653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.5e-07 Score=105.75 Aligned_cols=150 Identities=20% Similarity=0.239 Sum_probs=108.1
Q ss_pred HHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCCc-----------cccCCCCccChhhhc
Q 006244 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-----------RCVGTPEFMAPEVYE 114 (654)
Q Consensus 46 ~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~-----------~~vGTp~YmAPEvl~ 114 (654)
+.++..||.|+|.+. .+||+.|.|++|.++++ |.+||+.|+++......... .......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA-KVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc-ceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345668999999884 79999999999999965 79999999988765442111 012456899999887
Q ss_pred cc-CCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH-HcCCC-CcccccCCChHHHHHHHHHhh-CccCCCCHHH
Q 006244 115 EE-YNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV-ISGKK-PEALFKVEDPEVRQFIEKCLA-TVSSRLSARE 189 (654)
Q Consensus 115 ~~-ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki-~~G~~-p~~l~~~~spelrdLI~kCL~-dP~~RpTa~E 189 (654)
.. -+.++|++|+|+++|.+.. |..-+..... ...+... ..+.. ..-.....++++++=+.++|. ++..||++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 54 6778999999999999995 4444443222 2222211 11111 112234567899999999999 8999999999
Q ss_pred HhcCccccc
Q 006244 190 LLTDPFLQI 198 (654)
Q Consensus 190 LL~HPFf~~ 198 (654)
++.-|||..
T Consensus 262 l~~~~ff~D 270 (700)
T KOG2137|consen 262 LLSIPFFSD 270 (700)
T ss_pred hhcccccCC
Confidence 999999974
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.6e-07 Score=84.33 Aligned_cols=69 Identities=22% Similarity=0.160 Sum_probs=54.4
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP---PVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p---~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
.-++||||++|.++... ......++.+++.+|..||..+. .++|+|++|.||+++ + +.++++|||.+
T Consensus 65 ~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a 134 (170)
T cd05151 65 TGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYA 134 (170)
T ss_pred CCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccc
Confidence 34799999999988653 01124567899999999999861 259999999999998 3 57999999987
Q ss_pred hh
Q 006244 91 AI 92 (654)
Q Consensus 91 ~~ 92 (654)
..
T Consensus 135 ~~ 136 (170)
T cd05151 135 GM 136 (170)
T ss_pred cC
Confidence 53
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=5.6e-06 Score=86.83 Aligned_cols=78 Identities=18% Similarity=0.218 Sum_probs=66.0
Q ss_pred CeEEEEEecCCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------CCCcEE
Q 006244 13 RNINFVTEMFTSG-TLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG------NQGEVK 83 (654)
Q Consensus 13 ~~i~LVtEy~~gG-SL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~------~~g~VK 83 (654)
..-+||||++.+- +|.+++.. ....+......++.+|...+.-||..| |+|+||++.|||++. +.+.+.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence 4578999999875 89999864 345677788899999999999999999 999999999999974 246899
Q ss_pred EEecCchhh
Q 006244 84 IGDLGLAAI 92 (654)
Q Consensus 84 L~DFGLA~~ 92 (654)
++||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.8e-06 Score=96.42 Aligned_cols=75 Identities=20% Similarity=0.206 Sum_probs=58.0
Q ss_pred eEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 14 NINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILS-GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~-gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.-+|||||+.|++|.++.... ..++ ...++.+++. .+..+|..+ ++|+|+||.||+++. +|.++++|||++.
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~~-~g~i~liDfG~~~ 305 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG--FFHADLHPGNIFVLK-DGKIIALDFGIVG 305 (437)
T ss_pred CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC--ceeCCCCcccEEECC-CCcEEEEeCCCee
Confidence 458999999999999876532 1222 2345555555 477889988 999999999999974 4899999999987
Q ss_pred hhc
Q 006244 92 ILR 94 (654)
Q Consensus 92 ~l~ 94 (654)
.+.
T Consensus 306 ~l~ 308 (437)
T TIGR01982 306 RLS 308 (437)
T ss_pred ECC
Confidence 654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.6e-06 Score=96.24 Aligned_cols=126 Identities=23% Similarity=0.267 Sum_probs=92.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++|+..|+. ..++|||||-+. -|..++++.+ ...+..-+.||+.||.|||..+ .++|++|.-+.|||+. .|
T Consensus 72 l~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~-~G 142 (690)
T KOG1243|consen 72 LSYLDTTEE--EGTLYLVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNE-SG 142 (690)
T ss_pred hhhhhhhcc--cCceEEEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcC-CC
Confidence 467888877 679999999995 7888887643 6667777899999999998543 3999999999999985 48
Q ss_pred cEEEEecCchhhhcccCC--ccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhc
Q 006244 81 EVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTF 136 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~--~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG 136 (654)
..||++|.++........ ....---.|..|+.+... .-..|.|.||+++++++.|
T Consensus 143 eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 143 EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 999999988765433221 111111234444433211 1246999999999999998
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.1e-05 Score=86.22 Aligned_cols=172 Identities=18% Similarity=0.285 Sum_probs=121.0
Q ss_pred CeEEEEEecCCCCC-HHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEE
Q 006244 13 RNINFVTEMFTSGT-LRQYRL------KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85 (654)
Q Consensus 13 ~~i~LVtEy~~gGS-L~~~l~------k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~ 85 (654)
..+.++|..+.|.. +..+.. ......+..+.+.++.|+.+.+-||.+| .+-+|+.++|+|+. +.+.|.|.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LV 159 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLV 159 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEE
Confidence 34889999998742 222221 1234788899999999999999999999 88899999999997 55899998
Q ss_pred ecCchhhh-cccCCccccCCCCccChhhhc-c-----cCCcccchhhhhhHHHHHhhc-CCCCCCCC------CHHHHHH
Q 006244 86 DLGLAAIL-RKSHAARCVGTPEFMAPEVYE-E-----EYNELVDIYSFGMCILEMVTF-DYPYSECT------HPAQIYK 151 (654)
Q Consensus 86 DFGLA~~l-~~~~~~~~vGTp~YmAPEvl~-~-----~ys~ksDIWSLGiiL~ELlTG-~~Pf~~~~------~~~qi~k 151 (654)
|=...... ......-.+|.++|.+||.-+ . .-+...|.|.||+++++++.| +.||++.. ++.+ .
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~ 237 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--T 237 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--h
Confidence 74322211 111222347999999999875 2 245678999999999999986 89997631 2211 1
Q ss_pred HHHc-----------CCCCcc---cccCCChHHHHHHHHHhhC---ccCCCCHHH
Q 006244 152 KVIS-----------GKKPEA---LFKVEDPEVRQFIEKCLAT---VSSRLSARE 189 (654)
Q Consensus 152 ki~~-----------G~~p~~---l~~~~spelrdLI~kCL~d---P~~RpTa~E 189 (654)
.|.. |.+|.. .+....|.+..++.+|+.+ +.-|||++-
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 2222 333321 2345679999999999984 558999874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=6.8e-06 Score=81.78 Aligned_cols=70 Identities=24% Similarity=0.320 Sum_probs=59.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.....|+|||+.|-.|++++... . ..+++.|=.-+.-||..+ |+|+||.++||++.+ +.+.++||||+.
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~ 139 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGE 139 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCccc
Confidence 56788999999999999998876 2 455666777778899999 999999999999974 359999999986
Q ss_pred h
Q 006244 92 I 92 (654)
Q Consensus 92 ~ 92 (654)
.
T Consensus 140 ~ 140 (204)
T COG3642 140 F 140 (204)
T ss_pred c
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-05 Score=80.52 Aligned_cols=78 Identities=19% Similarity=0.244 Sum_probs=67.3
Q ss_pred CeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEEecCc
Q 006244 13 RNINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGL 89 (654)
Q Consensus 13 ~~i~LVtEy~~g-GSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~--g~VKL~DFGL 89 (654)
...+||||++++ -+|.+++......+......++.++...+.-||..+ |+|+|+++.|||++.+. ..+.++||+.
T Consensus 90 ~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~ 167 (206)
T PF06293_consen 90 YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDR 167 (206)
T ss_pred eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchh
Confidence 356999999988 489999887555788888999999999999999999 99999999999998553 2689999987
Q ss_pred hhh
Q 006244 90 AAI 92 (654)
Q Consensus 90 A~~ 92 (654)
+..
T Consensus 168 ~~~ 170 (206)
T PF06293_consen 168 MRF 170 (206)
T ss_pred cee
Confidence 654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.4e-05 Score=79.56 Aligned_cols=82 Identities=22% Similarity=0.393 Sum_probs=65.3
Q ss_pred EEecCCCeEEEEEecCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcE-
Q 006244 7 WVDTANRNINFVTEMFTS-GTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEV- 82 (654)
Q Consensus 7 fvd~~~~~i~LVtEy~~g-GSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~V- 82 (654)
|++ ...-.|+|||+.| .++++|+...- .........++++|=..|.-||.++ |||+||..+||++..+.+++
T Consensus 79 ~~D--~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 79 FID--TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred EEe--cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCc
Confidence 455 4566789999976 58999988753 2333444788899999999999999 99999999999998665555
Q ss_pred -EEEecCchhh
Q 006244 83 -KIGDLGLAAI 92 (654)
Q Consensus 83 -KL~DFGLA~~ 92 (654)
.++|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 8999999854
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.2e-06 Score=94.22 Aligned_cols=73 Identities=21% Similarity=0.234 Sum_probs=55.6
Q ss_pred eEEEEEecCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEE
Q 006244 14 NINFVTEMFTSGTLRQY--RLKHR----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ---GEVKI 84 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~--l~k~~----~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~---g~VKL 84 (654)
.-+|||||+.|+.|.++ +...+ .+.+..+..++.||+. .+ ++|+|+||.|||++.+. +++++
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-------~G--ffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-------DG--FFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------CC--eeeCCCChHHeEEecCCCCCCeEEE
Confidence 45799999999999875 33333 3555666667777753 66 99999999999998542 28999
Q ss_pred EecCchhhhcc
Q 006244 85 GDLGLAAILRK 95 (654)
Q Consensus 85 ~DFGLA~~l~~ 95 (654)
+|||++..+..
T Consensus 306 lDFGivg~l~~ 316 (537)
T PRK04750 306 LDFGIVGSLNK 316 (537)
T ss_pred EecceEEECCH
Confidence 99999976643
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=97.75 E-value=3.5e-05 Score=57.01 Aligned_cols=32 Identities=47% Similarity=0.593 Sum_probs=26.4
Q ss_pred EEEEEEeecccC------CccceeeecccCCCCHHHHH
Q 006244 291 IFLRLRIADKEG------RIRNIYFPFDIQTDTALSVA 322 (654)
Q Consensus 291 I~L~LRI~d~~g------~~r~I~F~Fd~~~DTa~sVA 322 (654)
|.|+||+.|+.. ...+|.|.|+++.|+|..||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999987 66899999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.65 E-value=7.6e-05 Score=73.24 Aligned_cols=78 Identities=23% Similarity=0.328 Sum_probs=60.8
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR---------------------------------- 59 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~---------------------------------- 59 (654)
..++||||++|++|...+.. ..+++.....++.+++.+|.+||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred CceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 67899999999988775432 3577777788888888888888842
Q ss_pred --------------------CCCeEecCCCCCcEEEeCC-CCcEEEEecCchhh
Q 006244 60 --------------------DPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAI 92 (654)
Q Consensus 60 --------------------~p~IIHRDLKpeNILId~~-~g~VKL~DFGLA~~ 92 (654)
...++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1347999999999999863 35689999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.63 E-value=4.3e-05 Score=76.23 Aligned_cols=74 Identities=27% Similarity=0.315 Sum_probs=50.3
Q ss_pred EEEEEecCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 15 INFVTEMFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLY-LHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 15 i~LVtEy~~--gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~Y-LHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
-+|||||+. |..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++. +.+.|+|||.+.
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~iIDf~qav 154 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYIIDFGQAV 154 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE--GTTEE
T ss_pred CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEEEecCcce
Confidence 369999998 6555544322 12245667788888886555 57888 999999999999984 389999999886
Q ss_pred hhc
Q 006244 92 ILR 94 (654)
Q Consensus 92 ~l~ 94 (654)
...
T Consensus 155 ~~~ 157 (188)
T PF01163_consen 155 DSS 157 (188)
T ss_dssp ETT
T ss_pred ecC
Confidence 543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00062 Score=76.62 Aligned_cols=160 Identities=17% Similarity=0.274 Sum_probs=112.8
Q ss_pred CCeEEEEEecCCC-CCHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 12 NRNINFVTEMFTS-GTLRQYRLK---------------HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 12 ~~~i~LVtEy~~g-GSL~~~l~k---------------~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+..++||++|.++ ++|.++.-. ..+.++..++.|+.||..||.++|+.| +.-+-|.+.+||+
T Consensus 349 D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv 426 (655)
T KOG3741|consen 349 DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILV 426 (655)
T ss_pred cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEe
Confidence 4689999999987 677665321 124788999999999999999999999 8889999999999
Q ss_pred eCCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+++. +++|...|....+..... +.+++ -.+-|.-.||.+++.|.||.---.......+...+
T Consensus 427 ~G~~-RIriS~C~i~Dvl~~d~~------------~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--- 488 (655)
T KOG3741|consen 427 TGKM-RIRISGCGIMDVLQEDPT------------EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--- 488 (655)
T ss_pred eCcc-eEEEecccceeeecCCCC------------cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH---
Confidence 9764 888887776655443320 11211 23468889999999999985432211222222111
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC---cccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD---PFLQ 197 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H---PFf~ 197 (654)
.+...++.+++++|.-... .+++ -++.+||.+ .||.
T Consensus 489 -----~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~ 528 (655)
T KOG3741|consen 489 -----RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFT 528 (655)
T ss_pred -----HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence 1334578889999998888 4655 788888865 4554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00018 Score=86.96 Aligned_cols=170 Identities=26% Similarity=0.382 Sum_probs=120.5
Q ss_pred EEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC---cEEEeCCCCcEEEE--ecCc
Q 006244 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD---NIFVNGNQGEVKIG--DLGL 89 (654)
Q Consensus 15 i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe---NILId~~~g~VKL~--DFGL 89 (654)
+.+..|+|++-++...+..-..++...++.|..++++||.|+|+.. ..|.-|... +--.++. +.+.++ ||+.
T Consensus 261 ~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~s 337 (1351)
T KOG1035|consen 261 LDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGE-GVVAISLSDFDS 337 (1351)
T ss_pred HHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCcc-ceeecchhhhcc
Confidence 4556789999999999888889999999999999999999999986 556555444 2223322 456666 8887
Q ss_pred hhhhcccCCc-cccCCCCccChhhhccc-C--CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccC
Q 006244 90 AAILRKSHAA-RCVGTPEFMAPEVYEEE-Y--NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 165 (654)
Q Consensus 90 A~~l~~~~~~-~~vGTp~YmAPEvl~~~-y--s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~ 165 (654)
...+...... ...-+..+.|+|..... + ....|+|.+|..+..+..|..+-..... +..+...
T Consensus 338 s~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~-------------~~~~l~~ 404 (1351)
T KOG1035|consen 338 SKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV-------------PVSLLDV 404 (1351)
T ss_pred cccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------------hhhhhcc
Confidence 7766543322 22355667788877644 3 3346999999999998887755432111 1111122
Q ss_pred CCh-HHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 166 EDP-EVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 166 ~sp-elrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+. ...++..+|+. +.++|+++.+++.|+|.+...
T Consensus 405 ~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 405 LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred ccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 222 67889999998 799999999999999997543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00061 Score=69.83 Aligned_cols=68 Identities=16% Similarity=0.220 Sum_probs=53.4
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
...+|||||++|..|.++.. +++ .+...|..++.-||..| ++|+|.+|.|++++. +.++++||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~--~~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSN--NGIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEEC--CcEEEEECccccc
Confidence 35679999999998877632 333 23456777899999999 999999999999983 4699999976543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0032 Score=64.26 Aligned_cols=78 Identities=15% Similarity=0.150 Sum_probs=64.2
Q ss_pred CCeEEEEEecCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEEe
Q 006244 12 NRNINFVTEMFTS-GTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGE--VKIGD 86 (654)
Q Consensus 12 ~~~i~LVtEy~~g-GSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~--VKL~D 86 (654)
...-+||||-+.| -+|.+++... .+.+......++.+|...|.-||..+ +.|+|+-+.|||++.. |. |+++|
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lID 173 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLD 173 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEE
Confidence 3467999997754 6899987663 35677788899999999999999999 9999999999999744 45 99999
Q ss_pred cCchhh
Q 006244 87 LGLAAI 92 (654)
Q Consensus 87 FGLA~~ 92 (654)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 976543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.97 E-value=6.8e-05 Score=85.80 Aligned_cols=175 Identities=22% Similarity=0.212 Sum_probs=118.2
Q ss_pred CCeEEEEEecCCCC-CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCc
Q 006244 12 NRNINFVTEMFTSG-TLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 89 (654)
Q Consensus 12 ~~~i~LVtEy~~gG-SL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGL 89 (654)
..+.+++++++.+| +-...+.. .-.+..-+....++.-+++|+|||+.. -+||| ||+... +.++.+||+.
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v 377 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAV 377 (829)
T ss_pred ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccC
Confidence 67899999999887 22211111 112344455566677788999999885 58888 888753 6899999999
Q ss_pred hhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCccc---c-
Q 006244 90 AAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL---F- 163 (654)
Q Consensus 90 A~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l---~- 163 (654)
...+... ......+|+.++|||+.. +.+..+.|.|++|.-..+|.-|.+|-.. .+.. ...-|.-|... .
T Consensus 378 ~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~---~~~~g~~p~s~~L~~~ 452 (829)
T KOG0576|consen 378 PPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAV---LPMIGNGPNSPMLTDK 452 (829)
T ss_pred CcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Cccc---cCCCCCCCCccccchh
Confidence 8877654 344567999999999775 5699999999999988888888877644 1111 01112212100 0
Q ss_pred cCCChH-HHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 164 KVEDPE-VRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 164 ~~~spe-lrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
...++. -+++...|+. .|..|+.+..++.|.+|..-
T Consensus 453 ~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 453 SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 011122 2347788888 69999999999999888643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0073 Score=63.76 Aligned_cols=73 Identities=22% Similarity=0.247 Sum_probs=54.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.+...+||||+.|-.|.... ++.+.+..++..|+.-+.-+-..| |||+|+.+-|||++. +|.+.++||-.+.
T Consensus 179 ~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~-dg~~~vIDwPQ~v 250 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTE-DGDIVVIDWPQAV 250 (304)
T ss_pred cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEec-CCCEEEEeCcccc
Confidence 46778999999997776542 234455556666666555555667 999999999999985 4789999996554
Q ss_pred h
Q 006244 92 I 92 (654)
Q Consensus 92 ~ 92 (654)
.
T Consensus 251 ~ 251 (304)
T COG0478 251 P 251 (304)
T ss_pred c
Confidence 3
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.045 Score=55.55 Aligned_cols=31 Identities=29% Similarity=0.205 Sum_probs=25.4
Q ss_pred CCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+.++|+|+.|.|||++. .+.+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~-~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDP-GKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeC-CcEEEEEEcccccc
Confidence 45999999999999985 35678999987643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.036 Score=55.31 Aligned_cols=85 Identities=22% Similarity=0.131 Sum_probs=63.0
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQ---YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP-PVIHRDLKCDNIFVNG 77 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~---~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p-~IIHRDLKpeNILId~ 77 (654)
|+||++ .-++|+||...+++.. .+......++....+++.+++..+++|+.... .+.-.|++++|+-++
T Consensus 24 k~lG~C------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~- 96 (188)
T PF12260_consen 24 KLLGSC------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN- 96 (188)
T ss_pred CeeeEC------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe-
Confidence 566655 2256899998776532 11222346899999999999999999987321 388889999999998
Q ss_pred CCCcEEEEecCchhhh
Q 006244 78 NQGEVKIGDLGLAAIL 93 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l 93 (654)
++|++|++|...+...
T Consensus 97 ~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 97 DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEEechhcchh
Confidence 4479999999776544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.029 Score=64.29 Aligned_cols=77 Identities=14% Similarity=0.190 Sum_probs=53.8
Q ss_pred CeEEEEEecCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 13 RNINFVTEMFTSGTLRQYR--LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l--~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
..-+|+|||+.|-.+.++. +. ..++.+.+.....++.- ..+-..+ ++|.|.+|.||+++.+ |++.+.|||+.
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~--~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~ 312 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFL--RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIV 312 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHH--HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcce
Confidence 4668999999998888873 33 44554443333333222 1122245 9999999999999865 89999999998
Q ss_pred hhhcc
Q 006244 91 AILRK 95 (654)
Q Consensus 91 ~~l~~ 95 (654)
..+..
T Consensus 313 g~l~~ 317 (517)
T COG0661 313 GRLDP 317 (517)
T ss_pred ecCCH
Confidence 76643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.042 Score=63.11 Aligned_cols=79 Identities=15% Similarity=0.174 Sum_probs=55.3
Q ss_pred CeEEEEEecCCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC---CCCcEEEEec
Q 006244 13 RNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDL 87 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~--l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~---~~g~VKL~DF 87 (654)
..-+|+||||.|..+.+. +.++ .++...+...+.++..-.-+ ..| ++|.|-+|.||+++. ..+.+.+.||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~~qIf--~~G--ffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYLEQIF--KTG--FFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHHHHHH--hcC--CccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 366999999999876543 4444 46666555544444333322 345 999999999999983 3568999999
Q ss_pred Cchhhhccc
Q 006244 88 GLAAILRKS 96 (654)
Q Consensus 88 GLA~~l~~~ 96 (654)
|+...+...
T Consensus 350 Gl~~~is~~ 358 (538)
T KOG1235|consen 350 GLYAVISHK 358 (538)
T ss_pred cccccccHH
Confidence 998876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.031 Score=58.46 Aligned_cols=74 Identities=23% Similarity=0.321 Sum_probs=55.8
Q ss_pred CeEEEEEecCCCC-----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 006244 13 RNINFVTEMFTSG-----TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQGEVKIGD 86 (654)
Q Consensus 13 ~~i~LVtEy~~gG-----SL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~g~VKL~D 86 (654)
..-.|||||+... .|.+. .+....+..+..+++..+.-|-. .+ ++|+||..-|||+. .+.+.|+|
T Consensus 139 ~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~~~p~iID 209 (268)
T COG1718 139 RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--DGEPYIID 209 (268)
T ss_pred cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--CCeEEEEE
Confidence 3568999999543 11111 23333688888899999988877 56 99999999999997 36899999
Q ss_pred cCchhhhcc
Q 006244 87 LGLAAILRK 95 (654)
Q Consensus 87 FGLA~~l~~ 95 (654)
||.|.....
T Consensus 210 ~~QaV~~~h 218 (268)
T COG1718 210 VSQAVTIDH 218 (268)
T ss_pred CccccccCC
Confidence 999876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.0031 Score=78.35 Aligned_cols=129 Identities=14% Similarity=0.103 Sum_probs=98.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCcEEEeCCCCcEEE
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSR---DPPVIHRDLKCDNIFVNGNQGEVKI 84 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~---~p~IIHRDLKpeNILId~~~g~VKL 84 (654)
...-|.+++|+.+|.+.+.+.+. ..++...+.....+.+.+..-+|+. +...+|++||+-|.+|..+. .||+
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny-~v~~ 1381 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNY-NVKL 1381 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCC-cccc
Confidence 45668899999999999998764 2455555666566657776666643 23579999999999999774 7999
Q ss_pred EecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCC
Q 006244 85 GDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYS 141 (654)
Q Consensus 85 ~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~ 141 (654)
+++|+.++.... .....+++|.|++|+.... .++.+.|+|..|+-+|+.-.|..+|-
T Consensus 1382 gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1382 GKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999999844332 2334568889999998875 47778999999999999888887774
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.23 Score=50.81 Aligned_cols=31 Identities=26% Similarity=0.414 Sum_probs=25.4
Q ss_pred CCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 60 ~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
.+.++|+|+.|.||+++.+ + +.|+||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 3468999999999999854 4 99999987653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.028 Score=64.63 Aligned_cols=65 Identities=26% Similarity=0.421 Sum_probs=54.3
Q ss_pred EEEEEEeecccC----CccceeeecccCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHHhhCCCcc
Q 006244 291 IFLRLRIADKEG----RIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWK 355 (654)
Q Consensus 291 I~L~LRI~d~~g----~~r~I~F~Fd~~~DTa~sVA~EMV~el~i~d~dv~~IA~~ID~~i~~l~p~w~ 355 (654)
+.|++|..|... +.+.|.|.|+++.|++.+||+|||++..+++.|-..+|+.+.+.+.+|--.-.
T Consensus 319 ~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~ 387 (632)
T KOG0584|consen 319 LSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRN 387 (632)
T ss_pred ccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhh
Confidence 446677766542 23589999999999999999999999999999999999999999988864443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=93.75 E-value=0.13 Score=52.29 Aligned_cols=30 Identities=23% Similarity=0.309 Sum_probs=23.9
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
.++|+|+.+.|||+++. +..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDG-RLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECC-CEEEEEeCcccCc
Confidence 38999999999999843 3456999997644
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.23 E-value=0.4 Score=53.03 Aligned_cols=73 Identities=19% Similarity=0.247 Sum_probs=57.3
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
..+.|+++++- |+.|.-. +-...+++..++.+.+.-|.-+..+- +.=||++..+||||+ + |.|.|+||-+++
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf-~fehrnlt~~niLId-~-GnvtLIDfklsR 369 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKF-PFEHRNLTLDNILID-E-GNVTLIDFKLSR 369 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcC-Ccccccccccceeee-c-CceEEEEeeeee
Confidence 45778888886 6665432 22466788888888888887777765 699999999999998 4 899999999987
Q ss_pred h
Q 006244 92 I 92 (654)
Q Consensus 92 ~ 92 (654)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=92.33 E-value=0.95 Score=45.78 Aligned_cols=79 Identities=24% Similarity=0.331 Sum_probs=53.8
Q ss_pred EEEEEEEecCCCeEEEEEecCCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 2 KFYTSWVDTANRNINFVTEMFTS------GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~g------GSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+|||.... +--..+|+|.+.. -+|.+|+.. +.++. .+...+.+ -..||-.++ |+.+||+|.||++
T Consensus 81 r~~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~---f~~~l~~~~--Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 81 RFYGFVET--NLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDE---FKRYLLDHH--IVIRDLNPHNIVV 151 (199)
T ss_pred cEeEEEec--CCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHH---HHHHHHHcC--CeecCCCcccEEE
Confidence 57885443 6677899998764 478898854 45666 44444443 345667777 9999999999999
Q ss_pred eCCC--C-cEEEEe-cCc
Q 006244 76 NGNQ--G-EVKIGD-LGL 89 (654)
Q Consensus 76 d~~~--g-~VKL~D-FGL 89 (654)
.... . .+.|+| ||-
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 6332 2 577787 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.63 E-value=0.32 Score=55.71 Aligned_cols=81 Identities=19% Similarity=0.096 Sum_probs=56.3
Q ss_pred cccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcc---------cccCCChHHHHHHHHHhh-CccCCCCHH
Q 006244 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEA---------LFKVEDPEVRQFIEKCLA-TVSSRLSAR 188 (654)
Q Consensus 119 ~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~---------l~~~~spelrdLI~kCL~-dP~~RpTa~ 188 (654)
+++|||++|.++.++.-|...+..-.+.++......-+..+.. +....+..+.++..+|+. .|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 3899999999999999988887654443333222111222211 122345667888889998 799999999
Q ss_pred HHhcCcccccC
Q 006244 189 ELLTDPFLQID 199 (654)
Q Consensus 189 ELL~HPFf~~~ 199 (654)
++++++-|...
T Consensus 190 ~~~k~~i~~ev 200 (725)
T KOG1093|consen 190 ELSKRCSFTEV 200 (725)
T ss_pred HHhcCccHHHH
Confidence 99999988654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=90.17 E-value=1.3 Score=53.82 Aligned_cols=41 Identities=22% Similarity=0.427 Sum_probs=30.3
Q ss_pred HHHHHHhCCC---------CeEecCCCCCcEEEeCCCCc-EEEEecCchhh
Q 006244 52 GLLYLHSRDP---------PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 92 (654)
Q Consensus 52 gL~YLHs~~p---------~IIHRDLKpeNILId~~~g~-VKL~DFGLA~~ 92 (654)
.+.+|..+-| .++|+|++++|||++.+.+. +-|.||+++..
T Consensus 207 l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 207 LIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred HHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 3567754433 39999999999999854344 47999998865
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.00 E-value=0.63 Score=48.81 Aligned_cols=31 Identities=23% Similarity=0.270 Sum_probs=26.1
Q ss_pred CCeEecCCCCCcEEEeCC---CCcEEEEecCchh
Q 006244 61 PPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAA 91 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~---~g~VKL~DFGLA~ 91 (654)
..++|+|+.+.|||++.+ .+.+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 468999999999999853 3689999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.24 E-value=0.54 Score=47.25 Aligned_cols=30 Identities=33% Similarity=0.378 Sum_probs=25.6
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.++|+|+.+.|||++++++.+.|+||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 499999999999998634679999998664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.19 E-value=1.7 Score=46.28 Aligned_cols=29 Identities=7% Similarity=0.258 Sum_probs=22.5
Q ss_pred CCCeEecCCCCCcEEEeCCCCc-EEEEecC
Q 006244 60 DPPVIHRDLKCDNIFVNGNQGE-VKIGDLG 88 (654)
Q Consensus 60 ~p~IIHRDLKpeNILId~~~g~-VKL~DFG 88 (654)
.|.++|+|+++.||+++...+. +.|+|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 4679999999999999855343 6677764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=88.04 E-value=0.37 Score=47.16 Aligned_cols=32 Identities=38% Similarity=0.522 Sum_probs=21.4
Q ss_pred CCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
..++|+|+.+.|||++...+.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 35999999999999984446778999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=87.18 E-value=1.3 Score=46.33 Aligned_cols=29 Identities=24% Similarity=0.375 Sum_probs=24.3
Q ss_pred CCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 35999999999999985 468999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=87.05 E-value=0.53 Score=51.44 Aligned_cols=70 Identities=20% Similarity=0.238 Sum_probs=51.5
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
.+..++|||++.|-.|.+... ..+. ..+...++.-+.-|..+| +||+|..--||+++. ++.++++||-..
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~---v~d~---~~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~d-d~~i~vIDFPQm 249 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRH---VEDP---PTLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKD-DDKIVVIDFPQM 249 (465)
T ss_pred ccceeeHHHhhcccceeeeee---cCCh---HHHHHHHHHHHHHHHHcC--ceecccchheeEEec-CCCEEEeechHh
Confidence 356789999999988876521 1233 334445555566677888 999999999999984 578999999543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.86 E-value=1.7 Score=45.91 Aligned_cols=29 Identities=34% Similarity=0.415 Sum_probs=23.6
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.++|+|++|.|||++++ ..+-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 59999999999999843 334799998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=84.56 E-value=1.5 Score=46.42 Aligned_cols=30 Identities=33% Similarity=0.437 Sum_probs=24.9
Q ss_pred CCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
..++|+|+++.||+++.+ +.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 359999999999999854 456899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=84.32 E-value=1.4 Score=47.89 Aligned_cols=30 Identities=27% Similarity=0.417 Sum_probs=25.8
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.++|+|+++.|||++...+.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 489999999999998555689999998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=81.30 E-value=2.2 Score=44.51 Aligned_cols=29 Identities=34% Similarity=0.456 Sum_probs=24.1
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.++|+|+.|.|||++.+ +.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 49999999999999853 456899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=80.75 E-value=1 Score=44.87 Aligned_cols=31 Identities=39% Similarity=0.560 Sum_probs=20.4
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
.+.|.||.+.|||++...+.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 4899999999999944557999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=80.20 E-value=3.5 Score=41.03 Aligned_cols=31 Identities=29% Similarity=0.425 Sum_probs=25.0
Q ss_pred CeEecCCCCCcEEEeCCC-C---cEEEEecCchhh
Q 006244 62 PVIHRDLKCDNIFVNGNQ-G---EVKIGDLGLAAI 92 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~-g---~VKL~DFGLA~~ 92 (654)
.++|+|+.+.||++..+. | .+.|+||..+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 599999999999997432 3 689999987654
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=80.16 E-value=1.5 Score=46.32 Aligned_cols=31 Identities=19% Similarity=0.342 Sum_probs=25.0
Q ss_pred CCeEecCCCCCcEEEeCCCCc-EEEEecCchhh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 92 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~-VKL~DFGLA~~ 92 (654)
+.++|+|+++.|||++.+ +. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDED-ARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCC-CCEEEEECcHhccc
Confidence 359999999999999853 44 56999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 654 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-58 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-16 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-16 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-16 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-106
Identities = 108/202 (53%), Positives = 142/202 (70%), Gaps = 3/202 (1%)
Query: 1 MKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 58
++FY SW T + I VTE+ TSGTL+ Y + + + I+ ++ WCRQIL GL +LH+
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYN 118
R PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S A +GTPEFMAPE+YEE+Y+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYD 207
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 178
E VD+Y+FGMC+LEM T +YPYSEC + AQIY++V SG KP + KV PEV++ IE C+
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 179 AT-VSSRLSARELLTDPFLQID 199
R S ++LL F Q +
Sbjct: 268 RQNKDERYSIKDLLNHAFFQEE 289
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 15/200 (7%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSR 59
+ +W + + TE +L Q + ++ V + R L L +LHS+
Sbjct: 121 RLEQAWEE--GGILYLQTE-LCGPSL-QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYN 118
++H D+K NIF+ G K+GD GL L + A G P +MAPE+ + Y
Sbjct: 177 G--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 178
D++S G+ ILE+ Q+ + + + L E+R + L
Sbjct: 234 TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL----SSELRSVLVMML 289
Query: 179 AT-VSSRLSARELLTDPFLQ 197
R +A LL P L+
Sbjct: 290 EPDPKLRATAEALLALPVLR 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 56/166 (33%), Positives = 81/166 (48%), Gaps = 16/166 (9%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR- 100
+ + +QIL GL YLH ++HRD+K DN+ +N G +KI D G + L +
Sbjct: 124 IGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181
Query: 101 -CVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156
GT ++MAPE+ ++ Y + DI+S G I+EM T P+ E P KV
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241
Query: 157 KK----PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
K PE++ E + FI KC R A +LL D FL+
Sbjct: 242 KVHPEIPESM----SAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 2 KFYTSWVD--------------TANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHW 45
+ W + + + E GTL Q+ + + +++
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAARCVGT 104
QI G+ Y+HS+ +I+RDLK NIF+ +VKIGD GL L+ R GT
Sbjct: 128 FEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 105 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 163
+M+PE + Y + VD+Y+ G+ + E++ E ++ + + G +
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF- 240
Query: 164 KVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 197
D + + ++K L+ R + E+L +
Sbjct: 241 ---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-42
Identities = 62/208 (29%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR----AVKHWCRQILSGLLYLH 57
++Y +D N + V E G L K + V Q+ L H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 58 SRDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPEV 112
R V+HRDLK N+F++G VK+GD GLA IL S A VGTP +M+PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187
Query: 113 YEEE-YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 170
YNE DI+S G C+L E+ P++ + ++ K+ G K + E+
Sbjct: 188 MNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQK-ELAGKIREG-KFRRIPYRYSDEL 244
Query: 171 RQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ I + L R S E+L +P +
Sbjct: 245 NEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 39/238 (16%)
Query: 2 KFYTSWVDTANRNIN-----------FVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQI 49
++Y +W++ N E +GTL ++ RQI
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 50 LSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--------- 100
L L Y+HS+ +IHRDLK NIF++ + VKIGD GLA + +S
Sbjct: 126 LEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 101 -------CVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151
+GT ++A EV + YNE +D+YS G+ EM+ YP+S I K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 152 KVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 206
K+ S P + ++ I + + R AR LL +L + D ++
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSR 59
++ S+ + N ++ V + G L + + V + W QI L ++H R
Sbjct: 87 QYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEEE- 116
++HRD+K NIF+ + G V++GD G+A +L A C+GTP +++PE+ E +
Sbjct: 145 K--ILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
YN DI++ G + E+ T + + E + K+ISG + ++R + +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-SFPPVSLHYSYDLRSLVSQ 259
Query: 177 CLATV-SSRLSARELLTDPFLQ 197
R S +L F+
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIA 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-40
Identities = 48/226 (21%), Positives = 87/226 (38%), Gaps = 38/226 (16%)
Query: 2 KFYTSWVDTANRNINF----------VTEMFTSGTLRQYRLKHRRVN----IRAVKHWCR 47
+++ +W++ ++ L+ + + R H
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW-MNGRCTIEERERSVCLHIFL 125
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-------- 99
QI + +LHS+ ++HRDLK NIF + VK+GD GL + +
Sbjct: 126 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 100 ------RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152
VGT +M+PE Y+ VDI+S G+ + E++ YP+S +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTD 239
Query: 153 VISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 197
V + K P LF + P ++ L+ R A ++ + +
Sbjct: 240 VRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 26/199 (13%)
Query: 18 VTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
++ L+ + R H QI + +LHS+ ++HRDLK NIF
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIF 196
Query: 75 VNGNQGEVKIGDLGLAAIL--------------RKSHAARCVGTPEFMAPEVYEEE-YNE 119
+ VK+GD GL + + VGT +M+PE Y+
Sbjct: 197 FTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
VDI+S G+ + E++ Y +S +I V + K P LF + P+ ++ L+
Sbjct: 256 KVDIFSLGLILFELL---YSFSTQMERVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLS 311
Query: 180 TV-SSRLSARELLTDPFLQ 197
+ R A +++ + +
Sbjct: 312 PSPTERPEATDIIENAIFE 330
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQY--RLKHRRVNI--RAVKHWCRQILSGLLYLH 57
K+Y S+++ + +N V E+ +G L + K ++ I R V + Q+ S L ++H
Sbjct: 96 KYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 58 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE 115
SR V+HRD+K N+F+ G VK+GDLGL + A VGTP +M+PE E
Sbjct: 154 SRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 116 E-YNELVDIYSFGMCILEMVTFDYPY-SECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 173
YN DI+S G + EM P+ + + + KK+ P E+RQ
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 174 IEKCLATV-SSRLSARELLTDPFLQ 197
+ C+ R +
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 56/173 (32%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 18 VTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
VTE + G+L + +++ R + G+ YLH+R+PP++HR+LK N+
Sbjct: 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYE-EEYNELVDIYSFGMCIL 131
V+ VK+ D GL+ + + + GTPE+MAPEV E NE D+YSFG+ +
Sbjct: 172 VDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 132 EMVTFDYPYSECTHPAQIYKKVISGKK----PEALFKVEDPEVRQFIEKCLAT 180
E+ T P+ +PAQ+ V K P L +P+V IE C
Sbjct: 231 ELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNL----NPQVAAIIEGCWTN 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 8/166 (4%)
Query: 18 VTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDP-PVIHRDLKCDNI 73
V E G+L WC Q G+ YLHS P +IHRDLK N+
Sbjct: 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNL 136
Query: 74 FVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 132
+ +KI D G A + ++H G+ +MAPEV+E Y+E D++S+G+ + E
Sbjct: 137 LLVAGGTVLKICDFGTACDI-QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 195
Query: 133 MVTFDYPYSECTHPAQ-IYKKVISGKKPEALFKVEDPEVRQFIEKC 177
++T P+ E PA I V +G +P L K + + +C
Sbjct: 196 VITRRKPFDEIGGPAFRIMWAVHNGTRPP-LIKNLPKPIESLMTRC 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 15/198 (7%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
+N E+ G+L Q + + ++ Q L GL YLH+R ++H D+K DN+
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNV 181
Query: 74 FVNGNQGEVKIGDLGLAAILRKSHAARC-------VGTPEFMAPEVYEEE-YNELVDIYS 125
++ + + D G A L+ + GT MAPEV + + VDI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 126 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCLAT-VS 182
+L M+ +P+++ K I+ + P P Q I++ L
Sbjct: 242 SCCMMLHMLNGCHPWTQYFRGPLCLK--IASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 183 SRLSARELLTDPFLQIDD 200
R SA EL + +
Sbjct: 300 HRASAMELRRKVGKALQE 317
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 41/221 (18%), Positives = 84/221 (38%), Gaps = 36/221 (16%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIR----AVKHWCRQILSGLLYLH 57
+++++W + + ++ E G+L ++ R+ +K Q+ GL Y+H
Sbjct: 75 RYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 58 SRDPPVIHRDLKCDNIFVNGN------------------QGEVKIGDLGLAAILRKSHAA 99
S ++H D+K NIF++ + KIGDLG +
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 189
Query: 100 RCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157
G F+A EV +E + DI++ + ++ + + ++ G+
Sbjct: 190 -EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----GDQWHEIRQGR 244
Query: 158 KPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQ 197
P + +V E + ++ + R SA L+ L
Sbjct: 245 LPR-IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP-PVIHRDLKCDNIFVN 76
V E G L + L +R+ + +W QI G+ YLH P+IHRDLK NI +
Sbjct: 84 VMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142
Query: 77 GNQGE-------VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGM 128
+KI D GLA ++ G +MAPEV +++ D++S+G+
Sbjct: 143 QKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
+ E++T + P+ A Y ++ + +E C
Sbjct: 203 LLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC-PEPFAKLMEDC 250
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 45/173 (26%), Positives = 71/173 (41%), Gaps = 18/173 (10%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E G L K + I G+ Y+ +++PP++HRDL+ NIF+
Sbjct: 99 VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ 158
Query: 77 GNQGE----VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMC 129
K+ D GL+ S + +G ++MAPE E Y E D YSF M
Sbjct: 159 SLDENAPVCAKVADFGLSQQSVHS-VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 130 ILEMVTFDYPYSECTH-PAQIYKKVISGKK----PEALFKVEDPEVRQFIEKC 177
+ ++T + P+ E ++ + + PE P +R IE C
Sbjct: 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC----PPRLRNVIELC 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 15/172 (8%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
VT+ +L + + ++ + RQ G+ YLH++ +IHRDLK +NIF++
Sbjct: 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLH 154
Query: 77 GNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEVYEEE----YNELVDIYSFGM 128
+ VKIGD GLA + + G+ +MAPEV + Y+ D+Y+FG+
Sbjct: 155 ED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI 213
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE---DPEVRQFIEKC 177
+ E++T PYS + QI + V G L KV +++ + +C
Sbjct: 214 VLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 39/181 (21%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+T + TL R +++ + ++I+ G+ YLH++ ++H+DLK N+F +
Sbjct: 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD 164
Query: 77 GNQGEVKIGDLGLAAILRKSHAAR-------CVGTPEFMAPEV----------YEEEYNE 119
G+V I D GL +I A R G +APE+ + +++
Sbjct: 165 --NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
D+++ G E+ ++P+ I ++ +G KP E+ + C A
Sbjct: 223 HSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWA 281
Query: 180 T 180
Sbjct: 282 F 282
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 59/158 (37%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
CR+ L L +LHS VIHRD+K DNI + G VK+ D G A + + R VG
Sbjct: 122 CRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 104 TPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
TP +MAPEV + Y VDI+S G+ +EM+ + PY +P + I+ L
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYL-IATNGTPEL 236
Query: 163 FKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
E R F+ +CL V R SA+ELL FL+
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 42/217 (19%), Positives = 86/217 (39%), Gaps = 26/217 (11%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ Y + ++ I V E + L + K + ++ K + + +L + +H
Sbjct: 72 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 61 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILR----KSHAARCVGTPEFMAPEV--- 112
++H DLK N V+G +K+ D G+A ++ VGT +M PE
Sbjct: 129 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 113 ---------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF 163
+ + + D++S G + M P+ + + +I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
Query: 164 KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 199
+ + +++ ++ CL R+S ELL P++QI
Sbjct: 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 45/223 (20%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ Y + ++ I V E + L + K + ++ K + + +L + +H
Sbjct: 91 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 61 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRK----SHAARCVGTPEFMAPEVYEE 115
++H DLK N V+G +K+ D G+A ++ VGT +M PE ++
Sbjct: 148 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 116 E------------YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
+ D++S G CIL M P+ + + +I
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 261
Query: 163 FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
+ + +++ ++ CL R+S ELL P++QI + +
Sbjct: 262 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 27/166 (16%), Positives = 69/166 (41%), Gaps = 11/166 (6%)
Query: 18 VTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+T G+L + V+ + + G+ +LH+ +P + L ++ +
Sbjct: 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI 146
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCIL 131
+ + +I + + + P ++APE +++ D++SF + +
Sbjct: 147 DED-MTARISMADVKFSFQSPGR---MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 132 EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
E+VT + P+++ ++ K + G +P + P V + ++ C
Sbjct: 203 ELVTREVPFADLSNMEIGMKVALEGLRPT-IPPGISPHVSKLMKIC 247
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 44/218 (20%), Positives = 87/218 (39%), Gaps = 28/218 (12%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ Y + ++ I V E + L + K + ++ K + + +L + +H
Sbjct: 119 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 61 PPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILR----KSHAARCVGTPEFMAPEVYEE 115
++H DLK N V+G +K+ D G+A ++ VG +M PE ++
Sbjct: 176 --IVHSDLKPANFLIVDGM---LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 116 E------------YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
+ D++S G CIL M P+ + + +I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289
Query: 163 FKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQID 199
+ + +++ ++ CL R+S ELL P++QI
Sbjct: 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 60/158 (37%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
C +L L YLH++ VIHRD+K D+I + G VK+ D G A + K R VG
Sbjct: 147 CEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVG 203
Query: 104 TPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEAL 162
TP +MAPEV Y VDI+S G+ ++EMV + PY P Q K+ + P L
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKR-LRDSPPPKL 261
Query: 163 FKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
P +R F+E+ L R +A+ELL PFL
Sbjct: 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 60/159 (37%), Positives = 85/159 (53%), Gaps = 15/159 (9%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
R+IL GL YLHS IHRD+K N+ ++ GEVK+ D G+A L + R VG
Sbjct: 125 LREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 104 TPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV---ISGKKP 159
TP +MAPEV ++ Y+ DI+S G+ +E+ + P+SE HP KV I P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPM----KVLFLIPKNNP 236
Query: 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
L +++F+E CL S R +A+ELL F+
Sbjct: 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-33
Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 9/178 (5%)
Query: 27 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86
+Q K + + + I+ L +LHS+ VIHRD+K N+ +N G+VK+ D
Sbjct: 96 YKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLIN-ALGQVKMCD 153
Query: 87 LGLAAILRKSHAARC-VGTPEFMAPEV-----YEEEYNELVDIYSFGMCILEMVTFDYPY 140
G++ L A G +MAPE ++ Y+ DI+S G+ ++E+ +PY
Sbjct: 154 FGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213
Query: 141 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
P Q K+V+ P+ E F +CL R + EL+ PF
Sbjct: 214 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 54/164 (32%), Positives = 87/164 (53%), Gaps = 18/164 (10%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
CRQ+L L +LHS+ +IHRDLK N+ + +G++++ D G++A K+ R +G
Sbjct: 123 CRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIG 179
Query: 104 TPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISG 156
TP +MAPEV + Y+ DI+S G+ ++EM + P+ E +P + + K I+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLK--IAK 236
Query: 157 KKPEALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
P L E R F++ L +R SA +LL PF+
Sbjct: 237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 43/231 (18%)
Query: 2 KFYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
F + + +T+ +G+L Y LK ++ +++ +SGL +LH+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDY-LKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 60 D------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEF 107
P + HRDLK NI V N G I DLGLA VGT +
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 108 MAPEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECTHP---- 146
M PEV +E + + D+YSFG+ + E+ + PY +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 147 AQIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 191
+ + V K P E ++ + + +C A +SRL+A +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 19/164 (11%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVG 103
CR+IL GL +LH VIHRD+K N+ + EVK+ D G++A L ++ R +G
Sbjct: 135 CREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIG 191
Query: 104 TPEFMAPEV------YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISG 156
TP +MAPEV + Y+ D++S G+ +EM P + HP + ++ I
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFL--IPR 248
Query: 157 KKPEALFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
L K + + + FIE CL S R + +L+ PF++
Sbjct: 249 NPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 57/159 (35%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VG 103
+ L GL YLH IHRD+K NI +N +G K+ D G+A L + A R +G
Sbjct: 131 LQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIG 187
Query: 104 TPEFMAPEV-YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPEA 161
TP +MAPEV E YN + DI+S G+ +EM PY++ HP + I+ I P
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFM--IPTNPPPT 244
Query: 162 LFKVED--PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
K E F+++CL + R +A +LL PF++
Sbjct: 245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 57/174 (32%), Positives = 75/174 (43%), Gaps = 30/174 (17%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---- 101
R++L GL YLH IHRD+K NI + G V+I D G++A L
Sbjct: 127 LREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 102 ---VGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV--- 153
VGTP +MAPEV E+ Y+ DI+SFG+ +E+ T PY + P KV
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-YPPM----KVLML 238
Query: 154 ISGKKPEALFKVED---------PEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
P +L R+ I CL R +A ELL F Q
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
+ + +++ N ++ E+ + + + + R + I+ L YL +
Sbjct: 88 QCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEV------YE 114
VIHRD+K NI ++ +G++K+ D G++ L A G +MAPE +
Sbjct: 146 -VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 115 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQF 173
+Y+ D++S G+ ++E+ T +PY C ++ KV+ + P + + + F
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSF 263
Query: 174 IEKCLA-TVSSRLSARELLTDPFLQ 197
++ CL R +LL F++
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 43/231 (18%)
Query: 2 KFYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
F S + + + + +T G+L Y L+ ++ + I SGL +LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 60 ------DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEF 107
P + HRDLK NI V N G+ I DLGLA + +S VGT +
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 108 MAPEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECT--HPA- 147
MAPEV +E + + VDI++FG+ + E+ + P+ + P+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 148 -QIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 191
+ K V ++ P F + + +++C S+RL+A +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 54/231 (23%), Positives = 82/231 (35%), Gaps = 43/231 (18%)
Query: 2 KFYTSWVDTANRNINF--VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
F + V++ G+L Y L V + + SGL +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 60 D------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEF 107
P + HRDLK NI V N G I DLGLA + VGT +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 108 MAPEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECTHP---- 146
MAPEV ++ E + DIY+ G+ E+ + PY +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 147 AQIYKKVISGKK----PEALFKVE-DPEVRQFIEKCLATV-SSRLSARELL 191
++ K V K P E + + + +C ++RL+A +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 13/175 (7%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGT 104
+ L +L + +IHRD+K NI ++ G +K+ D G++ L S A G
Sbjct: 131 TLATVKALNHLKE-NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGC 188
Query: 105 PEFMAPEV-----YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159
+MAPE + Y+ D++S G+ + E+ T +PY + +V+ G P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248
Query: 160 EALFKVED---PEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLRMIQY 210
+ E P F+ CL S R +ELL PF+ + + + + + Y
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE-ERAVEVACY 302
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP 105
L GL YLHS + +IHRD+K NI ++ G VK+GD G A+I+ +++ VGTP
Sbjct: 160 THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF--VGTP 214
Query: 106 EFMAPEV----YEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-IYKKVISGKKPE 160
+MAPEV E +Y+ VD++S G+ +E+ P + +Y I+ +
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYH--IAQNESP 271
Query: 161 ALFKVE-DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDLR 206
AL R F++ CL R ++ LL F+ + + +
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 319
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 30/188 (15%), Positives = 57/188 (30%), Gaps = 29/188 (15%)
Query: 25 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
L + H+ + A Q++ L LH ++H L+ +I ++ G V +
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 247
Query: 85 GDLGLAAILRKSHAARCVGTPEFMAPEVYEEE------------YNELVDIYSFGMCILE 132
+R + F PE+ D ++ G+ I
Sbjct: 248 TGFEHL--VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 133 MVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARE 189
+ D P ++ + + K P VR +E L RL +
Sbjct: 306 IWCADLPITK-DAALGGSEWIFRSCKNIP--------QPVRALLEGFLRYPKEDRLLPLQ 356
Query: 190 LLTDPFLQ 197
+ P +
Sbjct: 357 AMETPEYE 364
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 38/218 (17%), Positives = 67/218 (30%), Gaps = 29/218 (13%)
Query: 1 MKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-----VKHWCRQILSGL 53
++ + A + F GTL ++ + + I GL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNE-IERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 54 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-----------HAARCV 102
+H+ HRDLK NI + G+ + DLG A
Sbjct: 148 EAIHA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 103 GTPEFMAPEVYEEE----YNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGK 157
T + APE++ + +E D++S G C+L M+ + PY + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQ 263
Query: 158 KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDP 194
+ Q + + R LL+
Sbjct: 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 30/184 (16%), Positives = 57/184 (30%), Gaps = 16/184 (8%)
Query: 25 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
TL + I A+ Q++ L S+ ++H DN+F+ + G + +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLML 235
Query: 85 GDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEYNELVDIYSFGMCILEMVTFDYPY 140
GD+ + P AP + + ++ + G+ I + P+
Sbjct: 236 GDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 141 SECT-HPAQIYKKVISG--KKPEALFKVED---PEVRQFIEKCLAT-VSSRLSARELLTD 193
T +K+ F V+ I + L RL E +
Sbjct: 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353
Query: 194 PFLQ 197
P
Sbjct: 354 PEFL 357
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 20/195 (10%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
+ V E+ +L + + + + +++ RQI+ G YLH VIHRDLK N+
Sbjct: 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNL 146
Query: 74 FVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEEE-YNELVDIYSFGMC 129
F+N + EVKIGD GLA + + C GTP ++APEV ++ ++ VD++S G C
Sbjct: 147 FLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWSIG-C 203
Query: 130 IL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLATV-SSR 184
I+ ++ P+ Y ++ + + + P I+K L T ++R
Sbjct: 204 IMYTLLVGKPPFETSCLKE-TYLRIKKNE-----YSIPKHINPVAASLIQKMLQTDPTAR 257
Query: 185 LSARELLTDPFLQID 199
+ ELL D F
Sbjct: 258 PTINELLNDEFFTSG 272
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 38/225 (16%)
Query: 10 TANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
++ +NF+TE GTLR + + + + I SG+ YLHS + +IHRDL
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDL 134
Query: 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----------------CVGTPEFMAPEV 112
N V N V + D GLA ++ VG P +MAPE+
Sbjct: 135 NSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 113 YE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--------PEALF 163
Y+E VD++SFG+ + E++ + + + G P + F
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFF 253
Query: 164 KV------EDPEVR---QFIEKCLATVSSRLSARELLTDPFLQID 199
+ DPE R +E L T+ L+ L Q+D
Sbjct: 254 PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N + V E+ +L + + + + +++ RQI+ G YLH VIHRDLK
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLG 170
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYEEE-YNELVDIYSFG 127
N+F+N + EVKIGD GLA + + C GTP ++APEV ++ ++ VD++S G
Sbjct: 171 NLFLNED-LEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 128 MCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLATV-S 182
CI+ ++ P+ Y ++ + + + P I+K L T +
Sbjct: 229 -CIMYTLLVGKPPFETSCLKE-TYLRIKKNE-----YSIPKHINPVAASLIQKMLQTDPT 281
Query: 183 SRLSARELLTDPFLQID 199
+R + ELL D F
Sbjct: 282 ARPTINELLNDEFFTSG 298
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 47/239 (19%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
FY ++ + I+ E G+L Q K R+ + + ++ GL YL +
Sbjct: 95 GFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNEL 120
++HRD+K NI VN ++GE+K+ D G++ L S A VGT +M+PE + Y+
Sbjct: 153 -IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 210
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK----------------------- 157
DI+S G+ ++EM YP +
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 158 --KPEALFKVED----------------PEVRQFIEKCLATVSS-RLSARELLTDPFLQ 197
P A+F++ D E + F+ KCL + R ++L+ F++
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 29/183 (15%), Positives = 55/183 (30%), Gaps = 20/183 (10%)
Query: 25 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
L + H+ + A Q++ L LH ++H L+ +I ++ G V +
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFL 252
Query: 85 GDLGLAAILRKSHAARC---VGTPEFMAPEVY------EEEYNELVDIYSFGMCILEMVT 135
S + PE A + D ++ G+ I +
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 136 FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194
D P ++ + + K VR +E L RL + + P
Sbjct: 313 ADLPNTD-DAALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETP 365
Query: 195 FLQ 197
+
Sbjct: 366 EYE 368
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 38/209 (18%), Positives = 69/209 (33%), Gaps = 61/209 (29%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----- 100
+ +L L Y+H +HR +K +I ++ + G+V + L + +
Sbjct: 134 LQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 101 ----CVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153
V +++PEV ++ Y+ DIYS G+ E+ P+ + Q+ +
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEK 249
Query: 154 ISGKKPEALFKVED--------------------------------------------PE 169
++G P L P
Sbjct: 250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPH 309
Query: 170 VRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
F+E+CL +R SA LL F +
Sbjct: 310 FHHFVEQCLQRNPDARPSASTLLNHSFFK 338
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 27/230 (11%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLH 57
+K + +T R+ + E G+L + R ++ G+ +L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 58 SRDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY 113
++HR++K NI + K+ D G A L GT E++ P++Y
Sbjct: 130 ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 114 E---------EEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYKKVISGKKP 159
E ++Y VD++S G T F P+ ++ K+I+GK
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPS 245
Query: 160 EALFKVEDPEVRQFIEKCLATVSSRLS--ARELLTDPFLQIDDYDSDLRM 207
A+ V+ E VS LS + LLT I + D +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 48/190 (25%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ + E GT+ + K + + + + ++ + L Y HS+ VIHRD+K +
Sbjct: 81 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPE 138
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCI 130
N+ + G+ GE+KI D G + S GT +++ PE+ E ++E VD++S G+
Sbjct: 139 NLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
E + P E + YK++ P+ + R I + L S R
Sbjct: 198 YEFLV-GKPPFEANTYQETYKRISRVEFTFPDFV----TEGARDLISRLLKHNPSQRPML 252
Query: 188 RELLTDPFLQ 197
RE+L P++
Sbjct: 253 REVLEHPWIT 262
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 37/150 (24%), Positives = 60/150 (40%), Gaps = 20/150 (13%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS--------RDPPVIHRDLK 69
+T G+L + LK V+ + H + GL YLH P + HRD+K
Sbjct: 100 ITAFHEKGSLSDF-LKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 70 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEV------YEEEYNE 119
N+ + N I D GLA +A VGT +MAPEV ++ +
Sbjct: 159 SKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQI 149
+D+Y+ G+ + E+ + +
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 25/232 (10%)
Query: 12 NRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ E + TL++Y K +Q SGL +LHS + ++HRDLK
Sbjct: 90 RQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKP 146
Query: 71 DNIFVNGNQGE----VKIGDLGLAAILRK-----SHAARCVGTPEFMAPEVYEEE----Y 117
NI ++ I D GL L S + GT ++APE+ E+
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 118 NELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
VDI+S G +++ P+ + K ED R+ IEK
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEK 266
Query: 177 CLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEI----SPLLRQ 223
+A R SA+ +L PF + L+ Q +D E P+++Q
Sbjct: 267 MIAMDPQKRPSAKHVLKHPFFW--SLEKQLQFFQDVSDRIEKESLDGPIVKQ 316
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
++ Y + D + + V EM +G + +Y + + + + +H+ QI++G+LYLHS
Sbjct: 74 LELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYE-E 115
++HRDL N+ + N +KI D GLA L+ H C GTP +++PE+
Sbjct: 132 G--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRS 187
Query: 116 EYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKVEDPEVRQ 172
+ D++S G C+ ++ P+ T KV+ + P L E +
Sbjct: 188 AHGLESDVWSLG-CMFYTLLIGRPPFDTDTVKN-TLNKVVLADYEMPSFL----SIEAKD 241
Query: 173 FIEKCLATV-SSRLSARELLTDPFLQ 197
I + L + RLS +L PF+
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 41/223 (18%), Positives = 79/223 (35%), Gaps = 35/223 (15%)
Query: 1 MKFYTSWVDTANRNIN-----FVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSG 52
++F ++ + + G L ++ K ++ V Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 53 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--------------HA 98
+ ++H + PP+IHRDLK +N+ ++ G +K+ D G A +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 99 ARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCIL-EMVTFDYPYSECTHPAQIYKKV 153
TP + PE+ + E DI++ G CIL + +P+ + ++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED-----GAKLRI 261
Query: 154 ISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPF 195
++GK + I L RLS E++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 49/230 (21%), Positives = 84/230 (36%), Gaps = 27/230 (11%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLH 57
+K + +T R+ + E G+L + R ++ G+ +L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 58 SRDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY 113
++HR++K NI + K+ D G A L GT E++ P++Y
Sbjct: 130 ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 114 E---------EEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYKKVISGKKP 159
E ++Y VD++S G T F P+ ++ K+I+GK
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPS 245
Query: 160 EALFKVEDPEVRQFIEKCLATVSSRLS--ARELLTDPFLQIDDYDSDLRM 207
A+ V+ E VS LS + LLT I + D +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
+ V E+ G L + ++R+ K + Q+L + YLH +IHRDLK +N
Sbjct: 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPEN 269
Query: 73 IFV--NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE----YNELVDIYS 125
+ + +KI D G + IL ++ R GTP ++APEV YN VD +S
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 126 FGMCILEMVTFDY-------PYSECTHPAQIYKKVISGK---KPEALFKVEDPEVRQFIE 175
G IL + P+SE + ++ SGK PE +V + + ++
Sbjct: 330 LG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-KALDLVK 381
Query: 176 KCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 211
K L +R + E L P+LQ +D + + +
Sbjct: 382 KLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 12/190 (6%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ I + E G L + KH R + + + ++ L Y H R VIHRD+K +
Sbjct: 86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPE 143
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCI 130
N+ + G +GE+KI D G + GT +++ PE+ E + ++E VD++ G+
Sbjct: 144 NLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISG--KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
E + P+ +H ++++++ K P L + I K L RL
Sbjct: 203 YEFLVGMPPFDSPSHTE-THRRIVNVDLKFPPFL----SDGSKDLISKLLRYHPPQRLPL 257
Query: 188 RELLTDPFLQ 197
+ ++ P+++
Sbjct: 258 KGVMEHPWVK 267
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
+ V E+ G L + ++R+ K + Q+L + YLH +IHRDLK +N
Sbjct: 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPEN 144
Query: 73 IFVNGNQGE--VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE----YNELVDIYS 125
+ ++ + + +KI D G + IL ++ R GTP ++APEV YN VD +S
Sbjct: 145 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 204
Query: 126 FGMCILEMVTFDY-------PYSECTHPAQIYKKVISGK---KPEALFKVEDPEVRQFIE 175
G IL + P+SE + ++ SGK PE +V + + ++
Sbjct: 205 LG-VIL------FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE-KALDLVK 256
Query: 176 KCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 211
K L +R + E L P+LQ +D + + +
Sbjct: 257 KLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 13/205 (6%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N +I V E+ T G L + + R + +LS + Y H + V HRDLK +
Sbjct: 78 NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPE 135
Query: 72 NI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGM 128
N F+ + +K+ D GLAA + R VGTP +++P+V E Y D +S G
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAG- 194
Query: 129 CILEMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSS 183
++ ++ YP + +++ K+ G PE + P+ I + L
Sbjct: 195 VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252
Query: 184 RLSARELLTDPFLQIDDYDSDLRMI 208
R+++ + L + + S ++
Sbjct: 253 RITSLQALEHEWFEKQLSSSPRNLL 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MK Y + D RN V E + G L + + N +Q+LSG+ YLH +
Sbjct: 99 MKLYDFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 61 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEY 117
++HRDLK +N+ + + +KI D GL+A+ + +GT ++APEV ++Y
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIE 175
+E D++S G+ + ++ P+ T +I +KV GK +K + I+
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 176 KCLAT-VSSRLSARELLTDPFLQ 197
+ L R+SA++ L P+++
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIK 296
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 44/204 (21%), Positives = 92/204 (45%), Gaps = 12/204 (5%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K D ++ V E+ G + + + ++ + + + ++ G+ YLH +
Sbjct: 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQK 157
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA--ARCVGTPEFMAPEV---YEE 115
+IHRD+K N+ V + G +KI D G++ + S A + VGTP FMAPE +
Sbjct: 158 --IIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRK 214
Query: 116 EYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 174
++ + +D+++ G+ + V P+ + ++ K+ S +++ I
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC-LHSKIKSQALEFPDQPDIAEDLKDLI 273
Query: 175 EKCLAT-VSSRLSARELLTDPFLQ 197
+ L SR+ E+ P++
Sbjct: 274 TRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MK Y + D V E++T G L + +R + RQ+LSG+ Y+H
Sbjct: 89 MKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 61 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEY 117
++HRDLK +N+ + ++ ++I D GL+ S + +GT ++APEV Y
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 204
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIE 175
+E D++S G+ + +++ P++ I KKV GK +K + I
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 176 KCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
K L S R+SAR+ L ++Q +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 23/197 (11%)
Query: 17 FVTEMFTSGTLRQYRL-KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
V ++ G LR Y L ++ VK + +++ L YL ++ +IHRD+K DNI +
Sbjct: 92 MVVDLLLGGDLR-YHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILL 148
Query: 76 NGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE----YNELVDIYSFGMC 129
+ G V I D +AA+L + GT +MAPE++ Y+ VD +S G+
Sbjct: 149 D-EHGHVHITDFNIAAMLPRETQITTMA-GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206
Query: 130 ILEMVTFDYPYSECTH--PAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL-ATVSSR 184
E++ PY + +I + P A E+ ++K L R
Sbjct: 207 AYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAW----SQEMVSLLKKLLEPNPDQR 262
Query: 185 L-SARELLTDPFLQ-ID 199
++ P++ I+
Sbjct: 263 FSQLSDVQNFPYMNDIN 279
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 27/143 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-------RDPPVIHRDLKC 70
V E + +G+L +Y L + + + GL YLH+ P + HRDL
Sbjct: 90 VMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKSHAARC----------VGTPEFMAPEVYE------ 114
N+ V + G I D GL+ L + R VGT +MAPEV E
Sbjct: 149 RNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207
Query: 115 --EEYNELVDIYSFGMCILEMVT 135
E + VD+Y+ G+ E+
Sbjct: 208 DXESALKQVDMYALGLIYWEIFM 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 66/304 (21%), Positives = 105/304 (34%), Gaps = 16/304 (5%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNI---RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI- 73
E G LR+Y + ++ I S L YLH +IHRDLK +NI
Sbjct: 96 AMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIV 153
Query: 74 -FVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE-EEYNELVDIYSFGMCI 130
+ KI DLG A L + VGT +++APE+ E ++Y VD +SFG
Sbjct: 154 LQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAREL 190
E +T P+ P Q + K + K E + +D L T +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGK-VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
Query: 191 LTDPFLQID-DYDSDLRMIQYQTDYDEI-SPLLRQSLYGIYHSNSSSNNGCGHYIGYDTE 248
+ +LQ + R Q L + + + Y + E
Sbjct: 273 KLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENE 332
Query: 249 NGLDYHPHEFQESEIDLFTCQEDEHLTNFDISIKGKRREDDGIFLRLRIADKEGRIRNIY 308
N + Q++ I E++ L + + + D ++
Sbjct: 333 NLQNLKSWLQQDTGIPE----EEQELLQASGLALNSAQPLTQYVIDCTVIDGRQGEGDLI 388
Query: 309 FPFD 312
F FD
Sbjct: 389 FLFD 392
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 41/231 (17%), Positives = 84/231 (36%), Gaps = 33/231 (14%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAV--------KHWCRQILSG 52
+ + + + E + ++ ++ ++ K + +L+
Sbjct: 106 LTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNS 163
Query: 53 LLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV 112
Y+H+ + HRD+K NI ++ N G VK+ D G + + GT EFM PE
Sbjct: 164 FSYIHNEKN-ICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEF 221
Query: 113 YEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK------------ 157
+ E VDI+S G+C+ M P+S +++ + +
Sbjct: 222 FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLY 281
Query: 158 -----KPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYD 202
K E F++ L + R+++ + L +L + +
Sbjct: 282 PLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 4e-23
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 20/173 (11%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHA 98
+ + + RQI S L YLH++ + HRD+K +N F E+K+ D GL+ K +
Sbjct: 168 KLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 99 ARC------VGTPEFMAPEV---YEEEYNELVDIYSFGMCILEMVTFDYP--YSECTHPA 147
GTP F+APEV E Y D +S G +L ++ + A
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPGV--NDA 282
Query: 148 QIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+V++ K + V P R + L V R A L P++
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 7 WVDTANRNINFVTEMFTSGT-LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65
W +T V E L Y + + + + Q+++ + + HSR V+H
Sbjct: 106 WFET-QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVH 162
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYN-ELVDI 123
RD+K +NI ++ +G K+ D G A+L GT + PE +Y+ +
Sbjct: 163 RDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATV 222
Query: 124 YSFGMCIL-EMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLA 179
+S G+ +L +MV D P+ ++++ + P+ I +CLA
Sbjct: 223 WSLGI-LLYDMVCGDIPFER-------DQEILEAE-----LHFPAHVSPDCCALIRRCLA 269
Query: 180 T-VSSRLSARELLTDPFLQIDDYDSDLR 206
SSR S E+L DP++Q D L
Sbjct: 270 PKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K + + D + VTE + G L + + + + + +QILSG+ YLH +
Sbjct: 109 IKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166
Query: 61 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEY 117
++HRD+K +NI N N +KI D GL++ K + R +GT ++APEV +++Y
Sbjct: 167 --IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY 224
Query: 118 NELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQF 173
NE D++S G I+ ++ YP + + I KKV GK +K E ++
Sbjct: 225 NEKCDVWSCG-VIMYILLCGYPPFGGQ--NDQDIIKKVEKGKYYFDFNDWKNISDEAKEL 281
Query: 174 IEKCLAT-VSSRLSARELLTDPFLQ 197
I+ L + R +A E L +++
Sbjct: 282 IKLMLTYDYNKRCTAEEALNSRWIK 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 44/203 (21%), Positives = 74/203 (36%), Gaps = 34/203 (16%)
Query: 47 RQILSGLLYLHSRDPPVIHRDLKCDNIFVN------------GNQGEVKIGDLGLAAILR 94
RQI SG+ +LHS +IHRDLK NI V+ + I D GL L
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 95 ------KSHAARCVGTPEFMAPEV--------YEEEYNELVDIYSFGMCILEMVTFDYP- 139
+++ GT + APE+ + +DI+S G +++
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 140 -YSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT-VSSRLSARELLTDPFL 196
+ + + I + + S + + L E I + + R +A ++L P
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
Query: 197 QIDDYDSDLRMIQYQTDYDEISP 219
L + +D EI
Sbjct: 300 W--PKSKKLEFLLKVSDRLEIEN 320
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
MK + D + + V E++T G L +K +R + +Q+ SG+ Y+H +
Sbjct: 84 MKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 61 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEY 117
++HRDLK +NI + + ++KI D GL+ +++ + +GT ++APEV Y
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIE 175
+E D++S G+ + +++ P+ I K+V +GK ++ + + I
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 176 KCLAT-VSSRLSARELLTDPFLQ 197
K L S R++A + L P++Q
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQ 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 41/200 (20%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
+ + + E + G + Y + H R+ + + RQI+S + Y H + ++HRDLK +N
Sbjct: 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAEN 144
Query: 73 IFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMC 129
+ ++ + +KI D G + G P + APE+++ ++Y+ VD++S G+
Sbjct: 145 LLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 203
Query: 130 ILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLS 186
+ +V+ P+ ++ ++V+ GK P + + +++ L R +
Sbjct: 204 LYTLVSGSLPFDGQNLK-ELRERVLRGKYRIPFYM----STDCENLLKRFLVLNPIKRGT 258
Query: 187 ARELLTDPFLQIDDYDSDLR 206
+++ D ++ + +L+
Sbjct: 259 LEQIMKDRWINAGHEEDELK 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 44/199 (22%), Positives = 85/199 (42%), Gaps = 20/199 (10%)
Query: 12 NRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
N+ V E G L + + + ++ V +Q+++ L Y HS+ V+H+D
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKD 149
Query: 68 LKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIY 124
LK +NI F + + +KI D GLA + + + GT +MAPEV++ + DI+
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIW 209
Query: 125 SFGMCILEMVTFDYP--YSECTHPAQIYKKVISGK---KPEALFKVEDPEVRQFIEKCLA 179
S G ++ + ++ +K + E + P+ +++ L
Sbjct: 210 SAG-VVMYFLLTGCLPFTGT--SLEEVQQKATYKEPNYAVE--CRPLTPQAVDLLKQMLT 264
Query: 180 T-VSSRLSARELLTDPFLQ 197
R SA ++L + +
Sbjct: 265 KDPERRPSAAQVLHHEWFK 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 9e-22
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 23/199 (11%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ + V E++T G L +K +R + +Q+ SG+ Y+H + ++HRDLK +
Sbjct: 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPE 150
Query: 72 NIFVNGNQGE--VKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEEYNELVDIYSFGM 128
NI + + + +KI D GL+ +++ + +GT ++APEV Y+E D++S G
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG- 209
Query: 129 CILEMVTFDYP--YSECTHPAQIYKKVISGKKPEALFKVEDP-------EVRQFIEKCLA 179
IL ++ P Y + + I K+V +GK + + P + + I K L
Sbjct: 210 VILYILLSGTPPFYGK--NEYDILKRVETGK-----YAFDLPQWRTISDDAKDLIRKMLT 262
Query: 180 T-VSSRLSARELLTDPFLQ 197
S R++A + L P++Q
Sbjct: 263 FHPSLRITATQCLEHPWIQ 281
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 44/198 (22%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 7 WVDTANRNINFVTEMFT-SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65
W + + + E L + + + + + Q+L + + H+ V+H
Sbjct: 116 WFER-PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLH 172
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYN-ELVDI 123
RD+K +NI ++ N+GE+K+ D G A+L+ + GT + PE Y+ +
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 124 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLAT 180
+S G+ + +MV D P+ +++I G+ E + I CLA
Sbjct: 233 WSLGILLYDMVCGDIPFEH-------DEEIIRGQ-----VFFRQRVSSECQHLIRWCLAL 280
Query: 181 -VSSRLSARELLTDPFLQ 197
S R + E+ P++Q
Sbjct: 281 RPSDRPTFEEIQNHPWMQ 298
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 44/192 (22%), Positives = 86/192 (44%), Gaps = 10/192 (5%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
E + G L + + + Q+++G++YLH + HRD+K +N+
Sbjct: 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLL 137
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVYE-EEYN-ELVDIYSFGM 128
++ +KI D GLA + R ++ R GT ++APE+ + E++ E VD++S G+
Sbjct: 138 LDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
+ M+ + P+ + + Q Y K +K D + K L S+R++
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256
Query: 188 RELLTDPFLQID 199
++ D +
Sbjct: 257 PDIKKDRWYNKP 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 13/176 (7%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHA 98
V ++ RQ GL ++H ++H D+K +NI VKI D GLA L
Sbjct: 149 AEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206
Query: 99 AR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVI 154
+ T EF APE+ + E D+++ G + ++ E + + V
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVK 263
Query: 155 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRM 207
E F PE + FI+ L RL+ + L P+L+ D + R+
Sbjct: 264 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRI 319
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 41/179 (22%), Positives = 82/179 (45%), Gaps = 24/179 (13%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 104
+++ + +H +HRD+K DNI ++ G +++ D G L + + VGT
Sbjct: 183 EMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 105 PEFMAPEVYEEE------YNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGK 157
P++++PE+ + Y D +S G+C+ EM+ + P Y+E + Y K+++ K
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHK 297
Query: 158 K----PEALFKVEDPEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDLRMIQ 209
+ P + V + I + + + RL + PF D+D ++R +
Sbjct: 298 ERFQFPTQVTDV-SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD-NIRNCE 354
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+R + V E G L + + V + + + +++ L +HS IHRD+K D
Sbjct: 141 DRYLYMVMEYMPGGDLVNL-MSNYDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPD 197
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAPEV-----YEEEYNELVDI 123
N+ ++ G +K+ D G + K RC VGTP++++PEV + Y D
Sbjct: 198 NMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 124 YSFGMCILEMVTFDYP-YSECTHPAQIYKKVISGKKPEALFKVED--PEVRQFIEKCLAT 180
+S G+ + EM+ D P Y++ Y K+++ K D E + I L
Sbjct: 257 WSVGVFLYEMLVGDTPFYAD--SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 314
Query: 181 VSSRL---SARELLTDPFLQIDDYDSDLR 206
RL E+ F + D + +
Sbjct: 315 REVRLGRNGVEEIKRHLFFKNDQWAWETL 343
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 46/207 (22%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHA 98
R + + Q+ L +LHS + + H D++ +NI + +KI + G A L+
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 99 ARC-VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVI 154
R PE+ APEV++ + + D++S G ++ ++ +E QI + ++
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIM 216
Query: 155 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQ 211
+ + E FK E F+++ L SR++A E L P+L+ ++I+
Sbjct: 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL 276
Query: 212 TDYDEISPLLRQSLYGIYHSNSSSNNG 238
L+++ L + + S G
Sbjct: 277 KHRRYYHTLIKKDLNMVVSAARISCGG 303
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 24/180 (13%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 104
+I+ + +H +HRD+K DNI ++ G +++ D G LR R VGT
Sbjct: 170 EIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 105 PEFMAPEV--------YEEEYNELVDIYSFGMCILEMVTFDYP-YSECTHPAQIYKKVIS 155
P++++PE+ Y D ++ G+ EM P Y++ A+ Y K++
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--STAETYGKIVH 284
Query: 156 GKKPEALFKVED---PEVRQFIEKCLATVSSRL---SARELLTDPFLQIDDYDSDLRMIQ 209
K+ +L V++ E R FI++ L +RL A + T PF D+D LR
Sbjct: 285 YKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWD-GLRDSV 343
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 15/176 (8%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKS 96
+ +QIL G+ YLH++ + H DLK +NI + N +K+ D GLA +
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 97 HAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 152
+ GTPEF+APE+ E D++S G I ++ + +
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLAN 229
Query: 153 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 205
+ S E F + FI K L RL+ +E L P++ D +
Sbjct: 230 ITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAM 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-21
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 23/193 (11%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
F+ ++ G L + +H + ++ + +I+ GL ++H+R V++RDLK NI ++
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD 326
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEV--YEEEYNELVDIYSFGMCILEMV 134
G V+I DLGLA K VGT +MAPEV Y+ D +S G + +++
Sbjct: 327 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 135 T----FDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-- 185
F ++ H +I + ++ P++ PE+R +E L V+ RL
Sbjct: 386 RGHSPFRQHKTKDKH--EIDRMTLTMAVELPDSF----SPELRSLLEGLLQRDVNRRLGC 439
Query: 186 ---SARELLTDPF 195
A+E+ PF
Sbjct: 440 LGRGAQEVKESPF 452
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 39/216 (18%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N V ++ G L Y + ++ + + R +L + LH + ++HRDLK +
Sbjct: 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPE 153
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV-------YEEEYNELVDI 123
NI ++ + +K+ D G + L R GTP ++APE+ Y + VD+
Sbjct: 154 NILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 124 YSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKKPEALFKVEDP-------E 169
+S G I+ Y P+ + + ++SG ++ P
Sbjct: 213 WSTG-VIM------YTLLAGSPPFWHRKQM-LMLRMIMSGN-----YQFGSPEWDDYSDT 259
Query: 170 VRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
V+ + + L R +A E L PF Q +
Sbjct: 260 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 25/210 (11%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ + VTE+ G L L+ + + R I + YLH++ V+HRDLK
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPS 145
Query: 72 NIFV---NGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYS 125
NI +GN ++I D G A LR + T F+APEV E + Y+ DI+S
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWS 205
Query: 126 FGMCILEMVTFDYP--YSECT-HPAQIYKKVISGKKPEALFKVEDP-------EVRQFIE 175
G +L + Y + P +I ++ SGK F + + +
Sbjct: 206 LG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGK-----FSLSGGYWNSVSDTAKDLVS 259
Query: 176 KCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
K L RL+A +L P++ D
Sbjct: 260 KMLHVDPHQRLTAALVLRHPWIVHWDQLPQ 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
V ++ T G L + + + H +QIL + Y HS ++HR+LK +
Sbjct: 77 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPE 134
Query: 72 NI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFG 127
N+ + +G VK+ D GLA + S A GTP +++PEV +++ Y++ VDI++ G
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194
Query: 128 MCILEMVTFDY-------PYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 178
IL Y P+ + ++Y ++ +G P + PE + I+ L
Sbjct: 195 -VIL------YILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSML 246
Query: 179 AT-VSSRLSARELLTDPFLQIDD 200
R++A + L P++ +
Sbjct: 247 TVNPKKRITADQALKVPWICNRE 269
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 44/213 (20%), Positives = 87/213 (40%), Gaps = 25/213 (11%)
Query: 9 DTANRNINFVTEMFTSGTL--RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
R + + E G L R + R R I + + +LHS + + HR
Sbjct: 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHR 152
Query: 67 DLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDI 123
D+K +N+ + + + +K+ D G A ++ TP ++APEV E Y++ D+
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDM 212
Query: 124 YSFGMCILEMVTFDYP--YSECTH--PAQIYKKVISGKKPEALFKVEDP-------EVRQ 172
+S G I+ ++ +P YS + +++ G+ + +P + +Q
Sbjct: 213 WSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-----YGFPNPEWSEVSEDAKQ 266
Query: 173 FIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
I L T + RL+ + + P++
Sbjct: 267 LIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
F +G L +Y K + + + +I+S L YLH + +IHRDLK +NI +N
Sbjct: 107 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN 164
Query: 77 GNQGEVKIGDLGLAAILRK-SHAARC---VGTPEFMAPEV-YEEEYNELVDIYSFGMCIL 131
++I D G A +L S AR VGT ++++PE+ E+ + D+++ G I
Sbjct: 165 -EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 132 EMVTFDYP--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 178
++V P + + I++K+I + PE P+ R +EK L
Sbjct: 224 QLVA-GLPPFRAG--NEYLIFQKIIKLEYDFPEKF----FPKARDLVEKLL 267
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 50/250 (20%), Positives = 99/250 (39%), Gaps = 14/250 (5%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
E + G L + + + Q+++G++YLH + HRD+K +N+
Sbjct: 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLL 137
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPEVYE-EEYN-ELVDIYSFGM 128
++ +KI D GLA + R ++ R GT ++APE+ + E++ E VD++S G+
Sbjct: 138 LDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 196
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
+ M+ + P+ + + Q Y K +K D + K L S+R++
Sbjct: 197 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256
Query: 188 RELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDT 247
++ D + R E + + + ++ G+
Sbjct: 257 PDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSK 316
Query: 248 ENGLDYHPHE 257
E +H H
Sbjct: 317 E----HHHHH 322
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 13/175 (7%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHA 98
+ +QI G+ ++H ++H DLK +NI VN + ++KI D GLA +
Sbjct: 187 LDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 99 ARC-VGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVI 154
+ GTPEF+APEV + + D++S G+ I M+ + + A+ ++
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNIL 301
Query: 155 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 206
+ + + F+ E ++FI K L S R+SA E L P+L S L
Sbjct: 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 44/176 (25%), Positives = 72/176 (40%), Gaps = 15/176 (8%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKS 96
+ +QIL G+ YLH++ + H DLK +NI + N +K+ D GLA +
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 97 HAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 152
+ GTPEF+APE+ E D++S G I ++ + +
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLAN 229
Query: 153 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 205
+ + E F + FI K L RL+ +E L P++ D +
Sbjct: 230 ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVN-GNQGEVKIGDLGLAAILRKSH 97
H+ RQIL L Y H + +IHRD+K + + N VK+G G+A L +S
Sbjct: 130 AVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 98 AA--RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 152
VGTP FMAPEV + E Y + VD++ G IL ++ Y ++++
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEG 243
Query: 153 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
+I GK + + + + L + R++ E L P+L+ D +
Sbjct: 244 IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 16/192 (8%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
V E + G L Y KH RV + +QILS + Y H V+HRDLK +N+
Sbjct: 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVL 143
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCI 130
++ + KI D GL+ ++ R C G+P + APEV Y VDI+S G+ +
Sbjct: 144 LDAH-MNAKIADFGLSNMMSDGEFLRTSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
++ P+ + P ++KK+ G PE L + V + L R +
Sbjct: 202 YALLCGTLPFDDEHVPT-LFKKIRGGVFYIPEYL----NRSVATLLMHMLQVDPLKRATI 256
Query: 188 RELLTDPFLQID 199
+++ + + D
Sbjct: 257 KDIREHEWFKQD 268
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ V E+ G L + K + + + R+++S + ++H V+HRDLK +
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPE 135
Query: 72 NI-FVNGNQG-EVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVYEEE-YNELVDIYSF 126
N+ F + N E+KI D G A + + T + APE+ + Y+E D++S
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL 195
Query: 127 GMCILEMVTFDYP--YSE-----CTHPAQIYKKVISGKKPEALFKVEDP-------EVRQ 172
G IL + S CT +I KK+ G F E E +
Sbjct: 196 G-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-----FSFEGEAWKNVSQEAKD 249
Query: 173 FIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
I+ L + RL L + +LQ S
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS 282
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 52/266 (19%), Positives = 90/266 (33%), Gaps = 34/266 (12%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILRKSHA 98
+ RQ+ GL ++H + +H DLK +NI F E+K+ D GL A L +
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312
Query: 99 AR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVI 154
+ GT EF APEV E + D++S G + ++ E + + + V
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVK 369
Query: 155 SGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI--- 208
S ++ F + + FI K L ++R++ + L P+L + I
Sbjct: 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
Query: 209 -----------QYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGYDTENGLDYHPHE 257
+Y + + PL R S Y +
Sbjct: 430 RYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSI------RDAFWDRSEAQP 483
Query: 258 FQESEIDLFTCQEDEHLTNFDISIKG 283
+ E + F +
Sbjct: 484 RFIVKPYGTEVGEGQSAN-FYCRVIA 508
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
V ++ T G L + + + H +QIL + Y HS ++HR+LK +N
Sbjct: 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPEN 158
Query: 73 I-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGM 128
+ + +G VK+ D GLA + S A GTP +++PEV +++ Y++ VDI++ G
Sbjct: 159 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG- 217
Query: 129 CILEMVTFDY-------PYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA 179
IL Y P+ + ++Y ++ +G P + PE + I+ L
Sbjct: 218 VIL------YILLVGYPPFWDEDQH-RLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 270
Query: 180 T-VSSRLSARELLTDPFLQIDDYDSD 204
R++A + L P++ + +
Sbjct: 271 VNPKKRITADQALKVPWICNRERVAS 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 46/213 (21%), Positives = 85/213 (39%), Gaps = 26/213 (12%)
Query: 10 TANRNINFVTEMFTSGTL--RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
+ + V E G L R + R + I + YLHS + + HRD
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRD 186
Query: 68 LKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-YNELVDI 123
+K +N+ + + +K+ D G A ++ TP ++APEV E Y++ D+
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 124 YSFGMCILEMVTFDYP--YSECTHPAQ--IYKKVISGKKPEALFKVEDP-------EVRQ 172
+S G I+ ++ YP YS + ++ G+ ++ +P EV+
Sbjct: 247 WSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----YEFPNPEWSEVSEEVKM 300
Query: 173 FIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
I L T + R++ E + P++
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 16/181 (8%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKS 96
+ +QIL+G+ YLHS + H DLK +NI + N + +KI D GLA +
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 97 HAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 152
+ + GTPEF+APE+ E D++S G I ++ + +
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLAN 228
Query: 153 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDL-RMI 208
V + + F + FI + L R++ ++ L P+++ D L R
Sbjct: 229 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKA 288
Query: 209 Q 209
Sbjct: 289 S 289
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 35/217 (16%), Positives = 74/217 (34%), Gaps = 34/217 (15%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-----VKHWCRQILSGLLY 55
MKFY++ + V E+++ GTL ++ + V + ++L +
Sbjct: 130 MKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 56 LHSRDPPVIHRDLKCDNIFVNG----------NQGEVKIGDLGLAAILRKSHA-----AR 100
+H + +IH D+K DN + + + DLG + ++ A+
Sbjct: 188 VHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 101 CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159
C T F E+ + +N +D + + M+ Y + + +
Sbjct: 246 C-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPH 304
Query: 160 EALFKVEDPEVRQFIEKCL-ATVSSRLSARELLTDPF 195
++ +F L L + +LL
Sbjct: 305 LDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 43/165 (26%), Positives = 83/165 (50%), Gaps = 23/165 (13%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAARCVG 103
+Q+LS + YLH ++HRDLK +N+ ++ + ++ I D GL+ + + + G
Sbjct: 112 IQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACG 169
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKKPE 160
TP ++APEV ++ Y++ VD +S G I ++ YP Y E +++++K+ G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGY--- 223
Query: 161 ALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
++ E P + FI L + R + + L+ P++
Sbjct: 224 --YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 51/225 (22%), Positives = 86/225 (38%), Gaps = 46/225 (20%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
V E G++ + K R N + + S L +LH++ + HRDLK +
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPE 140
Query: 72 NI-FVNGNQG-EVKIGDLGLAAILRKSHAARC---------VGTPEFMAPEV------YE 114
NI + NQ VKI D L + ++ + G+ E+MAPEV
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 115 EEYNELVDIYSFG--MCIL------------EMVTFDYPYSECTHPAQIYKKVISGKKPE 160
Y++ D++S G + IL +D + +++ + GK
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK--- 257
Query: 161 ALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
++ D + I K L RLSA ++L P++Q
Sbjct: 258 --YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQ--GEVKIGDLGLAAILRKS 96
+ +QIL G+ YLHS+ + H DLK +NI ++ N +K+ D G+A +
Sbjct: 108 DEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 97 HAAR-CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKK 152
+ + GTPEF+APE+ E D++S G I ++ E T +
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE-TK-QETLTN 222
Query: 153 VISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
+ + E F + FI + L R++ + L +++ +
Sbjct: 223 ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 44/209 (21%), Positives = 90/209 (43%), Gaps = 39/209 (18%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ + V ++ G L Y + ++ + + R +L + +LH+ + ++HRDLK +
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPE 229
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEV-------YEEEYNELVDI 123
NI ++ N ++++ D G + L R GTP ++APE+ Y + VD+
Sbjct: 230 NILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 124 YSFGMCILEMVTFDY-------PYSECTHPAQIYKKVISGKKPEALFKVEDP-------E 169
++ G IL + P+ + + ++ G+ ++ P
Sbjct: 289 WACG-VIL------FTLLAGSPPFWHRRQI-LMLRMIMEGQ-----YQFSSPEWDDRSST 335
Query: 170 VRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
V+ I + L +RL+A + L PF +
Sbjct: 336 VKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 27 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86
+ + + QI+SGL +LH R+ +I+RDLK +N+ ++ + G V+I D
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISD 332
Query: 87 LGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVT----FDYP 139
LGLA ++ GTP FMAPE+ E Y+ VD ++ G+ + EM+ F
Sbjct: 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF-RA 391
Query: 140 YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELL 191
E ++ ++V+ P+ P + F E L RL S L
Sbjct: 392 RGEKVENKELKQRVLEQAVTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447
Query: 192 TDPF 195
T P
Sbjct: 448 THPL 451
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 39/168 (23%), Positives = 71/168 (42%), Gaps = 27/168 (16%)
Query: 46 CRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAAR-CV 102
+QIL + YLH ++HRDLK +N+ + +KI D GL+ I+ +
Sbjct: 154 VKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
Query: 103 GTPEFMAPEVYEEE-YNELVDIYSFG--MCILEMVTFDYP--YSECTHPAQIYKKVISGK 157
GTP + APE+ Y VD++S G IL + Y E +++++++ +
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRILNCE 267
Query: 158 KPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ P + + K + RL+ + L P++
Sbjct: 268 -----YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 19/171 (11%)
Query: 25 GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
+L++ + +++ + + +IL L YLHS +++ DLK +NI + Q +K+
Sbjct: 169 QSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLTEEQ--LKL 222
Query: 85 GDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECT 144
DLG + R + GTP F APE+ DIY+ G + + +
Sbjct: 223 IDLGAVS--RINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNG-R 279
Query: 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSR--LSARELLTD 193
+ + + K + + + + + +A E+
Sbjct: 280 YVDGLPEDDPVLKTY--------DSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 14/178 (7%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQ-GEVKIGDLGLAAILRKSH 97
V +QIL G+ YLH + ++H DLK NI + G++KI D G++ + +
Sbjct: 131 NDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 98 AAR-CVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKV 153
R +GTPE++APE+ + D+++ G+ I M+ E + Y +
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNI 245
Query: 154 ISGKK--PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 208
E F FI+ L R +A L+ +LQ D+++
Sbjct: 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
I V E + G L Y ++ +R+ + + +QI+ + Y H ++HRDLK +N+
Sbjct: 84 IVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLL 140
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCI 130
++ N VKI D GL+ I+ + + C G+P + APEV + Y VD++S G+ +
Sbjct: 141 LDDN-LNVKIADFGLSNIMTDGNFLKTSC-GSPNYAAPEVINGKLYAGPEVDVWSCGIVL 198
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
M+ P+ + P ++KKV S P+ L P + I + + R++
Sbjct: 199 YVMLVGRLPFDDEFIP-NLFKKVNSCVYVMPDFL----SPGAQSLIRRMIVADPMQRITI 253
Query: 188 RELLTDPFLQID 199
+E+ DP+ ++
Sbjct: 254 QEIRRDPWFNVN 265
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 53/172 (30%), Positives = 89/172 (51%), Gaps = 23/172 (13%)
Query: 20 EMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79
EMF+ LR + R + + + QI+ YLHS D +I+RDLK +N+ ++ Q
Sbjct: 127 EMFS--HLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQ 177
Query: 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY 138
G +++ D G A ++ C GTPE +APE+ + YN+ VD ++ G+ I EM Y
Sbjct: 178 GYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GY 235
Query: 139 P--YSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL-ATVSSRL 185
P +++ P QIY+K++SGK P +++ + L ++ R
Sbjct: 236 PPFFAD--QPIQIYEKIVSGKVRFPSHF----SSDLKDLLRNLLQVDLTKRF 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 5e-19
Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 25/148 (16%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CVG 103
++ L YLHS+D +I+RDLK +NI ++ G +KI D G A K C G
Sbjct: 114 EVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFA----KYVPDVTYTLC-G 165
Query: 104 TPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYP--YSECTHPAQIYKKVISGKK-- 158
TP+++APEV + YN+ +D +SFG+ I EM+ Y Y + + Y+K+++ +
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDS--NTMKTYEKILNAELRF 222
Query: 159 PEALFKVEDPEVRQFIEKCL-ATVSSRL 185
P + +V+ + + + +S RL
Sbjct: 223 PPFF----NEDVKDLLSRLITRDLSQRL 246
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
I V E + G L Y K+ R++ + + +QILSG+ Y H V+HRDLK +N+
Sbjct: 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVL 148
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCIL 131
++ + KI D GL+ ++ R G+P + APEV Y VDI+S G+ +
Sbjct: 149 LDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207
Query: 132 EMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRLSAR 188
++ P+ + P ++KK+ G P+ L +P V ++ L R + +
Sbjct: 208 ALLCGTLPFDDDHVPT-LFKKICDGIFYTPQYL----NPSVISLLKHMLQVDPMKRATIK 262
Query: 189 ELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSL 225
++ + + D L I + +
Sbjct: 263 DIREHEWFKQ-DLPKYLFPEDPSYSSTMIDDEALKEV 298
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 31/149 (20%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIH 65
V +++ + V E F L++Y ++ VK + Q+L GL + HSR+ V+H
Sbjct: 69 VLHSDKKLTLVFE-FCDQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLH 124
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----APEVY- 113
RDLK N+ +N GE+K+ + GL AR G + E + P+V
Sbjct: 125 RDLKPQNLLIN-RNGELKLANFGL---------ARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 114 -EEEYNELVDIYSFGMCIL-EMVTFDYPY 140
+ Y+ +D++S G CI E+ P
Sbjct: 175 GAKLYSTSIDMWSAG-CIFAELANAGRPL 202
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 20/193 (10%)
Query: 17 FVTEMFTSGTLRQ--YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
V + G L+ Y + + +I GL LH +++RDLK +NI
Sbjct: 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENIL 318
Query: 75 VNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILE 132
++ + G ++I DLGLA + + + VGT +MAPEV E Y D ++ G + E
Sbjct: 319 LD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
Query: 133 MVT----FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-- 185
M+ F + ++ + V + PE + P+ R + L + RL
Sbjct: 378 MIAGQSPF-QQRKKKIKREEVERLVK--EVPEEYSERFSPQARSLCSQLLCKDPAERLGC 434
Query: 186 ---SARELLTDPF 195
SARE+ P
Sbjct: 435 RGGSAREVKEHPL 447
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 53/229 (23%), Positives = 81/229 (35%), Gaps = 59/229 (25%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLA----AILR 94
VK QIL G+ YLH+ V+HRDLK NI V G +G VKI D+G A + L+
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 95 K-SHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT----F---------- 136
+ V T + APE+ Y + +DI++ G CI E++T F
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTSEPIFHCRQEDIKTS 246
Query: 137 ------------------------------DYPYSECTHPAQIYKKVISGKKPEALFKVE 166
++ Y K E
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 167 DPEVRQFIEKCLATV-SSRLSARELLTDPFLQIDDYDSDLRMIQYQTDY 214
D + ++K L R+++ + + DP+ D + Q Y
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPY 355
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 31/144 (21%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIH 65
V + R + V E F L++ L + ++ +K + Q+L G+ + H ++H
Sbjct: 87 VIHSERCLTLVFE-FMEKDLKKV-LDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILH 142
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----APEVY- 113
RDLK N+ +N + G +K+ D GL AR G T E + AP+V
Sbjct: 143 RDLKPQNLLIN-SDGALKLADFGL---------ARAFGIPVRSYTHEVVTLWYRAPDVLM 192
Query: 114 -EEEYNELVDIYSFGMCIL-EMVT 135
++Y+ VDI+S G CI EM+T
Sbjct: 193 GSKKYSTSVDIWSIG-CIFAEMIT 215
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 26 TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85
TL +Y H +++ ++ QIL G+ + H ++HRD+K NI + + +KI
Sbjct: 97 TLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILI-DSNKTLKIF 153
Query: 86 DLGLAAILRKS---HAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYPYS 141
D G+A L ++ +GT ++ +PE E +E DIYS G+ + EM+ + P++
Sbjct: 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
Query: 142 ECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLA-TVSSR-LSARELLTD 193
T I K I P V + I + ++R + +E+ D
Sbjct: 214 GET-AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 40 RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILRKSH 97
H +QIL +L+ H V+HR+LK +N+ + +G VK+ D GLA +
Sbjct: 110 ADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 98 AA--RCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDY-------PYSECTHPA 147
A GTP +++PEV ++ Y + VD+++ G IL Y P+ +
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG-VIL------YILLVGYPPFWDEDQ-H 219
Query: 148 QIYKKVISGKKPEALFKVEDP-------EVRQFIEKCLAT-VSSRLSARELLTDPFLQID 199
++Y+++ +G + P E + I K L S R++A E L P++
Sbjct: 220 RLYQQIKAGA-----YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274
Query: 200 DYDSD 204
+
Sbjct: 275 STVAS 279
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 31/146 (21%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
V N ++ + E + L++Y K+ V++R +K + Q+++G+ + HSR +HRD
Sbjct: 101 VIHHNHRLHLIFE-YAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRD 157
Query: 68 LKCDNIFVN----GNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----APEV 112
LK N+ ++ +KIGD GL AR G T E + PE+
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGL---------ARAFGIPIRQFTHEIITLWYRPPEI 208
Query: 113 Y--EEEYNELVDIYSFGMCIL-EMVT 135
Y+ VDI+S CI EM+
Sbjct: 209 LLGSRHYSTSVDIWSIA-CIWAEMLM 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 24/251 (9%)
Query: 13 RNINFVTEMFTSGT-LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
V E SG L + +H R++ + RQ++S + YL +D +IHRD+K +
Sbjct: 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDE 159
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-EEYN-ELVDIYSFGM 128
NI + + +K+ D G AA L + GT E+ APEV Y ++++S G+
Sbjct: 160 NIVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLAT-VSSRL 185
+ +V + P+ E ++ + P + E+ + L R
Sbjct: 219 TLYTLVFEENPFCE-------LEETVEAAIHPPYLV----SKELMSLVSGLLQPVPERRT 267
Query: 186 SARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGY 245
+ +L+TDP++ + + ++ + + + S S+
Sbjct: 268 TLEKLVTDPWVTQ-PVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSD--VAQAQEL 324
Query: 246 DTENGLDYHPH 256
G +H H
Sbjct: 325 CGGEGHHHHHH 335
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 20/143 (13%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGT 104
+I+ L +LH +I+RD+K +NI ++ + G V + D GL+ R GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 105 PEFMAPEVYEEE---YNELVDIYSFGMCILEMVT----FDYPYSECTHPAQIYKKVISGK 157
E+MAP++ +++ VD +S G+ + E++T F E A+I ++++ +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSE 282
Query: 158 K--PEALFKVEDPEVRQFIEKCL 178
P+ + + I++ L
Sbjct: 283 PPYPQEM----SALAKDLIQRLL 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 15 INFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74
+ + E + G L + R + + + +Q+LSG+ Y HS + HRDLK +N
Sbjct: 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTL 148
Query: 75 VNGNQ-GEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYE-EEYN-ELVDIYSFGMCI 130
++G+ +KI D G + + VGTP ++APEV +EY+ ++ D++S G+ +
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
Query: 131 LEMVTFDYPYSECTHPAQIYKK----VISGK--KPEALFKVEDPEVRQFIEKCLAT-VSS 183
M+ YP+ E + Y+K ++S K P+ + PE I + ++
Sbjct: 209 YVMLVGAYPF-EDPEEPRDYRKTIQRILSVKYSIPDDIRI--SPECCHLISRIFVADPAT 265
Query: 184 RLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSL 225
R+S E+ T + + +DL + QSL
Sbjct: 266 RISIPEIKTHSWFLK-NLPADLMNESNTGSQFQEPEQPMQSL 306
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 40/123 (32%), Positives = 54/123 (43%), Gaps = 27/123 (21%)
Query: 27 LRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
LR Y + + +K RQ L GL +LH+ ++HRDLK +NI V + G VK+
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKL 161
Query: 85 GDLGLAAILRKSHAARCVGTPEFM----------APEV-YEEEYNELVDIYSFGMCIL-E 132
D GL AR + APEV + Y VD++S G CI E
Sbjct: 162 ADFGL---------ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAE 211
Query: 133 MVT 135
M
Sbjct: 212 MFR 214
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 1e-17
Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 31/144 (21%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIH 65
V + + V E L++ L + + K + Q+L+G+ Y H R V+H
Sbjct: 68 VIHTKKRLVLVFE-HLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLH 123
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----APEVY- 113
RDLK N+ +N +GE+KI D GL AR G T E + AP+V
Sbjct: 124 RDLKPQNLLIN-REGELKIADFGL---------ARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 114 -EEEYNELVDIYSFGMCIL-EMVT 135
++Y+ +DI+S G CI EMV
Sbjct: 174 GSKKYSTTIDIWSVG-CIFAEMVN 196
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 24/174 (13%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL N+ V
Sbjct: 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK 151
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCIL 131
Q VKI D GLA +L + MA E + Y D++S+G+ +
Sbjct: 152 TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E++TF PY ++I + G++ ++ + D + R
Sbjct: 211 ELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSR 263
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 44/211 (20%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
++ + + + V E G + +R + + Q++ GL YLHS+
Sbjct: 69 IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPEVY- 113
++H+D+K N+ + G +KI LG+A L A G+P F PE+
Sbjct: 129 G--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIAN 184
Query: 114 -EEEYN-ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPE 169
+ ++ VDI+S G+ + + T YP+ E + ++++ + G P P
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDC----GPP 239
Query: 170 VRQFIEKCLAT-VSSRLSARELLTDPFLQID 199
+ ++ L + R S R++ + +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 40/123 (32%), Positives = 54/123 (43%), Gaps = 27/123 (21%)
Query: 27 LRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKI 84
L Y ++ V +K Q+L GL +LHS V+HRDLK NI V + G++K+
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKL 161
Query: 85 GDLGLAAILRKSHAARCVGTPEFM----------APEV-YEEEYNELVDIYSFGMCIL-E 132
D GL AR + APEV + Y VD++S G CI E
Sbjct: 162 ADFGL---------ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAE 211
Query: 133 MVT 135
M
Sbjct: 212 MFR 214
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 47/245 (19%), Positives = 85/245 (34%), Gaps = 68/245 (27%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
R ++ V E + T+ L + + VK Q L + + H + IHRD+K
Sbjct: 74 KRRLHLVFE-YCDHTVLHE-LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVK 129
Query: 70 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTP-EFM----------APEVY--EEE 116
+NI + +K+ D G AR + P ++ +PE+ + +
Sbjct: 130 PENILIT-KHSVIKLCDFGF---------ARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 117 YNELVDIYSFGMCIL-EMVTFDYPY----SECTHPAQIYK-------------------- 151
Y VD+++ G C+ E+++ P S+ Q+Y
Sbjct: 180 YGPPVDVWAIG-CVFAELLSGV-PLWPGKSD---VDQLYLIRKTLGDLIPRHQQVFSTNQ 234
Query: 152 --KVISGKKP------EALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQIDDYD 202
+ P E F ++ CL + RL+ +LL P+ +
Sbjct: 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294
Query: 203 SDLRM 207
DL
Sbjct: 295 EDLAK 299
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 39/186 (20%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----V 102
Q+L GL Y+HS + V+HRDLK N+F+N +KIGD GLA I+ ++ + +
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 103 GTPEFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------P 139
T + +P + Y + +D+++ G CI EM+T F
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 140 YSE----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191
+ E +Y + + L E F+E+ L + RL+A E L
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 192 TDPFLQ 197
+ P++
Sbjct: 305 SHPYMS 310
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 49/243 (20%), Positives = 84/243 (34%), Gaps = 65/243 (26%)
Query: 3 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 58
FY+S +N V + + T+ R Y + + + VK + Q+ L Y+HS
Sbjct: 116 FYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM---------- 108
+ HRD+K N+ ++ + +K+ D G A L + E
Sbjct: 175 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---------EPNVSYICSRYYR 223
Query: 109 APEVY--EEEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYK---------- 151
APE+ +Y +D++S G C+L E++ F P Q+ +
Sbjct: 224 APELIFGATDYTSSIDVWSAG-CVLAELLLGQPIF--PGDSGVD--QLVEIIKVLGTPTR 278
Query: 152 KVISGKKPEA----------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194
+ I P PE + L T ++RL+ E
Sbjct: 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338
Query: 195 FLQ 197
F
Sbjct: 339 FFD 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 67/247 (27%)
Query: 3 FYTSWVDTANRNINFVTEMFTSGTL----RQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 58
FY++ +N V E + T+ R Y + + + +K + Q+L L Y+HS
Sbjct: 101 FYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM---------- 108
+ HRD+K N+ ++ G +K+ D G A IL E
Sbjct: 160 IG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG---------EPNVSYICSRYYR 208
Query: 109 APEVY--EEEYNELVDIYSFGMCIL-EMVT----FDYPYSECTHPAQIYK---------- 151
APE+ Y +DI+S G C++ E++ F P Q+ +
Sbjct: 209 APELIFGATNYTTNIDIWSTG-CVMAELMQGQPLF--PGESGID--QLVEIIKVLGTPSR 263
Query: 152 KVISGKKP---------------EALFKVE-DPEVRQFIEKCLA-TVSSRLSARELLTDP 194
+ I P +F+ P+ I + L T S+RL+A E L P
Sbjct: 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 195 FLQIDDY 201
F D+
Sbjct: 324 FF--DEL 328
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 46/149 (30%), Positives = 69/149 (46%), Gaps = 36/149 (24%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA-------VKHWCRQILSGLLYLHSRD 60
V + V E F L++Y + R V VK++ Q+L GL + H
Sbjct: 71 VIHTENKLTLVFE-FMDNDLKKY-MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----A 109
++HRDLK N+ +N +G++K+GD GL AR G + E + A
Sbjct: 129 --ILHRDLKPQNLLIN-KRGQLKLGDFGL---------ARAFGIPVNTFSSEVVTLWYRA 176
Query: 110 PEVY--EEEYNELVDIYSFGMCIL-EMVT 135
P+V Y+ +DI+S G CIL EM+T
Sbjct: 177 PDVLMGSRTYSTSIDIWSCG-CILAEMIT 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 13/136 (9%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
++ L +LHS +I+RDLK +NI ++ +G +K+ D GL+ +I + A GT
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 162
E+MAPEV + + D +SFG+ + EM+T P+ + ++ K P+ L
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KETMTMILKAKLGMPQFL 249
Query: 163 FKVEDPEVRQFIEKCL 178
PE + +
Sbjct: 250 ----SPEAQSLLRMLF 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 21/191 (10%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + + +I+S L YLHSRD V++RD+K +N+ ++
Sbjct: 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD 139
Query: 77 GNQGEVKIGDLGLA-AILRKSHAAR--CVGTPEFMAPEVYEEE-YNELVDIYSFGMCILE 132
G +KI D GL + + C GTPE++APEV E+ Y VD + G+ + E
Sbjct: 140 K-DGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 133 MVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRL---- 185
M+ P+ H ++++ ++ + P L PE + + L RL
Sbjct: 198 MMCGRLPFYNQDH-ERLFELILMEEIRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGP 252
Query: 186 -SARELLTDPF 195
A+E++ F
Sbjct: 253 SDAKEVMEHRF 263
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 53/242 (21%), Positives = 91/242 (37%), Gaps = 66/242 (27%)
Query: 12 NRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ V E F T+ L ++ + V+ + QI++G+ + HS + +IHRD+K
Sbjct: 96 KKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKP 152
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM-----------APEVY--EEEY 117
+NI V+ G VK+ D G AR + P + APE+ + +Y
Sbjct: 153 ENILVS-QSGVVKLCDFGF---------ARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 118 NELVDIYSFGMCIL-EMVTFDYPY----SECTHPAQIYK--------------------- 151
+ VD+++ G C++ EM + P S+ Q+Y
Sbjct: 203 GKAVDVWAIG-CLVTEMFMGE-PLFPGDSD---IDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 152 -------KVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTDPFLQIDDYDS 203
++ + E + V +KCL R ELL F Q+D +
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317
Query: 204 DL 205
Sbjct: 318 RF 319
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 15/137 (10%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAR--CVGT 104
+I S L YLHS + +++RDLK +NI ++ +QG + + D GL + + C GT
Sbjct: 147 EIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFC-GT 202
Query: 105 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEA 161
PE++APEV ++ Y+ VD + G + EM+ P+ A++Y +++
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPLQLKPN 261
Query: 162 LFKVEDPEVRQFIEKCL 178
+ R +E L
Sbjct: 262 I----TNSARHLLEGLL 274
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 31/144 (21%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIH 65
+ +++ V E + L+QY L I VK + Q+L GL Y H + V+H
Sbjct: 68 IIHTEKSLTLVFE-YLDKDLKQY-LDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLH 123
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----APEVY- 113
RDLK N+ +N +GE+K+ D GL AR E + P++
Sbjct: 124 RDLKPQNLLIN-ERGELKLADFGL---------ARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 114 -EEEYNELVDIYSFGMCIL-EMVT 135
+Y+ +D++ G CI EM T
Sbjct: 174 GSTDYSTQIDMWGVG-CIFYEMAT 196
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 7e-17
Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 15/137 (10%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILRKSHAAR--CVGT 104
+I L +LH + +I+RDLK +NI +N +QG VK+ D GL + C GT
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFC-GT 184
Query: 105 PEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEA 161
E+MAPE+ +N VD +S G + +M+T P++ + K++ K P
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKCKLNLPPY 243
Query: 162 LFKVEDPEVRQFIEKCL 178
L E R ++K L
Sbjct: 244 L----TQEARDLLKKLL 256
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 46/193 (23%), Positives = 67/193 (34%), Gaps = 56/193 (29%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
IL GL LH V+HRDL NI + N ++ I D L AR
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNL---------AREDTADAN 189
Query: 108 M----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY--------- 138
APE+ + + +LVD++S G C++ EM F +
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYNQLNKIVE 248
Query: 139 ----PYSE-----CTHPAQIYKKVISGKKP----EALFKVEDPEVRQFIEKCLA-TVSSR 184
P E + A+ Y + P A+ DP I K L R
Sbjct: 249 VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308
Query: 185 LSARELLTDPFLQ 197
+S + L P+ +
Sbjct: 309 ISTEQALRHPYFE 321
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 16/160 (10%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
+I+ GL +LHS+ +++RDLK DNI ++ G +KI D G+ +L + GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 162
+++APE+ + YN VD +SFG+ + EM+ P+ +++ + P L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-EELFHSIRMDNPFYPRWL 241
Query: 163 FKVEDPEVRQFIEKCLA-TVSSRL-SARELLTDPFLQ-ID 199
+ E + + K RL ++ P + I+
Sbjct: 242 ----EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 24/174 (13%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E+ G + R + R+ ++ + +G+ YL S+ IHRDL N V
Sbjct: 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVT 247
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCIL 131
+KI D G++ A G + APE Y+ D++SFG+ +
Sbjct: 248 EK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E + PY ++ Q + V G + P+A+F++ +P R
Sbjct: 307 ETFSLGASPYPNLSN-QQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 49/195 (25%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPE- 106
Q L + LH + VIHRDLK N+ +N N ++K+ D GLA I+ +S A T +
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 107 -FM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY------- 138
M APEV +Y+ +D++S G CIL E+ F DY
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRPIFPGRDYRHQLLLI 235
Query: 139 ------PYSE------CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVS 182
P+S+ + A+ Y K + E +F +P+ +++ L +
Sbjct: 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPA 295
Query: 183 SRLSARELLTDPFLQ 197
R++A+E L P+LQ
Sbjct: 296 KRITAKEALEHPYLQ 310
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 34/136 (25%), Positives = 69/136 (50%), Gaps = 13/136 (9%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
+I+S L++LH + +I+RDLK DN+ ++ +G K+ D G+ I A GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 162
+++APE+ +E Y VD ++ G+ + EM+ P+ +++ +++ + P L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAILNDEVVYPTWL 247
Query: 163 FKVEDPEVRQFIEKCL 178
+ ++ +
Sbjct: 248 ----HEDATGILKSFM 259
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 32/103 (31%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHA 98
+K + +L+GL Y+H ++HRD+K N+ + G +K+ D GLA ++ + S
Sbjct: 126 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182
Query: 99 AR---CVGTPEFMAPEVY--EEEYNELVDIYSFGMCIL-EMVT 135
R V T + PE+ E +Y +D++ G CI+ EM T
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 31/144 (21%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRA--VKHWCRQILSGLLYLHSRDPPVIH 65
NI+ V + F L +K + + +K + L GL YLH ++H
Sbjct: 80 AFGHKSNISLVFD-FMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILH 135
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG------TPEFM-----APEVY- 113
RDLK +N+ ++ G +K+ D GL A+ G T + + APE+
Sbjct: 136 RDLKPNNLLLD-ENGVLKLADFGL---------AKSFGSPNRAYTHQVVTRWYRAPELLF 185
Query: 114 -EEEYNELVDIYSFGMCIL-EMVT 135
Y VD+++ G CIL E++
Sbjct: 186 GARMYGVGVDMWAVG-CILAELLL 208
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+ E G+LR Y KH+ R++ + + QI G+ YL ++ IHRDL NI V
Sbjct: 91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV- 147
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTP-EF----MAPEV-YEEEYNELVDIYSFGMCI 130
N+ VKIGD GL +L + V P E APE E +++ D++SFG+ +
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
E+ T Y E + + G + ++ + + ++
Sbjct: 208 YELFT----YIEKSKSPPAEFMRMIGNDKQG--QMIVFHLIELLKN 247
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 12/167 (7%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + + + +I+S L YLHS V++RDLK +N+ ++
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD 283
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 133
G +KI D GL I + GTPE++APEV E+ Y VD + G+ + EM
Sbjct: 284 K-DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 134 VTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCL 178
+ P+ H ++++ ++ + P L PE + + L
Sbjct: 343 MCGRLPFYNQDH-EKLFELILMEEIRFPRTL----GPEAKSLLSGLL 384
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 48/232 (20%), Positives = 85/232 (36%), Gaps = 43/232 (18%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL N+ V
Sbjct: 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK 151
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSFGMCIL 131
Q VKI D GLA +L + MA E + Y D++S+G+ +
Sbjct: 152 TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR------ 171
E++TF PY ++I + G++ ++ + D + R
Sbjct: 211 ELMTFGSKPYDGIP-ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 269
Query: 172 -QFIEKCLA------------TVSSRLSARELLTDPFLQIDDYDSDLRMIQY 210
K + + +D D + +Y
Sbjct: 270 IIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 42/199 (21%), Positives = 75/199 (37%), Gaps = 49/199 (24%)
Query: 42 VKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC 101
++ + +IL L Y HS ++HRD+K N+ ++ ++++ D GLA H +
Sbjct: 132 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQE 186
Query: 102 ----VGTPEFMAPE--VYEEEYNELVDIYSFGMCIL-EMVT------------------- 135
V + F PE V + Y+ +D++S G C+L M+
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 136 --------FDYPYSECTHPAQIYKKVISGKK--------PEALFKVEDPEVRQFIEKCLA 179
+DY + ++ + PE F++K L
Sbjct: 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 305
Query: 180 -TVSSRLSARELLTDPFLQ 197
SRL+ARE + P+
Sbjct: 306 YDHQSRLTAREAMEHPYFY 324
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 19/159 (11%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
+I GL +L S+ +I+RDLK DN+ ++ ++G +KI D G+ I GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEAL 162
+++APE+ + Y + VD ++FG+ + EM+ P+ ++++ ++ P+++
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIMEHNVAYPKSM 244
Query: 163 FKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPF 195
E + + RL R++ F
Sbjct: 245 ----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 41/180 (22%), Positives = 75/180 (41%), Gaps = 18/180 (10%)
Query: 26 TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85
TLR + + L + H +IHRD+K NI + VK+
Sbjct: 102 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMI-SATNAVKVM 158
Query: 86 DLGLAAILRKS-----HAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDYP 139
D G+A + S A +GT ++++PE + + D+YS G + E++T + P
Sbjct: 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 140 YSECTHPAQI-YKKVISGKKPEALFKVED---PEVRQFIEKCLA-TVSSR-LSARELLTD 193
++ + P + Y+ V + P + ++ + K LA +R +A E+ D
Sbjct: 219 FTGDS-PVSVAYQHV--REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
+I L YLH R +I+RDLK DN+ ++ +G +K+ D G+ + + GTP
Sbjct: 118 EISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTP 174
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152
++APE+ E Y VD ++ G+ + EM+ P+ +
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+ E G+LR Y KH+ R++ + + QI G+ YL ++ IHRDL NI V
Sbjct: 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV- 178
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTP-EF----MAPEV-YEEEYNELVDIYSFGMCI 130
N+ VKIGD GL +L + V P E APE E +++ D++SFG+ +
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
E+ T Y E + + G + V + + ++
Sbjct: 239 YELFT----YIEKSKSPPAEFMRMIGNDKQGQMIVF--HLIELLKN 278
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 53/192 (27%), Positives = 78/192 (40%), Gaps = 51/192 (26%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
QIL GL Y+HS + V+HRDLK N+ +N ++KI D GLA + H F
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH-----DHTGF 187
Query: 108 M----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY--------- 138
+ APE+ + Y + +DI+S G CIL EM++ F Y
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLSNRPIFPGKHYLDQLNHILG 246
Query: 139 ----PYSE-----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRL 185
P E A+ Y + K LF D + ++K L R+
Sbjct: 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
Query: 186 SARELLTDPFLQ 197
+ L P+L+
Sbjct: 307 EVEQALAHPYLE 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 46/167 (27%), Positives = 79/167 (47%), Gaps = 19/167 (11%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E SG LR + +HR R++ + + QI G+ YL SR +HRDL NI V
Sbjct: 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV- 160
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTP-EF----MAPE-VYEEEYNELVDIYSFGMCI 130
++ VKI D GLA +L V P + APE + + ++ D++SFG+ +
Sbjct: 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEK 176
E+ T+ D S P+ + +++ ++ + + +E+
Sbjct: 221 YELFTYCDKSCS----PSAEFLRMMGCERDV----PALSRLLELLEE 259
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 24/174 (13%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
VT+ G+L + +HR + + + +W QI G+ YL ++HR+L N+ +
Sbjct: 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK 149
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCIL 131
+V++ D G+A +L + MA E + +Y D++S+G+ +
Sbjct: 150 SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E++TF PY+ A++ + G++ ++ V D +R
Sbjct: 209 ELMTFGAEPYAGLR-LAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIR 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 7/144 (4%)
Query: 17 FVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
FV E G L + + R + +I GL +L S+ +I+RDLK DN+ ++
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD 476
Query: 77 GNQGEVKIGDLGLA--AILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEM 133
+G +KI D G+ I GTP+++APE+ + Y + VD ++FG+ + EM
Sbjct: 477 S-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 134 VTFDYPYSECTHPAQIYKKVISGK 157
+ P+ ++++ ++
Sbjct: 536 LAGQAPFEGEDED-ELFQSIMEHN 558
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 64/184 (34%), Positives = 85/184 (46%), Gaps = 41/184 (22%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTP 105
Q+L GL Y+HS V+HRDLK N+ VN + E+KI D GLA R + A V T
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA---RHADAEMTGYVVTR 187
Query: 106 EFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE 142
+ APEV YN+ VDI+S G CI+ EM+T F DY P +E
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVG-CIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 143 -----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193
A+ Y + + LF P+ +EK L V RL+A + LT
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 194 PFLQ 197
PF +
Sbjct: 307 PFFE 310
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILRKSHAARCVGTP 105
+I L YLH R +I+RDLK DN+ ++ +G +K+ D G+ + + GTP
Sbjct: 161 EISLALNYLHERG--IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTP 217
Query: 106 EFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152
++APE+ E Y VD ++ G+ + EM+ P+ +
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 10/125 (8%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V E G+LR Y L + + + + +QI G+ YLH++ IHRDL N+ +
Sbjct: 113 VMEYVPLGSLRDY-LPRHSIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL-D 168
Query: 78 NQGEVKIGDLGLAAILRKSHAARCVGT----PEF-MAPE-VYEEEYNELVDIYSFGMCIL 131
N VKIGD GLA + + H V P F APE + E ++ D++SFG+ +
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 132 EMVTF 136
E++T
Sbjct: 229 ELLTH 233
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 46/218 (21%), Positives = 70/218 (32%), Gaps = 55/218 (25%)
Query: 27 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86
R Y + +K + Q++ + LH V HRD+K N+ VN G +K+ D
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 87 LGLAAILRKSHAARCVGTPEFM----------APEVY--EEEYNELVDIYSFGMCIL-EM 133
G A+ + E APE+ + Y VDI+S G CI EM
Sbjct: 176 FGS---------AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEM 225
Query: 134 VT----F---DY-------------PYSE---CTHP--AQIYKKVISGKKPEALFKVE-- 166
+ F + P E +P + G +F
Sbjct: 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSL 285
Query: 167 --DPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201
E + L R+ E L P+ D+
Sbjct: 286 KDAKEAYDLLSALLQYLPEERMKPYEALCHPYF--DEL 321
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 39/174 (22%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V EM G L +Y ++R V + + Q+ G+ YL + +HRDL N+ +
Sbjct: 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLL-V 151
Query: 78 NQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCIL 131
Q KI D GL+ A+ + + ++ APE +++ D++SFG+ +
Sbjct: 152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMW 211
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E ++ PY ++ + G++ P ++ + D E R
Sbjct: 212 EAFSYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 3e-15
Identities = 23/98 (23%), Positives = 42/98 (42%), Gaps = 14/98 (14%)
Query: 265 LFTCQEDEHLTNFDISIKGKRRED---DGIFLRLRIAD---KEGRIRN---IYFPFDIQT 315
QE+ + ++ +D I L LRI D +G+ ++ I F FD++
Sbjct: 2 AMDPQEE-----TGVRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLER 56
Query: 316 DTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPE 353
D VA EMV + + D +A+ I ++ + +
Sbjct: 57 DVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIKRK 94
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 28/176 (15%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE T G L Y + R + AV + QI S + YL ++ IHR+L N V
Sbjct: 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLV 351
Query: 76 NGNQGEVKIGDLGLAAIL-----RKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMC 129
N VK+ D GL+ ++ A+ ++ APE ++ D+++FG+
Sbjct: 352 GEN-HLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVL 408
Query: 130 ILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ E+ T+ PY +Q+Y+ + + PE ++++ +P R
Sbjct: 409 LWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 56/182 (30%), Positives = 81/182 (44%), Gaps = 37/182 (20%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L GL Y+H+ +IHRDLK N+ VN + E+KI D GLA S V T +
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLARQA-DSEMTGYVVTRWY 191
Query: 108 MAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE-- 142
APEV Y + VDI+S G CI+ EM+T F D+ P +E
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVG-CIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 143 ---CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195
+ A+ Y K + + ++ P +EK L R++A E L P+
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310
Query: 196 LQ 197
+
Sbjct: 311 FE 312
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 42/225 (18%), Positives = 77/225 (34%), Gaps = 55/225 (24%)
Query: 15 INFVTE-MFT--SGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+N + E + L+ + R + + + + Q+ + ++HS + HRD+K
Sbjct: 113 LNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQ 170
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFM----------APEVY--EEEYNE 119
N+ VN +K+ D G A L S E APE+ EY
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPS---------EPSVAYICSRFYRAPELMLGATEYTP 221
Query: 120 LVDIYSFGMCIL-EMVT----F---DY-------------PYSE-----CTHPAQIYKKV 153
+D++S G C+ E++ F P E H ++
Sbjct: 222 SIDLWSIG-CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT 280
Query: 154 ISGKKPEALF-KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196
+ K + + +E+ L R++ E + PF
Sbjct: 281 LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 7e-15
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 24/174 (13%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
VTE + G+L + +R + QI SG+ Y+ + +HRDL+ NI V
Sbjct: 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV 313
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYEE-EYNELVDIYSFGMCIL 131
N K+ D GLA ++ + G ++ APE + D++SFG+ +
Sbjct: 314 GEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 372
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E+ T PY + ++ +V G + PE+L + ++PE R
Sbjct: 373 ELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 8e-15
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 24/174 (13%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
VTE + G+L + +R + QI SG+ Y+ + +HRDL+ NI V
Sbjct: 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILV 396
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTP---EFMAPEVYEE-EYNELVDIYSFGMCIL 131
N K+ D GLA ++ + G ++ APE + D++SFG+ +
Sbjct: 397 GEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLT 455
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E+ T PY + ++ +V G + PE+L + ++PE R
Sbjct: 456 ELTTKGRVPYPGMVNR-EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 56/184 (30%), Positives = 83/184 (45%), Gaps = 41/184 (22%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTP 105
QIL GL Y+HS D +IHRDLK N+ VN + E+KI D GLA R + V T
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA---RHTADEMTGYVATR 193
Query: 106 EFMAPEV--YEEEYNELVDIYSFGMCIL-EMVT----F---DY-------------PYSE 142
+ APE+ YN+ VDI+S G CI+ E++T F D+ P +E
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 143 -----CTHPAQIYKKVISGKKP---EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193
+ A+ Y + ++ +F +P +EK L R++A + L
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 194 PFLQ 197
+
Sbjct: 313 AYFA 316
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 41/228 (17%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK----------HWCRQILSGLLYLHSRDPPVIHRD 67
+ E+ T G L+ Y R +I G+ YL++ +HRD
Sbjct: 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRD 163
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVD 122
L N V + VKIGD G+ + ++ R G M+PE + + + D
Sbjct: 164 LAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSD 222
Query: 123 IYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDP 168
++SFG+ + E+ T + PY ++ Q+ + V+ G P+ LF++ +P
Sbjct: 223 VWSFGVVLWEIATLAEQPYQGLSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNP 281
Query: 169 EVR-QFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYD 215
++R F+E + S + +E + F ++ Y S+ + + D
Sbjct: 282 KMRPSFLE-----IISSI--KEEMEPGFREVSFYYSEENKLPEPEELD 322
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 25/174 (14%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
VTE ++G L Y R + + + C + G+ +L S IHRDL N V+
Sbjct: 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD 138
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCIL 131
+ VK+ D G+ + VGT +F APEV + +Y+ D+++FG+ +
Sbjct: 139 RD-LCVKVSDFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMW 196
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E+ + PY T+ +++ KV G + + ++++ E PE R
Sbjct: 197 EVFSLGKMPYDLYTN-SEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKR 249
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 38/173 (21%), Positives = 72/173 (41%), Gaps = 23/173 (13%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+ E++ G L Y + + + + QI + YL S + +HRD+ NI V
Sbjct: 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV- 146
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPEVYE-EEYNELVDIYSFGMCILE 132
+ VK+GD GL+ + + T P ++M+PE + D++ F +C+ E
Sbjct: 147 ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWE 206
Query: 133 MVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+++F P+ + + + G + P L+ + DP R
Sbjct: 207 ILSFGKQPFFWLEN-KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 39/173 (22%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+ E+ T G LR + + +++ ++ + Q+ + L YL S+ +HRD+ N+ V
Sbjct: 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV- 149
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPEVYEE-EYNELVDIYSFGMCILE 132
+ VK+GD GL+ + S + P ++MAPE + D++ FG+C+ E
Sbjct: 150 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 209
Query: 133 MVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
++ P+ + + ++ +G++ P L+ + DP R
Sbjct: 210 ILMHGVKPFQGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 27/185 (14%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIH 65
V I VTE G L Y L+ +R A C + G+ YL VIH
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIH 127
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNEL 120
RDL N V G +K+ D G+ + GT +F +PEV Y+
Sbjct: 128 RDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSK 185
Query: 121 VDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------E 166
D++SFG+ + E+ + PY ++ +++ + + +G + ++++ E
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFRLYKPRLASTHVYQIMNHCWRE 244
Query: 167 DPEVR 171
PE R
Sbjct: 245 RPEDR 249
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 41/211 (19%), Positives = 77/211 (36%), Gaps = 43/211 (20%)
Query: 10 TANRNINFVTEMFTSGTL--RQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
+ + V E G L R + R + I + YLHS + + HRD
Sbjct: 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRD 142
Query: 68 LKCDNI-FVNGNQG-EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYS 125
+K +N+ + + +K+ D G A E E+Y++ D++S
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFA-------------------KETTGEKYDKSCDMWS 183
Query: 126 FGMCILEMVTFDYP--YSECTHPAQ--IYKKVISGKKPEALFKVEDP-------EVRQFI 174
G I+ ++ YP YS + ++ G+ ++ +P EV+ I
Sbjct: 184 LG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-----YEFPNPEWSEVSEEVKMLI 237
Query: 175 EKCLAT-VSSRLSARELLTDPFLQIDDYDSD 204
L T + R++ E + P++
Sbjct: 238 RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 35/178 (19%), Positives = 63/178 (35%), Gaps = 33/178 (18%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V E G+L Y K++ +NI +Q+ + + +L +IH ++ NI +
Sbjct: 90 VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI 147
Query: 77 -------GNQGEVKIGDLGLAAILRKSHAARCVGTPEF-------MAPEV--YEEEYNEL 120
GN +K+ D G+ + V + + PE + N
Sbjct: 148 REEDRKTGNPPFIKLSDPGI---------SITVLPKDILQERIPWVPPECIENPKNLNLA 198
Query: 121 VDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
D +SFG + E+ + D P S + + L + E+ I C
Sbjct: 199 TDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR---HQLPAPKAAELANLINNC 252
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 16/94 (17%)
Query: 52 GLLYLHSR-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAA-RCVGTPEF 107
GL YLH DP +IHRD+K NI ++ E +GD GLA ++ + +H GT
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 108 MAPEVYEEEY------NELVDIYSFGMCILEMVT 135
+AP EY +E D++ +G+ +LE++T
Sbjct: 202 IAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 54/219 (24%)
Query: 31 RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV-----NGNQGEVKIG 85
+ +HR + + VK +Q+L GL Y+H R +IH D+K +N+ + N ++KI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 86 DLGLAAILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCILEMVT----FD--- 137
DLG A + H + T E+ +PEV + DI+S I E++T F+
Sbjct: 181 DLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239
Query: 138 --YPYSECTHPAQI--------------------------YKKVISGKKPEAL------- 162
+ H AQI + IS K L
Sbjct: 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299
Query: 163 FKVEDPEVRQF---IEKCLA-TVSSRLSARELLTDPFLQ 197
+K E ++ + L R A L+ P+L+
Sbjct: 300 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 38/161 (23%), Positives = 65/161 (40%), Gaps = 40/161 (24%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-------------AILR 94
Q++ + YLHS ++HRD+K NI +N VK+ D GL+ +
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 95 KSHAARCVGTPEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT----FD 137
+ + APE+ +Y + +D++S G CIL E++ F
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKPIF- 231
Query: 138 YPYSECTHPAQIYK--KVISGKKPEALFKVEDPEVRQFIEK 176
P S + Q+ + VI E + ++ P + IE
Sbjct: 232 -PGSSTMN--QLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 42/174 (24%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+TE +G L Y R R + + C+ + + YL S+ +HRDL N VN
Sbjct: 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN 154
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCIL 131
G VK+ D GL+ + VG+ +F PEV +++ DI++FG+ +
Sbjct: 155 DQ-GVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMW 212
Query: 132 EMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E+ + PY T+ ++ + + G + E ++ + E + R
Sbjct: 213 EIYSLGKMPYERFTN-SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 39/173 (22%), Positives = 80/173 (46%), Gaps = 23/173 (13%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+ E+ T G LR + + +++ ++ + Q+ + L YL S+ +HRD+ N+ V
Sbjct: 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLV- 524
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGT--P-EFMAPE-VYEEEYNELVDIYSFGMCILE 132
+ VK+GD GL+ + S + P ++MAPE + + D++ FG+C+ E
Sbjct: 525 SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 133 MVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
++ P+ + + ++ +G++ P L+ + DP R
Sbjct: 585 ILMHGVKPFQGVKNN-DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 10/126 (7%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
+ E SG+L++Y K++ ++N++ + QI G+ YL SR +HRDL N+ V
Sbjct: 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV- 159
Query: 77 GNQGEVKIGDLGLAAILRKSHAARCVGT----PEF-MAPE-VYEEEYNELVDIYSFGMCI 130
++ +VKIGD GL + V P F APE + + ++ D++SFG+ +
Sbjct: 160 ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 131 LEMVTF 136
E++T+
Sbjct: 220 HELLTY 225
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 34/88 (38%), Positives = 48/88 (54%), Gaps = 7/88 (7%)
Query: 52 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSH-AARCVGTPEF 107
G+ +LH + IHRD+K NI ++ KI D GLA ++ +R VGT +
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 108 MAPEVYEEEYNELVDIYSFGMCILEMVT 135
MAPE E DIYSFG+ +LE++T
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 41/100 (41%), Positives = 49/100 (49%), Gaps = 25/100 (25%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L G+ +LHS +IHRDLK NI V + +KI D GL AR GT
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGTSFM 219
Query: 108 M----------APEV-YEEEYNELVDIYSFGMCIL-EMVT 135
M APEV Y E VDI+S G CI+ EMV
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 39/181 (21%), Positives = 63/181 (34%), Gaps = 23/181 (12%)
Query: 26 TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85
L + + RQI S L H+ HRD+K +NI V+ + +
Sbjct: 120 DLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLV 176
Query: 86 DLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCIL-EMVTFDYPY 140
D G+A+ VGT +MAPE + DIY+ C+L E +T PY
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPY 235
Query: 141 SECTHPAQIYKKV------ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSR-LSARELLT 192
+ + + S +P I + +A R ++ +L
Sbjct: 236 QGDQ-LSVMGAHINQAIPRPSTVRPGI-----PVAFDAVIARGMAKNPEDRYVTCGDLSA 289
Query: 193 D 193
Sbjct: 290 A 290
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 40/100 (40%), Positives = 49/100 (49%), Gaps = 25/100 (25%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF 107
Q+L G+ +LHS +IHRDLK NI V + +KI D GL AR GT
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL---------ARTAGTSFM 182
Query: 108 M----------APEV-YEEEYNELVDIYSFGMCIL-EMVT 135
M APEV Y E VDI+S G CI+ EM+
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIK 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 26/175 (14%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE +G+L + + + K QI G+ ++ R+ IHRDL+ NI V
Sbjct: 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILV 142
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCI 130
+ KI D GLA ++ + G +F APE + D++SFG+ +
Sbjct: 143 SDT-LSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E+VT PY T+P ++ + + G + PE L+++ E PE R
Sbjct: 201 TEIVTHGRIPYPGMTNP-EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 45/180 (25%), Positives = 77/180 (42%), Gaps = 36/180 (20%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE T G L Y + R + AV + QI S + YL ++ IHRDL N V
Sbjct: 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLV 144
Query: 76 NGNQGEVKIGDLGLAAIL-----RKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYS 125
N VK+ D GL+ ++ A+ F APE +++ D+++
Sbjct: 145 GEN-HLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPESLAYNKFSIKSDVWA 197
Query: 126 FGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
FG+ + E+ T+ PY +Q+Y+ + + PE ++++ +P R
Sbjct: 198 FGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 39/144 (27%), Positives = 62/144 (43%), Gaps = 12/144 (8%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
VTE+ G+L KH+ + + + Q+ G+ YL S+ IHRDL N+ +
Sbjct: 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA 155
Query: 77 GNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCI 130
VKIGD GL A+ + + APE ++ D + FG+ +
Sbjct: 156 TRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 131 LEMVTF-DYPYSECTHPAQIYKKV 153
EM T+ P+ +QI K+
Sbjct: 215 WEMFTYGQEPWIGLN-GSQILHKI 237
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE G+L + K + QI G+ ++ R+ IHRDL+ NI V
Sbjct: 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILV 317
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCI 130
+ + KI D GLA ++ + G +F APE + D++SFG+ +
Sbjct: 318 SAS-LVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+E+VT+ PY ++P ++ + + G + PE L+ + PE R
Sbjct: 376 MEIVTYGRIPYPGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 429
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 31/115 (26%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--------------AIL 93
+L G ++H +IHRDLK N +N + VK+ D GLA
Sbjct: 137 NLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 94 RKSHAARCVGTPEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT 135
+ + + APE+ +E Y + +DI+S G CI E++
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 27/176 (15%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
VTE +G+L + L+ ++ R + +G+ YL +HRDL N+ V
Sbjct: 128 VTEYMENGSLDTF-LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLV 184
Query: 76 NGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMC 129
+ N K+ D GL+ + AA + APE ++ D++SFG+
Sbjct: 185 DSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 130 ILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ E++ + + PY T+ + V G + P AL ++ +D R
Sbjct: 244 MWEVLAYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 37/181 (20%)
Query: 18 VTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V EM G L ++ K + + V Q+ G+ YL ++ +HRDL N+ +
Sbjct: 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLL- 143
Query: 77 GNQGEVKIGDLGLAAIL-------RKSHAARCVGTPEF----MAPEVYE-EEYNELVDIY 124
N+ KI D GL+ L A + + APE +++ D++
Sbjct: 144 VNRHYAKISDFGLSKALGADDSYYTARSAGK------WPLKWYAPECINFRKFSSRSDVW 197
Query: 125 SFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEV 170
S+G+ + E +++ PY + ++ + GK+ P L+ + E
Sbjct: 198 SYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 256
Query: 171 R 171
R
Sbjct: 257 R 257
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 5e-13
Identities = 45/194 (23%), Positives = 86/194 (44%), Gaps = 32/194 (16%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
V EM G L ++ + R + + V Q+ G+ YL ++ +HR+L N+ +
Sbjct: 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL- 469
Query: 77 GNQGEVKIGDLGLAAILRKSHA---ARCVGT-P-EFMAPE-VYEEEYNELVDIYSFGMCI 130
N+ KI D GL+ L + AR G P ++ APE + +++ D++S+G+ +
Sbjct: 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR----- 171
E +++ PY + P ++ + GK+ P L+ + E R
Sbjct: 530 WEALSYGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT 588
Query: 172 --QFIEKCLATVSS 183
Q + C +++S
Sbjct: 589 VEQRMRACYYSLAS 602
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 18 VTEMFTSGTLRQYRLKHR------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
+ G L + L R + ++ + + I G+ YL SR+ IHRDL
Sbjct: 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAAR 166
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYSF 126
N + + V + D GL+ + R + +A E + + Y D+++F
Sbjct: 167 NCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 127 GMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR- 171
G+ + E++T PY+ + A+IY +I G + E ++ + DP+ R
Sbjct: 226 GVTMWEIMTRGQTPYAGIEN-AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284
Query: 172 --QFIEKCLATVSSRLSARELLTDP 194
+ L + LS DP
Sbjct: 285 SFTCLRMELENILGHLSVLSTSQDP 309
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 48/236 (20%), Positives = 90/236 (38%), Gaps = 46/236 (19%)
Query: 18 VTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76
VTE +G+L + KH + + + R I SG+ YL +HRDL NI +N
Sbjct: 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN 181
Query: 77 GNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMCI 130
N K+ D GL + AA + +PE ++ D++S+G+ +
Sbjct: 182 SN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV----------------- 165
E++++ + PY E ++ + K V G + P AL+++
Sbjct: 241 WEVMSYGERPYWEMSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQ 299
Query: 166 ---------EDPEVRQFIEKCLATVSSRLSARELLTDPFLQ-IDDYDSDLRMIQYQ 211
+P + I A S+ L + + + D+ + + +
Sbjct: 300 IVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGDWLNGVWTAHCK 355
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 30/175 (17%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
VTE G+L Y R + + + + YL + +HRDL N+ V
Sbjct: 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 150
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPEV-YEEEYNELVDIYSFGMCI 130
+ + K+ D GL +++ + + G + APE E++++ D++SFG+ +
Sbjct: 151 SED-NVAKVSDFGLT---KEASSTQDTG--KLPVKWTAPEALREKKFSTKSDVWSFGILL 204
Query: 131 LEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
E+ +F PY + +V G K P A+++V D +R
Sbjct: 205 WEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 258
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 28/177 (15%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
V G LR + +++ N + Q+ G+ YL S+ +HRDL N +
Sbjct: 105 VLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCML 161
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEF------MAPE-VYEEEYNELVDIYSFGM 128
+ VK+ D GLA + MA E + +++ D++SFG+
Sbjct: 162 DEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 220
Query: 129 CILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ E++T PY + I ++ G++ P+ L++V E+R
Sbjct: 221 LLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 8/89 (8%)
Query: 52 GLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILRKSHAA-RCVGTPEF 107
GL YLH+ +IHRD+K NI ++ N KI D G++ L ++H + GT +
Sbjct: 151 GLHYLHT--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 108 MAPEVYEEEY-NELVDIYSFGMCILEMVT 135
+ PE + + E D+YSFG+ + E++
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 9e-13
Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 12/125 (9%)
Query: 45 WCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGT 104
+ Q+ G+ +L SR IHRDL NI ++ VKI D GLA + K G
Sbjct: 198 YSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254
Query: 105 PEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG-- 156
MAPE +++ Y D++SFG+ + E+ + PY + +++ G
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 314
Query: 157 -KKPE 160
+ P+
Sbjct: 315 MRAPD 319
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 55/263 (20%), Positives = 84/263 (31%), Gaps = 97/263 (36%)
Query: 29 QYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV------------- 75
+ ++ + + VK +Q+L GL YLH+ +IH D+K +NI +
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAAE 193
Query: 76 -----------------------------------NGNQGEVKIGDLGLAAILRKSHAAR 100
N + +VKI DLG A + K
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TE 252
Query: 101 CVGTPEFMAPEVY-EEEYNELVDIYSFGMCILEMVTFDYP---------YSECTHPAQIY 150
+ T ++ + EV YN DI+S E+ T DY + H A I
Sbjct: 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 151 K--------------------------KVISGKKPEALFKV----------EDPEVRQFI 174
+ K I+ KP LF+V E F+
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL 372
Query: 175 EKCLATV-SSRLSARELLTDPFL 196
L + R +A E L P+L
Sbjct: 373 LPMLELIPEKRATAAECLRHPWL 395
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 31/120 (25%), Positives = 47/120 (39%), Gaps = 36/120 (30%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----------------- 90
+L G+ Y+HS ++HRDLK N VN + VK+ D GLA
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 91 --AILRKSHAARCVGTPEFM----------APEV--YEEEYNELVDIYSFGMCIL-EMVT 135
+ + APE+ +E Y E +D++S G CI E++
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 39/176 (22%), Positives = 64/176 (36%), Gaps = 32/176 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
VTE G+L Y R + + + + YL + +HRDL N+ V
Sbjct: 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLV 322
Query: 76 NGNQGEVKIGDLGLA-AILRKSHAARCVGTPEF----MAPEVYEE-EYNELVDIYSFGMC 129
+ + K+ D GL + APE E +++ D++SFG+
Sbjct: 323 SED-NVAKVSDFGLTKEASSTQDTGK------LPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 130 ILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ E+ +F PY + +V G K P A++ V D R
Sbjct: 376 LWEIYSFGRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 48/216 (22%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+TE +G L ++ L+ + ++ R I +G+ YL + + +HRDL NI V
Sbjct: 124 ITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILV 180
Query: 76 NGNQGEVKIGDLGLAAIL-------RKSHAARCVGTP-EFMAPEVYEE-EYNELVDIYSF 126
N N K+ D GL+ +L + + P + APE ++ D++SF
Sbjct: 181 NSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKI---PIRWTAPEAISYRKFTSASDVWSF 236
Query: 127 GMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR- 171
G+ + E++T+ + PY E ++ ++ K + G + P A++++ ++ R
Sbjct: 237 GIVMWEVMTYGERPYWELSN-HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP 295
Query: 172 QFIEKCLATVSSRLSARELLTDPFLQIDDYDSDLRM 207
+F + + S L D + D+D + +
Sbjct: 296 KFAD-----IVSILDKLIRAPDSLKTLADFDPRVSI 326
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 38/177 (21%), Positives = 71/177 (40%), Gaps = 28/177 (15%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+ G L Q+ ++ + N + Q+ G+ YL + +HRDL N +
Sbjct: 101 LLPYMCHGDLLQF-IRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCML 157
Query: 76 NGNQGEVKIGDLGLAAILRKSH--AARCVGTPEF----MAPE-VYEEEYNELVDIYSFGM 128
+ + VK+ D GLA + + + A E + + D++SFG+
Sbjct: 158 DES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGV 216
Query: 129 CILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ E++T PY P + + G++ P++L++V DP VR
Sbjct: 217 LLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVR 272
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 30/169 (17%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-----------------HWCRQILSGLLYLHSRD 60
+ E G L Y L+ +R K + Q+ G+ +L SR
Sbjct: 110 IVEFCKFGNLSTY-LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEE 115
IHRDL NI ++ VKI D GLA + K G MAPE +++
Sbjct: 169 --CIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 225
Query: 116 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG---KKPE 160
Y D++SFG+ + E+ + PY + +++ G + P+
Sbjct: 226 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 274
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 27 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIG 85
LR R V++ + + +Q+ + LL+L + + +IH DLK +NI N + +KI
Sbjct: 146 LRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 86 DLGLAAILRKSHAARCVGTPEFMAPEV-YEEEYNELVDIYSFGMCIL-EMVT 135
D G + L + + + + +PEV Y+ +D++S G CIL EM T
Sbjct: 204 DFGSSCQLGQRIYQ-YIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 41/190 (21%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-----------------HWCRQILSGLLYLHSRD 60
V E G L ++ L+ + + H QI SG++YL S+
Sbjct: 95 VFEYMKHGDLNKF-LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH 153
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEE 115
+HRDL N V N VKIGD G++ + + R G M PE +
Sbjct: 154 --FVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR 210
Query: 116 EYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKK-------PEALFKV-- 165
++ D++SFG+ + E+ T+ P+ + ++ ++ + + G+ P+ ++ V
Sbjct: 211 KFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECITQGRVLERPRVCPKEVYDVML 269
Query: 166 ----EDPEVR 171
+P+ R
Sbjct: 270 GCWQREPQQR 279
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 33/183 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-------HWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ E+ G L+ + + R + H R I G YL IHRD+
Sbjct: 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAA 168
Query: 71 DNIFVNGNQGE---VKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVD 122
N + G KIGD G+A + ++ R G M PE E + D
Sbjct: 169 RNCLLT-CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 227
Query: 123 IYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDP 168
+SFG+ + E+ + PY ++ ++ + V SG + P ++++ P
Sbjct: 228 TWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQP 286
Query: 169 EVR 171
E R
Sbjct: 287 EDR 289
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 32/171 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-------------------HWCRQILSGLLYLHS 58
+TE G L + L+ +R + K + Q+ G+ +L S
Sbjct: 105 ITEYCCYGDLLNF-LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VY 113
++ IHRDL NI + + KI D GLA ++ G MAPE ++
Sbjct: 164 KN--CIHRDLAARNILL-THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
Query: 114 EEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 160
Y D++S+G+ + E+ + PY ++ YK + G PE
Sbjct: 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE 271
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 37/188 (19%), Positives = 70/188 (37%), Gaps = 38/188 (20%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK---------------HWCRQILSGLLYLHSRDPP 62
V E G L ++ H Q+ +G++YL
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-- 178
Query: 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEY 117
+HRDL N V VKIGD G++ + + R G M PE + ++
Sbjct: 179 FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
Query: 118 NELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV---- 165
D++SFG+ + E+ T+ P+ + ++ + + G++ P ++ +
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQGRELERPRACPPEVYAIMRGC 296
Query: 166 --EDPEVR 171
+P+ R
Sbjct: 297 WQREPQQR 304
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 28/177 (15%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK--HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
V G LR + +++ N + Q+ G+ +L S+ +HRDL N +
Sbjct: 169 VLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCML 225
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPE------FMAPE-VYEEEYNELVDIYSFGM 128
+ VK+ D GLA + +MA E + +++ D++SFG+
Sbjct: 226 DEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 284
Query: 129 CILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
+ E++T PY + I ++ G++ P+ L++V E+R
Sbjct: 285 LLWELMTRGAPPYPDVN-TFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 45/225 (20%), Positives = 78/225 (34%), Gaps = 64/225 (28%)
Query: 33 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAA 91
K + ++ V+ + IL L LH +IH DLK +NI + +K+ D G +
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250
Query: 92 ILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCIL-EMVT-------------- 135
+ + + + APEV Y +D++S G CIL E++T
Sbjct: 251 YEHQRV-YTYIQSRFYRAPEVILGARYGMPIDMWSLG-CILAELLTGYPLLPGEDEGDQL 308
Query: 136 ------------------------FD---YPYSECTHPAQIYKKVISGKKP--------- 159
YP V++G +
Sbjct: 309 ACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPP 368
Query: 160 ------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197
AL +DP F+++CL + R++ + L P+L+
Sbjct: 369 ESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-----------------HWCRQILSGLLYLHSRD 60
+ + G L ++ L R + H QI +G+ YL S
Sbjct: 90 IFSYCSHGDLHEF-LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH 148
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEE 115
V+H+DL N+ V VKI DLGL + + + +G MAPE +
Sbjct: 149 --VVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG 205
Query: 116 EYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISG 156
+++ DI+S+G+ + E+ ++ PY ++ + + + +
Sbjct: 206 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIRNR 246
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 33/183 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-------HWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ E+ G L+ + + R + H R I G YL IHRD+
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAA 209
Query: 71 DNIFVNGNQGE---VKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVD 122
N + G KIGD G+A + ++ R G M PE E + D
Sbjct: 210 RNCLLT-CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTD 268
Query: 123 IYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDP 168
+SFG+ + E+ + PY ++ ++ + V SG + P ++++ P
Sbjct: 269 TWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQP 327
Query: 169 EVR 171
E R
Sbjct: 328 EDR 330
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 36/180 (20%), Positives = 68/180 (37%), Gaps = 31/180 (17%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-------HWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ G L Y L + R+ + I G+ YL +R+ +HRDL
Sbjct: 119 ILPFMKYGDLHTY-LLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAA 175
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEYNELVDIYS 125
N + + V + D GL+ + R + +A E + + Y D+++
Sbjct: 176 RNCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234
Query: 126 FGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV------EDPEVR 171
FG+ + E+ T PY ++Y ++ G + + L+++ DP R
Sbjct: 235 FGVTMWEIATRGMTPYPGVQ-NHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 40/168 (23%), Positives = 64/168 (38%), Gaps = 29/168 (17%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
+ Q+ G+ +L + +HRDL N+ V VKI D GLA + G
Sbjct: 176 CFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRG 232
Query: 104 TPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK 157
MAPE ++E Y D++S+G+ + E+ + PY A YK + +G
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 292
Query: 158 K-------PEALFKV------EDPEVR-------QFIEKCLATVSSRL 185
K E ++ + D R F+ LA +
Sbjct: 293 KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAM 340
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 42/168 (25%), Positives = 62/168 (36%), Gaps = 32/168 (19%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK----------------HWCRQILSGLLYLHSRDP 61
E G L + K R + H+ + G+ YL +
Sbjct: 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ- 162
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEE 116
IHRDL NI V N KI D GL+ R MA E +
Sbjct: 163 -FIHRDLAARNILVGENY-VAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESLNYSV 217
Query: 117 YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG---KKPE 160
Y D++S+G+ + E+V+ PY T A++Y+K+ G +KP
Sbjct: 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQGYRLEKPL 264
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-10
Identities = 79/570 (13%), Positives = 151/570 (26%), Gaps = 176/570 (30%)
Query: 108 MAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKV 165
M E E + Y +++ ++ + ++ +C + K ++S ++ + +
Sbjct: 7 MDFETGEHQYQYKDILSVF------EDAFVDNF---DCKDVQDMPKSILSKEEIDHIIMS 57
Query: 166 EDPE-----------------VRQFIEKCLAT----VSSRLSARELLTDPFLQIDDYDSD 204
+D V++F+E+ L + S + + P + Y
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR--QPSMMTRMYIEQ 115
Query: 205 LRMIQYQTDYDEISPL----------LRQSLYGIYHSNSSSNN-------GCG-HYIGYD 246
+ D + LRQ+L + + N G G ++ D
Sbjct: 116 RDRL--YNDNQVFAKYNVSRLQPYLKLRQALLEL----RPAKNVLIDGVLGSGKTWVALD 169
Query: 247 TENGLDYHPHEFQESEI---DLFTCQED----EHLTNF--DISIKGKRREDDGIFLRLRI 297
Y + +I +L C E L I R D ++LRI
Sbjct: 170 VCL--SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 298 ADKEGRIRNIYF---------------------PFDIQ------------TDTALSVATE 324
+ +R + F++ TD LS AT
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD-FLSAATT 286
Query: 325 MVSELDITDQDVTK------IAEIIDSEIASLVPEWKRGMAMEESP-HRSSFCHNCASNG 377
LD +T + + +D L E + +P S +
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-----VLTTNPRRLSIIAESIRDGL 341
Query: 378 CLPDYILSDGSGAKN------LQVL------QCSKDGCAAIHGRFEE---ITYQV----- 417
D L VL + ++ F I +
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR--LSV---FPPSAHIPTILLSLIW 396
Query: 418 -DGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLSSQGS-RDIHCDEEHKTLNQSSY 475
D + ++ S V E Q S S I+ + + K N+ Y
Sbjct: 397 FDVIKSDVMVVVNKLHK-YSLV----------EKQPKESTISIPSIYLELKVKLENE--Y 443
Query: 476 GAEEKIINMDSQSKCHERNCFSMNSAMDY-----------GLLDDYENEIRQ---ELRWL 521
I++ + K + + Y + R + R+L
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 522 KAKYQIQLRELRDQQLGVKYKSSSLTLITD 551
+ K +R S L +
Sbjct: 504 EQK-------IRHDSTAWNASGSILNTLQQ 526
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 78/547 (14%), Positives = 150/547 (27%), Gaps = 138/547 (25%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYR----LKHRRVNIRAVKHWCRQILSGLLYLH 57
KF S + T R + +T M+ R Y V+ R + ++ LL L
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL--KLRQALLELR 148
Query: 58 SRDPPVIH---------------RDLKCDNIFVNG----NQGEVKIGDLGLAAILRKSHA 98
+I K N + L + + +
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 99 ARCVGT--PEFMA--PEVYEEEYNELVDI-----YSFGMCILEMV-------TFDYPYSE 142
T + + EL + Y + +L V F+
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL---S 265
Query: 143 C-----THPAQI-------YKKVISGKKPEALFKVEDPEVRQFIEKCLATVSSRLSAREL 190
C T Q+ IS EV+ + K L L L
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 191 LTDPFL--QIDDYDSD-LRMIQY--QTDYDEISPLLRQSLYGIYHSNSSSNNGCGHYIGY 245
T+P I + D L + D+++ ++ SL
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL-------------------- 363
Query: 246 DTENGLDYHPHEFQESEIDLFTCQEDEHLTNFDISI---KGKRREDDGI---FLRLRIAD 299
N L+ P E+++ L H+ +S+ + + + + + +
Sbjct: 364 ---NVLE--PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418
Query: 300 KEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASLVPEWKRG-- 357
K+ + I P I + + + E I D I + DS+ L+P +
Sbjct: 419 KQPKESTISIP-SIYLELKVKLENEYALHRSIVDHY--NIPKTFDSD--DLIPPYLDQYF 473
Query: 358 -------MAMEESPHRSSF---------------CHNCASNGCLPDYILSDGSGAKNLQV 395
+ E P R + H+ + IL+ LQ
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS-TAWNASGSILNT------LQQ 526
Query: 396 LQCSKDGCAAIHGRFEEITYQV-DGAEQCAPEGADQAASPQSAVVHYADIWAQHEGQVLS 454
L+ K ++E + + D + + S + ++ A E + +
Sbjct: 527 LKFYKPYICDNDPKYERLVNAILDFLPKI---EENLICSKYTDLLRIA---LMAEDEAIF 580
Query: 455 SQGSRDI 461
+ + +
Sbjct: 581 EEAHKQV 587
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 29/168 (17%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK----------------HWCRQILSGLLYLHSRDP 61
+ E + G LR+Y R + Q+ G+ YL S+
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK- 177
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEE 116
IHRDL N+ V +KI D GLA + + MAPE +++
Sbjct: 178 -CIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 117 YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 160
Y D++SFG+ + E+ T PY +++K + G KP
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPA 282
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 40/167 (23%), Positives = 68/167 (40%), Gaps = 28/167 (16%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK---------------HWCRQILSGLLYLHSRDPP 62
+TE G L + L+ + + H+ Q+ G+ +L S++
Sbjct: 128 ITEYCCYGDLLNF-LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-- 184
Query: 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEEY 117
IHRD+ N+ + N KIGD GLA + G MAPE +++ Y
Sbjct: 185 CIHRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243
Query: 118 NELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 160
D++S+G+ + E+ + PY ++ YK V G +P
Sbjct: 244 TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPA 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 31/169 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK-----------------HWCRQILSGLLYLHSRD 60
+ E + G LR+Y L+ RR Q+ G+ YL S+
Sbjct: 165 IVEYASKGNLREY-LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEE 115
IHRDL N+ V +KI D GLA + + MAPE +++
Sbjct: 224 --CIHRDLAARNVLV-TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 280
Query: 116 EYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGK---KPE 160
Y D++SFG+ + E+ T PY +++K + G KP
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPA 328
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 48/224 (21%), Positives = 82/224 (36%), Gaps = 42/224 (18%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVK----------------HWCRQILSGLLYLHSRDP 61
+ E + G LR+Y R + Q+ G+ YL S+
Sbjct: 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 211
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEF----MAPE-VYEEE 116
IHRDL N+ V + +KI D GLA + + MAPE +++
Sbjct: 212 -CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 117 YNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISGKK-------PEALFKV--- 165
Y D++SFG+ + E+ T PY +++K + G + L+ +
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRD 328
Query: 166 ---EDPEVR---QFIEKCLATVSSRLSARELLTDPFLQIDDYDS 203
P R + + + L + + S +E+ DYD
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDI 372
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 13/126 (10%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
RQ+ +G+ YL R +HRDL N V N VKI D GL+ + + + G
Sbjct: 178 CIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADG 234
Query: 104 TPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG- 156
M PE ++ Y D++++G+ + E+ ++ PY H ++ V G
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDGN 293
Query: 157 --KKPE 160
PE
Sbjct: 294 ILACPE 299
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 32/126 (25%), Positives = 58/126 (46%), Gaps = 13/126 (10%)
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103
+ QI G+ YL ++HRDL NI V ++KI D GL+ + + +
Sbjct: 154 SFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRS 210
Query: 104 TPEF----MAPE-VYEEEYNELVDIYSFGMCILEMVTF-DYPYSECTHPAQIYKKVISG- 156
MA E +++ Y D++SFG+ + E+VT PY +++ + +G
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGH 269
Query: 157 --KKPE 160
++P+
Sbjct: 270 RMERPD 275
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 43/233 (18%), Positives = 72/233 (30%), Gaps = 80/233 (34%)
Query: 33 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG------------ 80
+ ++ QI + +LHS + H DLK +NI +
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
Query: 81 ------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSF 126
++K+ D G A + H+ R APEV +++ D++S
Sbjct: 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--------APEVILALGWSQPCDVWSI 220
Query: 127 GMCIL-EMVT-------------------------------------FDYPYSECTHPAQ 148
G CIL E F + + +
Sbjct: 221 G-CILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS 279
Query: 149 IYKKVISGKKP-EALFKVEDPEVRQ---FIEKCLA-TVSSRLSARELLTDPFL 196
+ V KP + +D E + I+K L + R++ RE L PF
Sbjct: 280 AGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 18/166 (10%), Positives = 45/166 (27%), Gaps = 33/166 (19%)
Query: 18 VTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77
V E G+L++ + + + + + H V + V+
Sbjct: 109 VAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSI 164
Query: 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFD 137
+ G+V + P+ DI G + ++
Sbjct: 165 D-GDVVLAYPATMP----------DANPQ--------------DDIRGIGASLYALLVNR 199
Query: 138 YPYSECTHPAQIYK--KVISGKKPEALFKVED--PEVRQFIEKCLA 179
+P E + + + +G+ E D ++ + +
Sbjct: 200 WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQ 245
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 8e-07
Identities = 37/234 (15%), Positives = 66/234 (28%), Gaps = 80/234 (34%)
Query: 33 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG------------ 80
+ + V+H Q+ L +LH + H DLK +NI ++
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEE 173
Query: 81 ------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNELVDIYSF 126
+++ D G A + H R PEV E + + D++S
Sbjct: 174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--------PPEVILELGWAQPCDVWSI 225
Query: 127 GMCIL-EMVT--------------------------------------FDYPYSECTHPA 147
G CIL E + + +
Sbjct: 226 G-CILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSS 284
Query: 148 QIYKKVISGKKPEALFKVEDPEVRQ---FIEKCLA-TVSSRLSARELLTDPFLQ 197
+ K ++ + E Q + + L + R++ E L PF
Sbjct: 285 DGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 44/244 (18%), Positives = 69/244 (28%), Gaps = 92/244 (37%)
Query: 33 KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG------------ 80
+ +I +K +C +IL L YL + H DLK +NI ++
Sbjct: 130 NYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTD 187
Query: 81 ------------EVKIGDLGLAAILRKSHAA-------RCVGTPEFMAPEV-YEEEYNEL 120
+K+ D G A H + R APEV ++
Sbjct: 188 GKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--------APEVILNLGWDVS 239
Query: 121 VDIYSFGMCIL-EMVT-------------------------------------------- 135
D++SFG C+L E+ T
Sbjct: 240 SDMWSFG-CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKD 298
Query: 136 -FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLATV-SSRLSARELLTD 193
+ E K V + ++ F+ L + R S ELL
Sbjct: 299 ELKLAWPENASSINSIKHVKKCLPLYKI--IKHELFCDFLYSILQIDPTLRPSPAELLKH 356
Query: 194 PFLQ 197
FL+
Sbjct: 357 KFLE 360
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 40/206 (19%), Positives = 64/206 (31%), Gaps = 26/206 (12%)
Query: 12 NRNINFVTEMFTSGT-LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ + V E G L Q R K ++ K Q+ + L + HRDL
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLS--SLATAKSILHQLTASLAVAEAS-LRFEHRDLHW 190
Query: 71 DNIFVN----------GNQGEVKIGDLGLAAIL------RKSHAARCVGTPEFMAPEVYE 114
N+ + N I GL + R V M +++
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250
Query: 115 EEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQF 173
+ + DIY +Y PYS + K++ + K P ++Q
Sbjct: 251 GDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT--KCNTPAMKQI 308
Query: 174 IEKCLATVSSRL---SARELLTDPFL 196
K + L SA +LL L
Sbjct: 309 KRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 17/71 (23%), Positives = 31/71 (43%), Gaps = 12/71 (16%)
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILRKSH--------- 97
++L L +LH + +H ++ +NIFV+ +Q +V + G A S
Sbjct: 167 RLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 98 AARCVGTPEFM 108
+ G EF+
Sbjct: 225 RSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 20/92 (21%), Positives = 36/92 (39%), Gaps = 12/92 (13%)
Query: 27 LRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIG 85
L++ ++ V ++L L Y+H + +H D+K N+ + N +V +
Sbjct: 138 LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLA 195
Query: 86 DLGLAAILR--KSHAARC-------VGTPEFM 108
D GL+ +H GT EF
Sbjct: 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 20/93 (21%)
Query: 30 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GNQGEVKIGDLG 88
Y +R + + V +IL L Y+H + +H D+K N+ +N N +V + D G
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 89 LAAILR-------------KSHAARCVGTPEFM 108
LA + H GT EF
Sbjct: 200 LAYRYCPEGVHKAYAADPKRCH----DGTIEFT 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 13/90 (14%)
Query: 30 YRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV--NGNQGEVKIGDL 87
+ R+ +++ V Q++S + Y+HS++ IHRD+K DN + V I D
Sbjct: 95 FNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDF 152
Query: 88 GLAAILRKSHAARCV---------GTPEFM 108
GLA R + + + GT +
Sbjct: 153 GLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 654 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.98 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.98 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.7 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.19 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.46 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.18 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.04 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.0 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.81 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.77 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 96.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.27 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.47 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 94.49 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 93.42 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 88.98 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 88.1 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=396.45 Aligned_cols=198 Identities=55% Similarity=1.024 Sum_probs=183.2
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||++|.+. .+..+|||||||+||+|.+++.+.+.+++..++.|++||+.||+|||+++++||||||||+|||+++.
T Consensus 88 V~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~ 167 (290)
T 3fpq_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167 (290)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST
T ss_pred CcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC
Confidence 6899999763 24579999999999999999999999999999999999999999999998889999999999999865
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
.|.+||+|||+|+..........+|||.|||||++.+.|+.++|||||||++|||+||++||.+..+..++++.+..+..
T Consensus 168 ~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 168 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC
Confidence 68999999999987766666677899999999999989999999999999999999999999988888999999999988
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
|..+....++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 888888899999999999999 8999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.79 Aligned_cols=194 Identities=28% Similarity=0.488 Sum_probs=174.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++++|||||||.||+|.+++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 95 v~l~~~~~~--~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g 169 (311)
T 4aw0_A 95 VKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-M 169 (311)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-S
T ss_pred CeEEEEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-C
Confidence 689999988 7899999999999999999999899999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 EVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+||+|||+|+.+... ...+.+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+..+++.++..
T Consensus 170 ~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~ 248 (311)
T 4aw0_A 170 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIK 248 (311)
T ss_dssp CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH
T ss_pred CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHc
Confidence 9999999999876432 2345689999999999975 599999999999999999999999986 678888899988
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHH------HhcCcccccCCcc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARE------LLTDPFLQIDDYD 202 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~E------LL~HPFf~~~~~~ 202 (654)
+... ++...++++++||.+||. +|.+|||+.| |++||||+.-++.
T Consensus 249 ~~~~--~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 249 LEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp TCCC--CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred CCCC--CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 7643 456689999999999999 9999999987 6899999877764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=373.72 Aligned_cols=193 Identities=32% Similarity=0.564 Sum_probs=170.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+||++|.+ ++.+|||||||+||+|.+++.+ +++++..++.|++||+.||+|||+++ ||||||||+|||++.+ |
T Consensus 134 V~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g 207 (346)
T 4fih_A 134 VEMYNSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-G 207 (346)
T ss_dssp CCEEEEEEE--TTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-C
T ss_pred CcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-C
Confidence 789999998 7899999999999999999876 56999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+|+.+... .....+|||.|||||++.+ .|+.++|||||||++|||++|.+||.+ .+..+++..+..+.
T Consensus 208 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~ 286 (346)
T 4fih_A 208 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNL 286 (346)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSS
T ss_pred CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCC
Confidence 9999999999877543 3456789999999999875 599999999999999999999999987 56677777777765
Q ss_pred CCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+. ..+...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 287 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 287 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 432 3345679999999999999 999999999999999997543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=367.26 Aligned_cols=194 Identities=24% Similarity=0.395 Sum_probs=172.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+.+|||||||+||+|.+++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 89 v~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g 163 (304)
T 3ubd_A 89 VKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-G 163 (304)
T ss_dssp ECEEEEEEE--TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-S
T ss_pred CeEEEEEEE--CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-C
Confidence 589999988 7899999999999999999999999999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+|+.... ......+|||.|||||++.+ .|+.++|||||||++|||+||.+||.+ .+..+++.++..+.
T Consensus 164 ~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~ 242 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAK 242 (304)
T ss_dssp CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCC
Confidence 999999999986543 23455689999999999875 599999999999999999999999987 56778888888876
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
.+ ++...++++++||.+||+ +|.+||| ++|+++||||+..++.
T Consensus 243 ~~--~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 243 LG--MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred CC--CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 54 456789999999999999 8999998 5899999999876653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=377.70 Aligned_cols=193 Identities=32% Similarity=0.564 Sum_probs=170.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+||++|.+ ++.+|||||||.||+|.+++.. +++++..++.|++||+.||+|||+++ ||||||||+|||++.+ |
T Consensus 211 V~l~~~~~~--~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g 284 (423)
T 4fie_A 211 VEMYNSYLV--GDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-G 284 (423)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-C
T ss_pred CceEEEEEE--CCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-C
Confidence 789999998 7899999999999999999865 56999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.|||+|||+|+.+... .....+|||.|||||++.+ .|+.++|||||||++|||++|++||.+ .+..+++..+..+.
T Consensus 285 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~ 363 (423)
T 4fie_A 285 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNL 363 (423)
T ss_dssp CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSC
T ss_pred CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCC
Confidence 9999999999877543 3456789999999999875 599999999999999999999999987 56667777777665
Q ss_pred CCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+. ..+...++++++||.+||. +|.+|||+.|||+||||+...
T Consensus 364 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 364 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 432 3345679999999999999 999999999999999998543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.02 Aligned_cols=190 Identities=26% Similarity=0.513 Sum_probs=161.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+.+||||||| +|+|.+++.+++++++..++.|++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 76 v~~~~~~~~--~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~ 149 (275)
T 3hyh_A 76 IKLYDVIKS--KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-L 149 (275)
T ss_dssp CCEEEEEEC--SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-C
T ss_pred CeEEEEEEE--CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-C
Confidence 689999987 78999999999 7899999999999999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+|+..... .....+|||.|||||++.+. | +.++|||||||++|+|+||..||.+ .+...+++.+..+.
T Consensus 150 ~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~ 228 (275)
T 3hyh_A 150 NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGV 228 (275)
T ss_dssp CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTC
T ss_pred CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCC
Confidence 9999999999876543 33456899999999999754 4 6799999999999999999999987 66788888888876
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+ ++...++++++||.+||. +|.+|||++|+|+||||+.+
T Consensus 229 ~~--~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 229 YT--LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 54 456789999999999999 89999999999999999743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.01 Aligned_cols=191 Identities=26% Similarity=0.514 Sum_probs=170.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||++|.+ ++.+|||||||+||+|.+++...+ .+++..++.|++||+.||.|||+++ ||||||||+|||++.+
T Consensus 86 V~~~~~~~~--~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~ 161 (350)
T 4b9d_A 86 VQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD 161 (350)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT
T ss_pred CcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC
Confidence 689999988 789999999999999999997654 5799999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
|.+||+|||+|+.+... .....+|||.|||||++.+ .|+.++|||||||++|||+||++||.+ .+..+++.++..
T Consensus 162 -g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~ 239 (350)
T 4b9d_A 162 -GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIIS 239 (350)
T ss_dssp -CCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHH
T ss_pred -CCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHc
Confidence 89999999999877543 2345679999999999975 599999999999999999999999987 567788888888
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..|. ++...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 240 ~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 240 GSFPP-VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp TCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred CCCCC-CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 87654 455689999999999999 8999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=365.40 Aligned_cols=193 Identities=26% Similarity=0.357 Sum_probs=165.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++.+|||||||+||+|.+++++.+.+++..++.|++||+.||+|||+++ ||||||||+|||++.+..
T Consensus 113 V~l~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~ 188 (336)
T 4g3f_A 113 VPLYGAVRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGS 188 (336)
T ss_dssp CCEEEEEEE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSC
T ss_pred CcEEEEEEE--CCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCC
Confidence 689999988 7899999999999999999999889999999999999999999999999 999999999999986644
Q ss_pred cEEEEecCchhhhcccC-------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH-------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||+|+.+.... ....+|||.|||||++.+ .|+.++|||||||++|||+||.+||.+. +...++.+
T Consensus 189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~ 267 (336)
T 4g3f_A 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY-FRGPLCLK 267 (336)
T ss_dssp CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT-CCSCCHHH
T ss_pred EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHH
Confidence 79999999998765321 223579999999999875 5999999999999999999999999874 34455666
Q ss_pred HHcCCCC-cccccCCChHHHHHHHHHhh-CccCCCCHHHH-------------hcCccccc
Q 006244 153 VISGKKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSAREL-------------LTDPFLQI 198 (654)
Q Consensus 153 i~~G~~p-~~l~~~~spelrdLI~kCL~-dP~~RpTa~EL-------------L~HPFf~~ 198 (654)
+..+..+ ..++...++++++||.+||. +|.+|||+.|| |+|||+..
T Consensus 268 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 268 IASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 6666554 34567789999999999999 89999999998 56888764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=351.03 Aligned_cols=191 Identities=21% Similarity=0.376 Sum_probs=156.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ++++|||||||.||+|.+++. .+++..++.|++||+.||+|||+++ |+||||||+|||++.+.+
T Consensus 83 v~l~~~~~~--~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~ 155 (361)
T 4f9c_A 83 MGVKYCFRK--NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLK 155 (361)
T ss_dssp CCCSEEEEE--TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTT
T ss_pred ceEEEEEEE--CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCC
Confidence 578888887 789999999999999999983 5999999999999999999999999 999999999999997768
Q ss_pred cEEEEecCchhhhccc------------------------------CCccccCCCCccChhhhcc--cCCcccchhhhhh
Q 006244 81 EVKIGDLGLAAILRKS------------------------------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGM 128 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~------------------------------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGi 128 (654)
.+||+|||+|+..... .....+|||.|||||++.+ .|+.++||||+||
T Consensus 156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 9999999999754321 1234579999999999864 4899999999999
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHHc--CC-------------------------------------------------
Q 006244 129 CILEMVTFDYPYSECTHPAQIYKKVIS--GK------------------------------------------------- 157 (654)
Q Consensus 129 iL~ELlTG~~Pf~~~~~~~qi~kki~~--G~------------------------------------------------- 157 (654)
++|||++|+.||....+.......+.. |.
T Consensus 236 il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 315 (361)
T 4f9c_A 236 IFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGH 315 (361)
T ss_dssp HHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------
T ss_pred HHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccc
Confidence 999999999999765554433333221 00
Q ss_pred -CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 -KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 -~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.....+...++++++||.+||+ ||.+|+||+|+|+||||+.
T Consensus 316 ~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 316 ATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp ------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0011234568899999999999 9999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=371.59 Aligned_cols=195 Identities=27% Similarity=0.470 Sum_probs=174.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+++|||||||.||+|.+++.+.+.+++..++.|++||+.||+|||+++ ||||||||+|||++.+ |
T Consensus 255 V~l~~~f~~--~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G 329 (689)
T 3v5w_A 255 VCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-G 329 (689)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-S
T ss_pred eEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-C
Confidence 689999988 7899999999999999999999999999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhc-c-cCCcccchhhhhhHHHHHhhcCCCCCCC--CCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-E-EYNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--~~~~qi~kki~~G 156 (654)
.|||+|||+|+.+......+.+|||.|||||++. + .|+.++|||||||++|||++|.+||.+. .+...+++.+..+
T Consensus 330 ~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~ 409 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409 (689)
T ss_dssp CEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC
T ss_pred CEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Confidence 9999999999988777777789999999999985 3 5999999999999999999999999653 3455666777665
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
... ++...++++++||.+||. +|.+|++ +.|+++||||+..++.
T Consensus 410 ~~~--~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 410 AVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp CCC--CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred CCC--CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 443 456789999999999999 9999998 8999999999987764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.36 Aligned_cols=186 Identities=27% Similarity=0.464 Sum_probs=157.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++. ++.++||||||+||+|.+++... .++++..+..|+.||+.||+|||+++ ||||||||+|||++.+
T Consensus 95 V~l~g~~~---~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~- 168 (307)
T 3omv_A 95 LLFMGYMT---KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG- 168 (307)
T ss_dssp CCEEEEEC---SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-
T ss_pred eeEEEEEE---CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-
Confidence 68999653 35789999999999999999765 57999999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhccc----CCccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||+|+..... .....+||+.|||||++.. .|+.++|||||||++|||+||+.||.+..+...+..
T Consensus 169 ~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~ 248 (307)
T 3omv_A 169 LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248 (307)
T ss_dssp EEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred CcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 79999999999876432 2344579999999999853 489999999999999999999999998777788877
Q ss_pred HHHcCCCCc---ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 152 KVISGKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 152 ki~~G~~p~---~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+..+. .++...++++++||.+||. +|.+|||+.+++.
T Consensus 249 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 249 MVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 777775443 3445678999999999999 8999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.48 Aligned_cols=194 Identities=24% Similarity=0.447 Sum_probs=152.7
Q ss_pred CEEEEEEEecCC----------CeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecC
Q 006244 1 MKFYTSWVDTAN----------RNINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67 (654)
Q Consensus 1 VkfY~sfvd~~~----------~~i~LVtEy~~gGSL~~~l~k~~~---Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRD 67 (654)
|+||++|++... .++|||||||.||+|.+++.+... ..+..++.|+.||+.||+|||+++ |+|||
T Consensus 66 V~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRD 143 (299)
T 4g31_A 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRD 143 (299)
T ss_dssp CCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCC
T ss_pred CeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--Ccccc
Confidence 689999987432 258999999999999999987654 455678999999999999999999 99999
Q ss_pred CCCCcEEEeCCCCcEEEEecCchhhhcccC--------------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHH
Q 006244 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH--------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILE 132 (654)
Q Consensus 68 LKpeNILId~~~g~VKL~DFGLA~~l~~~~--------------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~E 132 (654)
|||+|||++.+ |.+||+|||+|+.+.... ....+|||.|||||++.+ .|+.++|||||||++||
T Consensus 144 lKp~NILl~~~-~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 144 LKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp CCGGGEEECTT-CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CcHHHeEECCC-CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHH
Confidence 99999999855 799999999998765321 123579999999999875 59999999999999999
Q ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 133 MVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 133 LlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
|++ ||............+..+..|. .+...++.+++||.+||+ +|.+|||+.|+|+||||+.-++
T Consensus 223 ll~---Pf~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 223 LLY---PFSTQMERVRTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHS---CCSSHHHHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred Hcc---CCCCccHHHHHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 996 8865333334455566666554 334457888999999999 8999999999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=348.25 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=160.5
Q ss_pred CEEEEEEEec----CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~----~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+.|... ..+++|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||+++ ||||||||+|||++
T Consensus 116 v~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 116 IAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN 192 (398)
T ss_dssp CCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC
T ss_pred ceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC
Confidence 6788887643 2478999999995 789999999899999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcc------cCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 77 GNQGEVKIGDLGLAAILRK------SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~------~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
. .|.+||+|||+|+.+.. ......+||+.|||||++.+ .|+.++||||+||++|||++|.+||.+.+ ...
T Consensus 193 ~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~ 270 (398)
T 4b99_A 193 E-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVH 270 (398)
T ss_dssp T-TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHH
T ss_pred C-CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHH
Confidence 5 48999999999986543 23345689999999998864 47999999999999999999999998754 444
Q ss_pred HHHHHHc--CCCCcc---------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 149 IYKKVIS--GKKPEA---------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 149 i~kki~~--G~~p~~---------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+..|.. |..+.. +++..++++++||.+||. +|.+||||.|+|+||||+.
T Consensus 271 ~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 271 QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 4444432 222211 123468899999999999 9999999999999999975
Q ss_pred C
Q 006244 199 D 199 (654)
Q Consensus 199 ~ 199 (654)
.
T Consensus 351 ~ 351 (398)
T 4b99_A 351 Y 351 (398)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.94 Aligned_cols=188 Identities=24% Similarity=0.410 Sum_probs=164.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRD 67 (654)
|+||+++.+ ++.++||||||++|+|.+++.+++ .+++..+..|+.||+.||.|||+++ |||||
T Consensus 78 V~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRD 153 (299)
T 4asz_A 78 VKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRD 153 (299)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred ccEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCc
Confidence 789998876 689999999999999999998753 6999999999999999999999998 99999
Q ss_pred CCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCC
Q 006244 68 LKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYS 141 (654)
Q Consensus 68 LKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~ 141 (654)
|||+|||++.+ +.+||+|||+|+...... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.
T Consensus 154 lKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~ 232 (299)
T 4asz_A 154 LATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232 (299)
T ss_dssp CSGGGEEECGG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred cCHhhEEECCC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999855 799999999998765432 22346999999999987 569999999999999999999 899998
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+ .+..++...+..|..+. .+...++++.+||.+||+ +|.+|||+.+++ +||+
T Consensus 233 ~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 233 Q-LSNNEVIECITQGRVLQ-RPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp T-SCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred C-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 7 45778888888887654 456688999999999999 899999999994 4553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.94 Aligned_cols=186 Identities=23% Similarity=0.407 Sum_probs=156.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH---------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~---------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIH 65 (654)
|+||+++.+ .+.++||||||++|+|.+|+.++ .++++..+..|+.||+.||.|||+++ |||
T Consensus 106 V~l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiH 181 (329)
T 4aoj_A 106 VRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVH 181 (329)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred CcEEEEEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eec
Confidence 789998876 68999999999999999999864 25899999999999999999999998 999
Q ss_pred cCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCC
Q 006244 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYP 139 (654)
Q Consensus 66 RDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~P 139 (654)
|||||+|||++.+ +.+||+|||+|+.+.... ....+||+.|||||++.+ .|+.++|||||||++|||+| |+.|
T Consensus 182 RDLKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~P 260 (329)
T 4aoj_A 182 RDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260 (329)
T ss_dssp SCCCGGGEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccccHhhEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCC
Confidence 9999999999955 799999999998764332 234579999999999875 59999999999999999999 8999
Q ss_pred CCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 140 YSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 140 f~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
|.+ .+..+++..+..|..+. .+...++++.+||.+||. +|.+|||+.||+.+
T Consensus 261 f~~-~~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 261 WYQ-LSNTEAIDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCS-SCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCC-CCHHHHHHHHHcCCCCC-CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 987 45677788888887654 456789999999999999 89999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.01 Aligned_cols=188 Identities=24% Similarity=0.371 Sum_probs=163.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|+||+++..+ +..++||||||++|+|.+|+++. ..+++..+..|+.||+.||+|||+++ ||
T Consensus 131 V~l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--ii 207 (353)
T 4ase_A 131 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 207 (353)
T ss_dssp CCEEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EEEEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--ee
Confidence 6899987653 46799999999999999999864 24899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||+|+.+.... ....+||+.|||||++. +.|+.++|||||||++|||+| |..
T Consensus 208 HRDLK~~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 208 HRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred cCccCccceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 99999999999854 799999999998764432 23456999999999887 459999999999999999998 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.+......+.+.+..|..+. .+...++++.+||.+||. +|.+|||+.+|++|
T Consensus 287 Pf~~~~~~~~~~~~i~~g~~~~-~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 287 PYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9998777778888888887654 445689999999999999 89999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=355.37 Aligned_cols=196 Identities=24% Similarity=0.391 Sum_probs=172.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~- 78 (654)
|++|+.|.+ +..+|||||||.||+|.+++.+ ++.+++..++.|++||+.||.|||+++ |+||||||+|||++.+
T Consensus 217 v~l~~~~~~--~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~ 292 (573)
T 3uto_A 217 VNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKR 292 (573)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSS
T ss_pred CeEEEEEEE--CCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCC
Confidence 689999987 7899999999999999999864 457999999999999999999999999 9999999999999753
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.|.+||+|||+|+.+.... ....+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+.+..+..+
T Consensus 293 ~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~ 371 (573)
T 3uto_A 293 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSC 371 (573)
T ss_dssp CCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTT
T ss_pred CCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhC
Confidence 4799999999998875433 345679999999999875 499999999999999999999999987 5667777888776
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
.. +...+...++++++||.+||. +|.+|||+.|+|+||||+..+.
T Consensus 372 ~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 53 455567789999999999999 9999999999999999986543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=329.54 Aligned_cols=186 Identities=20% Similarity=0.292 Sum_probs=162.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|+|||++.. ...++||||||++|+|.+|+..+ ..+++..+..|+.||+.||+|||+++ ||
T Consensus 92 V~l~g~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--ii 167 (308)
T 4gt4_A 92 VCLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VV 167 (308)
T ss_dssp CCEEEEECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred CCcceEEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CC
Confidence 689998876 67899999999999999999753 24899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhccc----CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||+|+.+... .....+||+.|||||++. +.|+.++|||||||++|||+| |..
T Consensus 168 HRDLK~~NILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 168 HKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp CSCCSGGGEEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCccccceEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCC
Confidence 99999999999854 79999999999876432 223457999999999886 569999999999999999998 899
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.+ .+..++...+..|..+. .+...++++.+||.+||. +|.+|||+.||+.+
T Consensus 247 Pf~~-~~~~~~~~~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 247 PYCG-YSNQDVVEMIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9987 45677888888877654 455688999999999999 89999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.65 Aligned_cols=199 Identities=54% Similarity=1.023 Sum_probs=180.8
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|++|... .+..+++||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..
T Consensus 88 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 167 (290)
T 1t4h_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167 (290)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred eeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC
Confidence 5788988763 24679999999999999999998889999999999999999999999998789999999999999856
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
.+.+||+|||++............||+.|+|||++.+.++.++||||||+++|+|++|..||....+...++..+..+..
T Consensus 168 ~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 168 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCCEEEeeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC
Confidence 68999999999987666655566799999999999988999999999999999999999999998888999999988888
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+..+....++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 888888889999999999999 89999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.44 Aligned_cols=333 Identities=21% Similarity=0.331 Sum_probs=227.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
|++|++|.+ ...+|||||||.||+|.+++.+...+++..++.+++||+.||.|||+++ |+||||||+|||++..
T Consensus 99 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~ 174 (494)
T 3lij_A 99 MKLYDFFED--KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEK 174 (494)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSST
T ss_pred CeEEEEEEe--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCC
Confidence 689999887 7899999999999999999998889999999999999999999999999 9999999999999743
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+.+||+|||++....... ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.. .+...+...+..+.
T Consensus 175 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~ 253 (494)
T 3lij_A 175 DALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGK 253 (494)
T ss_dssp TCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTC
T ss_pred CCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Confidence 3569999999998765432 345579999999999998899999999999999999999999987 56677788888776
Q ss_pred CC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcch-----------hhhhhhhcccccccchhhhh
Q 006244 158 KP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS-----------DLRMIQYQTDYDEISPLLRQ 223 (654)
Q Consensus 158 ~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~-----------~~r~l~~~~~~~~i~pll~~ 223 (654)
.+ ...+...++++++||.+||. +|.+|||+.++|+||||+...... .+..+. .+..... +++
T Consensus 254 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-l~q 329 (494)
T 3lij_A 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMR---KFQNSQK-LAQ 329 (494)
T ss_dssp CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHH---TTTTCCH-HHH
T ss_pred CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHH---HHHHhHH-HHH
Confidence 53 34456789999999999999 899999999999999997431110 000000 0000000 111
Q ss_pred hhcccccCCCCC----CCCCCCcccccCCCCCCCCCccccc----ccc--------cccccccccccccccccccccccC
Q 006244 224 SLYGIYHSNSSS----NNGCGHYIGYDTENGLDYHPHEFQE----SEI--------DLFTCQEDEHLTNFDISIKGKRRE 287 (654)
Q Consensus 224 ~l~~~~~s~~s~----~~~~~~~~~~d~~~~~~~~~~e~~~----~~~--------~~~e~~~~~~~~~~d~~~~G~~~~ 287 (654)
.........-.. ..-...+..+|.+++..++.+|+.. .+. ...+..........|.+-.|.++.
T Consensus 330 a~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~ 409 (494)
T 3lij_A 330 AALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDY 409 (494)
T ss_dssp HHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEH
T ss_pred HHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcH
Confidence 100000000000 0000012234445555555566541 010 111111123344455555666665
Q ss_pred CCcEEEEEE--eecccCCccceeeecccCCCCHHHHHH--HHHhcCCCChhhHHHHHHH
Q 006244 288 DDGIFLRLR--IADKEGRIRNIYFPFDIQTDTALSVAT--EMVSELDITDQDVTKIAEI 342 (654)
Q Consensus 288 ~~~I~L~LR--I~d~~g~~r~I~F~Fd~~~DTa~sVA~--EMV~el~i~d~dv~~IA~~ 342 (654)
++++.+... .......++.++-.||.++|+.+++++ +++....++++++..+.+.
T Consensus 410 ~EF~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~ 468 (494)
T 3lij_A 410 SEFVTVAMDRKSLLSKDKLESAFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISG 468 (494)
T ss_dssp HHHHHHHSCHHHHTCHHHHHHHHHHHCTTCSSEECHHHHHHHC-CCSCCCHHHHHHHHT
T ss_pred HHHHHHHHhhhccccHHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHH
Confidence 554322111 122334578899999999999999987 5655556777766555443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=347.92 Aligned_cols=335 Identities=22% Similarity=0.342 Sum_probs=230.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++|++|.+ ...++||||||.||+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+.
T Consensus 109 v~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 109 IKLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNS 184 (504)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTC
T ss_pred CeEEEEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCC
Confidence 578999877 7899999999999999999998889999999999999999999999999 99999999999998543
Q ss_pred -CcEEEEecCchhhhccc-CCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 80 -GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 80 -g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
..+||+|||++...... .....+||+.|+|||++.+.|+.++||||||+++|+|++|..||.+ .+...+...+..+.
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGK 263 (504)
T ss_dssp CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Confidence 26999999999876543 3345579999999999998899999999999999999999999987 56677888888876
Q ss_pred CCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcch---hhhhh----hhcccccccchhhhhhhcc
Q 006244 158 KPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS---DLRMI----QYQTDYDEISPLLRQSLYG 227 (654)
Q Consensus 158 ~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~---~~r~l----~~~~~~~~i~pll~~~l~~ 227 (654)
... ..+...++++++||.+||. +|.+|||+.++|+||||+...... +...+ ..-..+..... +++....
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k-l~~a~l~ 342 (504)
T 3q5i_A 264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQK-LAQAAIL 342 (504)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSH-HHHHHHH
T ss_pred CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHH-HHHHHHH
Confidence 533 3346789999999999999 899999999999999997543221 11100 00000000000 0000000
Q ss_pred cccCCCCC----CCCCCCcccccCCCCCCCCCcccccc------------cccccccccccccccccccccccccCCCcE
Q 006244 228 IYHSNSSS----NNGCGHYIGYDTENGLDYHPHEFQES------------EIDLFTCQEDEHLTNFDISIKGKRREDDGI 291 (654)
Q Consensus 228 ~~~s~~s~----~~~~~~~~~~d~~~~~~~~~~e~~~~------------~~~~~e~~~~~~~~~~d~~~~G~~~~~~~I 291 (654)
.....-.. ..-...+..+|.+++..++.+|+... +....+.+........|.+-.|.++.++++
T Consensus 343 ~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 422 (504)
T 3q5i_A 343 FIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFI 422 (504)
T ss_dssp HHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 00000000 00000122344555555666665410 111111122233444555556666655443
Q ss_pred EEEEEe--ecccCCccceeeecccCCCCHHHHHH--HHHhcCCCChhhHHHHHH
Q 006244 292 FLRLRI--ADKEGRIRNIYFPFDIQTDTALSVAT--EMVSELDITDQDVTKIAE 341 (654)
Q Consensus 292 ~L~LRI--~d~~g~~r~I~F~Fd~~~DTa~sVA~--EMV~el~i~d~dv~~IA~ 341 (654)
.+.... ......++.++-.||.++|+.+++.+ .++....+++.++..+.+
T Consensus 423 ~~~~~~~~~~~~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~~~~ 476 (504)
T 3q5i_A 423 SVCMDKQILFSEERLRRAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLG 476 (504)
T ss_dssp HHHSCHHHHTCHHHHHHHHHHHCTTCCSEECHHHHHHHTTCSCCCHHHHHHHHH
T ss_pred HHHHhhhcccCHHHHHHHHHHhcCCCCCcCcHHHHHHHHhhCCCCHHHHHHHHH
Confidence 221111 12234678899999999999999987 666666678776655444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.41 Aligned_cols=338 Identities=22% Similarity=0.326 Sum_probs=230.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~ 78 (654)
|++|++|.+ .+.+++|||||.||+|.+++...+.+++..++.+++||+.||.|||+++ |+||||||+|||++ ..
T Consensus 89 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~ 164 (484)
T 3nyv_A 89 MKLYEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSK 164 (484)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSST
T ss_pred CcEEEEEEe--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCC
Confidence 578998877 7899999999999999999999889999999999999999999999999 99999999999995 24
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+.+||+|||++..+.... ....+||+.|+|||++.+.|+.++||||||+++|+|++|.+||.. .+...+...+..+.
T Consensus 165 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 165 DANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGK 243 (484)
T ss_dssp TCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CCcEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCC
Confidence 5789999999998765443 234579999999999998999999999999999999999999987 56677788888876
Q ss_pred CCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchh-------hhhhhhcccccccchhhhhhhcc
Q 006244 158 KPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSD-------LRMIQYQTDYDEISPLLRQSLYG 227 (654)
Q Consensus 158 ~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~-------~r~l~~~~~~~~i~pll~~~l~~ 227 (654)
... ..+...++++++||.+||. +|.+|||+.++|+||||+....... ...+.....+... ..+++....
T Consensus 244 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~kl~qa~l~ 322 (484)
T 3nyv_A 244 YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT-QKLAQAALL 322 (484)
T ss_dssp CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHH-HHHHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhh-hHHHHHHHH
Confidence 543 3445689999999999999 8999999999999999974322100 0000000000000 000000000
Q ss_pred cccCC----CCCCCCCCCcccccCCCCCCCCCccccc--------cccccc-------ccccccccccccccccccccCC
Q 006244 228 IYHSN----SSSNNGCGHYIGYDTENGLDYHPHEFQE--------SEIDLF-------TCQEDEHLTNFDISIKGKRRED 288 (654)
Q Consensus 228 ~~~s~----~s~~~~~~~~~~~d~~~~~~~~~~e~~~--------~~~~~~-------e~~~~~~~~~~d~~~~G~~~~~ 288 (654)
..... .....-...+..+|.+++..++.+|+.. .|.... +.+........|.+-.|.++.+
T Consensus 323 ~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~ 402 (484)
T 3nyv_A 323 YMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYS 402 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHH
T ss_pred HHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHH
Confidence 00000 0000000012233444444555555521 011111 1111233444455556666655
Q ss_pred CcEEEEEEe--ecccCCccceeeecccCCCCHHHHHH--HHHhcCCCChhhHHHHHHHHH
Q 006244 289 DGIFLRLRI--ADKEGRIRNIYFPFDIQTDTALSVAT--EMVSELDITDQDVTKIAEIID 344 (654)
Q Consensus 289 ~~I~L~LRI--~d~~g~~r~I~F~Fd~~~DTa~sVA~--EMV~el~i~d~dv~~IA~~ID 344 (654)
+++.+.... ......++.++-.||.++|+.+++.+ .++....++++++..+.+.+|
T Consensus 403 Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~D 462 (484)
T 3nyv_A 403 EFVTVAMDRKTLLSRERLERAFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEVD 462 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHC
T ss_pred HHHHHHHhccccCcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhc
Confidence 443221111 12234578899999999999999988 666667788888777666554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.67 Aligned_cols=195 Identities=32% Similarity=0.526 Sum_probs=167.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.. .+.+++|||||.||+|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 80 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~ 153 (297)
T 3fxz_A 80 VNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-G 153 (297)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-C
T ss_pred CeEeEEEEE--CCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-C
Confidence 578999988 68999999999999999998775 6999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++....... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||........++.....+.
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 233 (297)
T 3fxz_A 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (297)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999997765432 334579999999998864 589999999999999999999999987555555555555555
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
.....+...++.+++||.+||. +|.+|||+.++|+||||+....
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 4444556788999999999999 8999999999999999986543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.23 Aligned_cols=194 Identities=23% Similarity=0.474 Sum_probs=168.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+.+|||||||.||+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 87 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g 161 (353)
T 3txo_A 87 TQLFCCFQT--PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-G 161 (353)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred eeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-C
Confidence 578998887 6899999999999999999999889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++.... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++.++..+.
T Consensus 162 ~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~ 240 (353)
T 3txo_A 162 HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDE 240 (353)
T ss_dssp CEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999975432 23345679999999999875 499999999999999999999999987 56778888888776
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH------HHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA------RELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa------~ELL~HPFf~~~~~~ 202 (654)
.. ++...++++++||.+||. +|.+||++ .++++||||+..++.
T Consensus 241 ~~--~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 241 VV--YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred CC--CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 53 345578999999999999 89999998 999999999876654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.12 Aligned_cols=194 Identities=27% Similarity=0.502 Sum_probs=170.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--~ 78 (654)
|++|+++.+ ...+++|||||.||+|.+++.+.+.+++..++.+++||+.||.|||+++ |+||||||+|||++. .
T Consensus 84 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~ 159 (486)
T 3mwu_A 84 MKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEK 159 (486)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSST
T ss_pred CeEEEEEEc--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCC
Confidence 578998877 7899999999999999999998889999999999999999999999999 999999999999963 3
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+.+||+|||++....... ....+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+ .+...+...+..+.
T Consensus 160 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~ 238 (486)
T 3mwu_A 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGK 238 (486)
T ss_dssp TCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTC
T ss_pred CCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Confidence 4579999999998765433 344579999999999998999999999999999999999999987 56677778888776
Q ss_pred CCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+. ..+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 543 3345679999999999999 89999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.71 Aligned_cols=191 Identities=21% Similarity=0.481 Sum_probs=168.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.+.. .+.+|+||||+.||+|.+++..++++++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 77 v~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~ 151 (328)
T 3fe3_A 77 VKLFEVIET--EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-M 151 (328)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-S
T ss_pred eeEEEEEEE--CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-C
Confidence 578998876 7899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... .....+||+.|+|||++.+. + +.++||||||+++|+|++|..||.+ .+...+..++..+.
T Consensus 152 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~ 230 (328)
T 3fe3_A 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGK 230 (328)
T ss_dssp CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC
Confidence 9999999999876543 33456799999999998754 4 4789999999999999999999987 56777888888876
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.. ++...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 231 ~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 231 YR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp CC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred CC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 54 334578999999999999 89999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.17 Aligned_cols=193 Identities=26% Similarity=0.529 Sum_probs=170.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...+|+||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 69 v~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g 143 (318)
T 1fot_A 69 IRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-G 143 (318)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-S
T ss_pred ceEeEEEEe--CCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-C
Confidence 578999887 6899999999999999999999889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++...... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. .+....+.++..+...
T Consensus 144 ~~kL~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~ 221 (318)
T 1fot_A 144 HIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR 221 (318)
T ss_dssp CEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC
T ss_pred CEEEeecCcceecCCc-cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC
Confidence 9999999999876443 345679999999999875 589999999999999999999999987 4567777788776543
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
++...++++++||.+||. +|.+|| ++.++++||||+..++.
T Consensus 222 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 222 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred --CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 345678999999999999 899999 99999999999876653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.36 Aligned_cols=194 Identities=26% Similarity=0.475 Sum_probs=170.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...+||||||+.||+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 68 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g 142 (337)
T 1o6l_A 68 TALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-G 142 (337)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred cceEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-C
Confidence 578898887 6899999999999999999998889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++.... ......+||+.|+|||++.+ .|+.++||||||+++|||++|..||.. .+...++..+..+.
T Consensus 143 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~ 221 (337)
T 1o6l_A 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE 221 (337)
T ss_dssp CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC
Confidence 999999999976432 23345679999999999875 589999999999999999999999986 56677777777664
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
.. ++...++++++||.+||. +|.+|| ++.++++||||+..++.
T Consensus 222 ~~--~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 222 IR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred CC--CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 33 445679999999999999 899999 99999999999876653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.53 Aligned_cols=196 Identities=23% Similarity=0.409 Sum_probs=171.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...++||||||.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+.+
T Consensus 78 v~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 78 ITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTS
T ss_pred CcEEEEEEe--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCC
Confidence 578998877 6899999999999999999988889999999999999999999999999 999999999999975532
Q ss_pred ---cEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 ---EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ---~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+||+|||++..+.... ....+||+.|+|||++.. .|+.++||||||+++|+|++|..||.+ .+...++..+..
T Consensus 154 ~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~ 232 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITA 232 (361)
T ss_dssp SSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHT
T ss_pred CccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Confidence 79999999998765432 345679999999999875 599999999999999999999999987 566777788877
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+.. +...+...++++++||.+||. +|.+|||+.++|+||||+..+.
T Consensus 233 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 233 VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 654 334456789999999999999 8999999999999999986543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.38 Aligned_cols=191 Identities=26% Similarity=0.353 Sum_probs=147.4
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR------DPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~------~p~IIHRDLKpeN 72 (654)
|+||+++..... ..+|||||||++|+|.+++.++ .+++..+..++.||+.||+|||++ .++||||||||+|
T Consensus 60 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred CcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 689999987432 3789999999999999999764 699999999999999999999987 2359999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhcccC------CccccCCCCccChhhhcc-------cCCcccchhhhhhHHHHHhhcCCC
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~-------~ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
||++.+ +.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+||.+|
T Consensus 139 ILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~ 217 (303)
T 3hmm_A 139 ILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp EEECTT-SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred EEECCC-CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCC
Confidence 999855 799999999998764322 223579999999999864 367899999999999999999776
Q ss_pred CCCC--------------CCHHHHHHHHHcCCCCcccccC-----CChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 140 YSEC--------------THPAQIYKKVISGKKPEALFKV-----EDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 140 f~~~--------------~~~~qi~kki~~G~~p~~l~~~-----~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
|... .....+.+.+..+.....++.. ....+.+||.+||. +|.+|||+.|+++.
T Consensus 218 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 5321 1234455555443322222211 12468899999999 89999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.66 Aligned_cols=194 Identities=24% Similarity=0.493 Sum_probs=170.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...+|||||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 81 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g 155 (345)
T 1xjd_A 81 THMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-G 155 (345)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred CcEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-C
Confidence 578998887 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++... .......+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. .+...++..+..+.
T Consensus 156 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~ 234 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN 234 (345)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC
Confidence 99999999997643 223445679999999999875 589999999999999999999999986 56777888887765
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHH-HHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR-ELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~-ELL~HPFf~~~~~~ 202 (654)
.. ++...++++++||.+||. +|.+||++. ++++||||+..++.
T Consensus 235 ~~--~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 235 PF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred CC--CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 43 345678999999999999 899999998 99999999876654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.86 Aligned_cols=194 Identities=23% Similarity=0.429 Sum_probs=170.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.+ .+.+||||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 84 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g 158 (353)
T 2i0e_A 84 TQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-G 158 (353)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred eeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-C
Confidence 578888877 6899999999999999999998889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++.... ......+||+.|+|||++.+ .|+.++||||||+++|||++|..||.. .+...++.++..+.
T Consensus 159 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~ 237 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN 237 (353)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred cEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCC
Confidence 999999999986432 23445679999999999874 599999999999999999999999986 56778888888765
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
.. ++...++++++||.+||. +|.+|| ++.++++||||+..++.
T Consensus 238 ~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 238 VA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred CC--CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 43 345688999999999999 899999 47999999999876653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=316.75 Aligned_cols=195 Identities=22% Similarity=0.435 Sum_probs=167.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ...+|||||||.||+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 116 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g 190 (396)
T 4dc2_A 116 VGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-G 190 (396)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred CeeEEEEEE--CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-C
Confidence 578998887 7899999999999999999999889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC--------CCHHHH
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQI 149 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--------~~~~qi 149 (654)
.+||+|||+++... .......+||+.|+|||++.+ .|+.++|||||||++|||++|..||... .....+
T Consensus 191 ~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 191 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred CEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 99999999997532 233445679999999999875 5999999999999999999999999632 233446
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH------HHHhcCcccccCCcc
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA------RELLTDPFLQIDDYD 202 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa------~ELL~HPFf~~~~~~ 202 (654)
+..+..+... ++...++++++||.+||. +|.+||++ .++++||||+..++.
T Consensus 271 ~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 271 FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp HHHHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred HHHHhccccC--CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 6666665443 445689999999999999 89999985 899999999876654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-35 Score=308.97 Aligned_cols=193 Identities=27% Similarity=0.473 Sum_probs=171.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...+||||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 104 v~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g 178 (350)
T 1rdq_E 104 VKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-G 178 (350)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-S
T ss_pred CeEEEEEEc--CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-C
Confidence 578898887 6899999999999999999998889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++...... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. .+..+++.++..+...
T Consensus 179 ~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~~ 256 (350)
T 1rdq_E 179 YIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR 256 (350)
T ss_dssp CEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC
T ss_pred CEEEcccccceeccCC-cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 9999999999876543 334579999999998864 589999999999999999999999986 5677888888887643
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
++...++++++||.+||. +|.+||+ +.++++||||+..++.
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 345679999999999999 8999998 9999999999876653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.89 Aligned_cols=195 Identities=22% Similarity=0.442 Sum_probs=167.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ...+||||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 73 v~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g 147 (345)
T 3a8x_A 73 VGLHSCFQT--ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-G 147 (345)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred CeEEEEEEe--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-C
Confidence 578999887 6899999999999999999998889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC--------CCHHHH
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC--------THPAQI 149 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--------~~~~qi 149 (654)
.+||+|||+++.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||... .....+
T Consensus 148 ~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 227 (345)
T 3a8x_A 148 HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227 (345)
T ss_dssp CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred CEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence 999999999976422 23445679999999999875 5899999999999999999999999642 234456
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCH------HHHhcCcccccCCcc
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSA------RELLTDPFLQIDDYD 202 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa------~ELL~HPFf~~~~~~ 202 (654)
+..+..+... ++...++++++||.+||. +|.+||++ .++++||||+..++.
T Consensus 228 ~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 228 FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp HHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred HHHHHcCCCC--CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 6666665433 445688999999999999 89999995 899999999876653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=306.64 Aligned_cols=194 Identities=27% Similarity=0.430 Sum_probs=169.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++|+.|.+ .+.+|||||||.||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||+....
T Consensus 79 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~ 154 (342)
T 2qr7_A 79 ITLKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESG 154 (342)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSC
T ss_pred CeEEEEEEc--CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCC
Confidence 578998877 7899999999999999999999889999999999999999999999999 99999999999995433
Q ss_pred --CcEEEEecCchhhhccc--CCccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCC--CCHHHHHHH
Q 006244 80 --GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKK 152 (654)
Q Consensus 80 --g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~--~~~~qi~kk 152 (654)
+.+||+|||++...... .....+||+.|+|||++.+. |+.++||||||+++|+|++|..||... .+...++..
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~ 234 (342)
T 2qr7_A 155 NPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234 (342)
T ss_dssp SGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH
T ss_pred CcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH
Confidence 35999999999876543 23456799999999998754 899999999999999999999999753 467778888
Q ss_pred HHcCCCCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 153 VISGKKPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 153 i~~G~~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..+..+. ..+...++++++||.+||. +|.+|||+.++|+||||..
T Consensus 235 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 235 IGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 88876542 3456689999999999999 8999999999999999954
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.78 Aligned_cols=193 Identities=24% Similarity=0.451 Sum_probs=170.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--~ 78 (654)
|++|+.|.+ .+.+|||||||.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++. +
T Consensus 73 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~ 148 (444)
T 3soa_A 73 VRLHDSISE--EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLK 148 (444)
T ss_dssp CCEEEEEEC--SSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSST
T ss_pred CeEEEEEEE--CCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCC
Confidence 689998877 7899999999999999999999999999999999999999999999999 999999999999974 3
Q ss_pred CCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+.+||+|||++....... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|.+||.. .+...++..+..
T Consensus 149 ~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~ 227 (444)
T 3soa_A 149 GAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKA 227 (444)
T ss_dssp TCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHH
T ss_pred CCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHh
Confidence 4789999999998765432 234579999999999875 599999999999999999999999987 556777888887
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.. +...+...++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 754 334456789999999999999 8999999999999999964
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.73 Aligned_cols=194 Identities=26% Similarity=0.436 Sum_probs=170.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ .+.+||||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 102 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g 176 (373)
T 2r5t_A 102 VGLHFSFQT--ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-G 176 (373)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-S
T ss_pred CCEEEEEEe--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-C
Confidence 578998887 6899999999999999999999889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++.++..+.
T Consensus 177 ~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~ 255 (373)
T 2r5t_A 177 HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP 255 (373)
T ss_dssp CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC
T ss_pred CEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc
Confidence 999999999986432 23445679999999999875 489999999999999999999999987 56777888887764
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH----HHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA----RELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa----~ELL~HPFf~~~~~~ 202 (654)
.. +....++++++||.+||. +|.+||++ .++++||||+..++.
T Consensus 256 ~~--~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 256 LQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp CC--CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred cC--CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 32 445678999999999999 89999986 699999999877654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=305.41 Aligned_cols=194 Identities=22% Similarity=0.375 Sum_probs=168.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~- 78 (654)
|++|+.|.+ ...+++|||||.||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 64 v~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~ 139 (321)
T 1tki_A 64 LHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRR 139 (321)
T ss_dssp CCEEEEEEE--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSS
T ss_pred CeEeEEEec--CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCC
Confidence 579999987 789999999999999999997654 7999999999999999999999999 9999999999999852
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++..+.... .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.. .+..++...+..+
T Consensus 140 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~ 218 (321)
T 1tki_A 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNA 218 (321)
T ss_dssp CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHT
T ss_pred CCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcC
Confidence 5799999999998765432 2345699999999998754 79999999999999999999999987 4566777777776
Q ss_pred CCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
... ...+...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 543 23345678999999999999 89999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.23 Aligned_cols=195 Identities=24% Similarity=0.423 Sum_probs=167.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ...+|||||||.||+|.+++.+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 132 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g 205 (410)
T 3v8s_A 132 VQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-G 205 (410)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-S
T ss_pred CeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-C
Confidence 578999987 7899999999999999999876 46999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhccc-----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEEE-----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~~-----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||+++.+.... ....+||+.|+|||++... |+.++|||||||++|||++|..||.. .+...++.+
T Consensus 206 ~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~ 284 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSK 284 (410)
T ss_dssp CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHH
T ss_pred CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHH
Confidence 99999999998765432 3356799999999998642 78899999999999999999999986 567777888
Q ss_pred HHcCCC--CcccccCCChHHHHHHHHHhh-CccC--CCCHHHHhcCcccccCCcc
Q 006244 153 VISGKK--PEALFKVEDPEVRQFIEKCLA-TVSS--RLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 153 i~~G~~--p~~l~~~~spelrdLI~kCL~-dP~~--RpTa~ELL~HPFf~~~~~~ 202 (654)
+..+.. ........++++++||.+||. +|.+ |+++.|+++||||+..++.
T Consensus 285 i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 285 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 876532 222234678999999999999 5777 9999999999999987764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.09 Aligned_cols=196 Identities=22% Similarity=0.404 Sum_probs=167.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++|+.|.. ...+++||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 77 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 77 ITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSS
T ss_pred CcEEEEEEe--CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCC
Confidence 578998877 7899999999999999999988888999999999999999999999999 99999999999997542
Q ss_pred --CcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 --GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 --g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
..+||+|||++...... .....+||+.|+|||++.. .++.++||||||+++|+|++|..||.. .+.......+..
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~~~~ 231 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSA 231 (326)
T ss_dssp SSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHH
T ss_pred CCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHh
Confidence 17999999999876533 2344579999999999874 589999999999999999999999987 445555566655
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+.. +...+...++.+++||.+||. +|.+|||+.++|+||||+..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 443 333456678999999999999 8999999999999999986553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.82 Aligned_cols=193 Identities=24% Similarity=0.446 Sum_probs=169.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
|++|++|.+ .+.+|+|||||.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 91 v~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~ 166 (362)
T 2bdw_A 91 VRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAK 166 (362)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSST
T ss_pred CeEEEEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCC
Confidence 688998887 7899999999999999999988888999999999999999999999999 9999999999999753
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++....... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. .+...++..+..+
T Consensus 167 ~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAG 245 (362)
T ss_dssp TCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHT
T ss_pred CCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhC
Confidence 3469999999998765433 234579999999999875 599999999999999999999999987 4566777788777
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.. +...+...++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 246 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 54 334455678999999999999 8999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=315.96 Aligned_cols=196 Identities=25% Similarity=0.437 Sum_probs=166.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.+ .+.+|||||||.||+|.+++.+. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.+
T Consensus 124 v~l~~~~~~--~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~- 198 (412)
T 2vd5_A 124 TQLHFAFQD--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC- 198 (412)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-
T ss_pred eeEEEEEee--CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-
Confidence 578998887 68999999999999999999875 47999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc--------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE--------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~--------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
|.+||+|||+++...... ....+||+.|+|||++. ..|+.++|||||||++|||++|+.||.. .+...
T Consensus 199 g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~ 277 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAE 277 (412)
T ss_dssp SCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHH
T ss_pred CCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHH
Confidence 899999999998765432 23457999999999986 3589999999999999999999999987 55667
Q ss_pred HHHHHHcCCC---CcccccCCChHHHHHHHHHhhCccCC---CCHHHHhcCcccccCCcc
Q 006244 149 IYKKVISGKK---PEALFKVEDPEVRQFIEKCLATVSSR---LSARELLTDPFLQIDDYD 202 (654)
Q Consensus 149 i~kki~~G~~---p~~l~~~~spelrdLI~kCL~dP~~R---pTa~ELL~HPFf~~~~~~ 202 (654)
++.++..+.. ........++++++||.+||.+|.+| +++.|+++||||+..++.
T Consensus 278 ~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp HHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred HHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 7777765321 11223568899999999999988887 599999999999877765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.29 Aligned_cols=188 Identities=26% Similarity=0.389 Sum_probs=161.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+++++|.+ .+.++|||||+ +|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 120 v~l~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~- 193 (311)
T 3p1a_A 120 VRLEQAWEE--GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR- 193 (311)
T ss_dssp CCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-
T ss_pred EEEEEEEEe--CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-
Confidence 578999887 78999999999 77999988764 46999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 80 GEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
+.+||+|||++....... .....||+.|+|||++.+.++.++||||||+++|+|++|..|+.. ...+..+..+..
T Consensus 194 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~----~~~~~~~~~~~~ 269 (311)
T 3p1a_A 194 GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG----GEGWQQLRQGYL 269 (311)
T ss_dssp GCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS----HHHHHHHTTTCC
T ss_pred CCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC----ccHHHHHhccCC
Confidence 799999999987765433 234469999999999998999999999999999999999777654 233456666777
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..+....++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 777777889999999999999 8999999999999999973
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=318.71 Aligned_cols=195 Identities=22% Similarity=0.456 Sum_probs=166.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.+ .+.+|||||||.||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 137 v~l~~~~~~--~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~- 211 (437)
T 4aw2_A 137 TTLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN- 211 (437)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-
T ss_pred EEEEEEEee--CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-
Confidence 578998887 7899999999999999999987 468999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
|.+||+|||+++...... ....+||+.|+|||++. ..|+.++|||||||++|||++|..||.. .+..+.+
T Consensus 212 g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~ 290 (437)
T 4aw2_A 212 GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETY 290 (437)
T ss_dssp SCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHH
T ss_pred CCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHH
Confidence 899999999997654332 23357999999999985 3589999999999999999999999987 5666777
Q ss_pred HHHHcCC----CCcccccCCChHHHHHHHHHhh-CccC--CCCHHHHhcCcccccCCcc
Q 006244 151 KKVISGK----KPEALFKVEDPEVRQFIEKCLA-TVSS--RLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 151 kki~~G~----~p~~l~~~~spelrdLI~kCL~-dP~~--RpTa~ELL~HPFf~~~~~~ 202 (654)
.++..+. .|. .....++++++||.+||. +|.+ |+++.|+++||||+..++.
T Consensus 291 ~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 291 GKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp HHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred HhhhhccccccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 7776432 222 224578999999999998 5666 9999999999999987775
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=312.47 Aligned_cols=193 Identities=26% Similarity=0.466 Sum_probs=168.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
|+++++|.. .+.++||||||.||+|.+++.+.+.+++..++.++.||+.||+|||+ ++ |+||||||+|||++.+
T Consensus 211 v~l~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~- 285 (446)
T 4ejn_A 211 TALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD- 285 (446)
T ss_dssp CCEEEEEEE--TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-
T ss_pred eeEEEEEee--CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-
Confidence 578898887 68999999999999999999988899999999999999999999998 88 9999999999999854
Q ss_pred CcEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||+++.... ......+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. .+...++..+..+
T Consensus 286 ~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 286 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME 364 (446)
T ss_dssp SCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC
T ss_pred CCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhC
Confidence 7999999999986432 23345679999999999864 599999999999999999999999987 4566777777665
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
... ++...++++++||.+||. +|.+|| ++.++|+||||+..++
T Consensus 365 ~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 365 EIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp CCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCC--CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 543 345678999999999999 899999 9999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.47 Aligned_cols=193 Identities=21% Similarity=0.413 Sum_probs=164.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. ...++||||+ .+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 72 v~~~~~~~~--~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~ 144 (343)
T 3dbq_A 72 IRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DG 144 (343)
T ss_dssp CCEEEEEEC--SSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TT
T ss_pred EEEeeeEee--CCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CC
Confidence 578998887 7899999995 58899999999999999999999999999999999999 99999999999997 36
Q ss_pred cEEEEecCchhhhcccC----CccccCCCCccChhhhc------------ccCCcccchhhhhhHHHHHhhcCCCCCCCC
Q 006244 81 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE------------EEYNELVDIYSFGMCILEMVTFDYPYSECT 144 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~------------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~ 144 (654)
.+||+|||++..+.... ....+||+.|+|||++. ..++.++||||||+++|+|++|..||....
T Consensus 145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 89999999998764432 23457999999999985 358889999999999999999999998766
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+.......+........++...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 225 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 66666666666665556667778899999999999 899999999999999998543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=291.53 Aligned_cols=192 Identities=26% Similarity=0.412 Sum_probs=157.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.|.+ ++.++|||||+.+ +|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 64 v~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~- 137 (292)
T 3o0g_A 64 VRLHDVLHS--DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN- 137 (292)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-
T ss_pred eeEEeEEEe--CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-
Confidence 578999887 7899999999976 55555544 678999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-c-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... .....+||+.|+|||++.+ . ++.++||||||+++|+|++|..||....+.......+..
T Consensus 138 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp SCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 79999999999876533 2334579999999998864 3 899999999999999999999887665666666555543
Q ss_pred --CCCCc-------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 --GKKPE-------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 --G~~p~-------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..+. ......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 288 (292)
T 3o0g_A 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence 11111 1123467899999999999 8999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=294.80 Aligned_cols=195 Identities=24% Similarity=0.382 Sum_probs=159.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
+++|++|.+ .+.+++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 74 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~ 149 (316)
T 2ac3_A 74 LELIEFFEE--EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQ 149 (316)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSS
T ss_pred eeEEEEEee--CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCC
Confidence 578999887 7899999999999999999998889999999999999999999999999 99999999999998542
Q ss_pred -CcEEEEecCchhhhccc---------CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 80 -GEVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 80 -g~VKL~DFGLA~~l~~~---------~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
+.+||+|||++...... .....+||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 150 VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 23999999998765321 122346999999999986 34899999999999999999999999764
Q ss_pred CC--------------HHHHHHHHHcCCCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 144 TH--------------PAQIYKKVISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 144 ~~--------------~~qi~kki~~G~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.. ...++..+..+... ...+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 230 CGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp CCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred ccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 32 24456666666543 22234578999999999999 99999999999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=303.51 Aligned_cols=194 Identities=23% Similarity=0.398 Sum_probs=167.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+++.+ .+.++||||||.||+|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 68 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~ 142 (323)
T 3tki_A 68 VKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-D 142 (323)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-C
T ss_pred CeEEEEEec--CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-C
Confidence 578998877 7899999999999999999988888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc----CCccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+||+|||++..+... .....+||+.|+|||++.+. ++.++||||||+++|+|++|..||.........+....
T Consensus 143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 222 (323)
T 3tki_A 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222 (323)
T ss_dssp CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH
T ss_pred CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 9999999999865432 22345799999999998753 47789999999999999999999987665556666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
........+...++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 5555444556789999999999999 89999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=288.34 Aligned_cols=193 Identities=25% Similarity=0.417 Sum_probs=167.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~ 78 (654)
+++|+.+.+ ...+++||||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+. ..
T Consensus 69 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 144 (277)
T 3f3z_A 69 IRLYETFED--NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSP 144 (277)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSST
T ss_pred eeEEEEEec--CCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCC
Confidence 578998876 7899999999999999999998888999999999999999999999999 99999999999992 24
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+.+||+|||++....... .....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+.......+..+.
T Consensus 145 ~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~ 223 (277)
T 3f3z_A 145 DSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKIREGT 223 (277)
T ss_dssp TCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CCcEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCC
Confidence 4789999999998765432 334569999999999988899999999999999999999999987 45566667777765
Q ss_pred CC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+ ...+...++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 224 FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 43 22334678999999999999 8999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=298.48 Aligned_cols=194 Identities=26% Similarity=0.379 Sum_probs=164.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.. .+.+||||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 84 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~ 158 (327)
T 3a62_A 84 VDLIYAFQT--GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-G 158 (327)
T ss_dssp CCEEEEEEC--SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-S
T ss_pred cceeEEEEc--CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-C
Confidence 578998877 6899999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+....+.++..+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~ 237 (327)
T 3a62_A 159 HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCK 237 (327)
T ss_dssp CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTC
T ss_pred cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCC
Confidence 9999999999764322 2344579999999998864 589999999999999999999999987 45666677777665
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
.. ++...++++++||.+||. +|.+|| ++.++++||||+..++.
T Consensus 238 ~~--~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 238 LN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred CC--CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 43 345678999999999999 899999 89999999999865543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.71 Aligned_cols=192 Identities=23% Similarity=0.427 Sum_probs=164.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.+.+.....++|||||+.+|+|.+++ ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~ 174 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-G 174 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-S
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-C
Confidence 5789998876678999999999999998864 3457999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhccc----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+||+|||++....... .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.. .+...+...+.
T Consensus 175 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~ 253 (298)
T 2zv2_A 175 HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIK 253 (298)
T ss_dssp CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHH
T ss_pred CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHHHh
Confidence 99999999998765432 2345799999999998743 47789999999999999999999987 45566666776
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.+..+.......++++++||.+||. +|.+|||+.++|+||||+
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 254 SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6655444445678999999999999 899999999999999995
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.98 Aligned_cols=193 Identities=21% Similarity=0.414 Sum_probs=165.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+++.. ...+||||| +.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 119 v~~~~~~~~--~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~ 191 (390)
T 2zmd_A 119 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DG 191 (390)
T ss_dssp CCEEEEEEC--SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SS
T ss_pred EEEEEEEec--CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CC
Confidence 578998887 678999999 568999999999889999999999999999999999999 99999999999995 37
Q ss_pred cEEEEecCchhhhcccC----CccccCCCCccChhhhcc------------cCCcccchhhhhhHHHHHhhcCCCCCCCC
Q 006244 81 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVTFDYPYSECT 144 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~------------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~ 144 (654)
.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 89999999998765332 234579999999999864 58899999999999999999999998766
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+.......+..+.....++...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 272 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 66666677777665555666678899999999999 899999999999999997543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=291.29 Aligned_cols=193 Identities=24% Similarity=0.421 Sum_probs=158.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++|+++.+ ...+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 83 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~ 158 (285)
T 3is5_A 83 IKIFEVFED--YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQ 158 (285)
T ss_dssp CCEEEEEEC--SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEES
T ss_pred HhHHHheec--CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEe
Confidence 578998876 7899999999999999999854 367999999999999999999999999 99999999999995
Q ss_pred C--CCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 77 G--NQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 77 ~--~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
. ..+.+||+|||++....... .....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+
T Consensus 159 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~-~~~~~~~~~~ 237 (285)
T 3is5_A 159 DTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG-TSLEEVQQKA 237 (285)
T ss_dssp SSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHH
T ss_pred cCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC-CCHHHHHhhh
Confidence 3 24689999999998765432 344569999999999988899999999999999999999999987 4455555555
Q ss_pred HcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 154 ISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 154 ~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
....... ......++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 238 TYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 5443322 2223468999999999999 8999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=289.80 Aligned_cols=191 Identities=25% Similarity=0.431 Sum_probs=163.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|++|.+ ...+++||||+.+|+|.+++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 72 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~ 146 (279)
T 3fdn_A 72 LRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-G 146 (279)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-S
T ss_pred cchhheEec--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-C
Confidence 578998877 6899999999999999999998889999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++............||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+....+..+.....+
T Consensus 147 ~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~ 225 (279)
T 3fdn_A 147 ELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT 225 (279)
T ss_dssp CEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCC
T ss_pred CEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCCC
Confidence 99999999997765555556679999999998875 478899999999999999999999986 5566666777665443
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 345678999999999999 89999999999999999743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.22 Aligned_cols=194 Identities=22% Similarity=0.307 Sum_probs=157.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.......+|||||||. |+|.+++.. +.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 72 v~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~ 146 (388)
T 3oz6_A 72 VNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-C 146 (388)
T ss_dssp CCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-C
T ss_pred CeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-C
Confidence 57899998766678999999996 699999876 57999999999999999999999999 9999999999999855 7
Q ss_pred cEEEEecCchhhhcc-----------------------cCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhh
Q 006244 81 EVKIGDLGLAAILRK-----------------------SHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVT 135 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~-----------------------~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlT 135 (654)
.+||+|||+++.+.. ......+||+.|+|||++.+ .|+.++|||||||++|+|++
T Consensus 147 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 226 (388)
T 3oz6_A 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226 (388)
T ss_dssp CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh
Confidence 999999999976532 11234579999999998864 58999999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHcCCCCc-------------------------------c-------------cccCCChHHH
Q 006244 136 FDYPYSECTHPAQIYKKVISGKKPE-------------------------------A-------------LFKVEDPEVR 171 (654)
Q Consensus 136 G~~Pf~~~~~~~qi~kki~~G~~p~-------------------------------~-------------l~~~~spelr 171 (654)
|.+||.+.....++.+.+.....|. . .....+++++
T Consensus 227 g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (388)
T 3oz6_A 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306 (388)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHH
Confidence 9999988554444333221111110 0 0115688999
Q ss_pred HHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 172 QFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 172 dLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+||.+||. +|.+|||+.|+|+||||+.-
T Consensus 307 dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 307 DLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 99999999 99999999999999999743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=300.43 Aligned_cols=193 Identities=28% Similarity=0.515 Sum_probs=162.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILId~~~ 79 (654)
+++|++|.. .+.+++||||+.||+|.+++.+.+.+++..+..++.||+.||.|||+. + |+||||||+|||++.+
T Consensus 94 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~- 168 (360)
T 3eqc_A 94 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR- 168 (360)
T ss_dssp CCEEEEEEE--TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-
T ss_pred EEEeEEEEE--CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-
Confidence 578999887 789999999999999999999888999999999999999999999985 7 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH---------
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI--------- 149 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi--------- 149 (654)
+.+||+|||++............||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ...+
T Consensus 169 ~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~ 247 (360)
T 3eqc_A 169 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKELELMFGCQVE 247 (360)
T ss_dssp CCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC-HHHHHHHHC----
T ss_pred CCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhccccc
Confidence 799999999998776665566789999999998875 58999999999999999999999997632 2222
Q ss_pred ---------------------------------HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 150 ---------------------------------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 150 ---------------------------------~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
...+..+..+.......++++++||.+||. +|.+|||+.++|+|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 222333333433344568899999999999 8999999999999999
Q ss_pred cccC
Q 006244 196 LQID 199 (654)
Q Consensus 196 f~~~ 199 (654)
|+..
T Consensus 328 ~~~~ 331 (360)
T 3eqc_A 328 IKRS 331 (360)
T ss_dssp HHHH
T ss_pred hhcc
Confidence 9753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.10 Aligned_cols=195 Identities=29% Similarity=0.411 Sum_probs=157.8
Q ss_pred CEEEEEEEecCCC---eEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANR---NINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~---~i~LVtEy~~gGSL~~~l~k~~~--Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
|++|+.+...... .+++||||+. |+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~ 153 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILV 153 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEE
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEE
Confidence 5789988874322 6899999996 699999988654 999999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+ +.+||+|||++....... ....+||+.|+|||++. ..++.++||||||+++|+|++|..||.... ......++
T Consensus 154 ~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i 231 (308)
T 3g33_A 154 TSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-EADQLGKI 231 (308)
T ss_dssp CTT-SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-HHHHHHHH
T ss_pred cCC-CCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH
Confidence 854 799999999998765433 34457999999999886 459999999999999999999999998744 44444444
Q ss_pred Hc--CCCCcc-----------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 154 IS--GKKPEA-----------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 154 ~~--G~~p~~-----------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +..+.. .....++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 32 221111 123467899999999999 899999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=299.74 Aligned_cols=195 Identities=25% Similarity=0.373 Sum_probs=151.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++|++|.+ ...+|||||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 69 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~ 144 (325)
T 3kn6_A 69 VKLHEVFHD--QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDEND 144 (325)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC---
T ss_pred eEEEEEEEc--CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCC
Confidence 578999887 7899999999999999999999999999999999999999999999999 99999999999997542
Q ss_pred -CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC------CCHHHH
Q 006244 80 -GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC------THPAQI 149 (654)
Q Consensus 80 -g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~------~~~~qi 149 (654)
..+||+|||++...... .....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||... .....+
T Consensus 145 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 224 (325)
T 3kn6_A 145 NLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI 224 (325)
T ss_dssp -CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH
T ss_pred cccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH
Confidence 27999999999765432 2344568999999999875 5899999999999999999999999753 234567
Q ss_pred HHHHHcCCCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 150 YKKVISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 150 ~kki~~G~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
...+..+..+ ...+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 7777776643 23345678999999999999 89999999999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=300.71 Aligned_cols=196 Identities=22% Similarity=0.395 Sum_probs=162.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--~ 78 (654)
|++++.|.. ...+++||||+.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 111 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~ 186 (349)
T 2w4o_A 111 IKLKEIFET--PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAP 186 (349)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSST
T ss_pred cceeeeEec--CCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCC
Confidence 578998877 6899999999999999999988888999999999999999999999999 999999999999973 3
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||........++..+..+
T Consensus 187 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~ 266 (349)
T 2w4o_A 187 DAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNC 266 (349)
T ss_dssp TCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTT
T ss_pred CCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhC
Confidence 5799999999998765432 234569999999999875 58999999999999999999999998877777777888776
Q ss_pred CCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
... ...+...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 267 EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 543 33445678999999999999 899999999999999997554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=295.95 Aligned_cols=196 Identities=25% Similarity=0.392 Sum_probs=157.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC---
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--- 77 (654)
|++|+.+.. +..++|||||+. |+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 96 v~~~~~~~~--~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 96 IELKSVIHH--NHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp CCEEEEEEE--TTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC---
T ss_pred ceEEEEEec--CCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCC
Confidence 578999887 789999999997 599999999989999999999999999999999999 999999999999962
Q ss_pred -CCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 78 -NQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 78 -~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
..+.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||........+.+.
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 250 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250 (329)
T ss_dssp --CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence 3356999999999876533 2334568999999999864 4899999999999999999999999875544444433
Q ss_pred HHc-CCCCcc--------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 153 VIS-GKKPEA--------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 153 i~~-G~~p~~--------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+.. +..+.. +....++++++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred HHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 322 211111 011267899999999999 9999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=327.53 Aligned_cols=194 Identities=23% Similarity=0.442 Sum_probs=171.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.+ .+.+||||||+.||+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 405 ~~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g 479 (674)
T 3pfq_A 405 TQLHSCFQT--MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-G 479 (674)
T ss_dssp CCEEEECBC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-S
T ss_pred EEEEEEEEe--CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-C
Confidence 467887766 6899999999999999999999889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhc--ccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILR--KSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~--~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++... .......+||+.|+|||++. ..|+.++||||||+++|||++|..||.+ .+...++..+..+.
T Consensus 480 ~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHN 558 (674)
T ss_dssp CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSC
T ss_pred cEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCC
Confidence 99999999998543 22344567999999999987 4599999999999999999999999987 56788888888765
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCH-----HHHhcCcccccCCcc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSA-----RELLTDPFLQIDDYD 202 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa-----~ELL~HPFf~~~~~~ 202 (654)
.. ++...++++++||.+||. +|.+||++ .+|++||||+..++.
T Consensus 559 ~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 559 VA--YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp CC--CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred CC--CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 43 445689999999999999 89999997 999999999877654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=288.73 Aligned_cols=193 Identities=26% Similarity=0.406 Sum_probs=155.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+.. .+.+++||||+.+ +|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~- 136 (288)
T 1ob3_A 63 VKLYDVIHT--KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE- 136 (288)
T ss_dssp CCEEEEEEC--SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred eeeeeEEcc--CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-
Confidence 578998877 6799999999975 999998864 67999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||........+...+..
T Consensus 137 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 216 (288)
T 1ob3_A 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (288)
T ss_dssp SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 79999999999876532 2234569999999999864 4899999999999999999999999875544433332221
Q ss_pred -CCCC-------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 -GKKP-------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 -G~~p-------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+..+ .......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 1110 01123468899999999999 99999999999999999753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.47 Aligned_cols=193 Identities=34% Similarity=0.589 Sum_probs=165.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.. ...+++||||+.||+|.+++.+ ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 105 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~ 178 (321)
T 2c30_A 105 VEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-G 178 (321)
T ss_dssp CCEEEEEEE--TTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-C
T ss_pred ceEEEEEEE--CCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-C
Confidence 578999988 6899999999999999998764 57999999999999999999999998 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+..+.
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSP 257 (321)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSS
T ss_pred cEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC
Confidence 9999999999876543 2344579999999999864 589999999999999999999999987 45566666666655
Q ss_pred CCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+. ......++++++||.+||. +|.+|||+.++|+||||....
T Consensus 258 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 258 PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 443 2234578899999999999 899999999999999997544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=287.39 Aligned_cols=190 Identities=23% Similarity=0.415 Sum_probs=166.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.+ .+.+++||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 77 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~ 151 (284)
T 2vgo_A 77 LRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-G 151 (284)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-C
T ss_pred eeEEEEEEc--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-C
Confidence 578998877 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||++............||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..+...
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~ 230 (284)
T 2vgo_A 152 ELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNVDLK 230 (284)
T ss_dssp CEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC
T ss_pred CEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhccccC
Confidence 99999999997665544555679999999999875 489999999999999999999999986 4455566666655432
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
++...++++++||.+||. +|.+||++.++|+||||+.
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 345678999999999999 8999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.65 Aligned_cols=190 Identities=23% Similarity=0.353 Sum_probs=156.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~- 77 (654)
|++|+.|.. .+.++|||||+ +|+|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 99 v~~~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 99 VKYHGKFMY--YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDP 173 (360)
T ss_dssp CCEEEEEEE--TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCT
T ss_pred ecccceeeE--CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccc
Confidence 579999988 68999999999 999999998765 5999999999999999999999999 999999999999973
Q ss_pred -----------------------CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHH
Q 006244 78 -----------------------NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEM 133 (654)
Q Consensus 78 -----------------------~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~EL 133 (654)
..+.+||+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 2578999999999865443 345679999999998864 599999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHc--CCCCcc------------------------------------------cccCCChH
Q 006244 134 VTFDYPYSECTHPAQIYKKVIS--GKKPEA------------------------------------------LFKVEDPE 169 (654)
Q Consensus 134 lTG~~Pf~~~~~~~qi~kki~~--G~~p~~------------------------------------------l~~~~spe 169 (654)
++|..||.... .......+.. +..|.. .....++.
T Consensus 253 l~g~~pf~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 253 YTGSLLFRTHE-HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHSSCSCCCSS-HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHCCCCCCCCc-HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999998744 3333333332 111110 01123477
Q ss_pred HHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 170 VRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 170 lrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+.+||.+||+ +|.+|||+.|+|+||||+
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 8899999999 999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=299.28 Aligned_cols=193 Identities=25% Similarity=0.457 Sum_probs=164.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+.|.. .+.+|||||||.||+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 89 v~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~ 164 (351)
T 3c0i_A 89 VELLETYSS--DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLA 164 (351)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred CcEEEEEEe--CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEe
Confidence 679999987 78999999999999999887653 35899999999999999999999999 99999999999997
Q ss_pred CC--CCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 77 GN--QGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 77 ~~--~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
.+ .+.+||+|||++....... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.. ....++.
T Consensus 165 ~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~ 242 (351)
T 3c0i_A 165 SKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFE 242 (351)
T ss_dssp SSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHH
T ss_pred cCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHH
Confidence 43 2359999999998765432 234579999999999875 589999999999999999999999976 3466777
Q ss_pred HHHcCCCCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 152 KVISGKKPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 152 ki~~G~~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+..+.... ..+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 243 GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 777765432 2345678999999999999 89999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=306.27 Aligned_cols=195 Identities=25% Similarity=0.434 Sum_probs=168.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ...+|+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 78 v~l~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g 152 (384)
T 4fr4_A 78 VNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-G 152 (384)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-S
T ss_pred CcEEEEEEe--CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-C
Confidence 578999887 6899999999999999999999889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCC--CCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSEC--THPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~--~~~~qi~kki 153 (654)
.+||+|||++..+... .....+||+.|+|||++.. .|+.++|||||||++|+|++|..||... .....++..+
T Consensus 153 ~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~ 232 (384)
T 4fr4_A 153 HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232 (384)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 9999999999876543 3345679999999999853 4899999999999999999999999642 3455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCC-HHHHhcCcccccCCcc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-ARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-a~ELL~HPFf~~~~~~ 202 (654)
.....+ ++...++++++||.+||. +|.+||+ +.++++||||+..++.
T Consensus 233 ~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 233 ETTVVT--YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp HHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred hhcccC--CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 554432 345678999999999999 8999998 9999999999876654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=284.23 Aligned_cols=195 Identities=25% Similarity=0.456 Sum_probs=167.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
+++++.+.. ....++||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 68 ~~~~~~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~ 143 (284)
T 3kk8_A 68 VRLHDSIQE--ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAK 143 (284)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSST
T ss_pred CeEEEEEEc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCC
Confidence 578998876 7899999999999999999998889999999999999999999999999 9999999999999743
Q ss_pred CCcEEEEecCchhhhcccCC-ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAG 222 (284)
T ss_dssp TCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHT
T ss_pred CCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhc
Confidence 23599999999977654332 34569999999999875 489999999999999999999999987 4566677777766
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +...+...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 54 333445678999999999999 899999999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.50 Aligned_cols=194 Identities=22% Similarity=0.431 Sum_probs=157.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|++|.+ .+.++||||||.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~ 164 (389)
T 3gni_B 89 VPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD 164 (389)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT
T ss_pred CcEeEEEEE--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence 689999988 78999999999999999999876 67999999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc---------CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 79 QGEVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~---------~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
+.+||+|||++...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....
T Consensus 165 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 165 -GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp -CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred -CCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 79999999988654221 1223479999999999875 5899999999999999999999999875544
Q ss_pred HHHHHHHHcCCCC--------------------------------------------cccccCCChHHHHHHHHHhh-Cc
Q 006244 147 AQIYKKVISGKKP--------------------------------------------EALFKVEDPEVRQFIEKCLA-TV 181 (654)
Q Consensus 147 ~qi~kki~~G~~p--------------------------------------------~~l~~~~spelrdLI~kCL~-dP 181 (654)
..+...+ .+..+ .......++++++||.+||+ +|
T Consensus 244 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 322 (389)
T 3gni_B 244 QMLLEKL-NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322 (389)
T ss_dssp THHHHC---------------------------------------------------------CCHHHHHHHHHHTCSCT
T ss_pred HHHHHHh-cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 4433222 11111 11334568899999999999 89
Q ss_pred cCCCCHHHHhcCcccccCC
Q 006244 182 SSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 182 ~~RpTa~ELL~HPFf~~~~ 200 (654)
.+|||+.|+|+||||+...
T Consensus 323 ~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 323 DARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp TTSCCHHHHTTSGGGGGC-
T ss_pred ccCCCHHHHhcCHHHHHHh
Confidence 9999999999999997543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.23 Aligned_cols=188 Identities=22% Similarity=0.368 Sum_probs=158.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++|+.|.+ .+.+++||||+.||+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 74 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~ 149 (289)
T 1x8b_A 74 VRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFIS 149 (289)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred eeeeeeeec--CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEc
Confidence 578999987 78999999999999999999875 67999999999999999999999999 99999999999997
Q ss_pred C------------------CCCcEEEEecCchhhhcccCCccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhhc
Q 006244 77 G------------------NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTF 136 (654)
Q Consensus 77 ~------------------~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlTG 136 (654)
. +...+||+|||++...... ....||+.|+|||++.+. ++.++||||||+++|+|++|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp --------------------CCCEEECCCTTCEETTCS--CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCcccccccccccccCCceEEEEcccccccccCCc--cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 3 2347999999999876543 234599999999998754 56799999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 137 DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 137 ~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+|+... .....+..+..+. ++...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 228 ~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 228 EPLPRNG----DQWHEIRQGRLPR-IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCCCSSS----HHHHHHHTTCCCC-CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCCcch----hHHHHHHcCCCCC-CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 9887542 2345566665543 456688999999999999 89999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=293.90 Aligned_cols=193 Identities=24% Similarity=0.362 Sum_probs=156.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+.+ .+.+++||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 82 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~- 155 (311)
T 3niz_A 82 VSLIDVIHS--ERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD- 155 (311)
T ss_dssp CCEEEEECC--SSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-
T ss_pred eeeeeEEcc--CCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-
Confidence 578998876 689999999997 58888877654 5999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH-
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI- 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~- 154 (654)
+.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||........+.....
T Consensus 156 ~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 235 (311)
T 3niz_A 156 GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235 (311)
T ss_dssp CCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH
T ss_pred CCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 79999999999876532 2334579999999998864 489999999999999999999999987555444333221
Q ss_pred -cCCCCcc-------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 -SGKKPEA-------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 -~G~~p~~-------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
....+.. +....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred HCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 1111111 123357899999999999 99999999999999999754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=285.03 Aligned_cols=194 Identities=23% Similarity=0.398 Sum_probs=165.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. .+.+++||||+.+|+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~ 142 (276)
T 2yex_A 68 VKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-D 142 (276)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-C
T ss_pred eeeeeEEEc--CCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-C
Confidence 578998887 7899999999999999999887778999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc----CCccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+||+|||++...... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.........+..+.
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 222 (276)
T 2yex_A 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222 (276)
T ss_dssp CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH
T ss_pred CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh
Confidence 9999999999765432 23345699999999998753 47789999999999999999999987655545556665
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
............++.+++||.+||. +|.+|||+.++++||||+..
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 5544433445678999999999999 89999999999999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.83 Aligned_cols=194 Identities=25% Similarity=0.419 Sum_probs=153.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++|++|.. ...+++|||||.||+|.+++...+++++..++.+++||+.||.|||+++ |+||||||+|||++.+.
T Consensus 79 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~ 154 (361)
T 3uc3_A 79 VRFKEVILT--PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPA 154 (361)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSS
T ss_pred CcEEEEEee--CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCC
Confidence 578999887 6899999999999999999988889999999999999999999999999 99999999999997542
Q ss_pred CcEEEEecCchhhhcc-cCCccccCCCCccChhhhcc-cCCcc-cchhhhhhHHHHHhhcCCCCCCCC---CHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVYEE-EYNEL-VDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~-~~~~~~vGTp~YmAPEvl~~-~ys~k-sDIWSLGiiL~ELlTG~~Pf~~~~---~~~qi~kki 153 (654)
+.+||+|||+++.... ......+||+.|+|||++.+ .++.+ +||||||+++|+|++|..||.... ....+...+
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 234 (361)
T 3uc3_A 155 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI 234 (361)
T ss_dssp CCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH
T ss_pred ceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence 3599999999975432 22344579999999998864 45554 899999999999999999997643 234455555
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.............++++++||.+||. +|.+|||+.++|+||||..
T Consensus 235 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp HTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred hcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 55544433344578999999999999 8999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=286.76 Aligned_cols=192 Identities=27% Similarity=0.486 Sum_probs=155.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILI 75 (654)
+++|+.+.+ .+.+++||||+. |+|.+++.. ...+++..++.++.||+.||.|||++ + |+||||||+|||+
T Consensus 69 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~ 143 (290)
T 3fme_A 69 VTFYGALFR--EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLI 143 (290)
T ss_dssp CCEEEEEEC--SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEE
T ss_pred EEEeeeeec--cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEE
Confidence 578998887 678999999996 588777654 56799999999999999999999998 8 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhcccCC-ccccCCCCccChhhhc-----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~-----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
+.+ +.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|++|..||.........
T Consensus 144 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 222 (290)
T 3fme_A 144 NAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222 (290)
T ss_dssp CTT-CCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH
T ss_pred CCC-CCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH
Confidence 854 7999999999987654433 3346999999999962 34889999999999999999999999876666666
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.........+.......++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 666666666655556788999999999999 8999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.75 Aligned_cols=191 Identities=21% Similarity=0.477 Sum_probs=165.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
++++++|.. ...++|||||+.||+|.+++.....+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ |
T Consensus 163 v~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~ 237 (365)
T 2y7j_A 163 ITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-M 237 (365)
T ss_dssp CCEEEEEEB--SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-C
T ss_pred eEEEEEEee--CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-C
Confidence 578898877 6899999999999999999998888999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhcc-------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||++..+... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~ 316 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRM 316 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHH
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHH
Confidence 9999999999876543 2344579999999998853 478899999999999999999999987 455666677
Q ss_pred HHcCCCCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 153 VISGKKPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 153 i~~G~~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+..+.... ..+...++.+++||.+||. +|.+|||+.++|+||||+
T Consensus 317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 77665432 2335678899999999999 899999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.19 Aligned_cols=194 Identities=22% Similarity=0.408 Sum_probs=168.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~ 78 (654)
+++++.+.+ ...+++||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||+. .+
T Consensus 69 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~ 144 (304)
T 2jam_A 69 VTLEDIYES--TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEE 144 (304)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSST
T ss_pred eehhhhccc--CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCC
Confidence 578898876 6899999999999999999988888999999999999999999999999 99999999999993 24
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+.+||+|||++............||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+.
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~ 223 (304)
T 2jam_A 145 NSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGY 223 (304)
T ss_dssp TCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCC
T ss_pred CCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCC
Confidence 5789999999997665544445569999999999875 589999999999999999999999987 45667777777765
Q ss_pred CC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+ ...+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 43 33445678999999999999 89999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.82 Aligned_cols=197 Identities=20% Similarity=0.359 Sum_probs=157.3
Q ss_pred CEEEEEEEe--cCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd--~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++++.|.. .....+|||||||.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 118 v~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~ 195 (400)
T 1nxk_A 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYT 195 (400)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES
T ss_pred ceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEe
Confidence 578887764 23468999999999999999998754 5999999999999999999999999 99999999999998
Q ss_pred CC--CCcEEEEecCchhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH---HHH
Q 006244 77 GN--QGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP---AQI 149 (654)
Q Consensus 77 ~~--~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~---~qi 149 (654)
.. .+.+||+|||+++..... .....+||+.|+|||++. ..|+.++|||||||++|+|++|..||...... ..+
T Consensus 196 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 275 (400)
T 1nxk_A 196 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 275 (400)
T ss_dssp SSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH
T ss_pred cCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH
Confidence 53 578999999999866533 234567999999999986 45999999999999999999999999764321 123
Q ss_pred HHHHHcCCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 150 YKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 150 ~kki~~G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
...+..+.. +...+...++++++||.+||. +|.+|||+.++|+||||...
T Consensus 276 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 276 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 445555543 333345678999999999999 89999999999999999743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=291.05 Aligned_cols=195 Identities=24% Similarity=0.415 Sum_probs=168.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...+++||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+..
T Consensus 78 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 78 ITLHDVYEN--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTS
T ss_pred ceEEEEEec--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCC
Confidence 578898877 6899999999999999999998888999999999999999999999999 999999999999985532
Q ss_pred ---cEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 ---EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ---~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~ 232 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITS 232 (321)
T ss_dssp SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHT
T ss_pred CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHh
Confidence 79999999998765432 234569999999999874 589999999999999999999999987 455666666766
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+.. +...+...++.+++||.+||. +|.+|||+.++|+||||+..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 233 VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 543 333446678999999999999 899999999999999997554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=304.50 Aligned_cols=190 Identities=26% Similarity=0.514 Sum_probs=160.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.+.. ...++|||||+ +|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 72 v~l~~~~~~--~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~ 145 (336)
T 3h4j_B 72 IKLYDVITT--PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-L 145 (336)
T ss_dssp CCEEEEEEC--SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-C
T ss_pred CeEEEEEEe--CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-C
Confidence 578998877 68999999999 7899999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC-CccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++....... ....+||+.|+|||++.+. + +.++||||||+++|+|++|..||.... ...+++++..+.
T Consensus 146 ~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-~~~~~~~i~~~~ 224 (336)
T 3h4j_B 146 NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVNSCV 224 (336)
T ss_dssp CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS-STTCBCCCCSSC
T ss_pred CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHcCC
Confidence 99999999998765433 3456799999999998754 3 789999999999999999999997633 222222222222
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..++...++++++||.+||. +|.+|||+.|+++||||+..
T Consensus 225 --~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 225 --YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp --CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred --CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 22345678999999999999 89999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.45 Aligned_cols=195 Identities=24% Similarity=0.389 Sum_probs=166.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~-~ 78 (654)
|++|+.|.+ ...++||||||.||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 111 v~~~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~ 186 (387)
T 1kob_A 111 INLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKK 186 (387)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTT
T ss_pred CeEEEEEEe--CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCC
Confidence 578998877 789999999999999999987654 7999999999999999999999999 999999999999974 3
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++..+.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.. .+.......+..+
T Consensus 187 ~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~i~~~ 265 (387)
T 1kob_A 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRC 265 (387)
T ss_dssp CCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHC
T ss_pred CCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhC
Confidence 4689999999998765432 234469999999999875 589999999999999999999999987 4455566666665
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +...+...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 266 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 43 333445678999999999999 899999999999999998653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=289.95 Aligned_cols=192 Identities=27% Similarity=0.443 Sum_probs=158.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
|++|+.+.. .+.++|||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 66 v~~~~~~~~--~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl 140 (317)
T 2pmi_A 66 VRLYDVIHT--ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLL 140 (317)
T ss_dssp CCEEEEECC--TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred ceEEEEEEE--CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeE
Confidence 578998876 689999999997 6999998764 35999999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
++.+ |.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.... .....
T Consensus 141 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~ 218 (317)
T 2pmi_A 141 INKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-DEEQL 218 (317)
T ss_dssp ECTT-CCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHH
T ss_pred EcCC-CCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Confidence 9854 79999999999876532 2334579999999999864 48999999999999999999999998744 34444
Q ss_pred HHHHc--CCCCcc------------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 151 KKVIS--GKKPEA------------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 151 kki~~--G~~p~~------------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
..+.. |..+.. .....++++++||.+||. +|.+|||+.++|+||||+
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 298 (317)
T 2pmi_A 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298 (317)
T ss_dssp HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhh
Confidence 44432 211110 112467899999999999 899999999999999997
Q ss_pred cC
Q 006244 198 ID 199 (654)
Q Consensus 198 ~~ 199 (654)
..
T Consensus 299 ~~ 300 (317)
T 2pmi_A 299 EY 300 (317)
T ss_dssp GG
T ss_pred cc
Confidence 53
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.58 Aligned_cols=195 Identities=26% Similarity=0.375 Sum_probs=165.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN-GN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId-~~ 78 (654)
|++|++|.. .+.++|||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+. ..
T Consensus 149 v~~~~~~~~--~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~ 224 (373)
T 2x4f_A 149 IQLYDAFES--KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRD 224 (373)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETT
T ss_pred CeEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCC
Confidence 578998887 68999999999999999998765 46999999999999999999999999 99999999999984 24
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++..+.... ....+||+.|+|||++.. .++.++|||||||++|+|++|..||... +.......+..+
T Consensus 225 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~ 303 (373)
T 2x4f_A 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILAC 303 (373)
T ss_dssp TTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHT
T ss_pred CCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhc
Confidence 4789999999998765432 334569999999998874 5889999999999999999999999874 455556666655
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +...+...++++++||.+||. +|.+|||+.++|+||||+...
T Consensus 304 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 304 RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 43 333445678999999999999 899999999999999997543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.89 Aligned_cols=190 Identities=26% Similarity=0.483 Sum_probs=167.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.+.. ...+|||||||.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 79 v~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~ 153 (476)
T 2y94_A 79 IKLYQVIST--PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-M 153 (476)
T ss_dssp CCEEEEEEC--SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-C
T ss_pred CcEEEEEEE--CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-C
Confidence 578998877 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... .....+||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .+...++.++..+.
T Consensus 154 ~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~ 232 (476)
T 2y94_A 154 NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGI 232 (476)
T ss_dssp CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC-SSSHHHHHHHHTTC
T ss_pred CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCC
Confidence 9999999999876543 23456799999999998764 3 6899999999999999999999987 45567778888776
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.. .+...++++++||.+||. +|.+|||+.++++||||+.
T Consensus 233 ~~--~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 FY--TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp CC--CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred cC--CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 53 344578999999999999 8999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=292.58 Aligned_cols=197 Identities=24% Similarity=0.421 Sum_probs=163.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~- 77 (654)
+++|+.|.. .+.+++||||+.||+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 92 INLHEVYEN--TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSI 167 (327)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCB
T ss_pred EEEEEEEEe--CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecC
Confidence 578998876 78999999999999999998653 57999999999999999999999999 999999999999985
Q ss_pred -CCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 78 -NQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 78 -~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
..+.+||+|||++....... ....+||+.|+|||++.. .++.++||||||+++|+|++|..||... +....+..+.
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~ 246 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE-DNQETYLNIS 246 (327)
T ss_dssp TTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHH
T ss_pred CCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CchHHHHHHH
Confidence 24799999999998765432 234579999999999874 5899999999999999999999999874 4455555555
Q ss_pred cCC--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 155 SGK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 155 ~G~--~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
... .+...+...++.+++||.+||. +|.+|||+.++|+||||+..++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 247 QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 433 3444456688999999999999 89999999999999999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.97 Aligned_cols=194 Identities=23% Similarity=0.403 Sum_probs=164.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.|.. ...++|||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 122 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~ 196 (355)
T 1vzo_A 122 VTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-G 196 (355)
T ss_dssp CCEEEEEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-S
T ss_pred eEEEEEEee--CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-C
Confidence 578888877 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc---CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCC---CCHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSEC---THPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~---~~~~qi~k 151 (654)
.+||+|||++..+... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||... .....+.+
T Consensus 197 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 276 (355)
T 1vzo_A 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276 (355)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH
Confidence 9999999999765332 2234579999999999874 3788999999999999999999999642 34455556
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.+.....+ ++...++.+++||.+||. +|.+|| ++.++++||||+..++
T Consensus 277 ~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 277 RILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp HHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred HHhccCCC--CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 66554433 345678999999999999 899999 9999999999986554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=282.75 Aligned_cols=196 Identities=31% Similarity=0.510 Sum_probs=162.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++++.|.. .+.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 82 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~ 157 (295)
T 2clq_A 82 VQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINT 157 (295)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEET
T ss_pred eeEeeEEEe--CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEEC
Confidence 578999887 689999999999999999998753 4679999999999999999999999 999999999999987
Q ss_pred CCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
..+.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||............
T Consensus 158 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (295)
T 2clq_A 158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK 237 (295)
T ss_dssp TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH
T ss_pred CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh
Confidence 5689999999999876432 2234569999999999864 2889999999999999999999999765554443333
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.........++...++++++||.+||. +|.+||++.++|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 322223334556788999999999999 899999999999999998543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=281.64 Aligned_cols=194 Identities=23% Similarity=0.429 Sum_probs=166.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. ++.+++||||+.+|+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~ 161 (298)
T 1phk_A 87 IQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-M 161 (298)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-C
T ss_pred eeeeeeecc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-C
Confidence 578998876 7899999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhc-------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~ 240 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRM 240 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHH
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHH
Confidence 9999999999876543 233456999999999885 2478899999999999999999999987 455666667
Q ss_pred HHcCCCCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 153 VISGKKPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 153 i~~G~~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+..+.... ......++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 76665432 2334578999999999999 899999999999999998543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=287.01 Aligned_cols=197 Identities=27% Similarity=0.491 Sum_probs=161.2
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
+++|+.|.... ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl 161 (326)
T 2x7f_A 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVL 161 (326)
T ss_dssp CCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEE
T ss_pred eeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEE
Confidence 57899988743 56899999999999999999875 46999999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
++. .+.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.... .
T Consensus 162 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~ 239 (326)
T 2x7f_A 162 LTE-NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-P 239 (326)
T ss_dssp ECT-TCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC-H
T ss_pred EcC-CCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc-H
Confidence 985 479999999999876533 223456999999999985 358899999999999999999999998744 4
Q ss_pred HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 147 AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 147 ~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
......+..+..+.......++.+++||.+||. +|.+||++.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 240 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 444455555655555556778999999999999 8999999999999999986543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=283.68 Aligned_cols=197 Identities=29% Similarity=0.500 Sum_probs=164.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRL-KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~-k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.. ...+++||||+.+|+|.+++. ....+++..+..++.||+.||.|||+++ |+|+||||+|||++.+
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~- 161 (314)
T 3com_A 87 VKYYGSYFK--NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE- 161 (314)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-
T ss_pred ccEEEEEEe--CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-
Confidence 578998887 689999999999999999987 4568999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||........+ ..+..+
T Consensus 162 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~ 240 (314)
T 3com_A 162 GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FMIPTN 240 (314)
T ss_dssp CCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHS
T ss_pred CCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcC
Confidence 799999999997765432 234569999999999875 5899999999999999999999999875443333 333333
Q ss_pred CCC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcch
Q 006244 157 KKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDS 203 (654)
Q Consensus 157 ~~p-~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~ 203 (654)
..+ .......++.+++||.+||. +|.+|||+.++|+||||+......
T Consensus 241 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 241 PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 322 22344568899999999999 899999999999999998765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=290.72 Aligned_cols=197 Identities=21% Similarity=0.350 Sum_probs=157.0
Q ss_pred CEEEEEEEecC------CCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTA------NRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~------~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++++.+.... .+.++|||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 79 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NI 155 (351)
T 3mi9_A 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANV 155 (351)
T ss_dssp CCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred ccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHE
Confidence 57888887643 4679999999975 777776654 57999999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhccc------CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCC
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKS------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTH 145 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~ 145 (654)
|++.+ +.+||+|||++..+... .....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.+..
T Consensus 156 l~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~- 233 (351)
T 3mi9_A 156 LITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT- 233 (351)
T ss_dssp EECTT-SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred EEcCC-CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99854 79999999999865421 2234568999999998864 48999999999999999999999998744
Q ss_pred HHHHHHHHHc--CCCCcccccC----------------------------CChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 146 PAQIYKKVIS--GKKPEALFKV----------------------------EDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 146 ~~qi~kki~~--G~~p~~l~~~----------------------------~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
.......+.. +..+...+.. .++++++||.+||. +|.+|||+.|+|+||
T Consensus 234 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred hHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 3433333332 3333222211 26789999999999 999999999999999
Q ss_pred ccccCCcc
Q 006244 195 FLQIDDYD 202 (654)
Q Consensus 195 Ff~~~~~~ 202 (654)
||+.....
T Consensus 314 ~f~~~~~~ 321 (351)
T 3mi9_A 314 FFWSDPMP 321 (351)
T ss_dssp GGGSSSCC
T ss_pred CcCCCCCc
Confidence 99866544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=293.10 Aligned_cols=192 Identities=26% Similarity=0.435 Sum_probs=164.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+++++|.. ...++|||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 117 v~~~~~~~~--~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~- 190 (348)
T 1u5q_A 117 IQYRGCYLR--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP- 190 (348)
T ss_dssp CCEEEEEEE--TTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-
T ss_pred eeEEEEEEE--CCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-
Confidence 578999987 689999999997 688888754 567999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... ...+||+.|+|||++. +.++.++||||||+++|+|++|..||..... ......+..
T Consensus 191 ~~~kL~DfG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-~~~~~~~~~ 267 (348)
T 1u5q_A 191 GLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ 267 (348)
T ss_dssp TEEEECCCTTCBSSSSB--CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHH
T ss_pred CCEEEeeccCceecCCC--CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHh
Confidence 79999999999776432 3457999999999884 4589999999999999999999999987544 444445566
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+..+.......++.+++||.+||. +|.+|||+.++|+||||.....
T Consensus 268 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 666655556788999999999999 8999999999999999976543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=289.81 Aligned_cols=194 Identities=22% Similarity=0.344 Sum_probs=158.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.+.....+++||||+.+++|.+++. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+
T Consensus 94 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~ 168 (330)
T 3nsz_A 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHR 168 (330)
T ss_dssp CCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTT
T ss_pred EEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCC
Confidence 57889888766789999999999999999874 4899999999999999999999999 999999999999986655
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-- 155 (654)
.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||............+..
T Consensus 169 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~ 248 (330)
T 3nsz_A 169 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248 (330)
T ss_dssp EEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred EEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence 8999999999866543 3344579999999998864 4899999999999999999999999654443332222211
Q ss_pred -----------CCC----------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 -----------GKK----------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 -----------G~~----------------------p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
... +.......++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 110 001122368999999999999 99999999999999999743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=282.31 Aligned_cols=199 Identities=29% Similarity=0.512 Sum_probs=162.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.. .+.+++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 79 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~- 153 (302)
T 2j7t_A 79 VKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE- 153 (302)
T ss_dssp CCEEEEEEC--C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-
T ss_pred eeeeeeeee--CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-
Confidence 578998887 6799999999999999999876 567999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||... +......
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~ 232 (302)
T 2j7t_A 154 GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLL 232 (302)
T ss_dssp SCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHH
T ss_pred CCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHH
Confidence 79999999998654322 233456999999999873 34888999999999999999999999874 4455555
Q ss_pred HHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcchhh
Q 006244 152 KVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYDSDL 205 (654)
Q Consensus 152 ki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~~~~ 205 (654)
.+..+..+. ......++.++++|.+||. +|.+|||+.++++||||+.......+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~ 288 (302)
T 2j7t_A 233 KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL 288 (302)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHH
T ss_pred HHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhH
Confidence 555554433 2345578899999999999 89999999999999999876554333
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=285.38 Aligned_cols=195 Identities=23% Similarity=0.364 Sum_probs=156.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++.+.. .+.+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 65 ~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~ 139 (311)
T 4agu_A 65 VNLLEVFRR--KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-S 139 (311)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-S
T ss_pred cchhheeec--CCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-C
Confidence 578999887 7899999999999999999888888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
.+||+|||++....... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||........+......
T Consensus 140 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (311)
T 4agu_A 140 VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219 (311)
T ss_dssp CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999998765332 234579999999998864 5899999999999999999999999875544433221110
Q ss_pred CCC-------------------Cc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 GKK-------------------PE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 G~~-------------------p~--------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+.. +. ......++++.+||.+||. +|.+|||+.++|+||||+...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 110 00 0113467889999999999 899999999999999998544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=292.04 Aligned_cols=194 Identities=27% Similarity=0.427 Sum_probs=158.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------------------------------CCCCHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------------------------------RRVNIR 40 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------------------------------~~Lse~ 40 (654)
|++|++|.+ .+.++||||||.||+|.+++... ..+++.
T Consensus 91 v~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (345)
T 3hko_A 91 ARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168 (345)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHH
T ss_pred ceeehhhcc--CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHH
Confidence 578999877 78999999999999999998521 124678
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-CcEEEEecCchhhhcccC------CccccCCCCccChhhh
Q 006244 41 AVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVY 113 (654)
Q Consensus 41 ~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~-g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl 113 (654)
.++.++.||+.||.|||+++ |+||||||+|||++.+. +.+||+|||++..+.... .....||+.|+|||++
T Consensus 169 ~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 169 LISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 89999999999999999999 99999999999997442 289999999998654321 2345699999999998
Q ss_pred c---ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC--CcccccCCChHHHHHHHHHhh-CccCCCCH
Q 006244 114 E---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSA 187 (654)
Q Consensus 114 ~---~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa 187 (654)
. ..++.++||||||+++|+|++|..||.... .......+..+.. +.......++++++||.+||. +|.+||++
T Consensus 247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN-DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 6 458899999999999999999999998754 4455555555543 223344578999999999999 89999999
Q ss_pred HHHhcCcccccC
Q 006244 188 RELLTDPFLQID 199 (654)
Q Consensus 188 ~ELL~HPFf~~~ 199 (654)
.++|+||||+..
T Consensus 326 ~~~l~hp~~~~~ 337 (345)
T 3hko_A 326 MRALQHPWISQF 337 (345)
T ss_dssp HHHHHSHHHHTT
T ss_pred HHHhcChhhccC
Confidence 999999999743
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=286.69 Aligned_cols=178 Identities=25% Similarity=0.416 Sum_probs=147.3
Q ss_pred eEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCch
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 90 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~---Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA 90 (654)
.+++|||||.||+|.+++.+... .++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcc
Confidence 48999999999999999987643 566679999999999999999999 9999999999999854 79999999999
Q ss_pred hhhcccC--------------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 91 AILRKSH--------------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 91 ~~l~~~~--------------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
....... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..|+.. ...+...+..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~ 288 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRN 288 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHT
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhc
Confidence 8765431 233469999999999875 589999999999999999998777532 3344555555
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..|. .....++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 289 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 289 LKFPL-LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp TCCCH-HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cCCCc-ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 55543 233457889999999999 8999999999999999963
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-33 Score=287.54 Aligned_cols=192 Identities=26% Similarity=0.379 Sum_probs=153.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. .+.++|||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 63 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~- 136 (324)
T 3mtl_A 63 VTLHDIIHT--EKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER- 136 (324)
T ss_dssp CCEEEEEEC--SSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-
T ss_pred CeeeeEEee--CCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-
Confidence 578998877 688999999996 69999988754 5999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++...... .....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .......+..
T Consensus 137 ~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~i~~ 215 (324)
T 3mtl_A 137 GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-VEEQLHFIFR 215 (324)
T ss_dssp CCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHH
T ss_pred CCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHH
Confidence 79999999999765432 2234568999999998864 48999999999999999999999998744 3433333332
Q ss_pred --CCCCcc--------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 --GKKPEA--------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 --G~~p~~--------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
|..+.. .....++++++||.+||. +|.+|||+.|+|+||||...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred HhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 221111 112457899999999999 99999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=279.80 Aligned_cols=190 Identities=26% Similarity=0.460 Sum_probs=157.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. ...+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 74 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~ 148 (276)
T 2h6d_A 74 IKLYQVIST--PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-M 148 (276)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-S
T ss_pred eEEEEEEec--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-C
Confidence 578898876 6899999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC-CccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++....... .....||+.|+|||++.+. + +.++||||||+++|+|++|..||.. .+...++..+..+.
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~ 227 (276)
T 2h6d_A 149 NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGV 227 (276)
T ss_dssp CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCc
Confidence 99999999998765432 2345699999999998754 3 6799999999999999999999987 45667777777665
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+ ++...++.++++|.+||. +|.+|||+.++++||||+.
T Consensus 228 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 228 FY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred cc--CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 43 344578999999999999 8999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=295.18 Aligned_cols=184 Identities=23% Similarity=0.351 Sum_probs=150.6
Q ss_pred CCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEec
Q 006244 12 NRNINFVTEMFTSGTLRQYRL----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 87 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~----k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DF 87 (654)
...+++||||+. |+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++...+.+||+||
T Consensus 110 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Df 186 (383)
T 3eb0_A 110 NKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDF 186 (383)
T ss_dssp CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCC
T ss_pred ceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEEC
Confidence 456999999997 57766654 4568999999999999999999999999 9999999999999866689999999
Q ss_pred Cchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-CCCC----
Q 006244 88 GLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-GKKP---- 159 (654)
Q Consensus 88 GLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-G~~p---- 159 (654)
|++..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++...+.. |..+
T Consensus 187 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp TTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 999876443 3345579999999998864 4899999999999999999999999886555554443321 1110
Q ss_pred ---------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 160 ---------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 160 ---------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
..+....++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 01233467889999999999 8999999999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=284.47 Aligned_cols=191 Identities=21% Similarity=0.345 Sum_probs=155.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.. .+.+++||||+ +|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++..
T Consensus 80 ~~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 80 VQMLEWFEH--HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQS 154 (339)
T ss_dssp CCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCC
T ss_pred Eeeeccccc--CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecc
Confidence 468888877 68999999999 899999998765 6899999999999999999999999 9999999999999752
Q ss_pred ------------------CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCC
Q 006244 79 ------------------QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 79 ------------------~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
.+.+||+|||++...... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 233 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc-cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 457999999999765433 344579999999999875 589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHc--CCCCccc----------------------------------------ccCCChHHHHHHHHH
Q 006244 140 YSECTHPAQIYKKVIS--GKKPEAL----------------------------------------FKVEDPEVRQFIEKC 177 (654)
Q Consensus 140 f~~~~~~~qi~kki~~--G~~p~~l----------------------------------------~~~~spelrdLI~kC 177 (654)
|...... .....+.. +..|..+ ....++++++||.+|
T Consensus 234 f~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 234 FPTHDSK-EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp CCCSCHH-HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCChH-HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 9874433 32222211 2222110 011246789999999
Q ss_pred hh-CccCCCCHHHHhcCccccc
Q 006244 178 LA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 178 L~-dP~~RpTa~ELL~HPFf~~ 198 (654)
|. +|.+|||+.|+|+||||+.
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGG
T ss_pred hCcCcccccCHHHHhcCHHHHH
Confidence 99 8999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=284.79 Aligned_cols=193 Identities=21% Similarity=0.420 Sum_probs=161.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. ...+++||| +.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ + +
T Consensus 91 v~~~~~~~~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~-~ 163 (313)
T 3cek_A 91 IRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-G 163 (313)
T ss_dssp CCEEEEEEC--SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-T
T ss_pred EEEEEEeec--CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-C-C
Confidence 578998877 678999999 558999999999889999999999999999999999999 99999999999997 3 7
Q ss_pred cEEEEecCchhhhcccC----CccccCCCCccChhhhcc------------cCCcccchhhhhhHHHHHhhcCCCCCCCC
Q 006244 81 EVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVTFDYPYSECT 144 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~------------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~ 144 (654)
.+||+|||++....... .....||+.|+|||++.. .++.++||||||+++|+|++|..||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 99999999998764432 223469999999999864 58889999999999999999999998766
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
+.......+........+....+++++++|.+||. +|.+||++.++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 66666666666555555566678899999999999 899999999999999997643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.18 Aligned_cols=197 Identities=27% Similarity=0.456 Sum_probs=161.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
|+++++|. ...++|||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 203 v~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 203 IKIKNFFD---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CCCCEEEE---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSS
T ss_pred eeEEEEEe---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCC
Confidence 46778764 3578999999999999999988889999999999999999999999999 9999999999999743
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||++....... ....+||+.|+|||++. ..|+.++||||||+++|+|++|..||........+...+
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i 357 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357 (419)
T ss_dssp SCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH
T ss_pred cceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH
Confidence 3469999999998775443 23457999999999884 358889999999999999999999998766555666677
Q ss_pred HcCCCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 154 ISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
..+..+ ...+...++.+++||.+||. +|.+|||+.++|+||||+..+..
T Consensus 358 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 358 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409 (419)
T ss_dssp HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence 766543 23345678999999999999 89999999999999999865543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=313.51 Aligned_cols=195 Identities=24% Similarity=0.395 Sum_probs=167.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.|.+ +..+||||||+.||+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 247 v~l~~~~~~--~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~- 321 (576)
T 2acx_A 247 VSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDD- 321 (576)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT-
T ss_pred eeEEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeC-
Confidence 578898877 689999999999999999998754 3999999999999999999999999 999999999999985
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC---CHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~---~~~qi~kki 153 (654)
.|.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.... ....++..+
T Consensus 322 ~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i 401 (576)
T 2acx_A 322 HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401 (576)
T ss_dssp TSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH
T ss_pred CCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh
Confidence 4899999999998765432 344579999999999875 59999999999999999999999997643 456666666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
.... ..++...++++++||.+||. +|.+|| ++.|+++||||+..++.
T Consensus 402 ~~~~--~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 402 KEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred hccc--ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 6543 33456789999999999999 899999 89999999999876653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=281.78 Aligned_cols=193 Identities=27% Similarity=0.508 Sum_probs=168.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN-- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~-- 78 (654)
+++|+.+.. ...+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~ 159 (287)
T 2wei_A 84 MKLFEILED--SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEK 159 (287)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSST
T ss_pred cEEEEEEeC--CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCC
Confidence 578898876 6899999999999999999988888999999999999999999999999 9999999999999753
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+.+||+|||++....... .....||+.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+..+.
T Consensus 160 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGK 238 (287)
T ss_dssp TCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred cccEEEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Confidence 2479999999998765433 233458999999999988899999999999999999999999987 45667777777776
Q ss_pred CCcc--cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEA--LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~--l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+.. .+...++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 5433 335678999999999999 8999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=293.66 Aligned_cols=194 Identities=21% Similarity=0.378 Sum_probs=154.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~- 77 (654)
+++++.|.. .+.++|||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++.
T Consensus 119 v~~~~~~~~--~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~ 195 (382)
T 2vx3_A 119 VHLKRHFMF--RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195 (382)
T ss_dssp CCEEEEEEE--TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST
T ss_pred EEeeeeecc--CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC
Confidence 468888887 689999999995 6999999876 4699999999999999999999964334999999999999953
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
..+.+||+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... ......+..
T Consensus 196 ~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~ 273 (382)
T 2vx3_A 196 KRSAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE-VDQMNKIVEV 273 (382)
T ss_dssp TSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHH
T ss_pred CCCcEEEEeccCceecccc-cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence 3478999999999876543 345679999999999875 599999999999999999999999987544 343344332
Q ss_pred -CCCCcccccC------------------------------------------------------------CChHHHHHH
Q 006244 156 -GKKPEALFKV------------------------------------------------------------EDPEVRQFI 174 (654)
Q Consensus 156 -G~~p~~l~~~------------------------------------------------------------~spelrdLI 174 (654)
+..|..+... ..+++++||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 2211100000 013789999
Q ss_pred HHHhh-CccCCCCHHHHhcCcccccC
Q 006244 175 EKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 175 ~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+||. +|.+|||+.|+|+||||+..
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999 99999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=280.30 Aligned_cols=191 Identities=29% Similarity=0.460 Sum_probs=165.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.+ .+.+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 78 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~ 152 (294)
T 2rku_A 78 VGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-L 152 (294)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-C
T ss_pred eeeeeeecc--CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-C
Confidence 578998876 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ......+..+..+.
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~ 231 (294)
T 2rku_A 153 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNE 231 (294)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTC
T ss_pred CEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhhcc
Confidence 9999999999876432 2334569999999999875 488899999999999999999999987 44555666666554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+ ++...++.++++|.+||. +|.+|||+.++|+||||...
T Consensus 232 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 232 YS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CC--CccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 32 345678999999999999 89999999999999999744
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=301.69 Aligned_cols=196 Identities=22% Similarity=0.350 Sum_probs=151.9
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|++|.... ...+||||||+ +|+|.+++.....+++..++.+++||+.||.|||+++ |+||||||+|||++.
T Consensus 115 v~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~ 191 (458)
T 3rp9_A 115 VKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQ 191 (458)
T ss_dssp CCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECT
T ss_pred CceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECC
Confidence 57888886532 36899999998 6799999998888999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhccc-----------------------------CCccccCCCCccChhhhc--ccCCcccchhhh
Q 006244 78 NQGEVKIGDLGLAAILRKS-----------------------------HAARCVGTPEFMAPEVYE--EEYNELVDIYSF 126 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~-----------------------------~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSL 126 (654)
+ +.+||+|||+++..... .....+||+.|+|||++. ..|+.++|||||
T Consensus 192 ~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 192 D-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp T-CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred C-CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 5 79999999999875421 123457899999999763 459999999999
Q ss_pred hhHHHHHhh-----------cCCCCCCCCC--------------------HHHHHHHHH--cCCCC--------------
Q 006244 127 GMCILEMVT-----------FDYPYSECTH--------------------PAQIYKKVI--SGKKP-------------- 159 (654)
Q Consensus 127 GiiL~ELlT-----------G~~Pf~~~~~--------------------~~qi~kki~--~G~~p-------------- 159 (654)
||++|||++ |.++|.+... ..++. .+. -|..+
T Consensus 271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~i~~~~g~p~~~~~~~~~~~~~~~ 349 (458)
T 3rp9_A 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN-VIFNILGTPSEEDIEALEKEDAKR 349 (458)
T ss_dssp HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHH-HHHHHHCCCCHHHHHTSSCHHHHH
T ss_pred HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHH-HHHHHcCCCCHHHHhhcCCHHHHH
Confidence 999999999 6677755321 11111 111 01111
Q ss_pred -------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 160 -------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 160 -------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
...++..++++++||.+||. +|.+|||+.|+|+||||+....
T Consensus 350 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 350 YIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp HHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred HHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 12234568999999999999 9999999999999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=280.79 Aligned_cols=191 Identities=26% Similarity=0.490 Sum_probs=139.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.+ .+.+++||||+.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 74 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~- 148 (278)
T 3cok_A 74 LELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN- 148 (278)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-
T ss_pred EeEEEEEcc--CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-
Confidence 578998877 68999999999999999999875 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+...
T Consensus 149 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~ 227 (278)
T 3cok_A 149 MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-TLNKVVLA 227 (278)
T ss_dssp CCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS
T ss_pred CCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-HHHHHhhc
Confidence 79999999999876432 2234569999999998875 48889999999999999999999997644322 22222221
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. ...+...++++++||.+||. +|.+|||+.++|+||||...
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 1 12345578999999999999 89999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-33 Score=279.81 Aligned_cols=193 Identities=21% Similarity=0.408 Sum_probs=162.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
+++++.+.. ...+++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 71 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~ 146 (283)
T 3bhy_A 71 ITLHDIFEN--KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNV 146 (283)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSS
T ss_pred eehhheecC--CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCC
Confidence 578998877 6899999999999999999988888999999999999999999999999 99999999999997542
Q ss_pred --CcEEEEecCchhhhcccC-CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 --GEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 --g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.. .+.......+..
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~ 225 (283)
T 3bhy_A 147 PNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISA 225 (283)
T ss_dssp SSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT
T ss_pred CCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC-cchHHHHHHhHh
Confidence 279999999998764432 23456999999999987 4589999999999999999999999987 445556666665
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.. +.......++.+++||.+||. +|.+|||+.++|+||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 226 VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 543 333445678999999999999 8999999999999999964
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=279.68 Aligned_cols=194 Identities=31% Similarity=0.537 Sum_probs=155.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--------HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k--------~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeN 72 (654)
+++|+.+.. .+.+++||||+.||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 76 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~N 151 (303)
T 2vwi_A 76 VSYYTSFVV--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGN 151 (303)
T ss_dssp CCEEEEEES--SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGG
T ss_pred eeEEEEEee--cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhh
Confidence 578998887 6789999999999999999874 356999999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhccc-------CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKS-------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~-------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
||++.+ +.+||+|||++...... ......||+.|+|||++.. .++.++||||||+++|+|++|..||...
T Consensus 152 il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 152 ILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp EEECTT-CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEEcCC-CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 999854 79999999999876432 1233469999999999864 5899999999999999999999999875
Q ss_pred CCHHHHHHHHHcCCCC--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 144 THPAQIYKKVISGKKP--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 144 ~~~~qi~kki~~G~~p--------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
....... ....+..+ .......+++++++|.+||. +|.+|||+.++++||||+...
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 231 PPMKVLM-LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CGGGHHH-HHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred chhhHHH-HHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 5443333 33333222 12234567899999999999 899999999999999997543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=290.05 Aligned_cols=197 Identities=26% Similarity=0.409 Sum_probs=159.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. .+.+++||||+.+++|..++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 87 v~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~ 161 (331)
T 4aaa_A 87 VNLLEVCKK--KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-G 161 (331)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-S
T ss_pred eeEEEEeec--CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-C
Confidence 578998887 7899999999999999999888888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
.+||+|||++..+... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........+...+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 241 (331)
T 4aaa_A 162 VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241 (331)
T ss_dssp CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 9999999999876432 2334569999999999875 5889999999999999999999999876554444333221
Q ss_pred CCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 156 GKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 156 G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
+..+ .......++++++||.+||. +|.+|||+.|+|+||||+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316 (331)
T ss_dssp CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHH
T ss_pred CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChh
Confidence 1110 01123468899999999999 99999999999999999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=289.50 Aligned_cols=197 Identities=27% Similarity=0.457 Sum_probs=165.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
+++++++.. ..+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 78 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 78 IKIKNFFDA---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp CCEEEEEES---SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSS
T ss_pred ceEeeEEcC---CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCC
Confidence 578888754 348999999999999999988889999999999999999999999999 99999999999997542
Q ss_pred -CcEEEEecCchhhhcccC-CccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 80 -GEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 -g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||........+...+
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 232 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232 (322)
T ss_dssp SCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH
T ss_pred CCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH
Confidence 359999999998764432 12346999999999873 458899999999999999999999998765555556666
Q ss_pred HcCCCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCcc
Q 006244 154 ISGKKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDYD 202 (654)
Q Consensus 154 ~~G~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~~ 202 (654)
..+..+ ...+...++.+++||.+||. +|.+|||+.++|+||||+.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHH
T ss_pred HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHH
Confidence 666543 23345678999999999999 89999999999999999865543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=279.63 Aligned_cols=196 Identities=30% Similarity=0.473 Sum_probs=164.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRD---PPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~---p~IIHRDLKpeNI 73 (654)
+++|+.+.+.....+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ .+|+||||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NI 147 (279)
T 2w5a_A 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147 (279)
T ss_dssp CCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGE
T ss_pred CeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhE
Confidence 5789998887778999999999999999998764 34999999999999999999999986 3499999999999
Q ss_pred EEeCCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
|++.+ +.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+.
T Consensus 148 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~ 225 (279)
T 2w5a_A 148 FLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELA 225 (279)
T ss_dssp EECSS-SCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHH
T ss_pred EEcCC-CCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHH
Confidence 99854 799999999998765432 123469999999998875 589999999999999999999999987 4566777
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+..+..+. +....+++++++|.+||. +|.+||++.+||+|+|+...
T Consensus 226 ~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 226 GKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHhhccccc-CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 7787776543 445678999999999999 89999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.79 Aligned_cols=191 Identities=29% Similarity=0.460 Sum_probs=165.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.+ .+.+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 104 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~ 178 (335)
T 2owb_A 104 VGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-L 178 (335)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-C
T ss_pred CeEEEEEec--CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-C
Confidence 578998887 6899999999999999999998889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ......+..+..+.
T Consensus 179 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~ 257 (335)
T 2owb_A 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKNE 257 (335)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTC
T ss_pred CEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcCC
Confidence 9999999999876432 2334569999999999875 488999999999999999999999986 44555666666554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.. +....++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 258 ~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 258 YS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred CC--CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 32 345678999999999999 89999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=298.64 Aligned_cols=192 Identities=22% Similarity=0.360 Sum_probs=156.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.|.. ...++|||||+. |+|.+++.... .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 162 v~~~~~~~~--~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 162 IHMLENFTF--RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ 236 (429)
T ss_dssp CCEEEEEEE--TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST
T ss_pred EEEEeeccc--CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC
Confidence 578898887 689999999995 79999988764 4999999999999999999999998 9999999999999855
Q ss_pred CCc--EEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 79 QGE--VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 79 ~g~--VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+. +||+|||++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||........+...+..
T Consensus 237 -~~~~vkL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 237 -GRSGIKVIDFGSSCYEHQR-VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp -TSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred -CCcceEEeecccceecCCc-ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 55 999999999765433 345679999999998875 5999999999999999999999999875544433322211
Q ss_pred -CCCCcc-------------------------------------------------------cccCCChHHHHHHHHHhh
Q 006244 156 -GKKPEA-------------------------------------------------------LFKVEDPEVRQFIEKCLA 179 (654)
Q Consensus 156 -G~~p~~-------------------------------------------------------l~~~~spelrdLI~kCL~ 179 (654)
|..+.. +....++.+++||.+||.
T Consensus 315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~ 394 (429)
T 3kvw_A 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394 (429)
T ss_dssp HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTC
T ss_pred cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCC
Confidence 111110 112247889999999999
Q ss_pred -CccCCCCHHHHhcCcccccC
Q 006244 180 -TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 180 -dP~~RpTa~ELL~HPFf~~~ 199 (654)
+|.+|||+.|+|+||||+..
T Consensus 395 ~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 395 WDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp SSTTTSCCHHHHHTSTTTC--
T ss_pred CChhhCCCHHHHhCChhhccC
Confidence 99999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=309.01 Aligned_cols=195 Identities=27% Similarity=0.449 Sum_probs=167.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+.|.. ...+||||||+.||+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||++
T Consensus 248 v~l~~~~~~--~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~ 323 (543)
T 3c4z_A 248 VSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD 323 (543)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC
T ss_pred eeEEEEEee--CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe
Confidence 578888877 68999999999999999998864 36999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC---CHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT---HPAQIY 150 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~---~~~qi~ 150 (654)
.+ |.+||+|||++..+.... ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||.... ....++
T Consensus 324 ~~-g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~ 402 (543)
T 3c4z_A 324 DD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402 (543)
T ss_dssp TT-SCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH
T ss_pred CC-CCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH
Confidence 54 899999999998765432 234579999999999875 59999999999999999999999997643 456777
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCcc
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDYD 202 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~~ 202 (654)
..+..+... ++...++++++||.+||. +|.+||+ +.++++||||+..++.
T Consensus 403 ~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 403 QRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp HHHHHCCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred HHHhhcccC--CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 777766443 345678999999999999 8999995 5899999999876653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.65 Aligned_cols=197 Identities=24% Similarity=0.350 Sum_probs=156.8
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYR---LKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l---~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++|++|.... ...++|||||+.++.+..+. ...+.+++..++.|++||+.||.|||+++ |+||||||+||
T Consensus 95 v~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Ni 172 (394)
T 4e7w_A 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNL 172 (394)
T ss_dssp CCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred ceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHE
Confidence 57888887643 22488999999875444332 23567999999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
|++...+.+||+|||+++.+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++.
T Consensus 173 ll~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~ 252 (394)
T 4e7w_A 173 LLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252 (394)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99855689999999999876433 3345679999999998864 48999999999999999999999998865555444
Q ss_pred HHHHc-CCCC-------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 151 KKVIS-GKKP-------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 151 kki~~-G~~p-------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+.. |..+ ..+....++++++||.+||. +|.+|||+.|+|.||||+..
T Consensus 253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 33321 1110 01223478899999999999 89999999999999999754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.40 Aligned_cols=188 Identities=31% Similarity=0.515 Sum_probs=153.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~---Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|+++.. ...+++||||+.+|+|.+++.+... +++..+..++.||+.||.|||+++++|+||||||+|||++.
T Consensus 97 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 97 VLFMGAVTQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp CCEEEEECS--TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT
T ss_pred eeEEEEEEE--CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC
Confidence 578998866 6789999999999999999987653 99999999999999999999999888999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+ +.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. .+..+....+.
T Consensus 175 ~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~ 252 (309)
T 3p86_A 175 K-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVG 252 (309)
T ss_dssp T-CCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHH
T ss_pred C-CcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Confidence 4 799999999997654432 234569999999999875 489999999999999999999999987 45566666665
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.......++...++++++||.+||. +|.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5555555667789999999999999 8999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=290.68 Aligned_cols=196 Identities=23% Similarity=0.416 Sum_probs=167.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY------RLK--HRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~------l~k--~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpe 71 (654)
+++++.+.+ .+.+++||||+.+|+|.++ +.+ ...+++..+..++.||+.||.|||+ ++ |+||||||+
T Consensus 106 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~ 181 (348)
T 2pml_X 106 LTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181 (348)
T ss_dssp CCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGG
T ss_pred ceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChH
Confidence 467888877 6899999999999999998 665 5679999999999999999999999 88 999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccCCccccCCCCccChhhhccc--CCc-ccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YNE-LVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~--ys~-ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
|||++.+ +.+||+|||++............||+.|+|||++.+. ++. ++||||||+++|+|++|..||........
T Consensus 182 Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 182 NILMDKN-GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp GEEECTT-SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred hEEEcCC-CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999854 7999999999987665555566799999999998754 555 89999999999999999999988666577
Q ss_pred HHHHHHcCCCCccc-----------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 149 IYKKVISGKKPEAL-----------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 149 i~kki~~G~~p~~l-----------------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+...+..+..+... ....++++++||.+||. +|.+|||+.++|+||||+..+.
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 77777766543221 14578999999999999 8999999999999999986554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.59 Aligned_cols=185 Identities=25% Similarity=0.398 Sum_probs=157.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSG-TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gG-SL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.. .+.+++||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 92 v~~~~~~~~--~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~- 166 (335)
T 3dls_A 92 IKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED- 166 (335)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-
T ss_pred eeEEEEEee--CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-
Confidence 578998877 78999999999777 99999999889999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-CccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 80 GEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||++....... ....+||+.|+|||++.+. + +.++||||||+++|+|++|..||..... ....
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~ 239 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEA 239 (335)
T ss_dssp SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTT
T ss_pred CcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhh
Confidence 799999999998765433 3345699999999998754 4 7899999999999999999999975211 1111
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
....+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 240 --~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 240 --AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp --CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred --ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 112234578999999999999 89999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-33 Score=296.16 Aligned_cols=197 Identities=25% Similarity=0.382 Sum_probs=150.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
|++|++|.......++|||||+. |+|.+++..++ .+++..++.|+.||+.||.|||+++ |+||||||+
T Consensus 81 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~ 157 (405)
T 3rgf_A 81 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPA 157 (405)
T ss_dssp CCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGG
T ss_pred eeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHH
Confidence 57889998877889999999995 68888876422 4999999999999999999999999 999999999
Q ss_pred cEEEe---CCCCcEEEEecCchhhhccc-----CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCC
Q 006244 72 NIFVN---GNQGEVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYS 141 (654)
Q Consensus 72 NILId---~~~g~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~ 141 (654)
|||+. ...+.+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 158 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 158 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp GEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred HeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 99993 24479999999999876532 2234579999999998875 48999999999999999999999996
Q ss_pred CCCC---------HHHHHHHHHc-CCCCcccc----------------------------------cCCChHHHHHHHHH
Q 006244 142 ECTH---------PAQIYKKVIS-GKKPEALF----------------------------------KVEDPEVRQFIEKC 177 (654)
Q Consensus 142 ~~~~---------~~qi~kki~~-G~~p~~l~----------------------------------~~~spelrdLI~kC 177 (654)
.... ..++...+.. |..+...+ ...++.+++||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~ 317 (405)
T 3rgf_A 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317 (405)
T ss_dssp CCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHH
T ss_pred CccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHH
Confidence 5332 1222222111 22211111 11267899999999
Q ss_pred hh-CccCCCCHHHHhcCcccccCC
Q 006244 178 LA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 178 L~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
|. +|.+|||+.|+|+||||+...
T Consensus 318 L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 318 LTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred ccCCcccCCCHHHHhcChhhccCC
Confidence 99 999999999999999998654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=296.36 Aligned_cols=197 Identities=22% Similarity=0.312 Sum_probs=151.2
Q ss_pred CEEEEEEEecCC---CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTAN---RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~---~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|+.+..... ..+||||||+. |+|.+++.....+++..++.+++||+.||.|||+++ |+||||||+|||++.
T Consensus 88 v~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~ 164 (432)
T 3n9x_A 88 IRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQ 164 (432)
T ss_dssp CCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT
T ss_pred ceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECC
Confidence 578888876422 68999999995 699999998888999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC------------------------CccccCCCCccChhhhc--ccCCcccchhhhhhHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH------------------------AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCIL 131 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~------------------------~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ 131 (654)
+ +.+||+|||+++...... ....+||++|+|||++. ..|+.++|||||||++|
T Consensus 165 ~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ 243 (432)
T 3n9x_A 165 D-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243 (432)
T ss_dssp T-CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred C-CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence 5 799999999998764321 24567999999999863 45999999999999999
Q ss_pred HHhhcC-----------CCCCCCCC-----------------HHHHHHHHH-cCCCCc----------------------
Q 006244 132 EMVTFD-----------YPYSECTH-----------------PAQIYKKVI-SGKKPE---------------------- 160 (654)
Q Consensus 132 ELlTG~-----------~Pf~~~~~-----------------~~qi~kki~-~G~~p~---------------------- 160 (654)
||++|. ++|.+... ..++...+. -|..+.
T Consensus 244 ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 323 (432)
T 3n9x_A 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323 (432)
T ss_dssp HHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred HHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCC
Confidence 999843 33333210 111111100 011110
Q ss_pred -----ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 161 -----ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 161 -----~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
..++..++++++||.+||. +|.+|||+.|+|+||||+....
T Consensus 324 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 324 PINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 1124578999999999999 9999999999999999986543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=292.56 Aligned_cols=192 Identities=28% Similarity=0.438 Sum_probs=157.5
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++++.+.... ...+|+||||+ +++|.+++.. +.+++..++.+++||+.||.|||+++ |+||||||+|||++
T Consensus 87 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 87 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN 162 (367)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC
T ss_pred CCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc
Confidence 45677776532 14679999999 8999999876 57999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||+++..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++ ..+.
T Consensus 163 ~~-~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~ 239 (367)
T 1cm8_A 163 ED-CELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIM 239 (367)
T ss_dssp TT-CCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH
T ss_pred CC-CCEEEEeeecccccccc-cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence 54 79999999999875433 345679999999998865 5999999999999999999999999875544443 3332
Q ss_pred c--CCCCc---------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 S--GKKPE---------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~--G~~p~---------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. |..+. .++...++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 240 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 1 22211 2234568999999999999 99999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.7e-33 Score=285.36 Aligned_cols=195 Identities=21% Similarity=0.321 Sum_probs=156.6
Q ss_pred CEEEEEEEecCCC--eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~--~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+++...... .+|+||||+.||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 75 v~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~ 152 (311)
T 3ork_A 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT 152 (311)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT
T ss_pred ceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC
Confidence 5788888764332 56999999999999999998889999999999999999999999999 9999999999999855
Q ss_pred CCcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++..+.... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.........+..
T Consensus 153 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 231 (311)
T 3ork_A 153 -NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231 (311)
T ss_dssp -SCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred -CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 799999999998764421 223469999999998875 5899999999999999999999999875444444444
Q ss_pred HHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 153 VISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 153 i~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.....+. ......++++++||.+||. +|.+||++.++|.|+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 232 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 44433332 2345578999999999999 8999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=282.49 Aligned_cols=187 Identities=22% Similarity=0.357 Sum_probs=161.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~g-GSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. .+.+++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 111 ~~~~~~~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 111 IRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR 186 (320)
T ss_dssp CCEEEEEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT
T ss_pred eEEEEEEec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCC
Confidence 578898876 6899999999986 899999998889999999999999999999999999 99999999999998666
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-c-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+.+||+|||++............||+.|+|||++.. . ++.++||||||+++|+|++|..||... . .+..+.
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~----~~~~~~ 259 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRGQ 259 (320)
T ss_dssp TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHCC
T ss_pred CCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---h----hhhccc
Confidence 899999999998877665566679999999998864 3 467899999999999999999999752 1 223333
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +....++++++||.+||. +|.+|||+.++++||||+...
T Consensus 260 ~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 VF--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cc--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 22 345678999999999999 899999999999999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-33 Score=304.20 Aligned_cols=191 Identities=29% Similarity=0.410 Sum_probs=146.5
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+.|.... ...+||||||+.+ +|.+++. ..+++..++.+++||+.||+|||+++ |+||||||+|||++
T Consensus 124 v~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 198 (464)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred CcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe
Confidence 46778776532 2578999999975 5666654 35999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||+++...... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.....++ .++.
T Consensus 199 ~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~-~~i~ 276 (464)
T 3ttj_A 199 SD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVI 276 (464)
T ss_dssp TT-SCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH
T ss_pred CC-CCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence 54 799999999998776543 345679999999998875 5999999999999999999999999885544443 3332
Q ss_pred c--CCCCccc-------------------------------ccC-------CChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 S--GKKPEAL-------------------------------FKV-------EDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~--G~~p~~l-------------------------------~~~-------~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
. |..+... ... .++++++||.+||. +|.+|||++|+|+|
T Consensus 277 ~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2 2111100 000 15679999999999 99999999999999
Q ss_pred ccccc
Q 006244 194 PFLQI 198 (654)
Q Consensus 194 PFf~~ 198 (654)
|||+.
T Consensus 357 p~~~~ 361 (464)
T 3ttj_A 357 PYINV 361 (464)
T ss_dssp TTTGG
T ss_pred hhhhh
Confidence 99974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.6e-33 Score=290.44 Aligned_cols=196 Identities=21% Similarity=0.367 Sum_probs=138.6
Q ss_pred CEEEEEEEecC--CCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~--~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.|.... +..++||||||.||+|.+++.+.. .+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~ 162 (336)
T 3fhr_A 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYT 162 (336)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES
T ss_pred HHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEE
Confidence 46788876532 456999999999999999998764 6999999999999999999999999 99999999999997
Q ss_pred CC--CCcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH---HH
Q 006244 77 GN--QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ---IY 150 (654)
Q Consensus 77 ~~--~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q---i~ 150 (654)
.+ .+.+||+|||++............||+.|+|||++. ..++.++||||||+++|+|++|..||........ ..
T Consensus 163 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (336)
T 3fhr_A 163 SKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242 (336)
T ss_dssp CSSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred ecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH
Confidence 43 356999999999877655555667999999999886 4588999999999999999999999976332211 12
Q ss_pred HHHHcCC--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 151 KKVISGK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 151 kki~~G~--~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
..+..+. .+...+...++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 2222222 2333445678999999999999 8999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=281.80 Aligned_cols=193 Identities=18% Similarity=0.291 Sum_probs=153.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~- 77 (654)
+++++.+.. .+.++|||||+ +|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 85 ~~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 85 VLMSDWFNF--HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNS 159 (355)
T ss_dssp CCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCC
T ss_pred EEeeeeeee--CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecc
Confidence 356777777 68999999999 678888877654 6999999999999999999999998 999999999999931
Q ss_pred -----------------CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCC
Q 006244 78 -----------------NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 78 -----------------~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
..+.+||+|||++...... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc-ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 3478999999999765433 344579999999998864 589999999999999999999999
Q ss_pred CCCCCCHHHHHHHHH--cCCCCccc----------------------------------------ccCCChHHHHHHHHH
Q 006244 140 YSECTHPAQIYKKVI--SGKKPEAL----------------------------------------FKVEDPEVRQFIEKC 177 (654)
Q Consensus 140 f~~~~~~~qi~kki~--~G~~p~~l----------------------------------------~~~~spelrdLI~kC 177 (654)
|........+ ..+. .+..|..+ ....++++++||.+|
T Consensus 239 f~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 239 FQTHENREHL-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp CCCSSHHHHH-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCHHHHH-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 9875433322 2221 12222211 001135789999999
Q ss_pred hh-CccCCCCHHHHhcCcccccCC
Q 006244 178 LA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 178 L~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
|. +|.+|||+.++|+||||+..+
T Consensus 318 L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 318 LEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred hcCChhhCcCHHHHhcChhhcCCC
Confidence 99 899999999999999998543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=276.26 Aligned_cols=195 Identities=31% Similarity=0.509 Sum_probs=155.8
Q ss_pred CEEEEEEEec-----------CCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCC
Q 006244 1 MKFYTSWVDT-----------ANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68 (654)
Q Consensus 1 VkfY~sfvd~-----------~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDL 68 (654)
+++|+.|.+. ....+++||||+.||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||
T Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl 142 (303)
T 1zy4_A 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDL 142 (303)
T ss_dssp CCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred HHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccC
Confidence 5788888763 2468999999999999999998654 5889999999999999999999999 999999
Q ss_pred CCCcEEEeCCCCcEEEEecCchhhhccc----------------CCccccCCCCccChhhhcc--cCCcccchhhhhhHH
Q 006244 69 KCDNIFVNGNQGEVKIGDLGLAAILRKS----------------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCI 130 (654)
Q Consensus 69 KpeNILId~~~g~VKL~DFGLA~~l~~~----------------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL 130 (654)
||+|||++.+ +.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++
T Consensus 143 kp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (303)
T 1zy4_A 143 KPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221 (303)
T ss_dssp CGGGEEECTT-SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHH
T ss_pred CHHhEEEcCC-CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHH
Confidence 9999999854 79999999999765421 1234469999999999874 589999999999999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCC--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 131 LEMVTFDYPYSECTHPAQIYKKVISGK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 131 ~ELlTG~~Pf~~~~~~~qi~kki~~G~--~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
|+|++ ||....+...+...+..+. .|..+....++.++++|.+||. +|.+|||+.++|+||||+....
T Consensus 222 ~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 222 FEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp HHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred HHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 99998 6654344455556665543 3444555667889999999999 8999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=277.36 Aligned_cols=191 Identities=32% Similarity=0.552 Sum_probs=164.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+.+.. ...+++||||+.+|+|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 83 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~ 156 (303)
T 3a7i_A 83 TKYYGSYLK--DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-G 156 (303)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-S
T ss_pred eEEEEEEec--CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-C
Confidence 578999887 6899999999999999999765 57999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||... +.......+..+.
T Consensus 157 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~ 235 (303)
T 3a7i_A 157 EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNN 235 (303)
T ss_dssp CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSC
T ss_pred CEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhhcCC
Confidence 99999999997765432 234569999999999864 5889999999999999999999999874 4555555555554
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+ .+....++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 236 ~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 236 PP-TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CC-CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CC-CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 43 3556678999999999999 89999999999999999644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=294.66 Aligned_cols=195 Identities=20% Similarity=0.331 Sum_probs=155.5
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRL----KHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~----k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeN 72 (654)
|+++++|.... ..+++|||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 110 v~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~N 186 (420)
T 1j1b_A 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQN 186 (420)
T ss_dssp CCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGG
T ss_pred cceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhh
Confidence 57788776532 2357899999975 6665554 3567999999999999999999999999 9999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
||++.+.+.+||+|||+++.+... .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l 266 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999976678999999999876433 3345679999999998864 5899999999999999999999999886555554
Q ss_pred HHHHHc-CCC-----------------Cc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 150 YKKVIS-GKK-----------------PE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 150 ~kki~~-G~~-----------------p~--------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+.+.. |.. |. .+....++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 267 ~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 267 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp HHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 443321 111 00 0123457899999999999 8999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=289.20 Aligned_cols=193 Identities=28% Similarity=0.411 Sum_probs=151.4
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILI 75 (654)
+++|+.|... ....++|||||+ +|+|.+++.+. +.+++..++.++.||+.||.|||++ + |+||||||+|||+
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll 180 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILL 180 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEE
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeE
Confidence 5788888742 356899999999 67777777654 4699999999999999999999998 8 9999999999999
Q ss_pred eCCC------------------------------------------------CcEEEEecCchhhhcccCCccccCCCCc
Q 006244 76 NGNQ------------------------------------------------GEVKIGDLGLAAILRKSHAARCVGTPEF 107 (654)
Q Consensus 76 d~~~------------------------------------------------g~VKL~DFGLA~~l~~~~~~~~vGTp~Y 107 (654)
+.+. ..+||+|||++...... ....+||+.|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y 259 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQY 259 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGG
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-CccCCCCCcc
Confidence 8542 27999999999876543 3445799999
Q ss_pred cChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC-----HHHHHHHHH--cCCCCcc------------------
Q 006244 108 MAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH-----PAQIYKKVI--SGKKPEA------------------ 161 (654)
Q Consensus 108 mAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~-----~~qi~kki~--~G~~p~~------------------ 161 (654)
+|||++.+ .|+.++|||||||++|+|++|..||..... .......+. .|..|..
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99998875 499999999999999999999999975432 111111111 1222211
Q ss_pred --------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 162 --------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 162 --------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+....++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011123578899999999 899999999999999996
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=284.55 Aligned_cols=192 Identities=20% Similarity=0.342 Sum_probs=157.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR---VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV-- 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~---Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI-- 75 (654)
|++|+.+.......++|||||+.||+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~ 147 (319)
T 4euu_A 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVI 147 (319)
T ss_dssp CCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEE
T ss_pred ceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEec
Confidence 578999988766799999999999999999987543 999999999999999999999999 9999999999998
Q ss_pred --eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhc---------ccCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 76 --NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE---------EEYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 76 --d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~---------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
+ ..+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 148 ~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 148 GED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp CTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4 33679999999998765433 23456999999999885 45889999999999999999999999643
Q ss_pred CC---HHHHHHHHHcCCCCc-----------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 144 TH---PAQIYKKVISGKKPE-----------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 144 ~~---~~qi~kki~~G~~p~-----------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
.. ...+..++..+..+. .+....++.+.+||.+||. +|.+|||+.|+|+||-
T Consensus 227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32 234455555544321 1112234578999999999 9999999999999983
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-32 Score=284.12 Aligned_cols=195 Identities=22% Similarity=0.294 Sum_probs=153.1
Q ss_pred CEEEEEEEecCC-----CeEEEEEecCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeEecCCC
Q 006244 1 MKFYTSWVDTAN-----RNINFVTEMFTSGTLRQYR----LKHRRVNIRAVKHWCRQILSGLLYLH--SRDPPVIHRDLK 69 (654)
Q Consensus 1 VkfY~sfvd~~~-----~~i~LVtEy~~gGSL~~~l----~k~~~Lse~~i~~i~~QIl~gL~YLH--s~~p~IIHRDLK 69 (654)
|+++++|..... ..+++||||+.++ |...+ .....+++..++.++.||+.||.||| +++ |+|||||
T Consensus 82 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlk 158 (360)
T 3e3p_A 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIK 158 (360)
T ss_dssp CCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCC
T ss_pred ccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCC
Confidence 578888876322 2489999999764 44333 34567999999999999999999999 887 9999999
Q ss_pred CCcEEEeCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 70 CDNIFVNGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 70 peNILId~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
|+|||++...+.+||+|||++..+.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus 159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~- 237 (360)
T 3e3p_A 159 PHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS- 237 (360)
T ss_dssp GGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred HHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-
Confidence 9999998656899999999998765433 334569999999998853 389999999999999999999999987543
Q ss_pred HHHHHHHHc--CCCCc----------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 147 AQIYKKVIS--GKKPE----------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 147 ~qi~kki~~--G~~p~----------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
...+..+.. +..+. ......++++++||.+||+ +|.+|||+.|+|+|||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 333333332 11110 0111245789999999999 8999999999999999
Q ss_pred cccC
Q 006244 196 LQID 199 (654)
Q Consensus 196 f~~~ 199 (654)
|+..
T Consensus 318 f~~~ 321 (360)
T 3e3p_A 318 FDEL 321 (360)
T ss_dssp GGGG
T ss_pred cccc
Confidence 9753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-32 Score=277.12 Aligned_cols=195 Identities=29% Similarity=0.418 Sum_probs=159.1
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++|+.+... ....+++||||+. |+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili 153 (326)
T 1blx_A 77 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILV 153 (326)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEE
T ss_pred EeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEE
Confidence 5788888731 3568999999997 69999998754 4999999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 76 NGNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 76 d~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+ +.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+
T Consensus 154 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i 231 (326)
T 1blx_A 154 TSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKI 231 (326)
T ss_dssp CTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred cCC-CCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHH
Confidence 854 79999999999876533 2334569999999998864 5899999999999999999999999875443 333344
Q ss_pred Hc--CCCC-----------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 154 IS--GKKP-----------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 154 ~~--G~~p-----------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +..+ ..+....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 32 1110 11234568899999999999 899999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-32 Score=275.88 Aligned_cols=192 Identities=21% Similarity=0.415 Sum_probs=161.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++++.+.......+++||||+.+| |.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 69 IQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG 145 (305)
T ss_dssp CCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred eEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC
Confidence 5789988766678999999999876 8787776 356999999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhccc----CCccccCCCCccChhhhccc---CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEEE---YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~~---ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++...... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.. .+...++.
T Consensus 146 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~ 223 (305)
T 2wtk_C 146 -GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFE 223 (305)
T ss_dssp -CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHH
T ss_pred -CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHH
Confidence 79999999999765432 12344699999999998642 47799999999999999999999986 55667777
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+..+..+ +....++.+.+||.+||. +|.+|||+.++++||||+..
T Consensus 224 ~i~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 224 NIGKGSYA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHHHCCCC--CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHhcCCCC--CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 77776543 345678999999999999 89999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.3e-32 Score=285.49 Aligned_cols=192 Identities=21% Similarity=0.344 Sum_probs=157.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.. ...+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 75 v~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~- 148 (346)
T 1ua2_A 75 IGLLDAFGH--KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN- 148 (346)
T ss_dssp CCEEEEECC--TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-
T ss_pred CeEEEEEee--CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-
Confidence 578998876 6889999999975 8998887653 6999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
|.+||+|||++..+... .....+||+.|+|||++.+ .++.++||||||+++|+|++|.+||..... ...+..+..
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~ 227 (346)
T 1ua2_A 149 GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFE 227 (346)
T ss_dssp CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH
T ss_pred CCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHH
Confidence 79999999999876543 2344579999999999864 488999999999999999999999987544 444444432
Q ss_pred --CCCCcc------------------------cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 --GKKPEA------------------------LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 --G~~p~~------------------------l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
+..+.. +....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 221111 113456899999999999 89999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=287.59 Aligned_cols=186 Identities=25% Similarity=0.423 Sum_probs=158.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|++|+++.. .+.+||||||+.||+|.+++...+ .+++..+..++.||+.||.|||+++ |+
T Consensus 150 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 225 (370)
T 2psq_A 150 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 225 (370)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eeEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 578998866 678999999999999999998754 4899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ |.+||+|||++..+.... .....||+.|+|||++.+ .|+.++||||||+++|||++ |..
T Consensus 226 HrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~ 304 (370)
T 2psq_A 226 HRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304 (370)
T ss_dssp CSCCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999854 799999999998664322 223457889999998864 59999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.+ .+...++..+..+..+. .+...+++++++|.+||. +|.+||++.+++++
T Consensus 305 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 305 PYPG-IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp SSTT-CCGGGHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9987 45566777777776543 445678999999999999 89999999999964
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-32 Score=270.86 Aligned_cols=189 Identities=25% Similarity=0.414 Sum_probs=151.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP-PVIHRDLKCDNIFVNG-- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p-~IIHRDLKpeNILId~-- 77 (654)
+++|+++.. .+.+++||||+.||+|.+++. .+.+++..+..++.||+.||.|||+++. +|+||||||+|||++.
T Consensus 69 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~ 145 (271)
T 3dtc_A 69 IALRGVCLK--EPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145 (271)
T ss_dssp CCEEEEECC--C--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCC
T ss_pred eeEEEEEec--CCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccc
Confidence 578898876 678999999999999999875 4579999999999999999999999873 4889999999999974
Q ss_pred -----CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 78 -----NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 78 -----~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
..+.+||+|||++............||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ......
T Consensus 146 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~ 224 (271)
T 3dtc_A 146 ENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAY 224 (271)
T ss_dssp SSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-HHHHHH
T ss_pred ccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Confidence 25789999999998776655556679999999998875 48999999999999999999999998744 444555
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+..........++.++++|.+||. +|.+|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 5555555555667788999999999999 89999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-32 Score=275.34 Aligned_cols=192 Identities=23% Similarity=0.507 Sum_probs=155.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILId~~ 78 (654)
+++|+++.. ...+++||||+ ++.+..++.. ...+++..+..++.||+.||.|||++ + |+||||||+|||++.+
T Consensus 87 ~~~~~~~~~--~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~ 161 (318)
T 2dyl_A 87 VQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER 161 (318)
T ss_dssp CCEEEEEEC--SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT
T ss_pred eeEEEEEec--CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC
Confidence 578998887 67999999999 6677776654 56799999999999999999999995 8 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||...........
T Consensus 162 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (318)
T 2dyl_A 162 -GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240 (318)
T ss_dssp -SCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred -CCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 799999999997664432 33456999999999984 3488899999999999999999999988777777777
Q ss_pred HHHcCCCCccc-ccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 152 KVISGKKPEAL-FKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 152 ki~~G~~p~~l-~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.+..+..+... ....++++++||.+||. +|.+||++.++|+||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 241 KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 77776554322 23478999999999999 8999999999999999963
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=283.77 Aligned_cols=188 Identities=24% Similarity=0.386 Sum_probs=159.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC--------------------------------------------
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-------------------------------------------- 36 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~-------------------------------------------- 36 (654)
|++|++|... ...+++|||||.||+|.+++.....
T Consensus 89 v~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 89 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp CCEEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 5789988763 4569999999999999999987543
Q ss_pred ----------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhc
Q 006244 37 ----------------------VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR 94 (654)
Q Consensus 37 ----------------------Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~ 94 (654)
+++..+..|+.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeec
Confidence 899999999999999999999999 9999999999999844 799999999998664
Q ss_pred ccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCCh
Q 006244 95 KSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 168 (654)
Q Consensus 95 ~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~sp 168 (654)
... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||........+...+..+..+. .+...++
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 323 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-APDYTTP 323 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-CCTTCCH
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-CCCCCCH
Confidence 322 22345889999999886 458999999999999999998 9999988766666766666665443 4466889
Q ss_pred HHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 169 EVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 169 elrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+++++|.+||. +|.+|||+.++++|
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999 89999999999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-33 Score=296.23 Aligned_cols=172 Identities=17% Similarity=0.157 Sum_probs=140.4
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEe
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNI-------RAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGD 86 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse-------~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~D 86 (654)
..||||||+ +|+|.+++.+.+.+++ ..+..|+.||+.||+|||+++ |+||||||+|||++.+ |.+||+|
T Consensus 174 ~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~D 249 (377)
T 3byv_A 174 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLTG 249 (377)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECC
T ss_pred EEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEEe
Confidence 389999999 6899999987655555 888889999999999999999 9999999999999855 7999999
Q ss_pred cCchhhhcccCCccccCCCCccChhhhcc------------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 87 LGLAAILRKSHAARCVGTPEFMAPEVYEE------------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 87 FGLA~~l~~~~~~~~vGTp~YmAPEvl~~------------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
||+++.... .....+| +.|+|||++.+ .|+.++|||||||++|+|++|..||..... ......+.
T Consensus 250 FG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~-~~~~~~~~ 326 (377)
T 3byv_A 250 FEHLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA-LGGSEWIF 326 (377)
T ss_dssp GGGCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCSGGGG
T ss_pred chhheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc-ccchhhhh
Confidence 999986433 2334568 99999999864 599999999999999999999999976321 11111111
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
......++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 327 ------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 327 ------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp ------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred ------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 1124568999999999999 8999999999999999964
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-32 Score=276.91 Aligned_cols=187 Identities=25% Similarity=0.421 Sum_probs=156.0
Q ss_pred CEEEEEEEecCCCeEEEEEec-CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEM-FTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy-~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. .+.+++|+|+ +.+++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++...
T Consensus 101 ~~~~~~~~~--~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 101 IRLLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRR 176 (312)
T ss_dssp CCEEEEC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTT
T ss_pred eeEEEEEec--CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCC
Confidence 578888876 6789999999 789999999998888999999999999999999999999 99999999999998556
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cC-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EY-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+.+||+|||++............||+.|+|||++.+ .+ +.++||||||+++|+|++|..||... . .+....
T Consensus 177 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~----~~~~~~ 249 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---Q----EILEAE 249 (312)
T ss_dssp TEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHTC
T ss_pred CeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---H----HHhhhc
Confidence 899999999998877666666779999999998864 34 45899999999999999999999752 1 222222
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
. .+....++.+++||.+||. +|.+|||+.++|+||||+...
T Consensus 250 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 250 L--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred c--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 2 2345678999999999999 899999999999999998543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=275.31 Aligned_cols=191 Identities=24% Similarity=0.381 Sum_probs=155.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. .+.+++||||+.||+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 74 v~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~ 148 (294)
T 4eqm_A 74 VSMIDVDEE--DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-K 148 (294)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-S
T ss_pred ceEEEeeee--CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-C
Confidence 578898876 7899999999999999999999889999999999999999999999999 9999999999999855 7
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+||+|||++....... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ......+....
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~~~~~~ 227 (294)
T 4eqm_A 149 TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET-AVSIAIKHIQD 227 (294)
T ss_dssp CEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC-HHHHHHHHHSS
T ss_pred CEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHhhc
Confidence 99999999998765432 233569999999998875 48899999999999999999999998744 44444444444
Q ss_pred CCCc---ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 157 KKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 157 ~~p~---~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
..+. ......++.+.++|.+||. +|.+||+..+.+.+.|..
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 4432 2345678999999999999 899999666666666654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=267.04 Aligned_cols=187 Identities=15% Similarity=0.288 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.+.+.....+++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++++|+||||||+|||++.+
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 149 (271)
T 3kmu_A 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED 149 (271)
T ss_dssp ECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT
T ss_pred hheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC
Confidence 47899887755589999999999999999998765 4899999999999999999999998889999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhccc----CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE----YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~----ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.++|+|||++..... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.... .......+.
T Consensus 150 -~~~~l~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~ 224 (271)
T 3kmu_A 150 -MTARISMADVKFSFQS---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVA 224 (271)
T ss_dssp -SCEEEEGGGSCCTTSC---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHH
T ss_pred -cceeEEeccceeeecc---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHH
Confidence 7899998887654322 345689999999998743 3347999999999999999999998754 444444444
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.......++...+++++++|.+||. +|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4444445667789999999999999 8999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=289.87 Aligned_cols=192 Identities=29% Similarity=0.429 Sum_probs=142.4
Q ss_pred CEEEEEEEec----CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~----~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++++.|... ....+|+|+||+ +++|.+++.. +.+++..++.+++||+.||.|||+++ |+||||||+|||++
T Consensus 91 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~ 166 (367)
T 2fst_X 91 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 166 (367)
T ss_dssp CCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred CcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC
Confidence 4567776542 136789999999 7899998866 67999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||+++..... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....++ ..+.
T Consensus 167 ~~-~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l-~~i~ 243 (367)
T 2fst_X 167 ED-CELKILDFGLARHTADE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLIL 243 (367)
T ss_dssp TT-CCEEECC----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHH
T ss_pred CC-CCEEEeecccccccccc-CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence 54 79999999999876543 344679999999998864 5899999999999999999999999875544333 3332
Q ss_pred c--CCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 S--GKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~--G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. |..+ ...+...++.+++||.+||. +|.+|||+.++|.||||+..
T Consensus 244 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 2 2111 01123457899999999999 99999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-33 Score=292.43 Aligned_cols=182 Identities=15% Similarity=0.174 Sum_probs=142.7
Q ss_pred CeEEEEEecCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEE
Q 006244 13 RNINFVTEMFTSGTLRQYRLKH-RRVNIRAV------KHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i------~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~ 85 (654)
.++|||||||. |+|.+++... +.+....+ ..++.||+.||+|||+++ |+||||||+|||++.+ |.+||+
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~ 236 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPD-GRLMLG 236 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEECTT-SCEEEC
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--CccCcCCHHHEEECCC-CCEEEE
Confidence 45899999998 8999999874 33444444 566699999999999999 9999999999999854 799999
Q ss_pred ecCchhhhcccCCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCCCCHH-HHHHH---HHcC--
Q 006244 86 DLGLAAILRKSHAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSECTHPA-QIYKK---VISG-- 156 (654)
Q Consensus 86 DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~-qi~kk---i~~G-- 156 (654)
|||++........ ...+|+.|+|||++.+ .|+.++||||||+++|+|++|..||....... ..+.. ...+
T Consensus 237 DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 315 (371)
T 3q60_A 237 DVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315 (371)
T ss_dssp CGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCC
T ss_pred ecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhcccc
Confidence 9999987654322 4457799999999874 59999999999999999999999997642110 00000 0001
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..........++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 316 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 316 SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred ccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 11112234678999999999999 89999999999999999743
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=282.68 Aligned_cols=194 Identities=25% Similarity=0.396 Sum_probs=154.9
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|+++.... ...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 88 v~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 88 IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNT 163 (364)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT
T ss_pred ccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECC
Confidence 45677776532 257999999996 699999876 46999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
+ +.+||+|||++....... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+......+.
T Consensus 164 ~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 242 (364)
T 3qyz_A 164 T-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242 (364)
T ss_dssp T-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred C-CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence 4 799999999998764332 234579999999998753 38999999999999999999999998755443332
Q ss_pred HHHHc-CCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 151 KKVIS-GKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 151 kki~~-G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+.. |..+ ..+....++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 243 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 22211 1111 11224568899999999999 89999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=278.94 Aligned_cols=183 Identities=27% Similarity=0.431 Sum_probs=150.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.+ .+.+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 70 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~- 144 (310)
T 3s95_A 70 LKFIGVLYK--DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN- 144 (310)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-
T ss_pred ccEEEEEec--CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-
Confidence 578999987 7899999999999999999987 467999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC----------------ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCC
Q 006244 80 GEVKIGDLGLAAILRKSHA----------------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE 142 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~----------------~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~ 142 (654)
+.+||+|||++........ ...+||+.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 7999999999976543221 14579999999999875 589999999999999999999999865
Q ss_pred CCCHHH----HHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 143 CTHPAQ----IYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 143 ~~~~~q----i~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
...... ........ ......++.+.++|.+||. +|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 225 YLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 321110 01111111 1234567899999999999 8999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-32 Score=280.59 Aligned_cols=192 Identities=24% Similarity=0.462 Sum_probs=139.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-----HRRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-----~~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNIL 74 (654)
|++|+.+.. .+.+++||||+. |+|.+++.. ...+++..+..++.||+.||.|||++ + |+||||||+|||
T Consensus 84 v~~~~~~~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIl 158 (327)
T 3aln_A 84 VQFYGALFR--EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNIL 158 (327)
T ss_dssp CCEEEEEEC--SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEE
T ss_pred eeeeeEEEe--CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEE
Confidence 578999887 689999999997 588888764 56799999999999999999999998 8 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhcccCC-ccccCCCCccChhhhc-----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKSHA-ARCVGTPEFMAPEVYE-----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ 148 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~~~-~~~vGTp~YmAPEvl~-----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q 148 (654)
++.+ +.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|++|..||........
T Consensus 159 l~~~-~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (327)
T 3aln_A 159 LDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237 (327)
T ss_dssp EETT-TEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----
T ss_pred EcCC-CCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH
Confidence 9854 7999999999987654332 3346999999999983 3488999999999999999999999987543333
Q ss_pred HHHHHHcCCCCc---ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 149 IYKKVISGKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 149 i~kki~~G~~p~---~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
....+..+..+. ......++.+++||.+||. +|.+|||+.++++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 238 QLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 333333333322 2234578999999999999 8999999999999999964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=273.14 Aligned_cols=186 Identities=24% Similarity=0.411 Sum_probs=158.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR------------------------VNIRAVKHWCRQILSGLLYL 56 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~------------------------Lse~~i~~i~~QIl~gL~YL 56 (654)
|++|++|.. .+.+++||||+.+|+|.+++...+. +++..+..++.||+.||.||
T Consensus 89 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 166 (314)
T 2ivs_A 89 IKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL 166 (314)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH
Confidence 578998866 6789999999999999999987643 89999999999999999999
Q ss_pred HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHH
Q 006244 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCIL 131 (654)
Q Consensus 57 Hs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ 131 (654)
|+++ |+||||||+|||++.+ +.+||+|||++....... .....+|+.|+|||++.+ .++.++||||||+++|
T Consensus 167 H~~~--ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 243 (314)
T 2ivs_A 167 AEMK--LVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243 (314)
T ss_dssp HHTT--EECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HHCC--CcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHH
Confidence 9999 9999999999999854 799999999997654322 223457889999998864 5899999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 132 EMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 132 ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+|++ |..||.. .+...++..+..+..+. .....+++++++|.+||. +|.+||++.+++++
T Consensus 244 el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 244 EIVTLGGNPYPG-IPPERLFNLLKTGHRME-RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHTTSCCSSTT-CCGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCCCCCCC-CCHHHHHHHhhcCCcCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999 9999987 44566667776665443 445678999999999999 89999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=273.26 Aligned_cols=185 Identities=26% Similarity=0.438 Sum_probs=150.5
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
...+++||||+. |+|.+++.+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||++.
T Consensus 94 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 94 LNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp CSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred cCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 578999999997 699999864 57999999999999999999999999 99999999999998666799999999998
Q ss_pred hhccc-----CCccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC------
Q 006244 92 ILRKS-----HAARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK------ 158 (654)
Q Consensus 92 ~l~~~-----~~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~------ 158 (654)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||..... ......+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~ 248 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE-LEQMQLILESIPVVHEED 248 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHSCCCCHHH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCchhh
Confidence 75432 223345899999999875 4589999999999999999999999987543 333333332211
Q ss_pred ------------------C----cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 159 ------------------P----EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 159 ------------------p----~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+ .......++++++||.+||. +|.+|||+.++|+||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 0 11234578999999999999 8999999999999999985543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=269.16 Aligned_cols=187 Identities=15% Similarity=0.215 Sum_probs=153.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.. ...+++||||+ +|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+.
T Consensus 69 ~~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~ 143 (298)
T 1csn_A 69 PNVYYFGQE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPN 143 (298)
T ss_dssp CCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSS
T ss_pred CeEEeecCC--CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCC
Confidence 367777766 78999999999 999999998754 5999999999999999999999999 99999999999997442
Q ss_pred ----CcEEEEecCchhhhcccC---------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-
Q 006244 80 ----GEVKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT- 144 (654)
Q Consensus 80 ----g~VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~- 144 (654)
+.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 144 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred CCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 239999999998765432 234569999999999875 58999999999999999999999997643
Q ss_pred -CHHHHHHHHHcCCC---CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 145 -HPAQIYKKVISGKK---PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 145 -~~~qi~kki~~G~~---p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.....+..+..+.. ........+++++++|.+||. +|.+||++.+|++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 224 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 34455555443322 222344678999999999999 8999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=286.52 Aligned_cols=191 Identities=29% Similarity=0.408 Sum_probs=144.3
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++++.|.... ...+++||||+. |+|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 87 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 161 (371)
T ss_dssp CCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred cceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc
Confidence 57888887532 248999999996 57888876 45999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++....... ....+||+.|+|||++.+ .|+.++||||||+++|+|++|..||.+.. ....+.++.
T Consensus 162 ~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~ 239 (371)
T 2xrw_A 162 SD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWNKVI 239 (371)
T ss_dssp TT-SCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH
T ss_pred CC-CCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Confidence 54 799999999998765432 334579999999998875 58999999999999999999999998744 444444444
Q ss_pred cCCCC--cc-------------------------------ccc-------CCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKP--EA-------------------------------LFK-------VEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p--~~-------------------------------l~~-------~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..... .. ..+ ..++++++||.+||. +|.+|||+.++|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 32110 00 000 014679999999999 99999999999999
Q ss_pred ccccc
Q 006244 194 PFLQI 198 (654)
Q Consensus 194 PFf~~ 198 (654)
|||+.
T Consensus 320 p~~~~ 324 (371)
T 2xrw_A 320 PYINV 324 (371)
T ss_dssp HHHHT
T ss_pred cchhh
Confidence 99964
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.20 Aligned_cols=189 Identities=23% Similarity=0.307 Sum_probs=159.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------------------RVNIRAVKHWCRQILSGLLYLH 57 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-----------------------~Lse~~i~~i~~QIl~gL~YLH 57 (654)
+++|+++.. .+.++|||||+.+|+|.+++...+ .+++..+..++.||+.||.|||
T Consensus 112 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 189 (344)
T 1rjb_A 112 VNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189 (344)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 578998876 678999999999999999998753 2799999999999999999999
Q ss_pred hCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHH
Q 006244 58 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 132 (654)
Q Consensus 58 s~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~E 132 (654)
+++ |+||||||+|||++.+ +.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+
T Consensus 190 ~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 266 (344)
T 1rjb_A 190 FKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266 (344)
T ss_dssp HTT--EEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC--cccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHH
Confidence 999 9999999999999854 7999999999987654322 2335788999999886 458999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 133 MVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 133 LlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
|+| |..||........+...+..+..+ ..+...++++.+||.+||. +|.+|||+.+++++..
T Consensus 267 l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 267 IFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHcCCCCCcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 998 999998866666666666655443 3445678999999999999 8999999999998654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.81 Aligned_cols=194 Identities=26% Similarity=0.394 Sum_probs=148.4
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|++|... ....+++||||+. |+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA 168 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc
Confidence 4677877653 3458999999997 68888877643 6999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
.+ +.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+
T Consensus 169 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~i 246 (362)
T 3pg1_A 169 DN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-YNQLNKI 246 (362)
T ss_dssp TT-CCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHH
T ss_pred CC-CCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 54 79999999999765433 2334569999999998864 589999999999999999999999987543 3333333
Q ss_pred Hc--CCCC----------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 154 IS--GKKP----------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 154 ~~--G~~p----------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.. +..+ .......++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 22 1110 11223457889999999999 89999999999999999754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=283.10 Aligned_cols=195 Identities=27% Similarity=0.398 Sum_probs=151.3
Q ss_pred CEEEEEEEecC--CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSR-DPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~--~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~-~p~IIHRDLKpeNILI 75 (654)
++++++|.... ...+++||||+ +|+|.+++... +.+++..+..++.||+.||.|||++ + |+||||||+|||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll 165 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLM 165 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEE
Confidence 46777777632 23899999999 99999999874 4599999999999999999999998 8 9999999999999
Q ss_pred eC-----CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC----
Q 006244 76 NG-----NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH---- 145 (654)
Q Consensus 76 d~-----~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~---- 145 (654)
+. +.+.+||+|||++...... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred eccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 52 3347999999999876543 344579999999999875 489999999999999999999999975331
Q ss_pred -HHHHHHHHHc--CCCCcc--------------------------------------cccCCChHHHHHHHHHhh-CccC
Q 006244 146 -PAQIYKKVIS--GKKPEA--------------------------------------LFKVEDPEVRQFIEKCLA-TVSS 183 (654)
Q Consensus 146 -~~qi~kki~~--G~~p~~--------------------------------------l~~~~spelrdLI~kCL~-dP~~ 183 (654)
.......+.. |..|.. +....++++++||.+||. +|.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1111122211 222211 112235688999999999 8999
Q ss_pred CCCHHHHhcCcccccC
Q 006244 184 RLSARELLTDPFLQID 199 (654)
Q Consensus 184 RpTa~ELL~HPFf~~~ 199 (654)
|||+.++|+||||+..
T Consensus 325 Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 325 RADAGGLVNHPWLKDT 340 (373)
T ss_dssp CBCHHHHHTCGGGTTC
T ss_pred cCCHHHHhhChhhhcc
Confidence 9999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=266.47 Aligned_cols=186 Identities=22% Similarity=0.420 Sum_probs=159.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.+ ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~- 142 (269)
T 4hcu_A 68 VQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN- 142 (269)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-
T ss_pred eeEEEEEec--CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-
Confidence 578998876 67899999999999999999764 45999999999999999999999999 9999999999999754
Q ss_pred CcEEEEecCchhhhccc---CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+.
T Consensus 143 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~ 221 (269)
T 4hcu_A 143 QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDIS 221 (269)
T ss_dssp GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHH
T ss_pred CCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHh
Confidence 79999999999876432 223345788999999987 569999999999999999999 9999987 55667777777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .+...++.++++|.+||. +|.+|||+.+++++
T Consensus 222 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 222 TGFRLY-KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCccCC-CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 764433 345678999999999999 89999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=285.03 Aligned_cols=191 Identities=20% Similarity=0.325 Sum_probs=162.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++|+.+.. ....+||||||.||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 137 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NI 212 (367)
T 3l9p_A 137 VRCIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNC 212 (367)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred CeEEEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhE
Confidence 578998876 678899999999999999998753 4999999999999999999999999 99999999999
Q ss_pred EEeCC--CCcEEEEecCchhhhccc----CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCC
Q 006244 74 FVNGN--QGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTH 145 (654)
Q Consensus 74 LId~~--~g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~ 145 (654)
|++.+ ...+||+|||+++.+... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.. .+
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~ 291 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KS 291 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CC
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CC
Confidence 99833 235999999999865432 223346899999999886 459999999999999999998 9999987 55
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 146 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 146 ~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
...+...+..+..+. .....++.+.+||.+||. +|.+|||+.+++++.++.
T Consensus 292 ~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 292 NQEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 677777777776543 345678899999999999 899999999999998774
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=277.99 Aligned_cols=195 Identities=24% Similarity=0.376 Sum_probs=154.0
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++|+.+... ....+++||||+. |+|.+++.. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 72 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~ 147 (353)
T 2b9h_A 72 ITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINS 147 (353)
T ss_dssp CCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECT
T ss_pred CCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcC
Confidence 4677766542 1368999999996 699999876 57999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC------------CccccCCCCccChhhhc--ccCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 78 NQGEVKIGDLGLAAILRKSH------------AARCVGTPEFMAPEVYE--EEYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~------------~~~~vGTp~YmAPEvl~--~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
+ +.+||+|||++....... ....+||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 148 ~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 148 N-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp T-CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred C-CcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4 799999999998654321 12346899999999875 45899999999999999999999999875
Q ss_pred CCHHHHHHHHHc-CCCC----------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 144 THPAQIYKKVIS-GKKP----------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 144 ~~~~qi~kki~~-G~~p----------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.....+...... |..+ .......++++++||.+||. +|.+|||+.++|+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 227 DYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp SHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 433332221110 1110 01224578899999999999 99999999999999
Q ss_pred cccccCC
Q 006244 194 PFLQIDD 200 (654)
Q Consensus 194 PFf~~~~ 200 (654)
|||+...
T Consensus 307 p~~~~~~ 313 (353)
T 2b9h_A 307 PYLQTYH 313 (353)
T ss_dssp GGGTTTC
T ss_pred ccccccC
Confidence 9997543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=269.07 Aligned_cols=187 Identities=23% Similarity=0.424 Sum_probs=159.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. .+.+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 82 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~-~ 156 (283)
T 3gen_A 82 VQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVND-Q 156 (283)
T ss_dssp CCEEEEECS--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECT-T
T ss_pred eeEEEEEec--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcC-C
Confidence 578898865 6889999999999999999987 457999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+.......+.
T Consensus 157 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~-~~~~~~~~~~~ 235 (283)
T 3gen_A 157 GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-FTNSETAEHIA 235 (283)
T ss_dssp SCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHH
T ss_pred CCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc-cChhHHHHHHh
Confidence 799999999998764322 22334788999999887 569999999999999999998 9999987 45566667777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
.+..+. .+...++.++++|.+||. +|.+|||+.++++|-
T Consensus 236 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 236 QGLRLY-RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cccCCC-CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 665433 345678999999999999 899999999999763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=282.10 Aligned_cols=186 Identities=24% Similarity=0.423 Sum_probs=160.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|++|+++.. .+.++|||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+
T Consensus 138 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iv 213 (382)
T 3tt0_A 138 INLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CI 213 (382)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred hhheeeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--Ee
Confidence 578998866 678999999999999999998764 4999999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus 214 H~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~ 292 (382)
T 3tt0_A 214 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 292 (382)
T ss_dssp CSCCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999854 799999999998765421 223457889999998865 58999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.. .+..++...+..+..+. .....++++++||.+||. +|.+|||+.+++++
T Consensus 293 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 293 PYPG-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp SSTT-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9987 56677777777776543 345678999999999999 89999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=274.99 Aligned_cols=194 Identities=22% Similarity=0.344 Sum_probs=148.4
Q ss_pred CEEEEEEEecCCC----eEEEEEecCCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANR----NINFVTEMFTSGTLRQYRLKHR------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~----~i~LVtEy~~gGSL~~~l~k~~------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
+++|+++...... ..++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp 165 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAA 165 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCc
Confidence 5678888763221 2499999999999999987543 5999999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++.+ +.+||+|||++........ ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...
T Consensus 166 ~NIli~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~- 243 (323)
T 3qup_A 166 RNCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI- 243 (323)
T ss_dssp GGEEECTT-SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-
T ss_pred ceEEEcCC-CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcccc-
Confidence 99999854 7999999999987644321 22347889999998875 48999999999999999999 99999874
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCC-------HHHHhcCcccccC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-------ARELLTDPFLQID 199 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-------a~ELL~HPFf~~~ 199 (654)
+...++..+..+..+. .....++++++||.+||. +|.+||| +++++.|||+...
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 244 ENAEIYNYLIGGNRLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CGGGHHHHHHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ChHHHHHHHhcCCCCC-CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 4455666666665433 345678999999999999 8999999 7788899998643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=265.63 Aligned_cols=186 Identities=24% Similarity=0.411 Sum_probs=157.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. ...+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 66 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~- 140 (268)
T 3sxs_A 66 VKFYGVCSK--EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD- 140 (268)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-
T ss_pred eeEEEEEcc--CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-
Confidence 578898765 678999999999999999998754 5999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCc---cccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~---~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++......... ...+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+.......+.
T Consensus 141 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~ 219 (268)
T 3sxs_A 141 LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL-YTNSEVVLKVS 219 (268)
T ss_dssp CCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHH
T ss_pred CCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc-cChHHHHHHHH
Confidence 79999999999866543322 2346778999999875 58999999999999999999 9999987 44555666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 220 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 220 QGHRLY-RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTCCCC-CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665433 345578999999999999 89999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.10 Aligned_cols=185 Identities=21% Similarity=0.340 Sum_probs=155.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.+ .+.++|||||+.||+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 113 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~- 187 (325)
T 3kul_A 113 IRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN- 187 (325)
T ss_dssp CCEEEEECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-
T ss_pred CcEEEEEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-
Confidence 578998866 67899999999999999999765 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++........ ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...
T Consensus 188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~ 266 (325)
T 3kul_A 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISS 266 (325)
T ss_dssp CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHH
T ss_pred CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHH
Confidence 7999999999987654321 2234678999999987 458999999999999999999 9999987 456667777
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+. .....++++.+||.+||. +|.+|||+.++++
T Consensus 267 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 267 VEEGYRLP-APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC-CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 77765433 345678999999999999 8999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=282.09 Aligned_cols=189 Identities=19% Similarity=0.251 Sum_probs=151.1
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++|+++..... ..++|||||| ||+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEec
Confidence 578998887433 5689999999 99999999876 67999999999999999999999998 999999999999982
Q ss_pred -CCCcEEEEecCchhhhcccC---------CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 78 -NQGEVKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 78 -~~g~VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
..+.+||+|||+++.+.... ....+||+.|+|||++.+. ++.++||||||+++|+|+||..||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 34799999999997654321 1234599999999998754 999999999999999999999999853333
Q ss_pred HHHHHHHHcC---CCCcc-----cccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 AQIYKKVISG---KKPEA-----LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 ~qi~kki~~G---~~p~~-----l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.........+ ..+.. .....++++.+||..||. +|.+||++.+|++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3322221111 10000 014568899999999999 8999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=274.75 Aligned_cols=186 Identities=20% Similarity=0.286 Sum_probs=158.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH------------------------RRVNIRAVKHWCRQILSGLLYL 56 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~------------------------~~Lse~~i~~i~~QIl~gL~YL 56 (654)
|++|+++.. .+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.||
T Consensus 113 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 190 (343)
T 1luf_A 113 VKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190 (343)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEcc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 578998866 67899999999999999999874 5699999999999999999999
Q ss_pred HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHH
Q 006244 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCIL 131 (654)
Q Consensus 57 Hs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ 131 (654)
|+++ |+||||||+|||++.+ +.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|
T Consensus 191 H~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 191 SERK--FVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267 (343)
T ss_dssp HHTT--CCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC--eecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHH
Confidence 9999 9999999999999854 799999999998764332 22345889999999886 45999999999999999
Q ss_pred HHhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 132 EMVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 132 ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+|++ |..||.. .+...+...+..+..+. .+...+++++++|.+||. +|.+||++.+++++
T Consensus 268 el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 268 EIFSYGLQPYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHTTTCCTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCcCCC-CChHHHHHHHhCCCcCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999 9999987 45667777777776543 445678999999999999 89999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=273.49 Aligned_cols=186 Identities=25% Similarity=0.352 Sum_probs=157.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++|+++.. .+.+++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+
T Consensus 89 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 164 (327)
T 1fvr_A 89 INLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FI 164 (327)
T ss_dssp CCEEEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred hhhceeeee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 578999887 789999999999999999998764 6999999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYS 141 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~ 141 (654)
||||||+|||++.+ +.+||+|||++....... .....+|+.|+|||++.. .++.++||||||+++|+|++ |..||.
T Consensus 165 H~dlkp~NIl~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 165 HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCccceEEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 99999999999854 799999999997543322 233457899999998874 48999999999999999998 999998
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
. .+...++..+..+..+. .....++++++||.+||. +|.+|||+.+++++
T Consensus 244 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 244 G-MTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp T-CCHHHHHHHGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CcHHHHHHHhhcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7 45667777777664433 344578999999999999 89999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-31 Score=273.28 Aligned_cols=186 Identities=18% Similarity=0.241 Sum_probs=153.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.+ .+.++|||||+ +|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 68 ~~~~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~- 141 (330)
T 2izr_A 68 PQVYYFGPC--GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP- 141 (330)
T ss_dssp CCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-
T ss_pred CEEEEEEec--CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-
Confidence 578888887 78999999999 99999999874 67999999999999999999999999 9999999999999854
Q ss_pred Cc-----EEEEecCchhhhcccC---------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC-
Q 006244 80 GE-----VKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC- 143 (654)
Q Consensus 80 g~-----VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~- 143 (654)
+. +||+|||++..+.... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 142 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 142 GNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp GGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 55 9999999998764332 134579999999999875 4899999999999999999999999764
Q ss_pred -CCHHHHHHHHHcCCCCc--ccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 144 -THPAQIYKKVISGKKPE--ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 144 -~~~~qi~kki~~G~~p~--~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
......+..+..+..+. .......|+++++|..||. +|.+||++.+|++
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 222 ADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 33445555554433221 1112224599999999999 8999999999886
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=275.48 Aligned_cols=188 Identities=24% Similarity=0.358 Sum_probs=150.0
Q ss_pred CEEEEEEEecC--CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeEecCC
Q 006244 1 MKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR----------DPPVIHRDL 68 (654)
Q Consensus 1 VkfY~sfvd~~--~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~----------~p~IIHRDL 68 (654)
|++|+.+.... ...+++|||||.+|+|.+++... .+++..+..++.||+.||.|||+. + |+||||
T Consensus 81 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dl 157 (322)
T 3soc_A 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDI 157 (322)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCC
T ss_pred hhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCC
Confidence 67899988743 34689999999999999999774 599999999999999999999998 7 999999
Q ss_pred CCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc------cCCcccchhhhhhHHHHHhhcCC
Q 006244 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE------EYNELVDIYSFGMCILEMVTFDY 138 (654)
Q Consensus 69 KpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~------~ys~ksDIWSLGiiL~ELlTG~~ 138 (654)
||+|||++. .+.+||+|||++..+.... ....+||+.|+|||++.+ .++.++||||||+++|+|+||..
T Consensus 158 kp~Nill~~-~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 236 (322)
T 3soc_A 158 KSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236 (322)
T ss_dssp SGGGEEECT-TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBT
T ss_pred ChHhEEECC-CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCC
Confidence 999999985 4799999999997664322 233569999999999874 46778999999999999999999
Q ss_pred CCCCCC---------------CHHHHHHHHHcCCCCcccccC-----CChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 139 PYSECT---------------HPAQIYKKVISGKKPEALFKV-----EDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 139 Pf~~~~---------------~~~qi~kki~~G~~p~~l~~~-----~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
||.... ....+...+..+.....+... .++++.+||.+||. +|.+|||+.++++
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 996532 233333333333322222111 13459999999999 8999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=268.54 Aligned_cols=185 Identities=24% Similarity=0.447 Sum_probs=146.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++. .+.+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 79 v~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~- 152 (281)
T 1mp8_A 79 VKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN- 152 (281)
T ss_dssp CCEEEEEC---SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-
T ss_pred ceEEEEEc---cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-
Confidence 57888763 467899999999999999998764 6999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.... ...+...+.
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-~~~~~~~i~ 231 (281)
T 1mp8_A 153 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIE 231 (281)
T ss_dssp TEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHH
T ss_pred CCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-HHHHHHHHH
Confidence 799999999998765432 22334788999999987 458999999999999999997 999998743 445566666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .....++++.++|.+||. +|.+|||+.+++++
T Consensus 232 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 232 NGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665433 456678999999999999 89999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=269.68 Aligned_cols=187 Identities=21% Similarity=0.341 Sum_probs=158.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------RVNIRAVKHWCRQILSGLLYLHSRDPP 62 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~------------------~Lse~~i~~i~~QIl~gL~YLHs~~p~ 62 (654)
+++++++.. .+.+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++
T Consensus 90 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 165 (313)
T 1t46_A 90 VNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-- 165 (313)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eeEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 578898876 678999999999999999998764 3899999999999999999999999
Q ss_pred eEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-c
Q 006244 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-F 136 (654)
Q Consensus 63 IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G 136 (654)
|+||||||+|||++.+ +.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|+| |
T Consensus 166 i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 166 CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp CCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 9999999999999854 7999999999987654322 2334788999999876 458999999999999999999 9
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 137 DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 137 ~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..||............+..+..+. .....+++++++|.+||. +|.+|||+.+++++
T Consensus 245 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 245 SSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999988666666666665554432 345678999999999999 89999999999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=272.19 Aligned_cols=189 Identities=24% Similarity=0.385 Sum_probs=160.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR----------------VNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~----------------Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++|+++... +..+++||||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+
T Consensus 94 v~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~ 170 (316)
T 2xir_A 94 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 170 (316)
T ss_dssp CCEEEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred eeEEEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cc
Confidence 5788887653 4579999999999999999987654 899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++. .+.+||+|||++........ ....||+.|+|||++.+ .++.++||||||+++|+|+| |..
T Consensus 171 H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 171 HRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CSCCSGGGEEECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccCccceEEECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999984 47999999999986643321 23457899999998864 58999999999999999998 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
||........+...+..+..+. .....+++++++|.+||. +|.+|||+.++++|.
T Consensus 250 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 250 PYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccchhHHHHHHhccCccCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9988766667777777665433 345678999999999999 899999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=281.86 Aligned_cols=190 Identities=30% Similarity=0.427 Sum_probs=148.6
Q ss_pred CEEEEEEEecCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTAN----RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~----~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++++.|..... ..+++||||+. |+|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 104 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~ 178 (371)
T 4exu_A 104 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN 178 (371)
T ss_dssp CCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred hhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC
Confidence 467777765321 13499999996 68988764 45999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++...... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...... ...+.
T Consensus 179 ~~-~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~ 255 (371)
T 4exu_A 179 ED-CELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQIL 255 (371)
T ss_dssp TT-CCEEECSTTCC---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHH
T ss_pred CC-CCEEEEecCcccccccC-cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 54 79999999999866443 344579999999998865 589999999999999999999999987443333 33332
Q ss_pred c--CCCCc---------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 S--GKKPE---------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~--G~~p~---------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. |..+. ..+...++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 329 (371)
T 4exu_A 256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329 (371)
T ss_dssp HHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccccc
Confidence 2 11111 1123468999999999999 8999999999999999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=263.71 Aligned_cols=186 Identities=25% Similarity=0.423 Sum_probs=153.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.|.+ . .++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++++|+||||||+|||++.+
T Consensus 86 ~~~~~~~~~--~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~- 160 (287)
T 4f0f_A 86 VKLYGLMHN--P--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL- 160 (287)
T ss_dssp CCEEEEETT--T--TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-
T ss_pred hhhheeecC--C--CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-
Confidence 578887754 2 27999999999999988764 46999999999999999999999998779999999999999754
Q ss_pred Cc-----EEEEecCchhhhcccCCccccCCCCccChhhhc---ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHH-HHH
Q 006244 80 GE-----VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE---EEYNELVDIYSFGMCILEMVTFDYPYSECTHPA-QIY 150 (654)
Q Consensus 80 g~-----VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~---~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~-qi~ 150 (654)
+. +||+|||++...... .....||+.|+|||++. ..++.++||||||+++|+|++|..||....... ...
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 239 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVHS-VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSSC-EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred CCCCceeEEeCCCCcccccccc-ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence 44 999999999754432 33457999999999983 347899999999999999999999997654333 334
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+........+....+++++++|.+||. +|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 44455555555667789999999999999 8999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=267.04 Aligned_cols=186 Identities=28% Similarity=0.463 Sum_probs=149.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|++. . ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 83 v~~~~~~-~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~- 156 (289)
T 3og7_A 83 LLFMGYS-T--APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED- 156 (289)
T ss_dssp CCEEEEE-C--SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-
T ss_pred EEEEeec-c--CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-
Confidence 4677743 2 46789999999999999998654 46999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhccc----CCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||....+...+..
T Consensus 157 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 236 (289)
T 3og7_A 157 NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236 (289)
T ss_dssp TEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHH
T ss_pred CCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHH
Confidence 79999999999765431 223346999999999885 3478899999999999999999999998888888888
Q ss_pred HHHcCCCCccc---ccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 152 KVISGKKPEAL---FKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 152 ki~~G~~p~~l---~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+..+..+ ....++++++||.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 237 MVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 88777654433 34567899999999999 8999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=278.86 Aligned_cols=189 Identities=18% Similarity=0.263 Sum_probs=152.1
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+... ....++|||||+ ||+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence 5788988873 257899999999 9999999988778999999999999999999999999 9999999999999854
Q ss_pred C-CcEEEEecCchhhhcccC---------CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCC-CCH
Q 006244 79 Q-GEVKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSEC-THP 146 (654)
Q Consensus 79 ~-g~VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~-~~~ 146 (654)
. +.+||+|||+++.+.... .....||+.|+|||++.+. ++.++||||||+++|+|++|..||... .+.
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 2 389999999997654321 1344699999999998754 899999999999999999999999543 233
Q ss_pred HHHHHHH--HcCCCCcccc-----cCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 AQIYKKV--ISGKKPEALF-----KVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 ~qi~kki--~~G~~p~~l~-----~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+.... .....|..+. ...+++++++|.+||. +|.+||++.+|++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 268 VAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2222111 1122222111 1578899999999999 8999999999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=274.26 Aligned_cols=185 Identities=21% Similarity=0.396 Sum_probs=154.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++. ...+++||||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++. .
T Consensus 78 v~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~-~ 151 (325)
T 3kex_A 78 VRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKS-P 151 (325)
T ss_dssp CCEEEEEC---BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESS-S
T ss_pred CeEEEEEc---CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECC-C
Confidence 57888764 36799999999999999999875 47999999999999999999999999 999999999999975 4
Q ss_pred CcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||... ....+...+
T Consensus 152 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~ 230 (325)
T 3kex_A 152 SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-RLAEVPDLL 230 (325)
T ss_dssp SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CTTHHHHHH
T ss_pred CeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc-CHHHHHHHH
Confidence 799999999998765432 23345888999999987 569999999999999999999 99999874 445555666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..+. .....++++.++|.+||. +|.+||++.+++++
T Consensus 231 ~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 231 EKGERLA-QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HTTCBCC-CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HcCCCCC-CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6654332 344577899999999999 89999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.83 Aligned_cols=186 Identities=23% Similarity=0.428 Sum_probs=158.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. .+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 66 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~- 140 (267)
T 3t9t_A 66 VQLYGVCLE--QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN- 140 (267)
T ss_dssp CCEEEEECS--SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-
T ss_pred eeEEEEEcc--CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-
Confidence 578898876 67899999999999999999875 46999999999999999999999999 9999999999999744
Q ss_pred CcEEEEecCchhhhccc---CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++...... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+.
T Consensus 141 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~ 219 (267)
T 3t9t_A 141 QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDIS 219 (267)
T ss_dssp GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHH
T ss_pred CCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHh
Confidence 79999999999876432 223345788999999987 458999999999999999999 8999987 45666777777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .+...++.++++|.+||. +|.+||++.+++++
T Consensus 220 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 220 TGFRLY-KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp TTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCcCC-CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 765432 345678999999999999 89999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=272.24 Aligned_cols=185 Identities=26% Similarity=0.448 Sum_probs=155.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. ...++|+||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 80 v~~~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~- 153 (327)
T 3poz_A 80 CRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP- 153 (327)
T ss_dssp CCEEEEEES---SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-
T ss_pred eEEEEEEec---CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-
Confidence 578998876 4588999999999999999874 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+++.+..... ....||+.|+|||++.+ .++.++||||||+++|+|+| |..||.. .+...+...+
T Consensus 154 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~ 232 (327)
T 3poz_A 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSIL 232 (327)
T ss_dssp TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHH
T ss_pred CCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC-CCHHHHHHHH
Confidence 7999999999987754322 22347889999998864 58999999999999999999 9999986 3455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..+. .....++++.++|.+||. +|.+||++.+++.+
T Consensus 233 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 233 EKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HTTCCCC-CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HcCCCCC-CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 6655433 345678899999999999 89999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=271.90 Aligned_cols=186 Identities=25% Similarity=0.423 Sum_probs=159.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
+++|+++.. .+.+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+
T Consensus 104 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--iv 179 (334)
T 2pvf_A 104 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CI 179 (334)
T ss_dssp CCEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eeEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 578998866 678999999999999999998754 3899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||++....... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus 180 H~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 180 HRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp CSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999854 799999999998664422 223357889999998864 58999999999999999999 999
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||.. .+...+...+..+..+. .....+++++++|.+||. +|.+|||+.+++++
T Consensus 259 p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 259 PYPG-IPVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp SSTT-CCHHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCc-CCHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9987 45677777777776443 445678999999999999 89999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=267.19 Aligned_cols=183 Identities=20% Similarity=0.283 Sum_probs=150.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~-Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+.+ .+..++||||+.||+|.+++.+.+. +++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 75 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~- 149 (289)
T 4fvq_A 75 VLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIRE- 149 (289)
T ss_dssp CCEEEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEEC-
T ss_pred eEEEEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecC-
Confidence 578998876 6788999999999999999988764 999999999999999999999999 9999999999999855
Q ss_pred Cc--------EEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 80 GE--------VKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 80 g~--------VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
+. +||+|||++...... ....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.........
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred CcccccccceeeeccCcccccccCc--cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 44 999999998765332 23458999999999874 4899999999999999999965555444444444
Q ss_pred HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 150 YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 150 ~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
........ .++...++++++||.+||. +|.+|||+.+++++
T Consensus 228 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 228 LQFYEDRH---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHTTC---CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHhhccC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44333322 2334457889999999999 89999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=267.13 Aligned_cols=188 Identities=28% Similarity=0.421 Sum_probs=146.9
Q ss_pred CEEEEEEEecC--CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH--------SRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~--~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLH--------s~~p~IIHRDLKp 70 (654)
+++|+.+.... ...+++||||+.+|+|.++++. ..+++..+..++.||+.||.||| +++ |+||||||
T Consensus 65 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp 141 (301)
T 3q4u_A 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKS 141 (301)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCG
T ss_pred eeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCCh
Confidence 57888877632 3579999999999999999854 57999999999999999999999 887 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC------CccccCCCCccChhhhccc-------CCcccchhhhhhHHHHHhhc-
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEEE-------YNELVDIYSFGMCILEMVTF- 136 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~~-------ys~ksDIWSLGiiL~ELlTG- 136 (654)
+|||++.+ +.+||+|||++....... ....+||+.|+|||++.+. ++.++||||||+++|+|+||
T Consensus 142 ~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~ 220 (301)
T 3q4u_A 142 KNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220 (301)
T ss_dssp GGEEECTT-SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred HhEEEcCC-CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence 99999854 799999999997654332 2234799999999998753 45789999999999999999
Q ss_pred ---------CCCCCCCC----CHHHHHHHHHcCCCCcccc-----cCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 137 ---------DYPYSECT----HPAQIYKKVISGKKPEALF-----KVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 137 ---------~~Pf~~~~----~~~qi~kki~~G~~p~~l~-----~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..||.... ....+...+........++ ...++++.+||.+||. +|.+|||+.++++
T Consensus 221 ~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 88886532 2223322222222111111 1234679999999999 8999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.42 Aligned_cols=191 Identities=27% Similarity=0.342 Sum_probs=147.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~- 78 (654)
|++|+.+.+ ...+|||||||. |+|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 v~l~~~~~~--~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 81 IRYFCTEKD--RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPN 155 (432)
T ss_dssp CCEEEEEEE--TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCB
T ss_pred CeEEEEEec--CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCC
Confidence 678998887 789999999995 69999998754 4566677899999999999999999 9999999999999532
Q ss_pred ---CCcEEEEecCchhhhccc-----CCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhh-cCCCCCCCCC
Q 006244 79 ---QGEVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVT-FDYPYSECTH 145 (654)
Q Consensus 79 ---~g~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~ 145 (654)
...+||+|||++..+... .....+||+.|+|||++. ..++.++|||||||++|+|++ |..||....
T Consensus 156 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~- 234 (432)
T 3p23_A 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL- 234 (432)
T ss_dssp TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT-
T ss_pred CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh-
Confidence 236889999999876532 223456999999999986 347779999999999999999 999996533
Q ss_pred HHHHHHHHHcCCCCcc---cccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 146 PAQIYKKVISGKKPEA---LFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 146 ~~qi~kki~~G~~p~~---l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+.. . ..+..... .....++.+++||.+||. +|.+|||+.++|+||||...
T Consensus 235 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 235 QRQAN-I-LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp THHHH-H-HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHH-H-HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 22222 2 22222111 112235668999999999 89999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=263.52 Aligned_cols=177 Identities=27% Similarity=0.452 Sum_probs=150.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCc
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 89 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGL 89 (654)
...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 168 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGL 168 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTT
T ss_pred cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-CCEEECcchh
Confidence 45689999999999999999764 57999999999999999999999999 9999999999999854 7999999999
Q ss_pred hhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCC
Q 006244 90 AAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED 167 (654)
Q Consensus 90 A~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~s 167 (654)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ....+..+..+..+ ...+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~~~----~~~~ 241 (284)
T 2a19_B 169 VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIIS----DIFD 241 (284)
T ss_dssp CEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTCCC----TTSC
T ss_pred heeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccccc----ccCC
Confidence 98765432 334569999999998875 489999999999999999999998853 23444555555433 4568
Q ss_pred hHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 168 PEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 168 pelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.++++|.+||. +|.+|||+.+++++++.-.
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 899999999999 8999999999999987643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=264.03 Aligned_cols=184 Identities=21% Similarity=0.346 Sum_probs=157.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++ . ...+++||||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 81 ~~~~~~~-~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~ 154 (291)
T 1xbb_A 81 VRMIGIC-E--AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-H 154 (291)
T ss_dssp CCEEEEE-E--SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-T
T ss_pred EEEEEEE-C--CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-C
Confidence 5788887 3 5689999999999999999999888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCC-----ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+||+|||++........ ....+|+.|+|||++.. .++.++||||||+++|+|++ |..||.. .+...+...+
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~ 233 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAML 233 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHH
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHH
Confidence 999999999987643321 22346789999998864 58899999999999999999 9999987 4566677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .+...++.++++|.+||. +|.+||++.++++
T Consensus 234 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 234 EKGERMG-CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7766543 455678999999999999 8999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=261.55 Aligned_cols=178 Identities=22% Similarity=0.305 Sum_probs=145.8
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEecC
Q 006244 12 NRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKIGDLG 88 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~~g~VKL~DFG 88 (654)
...+++||||+ +|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+.+.+||+|||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 67999999999 9999999985 457999999999999999999999999 99999999999995 245789999999
Q ss_pred chhhhcccC---------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcC
Q 006244 89 LAAILRKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISG 156 (654)
Q Consensus 89 LA~~l~~~~---------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~--~~qi~kki~~G 156 (654)
++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ..+.+..+..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc
Confidence 998765432 234569999999999875 589999999999999999999999976322 22233333322
Q ss_pred C---CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 K---KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~---~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
. .+..+....++++.++|.+||. +|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1 1122335678999999999999 8999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=268.33 Aligned_cols=189 Identities=26% Similarity=0.441 Sum_probs=146.6
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeEecCCCC
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR--------DPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~--------~p~IIHRDLKp 70 (654)
+++|+.+..... ..+++||||+.+|+|.+++... .+++..+..++.||+.||.|||++ + |+||||||
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp 170 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKS 170 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCG
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccch
Confidence 578998887432 7899999999999999999764 699999999999999999999998 7 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccCC------ccccCCCCccChhhhccc-CCc------ccchhhhhhHHHHHhhc-
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSHA------ARCVGTPEFMAPEVYEEE-YNE------LVDIYSFGMCILEMVTF- 136 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~~------~~~vGTp~YmAPEvl~~~-ys~------ksDIWSLGiiL~ELlTG- 136 (654)
+|||++.+ +.+||+|||++..+..... ...+||+.|+|||++.+. +.. ++|||||||++|||+||
T Consensus 171 ~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 171 KNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGEEECTT-SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred HHEEECCC-CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 99999854 7999999999976543221 245799999999998754 333 38999999999999999
Q ss_pred ---------CCCCCCCC----CHHHHHHHHHcCCCCccccc-----CCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 137 ---------DYPYSECT----HPAQIYKKVISGKKPEALFK-----VEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 137 ---------~~Pf~~~~----~~~qi~kki~~G~~p~~l~~-----~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..||.... ....+...+........+.. ..++++.+||.+||. +|.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 77775422 22222222222222211211 234679999999999 89999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.64 Aligned_cols=191 Identities=25% Similarity=0.341 Sum_probs=145.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRV-------NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~L-------se~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++|+.+.. .+.+|||||||. |+|.+++...... ++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 72 v~~~~~~~~--~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NI 146 (434)
T 2rio_A 72 IRYYCSETT--DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNI 146 (434)
T ss_dssp CCEEEEEEC--SSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred CeEEEEEec--CCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhE
Confidence 678998876 789999999995 6999999876533 22345779999999999999999 99999999999
Q ss_pred EEeCC------------CCcEEEEecCchhhhcccC------CccccCCCCccChhhhcc--------cCCcccchhhhh
Q 006244 74 FVNGN------------QGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE--------EYNELVDIYSFG 127 (654)
Q Consensus 74 LId~~------------~g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLG 127 (654)
|++.+ .+.+||+|||++..+.... ....+||+.|+|||++.+ .++.++||||||
T Consensus 147 Ll~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG 226 (434)
T 2rio_A 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226 (434)
T ss_dssp EEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHH
T ss_pred EEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHH
Confidence 99742 3489999999998765432 123469999999999853 488999999999
Q ss_pred hHHHHHhh-cCCCCCCCCCHHHHHHHHHcCCCCcc-cc----cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 128 MCILEMVT-FDYPYSECTHPAQIYKKVISGKKPEA-LF----KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 128 iiL~ELlT-G~~Pf~~~~~~~qi~kki~~G~~p~~-l~----~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
|++|+|+| |..||....... ..+..+..... .. ...++++++||.+||. +|.+|||+.++|+||||...
T Consensus 227 ~il~ellt~g~~Pf~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 227 CVFYYILSKGKHPFGDKYSRE---SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHHHHHHTTSCCTTCSTTTHH---HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHHHHHHhCCCCCCCCchhhH---HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 99999999 999997644332 23334432211 11 1234789999999999 89999999999999999643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=268.65 Aligned_cols=185 Identities=21% Similarity=0.392 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.. ...+++||||+.||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .
T Consensus 92 v~~~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~ 165 (319)
T 2y4i_B 92 VLFMGACMS--PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--N 165 (319)
T ss_dssp CCCCEEEEC--SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---
T ss_pred eEEEEEEec--CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--C
Confidence 567888876 678999999999999999988755 6999999999999999999999999 99999999999997 3
Q ss_pred CcEEEEecCchhhhcc-------cCCccccCCCCccChhhhcc----------cCCcccchhhhhhHHHHHhhcCCCCCC
Q 006244 80 GEVKIGDLGLAAILRK-------SHAARCVGTPEFMAPEVYEE----------EYNELVDIYSFGMCILEMVTFDYPYSE 142 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~-------~~~~~~vGTp~YmAPEvl~~----------~ys~ksDIWSLGiiL~ELlTG~~Pf~~ 142 (654)
+.+||+|||++..... .......||+.|+|||++.. .++.++||||||+++|+|++|..||..
T Consensus 166 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp -CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 6899999999875432 12223458999999999863 378899999999999999999999987
Q ss_pred CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 143 CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 143 ~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.....+...+..+..+.......++++.++|.+||. +|.+|||+.++++
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 246 -QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -CCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -CCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 456677777878877765555678899999999999 8999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-31 Score=271.05 Aligned_cols=191 Identities=20% Similarity=0.325 Sum_probs=161.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-------RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-------~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
+++|+++.. ...+++||||+.||+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+||
T Consensus 96 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NI 171 (327)
T 2yfx_A 96 VRCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNC 171 (327)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred CeEEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHE
Confidence 578998876 678899999999999999998763 4899999999999999999999999 99999999999
Q ss_pred EEeC--CCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCC
Q 006244 74 FVNG--NQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTH 145 (654)
Q Consensus 74 LId~--~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~ 145 (654)
|++. +...+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.. .+
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~ 250 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KS 250 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CC
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cC
Confidence 9983 23469999999998654322 22345899999999886 458999999999999999998 9999986 45
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 146 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 146 ~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
...+...+..+..+. .....++.++++|.+||. +|.+||++.+++++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 251 NQEVLEFVTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 666777777765543 345678999999999999 899999999999998874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=262.98 Aligned_cols=187 Identities=31% Similarity=0.513 Sum_probs=150.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++|+.+.. .+.+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 95 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~ 170 (310)
T 2wqm_A 95 IKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT 170 (310)
T ss_dssp CCEEEEEEE--TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred eeEEEEEEc--CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc
Confidence 578999987 7899999999999999999875 456999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC--CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCC-CCHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSEC-THPAQIYKK 152 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~-~~~~qi~kk 152 (654)
.+ +.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||... .+...+...
T Consensus 171 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 249 (310)
T 2wqm_A 171 AT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249 (310)
T ss_dssp TT-SCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH
T ss_pred CC-CCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH
Confidence 54 799999999998765432 233469999999998864 5899999999999999999999999754 345566677
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+.......+++++++|.+||. +|.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 777776655556788999999999999 8999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=267.25 Aligned_cols=186 Identities=21% Similarity=0.382 Sum_probs=158.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
+++|+++.. .+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 91 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp 166 (322)
T 1p4o_A 91 VRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAA 166 (322)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSG
T ss_pred eeeEEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCcc
Confidence 578888765 67899999999999999998763 35799999999999999999999999 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~ 144 (654)
+|||++.+ +.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.. .
T Consensus 167 ~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~ 244 (322)
T 1p4o_A 167 RNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-L 244 (322)
T ss_dssp GGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-S
T ss_pred ceEEEcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-C
Confidence 99999854 799999999998664432 123357899999999864 58999999999999999999 8899976 4
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+..++...+..+..+. .....++.++++|.+||. +|.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 245 SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5667777777765543 345678999999999999 89999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=263.79 Aligned_cols=188 Identities=27% Similarity=0.447 Sum_probs=152.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.......+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~- 162 (302)
T 4e5w_A 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE- 162 (302)
T ss_dssp CCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-
T ss_pred eeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-
Confidence 578999988656889999999999999999955 457999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCC-----------
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSE----------- 142 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~----------- 142 (654)
+.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+..
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 242 (302)
T 4e5w_A 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242 (302)
T ss_dssp TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCC
Confidence 799999999998765432 233458889999998864 588999999999999999999988632
Q ss_pred ---CCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 143 ---CTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 143 ---~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
......+...+..+... ..+...++++.+||.+||. +|.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 243 THGQMTVTRLVNTLKEGKRL-PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CCGGGHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cccccCHHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11222333444444433 3455678999999999999 8999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=277.90 Aligned_cols=185 Identities=22% Similarity=0.338 Sum_probs=155.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+.. ...++|||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 175 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~- 249 (377)
T 3cbl_A 175 VRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK- 249 (377)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-
T ss_pred EEEEEEEec--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-
Confidence 578998865 678999999999999999998654 6999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCc----cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHAA----RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~----~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++......... ...+++.|+|||++. +.++.++||||||+++|||++ |..||... ...++...+
T Consensus 250 ~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~ 328 (377)
T 3cbl_A 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFV 328 (377)
T ss_dssp CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHH
T ss_pred CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 79999999999765432211 123567899999886 568999999999999999998 99999874 455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .+...++++.+||.+||. +|.+|||+.++++
T Consensus 329 ~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 329 EKGGRLP-CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6665432 345678899999999999 8999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=263.52 Aligned_cols=187 Identities=20% Similarity=0.347 Sum_probs=158.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+. .+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 73 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~- 146 (287)
T 1u59_A 73 VRLIGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR- 146 (287)
T ss_dssp CCEEEEEE---SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-
T ss_pred eEEEEEec---CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-
Confidence 57888883 46799999999999999998754 46999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.... ...+...
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~ 225 (287)
T 1u59_A 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAF 225 (287)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHH
T ss_pred CCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHH
Confidence 799999999998764322 12234789999999987 458999999999999999998 999998744 4556667
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
+..+..+. .+...+++++++|.+||. +|.+||++.+++++.+
T Consensus 226 i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 226 IEQGKRME-CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HhcCCcCC-CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 77765443 455788999999999999 8999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=282.29 Aligned_cols=185 Identities=21% Similarity=0.372 Sum_probs=155.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~--Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.+... +..++||||||.+|+|.+++.+.+. +++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 249 v~~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~ 325 (450)
T 1k9a_A 249 VQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED 325 (450)
T ss_dssp CCEEEEEECT-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT
T ss_pred EEEEEEEEcC-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC
Confidence 5789987763 3489999999999999999987543 799999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||+++...... ....+|+.|+|||++. ..++.++||||||+++|||++ |..||.... ..++...+..|
T Consensus 326 -~~~kl~DfG~a~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~ 402 (450)
T 1k9a_A 326 -NVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKG 402 (450)
T ss_dssp -SCEEECCCTTCEECC-------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC-TTTHHHHHHTT
T ss_pred -CCEEEeeCCCcccccccc-cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcC
Confidence 799999999997543322 2335789999999986 459999999999999999998 999998744 44566677777
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+. .+...++++.++|.+||. +|.+|||+.+++.
T Consensus 403 ~~~~-~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 YKMD-APDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5443 445678999999999999 8999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.24 Aligned_cols=186 Identities=22% Similarity=0.377 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEec
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHR 66 (654)
|++|+++.. .+.+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||
T Consensus 113 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~ 188 (333)
T 2i1m_A 113 VNLLGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHR 188 (333)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred eeEEEEEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccC
Confidence 578998866 67899999999999999998753 35899999999999999999999998 9999
Q ss_pred CCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCC
Q 006244 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPY 140 (654)
Q Consensus 67 DLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf 140 (654)
||||+|||++.+ +.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|+| |..||
T Consensus 189 Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 189 DVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp CCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999854 7999999999986644322 2334788999999886 458999999999999999999 99999
Q ss_pred CCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 141 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 141 ~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
........+...+..+..+ ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 268 PGILVNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp TTCCSSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccchhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 8766555555555555433 3345678999999999999 8999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=266.70 Aligned_cols=186 Identities=20% Similarity=0.215 Sum_probs=148.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. .+.+++||||+.|++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 97 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~ 171 (309)
T 2h34_A 97 VPIHDFGEI--DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-D 171 (309)
T ss_dssp CCEEEEEEE--TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-S
T ss_pred eEEEEEEee--CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-C
Confidence 578998887 7899999999999999999998888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC---CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||... +...+...+...
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~ 250 (309)
T 2h34_A 172 FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQA 250 (309)
T ss_dssp CEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSC
T ss_pred CEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccC
Confidence 99999999998765432 234569999999998864 5889999999999999999999999863 333444444433
Q ss_pred CC-CcccccCCChHHHHHHHHHhh-CccCCC-CHHHHhc
Q 006244 157 KK-PEALFKVEDPEVRQFIEKCLA-TVSSRL-SARELLT 192 (654)
Q Consensus 157 ~~-p~~l~~~~spelrdLI~kCL~-dP~~Rp-Ta~ELL~ 192 (654)
.. +.......+++++++|.+||. +|.+|| ++.+++.
T Consensus 251 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 251 IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 32 334456678999999999999 899999 7888875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-30 Score=259.32 Aligned_cols=178 Identities=22% Similarity=0.305 Sum_probs=145.0
Q ss_pred CCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEEecC
Q 006244 12 NRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQGEVKIGDLG 88 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~~g~VKL~DFG 88 (654)
....++||||+ +|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 68999999999 9999999985 457999999999999999999999999 99999999999993 245789999999
Q ss_pred chhhhcccC---------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH--HHHHHHHHcC
Q 006244 89 LAAILRKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP--AQIYKKVISG 156 (654)
Q Consensus 89 LA~~l~~~~---------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~--~qi~kki~~G 156 (654)
++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .+.+..+...
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 998765432 224569999999999875 5899999999999999999999999763321 1222333222
Q ss_pred CC---CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KK---PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~---p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.. ........++++++||.+||. +|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11 112234568899999999999 8999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-31 Score=275.03 Aligned_cols=190 Identities=29% Similarity=0.426 Sum_probs=148.6
Q ss_pred CEEEEEEEecCC----CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTAN----RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~----~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.+..... ..+++||||+. |+|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 86 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~ 160 (353)
T 3coi_A 86 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN 160 (353)
T ss_dssp CCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC
T ss_pred ccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC
Confidence 456777765321 24699999996 68888764 35999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++...... ....+||+.|+|||++.+ .++.++||||||+++|+|++|..||.+... ......+.
T Consensus 161 ~~-~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-~~~~~~i~ 237 (353)
T 3coi_A 161 ED-CELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQIL 237 (353)
T ss_dssp TT-CCEEECSTTCTTC---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-HHHHHHHH
T ss_pred CC-CcEEEeecccccCCCCC-ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 54 79999999999875433 334579999999998864 589999999999999999999999987443 33333322
Q ss_pred c--CCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 S--GKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~--G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. |..+ .......++++++||.+||. +|.+|||+.++|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp HHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1 1110 11234568999999999999 9999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=267.09 Aligned_cols=188 Identities=26% Similarity=0.426 Sum_probs=149.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.......+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 74 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~- 150 (295)
T 3ugc_A 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE- 150 (295)
T ss_dssp CCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-
T ss_pred eeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-
Confidence 57888887655678999999999999999998765 4999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH-------
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP------- 146 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~------- 146 (654)
+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|+||..||......
T Consensus 151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 230 (295)
T 3ugc_A 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230 (295)
T ss_dssp TEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCT
T ss_pred CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcC
Confidence 799999999998765432 12234778899999886 45899999999999999999999998641100
Q ss_pred --------HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 --------AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 --------~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+...+..+..+ ..+...++++.+||.+||. +|.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCCTHHHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccchhHHHHHHHHhccCcC-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0122223333322 2345678999999999999 8999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=262.33 Aligned_cols=185 Identities=21% Similarity=0.377 Sum_probs=152.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.+ ...++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 76 ~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~- 149 (281)
T 3cc6_A 76 VKLIGIIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP- 149 (281)
T ss_dssp CCEEEEECS---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-
T ss_pred ceEEEEEcC---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-
Confidence 578887653 4679999999999999999775 45999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.... .......+.
T Consensus 150 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-~~~~~~~~~ 228 (281)
T 3cc6_A 150 ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-NKDVIGVLE 228 (281)
T ss_dssp TEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-GGGHHHHHH
T ss_pred CcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-hHHHHHHHh
Confidence 799999999998765432 22345788999999886 458999999999999999998 999997643 344455555
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .....++.++++|.+||. +|.+|||+.+++++
T Consensus 229 ~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 229 KGDRLP-KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 554432 345678999999999999 89999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=261.69 Aligned_cols=185 Identities=24% Similarity=0.355 Sum_probs=155.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+++.. ..+++|+||+.+|+|.+++.+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 84 ~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~- 157 (291)
T 1u46_A 84 IRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR- 157 (291)
T ss_dssp CCEEEEECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-
T ss_pred ccEEEEEcc---CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-
Confidence 578888765 3489999999999999998874 56999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++....... .....+|+.|+|||++.. .++.++||||||+++|+|++ |..||.. .+..++...
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~ 236 (291)
T 1u46_A 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHK 236 (291)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHH
T ss_pred CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc-CCHHHHHHH
Confidence 799999999998764432 123457889999998864 58899999999999999999 9999987 456666677
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+.............+++++++|.+||. +|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 766554444556788999999999999 8999999999996
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=261.92 Aligned_cols=185 Identities=24% Similarity=0.343 Sum_probs=156.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+++.+ ...+++||||+.||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 72 ~~~~~~~~~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~ 147 (288)
T 3kfa_A 72 VQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN 147 (288)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG
T ss_pred eeEEEEEcc--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC
Confidence 578888766 678999999999999999998743 5999999999999999999999999 9999999999999744
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++........ ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+
T Consensus 148 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~ 225 (288)
T 3kfa_A 148 -HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELL 225 (288)
T ss_dssp -GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHH
T ss_pred -CCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 7999999999987654332 2234788999999886 458999999999999999999 9999986 4455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ..+...++.+++||.+||. +|.+|||+.++++
T Consensus 226 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 226 EKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCC-CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 655443 3445678999999999999 8999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=261.64 Aligned_cols=187 Identities=19% Similarity=0.298 Sum_probs=155.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++... +...++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++. .
T Consensus 85 v~~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~-~ 160 (298)
T 3pls_A 85 LALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDE-S 160 (298)
T ss_dssp CCCCEEECCS-SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT-T
T ss_pred eeEEEEEecC-CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcC-C
Confidence 5678877653 3445899999999999999987 456999999999999999999999999 999999999999985 4
Q ss_pred CcEEEEecCchhhhccc------CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS------HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~------~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..|+....+...+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~ 240 (298)
T 3pls_A 161 FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240 (298)
T ss_dssp CCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH
T ss_pred CcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH
Confidence 79999999999765332 2233458899999999875 5899999999999999999966666555666677777
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+. .....++.++++|.+||. +|.+|||+.++++
T Consensus 241 ~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 241 LAQGRRLP-QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCCCCC-CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 77665433 345678999999999999 8999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=265.18 Aligned_cols=185 Identities=29% Similarity=0.493 Sum_probs=146.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHS---RDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs---~~p~IIHRDLKpeNIL 74 (654)
|++|+.+. +.+++||||+.||+|.+++.... .++...+..|+.||+.||.|||+ ++ |+||||||+|||
T Consensus 64 v~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIl 137 (307)
T 2eva_A 64 VKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLL 137 (307)
T ss_dssp CCEEEBCT----TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEE
T ss_pred CeEEEEEc----CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEE
Confidence 56777654 45899999999999999998765 37899999999999999999999 66 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCC-HHHHHHH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTH-PAQIYKK 152 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~-~~qi~kk 152 (654)
++.+...+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+...
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 216 (307)
T 2eva_A 138 LVAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216 (307)
T ss_dssp EETTTTEEEECCCCC-------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH
T ss_pred EeCCCCEEEEcccccccccccc-cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH
Confidence 9865434899999999765433 233469999999999875 589999999999999999999999976443 3344445
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+..+..+. .....++.++++|.+||. +|.+|||+.+++++
T Consensus 217 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 217 VHNGTRPP-LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHTTCCCC-CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCC-cccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 55555443 445678999999999999 89999999999873
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=266.25 Aligned_cols=188 Identities=25% Similarity=0.361 Sum_probs=141.9
Q ss_pred CEEEEEEEe---cCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeEecCC
Q 006244 1 MKFYTSWVD---TANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR---------DPPVIHRDL 68 (654)
Q Consensus 1 VkfY~sfvd---~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~---------~p~IIHRDL 68 (654)
+++++.+.. .....++||||||++|+|.+++.... +++..+..++.||+.||.|||+. + |+||||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Di 146 (336)
T 3g2f_A 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDL 146 (336)
T ss_dssp CCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSC
T ss_pred hhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeeccc
Confidence 456665443 22447899999999999999997754 58999999999999999999999 7 999999
Q ss_pred CCCcEEEeCCCCcEEEEecCchhhhccc----------CCccccCCCCccChhhhcc--------cCCcccchhhhhhHH
Q 006244 69 KCDNIFVNGNQGEVKIGDLGLAAILRKS----------HAARCVGTPEFMAPEVYEE--------EYNELVDIYSFGMCI 130 (654)
Q Consensus 69 KpeNILId~~~g~VKL~DFGLA~~l~~~----------~~~~~vGTp~YmAPEvl~~--------~ys~ksDIWSLGiiL 130 (654)
||+|||++.+ +.+||+|||++..+... .....+||+.|+|||++.+ .++.++||||||+++
T Consensus 147 kp~Nill~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il 225 (336)
T 3g2f_A 147 NSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225 (336)
T ss_dssp SGGGEEECTT-SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEcCC-CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHH
Confidence 9999999854 79999999999765432 1224469999999999864 467789999999999
Q ss_pred HHHhhcCCCCCCCCC-----------------HHHHHHHHHcCCCCcccccC------CChHHHHHHHHHhh-CccCCCC
Q 006244 131 LEMVTFDYPYSECTH-----------------PAQIYKKVISGKKPEALFKV------EDPEVRQFIEKCLA-TVSSRLS 186 (654)
Q Consensus 131 ~ELlTG~~Pf~~~~~-----------------~~qi~kki~~G~~p~~l~~~------~spelrdLI~kCL~-dP~~RpT 186 (654)
|||++|..||..... ...+...+........++.. .++++++||.+||. +|.+|||
T Consensus 226 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp HHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc
Confidence 999999777633211 11222222222222222221 23479999999999 8999999
Q ss_pred HHHHhc
Q 006244 187 ARELLT 192 (654)
Q Consensus 187 a~ELL~ 192 (654)
+.++++
T Consensus 306 ~~e~l~ 311 (336)
T 3g2f_A 306 AQXAEE 311 (336)
T ss_dssp HHHHHH
T ss_pred hHHHHH
Confidence 999954
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.22 Aligned_cols=186 Identities=18% Similarity=0.269 Sum_probs=151.2
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
++++++.. .+..++|||||+ +|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 121 ~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~~~- 195 (352)
T 2jii_A 121 TCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPE- 195 (352)
T ss_dssp CCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEETT-
T ss_pred chhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEcCC-
Confidence 35666655 357999999999 99999999986 68999999999999999999999999 9999999999999854
Q ss_pred C--cEEEEecCchhhhcccC---------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC-CH
Q 006244 80 G--EVKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT-HP 146 (654)
Q Consensus 80 g--~VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~-~~ 146 (654)
+ .+||+|||++..+.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... +.
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 5 89999999997664321 123479999999999875 58999999999999999999999998754 44
Q ss_pred HHHHHHHH--cCCCCcc-----cccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 AQIYKKVI--SGKKPEA-----LFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 ~qi~kki~--~G~~p~~-----l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..... ....+.. .+...++++++||.+||. +|.+||++.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 44433332 1111111 112468999999999999 8999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=265.03 Aligned_cols=188 Identities=18% Similarity=0.338 Sum_probs=149.6
Q ss_pred CEEEEEEEecCCC---eEEEEEecCCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVDTANR---NINFVTEMFTSGTLRQYRLK------HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd~~~~---~i~LVtEy~~gGSL~~~l~k------~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
+++|+++...... ..++||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~ 176 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAAR 176 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGG
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcc
Confidence 5678888764332 56999999999999999853 346999999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCC
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTH 145 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~ 145 (654)
|||++.+ +.+||+|||++....... .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||... .
T Consensus 177 NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~ 254 (313)
T 3brb_A 177 NCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-Q 254 (313)
T ss_dssp GEEECTT-SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-C
T ss_pred eEEEcCC-CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC-C
Confidence 9999854 799999999998764322 123347889999999864 58999999999999999999 88999774 4
Q ss_pred HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 146 PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 146 ~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
...++..+..+..+. .....++++.++|.+||. +|.+|||+.+++.+
T Consensus 255 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 255 NHEMYDYLLHGHRLK-QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp GGGHHHHHHTTCCCC-CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCC-CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555666777665443 345678999999999999 89999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=262.21 Aligned_cols=186 Identities=21% Similarity=0.341 Sum_probs=151.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++... ++..++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~- 164 (298)
T 3f66_A 89 LSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK- 164 (298)
T ss_dssp CCCCEEECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-
T ss_pred eeeeeEEEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-
Confidence 4677776543 56889999999999999999764 46999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC------CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.. .+...+..
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~ 243 (298)
T 3f66_A 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITV 243 (298)
T ss_dssp CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHH
T ss_pred CCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHH
Confidence 799999999998654322 223457889999998864 58999999999999999999 5566655 44455556
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+..+. .+...++.+.++|.+||. +|.+|||+.++++
T Consensus 244 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 244 YLLQGRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCC-CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 666665433 345578899999999999 8999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=267.28 Aligned_cols=186 Identities=22% Similarity=0.363 Sum_probs=152.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++|+.+.. .+.++|||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 109 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~- 183 (333)
T 1mqb_A 109 IRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN- 183 (333)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred CcEEEEEec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-
Confidence 578888765 68999999999999999999875 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++........ ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~ 262 (333)
T 1mqb_A 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-LSNHEVMKA 262 (333)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHH
T ss_pred CcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc-CCHHHHHHH
Confidence 7999999999987654321 1224688999999986 458999999999999999999 9999987 445667777
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+..+..+. .....++.++++|.+||. +|.+||++.+++++
T Consensus 263 ~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 263 INDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHTTCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHCCCcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77765433 334578899999999999 89999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=261.38 Aligned_cols=185 Identities=22% Similarity=0.366 Sum_probs=148.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~--Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+.+... .+.+++||||+.+|+|.+++.+.+. +++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 77 v~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~ 153 (278)
T 1byg_A 77 VQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED 153 (278)
T ss_dssp CCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred eeEEEEEEcC-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC
Confidence 5788876653 4579999999999999999987543 899999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
+.+||+|||++....... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||... +...+...+..+
T Consensus 154 -~~~~l~Dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~ 230 (278)
T 1byg_A 154 -NVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKG 230 (278)
T ss_dssp -SCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTT
T ss_pred -CcEEEeeccccccccccc-cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcC
Confidence 799999999998654432 23458899999999864 58999999999999999998 99999874 445566666665
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+ ......++.++++|.+||. +|.+|||+.++++
T Consensus 231 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 YKM-DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 443 3445678999999999999 8999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-30 Score=267.83 Aligned_cols=184 Identities=27% Similarity=0.455 Sum_probs=149.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. ...++|+||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 80 v~~~~~~~~---~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~- 153 (327)
T 3lzb_A 80 CRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP- 153 (327)
T ss_dssp CCCCEEEES---SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-
T ss_pred eEEEEEEec---CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-
Confidence 567888875 4589999999999999999874 56999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||++....... .....||+.|+|||++.+ .|+.++||||||+++|+|++ |..||.. .+...+...+
T Consensus 154 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~ 232 (327)
T 3lzb_A 154 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSIL 232 (327)
T ss_dssp TEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHH
T ss_pred CCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHH
Confidence 799999999998764332 122347889999998864 58999999999999999999 9999987 4455566666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .....++++.++|.+||. +|.+||++.++++
T Consensus 233 ~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 233 EKGERLP-QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HTTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6555433 445678999999999999 8999999999996
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=273.88 Aligned_cols=185 Identities=22% Similarity=0.374 Sum_probs=146.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. .+.++|||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 109 v~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~- 183 (373)
T 2qol_A 109 IRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN- 183 (373)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred CeEEEEEee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-
Confidence 578998866 678999999999999999998764 6999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||++........ ....+|+.|+|||++. ..++.++||||||+++|||++ |..||.. .+...+...
T Consensus 184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~ 262 (373)
T 2qol_A 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKA 262 (373)
T ss_dssp CCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHH
T ss_pred CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH
Confidence 7999999999987654321 1123578899999887 459999999999999999998 9999987 455666677
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+..+. .....++.+.++|.+||. +|.+||++.++++
T Consensus 263 i~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 263 VDEGYRLP-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHTTEECC-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCC-CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 76664332 234567899999999999 8999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=258.46 Aligned_cols=184 Identities=23% Similarity=0.393 Sum_probs=154.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
+++|+++. .+.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 71 ~~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~- 144 (279)
T 1qpc_A 71 VRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSD- 144 (279)
T ss_dssp CCEEEEEC---SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT-
T ss_pred ceEEEEEc---CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcC-
Confidence 57888764 356899999999999999987543 6999999999999999999999999 999999999999984
Q ss_pred CCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||++....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~ 223 (279)
T 1qpc_A 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-MTNPEVIQNL 223 (279)
T ss_dssp TSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHH
T ss_pred CCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc-cCHHHHHHHH
Confidence 4799999999998765432 22334788999999987 458999999999999999999 9999987 4456666777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .....+++++++|.+||. +|.+|||+.++++
T Consensus 224 ~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 224 ERGYRMV-RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCC-CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 7665433 345678999999999999 8999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=264.99 Aligned_cols=189 Identities=25% Similarity=0.411 Sum_probs=155.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++++.....+.+++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~- 163 (327)
T 3lxl_A 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE- 163 (327)
T ss_dssp CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-
T ss_pred eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-
Confidence 5789988876678999999999999999999874 46999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC---------
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--------- 144 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--------- 144 (654)
+.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 164 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~ 243 (327)
T 3lxl_A 164 AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243 (327)
T ss_dssp TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-
T ss_pred CCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc
Confidence 799999999998764322 223458889999998864 48999999999999999999999985421
Q ss_pred -----CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 145 -----HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 145 -----~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
....+...+..+..+ ......++++++||.+||. +|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 244 ERDVPALSRLLELLEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp ---CCHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccccHHHHHHHhhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112333344444333 3456788999999999999 89999999999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=266.25 Aligned_cols=190 Identities=20% Similarity=0.299 Sum_probs=148.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----RVNIRAVKHWCRQILSGLLYLHSR---DPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----~Lse~~i~~i~~QIl~gL~YLHs~---~p~IIHRDLKpeNI 73 (654)
|++|+++.. ....++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++ + |+||||||+||
T Consensus 90 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Ni 165 (326)
T 3uim_A 90 LRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANI 165 (326)
T ss_dssp CCCCEEECC--SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGE
T ss_pred cceEEEEec--CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhE
Confidence 567888776 678899999999999999998654 399999999999999999999999 7 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCC---CCH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSEC---THP 146 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~---~~~ 146 (654)
|++.+ +.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||... ...
T Consensus 166 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 166 LLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EECTT-CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EECCC-CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 99854 799999999998764322 23345999999999886 45899999999999999999999999520 000
Q ss_pred HHHHHHHHcCCCCc-------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 147 AQIYKKVISGKKPE-------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 147 ~qi~kki~~G~~p~-------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
.........+.... ......++.+.++|.+||. +|.+|||+.++++|..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred chhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00111111111110 1111123679999999999 8999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-31 Score=277.22 Aligned_cols=183 Identities=19% Similarity=0.217 Sum_probs=144.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI 75 (654)
+++|+.+.. .+..+||||||.||+|.+++.. .+.+++..++.|+.||+.||+|||+++ |+||||||+|||+
T Consensus 130 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll 205 (365)
T 3e7e_A 130 MKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFIL 205 (365)
T ss_dssp CCEEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEE
T ss_pred hhhheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEe
Confidence 578898887 6889999999999999999984 456999999999999999999999999 9999999999999
Q ss_pred eCC----------CCcEEEEecCchhhhcc----cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCC
Q 006244 76 NGN----------QGEVKIGDLGLAAILRK----SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPY 140 (654)
Q Consensus 76 d~~----------~g~VKL~DFGLA~~l~~----~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf 140 (654)
+.. .+.+||+|||+++.+.. ......+||+.|||||++.+ .|+.++|||||||++|+|+||++||
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf 285 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence 751 47999999999976542 22344579999999999875 4899999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 141 SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 141 ~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
........ . .....+ ....+..+.+++.+||. +|.+|++..+.|.+.
T Consensus 286 ~~~~~~~~---~-~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 286 VKNEGGEC---K-PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp EEEETTEE---E-ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ccCCCCce---e-echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 54221000 0 000000 01235678999999999 788886655444443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=264.98 Aligned_cols=187 Identities=25% Similarity=0.434 Sum_probs=153.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++++++.+.....+++||||+.+|+|.+++.+. .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~ 171 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-R 171 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-C
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-C
Confidence 5789999987678999999999999999998765 4999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCH--------
Q 006244 81 EVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHP-------- 146 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~-------- 146 (654)
.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 251 (318)
T 3lxp_A 172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251 (318)
T ss_dssp CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence 99999999998765432 223458889999999875 5889999999999999999999999642110
Q ss_pred ------HHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 147 ------AQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 147 ------~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+...+..+.. .......++++.+||.+||. +|.+|||+.++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp CHHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHHhcccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 112223333333 33456678999999999999 8999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-30 Score=264.42 Aligned_cols=188 Identities=22% Similarity=0.370 Sum_probs=135.2
Q ss_pred CEEEEEEEe------cCCCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC
Q 006244 1 MKFYTSWVD------TANRNINFVTEMFTSGTLRQYRLK---HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71 (654)
Q Consensus 1 VkfY~sfvd------~~~~~i~LVtEy~~gGSL~~~l~k---~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpe 71 (654)
|++|+.+.. .....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+++++|+||||||+
T Consensus 89 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~ 167 (337)
T 3ll6_A 89 VQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167 (337)
T ss_dssp CCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGG
T ss_pred hhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcc
Confidence 578888864 23457999999995 799998875 45799999999999999999999999878999999999
Q ss_pred cEEEeCCCCcEEEEecCchhhhcccCC--------------ccccCCCCccChhhhc----ccCCcccchhhhhhHHHHH
Q 006244 72 NIFVNGNQGEVKIGDLGLAAILRKSHA--------------ARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEM 133 (654)
Q Consensus 72 NILId~~~g~VKL~DFGLA~~l~~~~~--------------~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~EL 133 (654)
|||++. .+.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|+|
T Consensus 168 NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el 246 (337)
T 3ll6_A 168 NLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246 (337)
T ss_dssp GCEECT-TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHH
T ss_pred cEEECC-CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHH
Confidence 999985 47999999999987643211 1345999999999883 3488899999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 134 VTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 134 lTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
++|..||..... . .+..+..........++.+++||.+||. +|.+|||+.+++++..
T Consensus 247 ~~g~~p~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 247 CFRQHPFEDGAK-L----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp HHSSCCC-----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HhCCCCCcchhH-H----HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999976332 1 2223333333345567889999999999 8999999999998753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-30 Score=278.68 Aligned_cols=184 Identities=22% Similarity=0.385 Sum_probs=155.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.+. ...++||||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 246 v~l~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~ 320 (454)
T 1qcf_A 246 VKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS 320 (454)
T ss_dssp CCEEEEEC---SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT
T ss_pred eeEEEEEe---CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC
Confidence 57888764 46799999999999999999754 36899999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+++...... .....+|+.|+|||++. +.++.++||||||+++|||+| |..||.+. +..++...+
T Consensus 321 -~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i 398 (454)
T 1qcf_A 321 -LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRAL 398 (454)
T ss_dssp -CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHH
T ss_pred -CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 799999999998764321 22334678999999987 569999999999999999999 99999874 456666777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .+...++++.+||.+||. +|.+|||+.+|+.
T Consensus 399 ~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 399 ERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7765443 345678999999999999 8999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-30 Score=261.33 Aligned_cols=188 Identities=24% Similarity=0.337 Sum_probs=151.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK---HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k---~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
+++|+++.. .+.+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 93 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 93 VELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDE 168 (307)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECT
T ss_pred EEEEEEEec--CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcC
Confidence 578888766 6789999999999999999874 346999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHH---HHH
Q 006244 78 NQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QIY 150 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~---qi~ 150 (654)
.+.+||+|||++....... .....||+.|+|||++.+.++.++||||||+++|+|++|..||....... .+.
T Consensus 169 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 -AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp -TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred -CCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 4799999999997654322 22346999999999998889999999999999999999999997643322 233
Q ss_pred HHHHcCCCC---------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 151 KKVISGKKP---------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 151 kki~~G~~p---------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+...... .......+..+.++|.+||. +|.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 333222110 11112234678999999999 89999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=277.85 Aligned_cols=190 Identities=21% Similarity=0.351 Sum_probs=154.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV-- 75 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILI-- 75 (654)
|++|+.+.......++||||||.||+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~ 147 (396)
T 4eut_A 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVI 147 (396)
T ss_dssp CCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEE
T ss_pred CeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEee
Confidence 57899998866678999999999999999987643 3999999999999999999999999 9999999999998
Q ss_pred --eCCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhc---------ccCCcccchhhhhhHHHHHhhcCCCCCCC
Q 006244 76 --NGNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE---------EEYNELVDIYSFGMCILEMVTFDYPYSEC 143 (654)
Q Consensus 76 --d~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~---------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~ 143 (654)
+ ..+.+||+|||++....... ....+||+.|+|||++. ..++.++|||||||++|+|++|..||...
T Consensus 148 ~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 148 GED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp CTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred cCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4 33579999999998765432 33456999999999885 35788999999999999999999999642
Q ss_pred ---CCHHHHHHHHHcCCCCccc-----------------------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 144 ---THPAQIYKKVISGKKPEAL-----------------------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 144 ---~~~~qi~kki~~G~~p~~l-----------------------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.....+..++..+..+..+ ....++.++++|.+||. +|.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 2334555566665543211 12234578999999999 99999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.4e-30 Score=282.44 Aligned_cols=185 Identities=23% Similarity=0.334 Sum_probs=156.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.+.. ...++||||||.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 279 v~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~- 353 (495)
T 1opk_A 279 VQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGE- 353 (495)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG-
T ss_pred eeEEEEEec--CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECC-
Confidence 578998766 67899999999999999999874 35999999999999999999999999 999999999999974
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||+++....... ....+|+.|+|||++. ..|+.++||||||+++|||+| |..||... +..+++..+
T Consensus 354 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~ 432 (495)
T 1opk_A 354 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELL 432 (495)
T ss_dssp GGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHH
T ss_pred CCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHH
Confidence 47999999999987654322 2234678999999887 459999999999999999999 99999874 455666666
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+ ..+...++++++||.+||. +|.+|||+.+|++
T Consensus 433 ~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 433 EKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 665443 2445678999999999999 8999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=264.84 Aligned_cols=189 Identities=20% Similarity=0.229 Sum_probs=148.9
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
+++|+++... ....+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 89 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl 166 (317)
T 2buj_A 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNIL 166 (317)
T ss_dssp CCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred eeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEE
Confidence 4678887743 24589999999999999999886 467999999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhcccC-----------CccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCC
Q 006244 75 VNGNQGEVKIGDLGLAAILRKSH-----------AARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~~-----------~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
++.+ +.+||+|||++....... .....||+.|+|||++.. .++.++||||||+++|+|++|..|
T Consensus 167 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 245 (317)
T 2buj_A 167 LGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245 (317)
T ss_dssp ECTT-SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred EcCC-CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9854 799999999886543211 112358999999999863 378899999999999999999999
Q ss_pred CCCCCC-HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 140 YSECTH-PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 140 f~~~~~-~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
|..... ...+...+.. ..........+++++++|.+||. +|.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 246 YDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp THHHHHTTSCHHHHHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhhcccchhhHHhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 953110 0112222222 22222345678999999999999 89999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=289.28 Aligned_cols=184 Identities=21% Similarity=0.338 Sum_probs=156.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+++.. ..++||||||.+|+|.+++...+.+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 433 v~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~ 506 (635)
T 4fl3_A 433 VRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-H 506 (635)
T ss_dssp CCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-T
T ss_pred eeEEEEEec---CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-C
Confidence 678997753 568999999999999999999889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+||+|||+++.+.... .....||+.|+|||++.. .|+.++|||||||++|||++ |..||.+ .+...+...+
T Consensus 507 ~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i 585 (635)
T 4fl3_A 507 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAML 585 (635)
T ss_dssp EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHH
T ss_pred CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 99999999998765432 122347789999999875 69999999999999999998 9999987 4556677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .+...++++.+||.+||. +|.+||++.+|++
T Consensus 586 ~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 586 EKGERMG-CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 7776543 445678999999999999 8999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=273.59 Aligned_cols=187 Identities=20% Similarity=0.336 Sum_probs=145.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+... ++..++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 153 v~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~- 228 (373)
T 3c1x_A 153 LSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK- 228 (373)
T ss_dssp CCCCEEECCC-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred ceEEEEEEcC-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-
Confidence 4677876543 46789999999999999999865 45899999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC------CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||+++.+.... .....+|+.|+|||++. ..++.++||||||+++|+|+| |.+||.... ..++..
T Consensus 229 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~ 307 (373)
T 3c1x_A 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITV 307 (373)
T ss_dssp CCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHH
T ss_pred CCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHH
Confidence 799999999998664321 12335788999999886 458999999999999999999 677887643 344555
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+..+. .+...++.+.++|.+||. +|.+|||+.+++++
T Consensus 308 ~~~~~~~~~-~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 308 YLLQGRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666665443 345678999999999999 89999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.8e-31 Score=271.60 Aligned_cols=189 Identities=21% Similarity=0.311 Sum_probs=148.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+++.. .+.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 98 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 98 VSLIGFCDE--RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD 173 (321)
T ss_dssp CCEEEECCC--TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC
T ss_pred eeEEEEEcC--CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC
Confidence 578888765 678999999999999999987643 5899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH-----
Q 006244 77 GNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP----- 146 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~----- 146 (654)
. .+.+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||......
T Consensus 174 ~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~ 252 (321)
T 2qkw_B 174 E-NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252 (321)
T ss_dssp T-TCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred C-CCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence 5 4799999999997643321 22345899999999885 56999999999999999999999999653221
Q ss_pred HHHH-HHHHcCCCCc--------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 147 AQIY-KKVISGKKPE--------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 147 ~qi~-kki~~G~~p~--------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
.... .....+.... .+....++.+.+++.+||. +|.+|||+.+++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1111 1111121111 1112234678999999999 899999999999765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=262.95 Aligned_cols=189 Identities=26% Similarity=0.390 Sum_probs=151.1
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH--------SRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLH--------s~~p~IIHRDLKp 70 (654)
+++++.+..... ..+++||||+.+|+|.+++.+. .+++..+..++.||+.||.||| +.+ |+||||||
T Consensus 99 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp 175 (342)
T 1b6c_B 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKS 175 (342)
T ss_dssp CCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSG
T ss_pred EEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCH
Confidence 578888877432 3899999999999999999774 6999999999999999999999 777 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC------CccccCCCCccChhhhccc-------CCcccchhhhhhHHHHHhhc-
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEEE-------YNELVDIYSFGMCILEMVTF- 136 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~~-------ys~ksDIWSLGiiL~ELlTG- 136 (654)
+|||++.+ +.+||+|||++....... .....||+.|+|||++.+. ++.++||||||+++|+|+||
T Consensus 176 ~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~ 254 (342)
T 1b6c_B 176 KNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 254 (342)
T ss_dssp GGEEECTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred HHEEECCC-CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence 99999854 799999999997765432 2345699999999998753 33689999999999999999
Q ss_pred ---------CCCCCCCC----CHHHHHHHHHcCCCCccccc-----CCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 137 ---------DYPYSECT----HPAQIYKKVISGKKPEALFK-----VEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 137 ---------~~Pf~~~~----~~~qi~kki~~G~~p~~l~~-----~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..||.... ....+...+........+.. .....+++||.+||. +|.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 255 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 78986532 33445555544333222221 123578999999999 89999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=259.66 Aligned_cols=177 Identities=20% Similarity=0.359 Sum_probs=140.5
Q ss_pred CEEEEEEEe--cCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd--~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
+++++.|.. .....++|||||+.||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~ 151 (299)
T 3m2w_A 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYT 151 (299)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES
T ss_pred hhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEe
Confidence 567887765 33568999999999999999998864 6999999999999999999999999 99999999999998
Q ss_pred CC--CCcEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH---
Q 006244 77 GN--QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK--- 151 (654)
Q Consensus 77 ~~--~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k--- 151 (654)
.. .+.+||+|||++.... ...|+.++||||||+++|+|++|..||...... ....
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~ 211 (299)
T 3m2w_A 152 SKRPNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMK 211 (299)
T ss_dssp SSSTTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSC
T ss_pred cCCCCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHH
Confidence 53 5789999999885432 134788999999999999999999999763321 1111
Q ss_pred -HHHcCCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 152 -KVISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 152 -ki~~G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+..+.. +...+...++++++||.+||. +|.+|||+.++|+||||+..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 1111111 112224578999999999999 89999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=276.22 Aligned_cols=184 Identities=22% Similarity=0.353 Sum_probs=151.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.+.. ..++|||||+.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 242 v~~~~~~~~---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~- 315 (452)
T 1fmk_A 242 VQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE- 315 (452)
T ss_dssp CCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG-
T ss_pred eeEEEEEcC---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECC-
Confidence 578887643 6789999999999999998753 56999999999999999999999999 999999999999974
Q ss_pred CCcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||+++....... ....+|+.|+|||++. +.++.++||||||+++|||++ |..||.+ ....++...+
T Consensus 316 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~-~~~~~~~~~i 394 (452)
T 1fmk_A 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQV 394 (452)
T ss_dssp GGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHH
T ss_pred CCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 47999999999987654322 2234778999999886 569999999999999999999 9999987 4456677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+..+. .+...++.+.+||.+||. +|.+|||+.+|+.
T Consensus 395 ~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 395 ERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7775433 345678899999999999 8999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=284.63 Aligned_cols=184 Identities=20% Similarity=0.362 Sum_probs=153.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. +.++||||||.+|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 399 v~l~~~~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~- 472 (613)
T 2ozo_A 399 VRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR- 472 (613)
T ss_dssp CCEEEEEES---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-
T ss_pred eeEEEEecc---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-
Confidence 678998764 5699999999999999998754 45999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC-----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||+++.+..... ....+|+.|+|||++. ..|+.++|||||||++|||++ |..||.... ..++...
T Consensus 473 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~ 551 (613)
T 2ozo_A 473 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAF 551 (613)
T ss_dssp TEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-SHHHHHH
T ss_pred CcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHH
Confidence 7999999999987643221 1223678999999987 569999999999999999998 999998754 4566777
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..|..+. .+...++++.+||.+||. +|.+||++.+|++
T Consensus 552 i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 552 IEQGKRME-CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHcCCCCC-CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 77776543 445678999999999999 8999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=260.52 Aligned_cols=188 Identities=26% Similarity=0.433 Sum_probs=150.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
+++++.+.......+++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 105 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~- 181 (326)
T 2w1i_A 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE- 181 (326)
T ss_dssp CCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-
T ss_pred eeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-
Confidence 57888887755568999999999999999998864 5999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC---------
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--------- 144 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--------- 144 (654)
+.+||+|||++....... .....+|+.|+|||++.+ .++.++||||||+++|+|+||..||....
T Consensus 182 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~ 261 (326)
T 2w1i_A 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261 (326)
T ss_dssp TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCT
T ss_pred CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcc
Confidence 799999999998765432 123357888999998864 58899999999999999999999985310
Q ss_pred --C----HHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 145 --H----PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 145 --~----~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
. ...+...+..+..+ ......++++.++|.+||. +|.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCCTHHHHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhhhHHHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00122233333322 2345678999999999999 8999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=274.91 Aligned_cols=185 Identities=21% Similarity=0.294 Sum_probs=150.3
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCC
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN--GNQ 79 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId--~~~ 79 (654)
++.++.. ....+|||||+ +|+|.+++.. .+.+++..++.|+.||+.||.|||+++ |+||||||+||||+ ...
T Consensus 68 i~~~~~~--~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~ 142 (483)
T 3sv0_A 68 VRWFGVE--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRA 142 (483)
T ss_dssp EEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGT
T ss_pred EEEEEee--CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCC
Confidence 3344444 68999999999 9999999986 567999999999999999999999999 99999999999994 245
Q ss_pred CcEEEEecCchhhhcccCC---------ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCC--CHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---------ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECT--HPA 147 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---------~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~--~~~ 147 (654)
+.+||+|||+++.+..... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ...
T Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~ 222 (483)
T 3sv0_A 143 NQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222 (483)
T ss_dssp TCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH
T ss_pred CeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH
Confidence 7999999999987654321 24569999999999875 58999999999999999999999997643 334
Q ss_pred HHHHHHHcCCC---CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 148 QIYKKVISGKK---PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 148 qi~kki~~G~~---p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+.+.++..... ...+....++++.+||.+||. +|.+||++.+|++
T Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 223 QKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 44444433221 223345678999999999999 8999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=266.84 Aligned_cols=175 Identities=19% Similarity=0.182 Sum_probs=140.6
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC----------
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQG---------- 80 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLH-s~~p~IIHRDLKpeNILId~~~g---------- 80 (654)
...+|||||||.+|++.+.+.+ +.+++..++.+++||+.||.||| +++ |+||||||+|||++.+ +
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~-~~~~~~~~~~~ 209 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKT-SLKKLHYTLNG 209 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEEC-SCSEEEEEETT
T ss_pred cCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEecc-CCcceeeeccC
Confidence 5799999999999977666644 57899999999999999999999 898 9999999999999854 4
Q ss_pred ----------cEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhH-HHHHhhcCCCCCCCCCHHHH
Q 006244 81 ----------EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMC-ILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 81 ----------~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGii-L~ELlTG~~Pf~~~~~~~qi 149 (654)
.+||+|||+|+..... ..+||+.|||||++.+..+.++||||||++ .+++++|..||........+
T Consensus 210 ~~~~~~~~~~~vkL~DFG~a~~~~~~---~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~ 286 (336)
T 2vuw_A 210 KSSTIPSCGLQVSIIDYTLSRLERDG---IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYL 286 (336)
T ss_dssp EEEEEECTTEEEEECCCTTCBEEETT---EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHH
T ss_pred ccccccCCCceEEEeeccccEecCCC---cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHH
Confidence 8999999999876543 457999999999998877899999998766 78899999999542111223
Q ss_pred HHHHHcCC-----CCcccccCCChHHHHHHHHHhhCccCCCCHHHHh-cCcccc
Q 006244 150 YKKVISGK-----KPEALFKVEDPEVRQFIEKCLATVSSRLSARELL-TDPFLQ 197 (654)
Q Consensus 150 ~kki~~G~-----~p~~l~~~~spelrdLI~kCL~dP~~RpTa~ELL-~HPFf~ 197 (654)
...+.... .+...+...++++++||.+||+.+ ||.|+| +||||+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 287 TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SHHHHHHHCGGGC
T ss_pred HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CHHHHHhcCCCcC
Confidence 33444221 122223346789999999999933 999999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=274.65 Aligned_cols=173 Identities=18% Similarity=0.198 Sum_probs=141.1
Q ss_pred CeEEEEEecCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEE
Q 006244 13 RNINFVTEMFTSGTLRQYRLK-------HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIG 85 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k-------~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~ 85 (654)
..++++|+++ +|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 178 ~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~~~-~~~kL~ 253 (413)
T 3dzo_A 178 LSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQR-GGVFLT 253 (413)
T ss_dssp CSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEEC
T ss_pred cceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEecC-CeEEEE
Confidence 3578888887 6899999852 234788899999999999999999999 9999999999999855 789999
Q ss_pred ecCchhhhcccCCccccCCCCccChhhh----------cc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 86 DLGLAAILRKSHAARCVGTPEFMAPEVY----------EE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 86 DFGLA~~l~~~~~~~~vGTp~YmAPEvl----------~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
|||+++..... ....+| +.|+|||++ .. .|+.++|||||||++|+|++|+.||.... .......+.
T Consensus 254 DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~~~~~~~ 330 (413)
T 3dzo_A 254 GFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA-ALGGSEWIF 330 (413)
T ss_dssp CGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG-GGSCSGGGG
T ss_pred eccceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc-hhhhHHHHH
Confidence 99998776544 344568 999999988 32 37889999999999999999999997633 222222221
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. .....++++++||.+||. +|.+||++.++|+||||+.
T Consensus 331 ~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 331 R------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp S------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred h------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 1 123467899999999999 8999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=277.37 Aligned_cols=184 Identities=22% Similarity=0.356 Sum_probs=155.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+.+.+ ..++||||||.+|+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 325 v~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~- 398 (535)
T 2h8h_A 325 VQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGE- 398 (535)
T ss_dssp CCEEEEECS---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG-
T ss_pred eeEEEEEee---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcC-
Confidence 578887643 6799999999999999998753 56999999999999999999999999 999999999999974
Q ss_pred CCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+.+||+|||+++.+.... .....+|+.|+|||++. ..++.++||||||+++|||++ |..||.+ ....++...+
T Consensus 399 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~-~~~~~~~~~i 477 (535)
T 2h8h_A 399 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-MVNREVLDQV 477 (535)
T ss_dssp GGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT-CCHHHHHHHH
T ss_pred CCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 4799999999998764321 22334778999999886 569999999999999999999 9999987 4456677777
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..+.... .....++.+.+||.+||. +|.+|||+.+|+.
T Consensus 478 ~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 478 ERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCC-CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7765432 345678899999999999 8999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=281.14 Aligned_cols=184 Identities=23% Similarity=0.441 Sum_probs=154.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+. .+.+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 454 v~l~~~~~---~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~- 527 (656)
T 2j0j_A 454 VKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN- 527 (656)
T ss_dssp CCEEEEEC---SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-
T ss_pred CeEEEEEe---cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-
Confidence 57888773 357899999999999999998754 6999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||++........ ....||+.|+|||++. ..++.++||||||+++|||++ |..||.+ .+...+...+.
T Consensus 528 ~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~-~~~~~~~~~i~ 606 (656)
T 2j0j_A 528 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIE 606 (656)
T ss_dssp TEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHH
T ss_pred CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHH
Confidence 7999999999987654321 2335788999999886 459999999999999999997 9999987 45566667777
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+. .+...++.+.+||.+||. +|.+|||+.+++.
T Consensus 607 ~~~~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 607 NGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCC-CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 765443 455678999999999999 8999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=282.40 Aligned_cols=196 Identities=27% Similarity=0.340 Sum_probs=151.7
Q ss_pred CEEEEEEEe----cCCCeEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVD----TANRNINFVTEMFTSGTLRQYRLKHR---RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd----~~~~~i~LVtEy~~gGSL~~~l~k~~---~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++++++.. ..++..++|||||.||+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 75 V~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NI 152 (676)
T 3qa8_A 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENI 152 (676)
T ss_dssp CCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTE
T ss_pred CceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHe
Confidence 356665433 12578899999999999999998754 5999999999999999999999999 99999999999
Q ss_pred EEeCCCC--cEEEEecCchhhhcccC-CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 74 FVNGNQG--EVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 74 LId~~~g--~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
|++.+.+ .+||+|||++....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||.....+.++
T Consensus 153 Ll~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~ 232 (676)
T 3qa8_A 153 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232 (676)
T ss_dssp EEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS
T ss_pred EeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh
Confidence 9985422 48999999998765433 34457999999999987 45899999999999999999999999764333222
Q ss_pred HHHHH-------------cCC--------CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 150 YKKVI-------------SGK--------KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 150 ~kki~-------------~G~--------~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
...+. .+. .|..+....++.+.+||.+||. +|.+|||+.++|.||||+.
T Consensus 233 ~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp STTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 11110 010 0112233356789999999999 8999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-28 Score=278.55 Aligned_cols=180 Identities=19% Similarity=0.260 Sum_probs=145.9
Q ss_pred CEEEEEEEecCCC---eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTANR---NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~~~---~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|++|...... .+||||||+.||+|.+++.. .+++..+..|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 142 v~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~ 217 (681)
T 2pzi_A 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE 217 (681)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS
T ss_pred CeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC
Confidence 5789988874321 27999999999999998765 7999999999999999999999999 999999999999984
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+.+||+|||++...... ...+||+.|+|||++.+.++.++||||||+++|+|++|.+||..... .+.
T Consensus 218 --~~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~ 284 (681)
T 2pzi_A 218 --EQLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGL 284 (681)
T ss_dssp --SCEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSC
T ss_pred --CcEEEEecccchhcccC--CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccc
Confidence 48999999999876543 45579999999999988889999999999999999999998864210 011
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
.........++.+.+||.+||. +|.+||++.+.|.|+|+.
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 1111111235789999999999 899999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-26 Score=231.87 Aligned_cols=161 Identities=14% Similarity=0.112 Sum_probs=128.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.. .+.+||||||+.||+|.+++.+. .....+..|+.||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 94 v~~~~~~~~--~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g 166 (286)
T 3uqc_A 94 ARVLDVVHT--RAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-G 166 (286)
T ss_dssp CCEEEEEEE--TTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-S
T ss_pred ceeeEEEEE--CCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-C
Confidence 578999887 68999999999999999998543 466678899999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH--HHHHcCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY--KKVISGKK 158 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~--kki~~G~~ 158 (654)
.+||+++ .|++| ++.++||||||+++|+|+||+.||........+. .+...+..
T Consensus 167 ~~kl~~~------------------~~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 222 (286)
T 3uqc_A 167 DVVLAYP------------------ATMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222 (286)
T ss_dssp CEEECSC------------------CCCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB
T ss_pred CEEEEec------------------cccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC
Confidence 8999844 34443 7889999999999999999999998644321110 01111111
Q ss_pred --CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 159 --PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 159 --p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+.......+++++++|.+||. +|.+| |+.++++.
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 113345678999999999999 89999 99999873
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-26 Score=258.00 Aligned_cols=132 Identities=12% Similarity=0.061 Sum_probs=99.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
+++|+++.+ ++.+|||||||+||+|.+++.+.+++++. .+++||+.||+|||++| ||||||||+|||++. +|
T Consensus 305 ~~~~~~~ed--~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~-dg 376 (569)
T 4azs_A 305 PAVLAHGEN--AQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDA-RQ 376 (569)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECT-TS
T ss_pred eEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECC-CC
Confidence 578999987 78999999999999999999998889875 47899999999999999 999999999999985 48
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPY 140 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf 140 (654)
.|||+|||+|+..... .....+|||.|||||++.+.+...+|+||+|+++++|.++..|+
T Consensus 377 ~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 377 HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred CEEEeecccCeeCCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 9999999999876543 23456799999999999999999999999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-18 Score=194.90 Aligned_cols=117 Identities=20% Similarity=0.215 Sum_probs=101.9
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
....|||||||+||+|.+++.+ +..|+.||+.||.|||+++ |+||||||+|||++. .+||+|||+++
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~ 477 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGK 477 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCE
T ss_pred CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCE
Confidence 5667999999999999999775 6789999999999999999 999999999999984 89999999998
Q ss_pred hhcccC---------CccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCC
Q 006244 92 ILRKSH---------AARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYS 141 (654)
Q Consensus 92 ~l~~~~---------~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~ 141 (654)
...... ....+||+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 765421 124579999999999974 48889999999999999888888874
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.19 E-value=5.3e-15 Score=128.63 Aligned_cols=62 Identities=32% Similarity=0.473 Sum_probs=59.4
Q ss_pred CcEEEEEEeecc---cCCcc---ceeeecccCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHHhh
Q 006244 289 DGIFLRLRIADK---EGRIR---NIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIASL 350 (654)
Q Consensus 289 ~~I~L~LRI~d~---~g~~r---~I~F~Fd~~~DTa~sVA~EMV~el~i~d~dv~~IA~~ID~~i~~l 350 (654)
.+|+|+|||.|+ .|+.| +|+|+||+++|||.+||+|||++++|.++|++.||+||+..|..+
T Consensus 24 ~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~ 91 (98)
T 2lru_A 24 IAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLI 91 (98)
Confidence 579999999999 59999 999999999999999999999999999999999999999998877
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=9.1e-15 Score=150.66 Aligned_cols=80 Identities=19% Similarity=0.179 Sum_probs=68.3
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+..++||||++||+|.+ +. ......++.||+.||.|||+++ |+||||||+|||++ .|.+||+|||++..
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIWIIDFPQSVE 241 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEEECCCTTCEE
T ss_pred cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEEEEECCCCeE
Confidence 45699999999999988 31 1235679999999999999999 99999999999999 58999999999853
Q ss_pred hcccCCccccCCCCccChhhhc
Q 006244 93 LRKSHAARCVGTPEFMAPEVYE 114 (654)
Q Consensus 93 l~~~~~~~~vGTp~YmAPEvl~ 114 (654)
+..++|||++.
T Consensus 242 -----------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 -----------VGEEGWREILE 252 (282)
T ss_dssp -----------TTSTTHHHHHH
T ss_pred -----------CCCCCHHHHHH
Confidence 45678999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=6.1e-12 Score=127.32 Aligned_cols=72 Identities=21% Similarity=0.236 Sum_probs=60.0
Q ss_pred eEEEEEecCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCCcEEEEec
Q 006244 14 NINFVTEMFTS-G----TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQGEVKIGDL 87 (654)
Q Consensus 14 ~i~LVtEy~~g-G----SL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLH-s~~p~IIHRDLKpeNILId~~~g~VKL~DF 87 (654)
..+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+||||||+|||++. .++|+||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~~---~~~liDF 213 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYID---KVYFIDM 213 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEESS---SEEECCC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEcC---cEEEEEC
Confidence 46899999932 3 78876433 235578899999999999999 888 999999999999974 8999999
Q ss_pred Cchhhh
Q 006244 88 GLAAIL 93 (654)
Q Consensus 88 GLA~~l 93 (654)
|+|...
T Consensus 214 G~a~~~ 219 (258)
T 1zth_A 214 GQAVTL 219 (258)
T ss_dssp TTCEET
T ss_pred cccccC
Confidence 999654
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.04 E-value=4.7e-10 Score=96.69 Aligned_cols=60 Identities=25% Similarity=0.355 Sum_probs=57.8
Q ss_pred CcEEEEEEeecccCCccceeeecccCCCCHHHHHHHHHhcCCCChhhHHHHHHHHHHHHH
Q 006244 289 DGIFLRLRIADKEGRIRNIYFPFDIQTDTALSVATEMVSELDITDQDVTKIAEIIDSEIA 348 (654)
Q Consensus 289 ~~I~L~LRI~d~~g~~r~I~F~Fd~~~DTa~sVA~EMV~el~i~d~dv~~IA~~ID~~i~ 348 (654)
++|.|+||+++...++++|.|+|.++.|||..||+|||+.+.|+..|+..||..++..|.
T Consensus 1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 368999999999999999999999999999999999999999999999999999999986
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.63 E-value=8.4e-09 Score=111.93 Aligned_cols=68 Identities=16% Similarity=0.194 Sum_probs=56.1
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----------cEEEE
Q 006244 16 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG----------EVKIG 85 (654)
Q Consensus 16 ~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g----------~VKL~ 85 (654)
+|||||+.|++|.++. ....+..++.||+.+|.|||+.+ ||||||||.|||++.+ | .+.|+
T Consensus 187 ~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~~d-gd~~d~~~~~~~~~iI 257 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIREE-KDAEDPSSITLTPIII 257 (397)
T ss_dssp EEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEEEE-ECSSCTTSEEEEEEEC
T ss_pred eEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeCC-CCcccccccccceEEE
Confidence 6999999999986542 22345678899999999999999 9999999999999743 3 38999
Q ss_pred ecCchhh
Q 006244 86 DLGLAAI 92 (654)
Q Consensus 86 DFGLA~~ 92 (654)
||+.+..
T Consensus 258 D~~Q~V~ 264 (397)
T 4gyi_A 258 XFPQMVS 264 (397)
T ss_dssp CCTTCEE
T ss_pred EeCCccc
Confidence 9997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=4.8e-06 Score=82.88 Aligned_cols=82 Identities=18% Similarity=0.076 Sum_probs=61.9
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD--------------------- 60 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~--------------------- 60 (654)
++++.... .+..|+||||++|.+|.+.. .+......++.++..+|..||+..
T Consensus 74 ~v~~~~~~--~~~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 74 KVLHFERH--DGWSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp CEEEEEEE--TTEEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred eEEEEEec--CCceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 45666655 67899999999999998752 122334578889999999999811
Q ss_pred ------------------------------------CCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 61 ------------------------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 61 ------------------------------------p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
+.++|+|++|.|||++. .+.+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 23999999999999974 2345799998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.00 E-value=3.5e-06 Score=86.40 Aligned_cols=124 Identities=19% Similarity=0.135 Sum_probs=84.3
Q ss_pred eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 006244 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD--------------------------------- 60 (654)
Q Consensus 14 ~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~--------------------------------- 60 (654)
.-|+|||+++|.+|..... ..++......++.|+...|..||+..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 3488999999988875433 24788888888899998888888621
Q ss_pred -----------------------CCeEecCCCCCcEEEeCC-CCcEEEEecCchhhhcccCCccccCCCCc---cChhhh
Q 006244 61 -----------------------PPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAILRKSHAARCVGTPEF---MAPEVY 113 (654)
Q Consensus 61 -----------------------p~IIHRDLKpeNILId~~-~g~VKL~DFGLA~~l~~~~~~~~vGTp~Y---mAPEvl 113 (654)
+.++|+|+++.||+++.+ .+.+.|+||+.+...... ........+ ..|+..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~--~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD--NDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT--HHHHTTCCTTTSCCHHHH
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH--HHHHHHHhhccccCHHHH
Confidence 248999999999999864 346789999988653211 000001111 233322
Q ss_pred c---ccCC------------cccchhhhhhHHHHHhhcCCCCC
Q 006244 114 E---EEYN------------ELVDIYSFGMCILEMVTFDYPYS 141 (654)
Q Consensus 114 ~---~~ys------------~ksDIWSLGiiL~ELlTG~~Pf~ 141 (654)
. ..|. .-.+.|++|.++|.+.+|..+|-
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 1221 12578999999999999988873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.81 E-value=2.5e-05 Score=76.52 Aligned_cols=80 Identities=15% Similarity=0.067 Sum_probs=57.0
Q ss_pred EEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------
Q 006244 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD--------------------- 60 (654)
Q Consensus 2 kfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~--------------------- 60 (654)
++|..... .+..++||||++|.+|. + ...+ ...++.++...|..||+..
T Consensus 79 ~~~~~~~~--~~~~~~v~e~i~G~~l~-~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~ 148 (264)
T 1nd4_A 79 AVLDVVTE--AGRDWLLLGEVPGQDLL-S----SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRM 148 (264)
T ss_dssp CEEEEEEC--SSCEEEEEECCSSEETT-T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHH
T ss_pred eEEEeccC--CCCCEEEEEecCCcccC-c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHH
Confidence 35665544 46789999999998884 1 1122 2356777888888888643
Q ss_pred -----------------------------------CCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 61 -----------------------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 61 -----------------------------------p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+.++|+|++|.|||++.+ +.+.|+|||.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~ 214 (264)
T 1nd4_A 149 EAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV 214 (264)
T ss_dssp HTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred hcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence 129999999999999743 4556999998643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.77 E-value=2.1e-05 Score=82.32 Aligned_cols=78 Identities=12% Similarity=0.196 Sum_probs=61.9
Q ss_pred CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 006244 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR--------------------------------- 59 (654)
Q Consensus 13 ~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~--------------------------------- 59 (654)
+..|+||||++|..+.+. ....++......++.++...|..||+.
T Consensus 114 g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 458999999999887541 123478888899999999999999973
Q ss_pred -----------------------CCCeEecCCCCCcEEEeCCCCc-EEEEecCchhh
Q 006244 60 -----------------------DPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 92 (654)
Q Consensus 60 -----------------------~p~IIHRDLKpeNILId~~~g~-VKL~DFGLA~~ 92 (654)
.+.++|+|+++.|||++.+.+. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 1359999999999999855333 58999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0052 Score=60.96 Aligned_cols=83 Identities=18% Similarity=0.089 Sum_probs=57.5
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD---------------------- 60 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~---------------------- 60 (654)
.+.+..+ .+.-++|||+++|.++.+..... ......+..++...|.-||...
T Consensus 85 v~~~~~~--~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 85 IKHFIRT--PDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp EEEEEEE--TTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred EEEEEEE--CCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 4555555 57889999999999888765432 2233445566666666666431
Q ss_pred ----------------------------------CCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 61 ----------------------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 61 ----------------------------------p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+.++|+|+.+.|||++.. +.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 137999999999999843 4566999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.39 E-value=0.021 Score=57.29 Aligned_cols=120 Identities=21% Similarity=0.230 Sum_probs=78.7
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCCccccC
Q 006244 26 TLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLH-SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVG 103 (654)
Q Consensus 26 SL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLH-s~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~~~vG 103 (654)
+|.+.++. ..++++++++.++.|.+.+|.-+- ...+ ..+=+.|..|++..+ |.|.+.+ +.+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~d-G~V~f~~-~~s~----------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRD-GAVTLAP-AADD----------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETT-SCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecC-Cceeccc-cccc----------cc
Confidence 78888775 568999999999999999987762 2221 122334688999855 7777664 2111 12
Q ss_pred CCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh
Q 006244 104 TPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179 (654)
Q Consensus 104 Tp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~ 179 (654)
...|.|||+.....+.+.-|||||+++|.-+-...| .......++.+-.||..|..
T Consensus 100 ~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 100 EPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTT
T ss_pred ccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHh
Confidence 335668887755556788999999999998863333 22345678999999998875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.01 Score=60.96 Aligned_cols=79 Identities=24% Similarity=0.158 Sum_probs=53.1
Q ss_pred CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q 006244 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR-------------------------------- 59 (654)
Q Consensus 12 ~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~-------------------------------- 59 (654)
.+.-++|||+++|.+|..... ..++......++.|+...|..||+.
T Consensus 85 ~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 85 DGNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp TSCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred CCceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 456789999999988876322 1244555555555555555555542
Q ss_pred --------------------------CCCeEecCCCCCcEEEeC--CCCc-EEEEecCchhh
Q 006244 60 --------------------------DPPVIHRDLKCDNIFVNG--NQGE-VKIGDLGLAAI 92 (654)
Q Consensus 60 --------------------------~p~IIHRDLKpeNILId~--~~g~-VKL~DFGLA~~ 92 (654)
.+.++|+|+++.|||++. ..+. +.|+||+.+..
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999985 1245 48999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=94.49 E-value=0.02 Score=59.33 Aligned_cols=31 Identities=19% Similarity=0.368 Sum_probs=25.0
Q ss_pred CCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+.++|+|+.+.|||++ +.+.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYR-DFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEE-TTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEe-CCcEEEEEccccccc
Confidence 3599999999999998 333578999987743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=93.42 E-value=0.074 Score=53.96 Aligned_cols=42 Identities=21% Similarity=0.230 Sum_probs=31.3
Q ss_pred HHHHHHHHHh-----------CCCCeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 49 ILSGLLYLHS-----------RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 49 Il~gL~YLHs-----------~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
+..++.+|+. ..+.++|+|+++.|||++.+ +.+.|+||+.+.
T Consensus 199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 4446667753 23459999999999999644 579999998653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=88.98 E-value=0.63 Score=47.00 Aligned_cols=29 Identities=21% Similarity=0.309 Sum_probs=23.8
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
.++|+|+.+.||+.+ .+.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil~~--~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLDT--GERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEEC--SSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEEC--CCCEEEEecccccC
Confidence 489999999999953 36789999987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=88.10 E-value=0.36 Score=51.53 Aligned_cols=30 Identities=20% Similarity=0.365 Sum_probs=25.1
Q ss_pred CCeEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 61 p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
+.++|+|+++.|||++.+ + ++|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQD-S-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSS-C-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCC-C-CEEEeCccccc
Confidence 349999999999999744 3 99999987754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 654 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-38 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-37 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-37 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-37 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-36 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-31 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-28 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-28 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-28 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-26 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-24 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-24 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-23 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-08 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 108/199 (54%), Positives = 140/199 (70%), Gaps = 3/199 (1%)
Query: 2 KFYTSWVDTA--NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
+FY SW T + I VTE+ TSGTL+ Y + + + I+ ++ WCRQIL GL +LH+R
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNE 119
PP+IHRDLKCDNIF+ G G VKIGDLGLA + R S A +GTPEFMAPE+YEE+Y+E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE 191
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
VD+Y+FGMC+LEM T +YPYSEC + AQIY++V SG KP + KV PEV++ IE C+
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251
Query: 180 T-VSSRLSARELLTDPFLQ 197
R S ++LL F Q
Sbjct: 252 QNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-40
Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR----VNIRAVKHWCRQILSGLLYL 56
+++Y +D N + V E G L K + ++ V Q+ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 57 HSR---DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPE 111
H R V+HRDLK N+F++G VK+GD GLA IL S A VGTP +M+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 112 VYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEV 170
YNE DI+S G + E+ P+ ++ K+ GK ++ E+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY-SDEL 242
Query: 171 RQFIEKCLAT-VSSRLSARELLTDPFL 196
+ I + L R S E+L +P +
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-38
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 10/198 (5%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
+ Y + D + + E GT+ + K + + + + ++ + L Y HS+
Sbjct: 70 RLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK-- 125
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNEL 120
VIHRD+K +N+ + GE+KI D G + S GT +++ PE+ E ++E
Sbjct: 126 RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT 180
VD++S G+ E + P+ E + YK++ + R I + L
Sbjct: 185 VDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFT--FPDFVTEGARDLISRLLKH 241
Query: 181 -VSSRLSARELLTDPFLQ 197
S R RE+L P++
Sbjct: 242 NPSQRPMLREVLEHPWIT 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSR 59
+K ++ N+ + E G + L+ R + ++ C+Q L L YLH
Sbjct: 72 VKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY---- 113
+IHRDLK NI + G++K+ D G++A ++ R +GTP +MAPEV
Sbjct: 130 K--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 114 --EEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEV 170
+ Y+ D++S G+ ++EM + P+ E P ++ K+ + P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 171 RQFIEKCLAT-VSSRLSARELLTDPFLQID 199
+ F++KCL V +R + +LL PF+ +D
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 4e-37
Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 13/201 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
++ ++ V E + + + + L GL YLHS
Sbjct: 79 QYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-- 134
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY----EEEY 117
+IHRD+K NI ++ G VK+GD G A+I+ ++ VGTP +MAPEV E +Y
Sbjct: 135 NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPAN--SFVGTPYWMAPEVILAMDEGQY 191
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
+ VD++S G+ +E+ P + +Y + + P R F++ C
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 178 LAT-VSSRLSARELLTDPFLQ 197
L R ++ LL F+
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 8e-37
Identities = 42/197 (21%), Positives = 83/197 (42%), Gaps = 10/197 (5%)
Query: 8 VDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRD 67
E + G L + + + Q+++G++YLH + HRD
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRD 128
Query: 68 LKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPEVYEEE--YNELV 121
+K +N+ ++ +KI D GLA + R+ + GT ++APE+ + + E V
Sbjct: 129 IKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 122 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT- 180
D++S G+ + M+ + P+ + + Q Y K +K D + K L
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 247
Query: 181 VSSRLSARELLTDPFLQ 197
S+R++ ++ D +
Sbjct: 248 PSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 10/210 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ + S++ + V E G+L + ++ + CR+ L L +LHS
Sbjct: 80 VNYLDSYLV--GDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--RKSHAARCVGTPEFMAPE-VYEEEY 117
VIHRD+K DNI + + G VK+ D G A + +S + VGTP +MAPE V + Y
Sbjct: 136 -QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
VDI+S G+ +EM+ + PY +Y +G + R F+ +C
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 178 LAT-VSSRLSARELLTDPFLQIDDYDSDLR 206
L V R SA+ELL FL+I S L
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 48/249 (19%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ FY ++ + I+ E G+L Q K R+ + + ++ GL YL +
Sbjct: 67 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK- 123
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNE 119
++HRD+K NI VN GE+K+ D G++ L S A VGT +M+PE + Y+
Sbjct: 124 HKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTH---------------------------------- 145
DI+S G+ ++EM YP
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 146 -------PAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
++ +++ P+ V E + F+ KCL + R ++L+ F++
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302
Query: 198 -IDDYDSDL 205
D + D
Sbjct: 303 RSDAEEVDF 311
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-36
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 16/191 (8%)
Query: 14 NINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
+ VT+ +L + + + + + RQ G+ YLH++ +IHRDLK +N
Sbjct: 77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNN 134
Query: 73 IFVNGNQGEVKIGDLGLAAILRK----SHAARCVGTPEFMAPEVYEEE----YNELVDIY 124
IF++ + VKIGD GLA + + + G+ +MAPEV + Y+ D+Y
Sbjct: 135 IFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVED---PEVRQFIEKCLAT- 180
+FG+ + E++T PYS + QI V G L KV +++ + +CL
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253
Query: 181 VSSRLSARELL 191
R ++L
Sbjct: 254 RDERPLFPQIL 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 8e-34
Identities = 45/197 (22%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N V ++ G L Y + ++ + + R +L + LH + ++HRDLK +
Sbjct: 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPE 139
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE-------YNELVDI 123
NI ++ + +K+ D G + L R GTP ++APE+ E Y + VD+
Sbjct: 140 NILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 198
Query: 124 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIEKCLAT- 180
+S G+ + ++ P+ + + ++SG + V+ + + L
Sbjct: 199 WSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ 257
Query: 181 VSSRLSARELLTDPFLQ 197
R +A E L PF Q
Sbjct: 258 PQKRYTAEEALAHPFFQ 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 127 bits (321), Expect = 7e-33
Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 12/229 (5%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRD 60
+ ++ D + + E + G L +++ V ++ RQ GL ++H
Sbjct: 90 NLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 147
Query: 61 PPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEY 117
++H D+K +NI + VKI D GLA L + T EF APE+ + E
Sbjct: 148 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISGKKPEALFKVEDPEVRQFIEK 176
D+++ G+ +++ P++ + K + E F PE + FI+
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 177 CLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQS 224
L RL+ + L P+L+ S+L + Y++I +++
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLK--GDHSNLTSRIPSSRYNKIRQKIKEK 312
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (314), Expect = 5e-32
Identities = 47/213 (22%), Positives = 91/213 (42%), Gaps = 10/213 (4%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ ++ D + + + E + G L + +H +++ + RQ+ GL ++H +
Sbjct: 87 NLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 61 PPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEY 117
+H DLK +NI + E+K+ D GL A L + + GT EF APEV E +
Sbjct: 145 --YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISGKKPEALFKVEDPEVRQFIEK 176
D++S G+ +++ P+ + K ++ F + + FI K
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 177 CLAT-VSSRLSARELLTDPFLQIDDYDSDLRMI 208
L ++R++ + L P+L + I
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-31
Identities = 50/245 (20%), Positives = 102/245 (41%), Gaps = 12/245 (4%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
+ + S+ + + E + + + +N R + + Q+ L +LHS
Sbjct: 64 LHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 60 DPPVIHRDLKCDNIFV-NGNQGEVKIGDLGLAAILRKSHAAR-CVGTPEFMAPEVYEEE- 116
+ H D++ +NI +KI + G A L+ R PE+ APEV++ +
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFI 174
+ D++S G + +++ P+ T QI + +++ + E FK E F+
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238
Query: 175 EKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQTDYDEISPLLRQSLYGIYHSNS 233
++ L SR++A E L P+L+ ++I+ L+++ L + +
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAAR 298
Query: 234 SSNNG 238
S G
Sbjct: 299 ISCGG 303
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (303), Expect = 7e-31
Identities = 38/206 (18%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
+ ++ + ++ + G L ++ R Q+L + YLH
Sbjct: 71 ALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD--L 126
Query: 62 PVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EEY 117
++HRDLK +N+ ++ I D GL+ + GTP ++APEV + Y
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFIE 175
++ VD +S G+ ++ P+ + + A+++++++ + + + FI
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245
Query: 176 KCLAT-VSSRLSARELLTDPFLQIDD 200
+ R + + L P++ D
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDT 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 1e-30
Identities = 42/194 (21%), Positives = 84/194 (43%), Gaps = 14/194 (7%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
W + + + + L + + + + + Q+L + + H+ V+HR
Sbjct: 77 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC--GVLHR 134
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YNELVDIY 124
D+K +NI ++ N+GE+K+ D G A+L+ + GT + PE + ++
Sbjct: 135 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 183
S G+ + +MV D P+ H +I + + ++ E + I CLA S
Sbjct: 195 SLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQR------VSSECQHLIRWCLALRPSD 245
Query: 184 RLSARELLTDPFLQ 197
R + E+ P++Q
Sbjct: 246 RPTFEEIQNHPWMQ 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+K Y ++ D + + F +G L +Y K + + + +I+S L YLH
Sbjct: 71 VKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----RKSHAARCVGTPEFMAPEVY-EE 115
+IHRDLK +NI +N + ++I D G A +L +++ A VGT ++++PE+ E+
Sbjct: 127 KGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 116 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQF 173
+ D+++ G I ++V P+ I++K+I + PE F P+ R
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLEYDFPEKFF----PKARDL 240
Query: 174 IEKCLAT-VSSRLSARELLTDPFLQ 197
+EK L + RL E+ L+
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 3e-30
Identities = 39/195 (20%), Positives = 75/195 (38%), Gaps = 14/195 (7%)
Query: 14 NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73
+ V EM G L +Y ++R V + + Q+ G+ YL +HRDL N+
Sbjct: 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNV 138
Query: 74 FVNGNQGEVKIGDLGLAAILRKSHAA-----RCVGTPEFMAPEVYE-EEYNELVDIYSFG 127
+ Q KI D GL+ LR ++ APE +++ D++SFG
Sbjct: 139 LLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG 197
Query: 128 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS 186
+ + E ++ +++ + G++ E+ + C V +R
Sbjct: 198 VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC-PREMYDLMNLCWTYDVENRPG 256
Query: 187 AREL---LTDPFLQI 198
+ L + + +
Sbjct: 257 FAAVELRLRNYYYDV 271
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-30
Identities = 40/194 (20%), Positives = 75/194 (38%), Gaps = 10/194 (5%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSR 59
+ V+ + VTE G+L Y R + + + + + YL
Sbjct: 64 QLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYN 118
+HRDL N+ V+ + K+ D GL + ++ APE E++++
Sbjct: 123 --NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGK-LPVKWTAPEALREKKFS 178
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 178
D++SFG+ + E+ +F + +V G K +A P V + ++ C
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC-PPAVYEVMKNCW 237
Query: 179 AT-VSSRLSARELL 191
+ R S +L
Sbjct: 238 HLDAAMRPSFLQLR 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 7e-29
Identities = 41/197 (20%), Positives = 78/197 (39%), Gaps = 12/197 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSR 59
++ Y ++ I V E G L Y R + C + G+ YL
Sbjct: 63 VQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 118
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVYE-E 115
+ VIHRDL N V N +K+ D G+ + + + + ++ +PEV+
Sbjct: 119 EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 116 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 175
Y+ D++SFG+ + E+ + E +++ + + +G + ++ V Q +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-KPRLASTHVYQIMN 236
Query: 176 KCLAT-VSSRLSARELL 191
C R + LL
Sbjct: 237 HCWKERPEDRPAFSRLL 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (290), Expect = 1e-28
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ ++ ++F+ ++ G L + +H + ++ + +I+ GL ++H+R
Sbjct: 70 VCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE--YN 118
V++RDLK NI ++ G V+I DLGLA K VGT +MAPEV ++ Y+
Sbjct: 128 --VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 178
D +S G + +++ P+ + + ++ L PE+R +E L
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 244
Query: 179 AT-VSSRLS-----ARELLTDPFLQIDDYDSDLR 206
V+ RL A+E+ PF + D+
Sbjct: 245 QRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 13/212 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
+ + + ++ + E+ G L + + + + +QIL+G+ YLHS
Sbjct: 77 TLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL-- 132
Query: 62 PVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPEVYE-EE 116
+ H DLK +NI + N + +KI D GLA + + + GTPEF+APE+ E
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 192
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK--PEALFKVEDPEVRQFI 174
D++S G+ +++ P+ + V + + F + FI
Sbjct: 193 LGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 175 EKCLAT-VSSRLSARELLTDPFLQIDDYDSDL 205
+ L R++ ++ L P+++ D L
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 1e-28
Identities = 38/195 (19%), Positives = 74/195 (37%), Gaps = 14/195 (7%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65
V T + + +TE +G+L + R + + + R I +G+ YL D +H
Sbjct: 94 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVH 151
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKS-------HAARCVGTPEFMAPEVYE-EEY 117
RDL NI VN N K+ D GL+ L A + APE + ++
Sbjct: 152 RDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKC 177
D++S+G+ + E++++ + + + + Q + C
Sbjct: 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC-PSALHQLMLDC 269
Query: 178 LAT-VSSRLSARELL 191
+ R +++
Sbjct: 270 WQKDRNHRPKFGQIV 284
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 42/202 (20%), Positives = 81/202 (40%), Gaps = 14/202 (6%)
Query: 8 VDTANRNINFVTEMFTSGTLRQY--RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65
+ + + V E G L + R + I + YLHS + + H
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAH 134
Query: 66 RDLKCDNIFVN--GNQGEVKIGDLGLAAILRKSHAARCV-GTPEFMAPEVYE-EEYNELV 121
RD+K +N+ +K+ D G A ++ TP ++APEV E+Y++
Sbjct: 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC 194
Query: 122 DIYSFGMCILEMVTFDYPYSECTHPA---QIYKKVISGKK--PEALFKVEDPEVRQFIEK 176
D++S G+ + ++ P+ A + ++ G+ P + EV+ I
Sbjct: 195 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254
Query: 177 CLAT-VSSRLSARELLTDPFLQ 197
L T + R++ E + P++
Sbjct: 255 LLKTEPTQRMTITEFMNHPWIM 276
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 11/189 (5%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ +T++ G L Y +H+ + + + +WC QI G+ YL R ++HRDL
Sbjct: 82 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAA 139
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYE-EEYNELVDIYS 125
N+ V VKI D GLA +L HA ++MA E Y D++S
Sbjct: 140 RNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198
Query: 126 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSR 184
+G+ + E++TF + ++I + G++ + +V + KC SR
Sbjct: 199 YGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-QPPICTIDVYMIMVKCWMIDADSR 257
Query: 185 LSARELLTD 193
REL+ +
Sbjct: 258 PKFRELIIE 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-28
Identities = 42/199 (21%), Positives = 79/199 (39%), Gaps = 12/199 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQY-RLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
++ Y R I +TE +G L Y R R + + C+ + + YL S+
Sbjct: 62 VQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYE-E 115
+HRDL N VN G VK+ D GL+ + + + PEV
Sbjct: 120 --QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 116 EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIE 175
+++ DI++FG+ + E+ + E ++ + + G + + +V +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-RPHLASEKVYTIMY 235
Query: 176 KCLAT-VSSRLSARELLTD 193
C R + + LL++
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 36/198 (18%), Positives = 75/198 (37%), Gaps = 15/198 (7%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ V EM G L ++ + R + + V Q+ G+ YL + +HRDL
Sbjct: 80 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAA 137
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPEVYE-EEYNELVDIY 124
N+ + KI D GL+ L + ++ APE +++ D++
Sbjct: 138 RNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVW 196
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 183
S+G+ + E +++ + ++ + GK+ E + PE+ + C
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC-PPELYALMSDCWIYKWED 255
Query: 184 RLSAREL---LTDPFLQI 198
R + + + +
Sbjct: 256 RPDFLTVEQRMRACYYSL 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 38/187 (20%), Positives = 69/187 (36%), Gaps = 11/187 (5%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRR--VNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
I VTE + G+L + + + + QI SG+ Y+ +HRDL+
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLR 140
Query: 70 CDNIFVNGNQGEVKIGDLGLAAILRKSHAAR---CVGTPEFMAPEVYE-EEYNELVDIYS 125
NI V N K+ D GLA ++ + ++ APE + D++S
Sbjct: 141 AANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 199
Query: 126 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSR 184
FG+ + E+ T ++ +V G + + + + +C R
Sbjct: 200 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC-PESLHDLMCQCWRKEPEER 258
Query: 185 LSARELL 191
+ L
Sbjct: 259 PTFEYLQ 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-27
Identities = 41/186 (22%), Positives = 81/186 (43%), Gaps = 10/186 (5%)
Query: 14 NINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
+ + E+ T G LR + +++ ++ + Q+ + L YL S+ +HRD+ N
Sbjct: 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARN 138
Query: 73 IFVNGNQGEVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEEE-YNELVDIYSFGM 128
+ V+ VK+GD GL+ + S A++ ++MAPE + D++ FG+
Sbjct: 139 VLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 197
Query: 129 CILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSA 187
C+ E++ + + ++ +G++ P + + KC A S R
Sbjct: 198 CMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC-PPTLYSLMTKCWAYDPSRRPRF 256
Query: 188 RELLTD 193
EL
Sbjct: 257 TELKAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 4e-27
Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 11/187 (5%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHSRDPPVIHRDLK 69
I +TE +G+L + + + + QI G+ ++ R IHRDL+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLR 136
Query: 70 CDNIFVNGNQGEVKIGDLGLAAILRKSHAARC---VGTPEFMAP-EVYEEEYNELVDIYS 125
NI V+ + KI D GLA ++ + ++ AP + + D++S
Sbjct: 137 AANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 126 FGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSR 184
FG+ + E+VT ++ + + G + E+ Q + C R
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC-PEELYQLMRLCWKERPEDR 254
Query: 185 LSARELL 191
+ L
Sbjct: 255 PTFDYLR 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
+ ++ N+ FV E G L + + ++ + +I+ GL +LHS+
Sbjct: 67 HMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA--RCVGTPEFMAPEVYE-EEYN 118
+++RDLK DNI ++ + G +KI D G+ A GTP+++APE+ ++YN
Sbjct: 124 -IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 119 ELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCL 178
VD +SFG+ + EM+ P+ +++ + + + E + + K
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLVKLF 238
Query: 179 AT-VSSRLSAR-ELLTDPFLQIDDYDSDLR 206
RL R ++ P + +++ R
Sbjct: 239 VREPEKRLGVRGDIRQHPLFREINWEELER 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 1e-26
Identities = 49/213 (23%), Positives = 99/213 (46%), Gaps = 16/213 (7%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
++ + ++ D + I + + G L K +R K + ++ L YLHS
Sbjct: 67 IRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-- 122
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNE 119
+I+RDLK +NI ++ N G +KI D G A + C GTP+++APEV + YN+
Sbjct: 123 KDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLC-GTPDYIAPEVVSTKPYNK 180
Query: 120 LVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA 179
+D +SFG+ I EM+ P+ + + Y+K+++ + + +V+ + + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAELR--FPPFFNEDVKDLLSRLIT 237
Query: 180 T------VSSRLSARELLTDPFLQIDDYDSDLR 206
+ + ++ P+ + ++ L
Sbjct: 238 RDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 42/188 (22%), Positives = 74/188 (39%), Gaps = 11/188 (5%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ VTE+ G+L KH+ + + + Q+ G+ YL S+ IHRDL
Sbjct: 82 TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAA 139
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEEE-YNELVDIY 124
N+ + VKIGD GL L ++ + APE + ++ D +
Sbjct: 140 RNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTW 198
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 183
FG+ + EM T+ + +QI K+ + + ++ + +C A
Sbjct: 199 MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPED 258
Query: 184 RLSARELL 191
R + L
Sbjct: 259 RPTFVALR 266
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 47/240 (19%), Positives = 85/240 (35%), Gaps = 41/240 (17%)
Query: 5 TSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64
S + +I V + + + +K + +L+GL Y+H ++
Sbjct: 82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR--NKIL 139
Query: 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC------VGTPEFMAPEVY--EEE 116
HRD+K N+ + + G +K+ D GLA + ++ V T + PE+ E +
Sbjct: 140 HRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 198
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-KVISGKKPEALFK----------- 164
Y +D++ G + EM T T Q+ + G ++
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258
Query: 165 -----------------VEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLR 206
V DP I+K L + R+ + + L F D SDL+
Sbjct: 259 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLK 318
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 2e-26
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
+ + + FV E G L + + R + + +I+S L YLHSR V++R
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--DVVYR 129
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYE-EEYNELVDI 123
D+K +N+ ++ + G +KI D GL A GTPE++APEV E +Y VD
Sbjct: 130 DIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 124 YSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VS 182
+ G+ + EM+ P+ ++++ ++ + + PE + + L
Sbjct: 189 WGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPK 245
Query: 183 SRLS-----ARELLTDPFLQIDDYDSDLR 206
RL A+E++ F ++ ++
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 42/227 (18%), Positives = 81/227 (35%), Gaps = 35/227 (15%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ ++ NI+ V + + + + +K + L GL YLH
Sbjct: 63 IGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR--CVGTPEFMAPEVY--EEE 116
++HRDLK +N+ ++ N G +K+ D GLA + A V T + APE+
Sbjct: 120 -WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK------------------------- 151
Y VD+++ G + E++ + Q+ +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 152 KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
K G +F ++ I+ +R++A + L +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-26
Identities = 41/228 (17%), Positives = 80/228 (35%), Gaps = 35/228 (15%)
Query: 3 FYTSWVDTANRNINFVTEMFTSG---TLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR 59
FY+S +N V + R Y + + + VK + Q+ L Y+HS
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK-SHAARCVGTPEFMAPEVY--EEE 116
+ HRD+K N+ ++ + +K+ D G A L + + + + APE+ +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199
Query: 117 YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP----------------- 159
Y +D++S G + E++ + + Q+ + + P
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF 259
Query: 160 ---------EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ PE + L ++RL+ E F
Sbjct: 260 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-25
Identities = 40/199 (20%), Positives = 82/199 (41%), Gaps = 14/199 (7%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRV-NIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70
+ + +TE +G L ++ + ++ + R I +G+ YL + +HRDL
Sbjct: 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN--MNYVHRDLAA 138
Query: 71 DNIFVNGNQGEVKIGDLGLAAILRKSHAAR-----CVGTPEFMAPE-VYEEEYNELVDIY 124
NI VN N K+ D GL+ +L A + APE + ++ D++
Sbjct: 139 RNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVW 197
Query: 125 SFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSS 183
SFG+ + E++T+ ++ K + G + + Q + +C +
Sbjct: 198 SFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC-PSAIYQLMMQCWQQERAR 256
Query: 184 RLSARELLT--DPFLQIDD 200
R ++++ D ++ D
Sbjct: 257 RPKFADIVSILDKLIRAPD 275
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 43/204 (21%), Positives = 71/204 (34%), Gaps = 23/204 (11%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQIL 50
+ E G L + K ++ + + H+ +
Sbjct: 78 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137
Query: 51 SGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMA 109
G+ YL IHRDL NI V N KI D GL+ +MA
Sbjct: 138 RGMDYLSQ--KQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMA 194
Query: 110 PE-VYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 168
E + Y D++S+G+ + E+V+ A++Y+K+ G + E D
Sbjct: 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC-DD 253
Query: 169 EVRQFIEKCLAT-VSSRLSARELL 191
EV + +C R S ++L
Sbjct: 254 EVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 46/220 (20%), Positives = 76/220 (34%), Gaps = 36/220 (16%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-----------------------VN 38
+ + I + E G L Y R +
Sbjct: 105 NLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 39 IRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK--- 95
+ + Q+ G+ +L + +HRDL N+ V VKI D GLA +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSN 219
Query: 96 -SHAARCVGTPEFMAPE-VYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKK 152
++MAPE ++E Y D++S+G+ + E+ + PY A YK
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 153 VISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 191
+ +G K + F E+ ++ C A R S L
Sbjct: 280 IQNGFKMDQPFYA-TEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 36/200 (18%), Positives = 74/200 (37%), Gaps = 14/200 (7%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR-VNIRAVKHWCRQILSGLLYLHSR 59
+ + + + V G LR + ++ + + Q+ G+ +L
Sbjct: 91 LSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 147
Query: 60 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA------RCVGTPEFMAPEVY 113
+HRDL N ++ VK+ D GLA + ++MA E
Sbjct: 148 SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 114 E-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQ 172
+ +++ D++SFG+ + E++T P + I ++ G++ + +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC-PDPLYE 265
Query: 173 FIEKCLAT-VSSRLSARELL 191
+ KC R S EL+
Sbjct: 266 VMLKCWHPKAEMRPSFSELV 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 4e-25
Identities = 56/222 (25%), Positives = 82/222 (36%), Gaps = 30/222 (13%)
Query: 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 62
S D + + T ++ V +K Q+L GL +LHS
Sbjct: 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-- 136
Query: 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEV-YEEEYNEL 120
V+HRDLK NI V + G++K+ D GLA I A V T + APEV + Y
Sbjct: 137 VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYK------------------------KVISG 156
VD++S G EM + + Q+ K S
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255
Query: 157 KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ E D + + KCL + R+SA L+ P+ Q
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (256), Expect = 7e-25
Identities = 45/229 (19%), Positives = 83/229 (36%), Gaps = 26/229 (11%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
W V E+ + R+ +++ V Q++S + Y+HS++ IHR
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHR 127
Query: 67 DLKCDNIFV--NGNQGEVKIGDLGLAAILRKSHAARC---------VGTPEFMAPEVYE- 114
D+K DN + V I D GLA R + + GT + + +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 115 EEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVISGK---KPEALFKVEDPE 169
E + D+ S G ++ + + Q Y+++ K E L K E
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 170 VRQFIEKCLA-TVSSRLSA---RELLTDPFLQI---DDYDSDLRMIQYQ 211
++ C + + R+L + F + DY D M+++
Sbjct: 248 FATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (251), Expect = 2e-24
Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 12/194 (6%)
Query: 9 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
A V E TLR + + L + H +IHRD+
Sbjct: 80 TPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN--GIIHRDV 137
Query: 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVD 122
K NI ++ VK+ D G+A + S A +GT ++++PE + + D
Sbjct: 138 KPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 196
Query: 123 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVE-DPEVRQFIEKCLAT- 180
+YS G + E++T + P++ + + Y+ V P + ++ + K LA
Sbjct: 197 VYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKN 256
Query: 181 VSSRL-SARELLTD 193
+R +A E+ D
Sbjct: 257 PENRYQTAAEMRAD 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (250), Expect = 4e-24
Identities = 49/227 (21%), Positives = 81/227 (35%), Gaps = 36/227 (15%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDP 61
K Y + + V E + + + K + Q+L+G+ Y H R
Sbjct: 64 KLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC--VGTPEFMAPEVYEEE--Y 117
V+HRDLK N+ +N GE+KI D GLA + T + AP+V Y
Sbjct: 120 RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK-------------------------- 151
+ +DI+S G EMV + + Q+ +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 152 KVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
V E+ K D + K L + R++A++ L + +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 100 bits (250), Expect = 4e-24
Identities = 33/185 (17%), Positives = 66/185 (35%), Gaps = 10/185 (5%)
Query: 13 RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDN 72
+ ++ S R ++ RQ+ +G+ YL +HRDL N
Sbjct: 113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRN 170
Query: 73 IFVNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMAPE-VYEEEYNELVDIYSFG 127
V N VKI D GL+ + + + +M PE ++ Y D++++G
Sbjct: 171 CLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229
Query: 128 MCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-VSSRLS 186
+ + E+ ++ ++ V G + E+ + C + + R S
Sbjct: 230 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPS 288
Query: 187 ARELL 191
+
Sbjct: 289 FCSIH 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (252), Expect = 5e-24
Identities = 44/236 (18%), Positives = 84/236 (35%), Gaps = 44/236 (18%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ D +R V E + +Q ++ + ++ + +IL L Y HS
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM- 148
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILR-KSHAARCVGTPEFMAPEVYEEE--Y 117
++HRD+K N+ ++ ++++ D GLA V + F PE+ + Y
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 118 NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALF-------------- 163
+ +D++S G + M+ P+ ++ E L+
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 164 ---------------------KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ PE F++K L SRL+ARE + P+
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 7e-24
Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
N N+ V E G + + + R + + + QI+ YLHS D +I+RDLK +
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPE 170
Query: 72 NIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY-EEEYNELVDIYSFGMCI 130
N+ ++ G +++ D G A ++ C GTPE +APE+ + YN+ VD ++ G+ I
Sbjct: 171 NLLIDQQ-GYIQVTDFGFAKRVKGRTWTLC-GTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 131 LEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT------VSSR 184
EM P+ P QIY+K++SGK +++ + L + +
Sbjct: 229 YEMAAGYPPF-FADQPIQIYEKIVSGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLK 285
Query: 185 LSARELLTDPFLQIDDYDSDLR 206
++ + D+ + +
Sbjct: 286 NGVNDIKNHKWFATTDWIAIYQ 307
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 7e-24
Identities = 54/232 (23%), Positives = 87/232 (37%), Gaps = 43/232 (18%)
Query: 1 MKFYTSWVDTANR--NINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS 58
+ F + + V++ G+L Y L V + + SGL +LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 59 ------RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPE 106
P + HRDLK NI V N G I DLGLA + VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 107 FMAPEVYEE-------EYNELVDIYSFGMCILEMVT----------FDYPYSECTHPA-- 147
+MAPEV ++ E + DIY+ G+ E+ + PY +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 148 --QIYKKVISGK-KPEALFKVEDPE----VRQFIEKCLAT-VSSRLSARELL 191
++ K V K +P + + E + + + +C ++RL+A +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 99.9 bits (248), Expect = 9e-24
Identities = 27/192 (14%), Positives = 67/192 (34%), Gaps = 21/192 (10%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
+ + V ++ L R+ +++ V +Q+L+ + +H + +++R
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYR 125
Query: 67 DLKCDNIFVN----GNQGEVKIGDLGLAAILRKSHAARC---------VGTPEFMAPEVY 113
D+K DN + N + + D G+ R + GT +M+ +
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 114 E-EEYNELVDIYSFGMCILEMVT--FDYPYSECTHPAQIYKKVISGKKP---EALFKVED 167
E + D+ + G + + + + Q Y+++ K+ L
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 168 PEVRQFIEKCLA 179
E +++
Sbjct: 246 EEFYKYMHYARN 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.4 bits (247), Expect = 1e-23
Identities = 42/198 (21%), Positives = 78/198 (39%), Gaps = 13/198 (6%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNI--RAVKHWCRQILSGLLYLHS 58
++ +TE T G L Y + R + + + QI S + YL
Sbjct: 76 VQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 59 RDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA---ARCVGTPEFMAP-EVYE 114
+ IHRDL N V N VK+ D GL+ ++ A ++ AP +
Sbjct: 134 K--NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 115 EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFI 174
+++ D+++FG+ + E+ T+ +Q+Y+ + + E + +V + +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME-RPEGCPEKVYELM 249
Query: 175 EKCLAT-VSSRLSARELL 191
C S R S E+
Sbjct: 250 RACWQWNPSDRPSFAEIH 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 1e-23
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 26/206 (12%)
Query: 10 TANRNINFVTEMFTSGTLRQY----------------RLKHRRVNIRAVKHWCRQILSGL 53
T + + + E + G LR+Y +++ + + Q+ G+
Sbjct: 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148
Query: 54 LYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAR----CVGTPEFMA 109
YL S+ IHRDL N+ V + +KI D GLA + + ++MA
Sbjct: 149 EYLASK--KCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205
Query: 110 PEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDP 168
PE + Y D++SFG+ + E+ T +++K + G + +
Sbjct: 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNC-TN 264
Query: 169 EVRQFIEKCLATV-SSRLSARELLTD 193
E+ + C V S R + ++L+ D
Sbjct: 265 ELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 53/243 (21%), Positives = 90/243 (37%), Gaps = 39/243 (16%)
Query: 9 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
T + + G LK + ++ + ++ QIL GL Y+HS V+HRDL
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA--NVLHRDL 135
Query: 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-----VGTPEFMAPEVYEEE--YNELV 121
K N+ +N ++KI D GLA + H V T + APE+ Y + +
Sbjct: 136 KPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 122 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP---------------------- 159
DI+S G + EM++ + + Q+ + P
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254
Query: 160 ------EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQYQT 212
LF D + ++K L R+ + L P+L+ SD + +
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPF 314
Query: 213 DYD 215
+D
Sbjct: 315 KFD 317
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 4e-23
Identities = 44/211 (20%), Positives = 76/211 (36%), Gaps = 27/211 (12%)
Query: 4 YTSWVDTANRNINFVTEMFTSGTLRQYRLKHRR----------------VNIRAVKHWCR 47
+ + E G L Y R + + + +
Sbjct: 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 141
Query: 48 QILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKS----HAARCVG 103
Q+ G+ +L SR IHRDL NI ++ VKI D GLA + K
Sbjct: 142 QVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL 198
Query: 104 TPEFMA-PEVYEEEYNELVDIYSFGMCILEMVTFDY-PYSECTHPAQIYKKVISGKKPEA 161
++MA +++ Y D++SFG+ + E+ + PY + +++ G +
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR- 257
Query: 162 LFKVEDPEVRQFIEKCLAT-VSSRLSARELL 191
PE+ Q + C S R + EL+
Sbjct: 258 APDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 6e-23
Identities = 51/223 (22%), Positives = 82/223 (36%), Gaps = 35/223 (15%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIH 65
V + V E + + + +K + Q+L GL + HS V+H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLH 125
Query: 66 RDLKCDNIFVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVY--EEEYNELV 121
RDLK N+ +N G +K+ D GLA V T + APE+ + Y+ V
Sbjct: 126 RDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 122 DIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP---------------------- 159
DI+S G EMVT + + Q+++ + P
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244
Query: 160 ----EALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ D + R + + L + R+SA+ L PF Q
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 9e-23
Identities = 47/206 (22%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 12 NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCD 71
++ + + G L + + R V+ + +I+ L +LH +I+RD+K +
Sbjct: 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLE 158
Query: 72 NIFVNGNQGEVKIGDLGLAAIL---RKSHAARCVGTPEFMAPEVY---EEEYNELVDIYS 125
NI ++ N G V + D GL+ A GT E+MAP++ + +++ VD +S
Sbjct: 159 NILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS 217
Query: 126 FGMCILEMVTFDYPY---SECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLAT-V 181
G+ + E++T P+ E A+I ++++ + P + + I++ L
Sbjct: 218 LGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDLIQRLLMKDP 275
Query: 182 SSRLS-----ARELLTDPFLQIDDYD 202
RL A E+ F Q ++D
Sbjct: 276 KKRLGCGPRDADEIKEHLFFQKINWD 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 1e-22
Identities = 35/214 (16%), Positives = 72/214 (33%), Gaps = 29/214 (13%)
Query: 2 KFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------RVNIRAVK 43
+ +TE G L + + R +++ +
Sbjct: 91 NLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 44 HWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AA 99
+ Q+ G+ +L S++ IHRDL NI + KI D GLA ++
Sbjct: 149 SFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKG 205
Query: 100 RCVGTPEFMAPEVYEEEY-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158
++MAPE D++S+G+ + E+ + + K+I
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265
Query: 159 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELL 191
+ E+ ++ C R + ++++
Sbjct: 266 RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 2e-22
Identities = 40/201 (19%), Positives = 78/201 (38%), Gaps = 20/201 (9%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKHRRV----------NIRAVKHWCRQILSGLLYL 56
V + + + E+ T G L+ Y R ++ + +I G+ YL
Sbjct: 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149
Query: 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC----VGTPEFMAPEV 112
++ +HRDL N V + VKIGD G+ + ++ R + +M+PE
Sbjct: 150 NAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 206
Query: 113 YE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVR 171
+ + D++SFG+ + E+ T + Q+ + V+ G + +
Sbjct: 207 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNC-PDMLF 265
Query: 172 QFIEKCLAT-VSSRLSARELL 191
+ + C R S E++
Sbjct: 266 ELMRMCWQYNPKMRPSFLEII 286
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 5e-22
Identities = 61/247 (24%), Positives = 97/247 (39%), Gaps = 36/247 (14%)
Query: 9 DTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDL 68
+T + +F M GT +KH ++ ++ Q+L GL Y+H+ HRDL
Sbjct: 90 ETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII--HRDL 147
Query: 69 KCDNIFVNGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSF 126
K N+ VN + E+KI D GLA S V T + APEV Y + VDI+S
Sbjct: 148 KPGNLAVNED-CELKILDFGLARQAD-SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205
Query: 127 GMCILEMVTFDYPYSECTHPAQIYKKV----------------------------ISGKK 158
G + EM+T + H Q+ + + + K
Sbjct: 206 GCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 265
Query: 159 PEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDDYDSDLRMIQ-YQTDYDE 216
++ P +EK L R++A E L P+ + D +Q Y +D+
Sbjct: 266 FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDD 325
Query: 217 ISPLLRQ 223
+ L +
Sbjct: 326 VDRTLDE 332
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.5 bits (231), Expect = 1e-21
Identities = 46/223 (20%), Positives = 81/223 (36%), Gaps = 35/223 (15%)
Query: 7 WVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHR 66
V +++ + V E + + + ++ VK + Q+L GL + HSR V+HR
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHR 125
Query: 67 DLKCDNIFVNGNQGEVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVY--EEEYNELVD 122
DLK N+ +N N GE+K+ + GLA + V T + P+V + Y+ +D
Sbjct: 126 DLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 123 IYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG-------------------------- 156
++S G E+ P K++
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 157 -KKPEALFKVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+ + R ++ L R+SA E L P+
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 2e-17
Identities = 51/213 (23%), Positives = 78/213 (36%), Gaps = 35/213 (16%)
Query: 16 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFV 75
+ G +K +++ V+ QIL GL Y+HS D +IHRDLK N+ V
Sbjct: 97 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAV 154
Query: 76 NGNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVY--EEEYNELVDIYSFGMCILEM 133
N E+KI D GLA T + APE+ YN+ VDI+S G + E+
Sbjct: 155 N-EDCELKILDFGLARHTDDEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 134 VTFDYPYSECTHPAQIYK----------------------------KVISGKKPEALFKV 165
+T + H Q+ + +F
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 166 EDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQ 197
+P +EK L R++A + L +
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 1e-16
Identities = 53/247 (21%), Positives = 90/247 (36%), Gaps = 48/247 (19%)
Query: 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPP 62
F +++ V E+ + + ++ + + Q+L G+ +LHS
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGI- 140
Query: 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAARC-VGTPEFMAPE-VYEEEYNEL 120
IHRDLK NI V + +KI D GLA S V T + APE + Y E
Sbjct: 141 -IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 121 VDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV--------------------------- 153
VDI+S G + EMV + + Q K +
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258
Query: 154 -----ISGKKPEALF-------KVEDPEVRQFIEKCLAT-VSSRLSARELLTDPFLQIDD 200
P++LF K++ + R + K L + R+S + L P++ +
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 201 YDSDLRM 207
+++
Sbjct: 319 DPAEVEA 325
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 74.7 bits (182), Expect = 6e-15
Identities = 50/258 (19%), Positives = 90/258 (34%), Gaps = 52/258 (20%)
Query: 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRD 60
+ + + + + + +HR + + VK +Q+L GL Y+H R
Sbjct: 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR- 144
Query: 61 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILRKSHAARCVGTPEFMAPEVYE-E 115
+IH D+K +N+ + + + +A A H + T E+ +PEV
Sbjct: 145 CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA 204
Query: 116 EYNELVDIYSFGMCILEMVTFDYPYS---------ECTHPAQIYK--------------- 151
+ DI+S I E++T D+ + + H AQI +
Sbjct: 205 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 264
Query: 152 -----------KVISGKKPEALFKV----------EDPEVRQFIEKCLAT-VSSRLSARE 189
+ IS K L V E E+ F+ L R A
Sbjct: 265 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324
Query: 190 LLTDPFLQIDDYDSDLRM 207
L+ P+L+ ++R+
Sbjct: 325 LVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 51.7 bits (123), Expect = 4e-08
Identities = 20/105 (19%), Positives = 35/105 (33%), Gaps = 16/105 (15%)
Query: 34 HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 93
RV + IL + + R ++H DL N+ V+ + I D + +
Sbjct: 97 LYRVRVENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEV 152
Query: 94 RKSHAARCVGTPEFMAPEV------YEEEYNELVDIYSFGMCILE 132
+ E + +V + Y DI S IL+
Sbjct: 153 GEEGW------REILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 654 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.39 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 95.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.69 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 91.44 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 84.44 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=374.66 Aligned_cols=197 Identities=55% Similarity=1.033 Sum_probs=183.0
Q ss_pred CEEEEEEEec--CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDT--ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~--~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||++|.+. .+..+|||||||+||+|.+++.+.+.+++..++.|++||+.||+|||+++++|+||||||+|||+++.
T Consensus 71 v~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~ 150 (270)
T d1t4ha_ 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 150 (270)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred eeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC
Confidence 6899999863 24579999999999999999999889999999999999999999999998889999999999999866
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhcccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKK 158 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~ 158 (654)
.+.+||+|||+|+..........+|||.|||||++.+.|+.++|||||||++|||++|+.||.+..+..++++.+..+..
T Consensus 151 ~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 151 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCCEEEeecCcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence 68999999999988766666677899999999999999999999999999999999999999988889999999999988
Q ss_pred CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 159 PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 159 p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
|..+....++++++||.+||. +|.+|||+.|+|+||||+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 888888899999999999999 899999999999999996
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=354.58 Aligned_cols=190 Identities=25% Similarity=0.433 Sum_probs=172.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++.+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 69 v~~~~~~~~--~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~ 143 (263)
T d2j4za1 69 LRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-G 143 (263)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-S
T ss_pred CeEEEEEEE--CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-C
Confidence 689999987 7899999999999999999999889999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||+|...........+||+.|||||++.+. |+.++|||||||++|+|++|+.||.+ .+..+++.++..+..+
T Consensus 144 ~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~ 222 (263)
T d2j4za1 144 ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFT 222 (263)
T ss_dssp CEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCCC
T ss_pred CEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC
Confidence 999999999988776666667899999999999864 89999999999999999999999976 6678888888876643
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
++...++++++||.+||. +|.+|||++|+|+||||+.
T Consensus 223 --~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 455689999999999999 8999999999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=355.94 Aligned_cols=193 Identities=23% Similarity=0.414 Sum_probs=170.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++.+|||||||+||+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 66 v~~~~~~~~--~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~ 140 (271)
T d1nvra_ 66 VKFYGHRRE--GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-D 140 (271)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-C
T ss_pred eeEeeeecc--CceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-C
Confidence 689999988 7899999999999999999988888999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc----CCccccCCCCccChhhhccc-C-CcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEEE-Y-NELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~~-y-s~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+||+|||+|+.+... .....+||+.|||||++.+. | +.++|||||||++|+|+||++||.........+..+.
T Consensus 141 ~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~ 220 (271)
T d1nvra_ 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220 (271)
T ss_dssp CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH
T ss_pred CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 9999999999876432 23456799999999998753 4 6789999999999999999999987666666666666
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
........+...++++++||.+||. +|.+|||++|+|+||||+.
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 6655555566789999999999999 8999999999999999973
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=353.52 Aligned_cols=194 Identities=32% Similarity=0.533 Sum_probs=169.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+.+|||||||+||+|.+++.+ +.+++..++.|++||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 80 v~~~~~~~~--~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~ 153 (293)
T d1yhwa1 80 VNYLDSYLV--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-G 153 (293)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-C
T ss_pred eeEeEEEEE--CCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-C
Confidence 689999998 7899999999999999998766 46999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+|+.+... .....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+......++..+..+.
T Consensus 154 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 9999999999876533 3345679999999999875 499999999999999999999999988665566666666665
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.+...+...++++++||.+||. +|.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 5555566789999999999999 899999999999999997543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=354.76 Aligned_cols=194 Identities=28% Similarity=0.501 Sum_probs=162.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.+ ..++|||||||.||+|.+++.+++.+++..++.++.||+.||.|||+ ++ |+||||||+|||++.+
T Consensus 67 v~l~~~~~~--~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~- 141 (322)
T d1s9ja_ 67 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR- 141 (322)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-
T ss_pred CcEEEEEEE--CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-
Confidence 689999987 68999999999999999999998899999999999999999999997 47 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHH-H--------
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQ-I-------- 149 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~q-i-------- 149 (654)
|.+||+|||+|+.+........+||+.|||||++.+ .|+.++|||||||++|||++|+.||........ .
T Consensus 142 ~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 221 (322)
T d1s9ja_ 142 GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221 (322)
T ss_dssp CCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------
T ss_pred CCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcC
Confidence 899999999999887776777899999999999875 599999999999999999999999975432211 0
Q ss_pred --------------------------------HHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 150 --------------------------------YKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 150 --------------------------------~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
...+.....|.......++++++||.+||+ +|.+||||+|+|+||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 111111112222223468899999999999 99999999999999999
Q ss_pred ccC
Q 006244 197 QID 199 (654)
Q Consensus 197 ~~~ 199 (654)
+..
T Consensus 302 ~~~ 304 (322)
T d1s9ja_ 302 KRS 304 (322)
T ss_dssp HHH
T ss_pred CcC
Confidence 743
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=346.24 Aligned_cols=193 Identities=31% Similarity=0.490 Sum_probs=157.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK----HRRVNIRAVKHWCRQILSGLLYLHSRD---PPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k----~~~Lse~~i~~i~~QIl~gL~YLHs~~---p~IIHRDLKpeNI 73 (654)
|++|++|.+...+.+|||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ .+|+||||||+||
T Consensus 66 v~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NI 145 (269)
T d2java1 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145 (269)
T ss_dssp CCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGE
T ss_pred eeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhc
Confidence 689999988667889999999999999999864 457999999999999999999999864 2499999999999
Q ss_pred EEeCCCCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
|++.+ |.+||+|||+|+.+... .....+|||.|||||++.+ .|+.++|||||||++|||+||..||.. .+..+++
T Consensus 146 ll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~ 223 (269)
T d2java1 146 FLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELA 223 (269)
T ss_dssp EECTT-SCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHH
T ss_pred CcCCC-CcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHH
Confidence 99855 79999999999987543 2345679999999999865 599999999999999999999999986 5677888
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccc
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFL 196 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf 196 (654)
.++..+..+. ++...++++++||.+||. +|.+|||+.|||+|||+
T Consensus 224 ~~i~~~~~~~-~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 224 GKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 8888887653 456789999999999999 89999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-41 Score=346.74 Aligned_cols=195 Identities=29% Similarity=0.572 Sum_probs=167.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.|.+ .+.++||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 72 v~l~~~~~~--~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~- 146 (288)
T d2jfla1 72 VKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD- 146 (288)
T ss_dssp CCEEEEEEE--TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-
T ss_pred CeEEEEEee--CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-
Confidence 689999988 7899999999999999999765 567999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhccc--CCccccCCCCccChhhhc------ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYE------EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~------~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
|.+||+|||+|+..... .....+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+. +..+++.
T Consensus 147 ~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-~~~~~~~ 225 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLL 225 (288)
T ss_dssp SCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHH
T ss_pred CCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-CHHHHHH
Confidence 79999999999765432 234567999999999873 34889999999999999999999999874 4555666
Q ss_pred HHHcCCCCc-ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 152 KVISGKKPE-ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 152 ki~~G~~p~-~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
++..+..+. ..+...++++++||.+||+ +|.+|||+.|+|+||||+.+..
T Consensus 226 ~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~ 277 (288)
T d2jfla1 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277 (288)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 777665443 3345679999999999999 8999999999999999986543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-40 Score=345.87 Aligned_cols=194 Identities=20% Similarity=0.412 Sum_probs=160.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--~ 78 (654)
|++|++|.+ ++.+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||+.. +
T Consensus 70 v~l~~~~~~--~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~ 145 (307)
T d1a06a_ 70 VALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDE 145 (307)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSST
T ss_pred CcEEEEEEE--CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCC
Confidence 689999987 7899999999999999999999889999999999999999999999999 999999999999953 3
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.|.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+++..+..+
T Consensus 146 ~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~ 224 (307)
T d1a06a_ 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKA 224 (307)
T ss_dssp TCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTT
T ss_pred CceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhcc
Confidence 5789999999998765433 345679999999999875 499999999999999999999999987 5567777888876
Q ss_pred CCC--cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKP--EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p--~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+ .......++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 643 33456688999999999999 89999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-40 Score=346.68 Aligned_cols=191 Identities=26% Similarity=0.448 Sum_probs=169.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|+||++|.+ ++++|||||||.||+|..++...+.+++..++.|++||+.||.|||+++ |+||||||+|||++.+ |
T Consensus 78 v~~~~~~~~--~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~ 152 (309)
T d1u5ra_ 78 IQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-G 152 (309)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-T
T ss_pred eeEEEEEEE--CCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-C
Confidence 689999988 7899999999999999988888889999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhc----ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE----EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~----~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+||+|||+|..... ....+||+.|||||++. +.|+.++|||||||++|||++|..||.+. +..+...++..+
T Consensus 153 ~~Kl~DFG~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 153 LVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQN 229 (309)
T ss_dssp EEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHS
T ss_pred CEEEeecccccccCC--CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhC
Confidence 999999999987644 34567999999999985 34899999999999999999999999874 455566677777
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..|.......++++++||.+||. +|.+|||++|+|+||||...
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 77666666789999999999999 89999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=344.40 Aligned_cols=194 Identities=28% Similarity=0.487 Sum_probs=169.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 71 v~l~~~~~~--~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~ 145 (288)
T d1uu3a_ 71 VKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-M 145 (288)
T ss_dssp CCEEEEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-S
T ss_pred eEEEEEEEE--CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-c
Confidence 689999987 7899999999999999999999899999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhccc----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 81 EVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
.+||+|||+|+.+... .....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.. .+..+++.++..
T Consensus 146 ~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 146 HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIK 224 (288)
T ss_dssp CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHT
T ss_pred eEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHc
Confidence 9999999999876432 2334579999999999875 599999999999999999999999987 577888888887
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHH------HhcCcccccCCcc
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARE------LLTDPFLQIDDYD 202 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~E------LL~HPFf~~~~~~ 202 (654)
+... ++...++++++||.+||. +|.+|||++| +++||||+.-++.
T Consensus 225 ~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 225 LEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TCCC--CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred CCCC--CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 7543 455689999999999999 8999999987 5889999876654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-40 Score=351.38 Aligned_cols=194 Identities=27% Similarity=0.460 Sum_probs=168.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+.+|||||||.||+|.+++.++..+++..++.|++||+.||+|||+++ |+||||||+|||++. .|
T Consensus 70 v~l~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~-~g 144 (364)
T d1omwa3 70 VCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDE-HG 144 (364)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS-SS
T ss_pred EEEEEEEEE--CCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcC-CC
Confidence 689999987 6899999999999999999999999999999999999999999999999 999999999999984 48
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhc-c-cCCcccchhhhhhHHHHHhhcCCCCCCCCC--HHHHHHHHHcC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-E-EYNELVDIYSFGMCILEMVTFDYPYSECTH--PAQIYKKVISG 156 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~--~~qi~kki~~G 156 (654)
.+||+|||+|+.+........+||+.|||||++. + .|+.++|||||||++|+|+||..||..... ...+.+.+ .
T Consensus 145 ~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~--~ 222 (364)
T d1omwa3 145 HVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--L 222 (364)
T ss_dssp CEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS--S
T ss_pred cEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--c
Confidence 9999999999988776666778999999999985 3 489999999999999999999999976432 22233322 2
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCC-----HHHHhcCcccccCCc
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLS-----ARELLTDPFLQIDDY 201 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpT-----a~ELL~HPFf~~~~~ 201 (654)
..+..++...++++++||.+||. +|.+||| |+|+|+||||+..++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 223 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 23344556789999999999999 8999999 899999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=347.27 Aligned_cols=193 Identities=26% Similarity=0.476 Sum_probs=173.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ++++|||||||+||+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 68 v~l~~~~~~--~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g 142 (337)
T d1o6la_ 68 TALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-G 142 (337)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-S
T ss_pred EEEEeeecc--ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-C
Confidence 689999988 7899999999999999999999999999999999999999999999999 9999999999999855 8
Q ss_pred cEEEEecCchhhhcc--cCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRK--SHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~--~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+|+.... ......+|||.|||||++.+ .|+.++|||||||++|||++|.+||.+ .+..++++++..+.
T Consensus 143 ~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 143 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE 221 (337)
T ss_dssp CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred CEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC
Confidence 999999999987543 23345679999999999875 599999999999999999999999987 66788888888876
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
.+ ++...++++++||.+||+ +|.+|+ ++.++++||||+..++
T Consensus 222 ~~--~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 222 IR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp CC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CC--CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 43 456789999999999999 899999 4999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=337.36 Aligned_cols=196 Identities=22% Similarity=0.404 Sum_probs=171.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ- 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~- 79 (654)
|++|++|.+ .+++|||||||+||+|.+++.+.+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+.
T Consensus 76 v~~~~~~~~--~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~ 151 (293)
T d1jksa_ 76 ITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNV 151 (293)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSS
T ss_pred CcEEEEEEE--CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCC
Confidence 689999987 7899999999999999999998889999999999999999999999999 99999999999997542
Q ss_pred --CcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 --GEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 --g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||+|...... ......||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+.+..+..
T Consensus 152 ~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~ 230 (293)
T d1jksa_ 152 PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSA 230 (293)
T ss_dssp SSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHT
T ss_pred cccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHh
Confidence 25999999999877543 3345679999999999975 599999999999999999999999987 567777788887
Q ss_pred CCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCCc
Q 006244 156 GKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDDY 201 (654)
Q Consensus 156 G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~~ 201 (654)
+.. +...+...++++++||.+||. +|.+|||++|+|+||||+..+.
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 754 334456789999999999999 8999999999999999986543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-39 Score=338.42 Aligned_cols=193 Identities=26% Similarity=0.529 Sum_probs=172.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ .+.+|+|||||.||+|..++.....+++..++.|++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 67 v~~~~~~~~--~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g 141 (316)
T d1fota_ 67 IRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-G 141 (316)
T ss_dssp CCEEEEEEC--SSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-S
T ss_pred hheeeeEee--CCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-C
Confidence 689999987 7899999999999999999999999999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||+|+..... ....+||+.|||||++.+ .|+.++|||||||++|+|+||..||.+ .+..+++.++..+..+
T Consensus 142 ~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~ 219 (316)
T d1fota_ 142 HIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELR 219 (316)
T ss_dssp CEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCCC
T ss_pred CEEEecCccceEeccc-cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCCC
Confidence 9999999999876544 345679999999999976 499999999999999999999999987 5677888888887643
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
++...+++++++|.+||. +|.+|+ |++++|+||||+..++.
T Consensus 220 --~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 220 --FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp --CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred --CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 445678999999999999 899996 99999999999876653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-39 Score=345.46 Aligned_cols=195 Identities=24% Similarity=0.396 Sum_probs=170.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~-~ 78 (654)
|++|++|.+ .+.+|||||||+||+|.+++.+ .+.+++..++.|++||+.||.|||+++ |+||||||+|||++. .
T Consensus 86 v~~~~~~~~--~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~ 161 (350)
T d1koaa2 86 VNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKR 161 (350)
T ss_dssp CCEEEEEEE--TTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTT
T ss_pred CcEEEEEEE--CCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCC
Confidence 689999988 7899999999999999999854 457999999999999999999999999 999999999999964 3
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.|.+||+|||+|+.+.... .....||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+
T Consensus 162 ~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~ 240 (350)
T d1koaa2 162 SNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSC 240 (350)
T ss_dssp SCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHT
T ss_pred CCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhC
Confidence 4789999999998775543 334679999999999875 489999999999999999999999986 5677777888776
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
.. +.......++++++||.+||. +|.+|||++|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 54 344556689999999999999 899999999999999998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-39 Score=331.54 Aligned_cols=192 Identities=23% Similarity=0.442 Sum_probs=169.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ++++|||||||+||+|.+++..++.+++..++.|+.||+.||+|||+++ |+||||||+|||++. ++
T Consensus 73 v~~~~~~~~--~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~-~~ 147 (277)
T d1phka_ 73 IQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDD-DM 147 (277)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECT-TC
T ss_pred EEEEeeccc--CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcC-CC
Confidence 689999987 7899999999999999999999889999999999999999999999999 999999999999984 47
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhcc-------cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-------EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-------~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
.+||+|||++..+... .....+||+.|+|||++.. .|+.++||||+||++|+|++|..||.+ .+...+...
T Consensus 148 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~ 226 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRM 226 (277)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHH
T ss_pred CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHH
Confidence 9999999999877543 3344579999999998852 378899999999999999999999987 566777777
Q ss_pred HHcCCC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 153 VISGKK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 153 i~~G~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..+.. +.......++++++||.+||+ +|.+|||++|+|+||||+.
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 877754 333455789999999999999 8999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-39 Score=345.06 Aligned_cols=194 Identities=24% Similarity=0.391 Sum_probs=170.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-C
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-N 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~-~ 78 (654)
|++|++|.+ ++.+|||||||+||+|.+++.+.+ ++++..++.|++||+.||.|||+++ |+||||||+|||++. .
T Consensus 89 v~~~~~~~~--~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~ 164 (352)
T d1koba_ 89 INLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKK 164 (352)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTT
T ss_pred CcEEEEEEE--CCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccC
Confidence 689999987 789999999999999999876654 6999999999999999999999999 999999999999973 4
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.|.+||+|||+|..+.... .....||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+...++..+..+
T Consensus 165 ~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~ 243 (352)
T d1koba_ 165 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRC 243 (352)
T ss_dssp CCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHHC
T ss_pred CCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC
Confidence 5799999999998876543 334579999999999875 499999999999999999999999987 4566677777776
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.. +...+...++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 54 444556789999999999999 89999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-39 Score=340.73 Aligned_cols=193 Identities=27% Similarity=0.473 Sum_probs=172.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...+++||||+.||+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++.+ |
T Consensus 104 v~~~~~~~~--~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g 178 (350)
T d1rdqe_ 104 VKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-G 178 (350)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-S
T ss_pred eeccccccc--ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-C
Confidence 689999987 7899999999999999999999899999999999999999999999999 9999999999999854 8
Q ss_pred cEEEEecCchhhhcccCCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCCCC
Q 006244 81 EVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGKKP 159 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~~p 159 (654)
.+||+|||+|+.+... ....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+ .+...++.++..+..+
T Consensus 179 ~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~~ 256 (350)
T d1rdqe_ 179 YIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVR 256 (350)
T ss_dssp CEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC
T ss_pred CEEeeeceeeeecccc-cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCCC
Confidence 9999999999877543 345679999999999875 499999999999999999999999986 5678888888877643
Q ss_pred cccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCcc
Q 006244 160 EALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDYD 202 (654)
Q Consensus 160 ~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~~ 202 (654)
++...++++++||.+||. +|.+|+ |+++||+||||+..++.
T Consensus 257 --~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred --CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 345689999999999999 899884 99999999999876653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=327.96 Aligned_cols=185 Identities=23% Similarity=0.378 Sum_probs=162.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTS-GTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~g-GSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|++|.+ .+.+++||||+.+ +++.+++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++.+.
T Consensus 72 v~~~~~~~~--~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 72 IRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNR 147 (273)
T ss_dssp CCEEEEEEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTT
T ss_pred cEEEEEEee--CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCC
Confidence 689999987 7899999999976 689999988889999999999999999999999999 99999999999999777
Q ss_pred CcEEEEecCchhhhcccCCccccCCCCccChhhhcc-c-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 80 GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE-E-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~-~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
+.+||+|||+|+..........+||+.|||||++.+ . ++.++|||||||++|+|+||+.||... ..+..+.
T Consensus 148 ~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-------~~i~~~~ 220 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQ 220 (273)
T ss_dssp TEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------HHHHHCC
T ss_pred CeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-------hHHhhcc
Confidence 899999999998877666667789999999999864 3 467899999999999999999999752 2344443
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. .+....++++++||.+||. +|.+|||++|+|+||||+.
T Consensus 221 ~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 221 V--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp C--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred c--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 3 2445689999999999999 8999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-39 Score=336.72 Aligned_cols=193 Identities=24% Similarity=0.486 Sum_probs=171.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++.+|||||||+||+|.+++...+++++..++.+++||+.||+|||+++ |+||||||+|||++. .|
T Consensus 66 v~~~~~~~~--~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~-~~ 140 (320)
T d1xjda_ 66 THMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDK-DG 140 (320)
T ss_dssp CCEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECT-TS
T ss_pred EEEEEEEcc--CCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecC-CC
Confidence 689999988 7899999999999999999999999999999999999999999999999 999999999999985 48
Q ss_pred cEEEEecCchhhhccc--CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcCC
Q 006244 81 EVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISGK 157 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G~ 157 (654)
.+||+|||+++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+ .+..+++.++..+.
T Consensus 141 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 141 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN 219 (320)
T ss_dssp CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC
T ss_pred ceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC
Confidence 9999999999865432 2334579999999999875 599999999999999999999999987 56788888888775
Q ss_pred CCcccccCCChHHHHHHHHHhh-CccCCCCHH-HHhcCcccccCCc
Q 006244 158 KPEALFKVEDPEVRQFIEKCLA-TVSSRLSAR-ELLTDPFLQIDDY 201 (654)
Q Consensus 158 ~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~-ELL~HPFf~~~~~ 201 (654)
. .+++..++++++||.+||. +|.+|||+. +|++||||+.-++
T Consensus 220 ~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 220 P--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp C--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred C--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 4 3456689999999999999 899999995 8999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=331.16 Aligned_cols=194 Identities=21% Similarity=0.322 Sum_probs=161.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.+ ++++|||||||.||++..++...+.+++..++.|++||+.||+|||+++ |+||||||+|||++. .+
T Consensus 63 v~~~~~~~~--~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~-~~ 137 (299)
T d1ua2a_ 63 IGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDE-NG 137 (299)
T ss_dssp CCEEEEECC--TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT-TC
T ss_pred eEEEeeecc--CCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecC-CC
Confidence 689999987 6889999999999888877766778999999999999999999999999 999999999999985 48
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
.+||+|||+++...... ....+||+.|||||++.. .|+.++|||||||++|||+||.+||.+....++ ..++..
T Consensus 138 ~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~ 216 (299)
T d1ua2a_ 138 VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFET 216 (299)
T ss_dssp CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHH
T ss_pred ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHh
Confidence 99999999998765432 344579999999998853 489999999999999999999999987554443 333332
Q ss_pred -CCCCc------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccCC
Q 006244 156 -GKKPE------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQIDD 200 (654)
Q Consensus 156 -G~~p~------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~~ 200 (654)
|..+. ......++++++||.+||+ +|.+||||.|+|+||||+...
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 11110 1123467899999999999 899999999999999998543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-39 Score=338.00 Aligned_cols=197 Identities=20% Similarity=0.355 Sum_probs=161.1
Q ss_pred CEEEEEEEe--cCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVD--TANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd--~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|++|.+ ..+.++|||||||+||+|.+++.+. ..+++..++.|++||+.||.|||+++ |+||||||+|||++
T Consensus 68 v~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~ 145 (335)
T d2ozaa1 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYT 145 (335)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES
T ss_pred CeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccc
Confidence 689999876 3356899999999999999999874 46999999999999999999999999 99999999999997
Q ss_pred C--CCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHH---HH
Q 006244 77 G--NQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPA---QI 149 (654)
Q Consensus 77 ~--~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~---qi 149 (654)
. +.+.+||+|||+|+..... .....+|||.|||||++.+ .|+.++|||||||++|+|+||.+||.+..... .+
T Consensus 146 ~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~ 225 (335)
T d2ozaa1 146 SKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225 (335)
T ss_dssp CSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred cccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH
Confidence 5 3467999999999876543 3345679999999999875 59999999999999999999999997643322 22
Q ss_pred HHHHHcCC--CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 150 YKKVISGK--KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 150 ~kki~~G~--~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
...+..+. .|...+...++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 22222222 2223334578999999999999 89999999999999999644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=333.14 Aligned_cols=193 Identities=22% Similarity=0.367 Sum_probs=169.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN- 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~- 78 (654)
|++|++|.+ .+++|||||||+||+|.+++...+ .+++..++.|+.||+.||+|||+++ |+||||||+|||++.+
T Consensus 64 v~~~~~~~~--~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~ 139 (321)
T d1tkia_ 64 LHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRR 139 (321)
T ss_dssp CCEEEEEEE--TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSS
T ss_pred CeEEEEEEE--CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCC
Confidence 689999988 789999999999999999998765 7999999999999999999999999 9999999999999743
Q ss_pred CCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~G 156 (654)
.+.+||+|||++....... .....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.. .+..+++..+..+
T Consensus 140 ~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~ 218 (321)
T d1tkia_ 140 SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNA 218 (321)
T ss_dssp CCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHT
T ss_pred ceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC
Confidence 3589999999998765432 334569999999998874 599999999999999999999999987 5677788888877
Q ss_pred CC--CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 157 KK--PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 157 ~~--p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
.. +...++..++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 64 344456789999999999999 8999999999999999964
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-38 Score=327.80 Aligned_cols=187 Identities=24% Similarity=0.324 Sum_probs=161.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-----------------------RVNIRAVKHWCRQILSGLLYLH 57 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-----------------------~Lse~~i~~i~~QIl~gL~YLH 57 (654)
|+||+.|.+ .+.+|||||||+||+|.+++...+ .+++..++.|+.||+.||+|||
T Consensus 104 v~l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH 181 (325)
T d1rjba_ 104 VNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181 (325)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEEee--CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 689999977 688999999999999999997653 4899999999999999999999
Q ss_pred hCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHH
Q 006244 58 SRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILE 132 (654)
Q Consensus 58 s~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~E 132 (654)
+++ |+||||||+|||++.+ +.+||+|||+|+....... ....||+.|||||++. +.|+.++|||||||++||
T Consensus 182 ~~~--IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~e 258 (325)
T d1rjba_ 182 FKS--CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258 (325)
T ss_dssp HTT--EEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCC--eeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHH
Confidence 999 9999999999999855 7999999999987654332 2345899999999886 569999999999999999
Q ss_pred Hhh-cCCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 133 MVT-FDYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 133 LlT-G~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
|+| |..||.+......+.+.+..+..+ ..+...++++++||.+||+ +|.+|||++||++|
T Consensus 259 mlt~g~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 259 IFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 998 899998866666666666665544 3456788999999999999 89999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-38 Score=320.00 Aligned_cols=187 Identities=27% Similarity=0.421 Sum_probs=158.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||++.. ...++||||||+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.+
T Consensus 67 v~~~~~~~---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~- 140 (276)
T d1uwha_ 67 LLFMGYST---APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED- 140 (276)
T ss_dssp CCEEEEEC---SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-
T ss_pred eeeeEEEe---ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-
Confidence 67888653 35789999999999999999765 56999999999999999999999998 9999999999999855
Q ss_pred CcEEEEecCchhhhccc----CCccccCCCCccChhhhcc----cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKS----HAARCVGTPEFMAPEVYEE----EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYK 151 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~----~~~~~vGTp~YmAPEvl~~----~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~k 151 (654)
+.+||+|||+|+..... ......||+.|||||++.. .|+.++|||||||++|||+||+.||.+..+..++..
T Consensus 141 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~ 220 (276)
T d1uwha_ 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220 (276)
T ss_dssp SSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred CCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 79999999999776432 2234579999999999852 489999999999999999999999998888888888
Q ss_pred HHHcCCCCc---ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 152 KVISGKKPE---ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 152 ki~~G~~p~---~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+..+. .+....++++++||.+||. +|.+|||+.+++.+
T Consensus 221 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 887776543 3345578999999999999 89999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=318.79 Aligned_cols=189 Identities=21% Similarity=0.352 Sum_probs=162.7
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.+.. +.++||||||++|+|.+++.+.+.+++..+..|+.||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 71 v~~~g~~~~---~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~ 144 (277)
T d1xbba_ 71 VRMIGICEA---ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-H 144 (277)
T ss_dssp CCEEEEEES---SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-T
T ss_pred ceEEEEecc---CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-C
Confidence 689998753 467999999999999999999999999999999999999999999999 9999999999999854 7
Q ss_pred cEEEEecCchhhhcccC-----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 81 EVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
.+||+|||+++.+.... .....||+.|||||++. ..|+.++|||||||++|||+| |+.||.+ .+..++...+
T Consensus 145 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i 223 (277)
T d1xbba_ 145 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAML 223 (277)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHH
T ss_pred cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHH
Confidence 99999999998764322 22346999999999886 459999999999999999998 8999987 4567788888
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHH---hcCcccc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL---LTDPFLQ 197 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~EL---L~HPFf~ 197 (654)
..|..+. .+...++++++||.+||. +|.+|||+.++ |+|+|+.
T Consensus 224 ~~~~~~~-~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 224 EKGERMG-CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCC-CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 8887654 456688999999999999 89999999998 5677764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-37 Score=313.87 Aligned_cols=195 Identities=27% Similarity=0.387 Sum_probs=158.0
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|+.|... ....+++++|||.+|.+..+... ...+++..++.+++||+.||+|||+++ |+||||||+|||++
T Consensus 73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~ 150 (305)
T d1blxa_ 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT 150 (305)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred ceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc
Confidence 5789988753 24589999999988777655443 356999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||++...... .....+||+.|||||++. ..|+.++|||||||++|||+||.+||...+ ......++.
T Consensus 151 ~~-~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~ 228 (305)
T d1blxa_ 151 SS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-DVDQLGKIL 228 (305)
T ss_dssp TT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHH
T ss_pred CC-CCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-HHHHHHHHH
Confidence 54 79999999999765433 334567999999999886 459999999999999999999999998754 444333333
Q ss_pred c--CCC-----------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 S--GKK-----------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 ~--G~~-----------------------p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
. |.. ...+....++.+++||.+||+ +|.+||||.|+|+||||+.-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 2 111 112234567899999999999 99999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=312.45 Aligned_cols=192 Identities=28% Similarity=0.428 Sum_probs=156.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|++|.+ +.++|||||||.+ .+.+++.. .+.+++..++.++.||+.||+|||+++ ||||||||+|||++.+
T Consensus 64 v~~~~~~~~--~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~ 138 (298)
T d1gz8a_ 64 VKLLDVIHT--ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE 138 (298)
T ss_dssp CCEEEEEEE--TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT
T ss_pred EEecccccc--ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc
Confidence 689999998 7899999999965 45555443 456999999999999999999999999 9999999999999855
Q ss_pred CCcEEEEecCchhhhccc--CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS--HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~--~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||+|+..... .....+||+.|+|||++.. .++.++|||||||++|+|++|++||.+.+....+++.+.
T Consensus 139 -~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 139 -GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp -SCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred -CcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 79999999999887543 3344579999999998764 367899999999999999999999988655555554433
Q ss_pred c-CCCCc-------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 155 S-GKKPE-------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 155 ~-G~~p~-------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
. +.... ......++++++||.+||+ +|.+|||+.|||+||||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 2 11111 0122457889999999999 8999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-37 Score=309.70 Aligned_cols=187 Identities=21% Similarity=0.367 Sum_probs=152.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++.. ++.++||||||.+|+|.+++... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 63 v~~~g~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~- 137 (263)
T d1sm2a_ 63 VQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN- 137 (263)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-
T ss_pred ccccceecc--CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-
Confidence 689998876 67899999999999999998765 56899999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+.+||+|||+++....... ....||+.|||||++.+ .|+.++|||||||++|||+|+..|+....+..+++..+..
T Consensus 138 ~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 138 QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217 (263)
T ss_dssp GCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred CCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence 7999999999987654322 23468999999999874 5999999999999999999965555455777888888888
Q ss_pred CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 156 GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 156 G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+..+. .+...++++.+||.+||+ +|.+|||++++++|
T Consensus 218 ~~~~~-~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 218 GFRLY-KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCC-CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 86654 345678999999999999 89999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-36 Score=309.51 Aligned_cols=191 Identities=26% Similarity=0.420 Sum_probs=157.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.. .+.+++|+||+.++.+..+....+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ +
T Consensus 63 v~~~~~~~~--~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~ 137 (286)
T d1ob3a_ 63 VKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-G 137 (286)
T ss_dssp CCEEEEEEC--SSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-S
T ss_pred Eeeeeeccc--CCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-C
Confidence 689999988 7899999999988888887777888999999999999999999999999 9999999999999855 8
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
.+||+|||++....... ....+||+.|+|||++.+ .++.++|||||||++|||++|++||.+.+...++. ++..
T Consensus 138 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~-~i~~~ 216 (286)
T d1ob3a_ 138 ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM-RIFRI 216 (286)
T ss_dssp CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHH
T ss_pred CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH-HHHHh
Confidence 99999999998875432 234469999999998864 47899999999999999999999998755444433 3321
Q ss_pred -CCCC-------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 156 -GKKP-------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 156 -G~~p-------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
|..+ .......++.+++||.+||+ +|++|||+.|+|+||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 1110 12234567899999999999 999999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-37 Score=314.15 Aligned_cols=188 Identities=24% Similarity=0.397 Sum_probs=154.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|++++.+... +..+++|||||++|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+
T Consensus 80 v~~~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iv 156 (299)
T d1ywna1 80 VNLLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CI 156 (299)
T ss_dssp CCEEEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred EEeeeeeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Confidence 4567766543 568999999999999999997542 4899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhc-CC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTF-DY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG-~~ 138 (654)
||||||+|||++.+ +.+||+|||+|+...... ....+||+.|||||++.+ .|+.++|||||||++|||+|| .+
T Consensus 157 HrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~ 235 (299)
T d1ywna1 157 HRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235 (299)
T ss_dssp CSCCCGGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCcCCccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCC
Confidence 99999999999854 799999999998764322 234569999999998874 599999999999999999986 56
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
||........+...+..|..+. .+...++++++||.+||. +|.+|||+.|+++|
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 236 PYPGVKIDEEFCRRLKEGTRMR-APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp SSTTCCCSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8887777777777888887664 456688999999999999 89999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-37 Score=314.28 Aligned_cols=189 Identities=20% Similarity=0.366 Sum_probs=162.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.. +.+|||||||+||+|.+++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 72 v~l~g~~~~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~- 145 (285)
T d1u59a_ 72 VRLIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR- 145 (285)
T ss_dssp CCEEEEEES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-
T ss_pred eeEeeeecc---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-
Confidence 689998754 5689999999999999997654 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||+++.+.... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.. ..++...
T Consensus 146 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~ 224 (285)
T d1u59a_ 146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAF 224 (285)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHH
T ss_pred CceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHH
Confidence 799999999998764322 22345899999999886 569999999999999999998 899998754 5667788
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHH---hcCcccc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSAREL---LTDPFLQ 197 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~EL---L~HPFf~ 197 (654)
+..|..+. .+...++++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 225 i~~~~~~~-~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 225 IEQGKRME-CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCC-CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 88887664 456788999999999999 89999999888 5677764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-36 Score=314.43 Aligned_cols=186 Identities=19% Similarity=0.341 Sum_probs=151.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++.. .+.++||||||++|+|.+++.+. +.+++..+..|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 90 v~l~g~~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~- 164 (299)
T d1jpaa_ 90 IHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN- 164 (299)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred ccEEEEEee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-
Confidence 689998866 68899999999999999998874 46999999999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccCC-------ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA-------ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIY 150 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~-------~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~ 150 (654)
+.+||+|||+++.+..... ....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+ .+..++.
T Consensus 165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~ 243 (299)
T d1jpaa_ 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVI 243 (299)
T ss_dssp CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHH
T ss_pred CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHH
Confidence 7999999999987654321 1234799999999986 469999999999999999998 8999987 4567777
Q ss_pred HHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 151 KKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 151 kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+..+..+. .+...++++++||.+||. +|.+|||+.++++.
T Consensus 244 ~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 244 NAIEQDYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8888776554 345678999999999999 89999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-36 Score=311.99 Aligned_cols=186 Identities=23% Similarity=0.334 Sum_probs=162.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||+.|.+ ++.++||||||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 76 v~~~~~~~~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~ 151 (287)
T d1opja_ 76 VQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN 151 (287)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred ecCCccEee--CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC
Confidence 689998876 68999999999999999999764 46899999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCc---cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSHAA---RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~---~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||+|+........ ...||+.|||||++. +.|+.++|||||||++|||++|..||....+..++++.+.
T Consensus 152 -~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~ 230 (287)
T d1opja_ 152 -HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230 (287)
T ss_dssp -GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred -CcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh
Confidence 79999999999887554322 234889999999876 5699999999999999999998887766678888888887
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+..+. .+...++++++||.+||. +|.+|||+.++++
T Consensus 231 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 KDYRME-RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 776543 456788999999999999 8999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-37 Score=310.96 Aligned_cols=190 Identities=22% Similarity=0.361 Sum_probs=162.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH--RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~--~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||+++.+ +.++||||||.+|+|.+++... .++++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 71 v~~~g~~~~---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~ 145 (272)
T d1qpca_ 71 VRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT 145 (272)
T ss_dssp CCEEEEECS---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred eEEEeeecc---CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc
Confidence 689997643 5789999999999999976543 36999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||+|+.+.... .....||+.|||||++. +.|+.++|||||||++|||+||..|+....+..++...+.
T Consensus 146 -~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~ 224 (272)
T d1qpca_ 146 -LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224 (272)
T ss_dssp -SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred -cceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999998775432 23456999999999887 5699999999999999999997766655577888888888
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc--Ccccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT--DPFLQ 197 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~--HPFf~ 197 (654)
.+..+. .+...++++++||.+||. +|.+|||+.++++ ++||.
T Consensus 225 ~~~~~~-~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 225 RGYRMV-RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCC-CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 876654 345678999999999999 8999999999988 77874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.2e-36 Score=310.70 Aligned_cols=194 Identities=22% Similarity=0.368 Sum_probs=159.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|++|.......+++|||||.+|+|..+ .+.+++..++.+++||+.||.|||+++ |+||||||+|||++.+.+
T Consensus 93 v~~~~~~~~~~~~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~ 167 (328)
T d3bqca1 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHR 167 (328)
T ss_dssp CCEEEEEECTTTCSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTT
T ss_pred cEEEEEEEecCCCceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCC
Confidence 679999987667899999999999999775 356999999999999999999999999 999999999999997666
Q ss_pred cEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc--
Q 006244 81 EVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS-- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~-- 155 (654)
.+||+|||+|+..... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|..||....+.......+..
T Consensus 168 ~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 168 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred eeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 7999999999876543 3445679999999998764 4899999999999999999999999775554433222211
Q ss_pred C-----------C----------------------CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 156 G-----------K----------------------KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 156 G-----------~----------------------~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
| . .+.......++++++||.+||. +|.+||||+|+|+||||+..
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0 0 0011223467899999999999 99999999999999999754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=312.60 Aligned_cols=196 Identities=20% Similarity=0.323 Sum_probs=156.0
Q ss_pred CEEEEEEEec----CCCeEEEEEecCCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcE
Q 006244 1 MKFYTSWVDT----ANRNINFVTEMFTSGTLRQY---RLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNI 73 (654)
Q Consensus 1 VkfY~sfvd~----~~~~i~LVtEy~~gGSL~~~---l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNI 73 (654)
|++|++|... ...++|||||||.+|.+..+ ......+++..++.|++||+.||+|||+++ |+||||||+||
T Consensus 76 v~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NI 153 (350)
T d1q5ka_ 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNL 153 (350)
T ss_dssp CCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGE
T ss_pred CcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceE
Confidence 5788888753 23578999999977644333 334567999999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEEecCchhhhccc-CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 74 FVNGNQGEVKIGDLGLAAILRKS-HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 74 LId~~~g~VKL~DFGLA~~l~~~-~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
|++.+...+||+|||++..+... .....+||+.|+|||++.+ .|+.++|||||||++|||++|.+||.......++.
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~ 233 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred EEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH
Confidence 99877568999999999876543 3445679999999998753 58999999999999999999999998755444443
Q ss_pred HHHHc-CCC-----------------C--------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 151 KKVIS-GKK-----------------P--------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 151 kki~~-G~~-----------------p--------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.+.. |.. + .......++++++||.+||. +|.+||||.|+|+||||+.
T Consensus 234 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 32211 111 0 01123468899999999999 9999999999999999963
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-36 Score=305.35 Aligned_cols=193 Identities=21% Similarity=0.327 Sum_probs=152.7
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+++..... ..+|||||||.||+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+
T Consensus 70 v~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~ 147 (277)
T d1o6ya_ 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT 147 (277)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT
T ss_pred CcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc
Confidence 678998887432 358999999999999999999899999999999999999999999999 9999999999999855
Q ss_pred CCcEEEEecCchhhhccc-----CCccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
+.++|+|||++...... .....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+ ..++..+
T Consensus 148 -~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~ 225 (277)
T d1o6ya_ 148 -NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQ 225 (277)
T ss_dssp -SCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHH
T ss_pred -ccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-HHHHHHH
Confidence 79999999998755332 2334579999999999875 49999999999999999999999998744 4444444
Q ss_pred HHc-CCCC-cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccc
Q 006244 153 VIS-GKKP-EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQ 197 (654)
Q Consensus 153 i~~-G~~p-~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~ 197 (654)
+.. +..+ .......++++++||.+||. +|.+||+..+.|.|+|++
T Consensus 226 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 444 3333 34456688999999999999 899999544444566654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-35 Score=305.79 Aligned_cols=195 Identities=21% Similarity=0.345 Sum_probs=153.7
Q ss_pred CEEEEEEEec------CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEE
Q 006244 1 MKFYTSWVDT------ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIF 74 (654)
Q Consensus 1 VkfY~sfvd~------~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNIL 74 (654)
+++|+++... .++++++|||||.++.+..+......+++..++.+++||+.||.|||+++ |+||||||+|||
T Consensus 72 i~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NIL 149 (318)
T d3blha1 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVL 149 (318)
T ss_dssp CCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred cceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchhee
Confidence 4677777552 24579999999988887776666678999999999999999999999999 999999999999
Q ss_pred EeCCCCcEEEEecCchhhhccc------CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCH
Q 006244 75 VNGNQGEVKIGDLGLAAILRKS------HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHP 146 (654)
Q Consensus 75 Id~~~g~VKL~DFGLA~~l~~~------~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~ 146 (654)
++.+ +.+||+|||++..+... .....+||+.|+|||++.. .|+.++|||||||++|||++|.+||.+.. .
T Consensus 150 l~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~ 227 (318)
T d3blha1 150 ITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-E 227 (318)
T ss_dssp ECTT-SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-H
T ss_pred ecCC-CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-H
Confidence 9855 79999999999765432 2234579999999998863 58999999999999999999999998744 3
Q ss_pred HHHHHHHHc--CCCCcccc----------------------------cCCChHHHHHHHHHhh-CccCCCCHHHHhcCcc
Q 006244 147 AQIYKKVIS--GKKPEALF----------------------------KVEDPEVRQFIEKCLA-TVSSRLSARELLTDPF 195 (654)
Q Consensus 147 ~qi~kki~~--G~~p~~l~----------------------------~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPF 195 (654)
......+.. +..+.... ...++++++||.+||+ +|.+||||.|+|+|||
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 333333322 22211110 1136788999999999 9999999999999999
Q ss_pred cccC
Q 006244 196 LQID 199 (654)
Q Consensus 196 f~~~ 199 (654)
|+..
T Consensus 308 f~~~ 311 (318)
T d3blha1 308 FWSD 311 (318)
T ss_dssp GSSS
T ss_pred hccC
Confidence 9854
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-36 Score=303.34 Aligned_cols=185 Identities=24% Similarity=0.440 Sum_probs=150.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++. .+.+|||||||++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 71 v~l~~~~~---~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~- 144 (273)
T d1mp8a_ 71 VKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN- 144 (273)
T ss_dssp CCEEEEEC---SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-
T ss_pred eeEEEEEe---cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-
Confidence 68999874 36899999999999999987664 46999999999999999999999999 9999999999999855
Q ss_pred CcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||+|+.+.... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..+++.++.
T Consensus 145 ~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~ 223 (273)
T d1mp8a_ 145 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIE 223 (273)
T ss_dssp TEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHH
T ss_pred CcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHH
Confidence 799999999998765432 23346899999999987 569999999999999999998 8899976 45677888888
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. +++..++++++||.+||. +|.+|||+.+|+++
T Consensus 224 ~~~~~~-~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 224 NGERLP-MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCC-CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 887653 556789999999999999 89999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-35 Score=301.11 Aligned_cols=186 Identities=23% Similarity=0.427 Sum_probs=162.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++.+ ++.+++||||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|||++. .
T Consensus 62 v~~~g~~~~--~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~-~ 136 (258)
T d1k2pa_ 62 VQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVND-Q 136 (258)
T ss_dssp CCEEEEECC--SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECT-T
T ss_pred eeEEEEEee--CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcC-C
Confidence 689998876 6899999999999999999665 457999999999999999999999998 999999999999985 4
Q ss_pred CcEEEEecCchhhhcccCC---ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSHA---ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~~---~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||+++.+..... ....||+.|+|||++. ..|+.++|||||||++|||+| |+.||... +..++..++.
T Consensus 137 ~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~ 215 (258)
T d1k2pa_ 137 GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIA 215 (258)
T ss_dssp CCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHH
T ss_pred CcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHH
Confidence 7999999999987654322 2346899999999987 569999999999999999998 89999874 5677888888
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
.+..+. .+...++++++||.+||+ +|.+|||+.++|+|
T Consensus 216 ~~~~~~-~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 216 QGLRLY-RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCCCC-CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hCCCCC-CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 886654 456788999999999999 89999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=301.85 Aligned_cols=186 Identities=20% Similarity=0.332 Sum_probs=156.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++.. .+.+++|||||.+|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 72 v~~~g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~- 146 (283)
T d1mqba_ 72 IRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN- 146 (283)
T ss_dssp CCEEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-
T ss_pred eeeeEEEec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-
Confidence 689998876 68899999999999999987765 57999999999999999999999999 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+++.+.... .....||+.|||||++. +.|+.++|||||||++|||++|..||....+..++++.+
T Consensus 147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i 226 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226 (283)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence 799999999998765432 12235899999999886 469999999999999999999777766667888899999
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
..|..+. .+...++++++||.+||. +|.+|||+.++++
T Consensus 227 ~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 227 NDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HTTCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hccCCCC-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8887664 345678999999999999 8999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-35 Score=297.52 Aligned_cols=193 Identities=24% Similarity=0.373 Sum_probs=164.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...+++|+|++.|++|..++..++.+++..++.+++|++.||+|||+++ |+||||||+|||++.+ +
T Consensus 64 v~~~~~~~~--~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~ 138 (292)
T d1unla_ 64 VRLHDVLHS--DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-G 138 (292)
T ss_dssp CCEEEEEEC--SSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-C
T ss_pred Eeecccccc--ccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-C
Confidence 679999988 7899999999999999999998999999999999999999999999999 9999999999999855 7
Q ss_pred cEEEEecCchhhhcccC--CccccCCCCccChhhhccc--CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc-
Q 006244 81 EVKIGDLGLAAILRKSH--AARCVGTPEFMAPEVYEEE--YNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS- 155 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~~--~~~~vGTp~YmAPEvl~~~--ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~- 155 (654)
.+||+|||.+....... .....+++.|+|||++... ++.++|||||||++|||++|..||....+..+.+.++..
T Consensus 139 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 218 (292)
T d1unla_ 139 ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_dssp CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHH
T ss_pred ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhh
Confidence 99999999998765432 2334588999999988643 789999999999999999999998776777776666543
Q ss_pred -CCC-------------------------CcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 -GKK-------------------------PEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 -G~~-------------------------p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+.. ........++.+++||.+||+ +|.+||||+|+|+||||+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 111 112233457899999999999 8999999999999999963
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=306.23 Aligned_cols=194 Identities=23% Similarity=0.403 Sum_probs=164.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQG 80 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g 80 (654)
|++|+.|.+ ...+++||||+.||+|.+++...+.+++..++.+++||+.||+|||+++ |+||||||+|||++.+ |
T Consensus 92 v~~~~~~~~--~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~ 166 (322)
T d1vzoa_ 92 VTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-G 166 (322)
T ss_dssp CCEEEEEEE--TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-S
T ss_pred EEeeeeecc--CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-C
Confidence 578998888 7899999999999999999999999999999999999999999999999 9999999999999865 7
Q ss_pred cEEEEecCchhhhccc---CCccccCCCCccChhhhcc---cCCcccchhhhhhHHHHHhhcCCCCCCC---CCHHHHHH
Q 006244 81 EVKIGDLGLAAILRKS---HAARCVGTPEFMAPEVYEE---EYNELVDIYSFGMCILEMVTFDYPYSEC---THPAQIYK 151 (654)
Q Consensus 81 ~VKL~DFGLA~~l~~~---~~~~~vGTp~YmAPEvl~~---~ys~ksDIWSLGiiL~ELlTG~~Pf~~~---~~~~qi~k 151 (654)
.+||+|||+++.+... ......||+.|+|||++.. .++.++|||||||++|+|++|..||... .....+.+
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999866432 2234569999999998863 3788999999999999999999999653 23444555
Q ss_pred HHHcCCCCcccccCCChHHHHHHHHHhh-CccCCC-----CHHHHhcCcccccCCc
Q 006244 152 KVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRL-----SARELLTDPFLQIDDY 201 (654)
Q Consensus 152 ki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~Rp-----Ta~ELL~HPFf~~~~~ 201 (654)
....+..+ ++...++++++||.+||. +|.+|| |++|+|+||||+..++
T Consensus 247 ~~~~~~~~--~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 247 RILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp HHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred hcccCCCC--CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 55554433 445689999999999999 899999 5899999999986544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-35 Score=302.95 Aligned_cols=186 Identities=24% Similarity=0.356 Sum_probs=161.5
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------------RRVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------------~~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|+||+++.+ ++.+++|||||+||+|.+++.+. ..+++..+..++.||+.||.|||+++ |+
T Consensus 74 v~~~~~~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--ii 149 (309)
T d1fvra_ 74 INLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FI 149 (309)
T ss_dssp CCEEEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred eeEEEEEec--CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--cc
Confidence 689999988 78999999999999999999764 56999999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccCCc-cccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCC-CCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAA-RCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDY-PYS 141 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~~-~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~-Pf~ 141 (654)
||||||+|||++.+ +.+||+|||+++........ ...||+.|+|||.+. +.|+.++|||||||++|||++|.. ||.
T Consensus 150 HrDlkp~NIL~~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 150 HRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccccceEEEcCC-CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999999999855 79999999999876544333 446999999999886 469999999999999999999765 565
Q ss_pred CCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 142 ECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 142 ~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+ .+..+++..+..|..+. .+...++++++||.+||. +|++|||+.+++++
T Consensus 229 ~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 229 G-MTCAELYEKLPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp T-CCHHHHHHHGGGTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCHHHHHHHHHhcCCCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4 67888888888887664 445678999999999999 89999999999976
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-35 Score=300.22 Aligned_cols=185 Identities=24% Similarity=0.413 Sum_probs=162.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeE
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR----------------RVNIRAVKHWCRQILSGLLYLHSRDPPVI 64 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~----------------~Lse~~i~~i~~QIl~gL~YLHs~~p~II 64 (654)
|+||+.|.+ ++.+++|||||.+|+|.+++...+ .+++..++.|+.||+.||+|||+++ |+
T Consensus 82 v~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--iv 157 (299)
T d1fgka_ 82 INLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CI 157 (299)
T ss_dssp CCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred Eeccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EE
Confidence 689999977 688999999999999999997653 4899999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCC
Q 006244 65 HRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDY 138 (654)
Q Consensus 65 HRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~ 138 (654)
||||||+|||++.+ +.+||+|||+++...... .....||+.|+|||++. +.|+.++||||||+++|||++ |.+
T Consensus 158 HrDiKp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~ 236 (299)
T d1fgka_ 158 HRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236 (299)
T ss_dssp CSCCSGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred eeeecccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence 99999999999854 799999999998775432 23356899999999886 569999999999999999998 678
Q ss_pred CCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 139 PYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 139 Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
||.+ .+..+++..+..|..+. .+...++++++||.+||+ +|.+|||+.||++
T Consensus 237 p~~~-~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 237 PYPG-VPVEELFKLLKEGHRMD-KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp SSTT-CCHHHHHHHHHTTCCCC-CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8865 66788888888887664 456788999999999999 8999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-35 Score=305.76 Aligned_cols=193 Identities=27% Similarity=0.424 Sum_probs=156.6
Q ss_pred CEEEEEEEecC----CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTA----NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~----~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|++|++|.... ..++||||||| |++|..+++ ++++++..++.+++||+.||+|||+++ |+||||||+|||++
T Consensus 80 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~ 155 (346)
T d1cm8a_ 80 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN 155 (346)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC
T ss_pred eEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc
Confidence 57888887642 24789999999 778888765 457999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+||+|||+|+..... ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+.....
T Consensus 156 ~~-~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 156 ED-CELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp TT-CCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cc-cccccccccceeccCCc-cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 55 79999999999876543 345679999999998864 478999999999999999999999987544333322111
Q ss_pred -cCCCC---------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 155 -SGKKP---------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 155 -~G~~p---------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
.+..| .......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 11111 12234568999999999999 99999999999999999743
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-35 Score=300.06 Aligned_cols=191 Identities=20% Similarity=0.318 Sum_probs=159.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLK--HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k--~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|+||+++.+ +.+++|||||.+|+|..++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 75 v~~~g~~~~---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~ 149 (285)
T d1fmka3 75 VQLYAVVSE---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN 149 (285)
T ss_dssp CCEEEEECS---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred eEEEEEEec---CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC
Confidence 689998743 568999999999999998754 357999999999999999999999999 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccC---CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 79 QGEVKIGDLGLAAILRKSH---AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~---~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
+.+||+|||+++...... .....||+.|+|||++. +.++.++||||||+++|||+||..||....+..++...+.
T Consensus 150 -~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~ 228 (285)
T d1fmka3 150 -LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228 (285)
T ss_dssp -GCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred -CcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999998764332 23356999999999886 4699999999999999999998777766677888888888
Q ss_pred cCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc--Cccccc
Q 006244 155 SGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT--DPFLQI 198 (654)
Q Consensus 155 ~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~--HPFf~~ 198 (654)
.+..+. .+...++++++||.+||. +|.+||++.+|+. ++||..
T Consensus 229 ~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hcCCCC-CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 876554 456788999999999999 8999999999987 778853
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=301.74 Aligned_cols=186 Identities=26% Similarity=0.444 Sum_probs=158.6
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+++.+ ...++|+||+.+|+|.+++..+ ..+++..+..|+.||+.||+|||+++ |+||||||+|||++.+
T Consensus 74 v~l~g~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~- 147 (317)
T d1xkka_ 74 CRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP- 147 (317)
T ss_dssp CCEEEEEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-
T ss_pred eeEEEEEec---CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-
Confidence 689999875 5678999999999999988765 57999999999999999999999998 9999999999999855
Q ss_pred CcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKV 153 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki 153 (654)
+.+||+|||+|+.+.... .....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+ .+..++...+
T Consensus 148 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i 226 (317)
T d1xkka_ 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSIL 226 (317)
T ss_dssp TEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHH
T ss_pred CCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHH
Confidence 799999999998875432 22345899999999876 469999999999999999999 7888876 4566778888
Q ss_pred HcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCc
Q 006244 154 ISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDP 194 (654)
Q Consensus 154 ~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HP 194 (654)
..|..+. .+...++++++||.+||. +|.+|||+.+++.|.
T Consensus 227 ~~~~~~~-~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 227 EKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHTCCCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCC-CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8887654 345678999999999999 899999999999884
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-34 Score=301.44 Aligned_cols=194 Identities=25% Similarity=0.374 Sum_probs=152.3
Q ss_pred CEEEEEEEecC---CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDTA---NRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~~---~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|+.+.... ...++|++ |+.||+|.+++..+ ++++..++.++.||+.||+|||+++ ||||||||+|||++.
T Consensus 69 v~~~~~~~~~~~~~~~~~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 69 IGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNT 144 (345)
T ss_dssp CCCCEEECCSSTTTCCCEEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT
T ss_pred CcEEEEEeeccccccceEEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECC
Confidence 56788876532 23455655 55699999998764 6999999999999999999999999 999999999999984
Q ss_pred CCCcEEEEecCchhhhccc-----CCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHH
Q 006244 78 NQGEVKIGDLGLAAILRKS-----HAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIY 150 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~-----~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~ 150 (654)
.|.+||+|||++...... .....+||+.|+|||++.. .|+.++||||+||++|+|++|.+||..........
T Consensus 145 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~ 223 (345)
T d1pmea_ 145 -TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223 (345)
T ss_dssp -TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred -CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH
Confidence 489999999999765432 2344579999999998853 47899999999999999999999998754333332
Q ss_pred HHHHcCCCC----------------------------cccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCcccccC
Q 006244 151 KKVISGKKP----------------------------EALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQID 199 (654)
Q Consensus 151 kki~~G~~p----------------------------~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~~ 199 (654)
..+.....+ .......++++++||.+||. +|.+||||.|+|+||||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 222110000 11234567899999999999 99999999999999999744
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-34 Score=295.06 Aligned_cols=185 Identities=21% Similarity=0.315 Sum_probs=158.9
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHH
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------------RVNIRAVKHWCRQILSGLLYL 56 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~------------------------~Lse~~i~~i~~QIl~gL~YL 56 (654)
|++|++|.. ...+++||||+.+|+|.+++.... .+++..+..++.||+.||+||
T Consensus 79 v~~~~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl 156 (301)
T d1lufa_ 79 VKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156 (301)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccceeeecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc
Confidence 578998876 689999999999999999997532 389999999999999999999
Q ss_pred HhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhcc-cCCcccchhhhhhHHH
Q 006244 57 HSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCIL 131 (654)
Q Consensus 57 Hs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ 131 (654)
|+++ ||||||||+|||++.+ +.+||+|||+|+.+.... .....||+.|||||++.+ .|+.++|||||||++|
T Consensus 157 H~~~--ivHrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 157 SERK--FVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp HHTT--CCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ccCC--eEeeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence 9999 9999999999999855 799999999998764432 223468899999998875 5999999999999999
Q ss_pred HHhhcC-CCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 132 EMVTFD-YPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 132 ELlTG~-~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
||++|. +||.+ .+..++...+..+..+. .+...++++.+||.+||. +|.+|||+.||++
T Consensus 234 ell~~~~~p~~~-~~~~e~~~~v~~~~~~~-~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 234 EIFSYGLQPYYG-MAHEEVIYYVRDGNILA-CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHTTTCCTTTT-SCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999986 56665 67788888899888654 456678999999999999 8999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-34 Score=292.77 Aligned_cols=185 Identities=24% Similarity=0.355 Sum_probs=155.1
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|++|+.+.+ ..+++|||||.+|+|.+++..+ +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 74 v~~~g~~~~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~- 147 (273)
T d1u46a_ 74 IRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR- 147 (273)
T ss_dssp CCEEEEECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-
T ss_pred EEEEEEEee---cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-
Confidence 689998854 4789999999999999987654 56999999999999999999999999 9999999999999865
Q ss_pred CcEEEEecCchhhhcccC-----CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH-----AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~-----~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||+++.+.... .....||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+ .+..++..+
T Consensus 148 ~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~ 226 (273)
T d1u46a_ 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHK 226 (273)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHH
T ss_pred cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHH
Confidence 799999999998764432 223357889999998874 58999999999999999998 8999987 556666677
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+.........+...++++++||.+||. +|.+|||+.+|++
T Consensus 227 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 766544444556788999999999999 8999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=292.20 Aligned_cols=186 Identities=20% Similarity=0.353 Sum_probs=153.2
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR--RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGN 78 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~--~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~ 78 (654)
|++|+++.+. ++.++|||||+++|+|.+|+.+.+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 63 v~~~g~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~ 139 (262)
T d1byga_ 63 VQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED 139 (262)
T ss_dssp CCEEEEECCC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred eeEEEEEEec-CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC
Confidence 6899988763 356899999999999999987643 5999999999999999999999998 9999999999999854
Q ss_pred CCcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-cCCCCCCCCCHHHHHHHHHcC
Q 006244 79 QGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-FDYPYSECTHPAQIYKKVISG 156 (654)
Q Consensus 79 ~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G~~Pf~~~~~~~qi~kki~~G 156 (654)
|.+||+|||+++..... .....+|+.|+|||++. +.|+.++|||||||++|||+| |.+||.. .+..+++..+..+
T Consensus 140 -~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~ 216 (262)
T d1byga_ 140 -NVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKG 216 (262)
T ss_dssp -SCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTT
T ss_pred -CCEeecccccceecCCC-CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcC
Confidence 79999999999876543 33456899999999886 569999999999999999998 6777765 5677888888888
Q ss_pred CCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 157 KKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 157 ~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
..+. ++...++++++||.+||. +|.+|||+.+|+++
T Consensus 217 ~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 YKMD-APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 7775 456688999999999999 89999999999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-34 Score=294.74 Aligned_cols=186 Identities=21% Similarity=0.350 Sum_probs=158.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR------------------RVNIRAVKHWCRQILSGLLYLHSRDPP 62 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~------------------~Lse~~i~~i~~QIl~gL~YLHs~~p~ 62 (654)
|+||+.+.+ ++.++||||||.+|+|.+++.+.. .+++..+..|+.||+.||+|||+++
T Consensus 90 v~~~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~-- 165 (311)
T d1t46a_ 90 VNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN-- 165 (311)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEEEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 689999876 678999999999999999998654 5899999999999999999999999
Q ss_pred eEecCCCCCcEEEeCCCCcEEEEecCchhhhcccCC----ccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhh-c
Q 006244 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA----ARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVT-F 136 (654)
Q Consensus 63 IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~~~~----~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlT-G 136 (654)
|+||||||+|||++.+ +.+||+|||+++....... ....||+.|+|||++. +.++.++||||||+++|||+| |
T Consensus 166 ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g 244 (311)
T d1t46a_ 166 CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (311)
T ss_dssp CCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eeeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence 9999999999999854 7999999999987654322 2346899999999887 458999999999999999999 5
Q ss_pred CCCCCCCCCHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 137 DYPYSECTHPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 137 ~~Pf~~~~~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
.+||........+.+.+..+..+. .+...++++++||.+||. +|.+|||+.+||+
T Consensus 245 ~p~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 245 SSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 666666555566666666666554 445678999999999999 8999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=293.64 Aligned_cols=188 Identities=20% Similarity=0.307 Sum_probs=158.0
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH-RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQ 79 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~-~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~ 79 (654)
|+||+++... ++.+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 91 v~~~g~~~~~-~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~- 166 (311)
T d1r0pa_ 91 LSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK- 166 (311)
T ss_dssp CCCCEEEEET-TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-
T ss_pred eEEeEEEEec-CCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-
Confidence 6789988763 46899999999999999998754 45888899999999999999999998 9999999999999854
Q ss_pred CcEEEEecCchhhhcccC------CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKK 152 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kk 152 (654)
+.+||+|||+++.+.... .....||+.|+|||++. +.++.++||||||+++|||+||..||....+..++...
T Consensus 167 ~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~ 246 (311)
T d1r0pa_ 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246 (311)
T ss_dssp CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH
T ss_pred CCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 799999999998764332 22346899999999876 56999999999999999999988888776677778888
Q ss_pred HHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 153 VISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 153 i~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
+..|..+. .+...++++.+||.+||. +|.+||++.|++++
T Consensus 247 i~~g~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 247 LLQGRRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCC-CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 88887664 445678999999999999 89999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-34 Score=297.07 Aligned_cols=192 Identities=27% Similarity=0.395 Sum_probs=149.3
Q ss_pred CEEEEEEEec---CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC
Q 006244 1 MKFYTSWVDT---ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG 77 (654)
Q Consensus 1 VkfY~sfvd~---~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~ 77 (654)
|++|+.|... .....++|++|+.||+|.+++.. +++++..++.+++||+.||.|||+++ |+||||||+|||++.
T Consensus 80 v~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNE 156 (348)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred eeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccc
Confidence 4677777642 12345566677789999998754 57999999999999999999999999 999999999999985
Q ss_pred CCCcEEEEecCchhhhcccCCccccCCCCccChhhhcc--cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHHc
Q 006244 78 NQGEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYEE--EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVIS 155 (654)
Q Consensus 78 ~~g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~~--~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~~ 155 (654)
+ |.+|++|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.. .......+..
T Consensus 157 ~-~~~kl~dfg~a~~~~~~-~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-~~~~~~~i~~ 233 (348)
T d2gfsa1 157 D-CELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-HIDQLKLILR 233 (348)
T ss_dssp T-CCEEECCC----CCTGG-GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHH
T ss_pred c-ccccccccchhcccCcc-cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHH
Confidence 5 89999999999776443 334569999999998764 36889999999999999999999998743 3333333322
Q ss_pred --CCCCc---------------------------ccccCCChHHHHHHHHHhh-CccCCCCHHHHhcCccccc
Q 006244 156 --GKKPE---------------------------ALFKVEDPEVRQFIEKCLA-TVSSRLSARELLTDPFLQI 198 (654)
Q Consensus 156 --G~~p~---------------------------~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~HPFf~~ 198 (654)
+..+. ......++++++||.+||. +|.+||||.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 11110 1123568899999999999 9999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-33 Score=287.99 Aligned_cols=185 Identities=21% Similarity=0.379 Sum_probs=159.3
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCC
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKH----------RRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKC 70 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~----------~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKp 70 (654)
|++|+.+.. +..+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||
T Consensus 86 v~~~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~ 161 (308)
T d1p4oa_ 86 VRLLGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAA 161 (308)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSG
T ss_pred eeeeeEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcC
Confidence 678998865 67899999999999999998753 24789999999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEEecCchhhhcccC----CccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcC-CCCCCCC
Q 006244 71 DNIFVNGNQGEVKIGDLGLAAILRKSH----AARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFD-YPYSECT 144 (654)
Q Consensus 71 eNILId~~~g~VKL~DFGLA~~l~~~~----~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~-~Pf~~~~ 144 (654)
+|||++.+ +.+||+|||+++.+.... .....||+.|+|||.+. +.++.++||||||+++|||+||. +||.+ .
T Consensus 162 ~NiLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-~ 239 (308)
T d1p4oa_ 162 RNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-L 239 (308)
T ss_dssp GGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-S
T ss_pred CceeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-C
Confidence 99999855 799999999998765432 23346899999999886 45899999999999999999985 66765 6
Q ss_pred CHHHHHHHHHcCCCCcccccCCChHHHHHHHHHhh-CccCCCCHHHHhc
Q 006244 145 HPAQIYKKVISGKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELLT 192 (654)
Q Consensus 145 ~~~qi~kki~~G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL~ 192 (654)
+..+++..+..+..+. .+...++.+.++|.+||+ +|.+|||+.+|++
T Consensus 240 ~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 240 SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7788888888887654 345678999999999999 8999999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-33 Score=296.98 Aligned_cols=191 Identities=27% Similarity=0.403 Sum_probs=143.0
Q ss_pred CEEEEEEEec----CCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDT----ANRNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~----~~~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId 76 (654)
|+||++|... ...++|+|||||.||.+. .+ .+.+++..++.+++||+.||.|||+++ |+||||||+|||++
T Consensus 79 v~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK 153 (355)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred eEEEEEEecccccccCceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc
Confidence 5788888653 247999999999765554 33 457999999999999999999999999 99999999999998
Q ss_pred CCCCcEEEEecCchhhhcccC-CccccCCCCccChhhhcc-cCCcccchhhhhhHHHHHhhcCCCCCCCCCHHHHHHHHH
Q 006244 77 GNQGEVKIGDLGLAAILRKSH-AARCVGTPEFMAPEVYEE-EYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVI 154 (654)
Q Consensus 77 ~~~g~VKL~DFGLA~~l~~~~-~~~~vGTp~YmAPEvl~~-~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi~kki~ 154 (654)
.+ +.+|++|||+++...... ....+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+ ......++.
T Consensus 154 ~~-~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~-~~~~~~~i~ 231 (355)
T d2b1pa1 154 SD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-YIDQWNKVI 231 (355)
T ss_dssp TT-CCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH
T ss_pred cc-cceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC-HHHHHHHHH
Confidence 55 789999999988765543 344569999999999875 58999999999999999999999998743 333333222
Q ss_pred c----------------------CCCCc-----------cc-------ccCCChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 155 S----------------------GKKPE-----------AL-------FKVEDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 155 ~----------------------G~~p~-----------~l-------~~~~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
. +..+. .. ....++++++||.+||. +|.+||||+|||+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1 11000 00 01135678999999999 99999999999999
Q ss_pred ccccc
Q 006244 194 PFLQI 198 (654)
Q Consensus 194 PFf~~ 198 (654)
|||+.
T Consensus 312 pw~~~ 316 (355)
T d2b1pa1 312 PYINV 316 (355)
T ss_dssp TTTGG
T ss_pred cccCC
Confidence 99985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.3e-32 Score=278.96 Aligned_cols=190 Identities=20% Similarity=0.276 Sum_probs=146.4
Q ss_pred EEEEEEecCCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CC
Q 006244 3 FYTSWVDTANRNINFVTEMFTSGTLRQYRLK-HRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG--NQ 79 (654)
Q Consensus 3 fY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k-~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~--~~ 79 (654)
++..+.. +..+++||||+ +|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++. ..
T Consensus 68 ~~~~~~~--~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~ 142 (299)
T d1ckia_ 68 IRWCGAE--GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG 142 (299)
T ss_dssp EEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGT
T ss_pred EEEEEec--CCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCC
Confidence 4444444 78999999999 5666666554 567999999999999999999999999 999999999999863 33
Q ss_pred CcEEEEecCchhhhcccC---------CccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCCCCHHHH
Q 006244 80 GEVKIGDLGLAAILRKSH---------AARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSECTHPAQI 149 (654)
Q Consensus 80 g~VKL~DFGLA~~l~~~~---------~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~~qi 149 (654)
..+||+|||+|+.+.... ....+||+.|||||++.+. |+.++|||||||++|||+||..||.........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 579999999998765321 2345799999999998764 999999999999999999999999764432221
Q ss_pred --HHHHHc---CCCCcccccCCChHHHHHHHHHhh-CccCCCCHHH---HhcCcccc
Q 006244 150 --YKKVIS---GKKPEALFKVEDPEVRQFIEKCLA-TVSSRLSARE---LLTDPFLQ 197 (654)
Q Consensus 150 --~kki~~---G~~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~E---LL~HPFf~ 197 (654)
+.+... ...+.......++++.+||.+||. +|.+||++.+ +|+|+|.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 223 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp --HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111111 112223445678999999999999 8999999874 56777653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-32 Score=283.01 Aligned_cols=191 Identities=25% Similarity=0.347 Sum_probs=147.2
Q ss_pred CEEEEEEEecCC--CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCc
Q 006244 1 MKFYTSWVDTAN--RNINFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSR------DPPVIHRDLKCDN 72 (654)
Q Consensus 1 VkfY~sfvd~~~--~~i~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~------~p~IIHRDLKpeN 72 (654)
|+||+++..... ..+|||||||++|+|.+++++. .+++..+..++.|++.||.|||+. .++|+||||||+|
T Consensus 60 v~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~N 138 (303)
T d1vjya_ 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGG
T ss_pred cceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccc
Confidence 689999987543 3789999999999999999875 699999999999999999999974 1249999999999
Q ss_pred EEEeCCCCcEEEEecCchhhhcccC------CccccCCCCccChhhhccc-------CCcccchhhhhhHHHHHhhcCCC
Q 006244 73 IFVNGNQGEVKIGDLGLAAILRKSH------AARCVGTPEFMAPEVYEEE-------YNELVDIYSFGMCILEMVTFDYP 139 (654)
Q Consensus 73 ILId~~~g~VKL~DFGLA~~l~~~~------~~~~vGTp~YmAPEvl~~~-------ys~ksDIWSLGiiL~ELlTG~~P 139 (654)
|||+.+ +.+||+|||+++...... ....+||+.|||||++... ++.++|||||||++|||+||..|
T Consensus 139 ILl~~~-~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~ 217 (303)
T d1vjya_ 139 ILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp EEECTT-SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred eEEcCC-CCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCC
Confidence 999855 899999999998764422 2345799999999998642 67789999999999999999887
Q ss_pred CCCC--------------CCHHHHHHHHHcCCCCcccccC-----CChHHHHHHHHHhh-CccCCCCHHHHhcC
Q 006244 140 YSEC--------------THPAQIYKKVISGKKPEALFKV-----EDPEVRQFIEKCLA-TVSSRLSARELLTD 193 (654)
Q Consensus 140 f~~~--------------~~~~qi~kki~~G~~p~~l~~~-----~spelrdLI~kCL~-dP~~RpTa~ELL~H 193 (654)
|... .....+...+..+.....++.. ....+.+|+.+||+ +|.+|||+.||+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 6321 1233344444333321111111 12358899999999 89999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.97 E-value=4.8e-31 Score=270.91 Aligned_cols=186 Identities=15% Similarity=0.221 Sum_probs=151.8
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLRQYRLKHR-RVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNG-- 77 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~~~l~k~~-~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~-- 77 (654)
+++|+++.. +...++||||+ +|+|.+++...+ .++...+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 64 ~~~~~~~~~--~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~ 138 (293)
T d1csna_ 64 PNVYYFGQE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPN 138 (293)
T ss_dssp CCEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSS
T ss_pred CEEEEEeec--CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcc
Confidence 357777776 78999999999 789999987754 6999999999999999999999999 999999999999964
Q ss_pred --CCCcEEEEecCchhhhccc---------CCccccCCCCccChhhhccc-CCcccchhhhhhHHHHHhhcCCCCCCC--
Q 006244 78 --NQGEVKIGDLGLAAILRKS---------HAARCVGTPEFMAPEVYEEE-YNELVDIYSFGMCILEMVTFDYPYSEC-- 143 (654)
Q Consensus 78 --~~g~VKL~DFGLA~~l~~~---------~~~~~vGTp~YmAPEvl~~~-ys~ksDIWSLGiiL~ELlTG~~Pf~~~-- 143 (654)
..+.+||+|||+|+.+... .....+|||.|||||++.+. |+.++||||||+++|||+||..||...
T Consensus 139 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 2468999999999876432 12345799999999998754 999999999999999999999999753
Q ss_pred CCHHHHHHHHHcCC---CCcccccCCChHHHHHHHHHhh-CccCCCCHHHHh
Q 006244 144 THPAQIYKKVISGK---KPEALFKVEDPEVRQFIEKCLA-TVSSRLSARELL 191 (654)
Q Consensus 144 ~~~~qi~kki~~G~---~p~~l~~~~spelrdLI~kCL~-dP~~RpTa~ELL 191 (654)
.+....+.++.... .+..+.+..++++.+++..|+. +|.+||+++.+.
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp CCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred hhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 23444444443322 2233445678999999999999 899999987664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=6e-30 Score=267.10 Aligned_cols=195 Identities=25% Similarity=0.376 Sum_probs=144.4
Q ss_pred CEEEEEEEecCCCeEEEEEecCCCCCHH-HHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEe
Q 006244 1 MKFYTSWVDTANRNINFVTEMFTSGTLR-QYRL--KHRRVNIRAVKHWCRQILSGLLYLHS-RDPPVIHRDLKCDNIFVN 76 (654)
Q Consensus 1 VkfY~sfvd~~~~~i~LVtEy~~gGSL~-~~l~--k~~~Lse~~i~~i~~QIl~gL~YLHs-~~p~IIHRDLKpeNILId 76 (654)
|++|++|........++|++++..+... .+.. ....+++..++.+++||+.||.|||+ .+ |+||||||+|||++
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLME 160 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeee
Confidence 5678888765567777777777665433 3222 24579999999999999999999998 77 99999999999997
Q ss_pred CCC-----CcEEEEecCchhhhcccCCccccCCCCccChhhhc-ccCCcccchhhhhhHHHHHhhcCCCCCCCCCH----
Q 006244 77 GNQ-----GEVKIGDLGLAAILRKSHAARCVGTPEFMAPEVYE-EEYNELVDIYSFGMCILEMVTFDYPYSECTHP---- 146 (654)
Q Consensus 77 ~~~-----g~VKL~DFGLA~~l~~~~~~~~vGTp~YmAPEvl~-~~ys~ksDIWSLGiiL~ELlTG~~Pf~~~~~~---- 146 (654)
.+. ..++++|||.+...... ....+||+.|+|||++. ..|+.++||||+||++++|++|..||......
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccCcccccceeeEeecccccccccc-cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 432 14899999999866543 34567999999999886 45999999999999999999999999643211
Q ss_pred --HHHHHHH-HcCCCCc--------------------------------------ccccCCChHHHHHHHHHhh-CccCC
Q 006244 147 --AQIYKKV-ISGKKPE--------------------------------------ALFKVEDPEVRQFIEKCLA-TVSSR 184 (654)
Q Consensus 147 --~qi~kki-~~G~~p~--------------------------------------~l~~~~spelrdLI~kCL~-dP~~R 184 (654)
..+...+ .-|..|. ......++++++||.+||. +|.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 1111111 0011100 0111235789999999999 99999
Q ss_pred CCHHHHhcCccccc
Q 006244 185 LSARELLTDPFLQI 198 (654)
Q Consensus 185 pTa~ELL~HPFf~~ 198 (654)
|||+|+|+||||+.
T Consensus 320 pta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 320 ADAGGLVNHPWLKD 333 (362)
T ss_dssp BCHHHHHTCGGGTT
T ss_pred cCHHHHhcCcccCC
Confidence 99999999999983
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.39 E-value=1.8e-14 Score=137.04 Aligned_cols=96 Identities=19% Similarity=0.205 Sum_probs=73.3
Q ss_pred EEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEEecCchhhhcc
Q 006244 16 NFVTEMFTSGTLRQYRLKHRRVNIRAVKHWCRQILSGLLYLHSRDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRK 95 (654)
Q Consensus 16 ~LVtEy~~gGSL~~~l~k~~~Lse~~i~~i~~QIl~gL~YLHs~~p~IIHRDLKpeNILId~~~g~VKL~DFGLA~~l~~ 95 (654)
+|||||+.++.+.+ ++...+..++.||+.||.|||+++ |+||||||+|||++. +.++|+|||+|.....
T Consensus 86 ~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~--~~~~liDFG~a~~~~~ 154 (191)
T d1zara2 86 AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGE 154 (191)
T ss_dssp EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEET--TEEEECCCTTCEETTS
T ss_pred EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeC--CCEEEEECCCcccCCC
Confidence 69999998866543 455667889999999999999999 999999999999984 3699999999876543
Q ss_pred cCCccccCCCCccC------hhhhcccCCcccchhhhhh
Q 006244 96 SHAARCVGTPEFMA------PEVYEEEYNELVDIYSFGM 128 (654)
Q Consensus 96 ~~~~~~vGTp~YmA------PEvl~~~ys~ksDIWSLGi 128 (654)
+... .|.. .+.+.+.|+..+|+||+.-
T Consensus 155 ~~~~------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 155 EGWR------EILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp TTHH------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred CCcH------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 2211 1111 1334567899999999743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=95.73 E-value=0.012 Score=55.66 Aligned_cols=29 Identities=34% Similarity=0.362 Sum_probs=23.1
Q ss_pred eEecCCCCCcEEEeCCCCcEEEEecCchhh
Q 006244 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 92 (654)
Q Consensus 63 IIHRDLKpeNILId~~~g~VKL~DFGLA~~ 92 (654)
++|+|+.|.|||++.+ +.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDG-KVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCC-ceEEEeechhccc
Confidence 7999999999999843 3456999987643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.69 E-value=0.033 Score=52.12 Aligned_cols=28 Identities=29% Similarity=0.207 Sum_probs=23.0
Q ss_pred eEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 63 VIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 63 IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
++|+|+.|.|||++.+ +.+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~-~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENG-RFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCC-ceEEEEEchhcc
Confidence 7999999999999843 346799998664
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=91.44 E-value=0.093 Score=53.46 Aligned_cols=28 Identities=36% Similarity=0.503 Sum_probs=23.8
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
.++|+|+.+.|||++.+ .++|+||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~--~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH--ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS--CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC--ceEEechhhcc
Confidence 49999999999999744 59999997664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=84.44 E-value=0.16 Score=49.30 Aligned_cols=29 Identities=38% Similarity=0.448 Sum_probs=24.1
Q ss_pred CeEecCCCCCcEEEeCCCCcEEEEecCchh
Q 006244 62 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 91 (654)
Q Consensus 62 ~IIHRDLKpeNILId~~~g~VKL~DFGLA~ 91 (654)
++||+|+.++||+++++ +..-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccc-cceeEecccccc
Confidence 49999999999999854 345799999764
|